PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ma, SJ; Dong, ZZ; Huang, YF; Liu, JY; Zhang, JT				Ma, Shijie; Dong, Zizheng; Huang, Yanfei; Liu, Jing-Yuan; Zhang, Jian-Ting			Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE AMPK; CANCER; PHOSPHORYLATION; LKB1; GROWTH; TRANSFORMATION; MECHANISMS; SUPPRESSOR; EXPRESSION; UPSTREAM	Eukaryotic translation initiation factor 3 subunit A (eIF3a), the largest subunit of the eIF3 complex, has been shown to be overexpressed in malignant cancer cells, potentially making it a proto-oncogene. eIF3a overexpression can drive cancer cell proliferation but contributes to better prognosis. While its contribution to prognosis was previously shown to be due to its function in suppressing synthesis of DNA damage repair proteins, it remains unclear how eIF3a regulates cancer cell proliferation. In this study, we show using genetic approaches that eIF3a controls cell proliferation by regulating glucose metabolism via the phosphorylation and activation of AMP activated protein kinase alpha (AMPK alpha) at Thr(172) in its kinase activation loop. We demonstrate that eIF3a regulates AMPK activation mainly by controlling synthesis of the small GTPase Rheb, largely independent of the well-known AMPK upstream liver kinase B1 and Ca2+/calmodulin-dependent protein kinase kinase 2, and also independent of mammalian target of rapamycin signaling and glucose levels. Our findings suggest that glucose metabolism in and proliferation of cancer cells may be translationally regulated via a novel eIF3a-Rheb- AMPK signaling axis.	[Ma, Shijie; Dong, Zizheng; Zhang, Jian-Ting] Univ Toledo, Dept Cell & Canc Biol, Coll Med & Life Sci, Toledo, OH 43614 USA; [Huang, Yanfei; Liu, Jing-Yuan] Univ Toledo, Dept Med, Coll Med & Life Sci, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, JT (corresponding author), Univ Toledo, Dept Cell & Canc Biol, Coll Med & Life Sci, Toledo, OH 43614 USA.	jianting.zhang@utoledo.edu	huang, yan/GWM-4747-2022		National Institutes of Health [R01 CA211904]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health grant (grant no.: R01 CA211904) .	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2020, BIOCHEM J, V477, P1939, DOI 10.1042/BCJ20200025; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Eichner LJ, 2019, CELL METAB, V29, P285, DOI 10.1016/j.cmet.2018.10.005; Eom M, 2008, PATHOL INT, V58, P226, DOI 10.1111/j.1440-1827.2008.02215.x; Fang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11662-3; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hindupur SK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0420-z; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laderoute KR, 2014, J BIOL CHEM, V289, P22850, DOI 10.1074/jbc.M114.576371; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Langendorf CG, 2020, J BIOL CHEM, V295, P16239, DOI 10.1074/jbc.RA120.013756; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ma SJ, 2022, ONCOGENE, V41, P2431, DOI 10.1038/s41388-022-02262-5; Martinez-Ordonez A, 2021, ONCOGENE, V40, P2725, DOI 10.1038/s41388-021-01740-6; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Qi J, 2016, CANCER RES, V76, P453, DOI 10.1158/0008-5472.CAN-15-1874; Rios M, 2014, EUR J CANCER, V50, P3187, DOI 10.1016/j.ejca.2014.09.014; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tumia R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00753; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yin JY, 2018, CANCER LETT, V412, P81, DOI 10.1016/j.canlet.2017.09.055; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	75	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102044	10.1016/j.jbc.2022.102044	http://dx.doi.org/10.1016/j.jbc.2022.102044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35595099	Green Published, gold			2022-12-26	WOS:000829549100009
J	Chen, JY; Wang, J; Hart, DA; Ahmed, AS; Ackermann, PW				Chen, Junyu; Wang, Jin; Hart, David A.; Ahmed, Aisha S.; Ackermann, Paul W.			Complement factor D as a predictor of Achilles tendon healing and long-term patient outcomes	FASEB JOURNAL			English	Article						Achilles tendon rupture; complement factor D; mass spectrometry; patient-reported; functional outcome; predictive biomarker; prognostic	EXPRESSION; MICRODIALYSIS; REPAIR; SECRETION; TISSUE; CELL	Dense connective tissue healing, such as tendon, is protracted leading to highly variable and unsatisfactory patient outcomes. Biomarkers prognostic of long-term clinical outcomes is, however, unknown. The present study was designed to investigate the proteomic profile of healing, identify potential biomarkers, and assess their association with the patient's long-term outcomes after ATR. Quantitative mass spectrometry analysis demonstrated 1423 proteins in healing and contralateral healthy Achilles tendons of 28 ATR patients. Comparing healing at 2 weeks and healthy protein profiles, we identified 821 overlapping, 390 upregulated, and 17 downregulated proteins. Upregulated proteins are related mainly to extracellular matrix organization and metabolism, while downregulated pathways were associated with exocytosis in immune modulation and thrombosis formation. Further proteomic profiling in relation to validated patient outcomes revealed the downregulated pro-inflammatory complement factor D (CFD) as the most reliable predictive biomarker of successful tendon healing. Our finding showed a comprehensive proteomic landscape and bioinformatics on human connective tissue, indicating subtype-specific and shared biological processes and proteins in healing and healthy Achilles tendons, as well as in tendons related to good and poor patient outcomes. Inflammatory protein CFD and serpin family B member 1 were finally identified as potential predictive biomarkers of effective healing outcomes when combined the proteomic profiles with a validated clinical database. Following the future elucidation of the mechanisms associated with the identified biomarkers as predictors of good outcomes, our findings could lead to improved prognostic accuracy and development of targeted treatments, thus improving the long-term healing outcomes for all patients.	[Chen, Junyu; Ahmed, Aisha S.; Ackermann, Paul W.] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Wang, Jin] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Key Lab Tumor Mol Diag & Individualized Med Zheji, Hangzhou, Peoples R China; [Wang, Jin] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	Karolinska Institutet; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Xi'an Jiaotong University; University of Calgary	Chen, JY; Ackermann, PW (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	junyu.chen@ki.se; paul.ackermann@ki.se			Swedish National Centre for Sports Research [2019-0079, 2020-0019]; Swedish Rheumatism Association [R-931941, R-940565]; King Gustav V Foundation [FAI-2018-0524, FAI-2019-0611]; Swedish Research Council [2017-00202, SLL20180348]	Swedish National Centre for Sports Research; Swedish Rheumatism Association; King Gustav V Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Swedish National Centre for Sports Research (2019-0079; 2020-0019), Swedish Rheumatism Association (R-931941; R-940565), and King Gustav V Foundation (FAI-2018-0524; FAI-2019-0611) to ASA. The Swedish Research Council (2017-00202) and the regional agreement on medical training and clinical research (ALF; SLL20180348) to PWA.	Ackermann PW, 2013, KNEE SURG SPORT TR A, V21, P1801, DOI 10.1007/s00167-012-2197-x; Alim MA, 2018, KNEE SURG SPORT TR A, V26, P2021, DOI 10.1007/s00167-017-4621-8; Alim MA., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2016-000114, DOI 10.1136/BMJSEM-2016-000114]; BALKE N, 1995, FEBS LETT, V371, P300, DOI 10.1016/0014-5793(95)00926-Z; Baraldo M, 2021, FASEB J, V35, DOI 10.1096/fj.202101054RR; Barratt J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.712572; Benarafa C, 2011, J LEUKOCYTE BIOL, V90, P21, DOI 10.1189/jlb.0810461; Bennet D, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.461; Bostick GP, 2010, J ORTHOP SPORT PHYS, V40, P345, DOI 10.2519/jospt.2010.3204; Dams OC, 2020, KNEE SURG SPORT TR A, V28, P3330, DOI 10.1007/s00167-020-05924-7; de la Pena A, 2000, ADV DRUG DELIVER REV, V45, P189, DOI 10.1016/S0169-409X(00)00106-X; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Ezure T, 2019, BIOFACTORS, V45, P556, DOI 10.1002/biof.1512; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Greve K, 2012, SCAND J MED SCI SPOR, V22, pE55, DOI 10.1111/j.1600-0838.2012.01475.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hajian-Tilaki KO, 2011, MED ONCOL, V28, P1296, DOI 10.1007/s12032-010-9629-6; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006; Justet C, 2015, CELL TISSUE RES, V362, P557, DOI 10.1007/s00441-015-2223-7; Karki RG, 2019, J MED CHEM, V62, P4656, DOI 10.1021/acs.jmedchem.9b00271; Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]; Li JP, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-019-0252-7; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lopez-Perez SJ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0117-3; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; O'Brien EJO, 2012, INT J EXP PATHOL, V93, P319, DOI 10.1111/j.1365-2613.2012.00829.x; Olesen JL, 2006, SCAND J RHEUMATOL, V35, P312, DOI 10.1080/03009740600556373; Olsson N, 2014, AM J SPORT MED, V42, P1448, DOI 10.1177/0363546514527409; Pillitteri D, 2007, PLATELETS, V18, P119, DOI 10.1080/09537100600800792; Qu FN, 2019, NAT REV RHEUMATOL, V15, P167, DOI 10.1038/s41584-018-0151-0; Qu FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01955-w; Sato N, 2016, J PROTEOME RES, V15, P4709, DOI 10.1021/acs.jproteome.6b00806; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svedman S, 2018, AM J SPORT MED, V46, P2929, DOI 10.1177/0363546518793655; Uchiyama K, 2012, AM J PHYSIOL-GASTR L, V302, pG1163, DOI 10.1152/ajpgi.00292.2011; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wang C, 2019, J BONE JOINT SURG AM, V101, P2226, DOI 10.2106/JBJS.18.01483; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Wang Y, 2021, J PERIODONTOL, V92, P863, DOI 10.1002/JPER.20-0397; Zhou HJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015275	44	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22365	10.1096/fj.202200200RR	http://dx.doi.org/10.1096/fj.202200200RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9AI	35596679				2022-12-26	WOS:000798204000001
J	Ajong, AB; Kenfack, B; Ali, IM; Yakum, MNT; Onydinma, UPT; Mangala, FNT; Aljerf, LT; Telefo, PBT				Ajong, Atem Bethel; Kenfack, Bruno; Ali, Innocent Mbulli; Yakum, Martin Ndinakie T.; Onydinma, Ukaogo Prince T.; Mangala, Fulbert Nkwele T.; Aljerf, Loai T.; Telefo, Phelix Bruno T.			Ionised and total hypocalcaemia in pregnancy: An analysis of prevalence and risk factors in a resource-limited setting, Cameroon	PLOS ONE			English	Article							CALCIUM; MAIDUGURI; NIGERIA; WOMEN	IntroductionHypocalcaemia remains a prevalent laboratory finding in pregnancy, capable of inducing adverse maternofoetal outcomes. This study compares the prevalence of hypocalcaemia in apparently healthy pregnant women from the ionised, and total calcaemia viewpoints and further identifies factors associated with total crude and ionised hypocalcaemia in pregnancy. MethodsA hospital-based cross-sectional study was conducted between November 2020 and September 2021, targeting apparently healthy pregnant women received in late pregnancy in four maternities in the Nkongsamba Health District, Cameroon. Blood samples were collected and analysed for serum ionised calcium concentrations and pH (by ion-selective electrode potentiometry), and for total calcium and albumin concentration (by atomic absorption spectrophotometry). Sociodemographic, obstetric and nutritional data were collected using an interviewer-administered questionnaire. ResultsThe average age of the 1074 participants included in the study was 28.20 +/- 6.08 years. The prevalence of total crude and total albumin-corrected hypocalcaemia in this study was 61.64 [58.69-64.50]% and 56.70 [53.72-59.64]%, respectively (p-value = 0.000). The prevalence of ionised hypocalcaemia was very low (2.89 [2.04-4.07]%) compared with the prevalence of total hypocalcaemia (p-value = 0.000). Monthly income below 100.000FCFA (179 USD) (AOR = 0.73, p-value = 0.024), taking more than 2 meals daily (AOR = 0.68, p-value = 0.006) and taking desserts (AOR = 0.73, p-value = 0.046) reduced the odds of total crude hypocalcaemia, while having banana/plantain and tubers as the content of their most consumed meal significantly increased the odds of total crude hypocalcaemia (AOR = 1.37, p-value = 0.012). Single women (AOR = 2.54, p-value = 0.021), with a higher education (AOR = 3.27, p-value = 0.017), who initiated antenatal care before 4 months (AOR = 2.47, p-value = 0.029), had their odds of ionised hypocalcaemia significantly increased. On the other hand, women below 30 years (AOR = 0.44, p-value = 0.039), with occupations other than housewife (AOR = 0.34, p-value = 0.027), and women who took desserts between meals (AOR = 0.45, p-value = 0.034) had their odds of ionised hypocalcaemia significantly reduced. Taking calcium supplements simultaneously with other supplements also significantly reduced the odds of total hypocalcaemia in pregnancy (OR = 0.69, p-value = 0.027). ConclusionIonised hypocalcaemia in pregnancy is a rare finding. Only 2.89% of all apparently healthy pregnant women have ionised hypocalcaemia in late pregnancy, while 56.70% have total hypocalcaemia. Factors like the daily number of meals, taking of desserts, the content of the most consumed meal and monthly revenue significantly affect the prevalence of total hypocalcaemia in pregnancy. On the other hand, factors like age above 30 years, having a higher education, being single, having initiated antenatal care before 4 months of pregnancy, being a housewife and not taking desserts between meals have a significantly positive association with ionised hypocalcaemia.	[Ajong, Atem Bethel] Kekem Dist Hosp, Kekem, West Region, Cameroon; [Ajong, Atem Bethel; Ali, Innocent Mbulli; Telefo, Phelix Bruno T.] Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon; [Kenfack, Bruno] Univ Dschang, Fac Med & Pharmaceut Sci, Dept Obstet Gynaecol & Maternal Hlth, Dschang, West Region, Cameroon; [Yakum, Martin Ndinakie T.] Kesmonds Int Univ, Sch Med & Hlth Sci, Dept Epidemiol & Biostat, Bamenda, Cameroon; [Onydinma, Ukaogo Prince T.] Abia State Univ, Dept Pure & Ind Chem, Uturu, Nigeria; [Mangala, Fulbert Nkwele T.] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Mangala, Fulbert Nkwele T.] Nkongsamba Reg Hosp, Matern Unit, Nkongsamba, Littoral Region, Cameroon; [Aljerf, Loai T.] Damascus Univ, Fac Dent, Dept Basic Sci, Damascus, Syria; [Aljerf, Loai T.] Damascus Univ, Fac Sci, Dept Chem, Key Lab Organ Ind, Damascus, Syria		Ajong, AB (corresponding author), Kekem Dist Hosp, Kekem, West Region, Cameroon.; Ajong, AB; Telefo, PBT (corresponding author), Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon.	christrah@yahoo.fr; bphelix@yahoo.co.uk	Yakum, Martin/R-5738-2019; Aljerf, Loai/D-9843-2016	Yakum, Martin/0000-0003-3149-2020; Aljerf, Loai/0000-0002-1132-9659; Ali, Innocent/0000-0002-1112-6376				Ajong AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241812; Ajong AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224855; Almaghamsi Abdulrahman, 2018, Oman Med J, V33, P453, DOI 10.5001/omj.2018.85; Ba DM, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz120; Baird GS, 2011, CLIN CHIM ACTA, V412, P696, DOI 10.1016/j.cca.2011.01.004; Bako B., 2021, African Journal of Biomedical Research, V24, P53; Bako B, 2021, NIGER J CLIN PRACT, V24, P75, DOI 10.4103/njcp.njcp_640_19; Balk EM, 2018, OSTEOPOROSIS INT, V29, P1223, DOI 10.1007/s00198-018-4447-3; Benali A. I., 2014, J NUTR FOOD SCI, V4, P4, DOI [10.4172/2155-9600.1000318, DOI 10.4172/2155-9600.1000318]; BIOLABO, 2019, CALCIUM CPC METH REA, P1; BIOLABO, 2011, ALBUMIN BCG METH RAA, P1; Blanc AK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1047-0; Boampong OL., 2020, AFR J MIDWIFERY WOME, V14, P1; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cormick G, 2019, BJOG-INT J OBSTET GY, V126, P444, DOI 10.1111/1471-0528.15512; Data For Impact Project, 2020, ANT CAR LEAST 4 VIS; Eli S., 2017, NIGER J MED, V26, P208; Fouelifack FY, 2019, PAN AFR MED J, V34, DOI 10.11604/pamj.2019.34.211.16446; Goff JP, 2014, J DAIRY SCI, V97, P1520, DOI 10.3168/jds.2013-7467; Goldberg D., 2019, MEDSCAPE; Gupta Anant, 2016, Indian J Community Med, V41, P223, DOI 10.4103/0970-0218.183591; INS & ICF, 2020, ENQ DEM SANT CAM 201; Silapeux AGK, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11020089; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kumar A, 2010, BIOL TRACE ELEM RES, V136, P26, DOI 10.1007/s12011-009-8523-6; Liu DM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028843; Maffeu AL., 2020, HABITUDES ALIMENTAIR; Mugyia ASN., 2016, J MED HLTH SCI, V17; Ohbal Takashi, 2014, Rinsho Byori, V62, P133; Ong GSY, 2012, J CLIN ENDOCR METAB, V97, P3138, DOI 10.1210/jc.2012-1429; Oyeyinka BO, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120598; Payne RB, 2019, CLIN CHEM, V65, P705, DOI 10.1373/clinchem.2018.300905; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; PAYNE RB, 1979, J CLIN PATHOL, V32, P56, DOI 10.1136/jcp.32.1.56; Puri BK, 2020, ADV EXP MED BIOL, V1131, P537, DOI 10.1007/978-3-030-12457-1_22; Qiu R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168906; Ranganathan Priya, 2015, Perspect Clin Res, V6, P169, DOI 10.4103/2229-3485.159943; Richa CG, 2018, CASE REP ENDOCRINOL, V2018, DOI 10.1155/2018/8316017; Samuel S, 2020, FOOD SCI NUTR, V8, P1978, DOI 10.1002/fsn3.1485; Simons J., 2019, CORRECTING MYTH CALC; Tangoh DA, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/4742574; Tizazu MA, 2020, RISK MANAG HEALTHC P, V13, P2783, DOI 10.2147/RMHP.S285875; Tsourdi E, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050475; Vatanparast H, 2005, AM J CLIN NUTR, V82, P700, DOI 10.1093/ajcn/82.3.700; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2013, WORLD HEAL ORGAN, P1; WHO, 2018, GLOBAL RECOMMENDATIO, V10; World Health Organization, 2020, GLOBAL CANC OBSERVAT; Yeop NSH, 2018, NUTR FOOD SCI, V48, P165, DOI [10.1108/nfs-04-2017-0078, 10.1108/NFS-04-2017-0078]	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268643	10.1371/journal.pone.0268643	http://dx.doi.org/10.1371/journal.pone.0268643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584129	Green Published, gold			2022-12-26	WOS:000834613800001
J	Andrade, JM; Pachar, P; Trujillo, L; Cartuche, L				Andrade, Jose Miguel; Pachar, Pamela; Trujillo, Luisa; Cartuche, Luis			Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador	PLOS ONE			English	Article							ERGOSTEROL PEROXIDE; ANTIMICROBIAL ACTIVITY; ALZHEIMERS-DISEASE; ANTIOXIDANT; ANTICHOLINESTERASE; CHROMATOGRAPHY; PRINCIPLE; GRIFOLIN; GROWTH; CANCER	Suillus luteus (L.) Roussel is an edible mushroom commonly known as slippery jack or "Kallampa" by indigenous people from Loja province. It is used in traditional medicine to manage gastrointestinal disorders and headaches. In addition, edible mushrooms have been used for neurodegenerative diseases; however, there is no report about the anticholinesterase effect produced by this species. The aim of this work was to isolate the main secondary metabolite of Suillus luteus and characterize its inhibitory potential against acetylcholinesterase. Fruiting bodies were extracted with ethanol (EtOH) and ethyl acetate (EtOAc). From the EtOAc, suillin, is reported as the major compound. The cholinesterase inhibitory potential of extracts and the major isolated compound was assessed by Ellman ' s method and progression curves were recorded at 405 nm for 60 min. Donepezil hydroclhoride was used as a positive control. The samples were dissolved in methanol at 10 mg/mL and two more 10x dilutions were included to obtain final concentrations of 1, 0.1 and 0.01 mg/mL at the mix of reaction. IC50, K-m, V-max, and K-i were calculated for suillin. Suillin (200 mg) along with linoleic acid, ergosterol peroxide and ergosterol were isolated. The EtOH and EtOAc extracts exerted a moderate inhibitory effect (IC50 > 200 mu g/mL. In adittion, suillin exerted a non-competitive mixed mechanism. against AChE with an IC50 value of 31.50 mu M and Ki of 17.25 mu M. To the best of our knowledge, this is the first report of the anticholinesterase effect of Suillus luteus and suillin. The kinetic parameters and the moderate potency of the compound determined in this study, encourage us to propose suillin as a promising chemopreventing agent for the treatment of neurodegenerative diseases such as Alzheimer.	[Andrade, Jose Miguel; Pachar, Pamela; Trujillo, Luisa; Cartuche, Luis] Univ Tecn Particular Loja UTPL, Dept Quim, Loja, Ecuador		Cartuche, L (corresponding author), Univ Tecn Particular Loja UTPL, Dept Quim, Loja, Ecuador.	lecartuche@utpl.edu.ec		Cartuche, Luis/0000-0001-7227-4092				Akata I, 2019, S AFR J BOT, V120, P95, DOI 10.1016/j.sajb.2018.01.008; Alves MJ, 2012, PLANTA MED, V78, P1707, DOI 10.1055/s-0032-1315370; Andrade J.M., 2012, B SOC MICOL MADRID, V36, P193; Andrade JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9343724; Armijos C, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-26; Biju John, 2013, Journal of Applied Pharmaceutical Science, V3, P63; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Buker SM, 2019, SLAS DISCOV, V24, P515, DOI 10.1177/2472555219829898; Chamutpong S, 2019, APPL MECH MAT, P14; Deveci E, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.13074; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gamboa-Trujillo P., 2019, ETHNOBOT RES APP, V18, DOI [10.32859/era.18.38.1-15, DOI 10.32859/ERA.18.38.1]; Geissler T, 2010, BIOORGAN MED CHEM, V18, P2173, DOI 10.1016/j.bmc.2010.01.074; Gross MD, 2005, J NUTR, V135, P326, DOI 10.1093/jn/135.2.326; Ha JW, 2020, NAT PROD SCI, V26, P118, DOI 10.20307/nps.2020.26.2.118; Haupt LJ, 2015, DRUG METAB DISPOS, V43, P1744, DOI 10.1124/dmd.115.066597; ISOBE M, 1968, TETRAHEDRON, V24, P945, DOI 10.1016/0040-4020(68)88044-5; JAGERS E, 1986, Z NATURFORSCH B, V41, P645, DOI 10.1515/znb-1986-0517; Jang Yun-Woo, 2009, Mycobiology, V37, P207, DOI 10.4489/MYCO.2009.37.3.207; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Kim SW, 1999, B KOREAN CHEM SOC, V20, P819; Kobori M, 2007, BRIT J PHARMACOL, V150, P209, DOI 10.1038/sj.bjp.0706972; Kruzselyi D, 2019, FITOTERAPIA, V137, DOI 10.1016/j.fitote.2019.104180; Krzyczkowski W, 2009, FOOD CHEM, V113, P351, DOI 10.1016/j.foodchem.2008.06.075; Lam Benjamin, 2009, Human Genomics, V4, P91; Lazarevic-Pasti T, 2017, CURR MED CHEM, V24, P3283, DOI 10.2174/0929867324666170705123509; Leon F, 2008, CHEM BIODIVERS, V5, P120, DOI 10.1002/cbdv.200890002; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu FY, 2009, CHEM-BIOL INTERACT, V181, P168, DOI 10.1016/j.cbi.2009.07.008; Nukata M, 2002, PHYTOCHEMISTRY, V59, P731, DOI 10.1016/S0031-9422(02)00050-X; Ozturk M, 2011, FOOD CHEM TOXICOL, V49, P1353, DOI 10.1016/j.fct.2011.03.019; Patoka J., 2012, MILIT MED SCI LETT, V81, P40; Rhee IK, 2001, J CHROMATOGR A, V915, P217, DOI 10.1016/S0021-9673(01)00624-0; Ribeiro B, 2009, MICROCHEM J, V93, P29, DOI 10.1016/j.microc.2009.04.005; ROBAIRE B, 1975, MOL PHARMACOL, V11, P722; RUSH RS, 1985, BIOCHEM PHARMACOL, V34, P2063, DOI 10.1016/0006-2952(85)90395-8; Sepcic K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216077; Takei T, 2005, BIOSCI BIOTECH BIOCH, V69, P212, DOI 10.1271/bbb.69.212; Teichert A, 2007, J NAT PROD, V70, P1529, DOI 10.1021/np070259w; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TRINGALI C, 1989, J NAT PROD, V52, P844, DOI 10.1021/np50064a030; Nguyen TK, 2016, MYCOBIOLOGY, V44, P291, DOI 10.5941/MYCO.2016.44.4.291; Valarezo E, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10020338; Willis LM, 2009, GENES NUTR, V4, P309, DOI 10.1007/s12263-009-0141-6; Wu SH, 2008, J CHROMATOGR A, V1180, P99, DOI 10.1016/j.chroma.2007.12.024; Yang Z, 2016, J SEP SCI, V39, P732, DOI 10.1002/jssc.201501028; Yaqoob A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231948; Ye M, 2005, FEBS LETT, V579, P3437, DOI 10.1016/j.febslet.2005.05.013; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zhu R, 2014, PHYTOMEDICINE, V21, P372, DOI 10.1016/j.phymed.2013.08.022	50	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268292	10.1371/journal.pone.0268292	http://dx.doi.org/10.1371/journal.pone.0268292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576219	Green Published, gold			2022-12-26	WOS:000834668900009
J	Liu, Y; Wang, JY; Wu, S; Yang, J				Liu, Yang; Wang, Junying; Wu, Song; Yang, Jie			A model for isoform-level differential expression analysis using RNA-seq data without pre-specifying isoform structure	PLOS ONE			English	Article								MotivationNext generation sequencing (NGS) technology has been widely used in biomedical research, particularly on those genomics-related studies. One of NGS applications is the high-throughput mRNA sequencing (RNA-seq), which is usually applied to evaluate gene expression level (i.e. copies of isoforms), to identify differentially expressed genes, and to discover potential alternative splicing events. Popular tools for differential expression (DE) analysis using RNA-seq data include edgeR and DESeq. These methods tend to identify DE genes at the gene-level, which only allows them to compare the total size of isoforms, that is, sum of an isoform's copy number times its length over all isoforms. Naturally, these methods may fail to detect DE genes when the total size of isoforms remains similar but isoform-wise expression levels change dramatically. Other tools can perform isoform-level DE analysis only if isoform structures are known but would still fail for many non-model species whose isoform information are missing. To overcome these disadvantages, we developed an isoform-free (without need to pre-specify isoform structures) splicing-graph based negative binomial (SGNB) model for differential expression analysis at isoform level. Our model detects not only the change in the total size of isoforms but also the change in the isoform-wise expression level and hence is more powerful. ResultsWe performed extensive simulations to compare our method with edgeR and DESeq. Under various scenarios, our method consistently achieved a higher detection power, while controlling pre-specified type I error. We also applied our method to a real data set to illustrate its applicability in practice.	[Liu, Yang; Wang, Junying; Wu, Song] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Yang, Jie] SUNY Stony Brook, Sch Med, Dept Family, Populat,Prevent Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, S (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.; Yang, J (corresponding author), SUNY Stony Brook, Sch Med, Dept Family, Populat,Prevent Med, Stony Brook, NY 11794 USA.	song.wu@stonybrook.edu; jie.yang@stonybrookmedicine.edu						Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bollina D, 2006, NUCLEIC ACIDS RES, V34, pW444, DOI 10.1093/nar/gkl268; Frazee AC, 2015, BIOINFORMATICS, V31, P2778, DOI 10.1093/bioinformatics/btv272; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; LeGault LH, 2013, BIOINFORMATICS, V29, P2300, DOI 10.1093/bioinformatics/btt396; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salzman J, 2011, STAT SCI, V26, P62, DOI 10.1214/10-STS343; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams CR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1457-z; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0266162	10.1371/journal.pone.0266162	http://dx.doi.org/10.1371/journal.pone.0266162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576204	gold, Green Published			2022-12-26	WOS:000835262300006
J	Nisal, A; Diwekar, U; Hanumante, N; Shastri, Y; Cabezas, H				Nisal, Apoorva; Diwekar, Urmila; Hanumante, Neeraj; Shastri, Yogendra; Cabezas, Heriberto			Integrated model for food-energy-water (FEW) nexus to study global sustainability: The main generalized global sustainability model (GGSM)	PLOS ONE			English	Article							DYNAMICS; POPULATION; INEQUALITY; SYSTEMS; GROWTH; EARTH	Over the years, several global models have been proposed to forecast global sustainability, provide a framework for sustainable policy-making, or to study sustainability across the FEW nexus. An integrated model is presented here with components like food-web ecosystem dynamics, microeconomics components, including energy producers and industries, and various socio-techno-economic policy dimensions. The model consists of 15 compartments representing a simplified ecological food-web set in a macroeconomic framework along with a rudimentary legal system. The food-web is modeled by Lotka-Volterra type expressions, whereas the economy is represented by a price-setting model wherein firms and human households attempt to maximize their economic well-being. The model development is done using global-scale data for stocks and flows of food, energy, and water, which were used to parameterize this model. Appropriate proportions for some of the ecological compartments like herbivores and carnivores are used to model those compartments. The modeling of the human compartment was carried out using historical data for the global mortality rate. Historical data were used to parameterize the model. Data for key variables like the human population, GDP growth, greenhouse gases like CO2 and NOX emissions were used to validate the model. The model was then used to make long-term forecasts and to study global sustainability over an extended time. The purpose of this study was to create a global model which can provide techno-socio-economic policy solutions for global sustainability. Further, scenario analysis was conducted for cases where the human population or human consumption increases rapidly to observe the impact on the sustainability of the planet over the next century. The results indicated that the planet can support increased population if the per capita consumption levels do not rise. However, increased consumption resulted in exhaustion of natural resources and increased the CO2 emissions by a multiple of 100.	[Nisal, Apoorva; Diwekar, Urmila] Univ Illinois, Dept Ind Engn, Chicago, IL 60607 USA; [Diwekar, Urmila] Vishwamitra Res Inst, Crystal Lake, IL 60514 USA; [Hanumante, Neeraj; Shastri, Yogendra] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Cabezas, Heriberto] Univ Miskolc, Res Inst Appl Earth Sci, Miskolc, Hungary	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Miskolc	Diwekar, U (corresponding author), Univ Illinois, Dept Ind Engn, Chicago, IL 60607 USA.; Diwekar, U (corresponding author), Vishwamitra Res Inst, Crystal Lake, IL 60514 USA.	urmila@vri-custom.org		Hanumante, Neeraj/0000-0002-6693-0548; Diwekar, Urmila/0000-0002-0933-5865; Nisal, Apoorva/0000-0002-8469-9503	Ministry of Human Resource Development, Government of India [P1238]; European Union; Szechenyi 2020 Plan [P1238]; European Structural and Investment Funds;  [GINOP-2.3.2-15-2016-00010]	Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); European Union(European Commission); Szechenyi 2020 Plan; European Structural and Investment Funds; 	NH, YS, UD acknowledge the support from the Ministry of Human Resource Development, Government of India, through the SPARC (project code: P1238). The research contribution by H. Cabezas was carried out in the GINOP-2.3.2-15-2016-00010 framework Development of enhanced engineering methods with the aim at utilization of subterranean energy resources" project at the Research Institute of Applied Earth Sciences of the University of Miskolc, the Szechenyi 2020 Plan, partially funded by the European Union, co-financed by the European Structural and Investment Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, WORLD3 MOD CLASS WOR; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Benavides PT, 2015, J COMPLEX NETW, V3, P566, DOI 10.1093/comnet/cnu051; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; BROWN BJ, 1987, ENVIRON MANAGE, V11, P713, DOI 10.1007/BF01867238; Bruntland G, 1987, WORLD COMMISSION ENV, P45; Cabezas H, 2018, ENVIRON PROG SUSTAIN, V37, P624, DOI 10.1002/ep.12887; Cabezas H, 2005, J CLEAN PROD, V13, P455, DOI 10.1016/j.jclepro.2003.09.011; Dietz T, 2007, FRONT ECOL ENVIRON, V5, P13, DOI 10.1890/1540-9295(2007)5[13:DTHEF]2.0.CO;2; Doshi R, 2015, CLEAN TECHNOL ENVIR, V17, P1573, DOI 10.1007/s10098-014-0889-2; Ganivet E, 2020, ENVIRON DEV SUSTAIN, V22, P4979, DOI 10.1007/s10668-019-00446-w; IEA, 2020, CO2 EM FUEL COMB; King CW, 2020, ECOL ECON, V169, DOI 10.1016/j.ecolecon.2019.106464; Kotecha P, 2013, CLEAN TECHNOL ENVIR, V15, P21, DOI 10.1007/s10098-012-0491-4; Meadows D., 2004, LIMITS GROWTH 30 YEA; Motesharrei S, 2016, NATL SCI REV, V3, P470, DOI 10.1093/nsr/nww081; Motesharrei S, 2014, ECOL ECON, V101, P90, DOI 10.1016/j.ecolecon.2014.02.014; Nace T., 2017, HUMANITY HAS OFFICIA; Nitzbon J, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7581; Puliafito SE, 2008, ECOL ECON, V65, P602, DOI 10.1016/j.ecolecon.2007.08.010; Randers J, 2019, GLOB SUSTAIN, V2, DOI 10.1017/sus.2019.22; Rodriguez-Gonzalez PT, 2020, ECOL MODEL, V426, DOI 10.1016/j.ecolmodel.2020.109018; Shastri Y, 2008, ENVIRON SCI TECHNOL, V42, P6710, DOI 10.1021/es800661x; Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002; The World Bank, 2020, GDP CURR USD DAT; The World Bank, 2020, CO2 EM METR TONS PER; un, 2021, SUST DEV 17 GOALS, DOI DOI 10.18356/9789210056083; United Nations Statistics Division, 2009, EN STAT YB; United Nations (UN) Department of Economic and Social Affairs Population Division, 2019, WORLD POP PROSP 2019; Van Vuuren DP, 2019, NAT SUSTAIN, V2, P1132, DOI 10.1038/s41893-019-0418-8; Victor PA, 2012, ECOL ECON, V84, P206, DOI 10.1016/j.ecolecon.2011.04.013; Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2; Whitmore HW, 2006, INTEGRATION EC IMPER	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267403	10.1371/journal.pone.0267403	http://dx.doi.org/10.1371/journal.pone.0267403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580075	Green Published, gold			2022-12-26	WOS:000835654800012
J	Pinto-Ramos, J; Moreira, T; Costa, F; Tavares, H; Cabral, J; Costa-Santos, C; Barroso, J; Sousa-Pinto, B				Pinto-Ramos, Joao; Moreira, Tiago; Costa, Frederico; Tavares, Helena; Cabral, Joao; Costa-Santos, Cristina; Barroso, Joana; Sousa-Pinto, Bernardo			Handheld dynamometer reliability to measure knee extension strength in rehabilitation patients-A cross-sectional study	PLOS ONE			English	Article							MUSCLE STRENGTH; PERFORMANCE; VALIDITY; BELT; HIP; DISABILITY; FORCE; SPEED; GAIT	IntroductionThe Handheld Dynamometer (HHD) has the potential to overcome some of the logistic and economic limitations of isokinetic dynamometers for measuring knee extension muscle strength. However, its reliability has not been fully assessed. The purpose of this study is to measure intra and inter-rater reliability of HHD for knee extension strength in patients receiving rehabilitation treatment, as well as to understand in which conditions is the reliability higher. MethodsTwenty-nine patients admitted in an inpatient Physical Medicine and Rehabilitation unit were consecutively included in this cross-sectional study. Two experienced and two inexperienced physicians made two assessments of knee extension strength with HHD, separated by three hours. Intraclass Correlation Coefficients (ICC), absolute differences between assessments, and correlations between strength and functional variables were calculated. ResultsIntra and inter-rater ICC were overall high (>= 0.950 and 0.927, respectively). Higher values were found when average of two measurements were made for estimating intra-rater ICC (ICC = 0.978; 95%CI = 0.969-0.985) but not for inter-rater ICC. ICC were not statistically significantly different when calculated based on measurements performed by inexperienced physicians and experienced ones. There was a moderate correlation between strength and functional variables. ConclusionHandheld Dynamometer seems to be a reliable option to measure knee extension muscle strength, particularly when two measurements are performed and their average is reported.	[Pinto-Ramos, Joao; Moreira, Tiago; Costa, Frederico; Tavares, Helena; Cabral, Joao; Barroso, Joana] Ctr Hosp Univ Sao Joao, Dept Phys Med & Rehabil, Porto, Portugal; [Pinto-Ramos, Joao; Costa-Santos, Cristina; Sousa-Pinto, Bernardo] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal; [Costa-Santos, Cristina; Sousa-Pinto, Bernardo] Univ Porto, Fac Med, MEDCIDS Dept Community Med Informat & Hlth Decis S, Porto, Portugal; [Barroso, Joana] Univ Porto, Fac Med, Dept Biomed, Porto, Portugal; [Barroso, Joana] Univ Porto, i3s Inst Hlth Res & Innovat, Porto, Portugal; [Barroso, Joana] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL USA; [Barroso, Joana] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Pinto-Ramos, J (corresponding author), Ctr Hosp Univ Sao Joao, Dept Phys Med & Rehabil, Porto, Portugal.; Pinto-Ramos, J (corresponding author), Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal.	jap_ramos@hotmail.com	Sousa-Pinto, Bernardo/O-2846-2014; Santos, Cristina/J-3255-2013; Ramos, João/GSM-7241-2022	Sousa-Pinto, Bernardo/0000-0002-1277-3401; Santos, Cristina/0000-0002-7109-1101; 	Doctoral Programme in Clinical and Health Services Research (Faculty of Medicine, University of Porto, Porto, Portugal); National Funds from Fundacao para a Cienciaea Tecnologia Instituto Publico, within Centro de Investigacao em Tecnologias e Servicos de Saude (CINTESIS), RD unit [UIDB/4255/2020]	Doctoral Programme in Clinical and Health Services Research (Faculty of Medicine, University of Porto, Porto, Portugal); National Funds from Fundacao para a Cienciaea Tecnologia Instituto Publico, within Centro de Investigacao em Tecnologias e Servicos de Saude (CINTESIS), RD unit	This study was partly funded by the Doctoral Programme in Clinical and Health Services Research (Faculty of Medicine, University of Porto, Porto, Portugal) and by the National Funds from Fundacao para a Cienciaea Tecnologia Instituto Publico, within Centro de Investigacao em Tecnologias e Servicos de Saude (CINTESIS), R&D unit (reference UIDB/4255/2020).	Arnold AS, 2005, J BIOMECH, V38, P2181, DOI 10.1016/j.jbiomech.2004.09.036; Bohannon RW, 2019, CLIN INTERV AGING, V14, P1681, DOI 10.2147/CIA.S194543; Bohannon RW, 2019, J CARDIOPULM REHABIL, V39, P2, DOI 10.1097/HCR.0000000000000336; Bohannon Richard W., 2012, Physiotherapy Theory and Practice, V28, P562, DOI 10.3109/09593985.2011.640385; Corrigan D, 2001, ARCH PHYS MED REHAB, V82, P1666, DOI 10.1053/apmr.2001.26811; dos Santos JRR, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2020.101043; Enright Paul L, 2003, Respir Care, V48, P783; Florencio LL, 2019, PHYS THER SPORT, V38, P115, DOI 10.1016/j.ptsp.2019.04.011; Fragala MS, 2016, J AM GERIATR SOC, V64, P144, DOI 10.1111/jgs.13871; HAYES V, 1995, AGE AGEING, V24, P120, DOI 10.1093/ageing/24.2.120; Huang CH, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111353; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jung HG, 2021, J AGING RES, V2021, DOI 10.1155/2021/6627767; Kear BM, 2017, J PRIM CARE COMMUNIT, V8, P9, DOI 10.1177/2150131916659282; Kim WK, 2014, ANN REHABIL MED-ARM, V38, P84, DOI 10.5535/arm.2014.38.1.84; Kojima N, 2014, GERIATR GERONTOL INT, V14, P674, DOI 10.1111/ggi.12158; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Martins J, 2017, J ATHL TRAINING, V52, P809, DOI 10.4085/1062-6050-52.6.04; MCMAHON L M, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P236; Mentiplay BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140822; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; Romero-Franco N, 2017, J SPORT SCI, V35, P2179, DOI 10.1080/02640414.2016.1260152; Schmitt LC, 2012, J ORTHOP SPORT PHYS, V42, P750, DOI 10.2519/jospt.2012.4194; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Stone CA, 2011, J REHABIL MED, V43, P808, DOI 10.2340/16501977-0860; Sung KS, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2703-0; Toemen A, 2011, HAND THER, V16, P67, DOI 10.1258/ht.2011.011010; Toonstra Jenny, 2013, J Sport Rehabil, V22, DOI 10.1123/jsr.2013.TR7; Turan Z, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03282-x; Vanhorebeek I, 2020, INTENS CARE MED, V46, P637, DOI 10.1007/s00134-020-05944-4; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502; Whiteley R, 2012, J SCI MED SPORT, V15, P444, DOI 10.1016/j.jsams.2012.01.003; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268254	10.1371/journal.pone.0268254	http://dx.doi.org/10.1371/journal.pone.0268254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580110	Green Published, gold			2022-12-26	WOS:000835654800005
J	Stoykova, Z; Kostadinova, T; Todorova, T; Niyazi, D; Bozhkova, M; Bizheva, S; Stoeva, T				Stoykova, Zhivka; Kostadinova, Tsvetelina; Todorova, Tatina; Niyazi, Denis; Bozhkova, Milena; Bizheva, Svetomira; Stoeva, Temenuga			Dealing with inconclusive SARS-CoV-2 PCR samples-Our experience	PLOS ONE			English	Article							VIRAL LOAD	PurposeEarly confirmation of SARS-CoV-2 is a key point in the timely management of infected patients and contact persons. Routine diagnostics of COVID-19 cases relies on RT-PCR detection of two or three unique sequences of the virus. A serious problem for the laboratories is how to interpret inconclusive samples which are positive for only one of the SARS-CoV-2 specific genes. Materials and methodsA total of 16364 naso-oropharyngeal swabs were collected and tested with SARS-CoV-2 Real-TM kit (Sacace Biotechnologies, Italy) between May and September 2020. We retrospectively analyzed their amplification plots to determine the number of inconclusive samples. We also reviewed the medical records to summarize the patient's COVID-19 testing history and basic demographic characteristics. ResultsWe obtained 136 (0.8%) inconclusive samples with amplification signal only for the N-gene. Thirty-nine of the samples were excluded from further analysis as no additional data were available for them. Of the rest of the samples, the majority- 48% (95% CI 38-59%) had a previous history of SARS-CoV-2 positivity, 14% (95% CI 8-23%)-a subsequent history of positivity and 37% (95% CI 28-48%) were considered as false positive. ConclusionA substantial proportion of the inconclusive results should be considered as positive samples at the beginning or the end of the infection. However, the number of false-positive results is also significant and each patient's result should be analyzed separately following the clinical symptoms and epidemiological data.	[Stoykova, Zhivka; Todorova, Tatina; Niyazi, Denis; Bozhkova, Milena; Stoeva, Temenuga] Med Univ Varna, Dept Microbiol & Virol, Varna, Bulgaria; [Stoykova, Zhivka; Kostadinova, Tsvetelina; Todorova, Tatina] Univ Hosp St Marina, Lab Virol, Varna, Bulgaria; [Kostadinova, Tsvetelina] Med Univ Varna, Med Coll, Varna, Bulgaria; [Niyazi, Denis; Bozhkova, Milena; Bizheva, Svetomira; Stoeva, Temenuga] Univ Hosp St Marina, Lab Microbiol, Varna, Bulgaria	Medical University Varna; Medical University Varna; Medical University Varna; Medical University Varna	Todorova, T (corresponding author), Med Univ Varna, Dept Microbiol & Virol, Varna, Bulgaria.; Todorova, T (corresponding author), Univ Hosp St Marina, Lab Virol, Varna, Bulgaria.	Tatina.Todorova@mu-varna.bg	Niyazi, Denis/AAD-7560-2022	Niyazi, Denis/0000-0003-3666-3802; Popova, Tsvetelina/0000-0001-6760-8043; Todorova, Tatina/0000-0002-4668-9347				Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501; Cento V, 2020, J INFECTION, V81, pE90, DOI 10.1016/j.jinf.2020.06.024; D'Ardes Damiano, 2020, Eur J Case Rep Intern Med, V7, P001707, DOI 10.12890/2020_001707; Das D, 2006, J VIROL METHODS, V137, P343, DOI 10.1016/j.jviromet.2006.06.029; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; European Center for Disease Control, 2020, PNEUM CAS POSS ASS N; HISCOX JA, 1995, VIRUS RES, V36, P119, DOI 10.1016/0168-1702(94)00108-O; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Joy V, 2020, J ACAD CLIN MICROBIO, V22, P59; Kim Mi-Na, 2020, Annals of Clinical Microbiology, V23, P1, DOI 10.5145/ACM.2020.23.4.4; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Lim YK, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06534-5; Mallett S, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01810-8; Neil M, 2021, Arxiv, DOI arXiv:2102.11612; Miller S, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.01494-21; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; WHO, 2020, CRIT REL COVID 19 PA; WHO, 2020, DIAGN TEST SARS COV; WHO World Health Organization, 2020, LAB TEST COR DIS COV; World Health Organization, 2020, PNEUM UNKN CAUS CHIN; Yang SX, 2021, AM J CLIN PATHOL, V155, P376, DOI [10.1093/ajcp/aqaa251, 10.1093/AJCP/AQAA251]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268187	http://dx.doi.org/10.1371/journal.pone.0268187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560147	Green Published, gold			2022-12-26	WOS:000835326900005
J	Zhang, YF; Martin, JE; Edmonds, KA; Winkler, ME; Giedroc, DP				Zhang, Yifan; Martin, Julia E.; Edmonds, Katherine A.; Winkler, Malcolm E.; Giedroc, David P.			SifR is an Rrf2-family quinone sensor associated with catechol iron uptake in Streptococcus pneumoniae D39	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMOLOGY WEB TOOLS; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; CYSTEINE METABOLISM; CRYSTAL-STRUCTURE; FERRIC REDUCTASE; BINDING-PROTEIN; GENE-REGULATION; REGULATOR; ENZYME	Streptococcus pneumoniae (pneumococcus) is a Grampositive commensal and human respiratory pathogen. How this bacterium satisfies its nutritional iron (Fe) requirement in the context of endogenously produced hydrogen peroxide is not well understood. Here, we characterize a novel virulence associated Rrf2-family transcriptional repressor that we term SifR (streptococcal IscR-like family transcriptional repressor) encoded by spd_1448 and conserved in Streptococci. Global transcriptomic analysis of a delta sifR strain defines the SifR regulon as genes encoding a candidate catechol dioxygenase CatE, an uncharacterized oxidoreductase YwnB, a candidate flavin-dependent ferric reductase YhdA, a candidate heme-based ferric reductase domain-containing protein and the Piu (pneumococcus iron uptake) Fe transporter (piuBCDA). Previous work established that membrane-anchored PiuA binds FeIII-bis-catechol or monocatechol complexes with high affinity, including the human catecholamine stress hormone, norepinephrine. We demonstrate that SifR senses quinone via a single conserved cysteine that represses its regulon when in the reduced form. Upon reaction with catechol-derived quinones, we show that SifR dissociates from the DNA leading to regulon derepression, allowing the pneumococcus to access a catechol-derived source of Fe while minimizing reactive electrophile stress induced by quinones. Consistent with this model, we show that CatE is an FeII-dependent 2,3-catechol dioxygenase with broad substrate specificity, YwnB is an NAD(P)H-dependent quinone reductase capable of reducing the oxidized and cyclized norepinephrine, adrenochrome, and YhdA is capable of reducing a number of FeIII complexes, including PiuA-binding transport substrates. These findings are consistent with a model where FeIII-catechol complexes serve as significant nutritional Fe sources in the host.	[Zhang, Yifan; Martin, Julia E.; Edmonds, Katherine A.; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Zhang, Yifan; Winkler, Malcolm E.; Giedroc, David P.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Martin, Julia E.] Idaho State Univ, Dept Biol Sci, Pocatello, ID USA; [Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Idaho; Idaho State University; Indiana University System; Indiana University Bloomington	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.; Giedroc, DP (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	giedroc@indiana.edu		Edmonds, Katherine/0000-0002-1282-9858	US National Institutes of Health, United States [R35 GM118157, R35 GM131767]	US National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported in part by grants from the US National Institutes of Health, United States (grant nos.: R35 GM118157 [to D. P. G.] and R35 GM131767 [to M. E. W.] ) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alghofaili F, 2021, MBIO, V12, DOI 10.1128/mBio.02569-21; Antelmann H., 2015, MOL MED MICROBIOLOGY, V2nd, P249; Antimicrobial Resistance Collaborators, 2022, LANCET, V399, P629, DOI [10.1016/S0140-6736(21)02724-0, DOI 10.1016/S0140-6736(21)02724-0]; Apuy JL, 2001, BIOCHEMISTRY-US, V40, P15164, DOI 10.1021/bi0112208; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Beasley FC, 2011, INFECT IMMUN, V79, P2345, DOI 10.1128/IAI.00117-11; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Capdevila DA, 2021, NAT CHEM BIOL, V17, DOI 10.1038/s41589-020-00671-9; Cheng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071451; Colabroy KL, 2008, ARCH BIOCHEM BIOPHYS, V479, P131, DOI 10.1016/j.abb.2008.08.022; Colomer-Winter C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007102; Crack JC, 2021, DALTON T, V50, P7887, DOI 10.1039/d1dt00993a; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delepelaire P, 2019, RES MICROBIOL, V170, P345, DOI 10.1016/j.resmic.2019.10.008; DENEER HG, 1995, MICROBIOL-UK, V141, P1985, DOI 10.1099/13500872-141-8-1985; Edmonds KA, 2020, BIOMOL NMR ASSIGN, V14, P233, DOI 10.1007/s12104-020-09952-9; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Fakhoury JN, 2021, NUCLEIC ACIDS RES, V49, P12556, DOI 10.1093/nar/gkab1040; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Gerlt JA, 2017, BIOCHEMISTRY-US, V56, P4293, DOI 10.1021/acs.biochem.7b00614; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Glanville DG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007052; Gonzales XF, 2013, MICROBIOL-SGM, V159, P2333, DOI 10.1099/mic.0.065607-0; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; Hayashi M, 1996, BBA-BIOENERGETICS, V1273, P165, DOI 10.1016/0005-2728(95)00138-7; Hillion M, 2015, BIOL CHEM, V396, P415, DOI 10.1515/hsz-2015-0102; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kajfasz JK, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00764-19; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kobylarz MJ, 2017, ACS CHEM BIOL, V12, P1778, DOI 10.1021/acschembio.7b00203; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lee SJ, 2016, P NATL ACAD SCI USA, V113, pE5202, DOI 10.1073/pnas.1604427113; Liger D, 2004, J BIOL CHEM, V279, P34890, DOI 10.1074/jbc.M405404200; Lisher JP, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00291-16; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Martin JE, 2019, NUCLEIC ACIDS RES, V47, P6885, DOI 10.1093/nar/gkz494; Martin JE, 2017, MOL MICROBIOL, V104, P334, DOI 10.1111/mmi.13630; Miethke M, 2011, BIOCHEMISTRY-US, V50, P10951, DOI 10.1021/bi201517h; Munnoch JT, 2016, SCI REP-UK, V6, DOI 10.1038/srep31597; Nakano MM, 2014, MOL MICROBIOL, V94, P815, DOI 10.1111/mmi.12798; Okai N, 2020, BIOMETALS, V33, P187, DOI 10.1007/s10534-020-00241-5; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Peng ED, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00874-16; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Perry WJ, 2019, P NATL ACAD SCI USA, V116, P21980, DOI 10.1073/pnas.1913991116; Pi HL, 2018, MBIO, V9, DOI 10.1128/mBio.01451-18; Puccio T, 2022, MOL MICROBIOL, V117, P375, DOI 10.1111/mmi.14854; Puccio T, 2022, MOL MICROBIOL, V117, P353, DOI 10.1111/mmi.14853; Raines DJ, 2016, P NATL ACAD SCI USA, V113, P5850, DOI 10.1073/pnas.1520829113; Raines DJ, 2013, ANGEW CHEM INT EDIT, V52, P4595, DOI 10.1002/anie.201300751; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Sandrini S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-180; Sedlacek V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096262; Sestok AE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00097b; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; Tai SS, 2003, FEMS MICROBIOL LETT, V220, P303, DOI 10.1016/S0378-1097(03)00135-6; Takeo M, 2007, BIOSCI BIOTECH BIOCH, V71, P1668, DOI 10.1271/bbb.70079; Tam LT, 2006, ENVIRON MICROBIOL, V8, P1408, DOI 10.1111/j.1462-2920.2006.01034.x; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Trindade IB, 2021, J BIOL INORG CHEM, V26, P313, DOI 10.1007/s00775-021-01854-y; Tumescheit C., 2021, BIORXIV, DOI [10.1101/2020.1109.1114.291484, DOI 10.1101/2020.1109.1114.291484]; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Valenzuela-Garcia LI, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01688-20; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; Volbeda A, 2019, J AM CHEM SOC, V141, P2367, DOI 10.1021/jacs.8b10823; Volbeda A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15052; Loi VV, 2018, ANTIOXID REDOX SIGN, V29, P615, DOI 10.1089/ars.2017.7354; Wang SN, 2011, J BACTERIOL, V193, P563, DOI 10.1128/JB.01062-10; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Yang XY, 2019, J PROTEOMICS, V194, P160, DOI 10.1016/j.jprot.2018.11.021; Yang XY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00078; Zallot R, 2018, CURR OPIN CHEM BIOL, V47, P77, DOI 10.1016/j.cbpa.2018.09.009; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126; Zhang YF, 2020, J MOL BIOL, V432, P5390, DOI 10.1016/j.jmb.2020.08.005; Zhang YF, 2020, CHEMBIOCHEM, V21, P1955, DOI 10.1002/cbic.201900778; Zygiel EM, 2019, J BIOL CHEM, V294, P3549, DOI 10.1074/jbc.RA118.006819	93	3	3	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102046	10.1016/j.jbc.2022.102046	http://dx.doi.org/10.1016/j.jbc.2022.102046			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35597283	gold, Green Published			2022-12-26	WOS:000829549100010
J	Wang, XG; Yin, YX; Qian, W; Peng, C; Shen, SN; Wang, TT; Zhao, SL				Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting; Zhao, Shuli			Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4/TXNIP-NLRP3-GSDMD pathway in ovarian cancer	FASEB JOURNAL			English	Article						citric acid; metabolite; ovarian cancer; pyroptosis	CELL-DEATH; CITRATE; GLUTATHIONE; ACTIVATION; AUTOPHAGY; CASPASES; CLEAVAGE; BIOLOGY; GSDMD	Malignant tumors display profound changes in cellular metabolism, yet how these altered metabolites affect the development and growth of tumors is not fully understood. Here, we used metabolomics to analyze the metabolic profile differences in ovarian cancer and found that citric acid (CA) is the most significantly downregulated metabolite. Recently, CA has been reported to inhibit the growth of a variety of tumor cells, but whether it is involved in pyroptosis of ovarian cancer and its potential molecular mechanisms still remains to be further investigated. Here, we demonstrated that CA inhibits the growth of ovarian cancer cells in a dose-dependent manner. RNA-seq analysis revealed that CA significantly promoted the expression of thioredoxin interacting protein (TXNIP) and caspase-4 (CASP4). Morphologic examination by transmission electron microscopy indicated that CA-treated ovarian cancer cells exhibited typical pyroptosis characteristics. Further mechanistic analyses showed that CA facilitates pyroptosis via the CASP4/TXNIP-NLRP3-Gesdermin-d (GSDMD) pathway in ovarian cancer. This study elucidated that CA induces ovarian cancer cell death through classical and non-classical pyroptosis pathways, which may be beneficial as an ovarian cancer therapy.	[Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting] Nanjing Univ, Med Sch, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting] Nanjing Univ, Med Sch, Div Immunol, Jiangsu Key Lab Mol Med, Nanjing, Peoples R China; [Zhao, Shuli] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Wang, TT (corresponding author), Nanjing Univ, Med Sch, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China.; Zhao, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Peoples R China.	wangtt@nju.edu.cn; shulizhao79@163.com		Wang, Xiaogang/0000-0002-3412-6651	National Natural Science Foundation of China [82072648, 81772542, 81872114]; Natural Science Foundation of Jiangsu Province [BK20211508, 20190134]; Fundamental Research Funds for the Central Universities [021414380500]; Jiangsu Provincial Special Program of Medical Science [BE2019617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Provincial Special Program of Medical Science	This work is supported by grants from the National Natural Science Foundation of China (82072648, 81772542, and 81872114), the Natural Science Foundation of Jiangsu Province (BK20211508 and 20190134), the Fundamental Research Funds for the Central Universities (021414380500), and the Jiangsu Provincial Special Program of Medical Science (BE2019617).	Abdel-Salam OME, 2014, J MED FOOD, V17, P588, DOI 10.1089/jmf.2013.0065; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Bucay AH, 2011, CLIN RES HEPATOL GAS, V35, P241, DOI 10.1016/j.clinre.2010.12.011; Bucay AH, 2009, MED HYPOTHESES, V73, P271, DOI 10.1016/j.mehy.2009.03.018; Cao M, 2012, ANAL SCI, V28, P451, DOI 10.2116/analsci.28.451; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Costello LC, 1999, PROSTATE, V38, P237, DOI 10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO;2-O; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fan XR, 2021, LIFE SCI, V275, DOI 10.1016/j.lfs.2021.119355; Fuhler GM, 2017, TRENDS MOL MED, V23, P3, DOI 10.1016/j.molmed.2016.12.001; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Heo MJ, 2019, GUT, V68, P708, DOI 10.1136/gutjnl-2017-315123; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Icard P, 2018, CANCER RES, V78, P5176, DOI 10.1158/0008-5472.CAN-18-1666; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jeong YM, 2009, PHARMAZIE, V64, P829, DOI 10.1691/ph.2009.9622; Jia YF, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101534; Kruspig B, 2012, CELL MOL LIFE SCI, V69, P4229, DOI 10.1007/s00018-012-1166-3; Li N, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.623489; Lu YF, 2011, ANTICANCER RES, V31, P797; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mycielska ME, 2015, CURR MOL MED, V15, P884, DOI 10.2174/1566524016666151123104855; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Qiao LQ, 2019, FASEB J, V33, P12760, DOI 10.1096/fj.201900483RR; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Ren JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04626-4; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shenoy N, 2018, CANCER CELL, V34, P700, DOI 10.1016/j.ccell.2018.07.014; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Toohey JI, 2008, CANCER LETT, V263, P164, DOI 10.1016/j.canlet.2008.02.002; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang L, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.635774; Wang YP, 2020, J BIOL CHEM, V295, P11938, DOI 10.1074/jbc.REV119.007624; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Zhang L, 2012, CLIN BIOCHEM, V45, P1064, DOI 10.1016/j.clinbiochem.2012.05.012; Zhang RJ, 2020, J AGR FOOD CHEM, V68, P1326, DOI 10.1021/acs.jafc.9b07908	47	1	1	8	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22362	10.1096/fj.202101993RR	http://dx.doi.org/10.1096/fj.202101993RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1L7YE	35608902				2022-12-26	WOS:000799499800001
J	Semler-Collery, A; Bloch, F; Hayek, G; Goetz, C; Perone, JM				Semler-Collery, Axelle; Bloch, Florian; Hayek, George; Goetz, Christophe; Perone, Jean Marc			Comparison of triple-DMEK to pseudophakic-DMEK: A cohort study of 95 eyes	PLOS ONE			English	Article							MEMBRANE ENDOTHELIAL KERATOPLASTY; CYSTOID MACULAR EDEMA; CLINICAL-OUTCOMES; PHACOEMULSIFICATION; PREVALENCE; RISK	Previous comparative studies show that triple Descemet membrane endothelial keratoplasty (DMEK) (i.e. phacoemulsification followed immediately by DMEK) has either equivalent or better visual outcomes than DMEK in pseudophakic patients. To resolve this discrepancy, a retrospective cohort study was conducted. All consecutive patients with Fuchs Endothelial Corneal Dystrophy who underwent triple or pseudophakic DMEK in 2015-2019 in a tertiary-care hospital (France) and were followed for >12 months were compared in terms of best spectacle-corrected visual acuity (BSCVA), final refractive outcomes, and endothelial-cell loss at 12 months as well as rebubbling rates. The triple-DMEK (40 eyes, 34 patients) and pseudophakic-DMEK (55 eyes, 43 patients) groups were similar in terms of age and other baseline variables. They also did not differ in final BSCVA (both 0.03 logMAR), final endothelial-cell loss (54% vs. 48%), or astigmatism (-1.25 vs. -1 D). At 12 months, triple-DMEK associated with significantly smaller residual hyperopia (0.75 vs. 1 D; p = 0.04) and spherical equivalence (0 vs. 0.5 D; p = 0.02). Triple-DMEK also tended to associate with more frequent rebubbling (40% vs. 24%, p = 0.09). In conclusion, while triple-DMEK and pseudophakic-DMEK achieved similar visual acuity improvement, triple-DMEK was superior in terms of final sphere and spherical refraction but also tended to have higher complication rates.	[Semler-Collery, Axelle; Bloch, Florian; Hayek, George; Perone, Jean Marc] Mercy Hosp, Metz Thionville Reg Hosp Ctr, Ophthalmol Dept, Metz, France; [Goetz, Christophe] Mercy Hosp, Metz Thionville Reg Hosp Ctr, Res Support Unit, Metz, France; [Perone, Jean Marc] Lorraine Univ, Inst Jean Lamour, UMR 7198, Team 404,Nanomat & Hlth, Nancy, France	CHR Metz-Thionville; CHR Metz-Thionville; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Perone, JM (corresponding author), Mercy Hosp, Metz Thionville Reg Hosp Ctr, Ophthalmol Dept, Metz, France.; Perone, JM (corresponding author), Lorraine Univ, Inst Jean Lamour, UMR 7198, Team 404,Nanomat & Hlth, Nancy, France.	jm.perone@chr-metz-thionville.fr		Hayek, George/0000-0002-4638-9635; perone, jean marc/0000-0002-1427-7567				Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Arnalich-Montiel F, 2013, GRAEF ARCH CLIN EXP, V251, P2575, DOI 10.1007/s00417-013-2460-y; Bamdad Shahram, 2018, Electron Physician, V10, P6616, DOI 10.19082/6616; Birbal RS, 2020, AM J OPHTHALMOL, V212, P79, DOI 10.1016/j.ajo.2019.12.011; Burkhart ZN, 2014, J CATARACT REFR SURG, V40, P430, DOI 10.1016/j.jcrs.2013.08.047; Busin M, 2018, AM J OPHTHALMOL, V193, P106, DOI 10.1016/j.ajo.2018.06.013; Chamberlain W, 2019, OPHTHALMOLOGY, V126, P19, DOI 10.1016/j.ophtha.2018.05.019; Chaurasia S, 2014, OPHTHALMOLOGY, V121, P454, DOI 10.1016/j.ophtha.2013.09.032; Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; de Mora MRC, 2016, JAMA OPHTHALMOL, V134, P91, DOI 10.1001/jamaophthalmol.2015.4499; Diaz-Valle D, 1998, J CATARACT REFR SURG, V24, P951, DOI 10.1016/S0886-3350(98)80049-7; Droutsas K, 2018, CORNEA, V37, P455, DOI 10.1097/ICO.0000000000001483; Duggan MJ, 2019, OPHTHALMOLOGY, V126, P946, DOI 10.1016/j.ophtha.2019.02.007; Fajardo-Sanchez J, 2021, CORNEA, V40, P420, DOI 10.1097/ICO.0000000000002636; Flanary WE, 2016, CORNEA, V35, P1040, DOI 10.1097/ICO.0000000000000870; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Godin MR, 2019, CORNEA, V38, P409, DOI 10.1097/ICO.0000000000001872; Gorovoy IR, 2015, AM J OPHTHALMOL, V159, P597, DOI 10.1016/j.ajo.2014.12.008; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Gundlach E, 2015, GRAEF ARCH CLIN EXP, V253, P909, DOI 10.1007/s00417-015-2956-8; Ham L, 2009, EYE, V23, P1990, DOI 10.1038/eye.2008.393; Hamzaoglu EC, 2015, OPHTHALMOLOGY, V122, P2193, DOI 10.1016/j.ophtha.2015.07.003; Hayashi T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68023-0; Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106; Hos D, 2019, PROG RETIN EYE RES, V73, DOI 10.1016/j.preteyeres.2019.07.001; Ighani M, 2019, CLIN OPHTHALMOL, V13, P1869, DOI 10.2147/OPTH.S219742; Kocaba V, 2018, CORNEA, V37, P277, DOI 10.1097/ICO.0000000000001501; Laaser K, 2012, AM J OPHTHALMOL, V154, P47, DOI 10.1016/j.ajo.2012.01.020; Leon P, 2018, AM J OPHTHALMOL, V187, P117, DOI 10.1016/j.ajo.2017.12.014; Maier AKB, 2015, EYE, V29, P327, DOI 10.1038/eye.2014.280; Marques RE, 2019, EUR J OPHTHALMOL, V29, P15, DOI 10.1177/1120672118757431; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Moshirfar M., 2021, FUCHS ENDOTHELIAL DY; Munir WMM., 2018, AM J OPHTHALMOL; Musa FU, 2013, J CATARACT REFR SURG, V39, P836, DOI 10.1016/j.jcrs.2012.12.032; Nanda GG, 2019, MOL VIS, V25, P295; Pavlovic I, 2017, CORNEA, V36, P1445, DOI 10.1097/ICO.0000000000001384; Perone JM, 2019, J FR OPHTALMOL, V42, P597, DOI 10.1016/j.jfo.2019.03.002; Price FW, 2017, ASIA-PAC J OPHTHALMO, V6, P388, DOI 10.22608/APO.2017127; Price MO, 2013, OPHTHALMOLOGY, V120, P246, DOI 10.1016/j.ophtha.2012.08.007; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; Sarnicola C, 2019, EYE CONTACT LENS, V45, P1, DOI 10.1097/ICL.0000000000000469; Schrittenlocher S, 2019, GRAEF ARCH CLIN EXP, V257, P321, DOI 10.1007/s00417-018-4193-4; SCHULTZ RO, 1986, ARCH OPHTHALMOL-CHIC, V104, P1164; Shahnazaryan D, 2020, AM J OPHTHALMOL, V218, P1, DOI 10.1016/j.ajo.2020.05.003; Stuart AJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.C.D012097.pub2; Sugar A, 2015, JAMA OPHTHALMOL, V133, P246, DOI 10.1001/jamaophthalmol.2014.3923; Terry MA, 2012, OPHTHALMOLOGY, V119, P1988, DOI 10.1016/j.ophtha.2012.05.021; Terry MA, 2009, OPHTHALMOLOGY, V116, P631, DOI 10.1016/j.ophtha.2008.11.004; Yoo SH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1052, DOI 10.1001/archopht.126.8.1052; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267940	10.1371/journal.pone.0267940	http://dx.doi.org/10.1371/journal.pone.0267940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551322	gold, Green Published			2022-12-26	WOS:000868179400007
J	Ueshima, S; Fang, J				Ueshima, Shuhei; Fang, Jia			Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis	ONCOGENE			English	Article							DNA METHYLATION; MESENCHYMAL TRANSITION; LUNG-CANCER; E-CADHERIN; FOXA2; PROGRESSION; EXPRESSION; ESET; TRANSCRIPTION; SUPPRESSOR	Non-small cell lung cancer (NSCLC) is one of leading causes of cancer-related mortality worldwide, which harbors various accumulated genetic and epigenetic abnormalities. Histone methyltransferase SETDB1 is a pivotal epigenetic regulator whose focal amplification and upregulation are commonly detected in NSCLC. However, molecular mechanisms underlying the pro-oncogenic function of SETDB1 remain poorly characterized. Here, we demonstrate that SETDB1 augments the migration and invasion capabilities of NSCLC cells by reinforcing invadopodia formation and mediated ECM degradation. At the molecular level, SETDB1 suppresses the expression of FOXA2, a crucial tumor and metastasis suppressor via coordinated epigenetic mechanisms - SETDB1 not only catalyzes histone H3K9 methylation on FOXA2 genomic locus, but also recruits DNMT3A to regulate DNA methylation on CpG island. Consequently, depletion of Setdb1 in murine lung adenocarcinoma cells completely abolished their full and spontaneous metastatic capabilities in mouse xenograft models. These findings together establish the pro-metastasis activity of SETDB1 in NSCLC and elucidate the underlying cellular and molecular mechanisms.	[Ueshima, Shuhei; Fang, Jia] Roswell Park Comprehens Canc Ctr, Dept Pharmacol Therapeut, Buffalo, NY 14263 USA		Fang, J (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Pharmacol Therapeut, Buffalo, NY 14263 USA.	Jia.Fang@RoswellPark.org		Fang, Jia/0000-0001-8583-1652	NIH [CA172774]; Roswell Park Alliance Foundation; RPCCC; NCI center grant [P30CA016056]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Alliance Foundation; RPCCC; NCI center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Tyler Jacks for murine lung adenocarcinoma cell lines, Dr. Shengyu Yang for technical assistance with invadopodia assays, Dr. David Goodrich for constructive discussion and suggestions and support from Roswell Park Comprehensive Cancer Center (RPCCC) Shared Resources, including BIOINFO, GSR, TISR, and LASR. This project was supported, in part, by grants from the NIH (CA172774) and Roswell Park Alliance Foundation (all to JF), and by RPCCC and NCI center grant P30CA016056.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Basseres DS, 2012, LUNG CANCER, V77, P31, DOI 10.1016/j.lungcan.2012.01.011; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cruz-Tapias P, 2019, CANCERS, V11, DOI 10.3390/cancers11081134; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Duruisseaux M, 2018, SEMIN CANCER BIOL, V51, P116, DOI 10.1016/j.semcancer.2017.09.005; Eckert MA, 2017, J CELL SCI, V130, P2036, DOI 10.1242/jcs.198200; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Fei Q, 2015, GENOME RES, V25, P1325, DOI 10.1101/gr.177576.114; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fukuda K, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060596; Gauchier M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3673; Griffin GK, 2021, NATURE, V595, P309, DOI 10.1038/s41586-021-03520-4; Guler GD, 2017, CANCER CELL, V32, P221, DOI 10.1016/j.ccell.2017.07.002; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Halpern KB, 2014, J BIOL CHEM, V289, P23882, DOI 10.1074/jbc.M114.573469; Hawkins AG, 2019, NEOPLASIA, V21, P1063, DOI 10.1016/j.neo.2019.08.007; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Juznic L, 2021, GUT, V70, P485, DOI 10.1136/gutjnl-2020-321339; Kang YK, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.573515; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Lafuente-Sanchis A, 2016, CLIN TRANSL ONCOL, V18, P798, DOI 10.1007/s12094-015-1440-6; Lee T, 2016, J PATHOL TRANSL MED, V50, P197, DOI 10.4132/jptm.2016.03.09; Leung D, 2014, P NATL ACAD SCI USA, V111, P6690, DOI 10.1073/pnas.1322273111; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Liu JH, 2018, CANCER MANAG RES, V10, P391, DOI 10.2147/CMAR.S150552; Lowy CM, 2015, CELL ADHES MIGR, V9, P112, DOI 10.1080/19336918.2015.1008331; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Naciri I, 2019, NUCLEIC ACIDS RES, V47, P3407, DOI 10.1093/nar/gkz080; Nyren-Erickson EK, 2013, BBA-GEN SUBJECTS, V1830, P4445, DOI 10.1016/j.bbagen.2013.05.011; Pelaez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181579; Rodriguez-Paredes M, 2014, ONCOGENE, V33, P2807, DOI 10.1038/onc.2013.239; Saini P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203661; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Strepkos D, 2021, CANCER RES, V81, P525, DOI 10.1158/0008-5472.CAN-20-2906; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Takikita S, 2016, J IMMUNOL, V197, P2269, DOI 10.4049/jimmunol.1502486; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wang BL, 2018, EXP THER MED, V16, P133, DOI 10.3892/etm.2018.6157; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu PC, 2014, CANCER RES, V74, P7333, DOI 10.1158/0008-5472.CAN-13-3572; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang SM, 2021, NATURE, V598, P682, DOI 10.1038/s41586-021-03994-2; Zhang Z, 2015, CANCER LETT, V361, P240, DOI 10.1016/j.canlet.2015.03.008	51	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 10	2022	41	24					3370	3380		10.1038/s41388-022-02345-3	http://dx.doi.org/10.1038/s41388-022-02345-3		MAY 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	2A3BO	35546351				2022-12-26	WOS:000793636100001
J	Gramotnev, DK; Gramotnev, G; Gramotnev, A; Summers, MJ				Gramotnev, Dmitri K.; Gramotnev, Galina; Gramotnev, Alexandra; Summers, Mathew J.			Path analysis of biomarkers for cognitive decline in early Parkinson's disease	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; ALPHA-SYNUCLEIN; MICROGLIAL RESPONSE; ALZHEIMERS-DISEASE; IMPAIRMENT; PROGRESSION; DEMENTIA; TAU; DYSFUNCTION; DEPRESSION	Clinical and biochemical diversity of Parkinson's disease (PD) and numerous demographic, clinical, and pathological measures influencing cognitive function and its decline in PD create problems with the determination of effects of individual measures on cognition in PD. This is particularly the case where these measures significantly interrelate with each other producing intricate networks of direct and indirect effects on cognition. Here, we use generalized structural equation modelling (GSEM) to identify and characterize significant paths for direct and indirect effects of 14 baseline measures on global cognition in PD at baseline and at 4 years later. We consider 269 drug-naive participants from the Parkinson's Progression Marker Initiative database, diagnosed with idiopathic PD and observed for at least 4 years after baseline. Two GSEM networks are derived, highlighting the possibility of at least two different molecular pathways or two different PD sub-types, with either CSF p-tau181 or amyloid beta (1-42) being the primary protein variables potentially driving progression of cognitive decline. The models provide insights into the interrelations between the 14 baseline variables, and determined their total effects on cognition in early PD. High CSF amyloid concentrations (> 500 pg/ml) are associated with nearly full protection against cognitive decline in early PD in the whole range of baseline age between 40 and 80 years, and irrespectively of whether p-tau181 or amyloid beta (1-42) are considered as the primary protein variables. The total effect of depression on cognition is shown to be strongly amplified by PD, but not at the time of diagnosis or at prodromal stages. CSF p-tau181 protein could not be a reliable indicator of cognitive decline because of its significantly heterogeneous effects on cognition. The outcomes will enable better understanding of the roles of the clinical and pathological measures and their mutual effects on cognition in early PD.	[Gramotnev, Dmitri K.; Gramotnev, Galina; Gramotnev, Alexandra] Res & Data Anal Ctr, Brisbane, Qld, Australia; [Gramotnev, Alexandra] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia; [Summers, Mathew J.] Univ Sunshine Coast, Sch Hlth & Behav Sci, Sippy Downs, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast	Gramotnev, DK (corresponding author), Res & Data Anal Ctr, Brisbane, Qld, Australia.	d.gramotnev@rdacentre.com	Summers, Mathew J/G-3168-2011	Summers, Mathew J/0000-0002-3869-4920; Gramotnev, Dmitri K./0000-0003-3827-5088				Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Acock AC, 2013, DISCOVERING STRUCTUR, VRev, DOI DOI 10.1080/10538712.2011.607753; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Barthelemy NR, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00596-4; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Bobela W, 2015, BIOMOLECULES, V5, P2675, DOI 10.3390/biom5042675; Bras IC, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020375; Bugalho P, 2012, J NEUROL, V259, P124, DOI 10.1007/s00415-011-6140-8; Bugalho P, 2011, COGN BEHAV NEUROL, V24, P169, DOI 10.1097/WNN.0b013e3182350a1f; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Caspell-Garcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175674; Castellani RJ, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120972; Chahine LM, 2016, PARKINSONISM RELAT D, V27, P102, DOI 10.1016/j.parkreldis.2016.03.006; Chatterjee S., 2012, REGRESSION ANAL EXAM; Chung SJ, 2018, PARKINSONISM RELAT D, V51, P43, DOI 10.1016/j.parkreldis.2018.02.048; Conrado DJ, 2018, CTS-CLIN TRANSL SCI, V11, P63, DOI 10.1111/cts.12492; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Damholdt MF, 2011, MOVEMENT DISORD, V26, P2045, DOI 10.1002/mds.23782; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Delenclos M, 2016, PARKINSONISM RELAT D, V22, pS106, DOI 10.1016/j.parkreldis.2015.09.048; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Djang DSW, 2012, J NUCL MED, V53, P154, DOI 10.2967/jnumed.111.100784; Edwards FA, 2019, TRENDS NEUROSCI, V42, P310, DOI 10.1016/j.tins.2019.03.003; Elgh E, 2009, EUR J NEUROL, V16, P1278, DOI 10.1111/j.1468-1331.2009.02707.x; Espay AJ, 2017, MOVEMENT DISORD, V32, P319, DOI 10.1002/mds.26913; Fereshtehnejad SM, 2017, BRAIN, V140, P1959, DOI 10.1093/brain/awx118; Fullard ME, 2016, PARKINSONISM RELAT D, V25, P45, DOI 10.1016/j.parkreldis.2016.02.013; Gramotnev DK, 2011, NEUROIMMUNOMODULAT, V18, P171, DOI 10.1159/000323282; Gramotnev G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54029-w; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hall S, 2016, MOVEMENT DISORD, V31, P898, DOI 10.1002/mds.26578; Hardy J, 2021, LANCET NEUROL, V20, P416, DOI 10.1016/S1474-4422(21)00133-2; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henchcliffe C, 2015, CURRENT BIOMARKER FI, V5, P1; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hu MTM, 2014, MOVEMENT DISORD, V29, P351, DOI 10.1002/mds.25748; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Kalia LV, 2018, PARKINSONISM RELAT D, V46, pS19, DOI 10.1016/j.parkreldis.2017.07.023; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Lee SH, 2021, NEURON, V109, P1283, DOI 10.1016/j.neuron.2021.02.010; Liu GQ, 2017, LANCET NEUROL, V16, P620, DOI 10.1016/S1474-4422(17)30122-9; Marek K, 2018, ANN CLIN TRANSL NEUR, V5, P1460, DOI 10.1002/acn3.644; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; MCDONALD JF, 1980, REV ECON STAT, V62, P318, DOI 10.2307/1924766; Mehta SH, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0607-4; Merchant KM, 2019, J PARKINSON DIS, V9, P31, DOI 10.3233/JPD-181471; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Norman S, 2002, J NEUROPSYCH CLIN N, V14, P31, DOI 10.1176/appi.neuropsych.14.1.31; Nussbaum JM, 2013, PRION, V7, P14, DOI 10.4161/pri.22118; Pellecchia MT, 2015, ACTA NEUROL SCAND, V131, P275, DOI 10.1111/ane.12365; Pellecchia MT, 2014, EUR J NEUROL, V21, P802, DOI 10.1111/ene.12137; Pellecchia MT, 2013, J NEUROL, V260, P438, DOI 10.1007/s00415-012-6648-6; Picillo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186508; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Schrag A, 2017, LANCET NEUROL, V16, P66, DOI 10.1016/S1474-4422(16)30328-3; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; StataCorp, 2021, STATA STAT SOFTWARE; Suarez-Calvet M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012921; Suwijn SR, 2019, EJNMMI RES, V9, DOI 10.1186/s13550-019-0537-2; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Terrelonge M, 2016, J MOL NEUROSCI, V58, P88, DOI 10.1007/s12031-015-0647-x; Tukey JW, 1977, EXPLORATORY DATA ANA; Visanji NP, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0172-x; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weintraub D, 2015, MOVEMENT DISORD, V30, P919, DOI 10.1002/mds.26170; Weintraub D, 2011, MOVEMENT DISORD, V26, P1022, DOI 10.1002/mds.23664; Yang LF, 2015, CURR NEUROPHARMACOL, V13, P494, DOI 10.2174/1570159X1304150831150507; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031	77	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268379	10.1371/journal.pone.0268379	http://dx.doi.org/10.1371/journal.pone.0268379			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560326	gold, Green Published			2022-12-26	WOS:000834668000002
J	Kazibwe, A; Oryokot, B; Mugenyi, L; Kagimu, D; Oluka, AI; Kato, D; Ouma, S; Tayebwakushaba, E; Odoi, C; Kakumba, K; Opito, R; Mafabi, CG; Ochwo, M; Nkabala, R; Tusiimire, W; Tusiime, AK; Alinga, SB; Miya, Y; Etukoit, MB; Biraro, IA; Kirenga, B				Kazibwe, Andrew; Oryokot, Bonniface; Mugenyi, Levicatus; Kagimu, David; Oluka, Abraham Ignatius; Kato, Darlius; Ouma, Simple; Tayebwakushaba, Edmund; Odoi, Charles; Kakumba, Kizito; Opito, Ronald; Mafabi, Ceasar Godfrey; Ochwo, Michael; Nkabala, Robert; Tusiimire, Wilber; Tusiime, Agnes Kateeba; Alinga, Sarah Barbara; Miya, Yunus; Etukoit, Michael Bernard; Biraro, Irene Andia; Kirenga, Bruce			Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study	PLOS ONE			English	Article							INFECTION; UGANDA	IntroductionIsoniazid preventive therapy (IPT) is effective in treating tuberculosis (TB) infection and hence limiting progression to active disease. However, the durability of protection, associated factors and cost-effectiveness of IPT remain uncertain in low-and-middle income countries, Uganda inclusive. The Uganda Ministry of health recommends a single standard-dose IPT course for eligible people living with HIV (PLHIV). In this study we determined the incidence, associated factors and median time to TB diagnosis among PLHIV on Antiretroviral therapy (ART) who initiated IPT. Materials and methodsWe conducted a retrospective cohort study at eleven The AIDS Support Organization (TASO) centers in Uganda. We reviewed medical records of 2634 PLHIV on ART who initiated IPT from 1(st) January 2016 to 30(th) June 2018, with 30(th) June 2021 as end of follow up date. We analyzed study data using STATA v.16. Incidence rate was computed as the number of new TB cases divided by the total person months. A Frailty model was used to determine factors associated with TB incidence. ResultsThe 2634 individuals were observed for 116,360.7 person months. IPT completion rate was 92.8%. Cumulative proportion of patients who developed TB in this cohort was 0.83% (22/2634), an incidence rate of 18.9 per 100,000 person months. The median time to TB diagnosis was 18.5 months (minimum- 0.47; maximum- 47.3, IQR: 10.1-32.4). World Health Organization (WHO) HIV clinical stage III (adjusted hazard ratio (aHR) 95%CI: 3.66 (1.08, 12.42) (P = 0.037) and discontinuing IPT (aHR 95%CI: 25.96(4.12, 169.48) (p = 0.001)), were associated with higher odds of TB diagnosis compared with WHO clinical stage II and IPT completion respectively. ConclusionIncidence rates of TB were low overtime after one course of IPT, and this was mainly attributed to high completion rates.	[Kazibwe, Andrew; Oryokot, Bonniface; Mugenyi, Levicatus; Kagimu, David; Oluka, Abraham Ignatius; Kato, Darlius; Ouma, Simple; Tayebwakushaba, Edmund; Odoi, Charles; Kakumba, Kizito; Opito, Ronald; Mafabi, Ceasar Godfrey; Ochwo, Michael; Nkabala, Robert; Tusiimire, Wilber; Tusiime, Agnes Kateeba; Alinga, Sarah Barbara; Miya, Yunus; Etukoit, Michael Bernard] AIDS Support Org TASO, Kampala, Uganda; [Kazibwe, Andrew; Biraro, Irene Andia; Kirenga, Bruce] Makerere Univ, Sch Med, Kampala, Uganda; [Oryokot, Bonniface] Univ Suffolk, Ipswich, England; [Kirenga, Bruce] Makerere Univ, Lung Inst, Kampala, Uganda	Makerere University; Makerere University	Oryokot, B (corresponding author), AIDS Support Org TASO, Kampala, Uganda.; Oryokot, B (corresponding author), Univ Suffolk, Ipswich, England.	bonory@gmail.com		Oryokot, Bonniface/0000-0003-3702-1537; Simple, Ouma/0000-0002-4510-6736; Kazibwe, Andrew/0000-0002-0738-8234				Abossie A, 2017, THER CLIN RISK MANAG, V13, P361, DOI 10.2147/TCRM.S127765; Adhikari N, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262720; Bastos ML, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003703; Department of Education and Training, 2018, 2018 2022 STRAT PLAN; FMOH, 2012, GUID CLIN PROGR MAN, V5; Fox GJ, 2017, INT J INFECT DIS, V56, P68, DOI 10.1016/j.ijid.2016.11.006; Geremew D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4031-2; Github, KOB TOOLB; Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849; Izudi J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029400; Kalema N, 2020, INT J TUBERC LUNG D, V25, P388, DOI 10.5588/ijtld.20.0956; Kalyesubula R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216060; Kim HW, 2018, TUBERC RESPIR DIS, V81, P6, DOI 10.4046/trd.2017.0052; Lucy Obonyo Nyang'au E., 2020, J TUBERC, V23, P1, DOI [10.1088/1755-1315/125/1/012006, DOI 10.1088/1755-1315/125/1/012006]; Lwevola P, 2021, J CLIN TUBER OTH MYC, V25, DOI 10.1016/j.jctube.2021.100269; MOH, 2019, TUB LEPR CAS MAN DES; Moonan PK, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001135; Muyinda Herbert., 2020, QUALITY TUBERCULOSIS; Nyathi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223076; Oryokot B., 2020, WORLD J AIDS, V10, P94, DOI [10.4236/wja.2020.102008, DOI 10.4236/WJA.2020.102008]; Pathmanathan I, 2018, INT J TUBERC LUNG D, V22, P596, DOI 10.5588/ijtld.17.0758; Ragonnet R, 2017, INT J TUBERC LUNG D, V21, P60, DOI 10.5588/ijtld.16.0297; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Sabasaba A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3696-x; Salazar-Austin N, 2019, AM J EPIDEMIOL, V188, P2078, DOI 10.1093/aje/kwz172; Samandari T, 2015, AIDS, V29, P351, DOI 10.1097/QAD.0000000000000535; Semu M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2109-7; Sensalire S, 2020, AIDS RES THER, V17, DOI 10.1186/s12981-020-00285-0; Suryana K, 2020, BALI MED J, V9, P219, DOI 10.15562/bmj.v9i1.1684; Uganda Ministry of Health (MOH), 2019, 2019 HIV EP SURV REP; Umeokonkwo CD., 2018, J INTERV EPIDEMIOL P, V1, P11, DOI [10.37432/jieph.2018.1.1.11, DOI 10.37432/JIEPH.2018.1.1.11]; UNAIDS, 2021, GLOB AIDS STRAT 2021; United States President's Emergency Plan for AIDS Relief, 2020, PEPFAR 2021 COUNTR R; Uppal A, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003712; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization, 2015, IMPL END TB STRAT ES; World Health Organization, 2020, WHO OP HDB TUB MOD; World Health Organization, 2015, GUIDELINES MANAGEMEN	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0266285	10.1371/journal.pone.0266285	http://dx.doi.org/10.1371/journal.pone.0266285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576223	gold, Green Published			2022-12-26	WOS:000835262300007
J	Lin, CW; Yang, ZW; Chen, CH; Cheng, YW; Tang, SC; Jeng, JS				Lin, Chao-Wen; Yang, Zih-Wei; Chen, Chih-Hao; Cheng, Yu-Wen; Tang, Sung-Chun; Jeng, Jiann-Shing			Reduced macular vessel density and inner retinal thickness correlate with the severity of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; WHITE-MATTER LESIONS; ABNORMALITIES; STROKE; IMPAIRMENT	BackgroundCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), caused by mutations in NOTCH3, is the most common cause of hereditary cerebral small vessel disease. Whether it will involve systemic vasculopathy such as retinal vessel remains unknown. Optical coherence tomography angiography (OCT-A) is a noninvasive technique for visualising retinal blood flow. We analysed vessel density and retinal thickness in patients with CADASIL and investigated their correlations with disease severity. MethodsThis prospective study enrolled 35 patients with CADASIL (59 eyes) and 35 healthy controls (54 eyes). OCT-A was used to measure the vessel density of the macular region and the thickness of retinal layers. Patients with CADASIL were divided into stroke (n = 20) and nonstroke (n = 15) subgroups and underwent cognition and gait speed evaluation. Neuroimaging markers of cortical thickness, white matter hyperintensity, lacunae, and cerebral microbleeds were examined through brain magnetic resonance imaging. ResultsThe OCT-A parameters, including vessel density, were comparable between the patients with CADASIL and the controls. In patients with CADASIL, vessel density in the superficial retinal plexus in the macula as was inner retinal thickness was significantly lower in the stroke than the nonstroke subgroup. Macular vessel density and inner retinal thickness were positively correlated with gait speed, while negatively correlated with number of lacunae. ConclusionsOCT-A is potentially a useful tool for evaluating disease severity, ischaemic burden, and neurodegeneration in patients with advanced CADASIL.	[Lin, Chao-Wen; Yang, Zih-Wei] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Chih-Hao; Tang, Sung-Chun; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Cheng, Yu-Wen] Natl Taiwan Univ Hosp, Dept Neurol, Hsin Chu Branch, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chen, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	antonyneuro@gmail.com		Chen, Chih-Hao/0000-0002-1258-8775; JENG, JIANN-SHING/0000-0002-1456-3686	National Taiwan University Hospital [108-N4163]	National Taiwan University Hospital(National Taiwan University)	This work was supported by National Taiwan University Hospital under the grant number 108-N4163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112311; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chen CH, 2019, J NEUROL NEUROSUR PS, V90, P841, DOI 10.1136/jnnp-2018-319268; Cummings SR, 2014, JAMA-J AM MED ASSOC, V311, P2061, DOI 10.1001/jama.2014.3033; Cumurciuc R, 2004, J NEUROL NEUROSUR PS, V75, P1058, DOI 10.1136/jnnp.2003.024307; Di Donato I, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0778-8; Fang XJ, 2017, CHINESE MED J-PEKING, V130, P1042, DOI 10.4103/0366-6999.204935; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Haritoglou C, 2004, AM J OPHTHALMOL, V138, P302, DOI 10.1016/j.ajo.2004.02.073; Haritoglou C, 2004, NEUROLOGY, V62, P1202, DOI 10.1212/01.WNL.0000118296.16326.E1; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Jouvent E, 2016, NEUROLOGY, V87, P1787, DOI 10.1212/WNL.0000000000003252; Koustenis A, 2017, BRIT J OPHTHALMOL, V101, P16, DOI 10.1136/bjophthalmol-2016-309389; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; Liao YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136501; Ling YF, 2017, STROKE, V48, P283, DOI 10.1161/STROKEAHA.116.015750; Liu Y, 2008, CLIN EXP OPHTHALMOL, V36, P532, DOI 10.1111/j.1442-9071.2008.01825.x; Mutlu U, 2017, NEUROBIOL AGING, V60, P183, DOI 10.1016/j.neurobiolaging.2017.09.003; Nelis P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26475-5; Parisi V, 2007, EUR J NEUROL, V14, P627, DOI 10.1111/j.1468-1331.2007.01795.x; Parisi V, 2003, NEUROLOGY, V60, P2008, DOI 10.1212/01.WNL.0000070411.13217.7E; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Robinson W, 2001, SURV OPHTHALMOL, V45, P445, DOI 10.1016/S0039-6257(00)00206-X; Roine S, 2006, OPHTHALMOLOGY, V113, P1411, DOI 10.1016/j.ophtha.2006.03.030; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; Rufa A, 2011, CEREBROVASC DIS, V31, P77, DOI 10.1159/000321339; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Tang SC, 2019, ANN CLIN TRANSL NEUR, V6, P121, DOI 10.1002/acn3.690; Wang DD, 2014, STROKE, V45, P1651, DOI 10.1161/STROKEAHA.113.004629; Wang XJ, 2021, NEUROL SCI, V42, P3615, DOI 10.1007/s10072-021-05038-z; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Zhang YQ, 2020, J OPHTHALMOL, V2020, DOI [10.1155/2020/8850309, 10.1155/2020/3012748]	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268572	http://dx.doi.org/10.1371/journal.pone.0268572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617208	gold, Green Published			2022-12-26	WOS:000835048800067
J	Yu, Y; Zhou, TY; Zhao, R; Li, ZL; Shen, C				Yu, Yang; Zhou, Tianyu; Zhao, Rui; Li, Zhanglong; Shen, Chao			A scenario analysis-based optimal management of water resources supply and demand balance: A case study of Chengdu, China	PLOS ONE			English	Article							SYSTEM DYNAMICS MODEL; CARRYING-CAPACITY; COMPREHENSIVE EVALUATION; SUSTAINABLE UTILIZATION; OPTIMIZATION; SIMULATION; CITY	Water resources scarcity has threatened the coordinative development of demographics, society and economy. As a typical rapidly urbanizing area and an emerging megacity in China, Chengdu is confronting the pressure of inadequate water supply. The present study divides the macroeconomic factors that affect the water resource supply and demand balance into six major subsystems: water resources supply, water demand, water drainage, population, ecological environment and economy. The combining variable interaction description and predictive simulation models are applied to simulate the water supply and demand ratio (S:D) from 2005 to 2035. Further, this study designs different development scenarios to simulate the change of S:D ratios by altering the parameter values of driving factors. The results show that: (1) the S:D ratio will decline if the current development scenario continues, implying the serious water resources shortage and the severe water supply-demand conflict in Chengdu; (2) socio-economic water demand and wastewater/rainwater reuse are the key driving parameters of S:D ratio, especially the water consumption per ten thousand yuan of industrial value-added; (3) the S:D ratio will increase from 0.92 in the current baseline scenario to 1.06 in the integrated optimization scenario in 2025, and the long-term planning brings 2035 from 0.71 to 1.03, with the proportion of unconventional water supply rise to 38% and 61%, respectively. This study can provide a decision-making tool for policy-makers to explore plausible policy scenarios necessary for bridging the gap between the water supply and demand in megacities.	[Yu, Yang; Zhou, Tianyu; Zhao, Rui; Li, Zhanglong] Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu, Sichuan, Peoples R China; [Shen, Chao] Chengdu Engn Corp Ltd, Power China, Chengdu, Sichuan, Peoples R China; [Shen, Chao] Urban Water Environm Treatment Engn Technol Res Ct, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University	Zhao, R (corresponding author), Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu, Sichuan, Peoples R China.	ruizhao@swjtu.edu.cn			National Natural Science Foundation of China [42101315, 41571520]; Open Fund of Sichuan Province Cyclic Economy Research Center [XHJJ-2005, XHJJ-2002]; Chengdu Soft Science Research Project [2020-RK00-00240-ZF, 2020-RK00-00246-ZF]; Fundamental Research Funds for the Central Universities [2682021CX069, 2682021ZTPY088]; Chinese Academy of Engineering [Q113520S02003]; Sichuan Youth Science and Technology Innovation Team Funding [2022JDTD0005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of Sichuan Province Cyclic Economy Research Center; Chengdu Soft Science Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Engineering; Sichuan Youth Science and Technology Innovation Team Funding	This research was funded by the National Natural Science Foundation of China through grants awarded to YY and RZ (No. 42101315; No. 41571520); the Open Fund of Sichuan Province Cyclic Economy Research Center through grants awarded to YY and RZ (No. XHJJ-2005; No. XHJJ-2002); the Chengdu Soft Science Research Project through grants awarded to YY and RZ (No. 2020-RK00-00240-ZF; No. 2020-RK00-00246-ZF); andthe Fundamental Research Funds for the Central Universities through grants awarded to YY and RZ (No. 2682021CX069; No. 2682021ZTPY088). The Consulting research project of Chinese Academy of Engineering (No. Q113520S02003) and the Sichuan Youth Science and Technology Innovation Team Funding (No.2022JDTD0005) also awarded grants to RZ.	Ali G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257509; Apostolaki S, 2019, SCI TOTAL ENVIRON, V679, P70, DOI 10.1016/j.scitotenv.2019.05.077; Bagheri A, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.105959; Brelsford C, 2020, ECOL SOC, V25, DOI 10.5751/ES-11515-250223; CBS. (Chengdu Bureau of Statistic), 2020, CHENGD STAT YB 2005; CFGA. (Chengdu Forestry and Garden Administration), 2020, 13 5 YEAR PLAN CHENG; CFGA. (Chengdu Forestry and Garden Administration), 2020, PLANN CHENGD PARK UR; Cheng L, 2010, WATER SCI ENG, V3, P144, DOI 10.3882/j.issn.1674-2370.2010.02.003; Choi S, 2017, J HYDRO-ENVIRON RES, V16, P58, DOI 10.1016/j.jher.2017.07.002; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CWA. (Chengdu Water Authority), 2020, CHENGD WAT RES B 200; CWA. (Chengdu Water Authority), 2021, PLANN WAT CONS CHENG; CWA. (Chengdu Water Authority), 2020, 13 5 YEAR PLAN CHENG; CWA. (Chengdu Water Authority), 2020, 2025 WAT EC PLAN CHE; Deng CX, 2021, J ENVIRON MANAGE, V299, DOI 10.1016/j.jenvman.2021.113660; Duran-Encalada JA, 2017, EUR J OPER RES, V256, P567, DOI 10.1016/j.ejor.2016.06.016; Fang CL, 2019, SCI TOTAL ENVIRON, V689, P820, DOI 10.1016/j.scitotenv.2019.06.430; Felisa G, 2022, WATER RESOUR MANAG, V36, P915, DOI 10.1007/s11269-022-03059-7; Filipska K, 2022, J ELDER ABUSE NEGL, V34, P56, DOI 10.1080/08946566.2021.2024106; Ganji F, 2021, ENVIRON SCI POLLUT R, V28, P31327, DOI 10.1007/s11356-021-12773-5; Ghodsvali M, 2019, ENVIRON SCI POLICY, V101, P266, DOI 10.1016/j.envsci.2019.09.003; Gozini H, 2021, INT J ENVIRON RES, V15, P349, DOI 10.1007/s41742-021-00321-5; Hoekema DJ, 2013, J AM WATER RESOUR AS, V49, P1327, DOI 10.1111/jawr.12092; Hu GZ, 2021, J ENVIRON MANAGE, V295, DOI 10.1016/j.jenvman.2021.113045; Hu WQ, 2021, RESOUR CONSERV RECY, V170, DOI 10.1016/j.resconrec.2021.105589; Huber L, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142962; Hui L., 2021, EARTH ENV SCI, V768, DOI [10.1088/1755-1315/768/1/012045, DOI 10.1088/1755-1315/768/1/012045]; Jiang ZQ, 2019, WATER-SUI, V11, DOI 10.3390/w11071426; Li J, 2022, J CLEAN PROD, V330, DOI 10.1016/j.jclepro.2021.129794; Li Q, 2020, J ENVIRON MANAGE, V270, DOI 10.1016/j.jenvman.2020.110878; Li RH, 2018, WATER RESOUR MANAG, V32, P1827, DOI 10.1007/s11269-018-1906-8; Li T, 2019, WATER-SUI, V11, DOI 10.3390/w11081708; Li TH, 2019, J CLEAN PROD, V207, P882, DOI 10.1016/j.jclepro.2018.10.052; [刘兴亮 LIU Xingliang], 2006, [水土保持研究, Research of Soil and Water Conservation], V13, P189; Luo LX, 2020, URBAN WATER J, V17, P512, DOI 10.1080/1573062X.2020.1797831; Ma WJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12103996; Mahmood S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237385; Maruyama Y, 2019, PROCEDIA MANUF, V39, P1801, DOI 10.1016/j.promfg.2020.01.259; MEE. (Ministry of Ecology and Environment of the People's Republic of China), 2020, INSTR DOM WAST GEN D; Mirdashtvan M, 2021, WATER RESOUR MANAG, V35, P5307, DOI 10.1007/s11269-021-03004-0; MOHURD (Ministry of Housing and Urban-Rural Development), 2020, CHIN URB CONSTR STAT; MOHURD. (Ministry of Housing and Urban-Rural Development of the People's Republic of China), 2020, T50331 MOHURD GB; Momeni M, 2021, WATER RESOUR MANAG, V35, P4233, DOI 10.1007/s11269-021-02942-z; Peng JY, 2019, ENVIRON SCI POLLUT R, V26, P16085, DOI 10.1007/s11356-019-04565-9; Phan TD, 2021, CLEAN ENVIRON SYST, V2, DOI 10.1016/j.cesys.2021.100031; Qin HH, 2018, WATER POLICY, V20, P53, DOI 10.2166/wp.2017.168; Sahin O, 2015, WATER RESOUR MANAG, V29, P253, DOI 10.1007/s11269-014-0794-9; SPBOQTS. (Sichuan Provincial Bureau of Quality and Technical Supervision), 2021, WATER QUOTA SICHUAN; SPBS. (Sichuan Provincial Bureau of Statistics), 2019, SICH STAT YB 2005; SPWRD. (Sichuan Provincial Water Resources Department), 2020, SICH WAT SAV ACT IMP; Sun YH, 2017, J CLEAN PROD, V142, P613, DOI 10.1016/j.jclepro.2016.07.110; Susnik J, 2013, WATER RESOUR MANAG, V27, P819, DOI 10.1007/s11269-012-0217-8; Wang BF, 2021, WATER-SUI, V13, DOI 10.3390/w13243534; Wang H, 2022, INT J WATER RESOUR D, V38, P447, DOI 10.1080/07900627.2021.1908235; Wang L, 2019, J GEOGR SCI, V29, P363, DOI 10.1007/s11442-019-1603-4; Wang YF, 2021, ENVIRON DEV SUSTAIN, V23, P10397, DOI 10.1007/s10668-020-01062-9; Wei FL, 2020, J CLEAN PROD, V273, DOI 10.1016/j.jclepro.2020.122537; Yang ZY, 2019, J ENVIRON MANAGE, V230, P221, DOI 10.1016/j.jenvman.2018.09.085; Ye QL, 2018, WATER RES, V129, P264, DOI 10.1016/j.watres.2017.11.036; Yu Y, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac0b69; Zhang J, 2019, J HYDROL, V568, P96, DOI 10.1016/j.jhydrol.2018.10.059; Zomorodian M, 2018, J ENVIRON MANAGE, V227, P294, DOI 10.1016/j.jenvman.2018.08.097	62	1	1	10	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267920	10.1371/journal.pone.0267920	http://dx.doi.org/10.1371/journal.pone.0267920			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576216	Green Published, gold			2022-12-26	WOS:000835262300011
J	Xiong, GF; Xu, R				Xiong, Gaofeng; Xu, Ren			Retinoid orphan nuclear receptor alpha (ROR alpha) suppresses the epithelial-mesenchymal transition (EMT) by directly repressing Snail transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROMOTES METASTASIS; HEPATOCELLULAR-CARCINOMA; ANDROGEN RECEPTOR; ACTIVATION; CELLS; PHOSPHORYLATION; EXPRESSION; REGULATOR; INVASION	Retinoid orphan nuclear receptor alpha (ROR alpha) is a member of the orphan nuclear factor family and regulates gene expression by binding to ROR response elements (ROREs). ROR alpha has been identified as a potential tumor suppressor; however, how downregulation of ROR alpha promotes cancer progression is not fully understood. Here, we showed that protein levels of ROR alpha were downregulated during the Snail-, Twist-, or transforming growth factor-beta-induced epithelial-mesenchymal transition (EMT). We found that silencing of ROR alpha induced expression of mesenchymal markers in MCF10A cells, accompanied by enhanced cell invasion, migration, and mammosphere formation. Furthermore, ectopic expression of ROR alpha suppressed transforming growth factor-beta-induced EMT processes in MCF10A and HMLE cells. These results indicate that downregulation of ROR alpha is crucial for the induction of EMT in mammary epithelial cells. By analyzing gene expression profiles in control and ROR alpha-expressing cells, we also identified Snail, a key regulator of EMT, as a potential target of ROR alpha. We show that RORa expression significantly inhibits Snail transcription in breast cancer cells. Chromatin immunoprecipitation analysis demonstrated that ROR alpha bound to the ROREs in promoter region of SNAI1 gene, and using the luciferase reporter assay, we showed that binding to the ROREs was critical for ROR alpha to repress Snail transcription. Finally, rescue experiments substantiated that Snail mediates ROR alpha function in suppressing EMT and mammosphere formation. These results reveal a novel function of ROR alpha in suppressing EMT and identify Snail as a direct target of ROR alpha in mammary epithelial cells.	[Xiong, Gaofeng; Xu, Ren] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Xiong, Gaofeng; Xu, Ren] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Xiong, GF; Xu, R (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.; Xiong, GF; Xu, R (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA.	geofeng.xiong@uky.edu; ren.xu20101@uky.edu			National Institutes of Health [1R01CA207772, 1R01CA215095]; American Cancer Society [IRG-16-182-28]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	This study was supported by funding from the National Institutes of Health (grant nos.: 1R01CA207772 and 1R01CA215095; to R. X.) and American Cancer Society (grant no.: IRG-16-182-28; to G. X.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Du J, 2012, INT J MOL SCI, V13, P15755, DOI 10.3390/ijms131215755; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Fu RD, 2014, TUMOR BIOL, V35, P7603, DOI 10.1007/s13277-014-2007-9; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jiang Y, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102651; Jin Y, 2015, CANCER LETT, V362, P70, DOI 10.1016/j.canlet.2015.03.037; Jin Y, 2017, EXP CELL RES, V360, P210, DOI 10.1016/j.yexcr.2017.09.010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Lee JH, 2017, NAT CELL BIOL, V19, P1260, DOI 10.1038/ncb3609; Ma ZF, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0042-9; Mao W, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910665; Miao L, 2017, CANCER RES, V77, P3101, DOI 10.1158/0008-5472.CAN-16-2169; Moretti RM, 2004, INT J CANCER, V112, P87, DOI 10.1002/ijc.20387; Oh SK, 2019, P NATL ACAD SCI USA, V116, P21140, DOI 10.1073/pnas.1907595116; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Robichaud N, 2015, ONCOGENE, V34, P2032, DOI 10.1038/onc.2014.146; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Wang KF, 2017, MOL CANCER RES, V15, P448, DOI 10.1158/1541-7786.MCR-16-0288; Wang YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24606; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wik E, 2013, CLIN CANCER RES, V19, P1094, DOI 10.1158/1078-0432.CCR-12-3039; Wilson MM, 2020, TRENDS CANCER, V6, P775, DOI 10.1016/j.trecan.2020.03.011; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Xia WF, 2015, ONCOL REP, V34, P655, DOI 10.3892/or.2015.4008; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Zhang H, 2018, CANCER LETT, V437, P67, DOI 10.1016/j.canlet.2018.08.021; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhao JS, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.699933; Zhao ZH, 2015, INT J CLIN EXP PATHO, V8, P10325; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	55	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102059	10.1016/j.jbc.2022.102059	http://dx.doi.org/10.1016/j.jbc.2022.102059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35605663	Green Published, gold			2022-12-26	WOS:000818686700010
J	Han, X; Ren, JL; Lohner, H; Yakoumatos, L; Liang, RQ; Wang, HZ				Han, Xiao; Ren, Junling; Lohner, Hannah; Yakoumatos, Lan; Liang, Ruqiang; Wang, Huizhi			SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; ACTIVATION; SERUM; CELLS; UBIQUITIN; COMPLEX; NEDD4-2; PHOSPHORYLATION	Serum- and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase that plays important roles in the cellular stress response. While SGK1 has been reported to restrain inflammatory immune responses, the molecular mechanisms involved remain elusive, especially in oral bacteria-induced inflammatory milieu. Here, we found that SGK1 curtails Porphyromonas gingivalis-induced inflammatory responses through maintaining levels of tumor necrosis factor receptor-associated factor (TRAF) 3, thereby suppressing NF kappa B signaling. Specifically, SGK1 inhibition significantly enhances production of proinflammatory cytokines, including tumor necrosis factor alpha, interleukin (IL)-6, IL-1 beta, and IL-8 in P. gingivalis-stimulated innate immune cells. The results were confirmed with siRNA and LysM-Cre-mediated SGK1 KO mice. Moreover, SGK1 deletion robustly increased NF-kappa B activity and c-Jun expression but failed to alter the activation of mitogen-activated protein kinase signaling pathways. Further mechanistic data revealed that SGK1 deletion elevates TRAF2 phosphorylation, leading to TRAF3 degradation in a proteasome-dependent manner. Importantly, siRNAmediated traf3 silencing or c-Jun overexpression mimics the effect of SGK1 inhibition on P. gingivalis-induced inflammatory cytokines and NF-kappa B activation. In addition, using a P. gingivalis infection-induced periodontal bone loss model, we found that SGK1 inhibition modulates TRAF3 and c-Jun expression, aggravates inflammatory responses in gingival tissues, and exacerbates alveolar bone loss. Altogether, we demonstrated for the first time that SGK1 acts as a rheostat to limit P. gingivalis-induced inflammatory immune responses and mapped out a novel SGK1-TRAF2/3-c-Jun-NF-kappa B signaling axis. These findings provide novel insights into the anti-inflammatory molecular mechanisms of SGK1 and suggest novel interventional targets to inflammatory diseases relevant beyond the oral cavity.	[Han, Xiao; Ren, Junling; Lohner, Hannah; Wang, Huizhi] Virginia Commonwealth Univ, Dept Oral & Craniofacial Mol Biol, VCU Philips Inst Oral Hlth Res, Richmond, VA 23284 USA; [Yakoumatos, Lan] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Liang, Ruqiang] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Virginia Commonwealth University; University of Louisville; University of California System; University of California Davis	Wang, HZ (corresponding author), Virginia Commonwealth Univ, Dept Oral & Craniofacial Mol Biol, VCU Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.	wangh3@vcu.edu		Lohner, Hannah/0000-0003-3421-8297; Wang, Huizhi/0000-0001-7692-2106; , xiao/0000-0002-5065-4489	US National Institutes of Health, National Institute of Dental and Craniofacial Research [DE026727, F31DE031968]; VCU Presidential Research Quest Fund award	US National Institutes of Health, National Institute of Dental and Craniofacial Research; VCU Presidential Research Quest Fund award	This research was supported by grants DE026727 (to H. W.) and F31DE031968 (to H. L.) from the US National Institutes of Health, National Institute of Dental and Craniofacial Research, and VCU Presidential Research Quest Fund award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Adamowicz K, 2012, MOL MED, V18, P1190, DOI 10.2119/molmed.2012.00180; Berker E, 2013, J PERIODONTOL, V84, P1337, DOI 10.1902/jop.2012.120422; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dhillon B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00104; Di Cristofano A, 2017, CURR TOP DEV BIOL, V123, P49, DOI 10.1016/bs.ctdb.2016.11.006; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Etemadi N, 2015, ELIFE, V4, DOI 10.7554/eLife.10592; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hajishengallis G, 2021, NAT REV IMMUNOL, V21, P426, DOI 10.1038/s41577-020-00488-6; Hajishengallis G, 2020, PERIODONTOL 2000, V82, P78, DOI 10.1111/prd.12313; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hroch M, 2012, J CHROMATOGR B, V880, P90, DOI 10.1016/j.jchromb.2011.11.022; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Lalani Almin I, 2015, Macrophage (Houst), V2, pe1009; Lang F, 2009, EXPERT OPIN THER TAR, V13, P1303, DOI 10.1517/14728220903260807; Li C, 2017, J PERIODONTOL, V88, pE129, DOI 10.1902/jop.2017.160815; Li JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10677-0; Li YJ, 2019, J IMMUNOL, V202, P2044, DOI 10.4049/jimmunol.1801286; Lin WJ, 2011, P NATL ACAD SCI USA, V108, P18354, DOI 10.1073/pnas.1109427108; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lu LH, 2020, FASEB J, V34, P9120, DOI 10.1096/fj.201902697RR; Lu XH, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0903-x; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Matthias J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau0683; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nakayama M, 2015, J BIOL CHEM, V290, P5190, DOI 10.1074/jbc.M114.591610; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30385; Parvatiyar K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05168-7; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pohl P, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02419-0; Ren JL, 2021, J IMMUNOL, V207, P268, DOI 10.4049/jimmunol.2001455; Schmid E, 2014, CELL PHYSIOL BIOCHEM, V34, P943, DOI 10.1159/000366311; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stafford P, 2013, MOL ORAL MICROBIOL, V28, P366, DOI 10.1111/omi.12030; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Workman LM, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00429-19; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xia Zong-Ping, 2005, Sci STKE, V2005, ppe7, DOI 10.1126/stke.2722005pe7; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu WZ, 2020, ADV PROTEIN CHEM STR, V120, P45, DOI 10.1016/bs.apcsb.2019.12.001; Yang DQ, 2020, MOL IMMUNOL, V118, P153, DOI 10.1016/j.molimm.2019.12.013; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Yang XD, 2015, IMMUNOL REV, V266, P56, DOI 10.1111/imr.12311; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou HX, 2015, FASEB J, V29, P3737, DOI 10.1096/fj.15-270462; Zhou Y, 2015, INFECT IMMUN, V83, P3195, DOI 10.1128/IAI.00302-15; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	76	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102036	10.1016/j.jbc.2022.102036	http://dx.doi.org/10.1016/j.jbc.2022.102036			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35588785	Green Published, gold			2022-12-26	WOS:000811813400002
J	Sakiyama, Y; Nagata, M; Yoshida, R; Kasho, K; Ozaki, S; Katayama, T				Sakiyama, Yukari; Nagata, Mariko; Yoshida, Ryusei; Kasho, Kazutoshi; Ozaki, Shogo; Katayama, Tsutomu			Concerted actions of DnaA complexes with DNA-unwinding sequences within and flanking replication origin oriC promote DnaB helicase loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI CHROMOSOMAL ORIGIN; ESCHERICHIA-COLI; STRUCTURAL BASIS; INITIATION COMPLEX; E. COLI; PROTEIN; RECOGNITION; SITES; RING; LOADER	Unwinding of the replication origin and loading of DNA helicases underlie the initiation of chromosomal replication. In Escherichia coli, the minimal origin oriC contains a duplex unwinding element (DUE) region and three (Left, Middle, and Right) regions that bind the initiator protein DnaA. The Left/ Right regions bear a set of DnaA-binding sequences, constituting the Left/Right-DnaA subcomplexes, while the Middle region has a single DnaA-binding site, which stimulates formation of the Left/Right-DnaA subcomplexes. In addition, a DUE -flanking AT-cluster element (TATTAAAAAGAA) is located just outside of the minimal oriC region. The Left-DnaA subcomplex promotes unwinding of the flanking DUE exposing TT[A/G]T(T) sequences that then bind to the Left-DnaA sub complex, stabilizing the unwound state required for DnaB helicase loading. However, the role of the Right-DnaA sub complex is largely unclear. Here, we show that DUE unwinding by both the Left/Right-DnaA subcomplexes, but not the LeftDnaA subcomplex only, was stimulated by a DUE-terminal subregion flanking the AT-cluster. Consistently, we found the Right-DnaA subcomplex-bound single-stranded DUE and AT-cluster regions. In addition, the Left/Right-DnaA sub complexes bound DnaB helicase independently. For only the Left-DnaA subcomplex, we show the AT-cluster was crucial for DnaB loading. The role of unwound DNA binding of the RightDnaA subcomplex was further supported by in vivo data. Taken together, we propose a model in which the Right-DnaA sub complex dynamically interacts with the unwound DUE, assisting in DUE unwinding and efficient loading of DnaB helicases, while in the absence of the Right-DnaA subcomplex, the AT-cluster assists in those processes, supporting robustness of replication initiation.	[Sakiyama, Yukari; Nagata, Mariko; Yoshida, Ryusei; Kasho, Kazutoshi; Ozaki, Shogo; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka, Japan; [Sakiyama, Yukari] Daiichi Sankyo Co Tokyo, Tokyo, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka, Japan.	katayama@phar.kyushu-u.ac.jp		Ozaki, Shogo/0000-0002-4384-1366; Kasho, Kazutoshi/0000-0003-0326-0740	JSPS KAKENHI [JP20H03212, JP17H03656, JP20K15717, JP19K23729]; JSPS [JP16J02075, JP22J11077]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-aid for Scientific Research, JSPS KAKENHI Grant numbers: JP20H03212, JP17H03656, JP20K15717, and JP19K23729, in addition to JSPS pre-doctoral fellowships (to Y. S. and R. Y.) : JP16J02075 and JP22J11077.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Amin A, 2020, CELL REP, V30, P3323, DOI 10.1016/j.celrep.2020.02.046; Arias-Palomo E, 2019, MOL CELL, V74, P173, DOI 10.1016/j.molcel.2019.01.023; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; ASAI T, 1990, EMBO J, V9, P4065, DOI 10.1002/j.1460-2075.1990.tb07628.x; BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chodavarapu S, 2016, ENZYMES, V39, P1, DOI 10.1016/bs.enz.2016.03.001; Chodavarapu S, 2016, NUCLEIC ACIDS RES, V44, P210, DOI 10.1093/nar/gkv961; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Coster G, 2017, SCIENCE, V357, P314, DOI 10.1126/science.aan0063; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2017, J BIOL CHEM, V292, P20871, DOI 10.1074/jbc.M117.807644; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Grimwade JE, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.732270; Hayashi C, 2020, J BIOL CHEM, V295, P11131, DOI 10.1074/jbc.RA120.014235; HWANG DS, 1992, J BIOL CHEM, V267, P23087; HWANG DS, 1992, J BIOL CHEM, V267, P23083; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kasho K, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.697712; Katayama T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02496; Kaur G, 2014, MOL MICROBIOL, V91, P1148, DOI 10.1111/mmi.12525; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Leonard AC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02009; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Nagata K, 2020, J BIOCHEM, V167, P1, DOI 10.1093/jb/mvz087; Noguchi Y, 2015, J BIOL CHEM, V290, P20295, DOI 10.1074/jbc.M115.662601; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Sakiyama Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02017; Sakiyama Y, 2017, NUCLEIC ACIDS RES, V45, P12354, DOI 10.1093/nar/gkx914; Shimizu M, 2016, P NATL ACAD SCI USA, V113, pE8021, DOI 10.1073/pnas.1609649113; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; Sugiyama R, 2019, NUCLEIC ACIDS RES, V47, P11209, DOI 10.1093/nar/gkz795; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; Wolanski M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00735	53	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102051	10.1016/j.jbc.2022.102051	http://dx.doi.org/10.1016/j.jbc.2022.102051			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35598828	gold, Green Published			2022-12-26	WOS:000816927100005
J	Wirth, A; Labus, J; Galil, DA; Schill, Y; Schmidt, S; Bunke, T; Gorinski, N; Yokoi, N; Fukata, M; Ponimaskin, E				Wirth, Alexander; Labus, Josephine; Galil, Dalia Abdel; Schill, Yvonne; Schmidt, Silke; Bunke, Tania; Gorinski, Nataliya; Yokoi, Norihiko; Fukata, Masaki; Ponimaskin, Evgeni			Palmitoylation of the small GTPase Cdc42 by DHHC5 modulates spine formation and gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; IDENTIFICATION; LOCALIZATION; CYCLES	The small GTPase Cdc42 exists in the form of two alternatively spliced variants that are modified by hydrophobic chains: the ubiquitously expressed Cdc42-prenyl and a brainspecific isoform that can be palmitoylated, Cdc42-palm. Our previous work demonstrated that Cdc42-palm can be palmitoylated at two cysteine residues, Cys188 and Cys189, while Cys188 can also be prenylated. We showed that palmitoylation of Cys188 is essential for the plasma membrane localization of Cdc42-palm and is critically involved in Cdc42-mediated regulation of gene transcription and neuronal morphology. However, the abundance and regulation of this modification was not investigated. In the present study, we found that only a minor fraction of Cdc42 undergoes monopalmitoylation in neuroblastoma cells and in hippocampal neurons. In addition, we identified DHHC5 as one of the major palmitoyl acyltransferases that could physically interact with Cdc42-palm. We demonstrate that overexpression of dominant negative DHHC5 mutant decreased palmitoylation and plasma membrane localization of Cdc42-palm. In addition, knockdown of DHHC5 significantly reduced Cdc42-palm palmitoylation, leading to a decrease of Cdc42-mediated gene transcription and spine formation in hippocampal neurons. We also found that the expression of DHHC5 in the brain is developmentally regulated. Taken together, these findings suggest that DHHC5-mediated palmitoylation of Cdc42 represents an important mechanism for the regulation of Cdc42 functions in hippocampus.	[Wirth, Alexander; Labus, Josephine; Galil, Dalia Abdel; Schill, Yvonne; Schmidt, Silke; Bunke, Tania; Gorinski, Nataliya; Ponimaskin, Evgeni] Hannover Med Sch, Cellular Neurophysiol, Hannover, Germany; [Yokoi, Norihiko; Fukata, Masaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Mol & Cellular Physiol, Div Membrane Physiol, Okazaki, Japan	Hannover Medical School; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Ponimaskin, E (corresponding author), Hannover Med Sch, Cellular Neurophysiol, Hannover, Germany.	Ponimaskin.Evgeni@mh-hannover.de	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806	DFG [PO732, LA4465]	DFG(German Research Foundation (DFG))	This work was supported by the DFG Grant PO732 to E. P. and grant LA4465 to J. L.	Abrami L, 2017, ELIFE, V6, DOI 10.7554/eLife.27826; Bijata M, 2017, CELL REP, V19, P1767, DOI 10.1016/j.celrep.2017.05.023; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Brigidi GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9200; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Globa AK, 2017, CURR OPIN NEUROBIOL, V45, P210, DOI 10.1016/j.conb.2017.02.016; Gorinski N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11876-5; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Kanadome T, 2019, METHODS MOL BIOL, V2009, P83, DOI 10.1007/978-1-4939-9532-5_7; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kobe F, 2012, J NEUROSCI, V32, P2915, DOI 10.1523/JNEUROSCI.2765-11.2012; Lee SJ, 2021, J CELL SCI, V134, DOI 10.1242/jcs.251967; Moutin E, 2017, CEREB CORTEX, V27, P3618, DOI 10.1093/cercor/bhw183; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Plain F, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01145-3; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Shimell JJ, 2021, J CELL SCI, V134, DOI 10.1242/jcs.254276; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Wang H, 2008, J CELL MOL MED, V12, P304, DOI 10.1111/j.1582-4934.2007.00155.x; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Wirth A, 2013, BIOCHEM J, V456, P311, DOI 10.1042/BJ20130788; Woodley KT, 2019, EMBO REP, V20, DOI 10.15252/embr.201847472; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yap K, 2016, CELL REP, V15, P1316, DOI 10.1016/j.celrep.2016.04.012; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016	34	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102048	10.1016/j.jbc.2022.102048	http://dx.doi.org/10.1016/j.jbc.2022.102048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35597282	Green Published, gold			2022-12-26	WOS:000811243600001
J	Dufeil, E; Kenfack, B; Tincho, E; Fouogue, J; Wisniak, A; Sormani, J; Vassilakos, P; Petignat, P				Dufeil, Eva; Kenfack, Bruno; Tincho, Evelyn; Fouogue, Jovanny; Wisniak, Ania; Sormani, Jessica; Vassilakos, Pierre; Petignat, Patrick			Addition of digital VIA/VILI to conventional naked-eye examination for triage of HPV-positive women: A study conducted in a low-resource setting	PLOS ONE			English	Article							HIV-INFECTED WOMEN; VISUAL INSPECTION; ACETIC-ACID; CANCER; ACCURACY; TESTS	Background World Health Organization guidelines for cervical cancer screening recommend HPV testing followed by visual inspection with acetic acid (VIA) for triage if HPV positive. In order to improve visual assessment and identification of cervical intraepithelial neoplasia grade 2 and worse (CIN2+), providers may use visual aids such as digital cameras. Objectives To determine whether combined examination by naked-eye and digital VIA (D-VIA) and VILI (D-VILI) improves detection of CIN2+ as compared to the conventional evaluation. Materials and methods Women (30-49 years) living in Dschang (West Cameroon) were prospectively invited to a cervical cancer screening campaign. Primary HPV-based screening was followed by VIA/VILI and D-VIA/VILI if HPV-positive. Health care providers independently defined diagnosis (pathological or non-pathological) based on naked-eye VIA/VILI and D-VIA/VILI. Decision to treat was based on combined examination (VIA/VILI and D-VIA/VILI). Cervical biopsy and endocervical curettage were performed in all HPV-positive participants and considered as reference standard. Diagnostic performance of individual and combined naked-eye VIA/VILI and D-VIA/VILI was evaluated. A sample size of 1,500 women was calculated assuming a prevalence of 20% HPV positivity and 10% CIN2+ in HPV-positive women. Results Due to the COVID-19 pandemic, the study had to terminate prematurely. A total of 1,081 women with a median age of 40 (IQR 35.5-45) were recruited. HPV positivity was 17.4% (n = 188) and 26 (14.4%) had CIN2+. Naked-eye VIA and D-VIA sensitivities were 80.8% (95% CI 60.6-93.4) and 92.0% (95% CI 74.0-99.0), and specificities were 31.2% (95% CI 24-39.1) and 31.6% (95% CI 24.4-39.6), respectively. The combination of both methods yielded a sensitivity of 92.3% (95% CI 74.9-99.1) and specificity of 23.2% (95% CI 16.8-30.7). A trend towards improved sensitivity was observed, but did not reach statistical significance. Conclusion Addition of D-VIA/VILI to conventional naked-eye examination may be associated with improved CIN2+ identification. Further studies including a larger sample size are needed to confirm these results.	[Dufeil, Eva; Petignat, Patrick] Univ Geneva, Fac Med, Geneva, Switzerland; [Kenfack, Bruno; Tincho, Evelyn] Univ Dschang, Fac Med & Pharmaceut Sci, Dschang, Cameroon; [Kenfack, Bruno] Dist Hosp Dschang, Dept Gynecol & Obstet, Dschang, Cameroon; [Tincho, Evelyn] Ctr Hosp Univ CHUY, Fac Med & Biomed Sci, Dept Gynecol & Obstet, Yaounde, Cameroon; [Fouogue, Jovanny] Bafoussam Reg Hosp, Dept Obstet & Gynecol, Bafoussam, Cameroon; [Wisniak, Ania; Sormani, Jessica; Vassilakos, Pierre; Petignat, Patrick] Univ Hosp Geneva, Dept Gynecol & Obstet, Gynecol Div, Geneva, Switzerland; [Wisniak, Ania] Geneva Univ Hosp, Dept Primary Care, Populat Epidemiol Unit, Geneva, Switzerland; [Sormani, Jessica] HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Applied Sciences & Arts Western Switzerland	Dufeil, E (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.	eva-camille.dufeil@etu.unige.ch		Tsuala Fouogue, Jovanny/0000-0003-0055-0902; Sormani, Jessica/0000-0001-7111-3975; KENFACK, Bruno/0000-0002-5157-1378; Wisniak, Ania/0000-0002-3942-2134; Dufeil, Eva/0000-0001-8260-8308	ESTHER Switzerland [17G1]; Service de Solidarite Internationale (Canton of Geneva); Hopitaux Universitaires de Geneve (HUG) (Switzerland); Fondation Privee of HUG; Commission des Affaires Humanitaires (CAH) of HUG; Groupement Romand de la Societe Suisse de Gynecologie et Obstetrique (GRSSGO); University of Dschang (Cameroon)	ESTHER Switzerland; Service de Solidarite Internationale (Canton of Geneva); Hopitaux Universitaires de Geneve (HUG) (Switzerland); Fondation Privee of HUG; Commission des Affaires Humanitaires (CAH) of HUG; Groupement Romand de la Societe Suisse de Gynecologie et Obstetrique (GRSSGO); University of Dschang (Cameroon)	This study was funded by ESTHER Switzerland 17G1, Service de Solidarite Internationale (Canton of Geneva), Hopitaux Universitaires de Geneve (HUG) (Switzerland), the Fondation Privee of HUG, the Commission des Affaires Humanitaires (CAH) of HUG, the Groupement Romand de la Societe Suisse de Gynecologie et Obstetrique (GRSSGO), and the University of Dschang (Cameroon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgary R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030528; Bae JK, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/16467; Bigoni J, 2015, INT J CANCER, V137, P127, DOI 10.1002/ijc.29353; Carli P, 2004, J AM ACAD DERMATOL, V50, P683, DOI 10.1016/j.jaad.2003.09.009; Catarino R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134309; Chaib Fadela, 2020, CERVICAL CANC FREE F; Chibwesha CJ, 2016, J LOW GENIT TRACT DI, V20, P218, DOI 10.1097/LGT.0000000000000206; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Firnhaber C, 2015, J LOW GENIT TRACT DI, V19, P7, DOI 10.1097/LGT.0000000000000040; Gallay C, 2017, INT J WOMENS HEALTH, V9, P455, DOI 10.2147/IJWH.S136351; Globocan, 2021, CAMEROON; Katanga J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218559; Kunckler M, 2017, CANCER MED-US, V6, P1752, DOI 10.1002/cam4.1089; Leisenring W, 2000, BIOMETRICS, V56, P345, DOI 10.1111/j.0006-341X.2000.00345.x; Levy J, 2020, CANCER MED-US, V9, P7293, DOI 10.1002/cam4.3355; Mezei AK, 2017, INT J CANCER, V141, P437, DOI 10.1002/ijc.30695; Mittal S., 2020, ATLAS VISUAL INSPECT; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Qiao L, 2015, J OBSTET GYNAECOL RE, V41, P1313, DOI 10.1111/jog.12732; Randall TC, 2019, PREV MED, V118, P81, DOI 10.1016/j.ypmed.2018.10.006; Ricard-Gauthier D, 2015, J LOW GENIT TRACT DI, V19, P295, DOI 10.1097/LGT.0000000000000136; Sankaranarayanan R, 2014, ANN GLOB HEALTH, V80, P412, DOI 10.1016/j.aogh.2014.09.014; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Tebeu P-M., 2015, INT J CANCER, P8; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Urner E, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6697; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Vassilakos P., 2019, REV M DICALE SUISSE, P5; Vassilakos P, 2021, INT J GYNECOL CANCER, V31, P808, DOI 10.1136/ijgc-2020-002302; WHO, 2013, WHO GUID SCREEN TREA; Yeates Karen E, 2016, J Glob Oncol, V2, P356, DOI 10.1200/JGO.2015.001768	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0268015	10.1371/journal.pone.0268015	http://dx.doi.org/10.1371/journal.pone.0268015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35552564				2022-12-26	WOS:000868179400013
J	Langenbucher, A; Szentmary, N; Cayless, A; Weisensee, J; Wendelstein, J; Hoffmann, P				Langenbucher, Achim; Szentmary, Nora; Cayless, Alan; Weisensee, Johannes; Wendelstein, Jascha; Hoffmann, Peter			Translation model for CW chord to angle Alpha derived from a Monte-Carlo simulation based on raytracing	PLOS ONE			English	Article							CORNEAL LIGHT REFLEX; PUPIL CENTER; CENTRATION; KAPPA; OUTCOMES; LASIK; EYES	BackgroundThe Chang-Waring chord is provided by many ophthalmic instruments, but proper interpretation of this chord for use in centring refractive procedures at the cornea is not fully understood. The purpose of this study is to develop a strategy for translating the Chang-Waring chord (position of pupil centre relative to the Purkinje reflex PI) into angle Alpha using raytracing techniques. MethodsThe retrospective analysis was based on a large dataset of 8959 measurements of 8959 eyes from 1 clinical centre, using the Casia2 anterior segment tomographer. An optical model based on: corneal front and back surface radius Ra and Rp, asphericities Qa and Qp, corneal thickness CCT, anterior chamber depth ACD, and pupil centre position (X-Y position: Pup(X) and Pup(Y)), was defined for each measurement. Using raytracing rays with an incident angle I-X and I-Y the CW chord (CWX and CWY) was calculated. Using these data, a multivariable linear model was built up in terms of a Monte-Carlo simulation for a simple translation of incident ray angle to CW chord. ResultsRaytracing allows for calculation of the CW chord CWX/CWY from biometric measures and the incident ray angle I-X/I-Y. In our dataset mean values of CWX = 0.32 +/- 0.30 mm and CWY = -0.10 +/- 0.26 mm were derived for a mean incident ray angle (angle Alpha) of I-X = -5.02 +/- 1.77 degrees and I-Y = 0.01 +/- 1.47 degrees. The raytracing results could be modelled with a linear multivariable model, and the effect sizes for the prediction model for CWX are identified as Ra, Qa, Rp, CCT, ACD, Pup(X), Pup(Y), I-X, and for CWY they are Ra, Rp, Pup(Y), and I-Y. ConclusionToday the CW chord can be directly measured with any biometer, topographer or tomographer. If biometric measures of Ra, Qa, Rp, CCT, ACD, Pup(X), Pup(Y) are available in addition to the CW chord components CWX and CWY, a prediction of angle Alpha is possible using a simple matrix operation.	[Langenbucher, Achim; Weisensee, Johannes; Wendelstein, Jascha] Univ Saarland, Dept Expt Ophthalmol, Homburg, Germany; [Szentmary, Nora] Univ Saarland, Dr Rolf M Schwiete Ctr Limbal Stem Cell & Aniridia, Homburg, Germany; [Szentmary, Nora] Semmelwe Univ, Dept Ophthalmol, Budapest, Hungary; [Cayless, Alan] Open Univ, Sch Phys Sci, Milton Keynes, England; [Wendelstein, Jascha] Johannes Kepler Univ Linz, Med Fac, Linz, Austria; [Hoffmann, Peter] Augen & Laserklin Castrop Rauxel, Castrop Rauxel, Germany	Saarland University; Saarland University; Semmelweis University; Open University - UK; Johannes Kepler University Linz	Langenbucher, A (corresponding author), Univ Saarland, Dept Expt Ophthalmol, Homburg, Germany.	achim.langenbucher@uks.eu	Wendelstein, Jascha Armin/F-5389-2018	Wendelstein, Jascha Armin/0000-0003-4145-2559; Weisensee, Johannes/0000-0001-7741-1447				[Anonymous], ST PIERRE J QUATERNI; Mosquera SA, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0014-6; Barragan-Garza E, 2018, J REFRACT SURG, V34, P164, DOI 10.3928/1081597X-20180103-02; Barry JC, 1997, INVEST OPHTH VIS SCI, V38, P2597; Basmak H, 2007, J REFRACT SURG, V23, P456, DOI 10.3928/1081-597X-20070501-06; Braga-Mele R, 2014, J CATARACT REFR SURG, V40, P313, DOI 10.1016/j.jcrs.2013.12.011; Chan CCK, 2006, J REFRACT SURG, V22, P467; Chang DH, 2014, AM J OPHTHALMOL, V158, P863, DOI 10.1016/j.ajo.2014.06.028; Chang JSM, 2016, J CATARACT REFR SURG, V42, P412, DOI 10.1016/j.jcrs.2015.09.030; Chen YA, 2011, J CATARACT REFR SURG, V37, P513, DOI 10.1016/j.jcrs.2010.10.041; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Erdem U, 2008, J REFRACT SURG, V24, P530, DOI 10.3928/1081597X-20080501-12; Espaillat A, 2021, CLIN OPHTHALMOL, V15, P495, DOI 10.2147/OPTH.S282469; Fisus AD, 2021, J CATARACT REFR SURG, V47, P1302, DOI 10.1097/j.jcrs.0000000000000633; Fisus AD, 2021, J CATARACT REFR SURG, V47, P87, DOI 10.1097/j.jcrs.0000000000000373; Holladay JT, 2019, J CATARACT REFR SURG, V45, P1198, DOI 10.1016/j.jcrs.2019.03.029; Jiang JY, 2020, CLIN EXP OPHTHALMOL, V48, P998, DOI 10.1111/ceo.13800; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Kim EK, 1998, YONSEI MED J, V39, P317, DOI 10.3349/ymj.1998.39.4.317; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; Liu YJ, 2019, J OPT SOC AM A, V36, pB103, DOI 10.1364/JOSAA.36.00B103; Mahr MA, 2020, J CATARACT REFR SURG, V46, P372, DOI 10.1097/j.jcrs.0000000000000066; Moshirfar Majid, 2013, Oman J Ophthalmol, V6, P151, DOI 10.4103/0974-620X.122268; Okamoto S, 2009, J REFRACT SURG, V25, pS944, DOI 10.3928/1081597X-20090915-09; Park CY, 2012, CURR OPIN OPHTHALMOL, V23, P269, DOI 10.1097/ICU.0b013e3283543c41; Prakash G, 2011, EYE, V25, P1187, DOI 10.1038/eye.2011.150; Reinstein DZ, 2013, J REFRACT SURG, V29, P518, DOI 10.3928/1081597X-20130719-08; Ru XY, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/9873504; Wildenmann U, 2013, OPHTHAL PHYSL OPT, V33, P634, DOI 10.1111/opo.12086; Yang YB, 2002, INVEST OPHTH VIS SCI, V43, P2508; Zhang JM, 2020, INT OPHTHALMOL, V40, P3555, DOI 10.1007/s10792-020-01506-1; Zhang J, 2017, INT J OPHTHALMOL-CHI, V10, P624, DOI 10.18240/ijo.2017.04.20	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267028	10.1371/journal.pone.0267028	http://dx.doi.org/10.1371/journal.pone.0267028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576202	Green Published, gold, Green Accepted			2022-12-26	WOS:000835262300012
J	Medina, HN; Callahan, KE; Koru-Sengul, T; Maheshwari, S; Liu, QR; Goel, N; Pinheiro, PS				Medina, Heidy N.; Callahan, Karen E.; Koru-Sengul, Tulay; Maheshwari, Sfurti; Liu, Qinran; Goel, Neha; Pinheiro, Paulo S.			Elevated breast cancer mortality among highly educated Asian American women	PLOS ONE			English	Article							PACIFIC ISLANDER POPULATIONS; UNITED-STATES; SOCIOECONOMIC-STATUS; RISK-FACTORS; ACCULTURATION; PATTERNS; TRENDS; LEVEL; RATES; AGE	BackgroundPostmenopausal breast cancer (PMBC) is the most commonly diagnosed and the second leading cause of cancer death among women in the US. Research examining the association between PMBC and education level has been inconsistent; no study in the US has examined how educational level impacts PMBC mortality in Asian American women, a largely immigrant population with above-average educational attainment. MethodsCalifornia Vital Statistics data from 2012-2017 were analyzed to derive age-adjusted mortality rate ratios (MRRs) by education level (associates degree or above referred to as "higher education", high school, less than high school) and race [Non-Hispanic White (NHW), Asian/Pacific Islander (Asian), and its two largest subpopulations: Chinese and Filipino] from negative binomial regression models. ResultsPMBC mortality for both NHWs and Asians was greater among women with higher education compared to those who did not complete high school: NHWs had 22% higher PMBC mortality (MRR 1.22; 95% CI: 1.14-1.31) and Asians had 2.6 times greater PMBC mortality (MRR 2.64; 95% CI: 2.32-3.00) than their counterparts who did not complete high school. Asians in the lowest education level had 70% lower mortality than NHWs (MRR 0.30; 95% CI: 0.27-0.34). This mortality advantage among Asians was greatly reduced to only 27% lower among the highest educated (MRR 0.73; 95% CI: 0.68-0.78). For higher educated Filipina women, no mortality advantage was evident compared to NHWs (MRR 0.96; 95% CI: 0.88-1.05). ConclusionPMBC mortality for higher educated Asian women is elevated in comparison to their counterparts with less education. Given that PMBC survival is greater among those with higher education, our findings strongly suggest an excess in the incidence of PMBC (more than double) among higher educated Asian women; this warrants more research into potentially modifiable causes of PMBC in this burgeoning population.	[Medina, Heidy N.; Liu, Qinran] Univ Miami Miller, Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Callahan, Karen E.; Maheshwari, Sfurti] Univ Nevada Vegas, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV USA; [Koru-Sengul, Tulay; Pinheiro, Paulo S.] Univ Miami Miller, Sch Med, Sylvester Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Goel, Neha] Univ Miami Miller, Sch Med, Dept Surg, Div Surg Oncol, Miami, FL USA	University of Miami; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Miami; University of Miami	Pinheiro, PS (corresponding author), Univ Miami Miller, Sch Med, Sylvester Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL 33136 USA.	ppinheiro@med.miami.edu		Medina, Heidy/0000-0002-1999-6448; Liu, Qinran/0000-0001-7090-8485	Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine; National Cancer Institute of the National Institutes of Health [P30CA240139]; Florida Education Fund McKnight Doctoral Fellowship	Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Education Fund McKnight Doctoral Fellowship	Supplemental funding was provided by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. This research was also supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA240139. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding was also received from the Florida Education Fund McKnight Doctoral Fellowship.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; American Cancer Society, 2010, CANC FACTS FIG 2010; American Cancer Society, BREAST CANC EARL DET; [Anonymous], SEER CANC STAT FACTS; Barcelo A, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08633-7; Blewett L. A., 2019, IPUMS Health Surveys: National Health Interview Survey, Version 6.4 [dataset], DOI [10.18128/D070.V6.4, DOI 10.18128/D070.V6.4]; Budiman A, 2021, KEY FACTS ASIAN AM D; Callahan KE, 2017, J IMMIGR MINOR HEALT, V19, P1330, DOI 10.1007/s10903-016-0475-2; Choi Y, 2016, J YOUTH ADOLESCENCE, V45, P1380, DOI 10.1007/s10964-016-0496-0; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Dong JY, 2020, MENOPAUSE, V27, P113, DOI 10.1097/GME.0000000000001425; Gadeyne S, 2012, INT J CANCER, V131, P2878, DOI 10.1002/ijc.27538; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gomez SL, 2014, CANCER EPIDEM BIOMAR, V23, P2202, DOI 10.1158/1055-9965.EPI-14-0624; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, pS125, DOI 10.2105/AJPH.2009.163931; Gomez SL, 2004, AM J PUBLIC HEALTH, V94, P1977, DOI 10.2105/AJPH.94.11.1977; Griggs JJ, 2007, J CLIN ONCOL, V25, P277, DOI 10.1200/JCO.2006.08.3063; Heck KE, 1997, AM J EPIDEMIOL, V145, P366, DOI 10.1093/oxfordjournals.aje.a009114; Heck KE, 1997, AM J PUBLIC HEALTH, V87, P1218, DOI 10.2105/AJPH.87.7.1218; Huang V, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/986408; Hussain SK, 2008, INT J CANCER, V122, P165, DOI 10.1002/ijc.23007; Islami F, 2021, JNCI-J NATL CANCER I, V113, P1648, DOI 10.1093/jnci/djab131; Jiang JM, 2021, STAT METHODS MED RES, V30, P535, DOI 10.1177/0962280220962516; Jin HB, 2016, INT J CANCER, V138, P2136, DOI 10.1002/ijc.29958; John EM, 2005, CANCER EPIDEM BIOMAR, V14, P2905, DOI 10.1158/1055-9965.EPI-05-0483; Keegan THM, 2007, INT J CANCER, V120, P1324, DOI 10.1002/ijc.22432; Kim Catherine, 2005, Gend Med, V2, P13, DOI 10.1016/S1550-8579(05)80005-1; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; LeEspiritu Y, 2003, HOME BOUND: FILIPINO AMERICAN LIVES ACROSS CULTURES, COMMUNITIES, AND COUNTRIES, P1; Liu Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006641; MANDELBLATT J, 1991, AM J PUBLIC HEALTH, V81, P646, DOI 10.2105/AJPH.81.5.646; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Medina HN, 2021, CANCER EPIDEM BIOMAR, V30, P1387, DOI 10.1158/1055-9965.EPI-20-1528; Menvielle G, 2006, BRIT J CANCER, V94, P152, DOI 10.1038/sj.bjc.6602907; Miller BA, 2008, CANCER CAUSE CONTROL, V19, P227, DOI 10.1007/s10552-007-9088-3; Morey BN, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180221; Pinheiro Paulo S., 2014, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgu016; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Rogot E., 1992, MORTALITY STUDY 1 3; Ruggles S., 2018, IPUMS US VERSION 9 0; Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372; Sprague BL, 2011, CANCER-AM CANCER SOC, V117, P1542, DOI 10.1002/cncr.25589; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Thompson CA, 2016, CANCER EPIDEM BIOMAR, V25, P1371, DOI 10.1158/1055-9965.EPI-16-0167; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; Torre LA, 2016, CA-CANCER J CLIN, V66, P182, DOI 10.3322/caac.21335; Trewin CB, 2017, EUR J PUBLIC HEALTH, V27, P160, DOI 10.1093/eurpub/ckw148; UCLA Center for Health Policy Research Los Angeles CA, ASKCHIS	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268617	10.1371/journal.pone.0268617	http://dx.doi.org/10.1371/journal.pone.0268617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584182	gold, Green Published			2022-12-26	WOS:000834613800007
J	Okorie, C; Gatsby, EE; Schroeck, F; Ismail, AAO; Lynch, K				Okorie, Chiamaka; Gatsby, Elise E.; Schroeck, Florian; Ould Ismail, A. Aziz; Lynch, Kristine			Using electronic health records to streamline provider recruitment for implementation science studies	PLOS ONE			English	Article							CLINICAL-RESEARCH; MEDICAL-RECORDS; CODING ERRORS	BackgroundHealthcare providers are often targeted as research participants, especially for implementation science studies evaluating provider- or system-level issues. Frequently, provider eligibility is based on both provider and patient factors. Manual chart review and self-report are common provider screening strategies but require substantial time, effort, and resources. The automated use of electronic health record (EHR) data may streamline provider identification for implementation science research. Here, we describe an approach to provider screening for a Veterans Health Administration (VHA)-funded study focused on implementing risk-aligned surveillance for bladder cancer patients. MethodsOur goal was to identify providers at 6 pre-specified facilities who performed >= 10 surveillance cystoscopy procedures among bladder cancer patients in the 12 months prior to recruitment start on January 16, 2020, and who were currently practicing at 1 of 6 pre-specified facilities. Using VHA EHR data (using CPT, ICD10 procedure, and ICD10 diagnosis codes), we identified cystoscopy procedures performed after an initial bladder cancer diagnosis (i.e., surveillance procedures). Procedures were linked to VHA staff data to determine the provider of record, the number of cystoscopies they performed, and their current location of practice. To validate this approach, we performed a chart review of 105 procedures performed by a random sample of identified providers. The proportion of correctly identified procedures was calculated (Positive Predictive Value (PPV)), along with binomial 95% confidence intervals (CI). FindingsWe identified 1,917,856 cystoscopies performed on 703,324 patients from October 1, 1999-January 16, 2020, across the nationwide VHA. Of those procedures, 40% were done on patients who had a prior record of bladder cancer and were completed by 15,065 distinct providers. Of those, 61 performed >= 10 procedures and were currently practicing at 1 of the 6 facilities of interest in the 1 year prior to study recruitment. The random chart review of 7 providers found 101 of 105 procedures (PPV: 96%; 95% CI: 91% to 99%) were surveillance procedures and were performed by the selected provider on the recorded date. ImplicationsThese results show that EHR data can be used for accurate identification of healthcare providers as research participants when inclusion criteria consist of both patient- (temporal relationship between diagnosis and procedure) and provider-level (frequency of procedure and location of current practice) factors. As administrative codes and provider identifiers are collected in most, if not all, EHRs for billing purposes this approach can be translated from provider recruitment in VHA to other healthcare systems. Implementation studies should consider this method of screening providers.	[Okorie, Chiamaka; Schroeck, Florian] Dartmouth Coll, Geisel Sch Med, Lebanon, NH USA; [Gatsby, Elise E.; Lynch, Kristine] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA; [Gatsby, Elise E.; Lynch, Kristine] Univ Utah, Salt Lake City, UT 84112 USA; [Schroeck, Florian; Ould Ismail, A. Aziz] White River Junct VA Med Ctr, White River Jct, VT USA; [Schroeck, Florian] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA; [Schroeck, Florian] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Schroeck, Florian] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Lynch, K (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA.; Lynch, K (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	Kristine.Lynch@VA.gov		Okorie, Chiamaka/0000-0003-2233-4557; Ould Ismail, Abdol Aziz/0000-0001-8775-5913	Department of Veterans Affairs Health Services Research Development [IIR 18-215, I01HX002780-01]	Department of Veterans Affairs Health Services Research Development(US Department of Veterans Affairs)	Disclaimer. Opinions expressed in this manuscript are those of the authors and do not constitute official positions of the US Federal Government or the Department of Veterans Affairs. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], HIST IT VA DIGITALVA; Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Bakaeen FG, 2014, JAMA SURG, V149, P507, DOI 10.1001/jamasurg.2013.4150; Ballaro A, 2000, BJU INT, V85, P389, DOI 10.1046/j.1464-410x.2000.00471.x; Bauer MS, 2020, PSYCHIAT RES, V283, DOI 10.1016/j.psychres.2019.04.025; Beauharnais CC, 2012, CLIN TRIALS, V9, P198, DOI 10.1177/1740774511434844; Coorevits P, 2013, J INTERN MED, V274, P547, DOI 10.1111/joim.12119; Cowie MR, 2017, CLIN RES CARDIOL, V106, P1, DOI 10.1007/s00392-016-1025-6; Dupont D, 2017, INT J MED INFORM, V97, P341, DOI 10.1016/j.ijmedinf.2016.11.003; Effoe VS, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1631-7; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Gordon MK, 2020, J ATTEN DISORD, V24, P1457, DOI 10.1177/1087054715624227; Hayrinen K, 2008, INT J MED INFORM, V77, P291, DOI 10.1016/j.ijmedinf.2007.09.001; Hysong SJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-125; Khwaja HA, 2002, BJU INT, V89, P178, DOI 10.1046/j.1464-4096.2001.01428.x; Kirchner JE, 2020, PSYCHIAT RES, V283, DOI 10.1016/j.psychres.2019.06.042; Lynch KE, 2019, APPL CLIN INFORM, V10, P794, DOI 10.1055/s-0039-1697598; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Schroeck FR, 2022, JCO ONCOL PRACT, V18, P79, DOI 10.1200/OP.21.00226; Schroeck FR, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3442; Schroeck FR, 2018, UROL ONCOL-SEMIN ORI, V36, P257, DOI 10.1016/j.urolonc.2017.12.016; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Thacker T, 2016, MOV DISORD CLIN PRAC, V3, P507, DOI 10.1002/mdc3.12318; van Dijk WB, 2021, J CLIN EPIDEMIOL, V132, P97, DOI 10.1016/j.jclinepi.2020.11.014; van Velthoven MH, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0332-1; Velarde KE, 2018, CONT CLIN TRIAL COMM, V11, P107, DOI 10.1016/j.conctc.2018.07.001; Weiskopf Nicole G, 2019, AMIA Annu Symp Proc, V2019, P903; Williamson Tyler, 2017, CMAJ Open, V5, pE830, DOI 10.9778/cmajo.20170077	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267915	http://dx.doi.org/10.1371/journal.pone.0267915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560153	Green Published, gold			2022-12-26	WOS:000835326900026
J	Reinders, JD; Reinders, EE; Robinson, EA; Moar, WJ; Price, PA; Head, GP; Meinke, LJ				Reinders, Jordan D.; Reinders, Emily E.; Robinson, Emily A.; Moar, William J.; Price, Paula A.; Head, Graham P.; Meinke, Lance J.			Characterizing the sublethal effects of SmartStax PRO dietary exposure on life history traits of the western corn rootworm, Diabrotica virgifera virgifera LeConte	PLOS ONE			English	Article							HELICOVERPA-ZEA LEPIDOPTERA; COLEOPTERA-CHRYSOMELIDAE; TRANSGENIC CORN; FITNESS COSTS; OVARIAN DEVELOPMENT; ADULT EMERGENCE; BT MAIZE; RESISTANCE; CRY3BB1; OVIPOSITION	The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte, is an economically important pest of field corn (Zea mays L.) across the United States (U.S.) Corn Belt. Repeated use of transgenic hybrids expressing Bacillus thuringiensis (Bt) proteins has selected for field-evolved resistance to all current rootworm-active Bt proteins. The newest product available for WCR management is SmartStax (R) PRO, a rootworm-active pyramid containing Cry3Bb1, Cry34/35Ab1 [now reclassified as Gpp34Ab1/Tpp35Ab1] and a new mode of action, DvSnf7 dsRNA. Understanding the fitness of adult WCR after dietary exposure to SmartStax (R) PRO will identify potential impacts on WCR population dynamics and inform efforts to optimize resistance management strategies. Therefore, the objective of the present study was to characterize the effect of SmartStax (R) PRO dietary exposure on WCR life history traits. Adult WCR were collected during 2018 and 2019 from emergence tents placed over replicated field plots of SmartStax (R) PRO or non-rootworm Bt corn at a site with a history of rootworm-Bt trait use and suspected resistance to Cry3Bb1 and Cry34/35Ab1. Adult survival was reduced by 97.1-99.7% in SmartStax (R) PRO plots relative to the non-rootworm Bt corn plots during the study. Individual male/female pairs were fed different diets of ear tissue to simulate lifetime or adult exposure. Life history parameters measured included adult longevity, adult head capsule width, lifetime female egg production, and egg viability. Results indicate that lifetime or adult exposure to SmartStax (R) PRO significantly reduced adult longevity and lifetime egg production. Larval exposure to SmartStax (R) PRO significantly reduced WCR adult size. Results from this study collectively suggest that SmartStax (R) PRO may negatively impact WCR life history traits, which may lead to reduced population growth when deployed in an area with WCR resistance to Bt traits.	[Reinders, Jordan D.; Reinders, Emily E.; Meinke, Lance J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Robinson, Emily A.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Moar, William J.; Price, Paula A.; Head, Graham P.] Bayer AG, Crop Sci Div, Chesterfield, MO USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Bayer AG	Reinders, JD (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	jordan.reinders3@gmail.com	Reinders, Jordan D./GZH-1953-2022	Reinders, Jordan D./0000-0003-3937-6745				Abendroth L.W., 2011, 1009 PMR; Al-Deeb MA, 2005, J KANSAS ENTOMOL SOC, V78, P142, DOI 10.2317/0403.04.1; Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Becker SC, 2006, THESIS U NEBRASKA LI; Bilbo TR, 2018, J ECON ENTOMOL, V111, P2233, DOI 10.1093/jee/toy203; Binning RR, 2010, J APPL ENTOMOL, V134, P551, DOI 10.1111/j.1439-0418.2010.01530.x; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; BRANSON TF, 1985, ENVIRON ENTOMOL, V14, P687, DOI 10.1093/ee/14.6.687; BRANSON TF, 1973, J ECON ENTOMOL, V66, P417, DOI 10.1093/jee/66.2.417; Calles-Torrez V, 2019, J ECON ENTOMOL, V112, P1875, DOI 10.1093/jee/toz111; Clark TL, 2012, J APPL ENTOMOL, V136, P721, DOI 10.1111/j.1439-0418.2012.01709.x; Crickmore N, 2021, J INVERTEBR PATHOL, V186, DOI 10.1016/j.jip.2020.107438; Crowder DW, 2005, J ECON ENTOMOL, V98, P534, DOI 10.1603/0022-0493-98.2.534; dataset] U.S. Environmental Protection Agency, 2017, EJSCREEN TECHN DOC; El Khishen AA, 2009, J ECON ENTOMOL, V102, P2350, DOI 10.1603/029.102.0642; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; FISHER JR, 1989, J KANSAS ENTOMOL SOC, V62, P607; Gassmann AJ, 2021, INSECTS, V12, DOI 10.3390/insects12020136; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GOULD F, 1986, ENVIRON ENTOMOL, V15, P1, DOI 10.1093/ee/15.1.1; Gray ME., 2015, ANTENNA ECE SPEC, V39, P100; Head G, 2014, CROP PROT, V57, P38, DOI 10.1016/j.cropro.2013.11.025; Head GP, 2017, PEST MANAG SCI, V73, P1883, DOI 10.1002/ps.4554; HILL RE, 1975, J ECON ENTOMOL, V68, P311, DOI 10.1093/jee/68.3.311; Hitchon AJ, 2015, J ECON ENTOMOL, V108, P1986, DOI 10.1093/jee/tov125; Ingber DA, 2015, J ECON ENTOMOL, V108, P2421, DOI 10.1093/jee/tov199; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; Kang J, 2009, J ECON ENTOMOL, V102, P2096, DOI 10.1603/029.102.0612; Kang J, 2009, ANN ENTOMOL SOC AM, V102, P326, DOI 10.1603/008.102.0215; Khajuria C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197059; Lefko SA, 2008, J APPL ENTOMOL, V132, P189, DOI 10.1111/j.1439-0418.2008.01279.x; Levine Eli, 2002, American Entomologist, V48, P94; Li HM, 2009, ENTOMOL EXP APPL, V131, P254, DOI 10.1111/j.1570-7458.2009.00856.x; Ludwick DC, 2017, J APPL ENTOMOL, V141, P28, DOI 10.1111/jen.12377; Martinez JC, 2016, ENVIRON ENTOMOL, V45, P747, DOI 10.1093/ee/nvw015; Meihls LN, 2016, ENVIRON ENTOMOL, V45, P526, DOI 10.1093/ee/nvv226; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2021, INSECTS, V12, DOI 10.3390/insects12020112; Meissle M, 2011, PEST MANAG SCI, V67, P807, DOI 10.1002/ps.2117; Moar W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169175; Monsanto Company, 2013, PET DET NONR STAT CO; Murphy AF, 2010, J ECON ENTOMOL, V103, P147, DOI 10.1603/EC09156; Murphy AF, 2011, ENVIRON ENTOMOL, V40, P1585, DOI 10.1603/EN11137; Murphy AF, 2011, ENTOMOL EXP APPL, V139, P8, DOI 10.1111/j.1570-7458.2011.01100.x; Nowatzki TM, 2006, J ECON ENTOMOL, V99, P927, DOI 10.1603/0022-0493-99.3.927; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Paddock KJ, 2021, PEST MANAG SCI, V77, P2385, DOI 10.1002/ps.6266; Pan ZQ, 2011, ENVIRON ENTOMOL, V40, P964, DOI 10.1603/EN10305; Pereira A. E., 2016, J RNAI GENE SILENCIN, V12, P528; Pereira AE, 2017, J ECON ENTOMOL, V110, P2545, DOI 10.1093/jee/tox263; Prasifka PL, 2013, J ECON ENTOMOL, V106, P823, DOI 10.1603/EC12392; QUIRING DT, 1990, J APPL ECOL, V27, P965, DOI 10.2307/2404390; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Reindere JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208266; Reinders JD, 2021, THESIS U NEBRASKA LI; Reinders JD, 2022, PEST MANAG SCI, V78, P1356, DOI 10.1002/ps.6752; Reisig DD, 2015, ENVIRON ENTOMOL, V44, P1275, DOI 10.1093/ee/nvv076; Sachs ES, 1996, ENVIRON ENTOMOL, V25, P1257, DOI 10.1093/ee/25.6.1257; SAS Institute Inc, 2001, SASSTAT USERS GUIDE; SHERWOOD DR, 1993, J ECON ENTOMOL, V86, P1664, DOI 10.1093/jee/86.6.1664; SHORT DE, 1972, J ECON ENTOMOL, V65, P685, DOI 10.1093/jee/65.3.685; Sousa FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156608; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; St Clair CR, 2020, J ECON ENTOMOL, V113, P2473, DOI 10.1093/jee/toaa168; St Clair CR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237094; Storer NP, 2001, J ECON ENTOMOL, V94, P1268, DOI 10.1603/0022-0493-94.5.1268; Stroup W.W., 2018, SAS MIXED MODELS INT; Stroup WW, 2015, AGRON J, V107, P811, DOI 10.2134/agronj2013.0342; U.S. Environmental Protection Agency, 2003, PEST PROD LAB CORN E; U.S. Environmental Protection Agency, 2012, PEST PROD LAB BT11 M; U.S. Environmental Protection Agency, 2009, PEST PROD LAB MON 89; U.S. Environmental Protection Agency, 2012, PEST PROD LAB 5307 C; U.S. Environmental Protection Agency, 2006, PEST PROD LAB AGR RW; U.S. Environmental Protection Agency, 2005, PEST PROD LAB HERC X; U.S. Environmental Protection Agency, 2016, FRAM DEL CORN ROOTW; Urquhart W, 2015, REGUL TOXICOL PHARM, V73, P607, DOI 10.1016/j.yrtph.2015.09.004; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wangila DS, 2017, J APPL ENTOMOL, V141, P372, DOI 10.1111/jen.12346; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; WHITE R, 1977, ANN ENTOMOL SOC AM, V70, P168, DOI 10.1093/aesa/70.2.168; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	84	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268902	10.1371/journal.pone.0268902	http://dx.doi.org/10.1371/journal.pone.0268902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3LQ	35613094	Green Published, gold			2022-12-26	WOS:000834666000007
J	Huang, X; Swanson, R; Olson, ST				Huang, Xin; Swanson, Richard; Olson, Steven T.			Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; SERVER; IDENTIFICATION	Protein Z (PZ)-dependent protease inhibitor (ZPI) is a plasma anticoagulant protein of the serpin superfamily, which is activated by its cofactor, PZ, to rapidly inhibit activated factor X (FXa) on a procoagulant membrane surface. ZPI is also activated by heparin to inhibit free FXa at a physiologically significant rate. Here, we show that heparin binding to ZPI antagonizes PZ binding to and activation of ZPI. Virtual docking of heparin to ZPI showed that a heparin-binding site near helix H close to the PZ-binding site as well as a previously mapped site in helix C was both favored. Alanine scanning mutagenesis of the helix H and helix C sites demonstrated that both sites were critical for heparin activation. The binding of heparin chains 72 to 5-saccharides in length to ZPI was similarly effective in antagonizing PZ binding and in inducing tryptophan fluorescence changes in ZPI. Heparin binding to variant ZPIs with either the helix C sites or the helix H sites mutated showed that heparin interaction with the higher affinity helix C site most distant from the PZ-binding site was sufficient to induce these tryptophan fluorescence changes. Together, these findings suggest that heparin binding to a site on ZPI extending from helix C to helix H promotes ZPI inhibition of FXa and allosterically antagonizes PZ binding to ZPI through long-range conformational changes. Heparin antagonism of PZ binding to ZPI may serve to spare limiting PZ and allow PZ and heparin cofactors to target FXa at different sites of action.	[Huang, Xin] Univ Illinois, Dept Pharmacol & Regenerat Med, Chicago, IL 60680 USA; [Swanson, Richard; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huang, X (corresponding author), Univ Illinois, Dept Pharmacol & Regenerat Med, Chicago, IL 60680 USA.	xinhuang@uic.edu			National Institutes of Health, United States [R56 HL149881]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a grant from the National Institutes of Health, United States (grant no.: R56 HL149881; to X. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2017, J BIOL CHEM, V292, P14625, DOI 10.1074/jbc.M117.793901; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2012, BLOOD, V120, P1726, DOI 10.1182/blood-2012-03-419598; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Tollefsen DM, 1997, ADV EXP MED BIOL, V425, P35; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c	23	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102022	10.1016/j.jbc.2022.102022	http://dx.doi.org/10.1016/j.jbc.2022.102022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35551912	gold, Green Published			2022-12-26	WOS:000811813400011
J	Nejatizadeh, A; Eftekhar, E; Shekari, M; Farshidi, H; Davoodi, SH; Shahmoradi, M; Poustchi, H; Ghanbarnejad, A; Aghamolaei, T; Yousefi, H; Rafati, S				Nejatizadeh, Azim; Eftekhar, Ebrahim; Shekari, Mohammad; Farshidi, Hossein; Davoodi, Seyed Hossein; Shahmoradi, Mehdi; Poustchi, Hossein; Ghanbarnejad, Amin; Aghamolaei, Teymour; Yousefi, Hadi; Rafati, Shideh			Cohort profile: Bandar Kong prospective study of chronic non-communicable diseases	PLOS ONE			English	Article							RISK-FACTORS; SOCIOECONOMIC-STATUS; GLOBAL BURDEN; HEALTH; IRAN; POPULATION	Chronic non-communicable diseases (NCDs), are the leading causes of death among adults worldwide. It is projected that half of the NCDs could be avoided by preventing measures. Under the prospective epidemiological research studies in Iran (PERSIAN), we established a prospective population-based cohort study in southern Iran. The present study was designed to observe changing pattern of lifestyle transition over time and investigate the incidence and prevalence of regional modifiable risk factors as well as their associations with major NCDs. At baseline, 4063 participants aged 35-70 years were recruited on Oct, 2016and planned to get re-evaluated every 5 years along with annual follow-up. Data using validated electronic questionnaire comprising 55 questions and 482 items including general, medical and nutrition queries was collected. Blood, hair, nails, urine specimens and anthropometric measurements were taken. The response rate was 99%. In the results; male and female participants were 42.5% and 57.5%, respectively. Of note, 30.4% of women and 16.1% of men were obese. The prevalence of hypertension in men and women was 14.6% and 21%; however, diabetic men and women were 17.4% and 12.4%, respectively. Living in rural areas increased the odds of having hypertension by 1.33 (AOR = 1.33, 95% CI:1-09, 1.61). Noteworthy, logistic regression displayed that aging could predispose individuals to be more overweight, hypertensive and diabetic. The prevalence of multimorbidity of 3 or more NCDs were 8% (No. 326) and 6% (No.240), respectively. Intake of fruits, vegetables and dairy was less than two servings per day in 9.2%, 13% and 58.3% of the participants. Lower cardiovascular diseases and serum level of FBS and higher HDL level in sailors/fishermen compared to other job groups were significant (p-value <0.001). The second annual follow-up was completed and now at the end of the third wave. Findings of the present study signified the high prevalence of behavioral risk factors and their associations with respective NCDs. Subsequently, it is essential to keep track lifestyle variations, the modifiable risk factors and NCDs trends by prospective population-based cohort studies.	[Nejatizadeh, Azim; Eftekhar, Ebrahim; Shekari, Mohammad; Shahmoradi, Mehdi] Hormozgan Univ Med Sci, Mol Med Res Ctr, Bandar Abbas, Iran; [Farshidi, Hossein] Hormozgan Univ Med Sci, Cardiovasc Res Ctr, Bandar Abbas, Iran; [Davoodi, Seyed Hossein] Shahid Beheshti Med Univ, Canc Res Ctr, Tehran, Iran; [Poustchi, Hossein] Univ Tehran Med Sci, Liver & Pancreatobiliary Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Ghanbarnejad, Amin; Aghamolaei, Teymour; Rafati, Shideh] Hormozgan Univ Med Sci, Fac Hlth, Social Determinants Hlth Promot Res Ctr, Bandar Abbas, Iran; [Yousefi, Hadi] Hormozgan Univ Med Sci, Fac Nursing & Midwifery, Dept Nursing, Bandar Abbas, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences	Nejatizadeh, A (corresponding author), Hormozgan Univ Med Sci, Mol Med Res Ctr, Bandar Abbas, Iran.	azimnejate@yahoo.com	Nejatizadeh, Azim/M-2608-2017; Rafati, Shideh/ABB-3051-2020; Ghanbarnejad, Amin/I-9565-2017	Nejatizadeh, Azim/0000-0001-6347-0163; Rafati, Shideh/0000-0003-3461-0555; Ghanbarnejad, Amin/0000-0002-6623-4163	Hormozgan University of Medical Sciences; Ministry of Health and Medical Education (MOHME), Iran [700/112]	Hormozgan University of Medical Sciences; Ministry of Health and Medical Education (MOHME), Iran	This work was supported by Hormozgan University of Medical Sciences through allocated grant and the Deputy of Technology and Research at the Ministry of Health and Medical Education (MOHME), Iran with assigned grant [No. 700/112, Date: Feb, 2016]. We are grateful to all of them for their support and financial provision.	Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Ahmadizadeh Fini A., 2011, HORMOZGAN MED J, V1, P42; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Amanolahi S, 2005, IRAN CAUCASUS IRAN C; [Anonymous], 2014, GLOBAL HLTH ESTIMATE; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Bandar Abbas W, 2011, NATURAL TRADE GATEWA; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Bijani A, 2017, CASP J INTERN MED, V8, P205, DOI 10.22088/cjim.8.3.205; Dashtyian MK, 2013, LIFE SCI J, V10, P405; Dean AG, OPENEPI OPEN SOURCE; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004; Gandomkar A, 2017, INT J PUBLIC HEALTH, V62, P397, DOI 10.1007/s00038-016-0848-2; Ghayour-Mobarhan M, 2009, J TRACE ELEM MED BIO, V23, P167, DOI 10.1016/j.jtemb.2009.03.006; Goorakani Y, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01594-y; Hakimi H, 2021, EUR J EPIDEMIOL, V36, P243, DOI 10.1007/s10654-020-00668-7; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Management and program Organization of Hormozgan province, 2007, STAT CAL HORM PROV; Mansour-Ghanaei R, 2019, J FAM MED PRIM CARE, V8, P923, DOI 10.4103/jfmpc.jfmpc_243_18; Mirzaei M, 2018, INT J EPIDEMIOL, V47, P697, DOI 10.1093/ije/dyx231; Moghadam MN, 2012, INT J HEALTH PLAN M, V27, pe121, DOI 10.1002/hpm.1105; Moghimi A, 2008, URBAN GEOMORPHOLOGY, V2ed; Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Postchi H., 2016, PROSPECTIVE EPIDEMIO, VEdition one; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Poustchi H, 2018, AM J EPIDEMIOL, V187, P647, DOI 10.1093/aje/kwx314; Prados-Torres A, 2018, INT J EPIDEMIOL, V47, P382, DOI 10.1093/ije/dyx259; Sepanlou Sadaf Ghajarieh, 2015, Middle East J Dig Dis, V7, P121; Sithey G, 2018, J PUBLIC HEALTH POL, V39, P327, DOI 10.1057/s41271-018-0135-y; Somi MDH, 2019, J CARDIOVASC THORAC, V11, P53, DOI 10.15171/jcvtr.2019.09; Wang YP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39326-8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO-EMRO, NONC DIS MRO	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265388	10.1371/journal.pone.0265388	http://dx.doi.org/10.1371/journal.pone.0265388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35550629	Green Published, gold			2022-12-26	WOS:000868164600003
J	Pagen, DME; Brinkhues, S; Dukers-Muijrers, NHTM; den Heijer, CDJ; Bouwmeester-Vincken, N; Hanssen, DAT; van Loo, IHM; Savelkoul, PHM; Hoebe, CJPA				Pagen, Demi M. E.; Brinkhues, Stephanie; Dukers-Muijrers, Nicole H. T. M.; den Heijer, Casper D. J.; Bouwmeester-Vincken, Noortje; Hanssen, Danielle A. T.; van Loo, Inge H. M.; Savelkoul, Paul H. M.; Hoebe, Christian J. P. A.			Exposure factors associated with SARS-CoV-2 seroprevalence during the first eight months of the COVID-19 pandemic in the Netherlands: A cross-sectional study	PLOS ONE			English	Article								Background The availability of valid Severe Acute Respiratory Syndrome Coronvirus-2 (SARS-CoV-2) serological tests overcome the problem of underestimated cumulative Coronavirus Disease 2019 (COVID-19) cases during the first months of the pandemic in The Netherlands. The possibility to reliably determine the number of truly infected persons, enabled us to study initial drivers for exposure risk in the absence of routine testing. Numerous activities or circumstances can accelerate virus spread, here defined as exposure factors. Hence, we aimed to evaluate a wide variety of demographic, behavioural and social exposure factors associated with seropositivity during the first eight months of the pandemic in Limburg, The Netherlands. Methods SARS-CoV-2 point-seroprevalence was determined cross-sectionally to indicate previous infection in a convenience sample of minimal 10,000 inhabitants of the study province. All adult (18+ years) inhabitants of the study province were eligible to register themselves for participation. Once the initial 10,000 registrations were reached, a reserve list was kept to ensure sufficient participants. Possible exposure factors were mapped by means of an extensive questionnaire. Associated exposure factors were determined using univariable and multivariable logistic regression models. Results Seropositivity was established in 19.5% (n = 1,948) of the 10,001 participants (on average 49 years old (SD = 15; range 18-90 years), majority women (n = 5,829; 58.3%). Exposure factors associated with seropositivity included current education, working in healthcare and not working from home, and being a member of three or four associations or clubs. Specifically for February-March 2020, visiting an apres-ski bar during winter sports in Austria, travelling to Spain, celebrating carnival, and participating in a singing activity or ball sport were associated with seropositivity. Conclusions Our results confirm that relevant COVID-19 exposure factors generally reflected circumstances where social distancing was impossible, and the number and duration of contacts was high, in particular for indoor activities.	[Pagen, Demi M. E.; Brinkhues, Stephanie; Dukers-Muijrers, Nicole H. T. M.; den Heijer, Casper D. J.; Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Heerlen, Netherlands; [Pagen, Demi M. E.; Brinkhues, Stephanie; den Heijer, Casper D. J.; Hoebe, Christian J. P. A.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Social Med, Maastricht, Netherlands; [Dukers-Muijrers, Nicole H. T. M.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Promot, Maastricht, Netherlands; [Bouwmeester-Vincken, Noortje] North Limburg Publ Hlth Serv, Dept Infect Dis, Venlo, Netherlands; [Hanssen, Danielle A. T.; van Loo, Inge H. M.; Savelkoul, Paul H. M.; Hoebe, Christian J. P. A.] Maastricht Univ, Med Ctr MUMC, Care & Publ Hlth Res Inst CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Savelkoul, Paul H. M.] Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam	Pagen, DME (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Heerlen, Netherlands.; Pagen, DME (corresponding author), Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Social Med, Maastricht, Netherlands.	Demi.Pagen@gggdzi.nl		Dukers-Muijrers, Nicole/0000-0003-4896-758X; Pagen, Demi Michaela Elisabeth/0000-0003-1475-5474; Hanssen, Danielle/0000-0003-2401-2703	Province of Limburg, the Netherlands	Province of Limburg, the Netherlands(Netherlands Government)	This work was financially supported by the Province of Limburg, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderweireld CEA., 2020, NEDERLANDSE TIJDSCHR; [Anonymous], 2020, ADVIES NAV OMT 2019; [Anonymous], 2020, EPIDEMIOLOGISCHE SIT; Backer JA, 2021, EUROSURVEILLANCE, V26, P19, DOI 10.2807/1560-7917.ES.2021.26.8.2000994; Beijing Wantai Biological Pharmacy Enterprise Co. L, WANTAI SARS COV 2 AB; Borak J, 2020, OCCUP MED-OXFORD, V70, P297, DOI 10.1093/occmed/kqaa080; Brinkhues S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3197-3; cbs, KWART 15 PLUSSERS SP; cbs, WELKE PROVINCIE OVER; den Hartog G, 2021, CLIN INFECT DIS, V73, P2155, DOI 10.1093/cid/ciab172; Fernandes S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260322; Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036; Linka K, 2020, COMPUT METHOD BIOMEC, V23, P710, DOI 10.1080/10255842.2020.1759560; Madsen JR, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab273; Magnusson K, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.40.2001875; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0; Slot E., ANTISTOFFEN TEGEN CO; Thakur V, 2022, INFECTION, V50, P309, DOI 10.1007/s15010-021-01734-2; van den Beld MJC, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00767-21; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vos ERA, 2021, CLIN INFECT DIS, V73, P2318, DOI 10.1093/cid/ciab264; World Health organization (WHO), COR COVID 19 DASHB	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0268057	10.1371/journal.pone.0268057	http://dx.doi.org/10.1371/journal.pone.0268057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551285	Green Submitted, Green Published, gold			2022-12-26	WOS:000868179400016
J	Yimgang, LV; Toghueo, RMK; Mbekou, IMK; Dize, D; Boyom, FF				Yimgang, Lorette Victorine; Toghueo, Rufin Marie Kouipou; Mbekou, Ines Michele Kanko; Dize, Darline; Boyom, Fabrice Fekam			Crude metabolites from endophytic fungi inhabiting Cameroonian Annona muricata inhibit the causative agents of urinary tract infections	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBACTERIAL ACTION; ANTIBIOTICS; MECHANISMS	Urinary tract infections (UTIs) are common bacterial infections. The global emergence of multidrug-resistant uropathogens in the last decade underlines the need to search for new antibiotics with novel mechanisms of action. In this regard, exploring endophytic fungi inhabiting medicinal plants used locally against urinary tract infections could be a promising strategy for novel drug discovery. This study investigates crude metabolites from endophytic fungi isolated from Annona muricata as potential sources of antibiotic drugs to fight against uropathogens and reduce related oxidative stress. Crude ethyl acetate extracts from 41 different endophytic fungi were screened against three bacterial strains using the broth microdilution method, and fungi producing active crude extracts were identified using ITS1-5.8S rRNA-ITS2 nucleotide sequences. The antibacterial modes of action of the five most active extracts were evaluated using Staphylococcus aureus ATCC 43300 and Klebsiella oxytoca strains. The DPPH and FRAP assays were used to investigate their antioxidant activity, and their cytotoxicity against the Vero cell line was evaluated using the MTT assay. Out of the 41 crude extracts tested, 17 were active with minimum inhibitory concentrations (MICs) ranging from 3.125 mu g/mL to 100 mu g/mL and were not cytotoxic against Vero cell lines with a cytotoxic concentration 50 (CC50) >100 mu g/mL. The more potent extracts (from Fusarium waitergamsii AMtw3, Aspergillus sp. AMtf15, Penicillium citrinum AMf6, Curvularia sp. AMf4, and Talaromyces annesophieaeAMsb23) significantly inhibited bacterial catalase activity, lysed bacterial cells, increased outer membrane permeability, and inhibited biofilm formation, and the time-kill kinetic assay revealed concentration-dependent bactericidal activity. All seventeen extracts showed weak ferric iron-reducing power (1.06 to 12.37 mu g equivalent NH2OH/g of extract). In comparison, seven extracts exhibited DPPH free radical scavenging activity, with RSA(50) ranging from 146.05 to 799.75 mu g/mL. The molecular identification of the seventeen active fungi revealed that they belong to six distinct genera, including Aspergillus, Curvularia, Fusarium, Meyerozyma, Penicillium, and Talaromyces. This investigation demonstrated that fungal endophytes from Cameroonian Annona muricata, a medicinal plant used locally to treat bacterial infections, might contain potent antibacterial metabolites with multiple modes of action. The antibacterial-guided fractionation of these active extracts is currently ongoing to purify and characterise potential antibacterial active ingredients.	[Yimgang, Lorette Victorine; Toghueo, Rufin Marie Kouipou; Mbekou, Ines Michele Kanko; Dize, Darline; Boyom, Fabrice Fekam] Univ Yaounde I, Lab Phytobiochem & Med Plants Studies, Antimicrobial & Biocontrol Agents Unit AmBcAU, Dept Biochem,Fac Sci, Yaounde, Cameroon	University of Yaounde I	Toghueo, RMK; Boyom, FF (corresponding author), Univ Yaounde I, Lab Phytobiochem & Med Plants Studies, Antimicrobial & Biocontrol Agents Unit AmBcAU, Dept Biochem,Fac Sci, Yaounde, Cameroon.	toghueo.rufin@yahoo.fr; fabrice.boyom@fulbrightmail.org	Toghueo, Rufin/ABA-3152-2021	Toghueo, Rufin/0000-0003-2144-0710				Ateba JET, 2018, J FUNGI, V4, DOI 10.3390/jof4020070; Babii C, 2016, J APPL MICROBIOL, V120, P630, DOI 10.1111/jam.13048; Bloom DE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00549; Caskurlu H, 2020, UROL INT, V104, P287, DOI 10.1159/000504415; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cockerill FR, 2012, METHODS DILUTION ANT; Cook RTA, 2009, MYCOL RES, V113, P616, DOI 10.1016/j.mycres.2009.01.010; Coria-Tellez AV, 2018, ARAB J CHEM, V11, P662, DOI 10.1016/j.arabjc.2016.01.004; Critchley IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220265; Cruz CD, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1321-6; Daniels AO, 2020, EJBIO, V1, DOI [10.24018/ejbio.2020.1.3.18, DOI 10.24018/EJBIO.2020.1.3.18]; Dawande AK, 2019, INTER J SCI RES BIOL, V6, P8186; Delcaru C, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040065; Ding Z, 2019, J MICROBIOL BIOTECHN, V29, P731, DOI 10.4014/jmb.1901.01015; Ditkoff EL, 2018, CAN J UROL, V25, P9486; Djague F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237076; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Gilbert P, 1984, Soc Appl Bacteriol Symp Ser, P175; Helaly SE, 2018, NAT PROD REP, V35, P992, DOI 10.1039/c8np00010g; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Ibrahim M, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-021-03269-3; Kaur N, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01143-y; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Manganyi MC, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8121934; Mazzariol A, 2017, J CHEMOTHERAPY, V29, P2, DOI [10.1080/1120009x.2017.1380395, 10.1080/1120009X.2017.1380395]; Mbekou MIK, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6697973; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nji CP, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2176569; Onana Jean Michel, 2015, Rodriguésia, V66, P961, DOI 10.1590/2175-7860201566403; Pham JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01404; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Simmering JE, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw281; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Toghueo RMK, 2017, S AFR J BOT, V109, P146, DOI 10.1016/j.sajb.2016.12.021; Toghueo RMK, 2020, PHYTOCHEM REV, V19, P743, DOI 10.1007/s11101-020-09679-4; Toghueo RMK, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-2081-1; Toghueo RMK, 2020, MYCOLOGY-UK, V11, P1, DOI 10.1080/21501203.2019.1645053; Toghueo RMK, 2019, J ETHNOPHARMACOL, V235, P111, DOI 10.1016/j.jep.2019.02.010; Toghueo RMK, 2018, PARASITOL RES, V117, P2473, DOI 10.1007/s00436-018-5936-1; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yoo Jae-Joon, 2012, Mycobiology, V40, P231, DOI 10.5941/MYCO.2012.40.4.231; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	46	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2022	17	5							e0267246	10.1371/journal.pone.0267246	http://dx.doi.org/10.1371/journal.pone.0267246			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2O1VP	35544583	Green Published, gold			2022-12-26	WOS:000818854500024
J	Li, ZR; Bruce, JL; Cohen, B; Cunningham, CV; Jack, WE; Kunin, K; Langhorst, BW; Miller, J; Moncion, RA; Poole, CB; Premsrirut, PK; Ren, GP; Roberts, RJ; Tanner, NA; Zhang, YH; Carlow, CKS				Li, Zhiru; Bruce, Jacqueline L.; Cohen, Barry; Cunningham, Caileigh, V; Jack, William E.; Kunin, Katell; Langhorst, Bradley W.; Miller, Jacob; Moncion, Reynes A.; Poole, Catherine B.; Premsrirut, Prem K.; Ren, Guoping; Roberts, Richard J.; Tanner, Nathan A.; Zhang, Yinhua; Carlow, Clotilde K. S.			Development and implementation of a simple and rapid extraction-free saliva SARS-CoV-2 RT-LAMP workflow for workplace surveillance	PLOS ONE			English	Article								Effective management of the COVID-19 pandemic requires widespread and frequent testing of the population for SARS-CoV-2 infection. Saliva has emerged as an attractive alternative to nasopharyngeal samples for surveillance testing as it does not require specialized personnel or materials for its collection and can be easily provided by the patient. We have developed a simple, fast, and sensitive saliva-based testing workflow that requires minimal sample treatment and equipment. After sample inactivation, RNA is quickly released and stabilized in an optimized buffer, followed by reverse transcription loop-mediated isothermal amplification (RT-LAMP) and detection of positive samples using a colorimetric and/or fluorescent readout. The workflow was optimized using 1,670 negative samples collected from 172 different individuals over the course of 6 months. Each sample was spiked with 50 copies/mu L of inactivated SARS-CoV-2 virus to monitor the efficiency of viral detection. Using pre-defined clinical samples, the test was determined to be 100% specific and 97% sensitive, with a limit of detection of 39 copies/mL. The method was successfully implemented in a CLIA laboratory setting for workplace surveillance and reporting. From April 2021-February 2022, more than 30,000 self-collected samples from 755 individuals were tested and 85 employees tested positive mainly during December and January, consistent with high infection rates in Massachusetts and nationwide.	[Li, Zhiru; Bruce, Jacqueline L.; Cohen, Barry; Cunningham, Caileigh, V; Jack, William E.; Kunin, Katell; Langhorst, Bradley W.; Miller, Jacob; Moncion, Reynes A.; Poole, Catherine B.; Ren, Guoping; Roberts, Richard J.; Tanner, Nathan A.; Zhang, Yinhua; Carlow, Clotilde K. S.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Premsrirut, Prem K.] Mirimus Inc, Brooklyn, NY USA	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	carlow@neb.com			New England Biolabs	New England Biolabs	New England Biolabs (www.neb.com) has funded this study. ZL, JLB, BC, CVC, WEJ, KK, BWL, JM, RAM, CBP, GR, RJR, NAT, YZ and CKSC are employees of New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abong RA, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008926; Ahn SJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4277-8; Amambo GN, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-020-04506-3; Amaral C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95799-6; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Baliga Sharmila, 2013, J Indian Soc Periodontol, V17, P461, DOI 10.4103/0972-124X.118317; Barat B, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02486-20; Bastos ML, 2021, ANN INTERN MED, V174, P501, DOI 10.7326/M20-6569; Batejat Christophe, 2021, J Biosaf Biosecur, V3, P1, DOI 10.1016/j.jobb.2020.12.001; Bender AT, 2020, J MOL DIAGN, V22, P1030, DOI 10.1016/j.jmoldx.2020.04.211; Bhadra S, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00911-20; BRADBURY S, 1956, Q J MICROSC SCI, V97, P323; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fowler VL, 2021, J INFECTION, V82, P117, DOI 10.1016/j.jinf.2020.10.039; Giron-Perez DA, 2021, J OCCUP ENVIRON MED, V63, P541, DOI 10.1097/JOM.0000000000002176; Griesemer SB, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01418-20; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Gyulai G, 2016, EXPRESS POLYM LETT, V10, P216, DOI 10.3144/expresspolymlett.2016.20; H.Wei, 2020, medRxiv, DOI 10.1101/2020.02.26.20028373; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hayden Andrew, 2021, J Biomol Tech, V32, P148, DOI 10.7171/jbt.21-3203-010; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hering I, 2020, ENVIRON TOXICOL PHAR, V76, DOI 10.1016/j.etap.2020.103353; Huang X, 2022, EBIOMEDICINE, V75, DOI 10.1016/j.ebiom.2021.103736; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Kapoor P, 2021, BDJ OPEN, V7, DOI 10.1038/s41405-021-00064-7; Klymus K.E., 2020, ENV DNA, V2, P271, DOI [10.1002/edn3.29, DOI 10.1002/EDN3.29]; Kobayashi GS, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081400; Kundrod KA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0264130; Laboratory RCG, ACCELERATED EMERGENC; Lalli MA, 2021, CLIN CHEM, V67, P415, DOI 10.1093/clinchem/hvaa267; Mendoza RP, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101028; Nagamine K, 2001, CLIN CHEM, V47, P1742; Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ott IM, 2021, EMERG INFECT DIS, V27, P1146, DOI 10.3201/eid2704.204199; Pasomsub E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.05.001; Poole CB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46550-9; Poole CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139286; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Ptasinska A, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.04.008; Rabe BA, 2020, P NATL ACAD SCI USA, V117, P24450, DOI 10.1073/pnas.2011221117; Rajh E, 2021, MOLECULES, V26, DOI 10.3390/molecules26216617; Rao M, 2021, J MED VIROL, V93, P2461, DOI 10.1002/jmv.26773; Sun Q, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243183; Tan SH, 2021, LANCET RESP MED, V9, P562, DOI 10.1016/S2213-2600(21)00178-8; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Toppings NB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92677-z; Uribe-Alvarez C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250202; Vahidy FS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245556; Vogels CBF, 2021, MED-CAMBRIDGE, V2, P263, DOI 10.1016/j.medj.2020.12.010; Wei S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81487-y; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Xu RS, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0080-z; Yang Qing, 2021, Elife, V10, DOI [10.1101/2020.07.16.20150250, 10.7554/eLife.65113]; Yokota I, 2021, CLIN INFECT DIS, V73, pE559, DOI 10.1093/cid/ciaa1388; Zhang Yinhua, 2020, Biotechniques, V69, P178, DOI 10.2144/btn-2020-0078	62	3	3	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268692	http://dx.doi.org/10.1371/journal.pone.0268692			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617204	gold, Green Published, Green Submitted			2022-12-26	WOS:000835048800069
J	Sarath, NG; Manzil, SA; Ali, S; Alsahli, AA; Puthur, JT				Sarath, Nair G.; Manzil, Shackira A.; Ali, Sajad; Alsahli, Abdulaziz Abdullah; Puthur, Jos T.			Physio-anatomical modifications and elemental allocation pattern in Acanthus ilicifolius L. subjected to zinc stress	PLOS ONE			English	Article							PHOTOSYNTHETIC ACTIVITY; BIOCHEMICAL-CHANGES; HYDROGEN-PEROXIDE; HEAVY-METALS; CADMIUM; RESPONSES; PLANTS; DROUGHT; WETLAND; PROTEIN	Physio-anatomical modifications and elemental distribution pattern in Acanthus ilicifolius subjected to Zn stress were analysed in this study. Survival of A. ilicifolius plants under a high concentration of ZnSO4 was compensated by the reduction in the photosynthetic efficacy. Micro and macro-elemental distribution pattern in the root tissues was significantly influenced by heavy metal exposure. Tolerance towards the excess toxic metal ions in the tissue of A. ilicifolius was aided by the modified anatomical features. Moreover, the increased deposition of Zn around the central vasculature of the root confirms the complexation of Zn2+ in the xylem vessels. Metal induced molecular level changes of root and leaf samples indicate the presence of OH, NH2, and CH3 deformation as well as C-O-H and C-O-C stretch. A prominent band corresponding to CH3 deformation, pointing hemicellulose fortification, occurs in the cell walls of the xylem, aiding in Zn localization. The phytostabilisation potential of A. ilicifolius is dependent on the coordinated responses which endow with phenotypic plasticity necessary to cope with Zn toxicity.	[Sarath, Nair G.; Puthur, Jos T.] Univ Calicut, Dept Bot, Plant Physiol & Biochem Div, Thenhipalam, Kerala, India; [Manzil, Shackira A.] Sir Syed Coll, Dept Bot, Kannur, Kerala, India; [Ali, Sajad] Yeungnam Univ, Dept Biotechnol, Gyongsan, South Korea; [Alsahli, Abdulaziz Abdullah] King Saud Univ, Fac Sci, Bot & Microbiol Dept, Riyadh, Saudi Arabia	University of Calicut; Yeungnam University; King Saud University	Puthur, JT (corresponding author), Univ Calicut, Dept Bot, Plant Physiol & Biochem Div, Thenhipalam, Kerala, India.	jtputhur@yahoo.com			KSCSTE Research Grant [KSCSTE/5179/2017-SRSLS]; Department of Science & Technology (DST), Government of India [SR/FST/LSI-532/2012]; King Saud University, Riyadh, Saudi Arabia [RSP-2021/236]	KSCSTE Research Grant; Department of Science & Technology (DST), Government of India(Department of Science & Technology (India)); King Saud University, Riyadh, Saudi Arabia(King Saud University)	This study was supported by the Kerala State Council for Science, Technology, and Environment in the form of a KSCSTE Research Grant to NGS and JTP [KSCSTE/5179/2017-SRSLS], the Department of Science & Technology (DST), Government of India in the form of the Fund for Improvement of S&T Infrastructure (FIST) programme [SR/FST/LSI-532/2012], and by the King Saud University, Riyadh, Saudi Arabia, Researchers Supporting Project Number [RSP-2021/236].	Abdul Majeed, 2019, Acta Ecologica Sinica - International Journal, V39, P284, DOI 10.1016/j.chnaes.2018.12.002; Adam S, 2014, EUR J EXP BIOL, V4, P25; Agarie S, 1995, J FAC AGR KYUSHU U, V40, P233; Ahanger MA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010147; Ahmad P, 2019, ENVIRON EXP BOT, V161, P1, DOI 10.1016/j.envexpbot.2019.02.017; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barthel M, 2011, NEW PHYTOL, V192, P925, DOI 10.1111/j.1469-8137.2011.03848.x; Basile A, 2012, ENVIRON POLLUT, V166, P208, DOI 10.1016/j.envpol.2012.03.018; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Blatt MR, 2000, CURR OPIN PLANT BIOL, V3, P196, DOI 10.1016/S1369-5266(00)00064-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cocozza C, 2008, IFOREST, V1, P96, DOI 10.3832/ifor0458-0010096; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Gao JJ, 2021, ENVIRON RES, V197, DOI 10.1016/j.envres.2021.110959; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Han RM, 2013, PHYSIOL PLANTARUM, V147, P352, DOI 10.1111/j.1399-3054.2012.01667.x; Handa N, 2019, ENVIRON EXP BOT, V161, P180, DOI 10.1016/j.envexpbot.2018.11.009; He HH, 2021, PLANT SOIL, V461, P119, DOI 10.1007/s11104-020-04793-w; Holland N, 2005, J AGR FOOD CHEM, V53, P8790, DOI 10.1021/jf051293o; Horemans N, 2015, PLANT BIOLOGY, V17, P91, DOI 10.1111/plb.12222; Hu SJ, 2017, SCI TOTAL ENVIRON, V586, P319, DOI 10.1016/j.scitotenv.2017.02.001; Hura T, 2007, ANN BOT-LONDON, V100, P767, DOI 10.1093/aob/mcm162; Jalloh MA, 2009, J HAZARD MATER, V162, P1081, DOI 10.1016/j.jhazmat.2008.05.146; Janeeshma E, 2021, ACTA PHYSIOL PLANT, V43, DOI 10.1007/s11738-020-03178-x; Junglee S., 2014, AM J ANAL CHEM, V05, P730, DOI [10.4236/ajac.2014.511081, DOI 10.4236/AJAC.2014.511081]; Kalaikandhan R., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P1056; Karimi N, 2013, J PLANT GROWTH REGUL, V32, P823, DOI 10.1007/s00344-013-9350-8; Kauss H, 2003, PLANT J, V33, P87, DOI 10.1046/j.1365-313X.2003.01606.x; Kaya C, 2020, PHYSIOL PLANTARUM, V168, P345, DOI 10.1111/ppl.13012; Khan AHA, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110780; Khan M, 2020, PHOTOSYNTHESIS, PRODUCTIVITY, AND ENVIRONMENTAL STRESS, P95; Khasim S, 2002, BOT MICROTECHNIQUE P; KOCHIAN LV, 1993, DEV PLANT SOIL SCI, V55, P45; Kohli SK, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120641; Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.01148.x; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Liu CW, 2014, WETLANDS, V34, P129, DOI 10.1007/s13157-013-0491-0; LONERAGAN JF, 1979, SOIL SCI SOC AM J, V43, P966, DOI 10.2136/sssaj1979.03615995004300050031x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luan S, 2002, PLANT CELL ENVIRON, V25, P229, DOI 10.1046/j.1365-3040.2002.00758.x; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; MacFarlane GR, 2000, AQUAT BOT, V68, P45, DOI 10.1016/S0304-3770(00)00105-4; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; Manousaki E, 2008, ENVIRON RES, V106, P326, DOI 10.1016/j.envres.2007.04.004; Mansoor S., 2014, HDB EMERGING TRENDS, P285; Marichali A, 2016, J AGR FOOD CHEM, V64, P1664, DOI 10.1021/acs.jafc.6b00274; Miras-Moreno Begona, 2014, Anales de Biologia, V36, P55, DOI 10.6018/analesbio.36.9; Mobin M, 2007, J PLANT PHYSIOL, V164, P601, DOI 10.1016/j.jplph.2006.03.003; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Niu YF, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29720; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Ova EA, 2015, PLANT SOIL, V393, P147, DOI 10.1007/s11104-015-2483-8; Ovecka M, 2014, BIOTECHNOL ADV, V32, P73, DOI 10.1016/j.biotechadv.2013.11.011; Pal M, 2006, J PLANT NUTR SOIL SC, V169, P239, DOI 10.1002/jpln.200520573; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Potassium Mengel K., 2007, HDB PLANT NUTR, P91; Przedpelska-Wasowicz EM, 2011, PROTOPLASMA, V248, P663, DOI 10.1007/s00709-010-0222-9; PUCHER GW, 1948, ANAL CHEM, V20, P850, DOI 10.1021/ac60021a016; Puthur JT., 2021, PHYSIOL PLANTARUM, DOI [10.1111/ppl.13310, DOI 10.1111/ppl.13310, DOI 10.1111/PPL.13310]; Rucinska-Sobkowiak R, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2277-5; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sahebi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/971985; Sairam RK, 1997, J AGRON CROP SCI, V178, P171, DOI 10.1111/j.1439-037X.1997.tb00486.x; Sarath NG, 2021, WETL ECOL MANAG, V29, P719, DOI 10.1007/s11273-020-09764-7; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Schat H, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P171; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Shackira AM, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6001-8; Shackira AM, 2017, INT J PHYTOREMEDIAT, V19, P319, DOI 10.1080/15226514.2016.1225284; Sharma A, 2010, MAR BIOL RES, V6, P511, DOI 10.1080/17451000903434064; SHARMA PN, 1995, PLANT PHYSIOL, V107, P751, DOI 10.1016/S0176-1617(11)81944-9; SINGH JP, 1988, CAN J SOIL SCI, V68, P345, DOI 10.4141/cjss88-032; Singh VP, 2005, TOXIC METALS ENV ISS; Solanki R, 2011, BIOLOGIA, V66, P195, DOI 10.2478/s11756-011-0005-6; Sruthi P., 2021, HDB HALOPHYTES MOL E, P1; Sruthi P, 2019, INT J PHYTOREMEDIAT, V21, P1423, DOI 10.1080/15226514.2019.1633263; Sruthi P, 2017, WETL ECOL MANAG, V25, P129, DOI 10.1007/s11273-016-9513-z; Stolarikova-Vaculikova M, 2015, ENVIRON EXP BOT, V109, P235, DOI 10.1016/j.envexpbot.2014.07.001; Subba P, 2014, PHYSIOL MOL BIOL PLA, V20, P461, DOI 10.1007/s12298-014-0254-2; Suthi P, 2022, BIOREMEDIAT J, V26, P89, DOI 10.1080/10889868.2021.1911923; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Turner A. P., 1994, Toxic metals in soil-plant systems., P153; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Verma S, 2001, BIOL PLANTARUM, V44, P117, DOI 10.1023/A:1017938809311; WEATHERLEY P. E., 1950, NEW PHYTOL, V49, P81, DOI 10.1111/j.1469-8137.1950.tb05146.x; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yang H-M., 2001, PLANT PHYSL COMMUNIC, V37, P269; Zhang HH, 2020, ECOTOX ENVIRON SAFE, V202, DOI 10.1016/j.ecoenv.2020.110856; Zhang HH, 2020, ECOTOX ENVIRON SAFE, V195, DOI 10.1016/j.ecoenv.2020.110469; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhong-qiu Z., 2005, J ZHEJIANG UNIV-SC A, V6, P643, DOI DOI 10.1007/BF02856167	99	2	2	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0263753	10.1371/journal.pone.0263753	http://dx.doi.org/10.1371/journal.pone.0263753			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580091	gold, Green Published			2022-12-26	WOS:000835654800008
J	van Kempen, TATG; Punal, SB; Huijser, J; De Smet, S				van Kempen, Theo A. T. G.; Benitez Punal, Samuel; Huijser, Jet; De Smet, Stefaan			Tocopherol more bioavailable than tocopheryl-acetate as a source of vitamin E for broilers	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; E SUPPLEMENTATION; MEAT QUALITY; PERFORMANCE; HYDROLYSIS; METABOLISM	Vitamin E is typically supplied in the form of tocopheryl-acetate (T-Ac) since tocopherol (T) has stability issues. Tocopheryl-acetate, however, must be hydrolyzed in the intestines before it can be absorbed, a step that is purportedly rate-limiting for its bioavailability. The objective of this study was to compare the efficiency of absorption of T-Ac and T in broilers. In addition, two test procedures were evaluated in which animals received the test substances for either 2 or 4 days only. Animals were adapted to diets without supplemental vitamin E (feedstuffs contributed 14 +/- 1 ppm natural vitamin E (RRR-tocopherol)) till the age of 25 d (individual housing) or 28 d (group housing). Subsequently, they were fed T-Ac at 80, 53, 36, 24, or 16 ppm or T at 80, 40, 20, 10, or 5 ppm for a period of 4 d (4-di) or 2 d (2-dg), after which serum and liver were collected for analysis of vitamin E. Measured feed vitamin E levels were used for the data analysis; the recovery of T-Ac was 85%, and that of T was 39%. Both test procedures (2 or 4 days) yielded good quality data. Based on linear regression analysis, the relative efficiency with which T-Ac raised tissue levels as compared to T was 0.24 (2-dg) to 0.37 (4-di), with liver and serum yielding similar results. Analysis using more complex dose response models imply that the hydrolysis of T-Ac was strongly dose-dependent and that it could be saturated at doses above approximately 50 ppm in animals only briefly fed T-Ac; for T there was no evidence of saturation. These data imply that T, provided that stable forms can be developed, has the potential to be much more efficient at providing vitamin E to the animal, and on top, can yield much higher tissue levels, than T-Ac.	[van Kempen, Theo A. T. G.] Trouw Nutr, Boxmeer, Netherlands; [van Kempen, Theo A. T. G.; Benitez Punal, Samuel; Huijser, Jet] North Carolina State Univ, Dept Anim Sci, Raleigh 27695, NC USA; [De Smet, Stefaan] Univ Ghent, Fac Biosci Engn, Lab Anim Nutr & Anim Prod Qual, Ghent, Belgium	University of North Carolina; North Carolina State University; Ghent University	van Kempen, TATG (corresponding author), Trouw Nutr, Boxmeer, Netherlands.; van Kempen, TATG (corresponding author), North Carolina State Univ, Dept Anim Sci, Raleigh 27695, NC USA.	theovankempen@yahoo.com	De Smet, Stefaan/N-7576-2017	De Smet, Stefaan/0000-0003-1422-805X; Huijser, Jet/0000-0003-2752-8641				Bottje WG, 1997, POULTRY SCI, V76, P1506, DOI 10.1093/ps/76.11.1506; BURTON GW, 1988, LIPIDS, V23, P834, DOI 10.1007/BF02536201; CHUNG YK, 1992, J ANIM SCI, V70, P2485, DOI 10.2527/1992.7082485x; Desmarchelier C, 2013, MOL NUTR FOOD RES, V57, P1237, DOI 10.1002/mnfr.201200720; Guo YM, 2001, ANIM FEED SCI TECH, V89, P165, DOI 10.1016/S0377-8401(00)00228-5; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Jensen SK, 1999, J NUTR, V129, P1355, DOI 10.1093/jn/129.7.1355; Lauridsen C, 2001, J NUTR BIOCHEM, V12, P219, DOI 10.1016/S0955-2863(00)00156-X; Li WJ, 2009, BRIT POULTRY SCI, V50, P188, DOI 10.1080/00071660902755409; NEN, FOODST DET VIT E HIG; Pompeu MA, 2018, LIVEST SCI, V208, P5, DOI 10.1016/j.livsci.2017.11.021; van Kempen TATG, 2016, J ANIM SCI, V94, P4188, DOI 10.2527/jas.2016-0640	12	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268894	10.1371/journal.pone.0268894	http://dx.doi.org/10.1371/journal.pone.0268894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3LQ	35613141	Green Published, gold			2022-12-26	WOS:000834666000001
J	Cleary, SR; Fang, X; Cho, EE; Pribadi, MP; Seflova, J; Beach, JR; Kekenes-Huskey, PM; Robia, SL				Cleary, Sean R.; Fang, Xuan; Cho, Ellen E.; Pribadi, Marsha P.; Seflova, Jaroslava; Beach, Jordan R.; Kekenes-Huskey, Peter M.; Robia, Seth L.			Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA; PHOSPHOLAMBAN; PHOSPHORYLATION; SERCA; ATPASE; CA2+-ATPASE; ACTIVATION; SKELETAL; MODULATION; COMPONENT	The ATP-dependent ion pump sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) sequesters Ca2+ in the endoplasmic reticulum to establish a reservoir for cell signaling. Because of its central importance in physiology, the activity of this transporter is tightly controlled via direct interactions with tissue specific regulatory micropeptides that tune SERCA function to match changing physiological conditions. In the heart, the micropeptide phospholamban (PLB) inhibits SERCA, while dwarf open reading frame (DWORF) stimulates SERCA. These competing interactions determine cardiac performance by modulating the amplitude of Ca2+ signals that drive the contraction/relaxation cycle. We hypothesized that the functions of these peptides may relate to their reciprocal preferences for SERCA binding; SERCA binds PLB more avidly at low cytoplasmic [Ca2+] but binds DWORF better when [Ca2+] is high. In the present study, we demonstrated this opposing Ca2+ sensitivity is due to preferential binding of DWORF and PLB to different intermediate states that SERCA samples during the Ca2+ transport cycle. We show PLB binds best to the SERCA E1-ATP state, which prevails at low [Ca2+]. In contrast, DWORF binds most avidly to E1P and E2P states that are more populated when Ca2+ is elevated. Moreover, FRET microscopy revealed dynamic shifts in SERCA-micropeptide binding equilibria during cellular Ca2+ elevations. A computational model showed that DWORF exaggerates changes in PLB-SERCA binding during the cardiac cycle. These results suggest a mechanistic basis for inhibitory versus stimulatory micropeptide function, as well as a new role for DWORF as a modulator of dynamic oscillations of PLB-SERCA regulatory interactions.	[Cleary, Sean R.; Fang, Xuan; Cho, Ellen E.; Pribadi, Marsha P.; Seflova, Jaroslava; Beach, Jordan R.; Kekenes-Huskey, Peter M.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	srobia@luc.edu	Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Cleary, Sean/0000-0002-4789-0042	National Institute of General Medical Sciences (NIGMS) [R35GM124977]; NIGMS [MIRA R35GM138183]; National Heart, Lung, and Blood Institute (NHLBI) [K22HL133150]; NHLBI [R01HL092321, R01HL143816]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigation was supported by the National Institutes of Health (NIH): Maximizing Investigators' Research Awards (MIRA) R35GM124977 from the National Institute of General Medical Sciences (NIGMS) to P. M. K.-H.; MIRA R35GM138183 from NIGMS and K22HL133150 from the National Heart, Lung, and Blood Institute (NHLBI) to J. R. B.; R01HL092321 and R01HL143816 from the NHLBI to S. L. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Alford RF, 2020, J BIOL CHEM, V295, P11262, DOI 10.1074/jbc.RA120.012948; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Bluhm WF, 2000, AM J PHYSIOL-HEART C, V278, pH249, DOI 10.1152/ajpheart.2000.278.1.H249; Bovo E, 2019, AM J PHYSIOL-HEART C, V316, pH1323, DOI 10.1152/ajpheart.00031.2019; Bovo E, 2016, AM J PHYSIOL-HEART C, V311, pH268, DOI 10.1152/ajpheart.00175.2016; Bowditch H. P., 1871, ARBEITEN PHYSL ANSTA; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Currie S, 1999, CARDIOVASC RES, V41, P135, DOI 10.1016/S0008-6363(98)00241-7; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Fernandez-de Gortari E, 2018, J BIOL CHEM, V293, P12405, DOI 10.1074/jbc.RA118.003752; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; Fisher ME, 2021, ELIFE, V10, DOI 10.7554/eLife.65545; Fukuzawa A, 2021, HUM MOL GENET, V30, P1131, DOI 10.1093/hmg/ddab010; GALANIKRANIAS E, 1980, BIOCHIM BIOPHYS ACTA, V628, P438, DOI 10.1016/0304-4165(80)90393-1; Greenberg B, 2016, LANCET, V387, P1178, DOI 10.1016/S0140-6736(16)00082-9; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hayward C, 2015, HUM GENE THER, V26, P293, DOI 10.1089/hum.2015.018; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Koch D, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109448; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lambert TJ, 2019, NAT METHODS, V16, P277, DOI 10.1038/s41592-019-0352-8; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Li A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100412; Makarewich CA, 2020, CIRC RES, V127, P1340, DOI 10.1161/CIRCRESAHA.120.317156; Makarewich CA, 2018, ELIFE, V7, DOI 10.7554/eLife.38319; Mbikou P, 2020, PEPTIDES, V124, DOI 10.1016/j.peptides.2019.170192; Meyer M, 1999, AM J PHYSIOL-HEART C, V276, pH779, DOI 10.1152/ajpheart.1999.276.3.H779; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Raguimova ON, 2018, J BIOL CHEM, V293, P10843, DOI 10.1074/jbc.RA118.002472; Reddy UV, 2022, STRUCTURE, V30, P360, DOI 10.1016/j.str.2021.11.003; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Seflova J., 2022, J BIOL CHEM, V298; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Stewart BD, 2018, CELL CALCIUM, V71, P65, DOI 10.1016/j.ceca.2017.11.006; Sun B, 2019, J CHEM THEORY COMPUT, V15, P2692, DOI 10.1021/acs.jctc.8b01312; TADA M, 1975, J BIOL CHEM, V250, P2640; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; Wu YM, 2012, J MOL CELL CARDIOL, V53, P429, DOI 10.1016/j.yjmcc.2012.06.019	61	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102060	10.1016/j.jbc.2022.102060	http://dx.doi.org/10.1016/j.jbc.2022.102060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35605666	Green Submitted, Green Published, gold			2022-12-26	WOS:000829549100003
J	Berardinelli, SJ; Eletsky, A; Valero-Gonzalez, J; Ito, A; Manjunath, R; Hurtado-Guerrero, R; Prestegard, JH; Woods, RJ; Haltiwanger, RS				Berardinelli, Steven J.; Eletsky, Alexander; Valero-Gonzalez, Jessika; Ito, Atsuko; Manjunath, Rajashri; Hurtado-Guerrero, Ramon; Prestegard, James H.; Woods, Robert J.; Haltiwanger, Robert S.			O-fucosylation stabilizes the TSR3 motif in thrombospondin-1 by interacting with nearby amino acids and protecting a disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PETERS-PLUS SYNDROME; MOLECULAR-DYNAMICS SIMULATIONS; GROWTH FACTOR-LIKE; CONGENITAL DISORDER; TYPE-1 REPEATS; GLYCOSYLATION; PROPERDIN; B3GALTL; FUCOSE; IDENTIFICATION	Thrombospondin type-1 repeats (TSRs) are small protein motifs containing six conserved cysteines forming three disulfide bonds that can be modified with an O-linked fucose. Protein O-fucosyltransferase 2 (POFUT2) catalyzes the addi-tion of O-fucose to TSRs containing the appropriate consensus sequence, and the O-fucose modification can be elongated to a Glucose-Fucose disaccharide with the addition of glucose by beta 3-glucosyltransferase (B3GLCT). Elimination of Pofut2 in mice results in embryonic lethality in mice, highlighting the biological significance of O-fucose modification on TSRs. Knockout of POFUT2 in HEK293T cells has been shown to cause complete or partial loss of secretion of many proteins containing O-fucosylated TSRs. In addition, POFUT2 is local-ized to the endoplasmic reticulum (ER) and only modifies folded TSRs, stabilizing their structures. These observations suggest that POFUT2 is involved in an ER quality control mechanism for TSR folding and that B3GLCT also participates in quality control by providing additional stabilization to TSRs. However, the mechanisms by which addition of these sugars result in stabilization are poorly understood. Here, we con-ducted molecular dynamics (MD) simulations and provide crystallographic and NMR evidence that the Glucose-Fucose disaccharide interacts with specific amino acids in the TSR3 domain in thrombospondin-1 that are within proximity to the O-fucosylation modification site resulting in protection of a nearby disulfide bond. We also show that mutation of these amino acids reduces the stabilizing effect of the sugars in vitro. These data provide mechanistic details regarding the impor-tance of O-fucosylation and how it participates in quality control mechanisms inside the ER.	[Berardinelli, Steven J.; Eletsky, Alexander; Ito, Atsuko; Manjunath, Rajashri; Prestegard, James H.; Woods, Robert J.; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Resource Ctr, Dept Biochem & Mol Biol, Athens, Athens, GA 30602 USA; [Valero-Gonzalez, Jessika; Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Hurtado-Guerrero, Ramon] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain; [Hurtado-Guerrero, Ramon] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark	University System of Georgia; University of Georgia; University of Zaragoza; University of Copenhagen	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Resource Ctr, Dept Biochem & Mol Biol, Athens, Athens, GA 30602 USA.	rhalti@uga.edu		Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Berardinelli, Steven/0000-0001-6882-0601; Eletsky, Alexander/0000-0002-1291-4315; Woods, Robert/0000-0002-2400-6293	NIH [HD090156, HD096030, GM033225]; Georgia Research Alliance; ARAID; Agencia Estatal de Investigacion (AEI) [BFU2016-75633-P, PID2019-105451GB-I00]; Gobierno de Aragon [E34_R17, LMP58_18]; FEDER (2014-2020) funds for "Building Europe from Aragon"	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; ARAID; Agencia Estatal de Investigacion (AEI); Gobierno de Aragon(Gobierno de Aragon); FEDER (2014-2020) funds for "Building Europe from Aragon"	This work was supported by funding from NIH (HD090156 and HD096030 to R. S. H., GM033225 to J. H. P.) and the Georgia Research Alliance. We thank ARAID, the Agencia Estatal de Investigacion (AEI; BFU2016-75633-P and PID2019-105451GB-I00 to R. H.-G.), Gobierno de Aragon (E34_R17 and LMP58_18 to R. H.-G.) with FEDER (2014-2020) funds for "Building Europe from Aragon" for financial support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Case D. A., 2016, AMBER 2016; Case DA, 2012, AMBER 12; Chang JY, 2001, J BIOL CHEM, V276, P4845, DOI 10.1074/jbc.M005160200; Chen CI, 2012, EMBO J, V31, P3183, DOI 10.1038/emboj.2012.143; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cunha DA, 2017, J BIOL CHEM, V292, P14977, DOI 10.1074/jbc.M116.769877; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dassie-Ajdid J, 2009, CLIN GENET, V76, P490, DOI 10.1111/j.1399-0004.2009.01253.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Dubail J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto T, 2018, J BIOL CHEM, V293, P18421, DOI 10.1074/jbc.RA118.003694; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hartmann S, 2000, J BIOL CHEM, V275, P28569, DOI 10.1074/jbc.M001732200; Heinonen TYK, 2009, ANN MED, V41, P2, DOI 10.1080/07853890802301975; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Holdener BC, 2019, HUM MOL GENET, V28, P4053, DOI 10.1093/hmg/ddz225; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Jaeken J, 2016, EUR J HUM GENET, V24, pE1, DOI 10.1038/ejhg.2016.32; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Keller R., 2004, COMPUTER AIDED RESON, V1; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neupane S., MATRIX BIOL, V107, P77; Neupane S, 2021, GLYCOBIOLOGY, V31, P988, DOI 10.1093/glycob/cwab033; Patel C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092138; Reis LM, 2008, AM J MED GENET A, V146A, P2603, DOI 10.1002/ajmg.a.32498; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Shcherbakova A, 2019, ELIFE, V8, DOI 10.7554/eLife.52978; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Soczewski E, 2020, MOL CELL ENDOCRINOL, V516, DOI 10.1016/j.mce.2020.110948; Sun Z, 2004, J MOL BIOL, V343, P1327, DOI 10.1016/j.jmb.2004.09.001; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; van den Bos RM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02097; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Wang J, 2021, CELL, V184, P5869, DOI 10.1016/j.cell.2021.10.016; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Weh E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184903; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100843; Zhang AO, 2020, J BIOL CHEM, V295, P15742, DOI 10.1074/jbc.RA120.014557; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	68	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102047	10.1016/j.jbc.2022.102047	http://dx.doi.org/10.1016/j.jbc.2022.102047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35597280	Green Published, gold			2022-12-26	WOS:000816927100003
J	Calcuttawala, F; Shaw, R; Sarbajna, A; Dutta, M; Sinha, S; Gupta, SKD				Calcuttawala, Fatema; Shaw, Rahul; Sarbajna, Arpita; Dutta, Moumita; Sinha, Saptarshi; Gupta, Sujoy K. Das			Apoptosis like symptoms associated with abortive infection of Mycobacterium smegmatis by mycobacteriophage D29	PLOS ONE			English	Article							TOXIN-ANTITOXIN MODULE; ELECTRON-MICROSCOPE; PHAGE; DEATH; LIGHT	Mycobacteriophages are phages that infect mycobacteria resulting in their killing. Although lysis is the primary mechanism by which mycobacteriophages cause cell death, others such as abortive infection may also be involved. We took recourse to perform immunofluorescence and electron microscopic studies using mycobacteriophage D29 infected Mycobacterium smegmatis cells to investigate this issue. We could observe the intricate details of the infection process using these techniques such as adsorption, the phage tail penetrating the thick mycolic acid layer, formation of membrane pores, membrane blebbing, and phage release. We observed a significant increase in DNA fragmentation and membrane depolarization using cell-biological techniques symptomatic of programmed cell death (PCD). As Toxin-Antitoxin (TA) systems mediate bacterial PCD, we measured their expression profiles with and without phage infection. Of the three TAs examined, MazEF, VapBC, and phd/doc, we found that in the case of VapBC, a significant decrease in the antitoxin (VapB): toxin (VapC) ratio was observed following phage infection, implying that high VapC may have a role to play in the induction of mycobacterial apoptotic cell death following phage infection. This study indicates that D29 infection causes mycobacteria to undergo morphological and molecular changes that are hallmarks of apoptotic cell death.	[Calcuttawala, Fatema] Sister Nivedita Univ, Dept Microbiol, Kolkata, India; [Shaw, Rahul; Gupta, Sujoy K. Das] Bose Inst, Dept Microbiol, Kolkata, India; [Sarbajna, Arpita; Dutta, Moumita] Natl Inst Cholera & Enter Dis, Div Electron Microscopy, Kolkata, India; [Sinha, Saptarshi] Bose Inst, Dept Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Calcuttawala, F (corresponding author), Sister Nivedita Univ, Dept Microbiol, Kolkata, India.	fatema.c@snuniv.ac.in		Das Gupta, Sujoy K/0000-0002-7200-3652	DBT-Research Associate program in biotechnology and life sciences of the Department of Biotechnology, Ministry of Science and Technology, Govt of India; University Grants Commission of India [814/(OBC)]	DBT-Research Associate program in biotechnology and life sciences of the Department of Biotechnology, Ministry of Science and Technology, Govt of India; University Grants Commission of India(University Grants Commission, India)	FC received a fellowship from the DBT-Research Associate program in biotechnology and life sciences of the Department of Biotechnology, Ministry of Science and Technology, Govt of India, granted in May 2016. RS received a research fellowship from the University Grants Commission of India (814/(OBC)(CSIR-UGC NET Dec 2016) to pursue his Ph.D. studies in life sciences. The<EM><STRONG> </STRONG></EM>funders had no role in the study design, data collection, or decision to publish the manuscript.	Allocati N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.570; Almeida GM, 2018, RES MICROBIOL, V169, P488, DOI 10.1016/j.resmic.2018.05.006; Bayles KW, 2014, NAT REV MICROBIOL, V12, P63, DOI 10.1038/nrmicro3136; Bhattacharya B, 2008, FEMS MICROBIOL LETT, V280, P64, DOI 10.1111/j.1574-6968.2007.01047.x; BOWMAN BU, 1958, J BACTERIOL, V76, P52, DOI 10.1128/JB.76.1.52-62.1958; Chatterjee S, 2000, FEMS MICROBIOL LETT, V188, P47; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; DAVID HL, 1984, INT J LEPROSY, V52, P515; Dedrick RM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1131-2; Dewachter L, 2015, MBIO, V6, DOI 10.1128/mBio.01935-15; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Ghosh S, 2016, J BACTERIOL, V198, P352, DOI 10.1128/JB.00669-15; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Guo YT, 2017, CYTOM PART A, V91A, P775, DOI 10.1002/cyto.a.23055; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hatfull GF, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0026-2018; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Jeon AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38064-7; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruger DH, 2000, LANCET, V355, P1713, DOI 10.1016/S0140-6736(00)02250-9; Lamprecht DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12393; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lin Derek M, 2017, World J Gastrointest Pharmacol Ther, V8, P162, DOI 10.4292/wjgpt.v8.i3.162; LUSTIG A, 1992, J VIROL, V66, P4629, DOI 10.1128/JVI.66.8.4629-4631.1992; Mayer O, 2016, J BACTERIOL, V198, P3220, DOI 10.1128/JB.00592-16; McKenzie JL, 2012, J BACTERIOL, V194, P2189, DOI 10.1128/JB.06790-11; McNerney R, 2005, J APPL MICROBIOL, V99, P223, DOI 10.1111/j.1365-2672.2005.02596.x; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; McNerney R, 1999, INT J TUBERC LUNG D, V3, P179; Mozaheb N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.600221; Pavoni E, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-79; Pope WH., 2015, BACTERIOPHAGE, V5, pe1084073, DOI [10.1080/21597081.2015.1084073, DOI 10.1080/21597081.2015.1084073]; Projan S, 2004, NAT BIOTECHNOL, V22, P167, DOI 10.1038/nbt0204-167; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI 10.1038/nrmicro3564; Samaddar S, 2016, APPL ENVIRON MICROB, V82, P124, DOI 10.1128/AEM.02700-15; SCHAFER R, 1977, EUR J BIOCHEM, V73, P239, DOI 10.1111/j.1432-1033.1977.tb11312.x; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Sharrock A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203412; TAKEYA K, 1961, J BIOPHYS BIOCHEM CY, V11, P441, DOI 10.1083/jcb.11.2.441; TAKEYA K, 1959, J BACTERIOL, V78, P307, DOI 10.1128/JB.78.3.307-312.1959; Winther K, 2016, NUCLEIC ACIDS RES, V44, P9860, DOI 10.1093/nar/gkw781	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0259480	10.1371/journal.pone.0259480	http://dx.doi.org/10.1371/journal.pone.0259480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580120	gold, Green Published			2022-12-26	WOS:000835654800006
J	Ho, WJ; Smith, JNP; Park, YS; Hadiono, M; Christo, K; Jogasuria, A; Zhang, YY; Broncano, AV; Kasturi, L; Dawson, DM; Gerson, SL; Markowitz, SD; Desai, AB				Ho, Won Jin; Smith, Julianne N. P.; Park, Young Soo; Hadiono, Matthew; Christo, Kelsey; Jogasuria, Alvin; Zhang, Yongyou; Broncano, Alyssia V.; Kasturi, Lakshmi; Dawson, Dawn M.; Gerson, Stanton L.; Markowitz, Sanford D.; Desai, Amar B.			15-PGDH regulates hematopoietic and gastrointestinal fitness during aging	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; STEM-CELL SURVIVAL; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; AGE; PROSTAGLANDIN-E2; PROLIFERATION; MAINTENANCE; RECOVERY; DEFECTS; COLITIS	Emerging evidence implicates the eicosanoid molecule prostaglandin E2 (PGE2) in conferring a regenerative phenotype to multiple organ systems following tissue injury. As aging is in part characterized by loss of tissue stem cells' regenerative capacity, we tested the hypothesis that the prostaglandin-degrading enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) contributes to the diminished organ fitness of aged mice. Here we demonstrate that genetic loss of 15-PGDH (Hpgd) confers a protective effect on aging of murine hematopoietic and gastrointestinal (GI) tissues. Aged mice lacking 15-PGDH display increased hematopoietic output as assessed by peripheral blood cell counts, bone marrow and splenic stem cell compartments, and accelerated post-transplantation recovery compared to their WT counterparts. Loss of Hpgd expression also resulted in enhanced GI fitness and reduced local inflammation in response to colitis. Together these results suggest that 15-PGDH negatively regulates aged tissue regeneration, and that 15-PGDH inhibition may be a viable therapeutic strategy to ameliorate age-associated loss of organ fitness.	[Ho, Won Jin] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Ho, Won Jin; Smith, Julianne N. P.; Park, Young Soo; Hadiono, Matthew; Christo, Kelsey; Jogasuria, Alvin; Zhang, Yongyou; Broncano, Alyssia V.; Kasturi, Lakshmi; Dawson, Dawn M.; Gerson, Stanton L.; Markowitz, Sanford D.; Desai, Amar B.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ho, Won Jin; Smith, Julianne N. P.; Park, Young Soo; Hadiono, Matthew; Christo, Kelsey; Jogasuria, Alvin; Zhang, Yongyou; Broncano, Alyssia V.; Kasturi, Lakshmi; Dawson, Dawn M.; Gerson, Stanton L.; Markowitz, Sanford D.; Desai, Amar B.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland Hts, OH 44106 USA; [Gerson, Stanton L.; Markowitz, Sanford D.] Univ Hosp Seidman Canc Ctr, Cleveland Hts, OH USA	Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; Case Western Reserve University	Desai, AB (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Desai, AB (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland Hts, OH 44106 USA.	amar.desai@case.edu		Ho, Won Jin/0000-0003-2644-5086; zhang, yongyou/0000-0003-2413-9106	National Cancer Institute (NIH) [R35CA197442]; National Heart Lung and Blood (NIH) [R00HL135740]; National Institute of Biomedical Imaging and Bioengineering (NIH) [T32EB005583]	National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart Lung and Blood (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by National Cancer Institute (NIH) funding support to Sanford Markowitz (R35CA197442), National Heart Lung and Blood (NIH) funding support to Amar Desai (R00HL135740) and the National Institute of Biomedical Imaging and Bioengineering (NIH) funding support to Julianne Smith (T32EB005583). The funders had no role in study design, data decreased capacity environmental tion, signaling relevant (BM) collection and analysis, decision to publish, or preparation of the manuscript.	ALLGAYER H, 1989, GASTROENTEROLOGY, V96, P1290, DOI 10.1016/S0016-5085(89)80016-2; Beerman I, 2017, SEMIN HEMATOL, V54, P12, DOI 10.1053/j.seminhematol.2016.11.001; Belley A, 1999, GASTROENTEROLOGY, V117, P1352, DOI 10.1016/S0016-5085(99)70285-4; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Desai A, 2018, HAEMATOLOGICA, V103, P1054, DOI 10.3324/haematol.2017.178376; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P7578, DOI 10.3748/wjg.v12.i47.7578; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Florian MC, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003389; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Guidi N, 2017, EMBO J, V36, P1463, DOI 10.15252/embj.201796968; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Ho YH, 2020, HAEMATOLOGICA, V105, P38, DOI 10.3324/haematol.2018.211334; Hoggatt J, 2013, BLOOD CELL MOL DIS, V50, P147, DOI 10.1016/j.bcmd.2012.11.006; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; HOHN P, 1978, MECH AGEING DEV, V7, P217, DOI 10.1016/0047-6374(78)90068-4; Hokari R, 2005, AM J PHYSIOL-GASTR L, V289, pG949, DOI 10.1152/ajpgi.00142.2005; Ikushima YM, 2013, BLOOD, V121, P1995, DOI 10.1182/blood-2012-06-437889; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Mejia-Ramirez E, 2020, HAEMATOLOGICA, V105, P22, DOI 10.3324/haematol.2018.211342; Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Palla AR, 2021, SCIENCE, V371, P483, DOI 10.1126/science.abc8059; Popplewell LL, 2002, BONE MARROW TRANSPL, V29, P277, DOI 10.1038/sj.bmt.1703382; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Sovran B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35228-3; Sturm A, 2017, J CROHNS COLITIS, V11, P263, DOI 10.1093/ecco-jcc/jjw188; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; WARREN PM, 1978, LANCET, V2, P849; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106; Zhang L, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00994-z; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	56	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268787	10.1371/journal.pone.0268787	http://dx.doi.org/10.1371/journal.pone.0268787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3R0QK	35587945	gold, Green Published			2022-12-26	WOS:000838625000006
J	Khan, A; Ali, H; Rehman, UU; Belduz, AO; Bibi, A; Abdurahman, MA; Shah, AA; Badshah, M; Hasan, F; Kilic, AO; Ullah, A; Jahan, S; Rehman, MMU; Mansoor, R; Khan, S				Khan, Anum; Ali, Huma; Rehman, Ubaid Ur; Belduz, Ali Osman; Bibi, Amna; Abdurahman, Mujib Abdulkadir; Shah, Aamer Ali; Badshah, Malik; Hasan, Fariha; Kilic, Ali Osman; Ullah, Asad; Jahan, Sarwat; Rehman, Muhammad Maqsood Ur; Mansoor, Rashid; Khan, Samiullah			Prebiotic potential of enzymatically prepared resistant starch in reshaping gut microbiota and their respond to body physiology	PLOS ONE			English	Article							MECHANISMS; LIPIDS; FIBER; RATS	The increase in consumer demand for high-quality food products has led to growth in the use of new technologies and ingredients. Resistant starch (RS) is a recently recognised source of fibre and has received much attention for its potential health benefits and functional properties. However, knowledge about the fate of RS in modulating complex intestinal communities, the microbial members involved in its degradation, enhancement of microbial metabolites, and its functional role in body physiology is still limited. For this purpose, the current study was designed to ratify the physiological and functional health benefits of enzymatically prepared resistant starch (EM-RSIII) from maize flour. To approve the beneficial health effects as prebiotic, EM-RSIII was supplemented in rat diets. After 21 days of the experiment, EM-RSIII fed rats showed a significant reduction in body weight gain, fecal pH, glycemic response, serum lipid profile, insulin level and reshaping gut microbiota, and enhancing short-chain fatty acid compared to control. The count of butyrate-producing and starch utilizing bacteria, such as Lactobacillus, Enterococcus, and Pediococcus genus in rat's gut, elevated after the consumption of medium and high doses of EM-RSIII, while the E. coli completely suppressed in high EM-RSIII fed rats. Short-chain fatty acids precisely increased in feces of EM-RSIII feed rats. Correlation analysis demonstrated that the effect of butyrate on functional and physiological alteration on the body had been investigated during the current study. Conclusively, the present study demonstrated the unprecedented effect of utilising EM-RSIII as a diet on body physiology and redesigning gut microorganisms.	[Khan, Anum; Ali, Huma; Rehman, Ubaid Ur; Bibi, Amna; Shah, Aamer Ali; Badshah, Malik; Hasan, Fariha; Rehman, Muhammad Maqsood Ur; Khan, Samiullah] Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan; [Belduz, Ali Osman] Karadeniz Tech Univ, Fac Sci, Dept Biol, Trabzon, Turkey; [Abdurahman, Mujib Abdulkadir; Kilic, Ali Osman] Karadeniz Tech Univ, Fac Med, Dept Med Microbiol, Trabzon, Turkey; [Ullah, Asad; Jahan, Sarwat] Quaid I Azam Univ, Fac Biol Sci, Dept Zool, Islamabad, Pakistan; [Mansoor, Rashid] UCL, Dept Stat Sci, London, England	Quaid I Azam University; Karadeniz Technical University; Karadeniz Technical University; Quaid I Azam University; University of London; University College London	Khan, S (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan.	samikhan@qau.edu.pk	BELDUZ, Ali Osman/A-1642-2018; Kilic, Ali O/AAG-5328-2019	BELDUZ, Ali Osman/0000-0003-2240-7568; Mansoor, Rashid/0000-0002-3011-4952; Abdurahman, Mujib Abdulkadir/0000-0001-6273-1536	Samiullah Khan Grant [9-5(Ph-1-MG-4)/Pak-Turk/RD/HEC/2017]; Higher Education Commission of Pakistan; Office of Scientific Research Projects of Karadeniz Technical University [FBA-2018-7476]; Council of Higher Education of Turkey [MEV-2018-474]	Samiullah Khan Grant; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Office of Scientific Research Projects of Karadeniz Technical University; Council of Higher Education of Turkey(Ministry of National Education - Turkey)	SK": Samiullah Khan Grant No. 9-5(Ph-1MG-4)/Pak-Turk/R&D/HEC/2017. Higher Education Commission of Pakistan' "AOB": Ali Osman BELDU<spacing diaeresis> Z Project Number: FBA-2018-7476 Office of Scientific Research Projects of Karadeniz Technical University Gran No. MEV-2018-474 Council of Higher Education of Turkey The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrashidi NA, 2021, STARCH-STARKE, V73, DOI 10.1002/star.202000036; Aziz AA, 2009, J NUTR, V139, P1881, DOI 10.3945/jn.109.110650; Behall KM, 2005, CEREAL CHEM, V82, P654, DOI 10.1094/CC-82-0654; Brites CM, 2011, NUTR RES, V31, P302, DOI 10.1016/j.nutres.2011.02.001; Bushara YM., 2017, J DIABETES MELLITUS, V7, P1; Cabre E., 2011, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V6, pe85, DOI 10.1016/j.eclnm.2011.01.003; Coppola S, 2021, MOLECULES, V26, DOI 10.3390/molecules26030682; DeFrance A, 2011, THER DRUG MONIT, V33, P128, DOI 10.1097/FTD.0b013e3181fd4c30; den Besten G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136364; Deng QY, 2021, EUR J CLIN NUTR, V75, P602, DOI 10.1038/s41430-020-00749-6; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Garcia-Carpintero Fernandez-Pacheco S., GUT MICROBIOTA PATTE; Han KH, 2003, LIPIDS, V38, P919, DOI 10.1007/s11745-003-1145-2; Holmback U., 2019, GLOBAL PERSPECTIVES, P195, DOI [10.1021/acs.est.8b05656, DOI 10.1021/ACS.EST.8B05656]; Khan A, 2019, MOL BIOL REP, V46, P4565, DOI 10.1007/s11033-019-04913-5; Khangwal I, 2019, J FOOD DRUG ANAL, V27, P649, DOI 10.1016/j.jfda.2019.02.003; Kleessen B, 1997, J ANIM SCI, V75, P2453; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Lockyer S, 2017, NUTR BULL, V42, P10, DOI 10.1111/nbu.12244; Lopez HW, 2001, J NUTR, V131, P1283, DOI 10.1093/jn/131.4.1283; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ma Z, 2018, CRIT REV FOOD SCI, V58, P1059, DOI 10.1080/10408398.2016.1230537; Martinez-Flores HE, 2004, NUTR RES, V24, P85, DOI 10.1016/j.nutres.2003.08.016; McNabney SM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121348; Meenu M, 2019, CRIT REV FOOD SCI, V59, P3019, DOI 10.1080/10408398.2018.1481360; Olli K, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-2; Ozturk S, 2019, STARCHES FOR FOOD APPLICATION: CHEMICAL, TECHNOLOGICAL AND HEALTH PROPERTIES, P297, DOI 10.1016/B978-0-12-809440-2.00008-3; Peng M, 2019, DIETARY INTERVENTION, P135; Romani-Perez M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115830; Saez-Orviz S., 2021, Food Hydrocolloids, V119, DOI 10.1016/j.foodhyd.2021.106849; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; Shen RL, 2015, FOOD AGR IMMUNOL, V26, P120, DOI 10.1080/09540105.2013.876976; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Tan ZN, 2015, J FOOD SCI, V80, pH875, DOI 10.1111/1750-3841.12817; Vento PJ, 2008, J AM ASSOC LAB ANIM, V47, P46; Wang Y, 2021, MOLECULES, V26, DOI 10.3390/molecules26030703; Wang ZY, 2022, J AGR FOOD CHEM, V70, P1525, DOI 10.1021/acs.jafc.1c06000; Wu Y, 2019, RSC ADV, V9, P33290, DOI 10.1039/c9ra04867g	38	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267318	10.1371/journal.pone.0267318	http://dx.doi.org/10.1371/journal.pone.0267318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576192	gold, Green Published			2022-12-26	WOS:000835262300009
J	Li, HL; Wang, F; Liu, JB; Song, HR; Hou, ZX; Dai, P				Li, Hailang; Wang, Fan; Liu, Junbo; Song, Haoran; Hou, Zhixiong; Dai, Peng			Ensemble model for rail surface defects detection	PLOS ONE			English	Article							WHEEL FLAT	The detection of rail surface defects is vital for high-speed rail maintenance and management. The CNN-based computer vision approach has been proved to be a strong detection tool widely used in various industrial scenarios. However, the CNN-based detection models are diverse from each other in performance, and most of them require sufficient training samples to achieve high detection performance. Selecting an appropriate model and tuning it with insufficient annotated rail defect images is time-consuming and tedious. To overcome this challenge, motivated by ensemble learning that uses multiple learning algorithms to obtain better predictive performance, we develop an ensemble framework for industrialized rail defect detection. We apply multiple backbone networks individually to obtain features, and mix them in a binary format to obtain better and more diverse sub-networks. Image augmentation and feature augmentation operations are randomly applied to further make the model more diverse. A shared feature pyramid network is adopted to reduce model parameters as well as computation cost. Experimental results substantiate that the approach outperforms single detecting architecture in our specified rail defect task. On the collected dataset with 8 defect classes, our algorithm achieves 7.4% higher mAP.5 compared with YOLOv5 and 2.8% higher mAP.5 compared with Faster R-CNN.	[Li, Hailang; Wang, Fan; Liu, Junbo; Song, Haoran; Hou, Zhixiong; Dai, Peng] China Acad Railway Sci, Railway Infrastruct Inspect Inst, Beijing, Peoples R China		Dai, P (corresponding author), China Acad Railway Sci, Railway Infrastruct Inspect Inst, Beijing, Peoples R China.	daipeng_iic@protonmail.com						Adeva JJG., 2005, CLEI ELECT J, V9, P1, DOI DOI 10.19153/CLEIEJ.12.1.1; Andrew G. Howard, 2017, Arxiv, DOI arXiv:1704.04861; Attoh-Okine NO., 2017, BIG DATA DIFFERENTIA; Blockeel H., 2011, ENCY MACHINE LEARNIN, V1, P511; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004; Cannon DF, 2003, FATIGUE FRACT ENG M, V26, P865, DOI 10.1046/j.1460-2695.2003.00693.x; Casado-Garcia A, 2020, FRONT ARTIF INTEL AP, V325, P2688, DOI 10.3233/FAIA200407; De Becker D, 2021, P I MECH ENG F-J RAI, V235, P763, DOI 10.1177/0954409720962252; Deng J., 2009, 2009 IEEE C COMP VIS, P248, DOI [10.1109/CVPR.2009.5206848, DOI 10.1109/CVPR.2009.5206848]; Deutschl E, 2004, 2004 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P507; Fan Q, 2020, PROC CVPR IEEE, P4012, DOI 10.1109/CVPR42600.2020.00407; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hu HZ, 2021, PROC CVPR IEEE, P10180, DOI 10.1109/CVPR46437.2021.01005; Kaewunruen S, 2022, INT J STRUCT STAB DY, V22, DOI 10.1142/S0219455422501097; Kaewunruen S, 2021, STRUCT MONIT MAINT, V8, P151, DOI 10.12989/smm.2021.8.2.151; Kang BY, 2019, IEEE I CONF COMP VIS, P8419, DOI 10.1109/ICCV.2019.00851; Kishore MB, 2019, J MECH SCI TECHNOL, V33, P4209, DOI 10.1007/s12206-019-0816-x; Korez A, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9060370; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Lee H, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21248335; Liang B, 2013, CHEM ENGINEER TRANS, V33, P745, DOI 10.3303/CET1333125; Lin J, 2009, PROC IEEE INT SYMP, P764; Lin T.-Y., 2014, EUR C COMP VIS, P740, DOI 10.1007/978-3-319-10602-1_48; Lin T.Y., 2017, P IEEE C COMP VIS PA, P2117, DOI DOI 10.48550/ARXIV.1612.03144; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Ngamkhanong C, 2020, ENG STRUCT, V214, DOI 10.1016/j.engstruct.2020.110604; Niu MH, 2021, IEEE T IND INFORM, V17, P2271, DOI 10.1109/TII.2020.3004397; Park JW, 2021, J NONDESTRUCT EVAL, V40, DOI 10.1007/s10921-021-00810-9; Rame A, 2021, ARXIV; Sagi O, 2018, WIRES DATA MIN KNOWL, V8, DOI 10.1002/widm.1249; Santur Y, 2016, 2016 NATIONAL CONFERENCE ON ELECTRICAL, ELECTRONICS AND BIOMEDICAL ENGINEERING (ELECO), P745; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Sollich P, 1996, ADV NEUR IN, V8, P190; Solovyev R, 2021, IMAGE VISION COMPUT, V107, DOI 10.1016/j.imavis.2021.104117; Sresakoolchai J, 2021, INSIGHT, V63, P393, DOI 10.1784/insi.2021.63.7.393; Sresakoolchai J, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10062-w; Sresakoolchai J, 2021, VIBRATION-BASEL, V4, P341, DOI 10.3390/vibration4020022; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tastimur C, 2016, IEEE INTL CONF IND I, P411, DOI 10.1109/INDIN.2016.7819194; Toliyat HA, 2003, IEEE T IND APPL, V39, P1454, DOI 10.1109/TIA.2003.816474; Veit A, 2016, ADV NEUR IN, V29; Wei XK, 2019, ENG APPL ARTIF INTEL, V80, P66, DOI 10.1016/j.engappai.2019.01.008; Wu YP, 2022, COMPUT-AIDED CIV INF, V37, P227, DOI 10.1111/mice.12710; Wu Yuxin, 2019, DETECTRON; Yang RS, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/7012710; Yu HM, 2019, IEEE T INSTRUM MEAS, V68, P656, DOI 10.1109/TIM.2018.2853958; Yu JH, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12010023; Yun S, 2019, IEEE I CONF COMP VIS, P6022, DOI 10.1109/ICCV.2019.00612; Zhang H, 2018, IEEE T INSTRUM MEAS, V67, P1593, DOI 10.1109/TIM.2018.2803830; Zhang Y, 2022, ENG REP, V4, DOI 10.1002/eng2.12486; Zhang Z, 2021, RAIL 5K REAL WORLD D; Zoph Barret, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12372), P566, DOI 10.1007/978-3-030-58583-9_34	53	0	0	9	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268518	10.1371/journal.pone.0268518	http://dx.doi.org/10.1371/journal.pone.0268518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580111	Green Published, gold			2022-12-26	WOS:000886501700004
J	Guo, YL; Peng, Q; Hao, LY; Ji, JM; Zhang, ZQ; Xue, Y; Liu, YW; Gao, YT; Li, CG; Shi, XL				Guo, Yinglin; Peng, Qing; Hao, Liyuan; Ji, Jingmin; Zhang, Zhiqin; Xue, Yu; Liu, Yiwei; Gao, Yuting; Li, Caige; Shi, Xinli			Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma	FASEB JOURNAL			English	Article						bile acids; dihydroartemisinin; farnesoid X receptor; hepatocellular carcinoma; YAP1	X-RECEPTOR; BILE-ACID; NUCLEAR RECEPTOR; OBETICHOLIC ACID; LIVER-INJURY; CANCER; IDENTIFICATION; METABOLISM; SENESCENCE; PROTECTS	Loss of FXR, one of bile acid receptors, enlarged livers. Yes-associated protein 1 (YAP1), a dominant oncogene, promotes hepatocellular carcinoma (HCC). However, the relationship between FXR and YAP1 was unspecified in bile acid homeostasis in HCC. Here, we used TIMER2.0, the Cancer Genome Atlas (TCGA) Database, and Kaplan-Meier Plotter Database and discovered that FXR was positively correlated with better prognosis in liver cancer patients. Our previous research showed that dihydroartemisinin (DHA) inhibited cell proliferation in HepG2 and HepG22215 cells. However, the relationship of YAP1 and the bile acid receptor FXR remains elusive during DHA treatment. Furthermore, we showed that DHA improved FXR and reduced YAP1 in the liver cancer cells and mice. Additionally, the expression of nucleus protein FXR was enhanced in Yap1(LKO) mice with liver cancer. DHA promoted the expression level of whole and nuclear protein FXR independent of YAP1 in Yap1(LKO) mice with liver cancer. DHA declined cholesterol 7 alpha-hydroxylase, but not sterol 27-hydroxylase, and depressed cholic acid and chenodeoxycholic acid of liver tissue in Yap1(LKO) mice with liver cancer. Generally, our results suggested that DHA improved FXR and declined YAP1 to suppress bile acid metabolism. Thus, we suggested that FXR acted as a potential therapeutic target in HCC.	[Guo, Yinglin; Peng, Qing; Hao, Liyuan; Ji, Jingmin; Zhang, Zhiqin; Xue, Yu; Liu, Yiwei; Gao, Yuting; Li, Caige; Shi, Xinli] Hebei Univ Chinese Med, Dept Pathobiol & Immunol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China	Hebei University of Chinese Medicine	Shi, XL (corresponding author), Hebei Univ Chinese Med, Dept Pathobiol & Immunol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China.	sxlsunshine@sina.com		Shi, Xinli/0000-0003-1164-1156	National Natural Science Foundation of China [81873112]; Science and Technology Project of Hebei Education Department [ZD2022120]; Scientific and technological capability improvement project of Hebei University of Chinese Medicine [KTZ2019002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Hebei Education Department; Scientific and technological capability improvement project of Hebei University of Chinese Medicine	The study was supported by National Natural Science Foundation of China (81873112), Science and Technology Project of Hebei Education Department (ZD2022120), and Scientific and technological capability improvement project of Hebei University of Chinese Medicine (KTZ2019002).	Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Attia YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12629-4; Bai H., 2015, FASEB J, V29, DOI [10.1096/fasebj.29.1_supplement.45.4, DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.45.4]; Bergmann J, 2017, HEPATOLOGY, V65, P89, DOI 10.1002/hep.28874; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bhargava P, 2020, J CLIN INVEST, V130, P3467, DOI 10.1172/JCI129401; Bray F, 2020, CA-CANCER J CLIN, V70, P313, DOI 10.3322/caac.21609; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Cariello M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11549-7; Cox AG, 2016, NAT CELL BIOL, V18, P886, DOI 10.1038/ncb3389; Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274; Deuschle U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043044; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gulfo J, 2020, J HEPATOL, V73, P1131, DOI 10.1016/j.jhep.2020.05.007; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Hao LY, 2021, ONCOL LETT, V22, DOI 10.3892/ol.2021.12914; He JL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0427-9; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Huang TE, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.599067; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ibar C, 2020, DEV CELL, V54, P256, DOI 10.1016/j.devcel.2020.06.025; Ji SY, 2019, DEV CELL, V48, P460, DOI 10.1016/j.devcel.2018.12.021; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146; Kim DH, 2019, FASEB J, V33, P11109, DOI 10.1096/fj.201900325R; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Li SH, 2020, MOL CELL BIOCHEM, V475, P79, DOI 10.1007/s11010-020-03861-0; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Lozano E, 2014, MOL CANCER RES, V12, P91, DOI 10.1158/1541-7786.MCR-13-0503; Lv B, 2018, CELL PHYSIOL BIOCHEM, V48, P158, DOI 10.1159/000491715; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Out C, 2011, HEPATOLOGY, V53, P2075, DOI 10.1002/hep.24286; Peng ZS, 2019, J BIOL CHEM, V294, P8529, DOI 10.1074/jbc.RA118.004361; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Rowen RJ., 2002, BREAKTHROUGHS PREVEN; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Shi XL, 2019, PHYTOTHER RES, V33, P1413, DOI 10.1002/ptr.6332; Sun LL, 2021, NAT REV GASTRO HEPAT, V18, P335, DOI 10.1038/s41575-020-00404-2; Takahashi S, 2017, TOXICOL SCI, V158, P334, DOI 10.1093/toxsci/kfx094; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Trauner M, 2019, HEPATOLOGY, V70, P788, DOI 10.1002/hep.30509; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wen M, 2021, PHYTOTHER RES, V35, P3799, DOI 10.1002/ptr.7086; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956; Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yang ZX, 2010, HEPATOL INT, V4, P741, DOI 10.1007/s12072-010-9202-6; Ye C, 2021, PHYTOTHER RES, V35, P3406, DOI 10.1002/ptr.7062; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zou J, 2019, BMB REP, V52, P520, DOI 10.5483/BMBRep.2019.52.8.058	67	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22361	10.1096/fj.202200171R	http://dx.doi.org/10.1096/fj.202200171R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AV	35616366				2022-12-26	WOS:000800258400001
J	Noor, NAM; Shafie, S; Hamed, YS; Admon, MA				Noor, Nur Azlina Mat; Shafie, Sharidan; Hamed, Y. S.; Admon, Mohd Ariff			Soret and Dufour effects on MHD squeezing flow of Jeffrey fluid in horizontal channel with thermal radiation	PLOS ONE			English	Article							HEAT-TRANSFER; CHEMICAL-REACTION; MASS-TRANSFER; VISCOUS DISSIPATION; STRETCHING SURFACE; PERISTALTIC FLOW; FREE-CONVECTION; MODEL; NANOFLUIDS	The fluid flow with chemical reaction is one of well-known research areas in the field of computational fluid dynamic. It is potentially useful in the modelling of flow on a nuclear reactor. Motivated by the implementation of the flow in the industrial application, the aim of this study is to explore the time-dependent squeeze flow of magnetohydrodynamic Jeffrey fluid over permeable medium in the influences of Soret and Dufour, heat source/sink and chemical reaction. The presence of joule heating, joule dissipation and radiative heat transfer are analyzed. The flow is induced due to compress of two surfaces. Conversion of partial differential equations (PDEs) into ordinary differential equations (ODEs) is accomplished by imposing similarity variables. Then, the governing equations are resolved using Keller-box approach. The present outcomes are compared with previously outcomes in the literature to validate the precision of present outcomes. Both outcomes are shown in close agreement. The tabular and graphical results demonstrate that wall shear stress and velocity profile accelerate with the surfaces moving towards one another. Moreover, the concentration, temperature and velocity profiles decreasing for the increment of Hartmann numbers and Jeffrey fluid parameters. The impacts of heat generation/absorption, joule dissipation and Dufour numbers enhance the heat transfer rate and temperature profile. In contrast, the temperature profile drops and the heat transfer rate boosts when thermal radiation increases. The concentration profile decelerates, and the mass transfer rate elevates with raise in Soret number. Also, the mass transfer rate rises for destructive chemical reaction and contrary result is noted for convective chemical reaction.	[Noor, Nur Azlina Mat; Shafie, Sharidan; Admon, Mohd Ariff] Univ Teknol Malaysia, Dept Math Sci, Fac Sci, Johor Baharu, Johor, Malaysia; [Hamed, Y. S.] Taif Univ, Dept Math & Stat, Coll Sci, Taif, Saudi Arabia	Universiti Teknologi Malaysia; Taif University	Admon, MA (corresponding author), Univ Teknol Malaysia, Dept Math Sci, Fac Sci, Johor Baharu, Johor, Malaysia.	ariffadmon@utm.my		MAT NOOR, NUR AZLINA/0000-0001-6402-5977; Hamed, Y. S./0000-0002-0365-0282	Taif University Researchers, Taif, Saudi Arabia [TURSP2020/155]; Ministry of Higher Education Malaysia and Research Management Centre-UTM, Universiti Teknologi Malaysia (UTM) [08G33, 17J98]	Taif University Researchers, Taif, Saudi Arabia; Ministry of Higher Education Malaysia and Research Management Centre-UTM, Universiti Teknologi Malaysia (UTM)	The authors would like to acknowledge Taif University Researchers, Taif, Saudi Arabia for financial support through project number TURSP2020/155 and the Ministry of Higher Education Malaysia and Research Management Centre-UTM, Universiti Teknologi Malaysia (UTM) for financial support through vote numbers 08G33 and 17J98.	Ahmad K, 2016, MALAYS J MATH SCI, V10, P311; Ahmad K, 2017, THERM SCI, V21, P267, DOI 10.2298/TSCI141103029A; Ahmad S, 2019, ADV MECH ENG, V11, DOI 10.1177/1687814019883774; Ahmed J, 2015, AIP ADV, V5, DOI 10.1063/1.4935571; Akbar NS, 2013, RESULTS PHYS, V3, P152, DOI 10.1016/j.rinp.2013.08.006; Akbar NS, 2011, J MECH MED BIOL, V11, P529, DOI 10.1142/S0219519411003879; Alam MK, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9192404; Alsaedi A, 2012, Z NATURFORSCH A, V67, P517, DOI 10.5560/ZNA.2012-0054; Alsaedi Ahmed, 2014, Z NATURFORSCH A, V67, P517, DOI [10.5560/zna.2012-0054, DOI 10.5560/ZNA.2012-0054]; Archibald FR, 1956, T AM SOC MECH ENG, V78, P231, DOI [10.1016/0043-5101648(73)90161-0, DOI 10.1016/0043-5101648(73)90161-0, 10.1016/0043-1648%2873%2990161-0, DOI 10.1016/0043-1648(73)90161-0]; Bakr AA, 2011, COMMUN NONLINEAR SCI, V16, P698, DOI 10.1016/j.cnsns.2010.04.040; Baranovskii ES, 2017, MATH METHOD APPL SCI, V40, P5035, DOI 10.1002/mma.4368; Brizhik L., CHEM PHYS, V324, P259, DOI [10.1111/zsc.12452, DOI 10.1016/J.CHEMPHYS.2006.01.033, 10.1016/j.chemphys.2006.01.033]; BUJURKE NM, 1995, FLUID DYN RES, V16, P173, DOI 10.1016/0169-5983(94)00058-8; Frolovskaya OA, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10060684; GRIMM RJ, 1976, APPL SCI RES, V32, P149, DOI 10.1007/BF00383711; Hamza S, 2016, GLOBAL J PHYS, V5, P505; Hashim, 2018, PHYS LETT A, V382, P1982, DOI 10.1016/j.physleta.2018.04.057; Hayat T, 2015, HEAT TRANSF RES, V46, P515, DOI 10.1615/HeatTransRes.2015007363; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13085-1; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P1301, DOI 10.1007/s10483-012-1623-6; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2400, DOI 10.1016/j.cnsns.2009.09.033; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Hayat T, 2014, THERM SCI, V18, P1069, DOI 10.2298/TSCI110907092H; Hayat T, 2011, Z NATURFORSCH A, V66, P606, DOI 10.5560/ZNA.2011-0024; Ibrahim SM, 2013, SRN COMPUTATIONAL MA, P1, DOI [10.1155/2013/765408, DOI 10.1155/2013/765408]; Idowu AS, 2013, J MATH-UK, V8, P74; Ishizawa S, 1966, B JSME, V9, P533, DOI [10.1299/jsme1958.9.533, DOI 10.1299/JSME1958.9.533]; Jackson J.D., 1963, APPL SCI RES, V11, P148, DOI [10.1007/bf03184719, DOI 10.1007/BF03184719, 10.1007/BF03184719]; Jaluria Y, 1980, NATURAL CONVECTION H; Kavita K, 2012, ADV APPL SCI RES, V3, P2312; Khan U, 2014, ALEX ENG J, V53, P463, DOI 10.1016/j.aej.2014.02.002; LEIDER PJ, 1974, IND ENG CHEM FUND, V13, P336, DOI 10.1021/i160052a007; Lund LA, 2019, ENERGIES, V12, DOI 10.3390/en12244617; Noor NAM, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9111215; Noor NAM, 2021, PHYS SCRIPTA, V96, DOI 10.1088/1402-4896/abd821; Noor NAM, 2020, EUR PHYS J PLUS, V135, DOI 10.1140/epjp/s13360-020-00868-w; Muhammad T, 2017, CHINESE J PHYS, V55, P1511, DOI 10.1016/j.cjph.2017.05.008; Nadeem S, 2009, Z NATURFORSCH A, V64, P713, DOI 10.1515/zna-2009-1107; Naduvinamani NB, 2019, SADHANA-ACAD P ENG S, V44, DOI 10.1007/s12046-019-1154-5; Nallapu Santhosh, 2014, International Journal of Engineering Mathematics, DOI 10.1155/2014/713831; Noor NAM., 2020, J ADV RES FLUID MECH, V68, P94, DOI [10.37934/arfmts.68.2.94111, DOI 10.37934/ARFMTS.68.2.94111]; Noor NAM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250402; Noor NAM, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/abb695; Noor NAM, 2019, MATEMATIKA, V35, P33; Pal D, 2016, APPL MATH COMPUT, V287, P184, DOI 10.1016/j.amc.2016.04.037; Pandey SK, 2010, INT J BIOMATH, V3, P473, DOI 10.1142/S1793524510001094; PAVLOVSK.VA, 1971, DOKL AKAD NAUK SSSR+, V200, P809; Prasad K. V., 2013, Journal of King Saud University Science, V25, P313, DOI 10.1016/j.jksus.2013.02.005; Ramesh K, 2018, PROPULS POWER RES, V7, P329, DOI 10.1016/j.jppr.2018.11.008; Rao ME, 2017, GLOBAL J PURE APPL M, V13, P3985; Rao ME, 2017, INTERJOURNAL PHARM T, V9, P31059; Rashidi MM, 2008, MATH PROBL ENG, V2008, DOI 10.1155/2008/935095; Reynolds O., 1886, PHILOS T R SOC LONDO, V177, P157, DOI 10.1098/rstl.1886.0005; Saadati H, 2018, NUCL ENG TECHNOL, V50, P639, DOI 10.1016/j.net.2018.01.015; Saleem S, 2018, COMMUN THEOR PHYS, V70, P534, DOI 10.1088/0253-6102/70/5/534; Sandeep N, 2018, AIN SHAMS ENG J, V9, P517, DOI 10.1016/j.asej.2016.02.008; Shah NA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81417-y; Smith Tim, 2017, J LOW POWER ELECT AP, V10, P573, DOI [10.1155/2018/1254529, DOI https://doi.org/10.3390/su10124810, 10.3390/en10040573, DOI 10.3390/JLPEA11020023]; Song J, 2018, FRONT ENERGY RES, V6, P1, DOI [10.3389/fenrg.2018.00029, DOI 10.3389/FENRG.2018.00029, 10.3389/fenrg.2018.0002958846, DOI 10.3389/fenrg.2018.00029]; Stefan M, 1874, LONDON EDINBURGH DUB, V47, P465, DOI [10.1080/14786447408641062, DOI 10.1080/14786447408641062, 10.1002/htj.21587]; Sulochana C, 2021, HEAT TRANSF, V50, P3704, DOI 10.1002/htj.22049; Ullah I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01205-5; Ullah I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165348; WANG CY, 1976, J APPL MECH-T ASME, V43, P579, DOI 10.1115/1.3423935; Zokri SM, 2018, MALAYS J FUNDAM APPL, V14, P40	67	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0266494	10.1371/journal.pone.0266494	http://dx.doi.org/10.1371/journal.pone.0266494			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6G4UX	35587920	Green Published, gold			2022-12-26	WOS:000884750900001
J	Zhao, Y; Sun, HF; Zhao, YY; Liu, QQ; Liu, Y; Hou, YF; Jin, W				Zhao, Yang; Sun, Hefen; Zhao, Yuanyuan; Liu, Qiqi; Liu, Yang; Hou, Yifeng; Jin, Wei			NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/T beta R1/EMT axis	ONCOGENE			English	Article							SPECKLE-RELATED PROTEIN; ISOFORM; EXPRESSION; NUMB; ABERRANT	Alternative splicing of mRNA precursors allows cancer cells to create different protein isoforms that promote growth and survival. Compared to normal cells, cancer cells frequently exhibit a higher diversity of their transcriptomes. A comprehensive understanding of splicing regulation is required to correct the splicing alterations for the future precision oncology. A quantitative proteomic screen was performed to identify the regulators associated the metastasis in triple-negative breast cancer. Multiple in vitro and in vivo functional analyses were used to study the effects of NSrp70 on breast cancer metastasis. Next, transcriptomic sequencing (RNA-seq) and alternative splicing bioinformatics analysis was applied to screen the potential targets of NSrp70. Moreover, in vitro splicing assays, RNA pull-down, and RNA immunoprecipitation assay were used to confirm the specific binding between NSrp70 and downstream target genes. Furthermore, the prognostic value of NSrp70 was analyzed in a cohort of patients by performing IHC. We uncovered NSrp70 as a novel suppressor of breast cancer metastasis. We discovered that NSrp70 inhibited the skipped exon alternative splicing of NUMB, promoted the degradation of transforming growth factor receptor 1 through lysosome pathway, and regulated TGF beta/SMAD-mediated epithelial-mesenchymal transition phenotype in breast cancer cells. Furthermore, high NSrp70 expression correlated with a better prognosis in breast cancer patients. Our findings revealed that splicing regulator NSrp70 serves as a metastasis suppressor.	[Zhao, Yang; Sun, Hefen; Zhao, Yuanyuan; Liu, Qiqi; Liu, Yang; Hou, Yifeng; Jin, Wei] Fudan Univ, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Zhao, Yang; Sun, Hefen; Zhao, Yuanyuan; Liu, Qiqi; Hou, Yifeng; Jin, Wei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Sun, HF; Jin, W (corresponding author), Fudan Univ, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.; Sun, HF; Jin, W (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.	sunhefen2006@163.com; jinwei@fudan.edu.cn	ZHAO, YUAN/HCI-5831-2022; jin, wei/M-4717-2018	jin, wei/0000-0001-8263-571X	National Natural Science Foundation of China [81972727]; Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai [2017BR028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai	This work was supported by a grant from National Natural Science Foundation of China (81972727) and the Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines in Shanghai (2017BR028). We gratefully acknowledge the help of professor Igor Vladimirovich Reshetov (I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation) for the support of clinical statistical analysis.	Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Choi DB, 2014, LEUKEMIA RES, V38, P1252, DOI 10.1016/j.leukres.2014.08.001; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Erb U, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-29; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Kandachar V, 2012, CURR OPIN CELL BIOL, V24, P534, DOI 10.1016/j.ceb.2012.06.006; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim CH, 2016, J BIOL CHEM, V291, P6169, DOI 10.1074/jbc.M115.689414; Kim YD, 2011, NUCLEIC ACIDS RES, V39, P4300, DOI 10.1093/nar/gkq1267; Ladomery Michael, 2013, Int J Cell Biol, V2013, P463786, DOI 10.1155/2013/463786; Lee SH, 2016, BIOCHEM BIOPH RES CO, V479, P238, DOI 10.1016/j.bbrc.2016.09.051; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li N, 2000, BJU INT, V85, P514, DOI 10.1046/j.1464-410x.2000.00483.x; Loh TJ, 2014, ONCOL REP, V31, P273, DOI 10.3892/or.2013.2812; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Read A, 2018, ENDOCR-RELAT CANCER, V25, pR467, DOI 10.1530/ERC-18-0068; Reithmeier A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3616-7; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Sherman LS, 2000, J CELL BIOL, V150, P1071, DOI 10.1083/jcb.150.5.1071; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Sun HY, 2017, BIOCHEM BIOPH RES CO, V491, P780, DOI 10.1016/j.bbrc.2017.07.084; Sun HF, 2019, CANCER LETT, V440, P189, DOI 10.1016/j.canlet.2018.10.018; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZZ, 2010, CELL ADHES MIGR, V4, P176, DOI 10.4161/cam.4.2.10690; Xiao XY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-151; Xie J, 2015, NEUROSCIENCE, V310, P723, DOI 10.1016/j.neuroscience.2015.10.012; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289	42	1	1	4	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2022	41	25					3409	3422		10.1038/s41388-022-02349-z	http://dx.doi.org/10.1038/s41388-022-02349-z		MAY 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	2E6DK	35568738	Green Submitted			2022-12-26	WOS:000795517600001
J	Orr, CE; Wang, PL; Chen, LN; Wang, T				Orr, Christine E.; Wang, Peter L.; Chen, Lina; Wang, Tao			Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SUSTAINED VIROLOGICAL RESPONSE; TENOFOVIR DISOPROXIL FUMARATE; SINUSOIDAL ENDOTHELIAL-CELLS; CIRRHOSIS REGRESSION; HISTOLOGICAL IMPROVEMENT; ANTIVIRAL THERAPY; C PATIENTS; REVERSIBILITY; FIBROSIS/CIRRHOSIS	Cirrhosis is a major risk factor for developing hepatocellular carcinoma (HCC). However, many surgically resected HCCs are presumably non-cirrhotic. The dynamic nature of chronic liver disease leads to periods of hepatic repair and fibrosis regression. We hypothesize that most resected HCCs, including those from non-cirrhotic patients, exhibit features of fibrosis regression in their background liver, suggesting previously more advanced liver disease. We reviewed the histology of 37 HCC resections performed between 2005-2020, including 30 from non-cirrhotic patients. The non-neoplastic liver was evaluated for features of liver disease and of the hepatic repair complex (HRC). CD34 immunohistochemistry was performed as a marker of sinusoidal capillarization. CD34 staining was evaluated manually and also by a digital image classifier algorithm. Overall, 28 cases (76%) had a high number of fibrosis regression and hepatic repair features (>= 4 out of 8 features). Amongst the 30 non-cirrhotic patients, 21 (70%) showed a high number of repair features. Relative CD34 expression was increased in cases with a high number (>= 4) of HRC features versus a low number (<= 3) of features (p = 0.019). High HRC cases were more likely to exhibit nodular circumferential CD34 staining (p = 0.019). Our findings suggest that most resected HCC from non-cirrhotic patients display features of fibrosis regression in their background liver. Thus many, if not most, HCC patients who are "non-cirrhotic" may in fact have regressed cirrhosis. This finding reinforces that patients with regressed cirrhosis continue to be at high risk for HCC.	[Orr, Christine E.; Wang, Tao] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Wang, Peter L.] Queens Univ, Dept Med, Div Gastroenterol, Kingston, ON, Canada; [Chen, Lina] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Wang, T (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	tao.wang@kingstonhsc.ca			 [389199]		TW Internal Research Initiation Grant 389199 Queen's University http://www.queensu.ca The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar E, 2015, LIVER INT, V35, P30, DOI 10.1111/liv.12576; Bardou-Jacquet E, 2020, CLIN GASTROENTEROL H, V18, P1851, DOI 10.1016/j.cgh.2019.10.010; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; COUVELARD A, 1993, AM J PATHOL, V143, P738; Cui SJ, 1996, PATHOL INT, V46, P751, DOI 10.1111/j.1440-1827.1996.tb03544.x; Czaja AJ, 2004, J HEPATOL, V40, P646, DOI 10.1016/j.jhep.2004.01.009; D'Ambrosio R, 2018, LIVER INT, V38, P1459, DOI 10.1111/liv.13707; D'Ambrosio R, 2016, LIVER INT, V36, P783, DOI 10.1111/liv.13106; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; Delis SG, 2008, WORLD J GASTROENTERO, V14, P3452, DOI 10.3748/wjg.14.3452; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; Everson GT, 2008, ALIMENT PHARM THERAP, V27, P542, DOI 10.1111/j.1365-2036.2008.03620.x; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477; Guido M, 2018, LIVER INT, V38, P1770, DOI 10.1111/liv.13718; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Khan Ruben, 2018, Clin Liver Dis (Hoboken), V12, P137, DOI 10.1002/cld.707; Kim SU, 2012, J HEPATOL, V57, P556, DOI 10.1016/j.jhep.2012.04.029; Laursen TL, 2020, J VIRAL HEPATITIS, V27, P28, DOI 10.1111/jvh.13204; Manne V, 2014, J CLIN GASTROENTEROL, V48, pE76, DOI 10.1097/MCG.0000000000000162; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Papachrysos N, 2015, ANN GASTROENTEROL, V28, P374; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Semmler G, 2022, J HEPATOL, V76, P812, DOI 10.1016/j.jhep.2021.11.025; Serpaggi J, 2006, HUM PATHOL, V37, P1519, DOI 10.1016/j.humpath.2006.07.007; Sun YM, 2017, HEPATOLOGY, V65, P1438, DOI 10.1002/hep.29009; Torbensen M., 2019, HEPATOCELLULAR CARCI, P229; Tsai NC, 2015, DIGEST DIS SCI, V60, P260, DOI 10.1007/s10620-014-3336-7; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; Xu B, 2015, J GASTROEN HEPATOL, V30, P372, DOI 10.1111/jgh.12718	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267474	10.1371/journal.pone.0267474	http://dx.doi.org/10.1371/journal.pone.0267474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552548	Green Published, gold			2022-12-26	WOS:000868164600025
J	Wagner, LD; Minnis, AM; Shea, J; Agot, K; Ahmed, K; van der Straten, A				Wagner, Laura Danielle; Minnis, Alexandra M.; Shea, Jaclyn; Agot, Kawango; Ahmed, Khatija; van der Straten, Ariane			Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya	PLOS ONE			English	Article							HIV PREVENTION; VAGINAL MICROBICIDE; CLINICAL-TRIAL; COVERT USE; ACCEPTABILITY; GEL; ADHERENCE; CONTEXT; COUPLES; MALAWI	Background Male partner awareness and acceptance of microbicide and family planning product use has been shown to increase women's own acceptance and adherence of a product. However, little is known about preferences regarding potential Multipurpose Prevention Technology (MPT) product delivery forms. As part of the TRIO study, men's reactions to their female partner's TRIO product use and comparisons of men's and women's views of TRIO product attributes and use acceptability were explored to better understand product preferences. Methods Women in TRIO used three placebo products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections. Male partners (N = 39) and women (N = 88) completed in-depth interviews on their own and their partner's experiences with these products. Qualitative coding and analyses followed a conceptual model of HIV prevention product acceptability, and here, we explored themes of disclosure, trust and infidelity as they informed barriers and facilitators to product use. Results Men expressed a desire to know of their partner's product use decisions and be informed and educated on the products to better support their partners, in some cases, expressing a high level of concern regarding maximizing the ease of product adherence for their partner. They also wanted to understand the effects of products on sexual encounters with their partner, but in some cases, wanted more knowledge in order to control their partner's product use decisions. Similarly to women, men found long-acting, discreet products that have little to no effect on sexual encounters or libido the most acceptable for their female partners' use. Product use was most acceptable to men if they were informed of use without inadvertent discovery. Conclusions Men's product attribute preferences often aligned with women's opinions of the same products. To support women's correct use of MPTs, further research is needed to determine the best strategy for achieving male partner acceptance and support of product use, particularly for less familiar delivery forms, such as the vaginal ring.	[Wagner, Laura Danielle; Minnis, Alexandra M.] RTI Int, Womens Global Hlth Imperat, Berkeley, CA 94704 USA; [Shea, Jaclyn] Youth Tech Hlth, Oakland, CA USA; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ahmed, Khatija] Setshaba Res Ctr, Soshanguve, South Africa; [van der Straten, Ariane] ASTRA Consulting, Berkeley, CA USA	Research Triangle Institute	Wagner, LD (corresponding author), RTI Int, Womens Global Hlth Imperat, Berkeley, CA 94704 USA.	wagner@rti.org		Wagner, Danielle/0000-0002-3417-491X	Bill & Melinda Gates Foundation [OPP1114942]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the Bill & Melinda Gates Foundation under Grant OPP1114942. Funding was granted to AVS and AM. Funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder website: https://www.gatesfoundation.org/.	Barker G., 2007, ENGAGING MEN BOYS CH; Bayer AM, 2010, CULT HEALTH SEX, V12, P771, DOI [10.1080/13691058.2010.488299, 10.1080/13691051003728599]; Becker S, 1996, STUD FAMILY PLANN, V27, P291, DOI 10.2307/2138025; Gafos M, 2010, CULT HEALTH SEX, V12, P929, DOI 10.1080/13691058.2010.507876; Green G, 2001, SOC SCI MED, V52, P585, DOI 10.1016/S0277-9536(00)00162-3; Griffin JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224898; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Marlow HM, 2010, CULT HEALTH SEX, V12, P899, DOI 10.1080/13691058.2010.508843; Minnis AM., 2018, AIDS BEHAV, P1; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Montgomery CM, 2010, CULT HEALTH SEX, V12, P649, DOI 10.1080/13691051003736261; Montgomery ET, 2011, AIDS BEHAV, V15, P959, DOI 10.1007/s10461-010-9806-9; Muchomba FM, 2012, JAIDS-J ACQ IMM DEF, V61, P490, DOI 10.1097/QAI.0b013e31826f9962; Pistorius A G, 2004, SAHARA J, V1, P78; Pool R, 2000, Cult Health Sex, V2, P197, DOI 10.1080/136910500300804; Pool R, 2000, INT J STD AIDS, V11, P162, DOI 10.1258/0956462001915606; Richter L, 2015, SAMJ, S. Afr. med. j., V105, P304, DOI 10.7196/SAMJ.8925; Rosen RK, 2008, J WOMENS HEALTH, V17, P383, DOI 10.1089/jwh.2006.0325; Sahin-Hodoglugil NN, 2009, SOC SCI MED, V69, P1547, DOI 10.1016/j.socscimed.2009.08.014; Salter ML, 2008, AIDS CARE, V20, P853, DOI 10.1080/09540120701742300; Settergren SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206074; Shapley-Quinn MK., 2017, AIDS IMPACT; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Silverman JG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001723; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van der Straten A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25094; Whitehead SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014831; Woodsong C, 2004, PERSPECT SEX REPRO H, V36, P127, DOI 10.1111/j.1931-2393.2004.tb00201.x; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265303	10.1371/journal.pone.0265303	http://dx.doi.org/10.1371/journal.pone.0265303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551318	gold, Green Published			2022-12-26	WOS:000868164600002
J	Alvarez-Rodriguez, E; Sanchez-Franco, CM; Perez-Haro, MJ; Bello-Otero, L; Aguado-Valcarcel, M; Gonzalez-Suarez, I				Alvarez-Rodriguez, Elena; Sanchez-Franco, Cesar Manuel; Perez-Haro, Maria Jose; Bello-Otero, Laura; Aguado-Valcarcel, Marta; Gonzalez-Suarez, Ines			Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients	PLOS ONE			English	Article							TREATMENT SATISFACTION QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; VALIDATION; PREFERENCES; MEDICATION; AID	In the last years, therapeutic decisions in multiple sclerosis (MS) have become challenging due to expanded options with different treatment profiles attending to efficacy, safety, and route and frequency of administration. Moreover, patients with multiple sclerosis (PwMS) increasingly wish to be involved in their therapeutic decision process. Therefore, a new, patient-centric shared decision model (SDM), is gaining relevance. However, validated scales oriented to assess the quality of the process itself are lacking. The AGA-25 scale is a fit-for-purpose 25-item scale based on two validated scales in MS (Treatment Satisfaction Questionnaire for Medication (TSQM) and Decisional Conflict Scale (DCS)). The aim of this work is to develop and validate the AGAS-25 in Spanish. Two hundred and three PwMS (aged 17 to 67; 155 [76.4%] females) undergoing stable disease modifying treatment in the last 6 months were consecutively recruited. The Principal Component Analysis suggested a four-factor structure for the 25-item version of the questionnaire: 1) satisfaction with the SDM process 2) adverse events with the DMT, 3) convenience of the chosen-DMT and 4) information reliability. The internal consistency of the measurement was adequate (Cronbach's alpha = 0.88). Our results support the use of the AGAS-25 scale to assist SDM in Spanish-speaking PwMS.	[Alvarez-Rodriguez, Elena; Bello-Otero, Laura; Aguado-Valcarcel, Marta; Gonzalez-Suarez, Ines] Hosp Alvaro Cunqueiro, Neurol Dept, Neurologist, Vigo, Spain; [Sanchez-Franco, Cesar Manuel] Hosp Alvaro Cunqueiro, Sch Nursing, Neurol Dept, Vigo, Spain; [Perez-Haro, Maria Jose] Biostatech Advice Training & Innovat Biostat SL, Santiago De Compostela, Spain		Gonzalez-Suarez, I (corresponding author), Hosp Alvaro Cunqueiro, Neurol Dept, Neurologist, Vigo, Spain.	igonsua@gmail.com		Gonzalez-Suarez, Ines/0000-0002-9897-0771; Alvarez Rodriguez, Elena/0000-0003-2687-7532; Perez-Haro, Maria Jose/0000-0001-8837-7643				[Anonymous], MEASURING SHARED DEC; Atkinson Mark J, 2004, Health Qual Life Outcomes, V2, P12, DOI 10.1186/1477-7525-2-12; Ballesteros J, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0656-2; Ben-Zacharia Aliza, 2018, Int J MS Care, V20, P287, DOI 10.7224/1537-2073.2017-070; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Cocco E, 2017, EXPERT REV NEUROTHER, V17, P173, DOI 10.1080/14737175.2016.1217155; De las Cuevas C, 2016, PATIENT PREFER ADHER, V10, P2351, DOI [10.2147/PPA.S122377, 10.2147/PPA.S107299]; Doherr H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173904; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Elwyn G, 2010, HEALTH EXPECT, V13, P139, DOI 10.1111/j.1369-7625.2009.00572.x; Giovannoni G, 2018, CURR OPIN NEUROL, V31, P233, DOI 10.1097/WCO.0000000000000561; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kopke S, 2014, J NEUROL NEUROSUR PS, V85, P411, DOI 10.1136/jnnp-2013-306441; Koudriavtseva T, 2012, NEUROL SCI, V33, P575, DOI 10.1007/s10072-011-0776-0; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Lizan L, 2014, PATIENT PREFER ADHER, V8, P1653, DOI 10.2147/PPA.S67253; Olivas EM, 2017, NEUROLOGIA, V32, P29, DOI 10.1016/j.nrl.2014.12.011; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Reen GK, 2017, J NEUROL SCI, V375, P107, DOI 10.1016/j.jns.2016.12.038; Regnault A, 2012, J CYST FIBROS, V11, P494, DOI 10.1016/j.jcf.2012.04.007; Shay LA, 2015, MED DECIS MAKING, V35, P114, DOI 10.1177/0272989X14551638; Solari A, 2010, MULT SCLER, V16, P1393, DOI 10.1177/1352458510380417; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Vermersch P, 2017, MULT SCLER J, V23, P604, DOI 10.1177/1352458516657441; Weaver M, 1997, AM J MANAG CARE, V3, P579	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268125	http://dx.doi.org/10.1371/journal.pone.0268125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560185	Green Published, gold			2022-12-26	WOS:000835326900001
J	Fudali-Czyz, A; Mamcarz, PJ; Martynowska, K; Domagala-Zysk, E; Rothwell, A				Fudali-Czyz, Agnieszka; Mamcarz, Piotr Janusz; Martynowska, Klaudia; Domagala-Zysk, Ewa; Rothwell, Andrew			Sex differences in self-perceived employability and self-motivated strategies for learning in Polish first-year students	PLOS ONE			English	Article							GENDER; CAREER; EFFICACY; CHOICE; VALIDATION; SCIENCE	Self-perceived employability (SPE) is defined as the ability to attain sustainable employment appropriate to one's qualification level (Rothwell 2008) and perceived as a crucial factor in university graduates' career development. Meanwhile, University students are mainly assessed through the lens of academic achievement, which depend, inter alia, on the self-motivated strategies for learning (MSL). Firstly, we tested hypothesised sex differences in SPE's and MSL's factors in a group of the first-year university students (n = 600) in a Central European context. Our analyses revealed that female students, despite their higher results in MSL's factors (self-regulation, learning strategies, intrinsic values, self-efficacy) presented lower internal SPE than male students. Secondly, we explored how much general SPE can be predicted from general MSL, taking into account sex as a moderator, finding that sex factor was not significant as a moderator. We can consider general MSL as a good predictor of general SPE in both sex groups. The results will provide evidence to support HEI curricular development and strategies for workplace attitude change to address existing sex inequalities. In addition, our findings relating to MSL will provide evidence to support the development of approaches to enhancing student employability with additional long term benefits in mental health and well-being.	[Fudali-Czyz, Agnieszka] Uniwersytet Pedag Krakowie, Neurocognit Psychol, Krakow, Poland; [Mamcarz, Piotr Janusz] Katolicki Uniwersytet Lubelski Jana Pawla II, Emot & Motivat Psychol, Lublin, Poland; [Martynowska, Klaudia; Domagala-Zysk, Ewa] Katolicki Uniwersytet Lubelski Jana Pawla II, Special Pedag, Lublin, Poland; [Rothwell, Andrew] Loughborough Univ, Sch Business & Econ, Loughborough, England	Catholic University of Lublin; Catholic University of Lublin; Loughborough University	Mamcarz, PJ (corresponding author), Katolicki Uniwersytet Lubelski Jana Pawla II, Emot & Motivat Psychol, Lublin, Poland.	pmamcarz@kul.pl		Domagala-Zysk, Ewa/0000-0002-2227-7102; Mamcarz, Piotr/0000-0001-6307-6326; Rothwell, Andrew/0000-0003-2740-2598				Ahmed W, 2017, INT J PSYCHOL ED STU, V4, P1, DOI [10.17220/ijpes.2017.03.001, DOI 10.17220/IJPES.2017.03.001]; Al Khatib S.A., 2010, INT J RES ED IJRE, V27, P57; ANDERMAN EM, 1994, J RES SCI TEACH, V31, P811, DOI 10.1002/tea.3660310805; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Barrows J., 2013, UNIVERSAL J ED RES, V1, P204, DOI [10.13189/ujer. 2013.010310, DOI 10.13189/UJER.2013.010310, 10.13189/UJER.2013.010310]; Bembenutty H, 2011, J ADV ACAD, V22, P448, DOI 10.1177/1932202X1102200304; Bengtsson E, 2019, BUS MANAGE ED, V17, P111, DOI 10.3846/bme.2019.10512; Berntson E, 2007, WORK STRESS, V21, P279, DOI 10.1080/02678370701659215; Bidjerano T., 2005, ANN M NE ED RES ASS, V1; Cerezo R, 2019, REV PSICODIDACT, V24, P1, DOI 10.1016/j.psicod.2018.08.001; Chin W.S., 2015, INT J ACAD RES BUSIN, V5, P56, DOI 10.6007/IJARBSS/v5-i10/1842; Cifre E, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02467; Correll SJ, 2001, AM J SOCIOL, V106, P1691, DOI 10.1086/321299; Czarnik S., 2015, EDUKACJA RYNEK PRACY, P1; De Cuyper N, 2010, J CAREER DEV, V37, P635, DOI 10.1177/0894845309357051; Erturan Ilker G, 2014, KURAM UYGUL EGIT BIL, V14, P829; Fugate M, 2004, J VOCAT BEHAV, V65, P14, DOI 10.1016/j.jvb.2003.10.005; Goraus K., 2014, EKONOMIA RYNEK GOSPO, DOI [10.17451/EKO/36/2014/30, DOI 10.17451/EKO/36/2014/30]; Greer TW, 2017, ADV DEV HUM RESOUR, V19, P190, DOI 10.1177/1523422317695230; Heilman ME, 2012, RES ORGAN BEHAV, V32, P113, DOI 10.1016/j.riob.2012.11.003; Huberty C.J., 2000, HDB APPL MULTIVARIAT, P183; Iszkowska, 2021, CLOSING GENDER GAP C; Iwaniec J, 2019, INT J APPL LINGUIST, V29, P130, DOI 10.1111/ijal.12251; Jackson D, 2021, J HIGH EDUC POLICY M, V43, P182, DOI 10.1080/1360080X.2020.1777634; Jackson D, 2017, HIGH EDUC RES DEV, V36, P747, DOI 10.1080/07294360.2016.1229270; Kucharczyk I., 2016, KUCHARCZYK CZ OWIEK, V4, P77, DOI [10.5604/17345537.1233888, DOI 10.5604/17345537.1233888]; LENT RW, 1994, J VOCAT BEHAV, V45, P79, DOI 10.1006/jvbe.1994.1027; Lodi E, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10050082; Lu CQ, 2016, J CAREER DEV, V43, P37, DOI 10.1177/0894845315576372; McSweeney B, 2002, HUM RELAT, V55, P89, DOI 10.1177/0018726702551004; Meyers L., 2017, APPL MULTIVARIRIATE, V3rd ed.; PINTRICH PR, 1990, J EDUC PSYCHOL, V82, P33, DOI 10.1037/0022-0663.82.1.33; Dorantes MDR, 2013, ELECTRON J RES EDUC, V11, P193; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Rothwell A, 2008, J VOCAT BEHAV, V73, P1, DOI 10.1016/j.jvb.2007.12.001; Rothwell A, 2007, PERS REV, V36, P23, DOI 10.1108/00483480710716704; Rubin D. B., 1988, PROC SURVEY RES SECT, P79, DOI DOI 10.1080/01944368808977158; SMITH J., CULTURAL COMPASS REP; Sojkin B, 2015, HIGH EDUC, V69, P209, DOI 10.1007/s10734-014-9770-9; Tek OE., 2011, JURNAL PENDIDIKAN BI, V4, P92; Ulstad S. O., 2016, ADVANCES IN PHYSICAL, V6, P27, DOI DOI 10.4236/APE.2016.61004; Van Der Heijde CMP., 2006, MIAMI; van Harten J, 2022, EUR J WORK ORGAN PSY, V31, P145, DOI 10.1080/1359432X.2021.1942847; Vargas R, 2018, EDUC TRAIN, V60, P226, DOI 10.1108/ET-03-2017-0037; Velayutham S, 2012, INT J SCI MATH EDUC, V10, P1347, DOI 10.1007/s10763-012-9339-y; Wawrzyniak A.J., 2018, POSTTRAUMATIC STRESS, P229, DOI 10.1093/med/9780190259440.001.0001; Williams CM, 2006, J VOCAT BEHAV, V69, P262, DOI 10.1016/j.jvb.2006.02.007; Wolters CA, 1999, LEARN INDIVID DIFFER, V11, P281, DOI 10.1016/S1041-6080(99)80004-1; Zimmerman B. J., 2009, SELF REGULATION META; ZIMMERMAN BJ, 1990, J EDUC PSYCHOL, V82, P51, DOI 10.1037/0022-0663.82.1.51	50	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0264817	http://dx.doi.org/10.1371/journal.pone.0264817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560324	gold, Green Published			2022-12-26	WOS:000835326900009
J	Kaggwa, MM; Abaatyo, J; Alol, E; Muwanguzi, M; Najjuka, SM; Favina, AA; Rukundo, GZ; Ashaba, S; Mamun, M				Kaggwa, Mark Mohan; Abaatyo, Joan; Alol, Emmanuel; Muwanguzi, Moses; Najjuka, Sarah Maria; Favina, Alain A.; Rukundo, Godfrey Zari; Ashaba, Scholastic; Mamun, Mohammed			Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: Retrospective findings from a psychiatric ward registry	PLOS ONE			English	Article							ALCOHOL; AGE; SYMPTOMS; BRAIN	It has been reported that the COVID-19 pandemic has predisposed adolescents to risky behaviors such as substance use and subsequent substance use disorder (SUD). However, it is unknown how the pandemic has changed the prevalence of SUD among adolescents in Uganda. We aimed to determine the prevalence of SUD and associated factors among adolescents in southwestern Uganda. Retrospectively, psychiatry ward records from November 2018 to July 2021 were collected from the largest tertiary hospital in southwestern Uganda. A total of 441 adolescent records were included in the analysis, with a mean age was 17 +/- 1.88 years, and the majority were males (50.34%). The overall prevalence of SUD was 7.26% (5.90% and 9.80% before and during the pandemic). Despite a little rise in SUD (3.9% increment) during the COVID-19 pandemic, there was no statistical difference compared to before the pandemic. The likelihood of being diagnosed with SUD was more among older adolescents at any period. In addition, having a diagnosis of bipolar mood disorder reduced the likelihood of SUD during the pandemic. This study indicated no statistical change in the diagnosis of SUD among adolescents before and during the COVID-19 pandemic. As older-male adolescents (17 to 19 years) were at higher risk of SUD, there is a need for early intervention for this group.	[Kaggwa, Mark Mohan; Abaatyo, Joan; Alol, Emmanuel; Favina, Alain A.; Rukundo, Godfrey Zari; Ashaba, Scholastic] Mbarara Univ Sci & Technol, Fac Med, Dept Psychiat, Mbarara, Uganda; [Kaggwa, Mark Mohan; Rukundo, Godfrey Zari] African Ctr Suicide Prevent & Res, Mbarara, Uganda; [Muwanguzi, Moses] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda; [Najjuka, Sarah Maria] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Mamun, Mohammed] CHINTA Res Bangladesh, Dhaka, Bangladesh; [Mamun, Mohammed] Univ South Asia, Dept Publ Hlth, Dhaka, Bangladesh; [Mamun, Mohammed] Daffodil Int Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Mamun, Mohammed] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Makerere University; University of South Asia; Daffodil International University; Jahangirnagar University	Kaggwa, MM; Abaatyo, J (corresponding author), Mbarara Univ Sci & Technol, Fac Med, Dept Psychiat, Mbarara, Uganda.; Kaggwa, MM (corresponding author), African Ctr Suicide Prevent & Res, Mbarara, Uganda.	Kmarkmohan@gmail.com; joandux@gmail.com	Kaggwa, Mark mohan/AAD-9733-2021; MUWANGUZI, MOSES/AFH-7079-2022	Kaggwa, Mark mohan/0000-0002-4733-154X; MUWANGUZI, MOSES/0000-0002-7760-7535; Favina, Alain/0000-0002-2739-1713; Mamun, Mohammed/0000-0002-1728-8966				Abbo Catherine, 2016, Int Neuropsychiatr Dis J, V7, P25387; Argyriou E, 2018, PHARMACOL BIOCHEM BE, V164, P106, DOI 10.1016/j.pbb.2017.07.013; Association of Maternal & Child Health Programs, 2021, AD DEV; Basu D, 2018, INDIAAN J SOCIAL PSY, V34, P54, DOI [10.4103/ijsp.ijsp_83_17, DOI 10.4103/IJSP.IJSP_83_17]; Blanco C, 2018, AM J ADDICTION, V27, P477, DOI 10.1111/ajad.12764; Centers for Disease Control and Prevention, 2021, SCH REM CLOS UG 77 W; Cetty L, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2073-z; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Dodge Kenneth A, 2021, Addict Behav Rep, V14, P100388, DOI 10.1016/j.abrep.2021.100388; Dsouza DD, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113145; Dumbili EW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1499-6; Dumontheil I, 2016, CURR OPIN BEHAV SCI, V10, P39, DOI 10.1016/j.cobeha.2016.04.012; Enns A, 2020, HEALTH PROMOT CHRON, V40, P342, DOI 10.24095/hpcdp.40.11/12.03; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Garofoli M, 2020, PRIMARY CARE, V47, P383, DOI 10.1016/j.pop.2020.02.013; Gray KM, 2018, J CHILD PSYCHOL PSYC, V59, P618, DOI 10.1111/jcpp.12783; Hamidullah S, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00298; Hearst MO, 2007, PREV MED, V44, P471, DOI 10.1016/j.ypmed.2007.02.018; Henry MB, 2019, AFR HEALTH SCI, V19, P1888, DOI 10.4314/ahs.v19i2.12; Iwamoto DK, 2011, ADDICT BEHAV, V36, P906, DOI 10.1016/j.addbeh.2011.04.005; Jaworska N, 2015, J PSYCHIATR NEUROSCI, V40, P291, DOI 10.1503/jpn.150268; Johnston LD, 2019, MONITORING FUTURE NA, DOI DOI 10.3998/2027.42/148123; Kabwama SN, 2021, SUBST ABUSE TREAT PR, V16, DOI 10.1186/s13011-021-00385-8; Kaggwa Mark Mohan, 2021, Risk Manag Healthc Policy, V14, P2789, DOI 10.2147/RMHP.S314451; Kasirye R., 2016, UGANDA NEW ALCOHOL C; Kimbui E, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0222-2; Lenk KM, 2014, J CHILD ADOLES SUBST, V23, P137, DOI 10.1080/1067828X.2012.750972; Lisdahl KM, 2018, DEV COGN NEUROS-NETH, V32, P80, DOI 10.1016/j.dcn.2018.02.007; Meyer TD, 2012, J AFFECT DISORDERS, V136, P926, DOI 10.1016/j.jad.2011.09.005; Miech R, 2021, DRUG ALCOHOL DEPEN, V226, DOI 10.1016/j.drugalcdep.2021.108822; Moonajilin MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254926; Muhindo R., 2016, CONTEXTUAL CHALLENGE, P4, DOI [10.4172/2315-7844.1000190, DOI 10.4172/2315-7844.1000190]; Olawole-Isaac A, 2018, S AFR J CHILD HEALTH, pS79, DOI 10.7196/SAJCH.2018.v12i2.1524; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Sen LT, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.739698; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Syed NK, 2020, J PSYCHIATR RES, V130, P289, DOI 10.1016/j.jpsychires.2020.08.021; TAIOLI E, 1991, NEW ENGL J MED, V325, P968; The School Series, 2022, SCH SER; Thorpe HHA, 2020, PHARMACOL THERAPEUT, V206, DOI 10.1016/j.pharmthera.2019.107431; Viner RM, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2005.038117; Wabe Nasir Tajure, 2011, Addict Health, V3, P137; Wang QQ, 2021, MOL PSYCHIATR, V26, P30, DOI 10.1038/s41380-020-00880-7; Wardell JD, 2020, ALCOHOL CLIN EXP RES, V44, P2073, DOI 10.1111/acer.14425; Weatherson KA, 2018, J ADOLESCENT HEALTH, V63, P724, DOI 10.1016/j.jadohealth.2018.07.002; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; World Health Organisation, 2021, ADOLESCENT HEALTH; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	49	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0269044	http://dx.doi.org/10.1371/journal.pone.0269044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617261	Green Published, gold			2022-12-26	WOS:000835048800028
J	Kang, J; Kim, H; Park, H; Lee, B; Lee, KY				Kang, J.; Kim, H.; Park, H.; Lee, B.; Lee, K. Y.			RISK FACTORS AND ECONOMIC BURDEN OF POSTOPERATIVE ANASTOMOTIC LEAKAGE RELATED EVENTS IN PATIENTS WHO UNDERWENT SURGERIES FOR COLORECTAL CANCER	VALUE IN HEALTH			English	Meeting Abstract									[Kang, J.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea; [Kim, H.; Park, H.] Johnson & Johnson Med, Seoul, South Korea; [Lee, B.] Seoul Natl Univ, Seoul, South Korea; [Lee, K. Y.] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Johnson & Johnson; Seoul National University (SNU); Yonsei University; Yonsei University Health System				Kang, Jeonghyun/0000-0001-7311-6053					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	JAN	2022	25	1		S		POSA94	S51	S52						2	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	YM3PT	35584082	Green Published, gold			2022-12-26	WOS:000746490200226
J	Unruh, L; Dharmapuri, S; Xia, YL; Soyemi, K				Unruh, Larissa; Dharmapuri, Sadhana; Xia, Yinglin; Soyemi, Kenneth			Health disparities and COVID-19: A retrospective study examining individual and community factors causing disproportionate COVID-19 outcomes in Cook County, Illinois	PLOS ONE			English	Article							SOCIAL DETERMINANTS; UNITED-STATES; DEPRIVATION; AREA; ASSOCIATION	Early data from the COVID-19 pandemic suggests that the disease has had a disproportionate impact on communities of color with higher infection and mortality rates within those communities. This study used demographic data from the 2018 US census estimates, mortality data from the Cook County Medical Examiner's office, and testing results from the Illinois Department of Public Health to perform bivariate and multivariate regression analyses to explore the role race plays in COVID-19 outcomes at the individual and community levels. We used the ZCTA Social Deprivation Index (SDI), a measure of ZCTA area level deprivation based on seven demographic characteristics to quantify the socio-economic variation in health outcomes and levels of disadvantage across ZCTAs. Principal findings showed that: 1) while Black individuals make up 22% of Cook County's population, they account for 28% of the county's COVID-19 related deaths; 2) the average age of death from COVID-19 is seven years younger for Non-White compared with White decedents; 3) residents of Minority ZCTA areas were 1.02 times as likely to test positive for COVID-19, (Incidence Rate Ratio (IRR) 1.02, [95% CI 0.95, 1.10]); 1.77 times as likely to die (IRR 1.77, [95% CI 1.17, 2.66]); and were 1.15 times as likely to be tested (IRR 1.15, [95% CI 0.99, 1.33]). There are notable differences in COVID-19 related outcomes between racial and ethnic groups at individual and community levels. This study illustrates the health disparities and underlying systemic inequalities experienced by communities of color.	[Unruh, Larissa] John H Stroger Jr Hosp Cook Cty Hlth, Dept Emergency Med, Chicago, IL USA; [Dharmapuri, Sadhana; Soyemi, Kenneth] Cook Cty Juvenile Temporary Detent Ctr, Cermak Hlth Serv, Chicago, IL 60612 USA; [Dharmapuri, Sadhana; Soyemi, Kenneth] John H Stroger Jr Hosp Cook Cty, Dept Pediat, Chicago, IL 60612 USA; [Xia, Yinglin] Univ Illinois, Dept Med, Chicago, IL USA	John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Soyemi, K (corresponding author), Cook Cty Juvenile Temporary Detent Ctr, Cermak Hlth Serv, Chicago, IL 60612 USA.; Soyemi, K (corresponding author), John H Stroger Jr Hosp Cook Cty, Dept Pediat, Chicago, IL 60612 USA.	ksoyemi@cookcountyhhs.org						Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Cook B.C., 2020, CHICAGO SUN TIM 0604; Cook County Medical Examiner, COOK COUNT MED EX CO; Del Brutto OH, 2021, J COMMUN HEALTH, V46, P292, DOI 10.1007/s10900-020-00887-9; Dyer O, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1483; Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370; Ferguson JM, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-03967-5; Gaglioti AH, 2021, J PUBLIC HEALTH MAN, V27, P268, DOI 10.1097/PHH.0000000000001354; Hacker KA, 2021, PREV CHRONIC DIS, V18, DOI 10.5888/pcd18.210086; Hua MJ., 2022, J RACIAL ETHN HLTH D, P1, DOI [10.1007/s40615-021-01219-w, DOI 10.1007/S40615-021-01219-W]; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297; Kitchen C, 2021, AIMS PUBLIC HEALTH, V8, P519, DOI 10.3934/publichealth.2021042; Lewis NM, 2020, MMWR-MORBID MORTAL W, V69, P1369, DOI 10.15585/mmwr.mm6938a4; Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306; Magesh S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.34147; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Munoz-Price LS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21892; Our World in Data, COR PAND COVID 19 DA; Phillips RL, 2016, HEALTH AFFAIR, V35, P1991, DOI 10.1377/hlthaff.2016.0709; Poteat T, 2020, ANN EPIDEMIOL, V47, P1, DOI 10.1016/j.annepidem.2020.05.004; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa038; Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268317	10.1371/journal.pone.0268317	http://dx.doi.org/10.1371/journal.pone.0268317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576226	gold, Green Published			2022-12-26	WOS:000834668900008
J	Zararsiz, GE; Bolat, S; Cephe, A; Kochan, N; Yerlitas, SI; Dogan, HO; Zararsiz, G				Zararsiz, Goezde Ertuerk; Bolat, Serkan; Cephe, Ahu; Kochan, Necla; Yerlitas, Serra Ilayda; Dogan, Halef Okan; Zararsiz, Goekmen			Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations	PLOS ONE			English	Article							LDL-C; ACCURATE; FORMULA	BackgroundLow-density lipoprotein cholesterol (LDL-C) is an important biomarker for determining cardiovascular risk and regulating lipid lowering therapy. Therefore, the accurate estimation of LDL-C concentration is essential in cardiovascular disease diagnosis and prognosis. Sampson recently proposed a new formula for the estimation of LDL-C. However, little is known regarding the validation of this formula. ObjectivesThis study aimed to validate this new formula with other well-known formulas in Turkish population, composed of adults. MethodsA total of 88,943 participants above 18 years old at Sivas Cumhuriyet University Hospital (Sivas, Turkey) were included to this study. LDL-C was directly measured by homogeneous assays, i.e., Roche, Beckman and Siemens and estimated by Friedewald's, Martin-Hopkins', extended Martin-Hopkins' and Sampson's formulas. The concordances between the estimations obtained by the formulas and the direct measurements were evaluated both in general and separately for the LDL-C, TG and non-HDL-C sublevels. Linear regression analysis was applied and residual error plots were generated between each estimation and direct measurement method. Coefficient of determination (R-2) and mean absolute deviations were also calculated. ResultsThe results showed that the extended Martin-Hopkins approach provided the most concordant results with the direct assays for LDL-C estimation. The results also showed that the highest concordances were obtained between the direct assays with the extended Martin-Hopkins formula calculated with the median statistics obtained from our own population. On the other hand, it was observed that the results of the methods may differ in different assays. The extended Martin-Hopkins approach, calculated from the median statistics of our population, gave the most concordant results in patients with "low LDL-C level (LDL-C levels < 70 mg/dL) or hypertriglyceridemia (TG levels >= 400 mg/dL)". ConclusionsAlthough the results of the formulas in different assays may vary, the extended Martin-Hopkins approach was the best one with the highest overall concordances. The validity of the Martin Hopkins' and Sampson's formulas has to be further investigated in different populations.	[Zararsiz, Goezde Ertuerk; Yerlitas, Serra Ilayda; Zararsiz, Goekmen] Erciyes Univ, Sch Med, Dept Biostat, Kayseri, Turkey; [Zararsiz, Goezde Ertuerk; Yerlitas, Serra Ilayda; Zararsiz, Goekmen] Erciyes Univ, Drug Applicat & Res Ctr ERFARMA, Kayseri, Turkey; [Bolat, Serkan; Dogan, Halef Okan] Sivas Cumhuriyet Univ, Sch Med, Dept Biochem, Sivas, Turkey; [Cephe, Ahu] Erciyes Univ Rectorate, Inst Data Management & Analyt Unit, Kayseri, Turkey; [Kochan, Necla] Izmir Biomed & Genome Ctr IBG, Izmir, Turkey	Erciyes University; Erciyes University; Cumhuriyet University; Erciyes University	Zararsiz, G (corresponding author), Erciyes Univ, Sch Med, Dept Biostat, Kayseri, Turkey.; Zararsiz, G (corresponding author), Erciyes Univ, Drug Applicat & Res Ctr ERFARMA, Kayseri, Turkey.	gokmenzararsiz@erciyes.edu.tr	YERLİTAŞ, Serra İlayda/HIR-2194-2022	Yerlitas, Serra Ilayda/0000-0003-2830-3006; DOGAN, Halef Okan/0000-0001-8738-0760; Zararsiz, Gokmen/0000-0001-5801-1835; Kochan, Necla/0000-0003-2355-4826	Research Fund of Erciyes University [TSG-2021-10912]	Research Fund of Erciyes University(Erciyes University)	This study was supported by the Research Fund of Erciyes University [TSG-2021-10912]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1995, NIH PUBLICATION, P31; Brownstein AJ, 2020, CLIN CHIM ACTA, V506, P149, DOI 10.1016/j.cca.2020.03.030; Centers for Disease Control and Prevention Cholesterol Reference Method Laboratory Network (CRMLN), 2004, TOT CHOL CERT PROT M; Chaen H, 2016, J ATHEROSCLER THROMB, V23, P1355, DOI 10.5551/jat.35972; Chung S, 2018, MED PRIN PRACT, V27, P8, DOI 10.1159/000485977; Cicero AFG, 2021, NUTR METAB CARDIOVAS, V31, P1911, DOI 10.1016/j.numecd.2021.02.034; Cordova Caio Mauricio Mendes de, 2004, Arq Bras Cardiol, V83, P482; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625; Hermans MP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-56; Martin SS, 2018, JAMA CARDIOL, V3, P749, DOI 10.1001/jamacardio.2018.1533; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; de Cordova CMM, 2013, ANN CLIN BIOCHEM, V50, P13, DOI 10.1258/acb.2012.011259; Piani F, 2021, INT J CARDIOL, V330, P221, DOI 10.1016/j.ijcard.2021.02.009; Piani F, 2021, EUR J INTERN MED, V83, P99, DOI 10.1016/j.ejim.2020.09.009; Rossouw HM, 2021, CLIN CHEM LAB MED, V59, P1930, DOI 10.1515/cclm-2021-0747; Sajja A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.28817; Sampson M, 2020, JAMA CARDIOL, V5, P540, DOI 10.1001/jamacardio.2020.0013; Sathiyakumar V, 2020, AM COLL CARDIOLOGY; Sathiyakumar V, 2018, CIRCULATION, V138, P244, DOI 10.1161/CIRCULATIONAHA.117.032463; Shin D, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010612; Song Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92625-x; Sweeney T, 2021, EXPERT REV PRECIS ME, V6, P247, DOI 10.1080/23808993.2021.1930531; Turkalp Isik, 2005, Anadolu Kardiyol Derg, V5, P13; Vargas-Vazquez A, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01471-3; World Health Organisation, 2021, CARD DIS CVDS; Zafrir B, 2020, J ATHEROSCLER THROMB, V27, P1359, DOI 10.5551/jat.57133	27	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0263860	http://dx.doi.org/10.1371/journal.pone.0263860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559957	Green Published, gold			2022-12-26	WOS:000835326900023
J	Zhang, NN; Wu, J; Zhang, SP; Yuan, MR; Xu, H; Li, J; Zhang, PP; Wang, MZ; Kempher, ML; Tao, XY; Zhang, LQ; Ge, HH; He, YX				Zhang, Nannan; Wu, Jin; Zhang, Siping; Yuan, Maoran; Xu, Hang; Li, Jie; Zhang, Pingping; Wang, Mingzhu; Kempher, Megan L.; Tao, Xuanyu; Zhang, Li-Qun; Ge, Honghua; He, Yong-Xing			Molecular basis for coordinating secondary metabolite production by bacterial and plant signaling molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETR FAMILY; PSEUDOMONAS-AERUGINOSA; BIOLOGICAL-CONTROL; STRUCTURAL BASIS; GENE-CLUSTER; BIOSYNTHESIS; 2,4-DIACETYLPHLOROGLUCINOL; PROTEIN; IDENTIFICATION; PERSPECTIVES	The production of secondary metabolites is a major mechanism used by beneficial rhizobacteria to antagonize plant pathogens. These bacteria have evolved to coordinate the production of different secondary metabolites due to the heavy metabolic burden imposed by secondary metabolism. However, for most secondary metabolites produced by bacteria, it is not known how their biosynthesis is coordinated. Here, we showed that PhlH from the rhizobacterium Pseudomonas fluorescens is a TetR-family regulator coordinating the expression of enzymes related to the biosynthesis of several secondary metabolites, including 2,4-diacetylphloroglucinol (2,4-DAPG), mupirocin, and pyoverdine. We present structures of PhlH in both its apo form and 2,4-DAPG-bound form and elucidate its ligand-recognizing and allosteric switching mechanisms. Moreover, we found that dissociation of 2,4-DAPG from the ligand-binding domain of PhlH was sufficient to allosterically trigger a pendulum-like movement of the DNA-binding domains within the PhlH dimer, leading to a closed-to-open conformational transition. Finally, molecular dynamics simulations confirmed that two distinct conformational states were stabilized by specific hydrogen bonding interactions and that disruption of these hydrogen bonds had profound effects on the conformational transition. Our findings not only reveal a well-conserved route of allosteric signal transduction in TetR-family regulators but also provide novel mechanistic insights into bacterial metabolic coregulation.	[Zhang, Nannan; Wu, Jin; Yuan, Maoran; Li, Jie; Zhang, Pingping; Wang, Mingzhu; Ge, Honghua] Anhui Univ, Sch Life Sci, Hefei, Peoples R China; [Zhang, Nannan; Zhang, Pingping] Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei, Anhui, Peoples R China; [Wu, Jin; Yuan, Maoran; Li, Jie; Wang, Mingzhu; Ge, Honghua] Anhui Univ, Informat Mat & Intelligent Sensing Lab Anhui Prov, Inst Mat Sci & Informat Technol, Hefei, Anhui, Peoples R China; [Zhang, Siping; Xu, Hang; He, Yong-Xing] Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou, Peoples R China; [Kempher, Megan L.; Tao, Xuanyu] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK USA; [Kempher, Megan L.; Tao, Xuanyu] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Zhang, Li-Qun] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China	Anhui University; Anhui University; Anhui University; Lanzhou University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; China Agricultural University	Zhang, NN; Ge, HH (corresponding author), Anhui Univ, Sch Life Sci, Hefei, Peoples R China.; Zhang, NN (corresponding author), Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei, Anhui, Peoples R China.; Ge, HH (corresponding author), Anhui Univ, Informat Mat & Intelligent Sensing Lab Anhui Prov, Inst Mat Sci & Informat Technol, Hefei, Anhui, Peoples R China.; He, YX (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou, Peoples R China.	zhangnn@ahu.edu.cn; hhge@ahu.edu.cn; heyx@lzu.edu.cn	Zhang, Li/GWM-7501-2022	Ge, Honghua/0000-0001-7176-6853	National Natural Science Foundation of China [31970103, 31971422]; Key Research and Development Plan Project of Anhui Province [202004a06020035]; Anhui Natural Science Foundation of China [2108085MC76]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan Project of Anhui Province; Anhui Natural Science Foundation of China(Natural Science Foundation of Anhui Province)	This work was supported by the grants from the National Natural Science Foundation of China (grant Nos. 31970103 and 31971422), Key Research and Development Plan Project of Anhui Province (grant No. 202004a06020035), and Anhui Natural Science Foundation of China (grant No. 2108085MC76).	Abbas A, 2004, MICROBIOL-SGM, V150, P2443, DOI 10.1099/mic.0.27033-0; Achkar J, 2005, J AM CHEM SOC, V127, P5332, DOI 10.1021/ja042340g; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Guo DD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01423; Gurney R, 2011, APPL MICROBIOL BIOT, V90, P11, DOI 10.1007/s00253-011-3128-3; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Haas D, 2000, CURR OPIN BIOTECH, V11, P290, DOI 10.1016/S0958-1669(00)00098-7; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang XQ, 2004, FEMS MICROBIOL LETT, V232, P197, DOI 10.1016/S0378-1097(04)00074-6; Kapoor I, 2020, ELIFE, V9, DOI 10.7554/eLife.57824; Khan SR, 2005, J BACTERIOL, V187, P6517, DOI 10.1128/JB.187.18.6517-6527.2005; Lara J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17504-x; Latour X, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111746; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lucke M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.589416; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Pavkov-Keller T, 2019, CHEMBIOCHEM, V20, P88, DOI 10.1002/cbic.201800462; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Siddiqui Z. A., 2006, PGPR BIOCONTROL BIOF; Tengerdy RP, 1998, J BIOTECHNOL, V66, P91, DOI 10.1016/S0168-1656(98)00138-2; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09479-1; Wang Y, 2019, ENVIRON MICROBIOL, V21, P1740, DOI 10.1111/1462-2920.14538; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Wells G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189331; Williams M. A, 2008, PROTEIN SCI ENCYCL, DOI 10.1002/; Yan X, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.01419-17, 10.1128/AEM.01419-17]; Yeo HK, 2017, NUCLEIC ACIDS RES, V45, P4244, DOI 10.1093/nar/gkx009; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu XQ, 2020, ENVIRON MICROBIOL, V22, P5073, DOI 10.1111/1462-2920.15052; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Zhou SS, 2021, NATURE, V590, P463, DOI 10.1038/s41586-021-03195-x	55	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102027	10.1016/j.jbc.2022.102027	http://dx.doi.org/10.1016/j.jbc.2022.102027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35568198	gold, Green Published			2022-12-26	WOS:000811813400012
J	Hamad, SH; Montgomery, SA; Simon, JM; Bowman, BM; Spainhower, KB; Murphy, RM; Knudsen, ES; Fenton, SE; Randell, SH; Holt, JR; Hayes, DN; Witkiewicz, AK; Oliver, TG; Ben Major, M; Weissman, BE				Hamad, Samera H.; Montgomery, Stephanie A.; Simon, Jeremy M.; Bowman, Brittany M.; Spainhower, Kyle B.; Murphy, Ryan M.; Knudsen, Erik S.; Fenton, Suzanne E.; Randell, Scott H.; Holt, Jeremiah R.; Hayes, D. Neil; Witkiewicz, Agnieszka K.; Oliver, Trudy G.; Ben Major, M.; Weissman, Bernard E.			TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice	ONCOGENE			English	Article							KEAP1-NRF2 PATHWAY; 3Q AMPLIFICATION; MUTATIONS; CARCINOMA; NRF2; INACTIVATION; ACTIVATION; MECHANISMS; GENES; P63	Studies have shown that Nrf2(E79Q/+) is one of the most common mutations found in human tumors. To elucidate how this genetic change contributes to lung cancer, we compared lung tumor development in a genetically-engineered mouse model (GEMM) with dual Trp53/p16 loss, the most common mutations found in human lung tumors, in the presence or absence of Nrf2(E79Q/+). Trp53/p16-deficient mice developed combined-small cell lung cancer (C-SCLC), a mixture of pure-SCLC (P-SCLC) and large cell neuroendocrine carcinoma. Mice possessing the LSL-Nrf2(E79Q) mutation showed no difference in the incidence or latency of C-SCLC compared with Nrf2(+/+) mice. However, these tumors did not express NRF2 despite Cre-induced recombination of the LSL-Nrf2(E79Q) allele. Trp53/p16-deficient mice also developed P-SCLC, where activation of the NRF2(E79Q) mutation associated with a higher incidence of this tumor type. All C-SCLCs and P-SCLCs were positive for NE-markers, NKX1-2 (a lung cancer marker) and negative for P63 (a squamous cell marker), while only P-SCLC expressed NRF2 by immunohistochemistry. Analysis of a consensus NRF2 pathway signature in human NE+-lung tumors showed variable activation of NRF2 signaling. Our study characterizes the first GEMM that develops C-SCLC, a poorly-studied human cancer and implicates a role for NRF2 activation in SCLC development.	[Hamad, Samera H.; Montgomery, Stephanie A.; Simon, Jeremy M.; Bowman, Brittany M.; Ben Major, M.; Weissman, Bernard E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Montgomery, Stephanie A.; Weissman, Bernard E.] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27515 USA; [Simon, Jeremy M.] Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA; [Simon, Jeremy M.] Univ N Carolina, UNC Neurosci Ctr, Sch Med, Chapel Hill, NC 27515 USA; [Spainhower, Kyle B.; Oliver, Trudy G.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT USA; [Murphy, Ryan M.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27515 USA; [Knudsen, Erik S.; Witkiewicz, Agnieszka K.] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA; [Fenton, Suzanne E.] NIEHS, Div Natl Toxicol Program, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Randell, Scott H.] Univ N Carolina, Sch Med, Marsico Lung Inst, Chapel Hill, NC 27515 USA; [Holt, Jeremiah R.; Hayes, D. Neil] Univ Tennessee, Hlth Sci Ctr Canc Res, Dept Med, Div Hematol & Oncol, Memphis, TN USA; [Ben Major, M.] Univ N Carolina, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ben Major, M; Weissman, BE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Weissman, BE (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27515 USA.; Ben Major, M (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC 27515 USA.	bmajor@wustl.edu; weissman@med.unc.edu	, Pathology Services Core/CEZ-2246-2022	Holt, Jeremiah/0000-0002-5201-5015	National Institutes of Environmental and Health Sciences [T32ES007126]; Golberg; National Cancer Institute [CA216051]; UNC Lineberger Clinical/Translational Research Award;  [5R01CA244841-02];  [5U01CA231844-04];  [5U24CA213274-05]	National Institutes of Environmental and Health Sciences; Golberg; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Lineberger Clinical/Translational Research Award; ; ; 	This study was supported by a grant from the National Institutes of Environmental and Health Sciences (T32ES007126) (S.H.H), a Golberg Postdoctoral Fellow (S.H.H.), a grant from the National Cancer Institute (CA216051) (B.E.W, M.B.M.) and by grants 5R01CA244841-02, 5U01CA231844-04, and 5U24CA213274-05 (T.G.O.). These studies were also supported in part by a UNC Lineberger Clinical/Translational Research Award.	Alcala N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11276-9; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bowman BM, 2020, J PATHOL, V252, P125, DOI 10.1002/path.5504; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cancer Genome Atlas Research N, 2014, NATURE, V511, P50, DOI [10.1038/nature133851:CAS:528:DC%2BC2cXht1ChurnI, DOI 10.1038/NATURE133851:CAS:528:DC%2BC2CXHT1CHURNI]; Cescon DW, 2015, CLIN CANCER RES, V21, P2499, DOI 10.1158/1078-0432.CCR-14-2206; Cloer EW, 2019, CANCER RES, V79, P889, DOI 10.1158/0008-5472.CAN-18-2723; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Demirhan O, 2010, CANCER EPIDEMIOL, V34, P472, DOI 10.1016/j.canep.2010.03.018; Desai A, 2016, CANCER BIOL MED, V13, P77, DOI 10.28092/j.issn.2095-3941.2016.0008; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Engel NW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166690; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Gabriel AAG, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa112; George J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03099-x; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Hamad Samera H, 2017, Tob Regul Sci, V3, P459, DOI 10.18001/TRS.3.4.7; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ireland AS, 2020, CANCER CELL, V38, P60, DOI 10.1016/j.ccell.2020.05.001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kazanets A, 2016, BBA-REV CANCER, V1865, P275, DOI 10.1016/j.bbcan.2016.04.001; Kerins MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31281-0; Kim JH, 2017, ONCOTARGET, V8, P48248, DOI 10.18632/oncotarget.17594; Kodama T, 2014, MOL CANCER THER, V13, P2910, DOI 10.1158/1535-7163.MCT-14-0274; KOIKE K, 1990, J VIROL, V64, P3988, DOI 10.1128/JVI.64.8.3988-3991.1990; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Laddha SV, 2019, CANCER RES, V79, P4339, DOI 10.1158/0008-5472.CAN-19-0214; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Leversha MA, 2003, J PATHOL, V200, P610, DOI 10.1002/path.1374; Li SY, 2016, J THORAC ONCOL, V11, P2129, DOI 10.1016/j.jtho.2016.08.142; Lubet R, 2005, EXP LUNG RES, V31, P117, DOI 10.1080/01902140490495499; Lubojemska A, 2016, VET COMP ONCOL, V14, pE70, DOI 10.1111/vco.12102; Maronpot RR, 1999, PATHOLOGY MOUSE REFE; Massion PP, 2003, CANCER RES, V63, P7113; McCaughan F, 2010, AM J RESP CRIT CARE, V182, P83, DOI 10.1164/rccm.201001-0005OC; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Reznik GK, 1994, IARC PUBL, P30524; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Sanchez-Cespedes M, 1999, ONCOGENE, V18, P5843, DOI 10.1038/sj.onc.1203003; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Snow AN, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-30; Society AC, 2019, CANC FACTS FIGURES 2; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sonkin D, 2019, LUNG CANCER MANAG, V8, DOI 10.2217/lmt-2019-0005; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Travis WD, 2014, PATHOLOGE, V35, P188, DOI 10.1007/s00292-014-1974-3; Travis William D, 2009, Eur J Cancer, V45 Suppl 1, P251, DOI 10.1016/S0959-8049(09)70040-1; WAALKES MP, 1987, CANCER RES, V47, P2445; Wang SH, 2019, MAYO CLIN PROC, V94, P1599, DOI 10.1016/j.mayocp.2019.01.034; Wu MX, 2003, AM J CLIN PATHOL, V119, P696, DOI 10.1309/XCP6EWPB3BMRKA; Yamano S, 2016, CANCER SCI, V107, P123, DOI 10.1111/cas.12855; Zheng M, 2016, SURG ONCOL CLIN N AM, V25, P447, DOI 10.1016/j.soc.2016.02.003; Zhu Yanliang, 2008, Zhongguo Fei Ai Za Zhi, V11, P681, DOI 10.3779/j.issn.1009-3419.2008.05.009	69	1	1	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2022	41	25					3423	3432		10.1038/s41388-022-02348-0	http://dx.doi.org/10.1038/s41388-022-02348-0		MAY 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	2E6DK	35577980	Green Submitted			2022-12-26	WOS:000796348100001
J	Ma, L; Bian, MY; Gao, H; Zhou, Z; Yi, W				Ma, Lei; Bian, Mengyao; Gao, Hui; Zhou, Zhi; Yi, Wei			A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer	PLOS ONE			English	Article							CELL-CYCLE ARREST; TARGETING ER-ALPHA; INFLAMMATORY CASPASES; BIOLOGICAL EVALUATION; MULTIPLE-MYELOMA; GASDERMIN D; CLEAVAGE; DFNA5; DERIVATIVES; PROGRESSION	Breast cancer is the most common malignancy among women worldwide, accordingly, numerous chemotherapeutic drugs have been discovered thus far. However, the development and application of these drugs is severely constrained because of their unclear mechanism. To address this issue, our previous work has defined 3-acyl isoquinolin-1(2H)-one derivatives as potent anti-tumor agents, among which the compound 4f possessed relatively higher activity in vitro. In this study, we aim to further explore the anti-cancer effect and the underlying molecular mechanism of 4f in breast cancer cells. Therefore, CCK8 assay was used to detect cell viability and flow cytometry was used to analyze cell cycle and apoptosis. Meanwhile, related proteins that regulate cell cycle and apoptosis were detected. The results showed that 4f induced cell apoptosis and inhibited cell proliferation in breast cancer cells in a dose-depended manner without significant toxicity to human normal mammary epithelial cell. The cell cycle was arrested at G2 phase with the suppressed expression of the CDK1 protein. Additionally, 4f was confirmed to induce the cell apoptosis with the up-regulation of bax, down-regulation of bcl-2, activation of cleaved-caspase3/7/9 and cleaved-PARP, together with the inhibition of MEK/ERK and p38 MAPK pathway. Moreover, the GSDME-mediated pyroptosis was also induced by 4f in breast cancer cells. Together, these results demonstrated that 4f could serve as a new and promising candidate for the treatment of breast cancer.	[Zhou, Zhi; Yi, Wei] Guangzhou Med Univ, Guangzhou Municipal & Guangdong Prov Key Lab Prot, State Key Lab Resp Dis, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; Guangzhou Med Univ, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Zhou, Z; Yi, W (corresponding author), Guangzhou Med Univ, Guangzhou Municipal & Guangdong Prov Key Lab Prot, State Key Lab Resp Dis, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	zhouzhi@gzhmu.edu.cn; yiwei@gzhmu.edu.cn	Zhou, Zhi/R-3928-2018; Gao, Hui/E-6278-2011	Zhou, Zhi/0000-0002-6521-8946; Gao, Hui/0000-0002-8736-4485	NSFC [21877020, 22007020]; Guangdong Natural Science Funds for Distinguished Young Scholar [2017A030306031]; Natural Science Foundation of Guangdong Province [2019A1515010935]	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This research was supported by NSFC (21877020, 22007020), Guangdong Natural Science Funds for Distinguished Young Scholar (2017A030306031) and Natural Science Foundation of Guangdong Province (2019A1515010935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2008, BIOORGAN MED CHEM, V16, P4699, DOI 10.1016/j.bmc.2008.02.028; Bian MY, 2020, CHEMPLUSCHEM, V85, P405, DOI 10.1002/cplu.201900616; Burmistrova O, 2011, CANCER LETT, V309, P71, DOI 10.1016/j.canlet.2011.05.018; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen HY, 2019, MOLECULES, V24, DOI 10.3390/molecules24152722; Chen LP, 2019, APOPTOSIS, V24, P74, DOI 10.1007/s10495-018-1499-y; Cramer H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010802.pub2; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; de Beeck KO, 2012, ANN OTO RHINOL LARYN, V121, P197; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Ding QY, 2020, J CELL PHYSIOL, V235, P2911, DOI 10.1002/jcp.29197; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He LJ, 2018, BIOORGAN MED CHEM, V26, P3899, DOI 10.1016/j.bmc.2018.06.010; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li Q, 2019, CHEM-BIOL INTERACT, V313, DOI 10.1016/j.cbi.2019.108820; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Liu YY, 2013, EUR J PHARMACOL, V698, P95, DOI 10.1016/j.ejphar.2012.10.013; Lu HJ, 2018, CLIN CANCER RES, V24, P6066, DOI 10.1158/1078-0432.CCR-18-1478; Mai FY, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12663; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Sanchez-Martinez C, 2015, BIOORG MED CHEM LETT, V25, P3420, DOI 10.1016/j.bmcl.2015.05.100; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Song J, 2019, J CONTROL RELEASE, V294, P27, DOI 10.1016/j.jconrel.2018.11.014; Tang ZC, 2016, EUR J MED CHEM, V118, P328, DOI 10.1016/j.ejmech.2016.04.029; Tang ZC, 2014, BIOORG MED CHEM LETT, V24, P2129, DOI 10.1016/j.bmcl.2014.03.042; Wang YB, 2018, BIOCHEM BIOPH RES CO, V495, P1418, DOI 10.1016/j.bbrc.2017.11.156; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Xiao WQ, 2019, CANCER LETT, V444, P45, DOI 10.1016/j.canlet.2018.12.014; Yu JH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1441-4; Zhang CC, 2019, APOPTOSIS, V24, P312, DOI 10.1007/s10495-019-01515-1; Zhang ZY, 2013, INT J ONCOL, V43, P289, DOI 10.3892/ijo.2013.1946; Zheng XB, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117186; Zhu M, 2018, EUR J MED CHEM, V157, P1395, DOI 10.1016/j.ejmech.2018.08.072	40	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0268060	10.1371/journal.pone.0268060	http://dx.doi.org/10.1371/journal.pone.0268060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551332	gold, Green Published			2022-12-26	WOS:000868179400018
J	Chung, YC; Chen, CY; Chang, CM; Lin, YL; Liao, KK; Lin, HC; Chen, WY; Yang, YR; Shih, YF				Chung, Ya-Chu; Chen, Chao-Ying; Chang, Chia-Ming; Lin, Yin-Liang; Liao, Kwong-Kum; Lin, Hsiu-Chen; Chen, Wen-Yin; Yang, Yea-Ru; Shih, Yi-Fen			Altered corticospinal excitability of scapular muscles in individuals with shoulder impingement syndrome	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX; CORTICAL EXCITABILITY; RECRUITMENT PATTERNS; TRAPEZIUS MUSCLE; PAIN; PEOPLE; NEUROPLASTICITY; MUSCULOSKELETAL; REHABILITATION	The purpose of this study is to assess and compare corticospinal excitability in the upper and lower trapezius and serratus anterior muscles in participants with and without shoulder impingement syndrome (SIS). Fourteen participants with SIS, and 14 without SIS were recruited through convenient sampling in this study. Transcranial magnetic stimulation assessment of the scapular muscles was performed while the participants were holding their arm at 90 degrees scaption. The motor-evoked potential (MEP), active motor threshold (AMT), latency of MEP, cortical silent period (CSP), activated area and center of gravity (COG) of cortical mapping were compared between groups using the Mann-Whitney U tests. The SIS group demonstrated following significances, higher AMTs of the lower trapezius (SIS: 0.60 +/- 0.06; Comparison: 0.54 +/- 0.07, p = 0.028) and the serratus anterior (SIS: 0.59 +/- 0.04; Comparison: 0.54 +/- 0.06, p = 0.022), longer CSP of the lower trapezius (SIS: 62.23 +/- 22.87 ms; Comparison: 45.22 +/- 14.64 ms, p = 0.019), and posteriorly shifted COG in the upper trapezius (SIS: 1.88 +/- 1.06; Comparison: 2.76 +/- 1.55, p = 0.048) and the serratus anterior (SIS: 2.13 +/- 1.02; Comparison: 3.12 +/- 1.88, p = 0.043), than the control group. In conclusion, participants with SIS demonstrated different organization of the corticospinal system, including decreased excitability, increased inhibition, and shift in motor representation of the scapular muscles.	[Chung, Ya-Chu; Lin, Yin-Liang; Chen, Wen-Yin; Yang, Yea-Ru; Shih, Yi-Fen] Natl Yang Ming Chiao Tung Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan; [Chen, Chao-Ying] Chang Gung Univ, Sch Phys Therapy, Tao Yuan City, Taiwan; [Chang, Chia-Ming; Lin, Hsiu-Chen] China Med Univ, Dept Phys Therapy, Taichung, Taiwan; [Liao, Kwong-Kum] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; Taipei Veterans General Hospital	Shih, YF (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan.	yfshih@nycu.edu.tw			Ministry of Science and Technology, Taiwan [MOST110-2410-H-A49A-515]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially funded by the Ministry of Science and Technology, Taiwan (MOST110-2410-H-A49A-515).	Alexander CM, 2007, CLIN NEUROPHYSIOL, V118, P2664, DOI 10.1016/j.clinph.2007.09.057; Badawy RAB, 2012, FUNCT NEUROL, V27, P131; Boroojerdi B, 1999, CLIN NEUROPHYSIOL, V110, P699, DOI 10.1016/S1388-2457(98)00027-3; Boudreau SA, 2010, MANUAL THER, V15, P410, DOI 10.1016/j.math.2010.05.008; Bradnam L, 2016, CLIN NEUROPHYSIOL, V127, P769, DOI 10.1016/j.clinph.2015.03.012; Burianova H, 2016, CEREB CORTEX, V26, P1072, DOI 10.1093/cercor/bhu287; Burns E, 2016, EUR J PAIN, V20, P1203, DOI 10.1002/ejp.859; Cavaleri R, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0440-8; Chester R, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-45; Cools AM, 2007, SCAND J MED SCI SPOR, V17, P25, DOI 10.1111/j.1600-0838.2006.00570.x; Cools AM, 2003, AM J SPORT MED, V31, P542, DOI 10.1177/03635465030310041101; Cram J, 1998, INTRO SURFACE ELECTR; Curra A, 2002, NEUROLOGY, V59, P1851, DOI 10.1212/01.WNL.0000038744.30298.D4; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; JOHNSON G, 1994, CLIN BIOMECH, V9, P44, DOI 10.1016/0268-0033(94)90057-4; Kallioniemi Elisa, 2015, Open Neurol J, V9, P62, DOI 10.2174/1874205X01509010062; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Magee D. J., 2020, ORTHOPEDIC PHYS ASSE, V7th; Masse-Alarie H, 2016, EXP BRAIN RES, V234, P1033, DOI 10.1007/s00221-015-4528-x; McLeod MM, 2015, J ATHL TRAINING, V50, P847, DOI 10.4085/1062-6050-50.4.06; Michener LA, 2003, CLIN BIOMECH, V18, P369, DOI 10.1016/S0268-0033(03)00047-0; Neva JL, 2016, BEHAV BRAIN RES, V297, P187, DOI 10.1016/j.bbr.2015.10.015; Ngomo S, 2012, NEUROSCIENCE, V220, P208, DOI 10.1016/j.neuroscience.2012.06.018; Ngomo S, 2015, CLIN NEUROPHYSIOL, V126, P365, DOI 10.1016/j.clinph.2014.05.035; Parker RS, 2016, BRAIN STIMUL, V9, P488, DOI 10.1016/j.brs.2016.03.020; PEAT M, 1977, AM J PHYS MED REHAB, V56, P223; Pelletier R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0480-y; Rohel A, 2021, EUR J PAIN, V25, P1209, DOI 10.1002/ejp.1746; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; SEEGER LL, 1988, AM J ROENTGENOL, V150, P343, DOI 10.2214/ajr.150.2.343; Smith M, 2009, PHYS THER SPORT, V10, P45, DOI 10.1016/j.ptsp.2008.12.002; Snodgrass SJ, 2014, MANUAL THER, V19, P614, DOI 10.1016/j.math.2014.01.006; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Struyf F, 2011, SCAND J MED SCI SPOR, V21, P352, DOI 10.1111/j.1600-0838.2010.01274.x; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; Wadsworth DJS, 1997, INT J SPORTS MED, V18, P618, DOI 10.1055/s-2007-972692; Ward SH, 2016, KNEE, V23, P582, DOI 10.1016/j.knee.2016.04.001; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268533	10.1371/journal.pone.0268533	http://dx.doi.org/10.1371/journal.pone.0268533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576229	Green Published, gold			2022-12-26	WOS:000834668900001
J	Huang, YT; Sun, YS; Chen, MC				Huang, Yi-Ting; Sun, Yeali S.; Chen, Meng Chang			TagSeq: Malicious behavior discovery using dynamic analysis	PLOS ONE			English	Article							NEURAL-NETWORKS	In recent years, studies on malware analysis have noticeably increased in the cybersecurity community. Most recent studies concentrate on malware classification and detection or malicious patterns identification, but as to malware activity, it still relies heavily on manual analysis for high-level semantic descriptions. We develop a sequence-to-sequence (seq2seq) neural network, called TagSeq, to investigate a sequence of Windows API calls recorded from malware execution, and produce tags to label their malicious behavior. We propose embedding modules to transform Windows API function parameters, registry, filenames, and URLs into low-dimension vectors, while still preserving the closeness property. Moreover, we utilize an attention mechanism to capture the relations between generated tags and certain API invocation calls. Results show that the most possible malicious actions are identified by TagSeq. Examples and a case study demonstrate that the proposed embedding modules preserve semantic-physical relations and that the predicted tags reflect malicious intentions. We believe this work is suitable as a tool to help security analysts recognize malicious behavior and intent with easy-to-understand tags.	[Huang, Yi-Ting; Chen, Meng Chang] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Sun, Yeali S.] Natl Taiwan Univ, Dept Informat Management, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chen, MC (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	mcc@iis.sinica.edu.tw	huang, yiting/HDM-3648-2022	Huang, Yi-Ting/0000-0002-6315-8927	Ministry of Science and Technology, R.O.C. [109-2221-E-001-010-MY3, 108-2218-E-002-045]	Ministry of Science and Technology, R.O.C.	This study was supported by Ministry of Science and Technology, R.O.C. in the form of grants awarded to M.C.C. (109-2221-E-001-010-MY3) and Y.S.S. (108-2218-E-002-045). No additional external funding was received for this study.	Agrawal R, 2019, INT CONF ACOUST SPEE, P3222, DOI 10.1109/ICASSP.2019.8682899; Amer E, 2020, COMPUT SECUR, V92, DOI 10.1016/j.cose.2020.101760; Athiwaratkun B, 2017, INT CONF ACOUST SPEE, P2482, DOI 10.1109/ICASSP.2017.7952603; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bayer U., 2009, NDSS, V9, P8; BAYER U., 2006, 15 ANN C EUR I COMP; Beck D, 2006, P VIR B C; CARO, NEW VIR NAM CONV; Ceponis D, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072373; Ceponis D, 2019, SECUR COMMUN NETW, V2019, DOI 10.1155/2019/2317976; Chen H, 2004, NDSS, V4, P171; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Chorowski J., 2014, P NIPS WORKSH DEEP L; Dahl GE, 2013, INT CONF ACOUST SPEE, P3422, DOI 10.1109/ICASSP.2013.6638293; Damasevicius R, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10040485; Egele M, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2089125.2089126; Feng HH, 2004, P IEEE S SECUR PRIV, P194; Forrest S, 1996, P IEEE S SECUR PRIV, P120, DOI 10.1109/SECPRI.1996.502675; Gandotra E., 2014, J INF SECUR, V2014, P44440, DOI [10.4236/jis.2014.52006, DOI 10.4236/JIS.2014.52006]; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hsiao SW, 2020, IEEE T INF FOREN SEC, V15, P2402, DOI 10.1109/TIFS.2020.2969514; Huang YT, 2019, LECT NOTES COMPUT SC, V11547, P660, DOI 10.1007/978-3-030-21548-4_38; Hurier M, 2017, IEEE WORK CONF MIN S, P425, DOI 10.1109/MSR.2017.57; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kim S, 2017, INT CONF ACOUST SPEE, P4835, DOI 10.1109/ICASSP.2017.7953075; Kingma DP., 2014, ADAM METHOD STOCHAST; Lee W, 1998, PROCEEDINGS OF THE SEVENTH USENIX SECURITY SYMPOSIUM, P79; Luong M.-T., 2015, P 2015 C EMP METH NA, DOI [DOI 10.18653/V1/D15-1166, 10.18653/v1/D15-1166]; Pascanu R, 2015, INT CONF ACOUST SPEE, P1916, DOI 10.1109/ICASSP.2015.7178304; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Qiu JY, 2019, IEEE ACCESS, V7, P147156, DOI 10.1109/ACCESS.2019.2946392; Ravi C., 2012, INT J COMPUTER APPL, V43, P12, DOI 10.5120/6194-8715; Saxe J, 2015, 2015 10TH INTERNATIONAL CONFERENCE ON MALICIOUS AND UNWANTED SOFTWARE (MALWARE), P11, DOI 10.1109/MALWARE.2015.7413680; Sebastian M, 2016, LECT NOTES COMPUT SC, V9854, P230, DOI 10.1007/978-3-319-45719-2_11; Sebastio S, 2020, COMPUT SECUR, V93, DOI 10.1016/j.cose.2020.101775; Sethi K., 2019, P 2019 INT C CYBER S, P1; Sornil Ohm, 2013, International Journal of Information Processing and Management, V4, P59, DOI 10.4156/ijipm.vol4.issue5.7; Susanto, 2020, 2020 7th International Conference on Electrical Engineering, Computer Sciences and Informatics (EECSI), P15, DOI 10.23919/EECSI50503.2020.9251304; Sutskever I, 2014, ADV NEUR IN, V27; Tesauro GJ, 1996, IEEE EXPERT, V11, P5, DOI 10.1109/64.511768; Ucci D, 2019, COMPUT SECUR, V81, P123, DOI 10.1016/j.cose.2018.11.001; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vaswani A, 2017, ADV NEUR IN, V30; Veeramani R, 2012, INT C NETW CYB SEC, V25; Wenyi Huang, 2016, Detection of Intrusions and Malware, and Vulnerability Assessment. 13th International Conference, DIMVA 2016. Proceedings: LNCS 9721, P399, DOI 10.1007/978-3-319-40667-1_20; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yakura H, 2019, COMPUT SECUR, V87, DOI 10.1016/j.cose.2019.101592; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	49	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0263644	10.1371/journal.pone.0263644	http://dx.doi.org/10.1371/journal.pone.0263644			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576222	Green Published, gold			2022-12-26	WOS:000835262300008
J	Reidy, W; Kambale, HN; Hughey, AB; Nhlengethwa, TT; Tailor, J; Lukhele, N; Mthethwa, S; Hettema, A; Preko, P; Rabkin, M				Reidy, William; Kambale, Herve Nzereka; Hughey, Allison B.; Nhlengethwa, Tengetile Tezzy; Tailor, Janki; Lukhele, Nomthandazo; Mthethwa, Simangele; Hettema, Anita; Preko, Peter; Rabkin, Miriam			Client and healthcare worker experiences with differentiated HIV treatment models in Eswatini	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PROVIDER; STIGMA	IntroductionUniversal access to antiretroviral therapy (ART) is a cornerstone of Eswatini's national HIV strategy, and the number of people on ART in the country more than tripled between 2010 and 2019. Building on these achievements, the Ministry of Health (MOH) is scaling up differentiated service delivery, including less-intensive differentiated ART (DART) models for people doing well on treatment. We conducted a mixed-methods study to explore client and health care worker (HCW) perceptions of DART in Eswatini. MethodsThe study included structured site assessments at 39 purposively selected health facilities (HF), key informant interviews with 20 HCW, a provider satisfaction survey with 172 HCW and a client satisfaction survey with 270 adults. ResultsAll clients had been on ART for more than a year; 69% were on ART for >= 5 years. The most common DART models were Fast-Track (44%), Outreach (26%) and Community ART Groups (20%). HCW and clients appreciated DART, noting that the models often decrease provider workload and client wait time. Clients also reported that DART models helped them to adhere to ART, 96% said they were "very satisfied" with their current model, and 90% said they would recommend their model to others, highlighting convenience, efficiency and cost savings. The majority of HCW (52%) noted that implementation of DART reduced their workload, although some models, such as Outreach, were more labor-intensive. Each model had advantages and disadvantages; for example, clients concerned about stigma and inadvertent disclosure of HIV status were less interested in group models. ConclusionsClients in DART models were very satisfied with their care. HCW were also supportive of the new approach to HIV treatment delivery, noting its advantages to HF, HCW and to clients. Given the heterogeneous needs of people living with HIV, no single DART model will suit every client; a diverse portfolio of DART models is likely the best strategy.	[Reidy, William; Tailor, Janki; Rabkin, Miriam] Columbia Univ, ICAP, New York, NY 10027 USA; [Reidy, William; Rabkin, Miriam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Kambale, Herve Nzereka; Lukhele, Nomthandazo; Mthethwa, Simangele] Minist Hlth, Swaziland Natl AIDS Programme, Mbabane, Hhohho, Eswatini; [Hughey, Allison B.; Nhlengethwa, Tengetile Tezzy; Hettema, Anita] Clinton Hlth Access Initiat, Mbabane, Hhohho, Eswatini; [Preko, Peter] Columbia Univ, ICAP, Mbabane, Hhohho, Eswatini	Columbia University; Columbia University	Reidy, W (corresponding author), Columbia Univ, ICAP, New York, NY 10027 USA.; Reidy, W (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	wr2205@cumc.columbia.edu		Reidy, William/0000-0001-5701-038X	Bill & Melinda Gates Foundation; ICAP at Columbia University [OPP1152764]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); ICAP at Columbia University	This work was supported by the Bill & Melinda Gates Foundation through a grants to the Clinton Health Access Initiative (grant #TBD) and ICAP at Columbia University (MR, grant number OPP1152764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjetey V, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3878-7; Bond V, 2019, HEALTH PLACE, V55, P87, DOI 10.1016/j.healthplace.2018.11.006; Dlamini A., 2021, CQUIN 5 ANN M; Ehrenkranz P, 2019, CURR OPIN HIV AIDS, V14, P60, DOI 10.1097/COH.0000000000000509; Eshun-Wilson I, 2020, CURR HIV-AIDS REP, V17, P467, DOI 10.1007/s11904-020-00520-3; Eshun-Wilson I, 2019, JAIDS-J ACQ IMM DEF, V81, P540, DOI 10.1097/QAI.0000000000002070; Fatti G, 2020, JAIDS-J ACQ IMM DEF, V84, P162, DOI 10.1097/QAI.0000000000002333; Faturiyele I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5594-3; Fox MP, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002874; Geibel S, 2017, J ADOLESCENT HEALTH, V60, pS35, DOI 10.1016/j.jadohealth.2016.09.026; Grimsrud A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.22024; Hubbard J, 2020, GLOB HEALTH-SCI PRAC, V8, P18, DOI 10.9745/GHSP-D-19-00286; Joint United Nations Programme on HIV/AIDS (UNAIDS), AIDSINFO; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2020, UNAIDS DAT 2020, DOI [10.1186/s13104-020-04957-y, DOI 10.1186/S13104-020-04957-Y]; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Keene Claire Marriott, 2020, BMJ Open, V10, pe037545, DOI 10.1136/bmjopen-2020-037545; Macdonald V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21658; Mantell JE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25403; Mavhu W, 2020, LANCET GLOB HEALTH, V8, pE264, DOI 10.1016/S2214-109X(19)30526-1; McBride K, 2019, AIDS BEHAV, V23, P2629, DOI 10.1007/s10461-019-02580-y; Mudavanhu M, 2020, AIDS BEHAV, V24, P1197, DOI 10.1007/s10461-019-02681-8; Myer L, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21636; Nichols BE, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25692; Pascoe SJS, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25409; Pellecchia U, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21374; Phiri K, 2021, AIDS CARE, V33, P541, DOI 10.1080/09540121.2020.1755010; Prust ML, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21650; R Core Team, 2020, R LANG ENV STAT COMP; Rabkin M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228148; Rosen Sydney, 2021, Gates Open Res, V5, P177, DOI 10.12688/gatesopenres.13458.1; Sungsing T., 2018, INT AIDS C AIDS 2018; Swaziland Ministry of Health, 2016, NAT POL GUID COMM CT; Swaziland Ministry of Health, 2015, SWAZIL INT HIV MAN G; Teasdale CA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25210; Trafford Z, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5836-4; UNAIDS, 2020, HIV AIDS ESTIMATES; Venables E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218340; World Health Organization, 2021, UPD REC SERV DEL TRE; Zanolini A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002636	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0269020	10.1371/journal.pone.0269020	http://dx.doi.org/10.1371/journal.pone.0269020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3LQ	35613146	gold, Green Published			2022-12-26	WOS:000834666000012
J	Sagath, L; Lehtokari, VL; Wallgren-Pettersson, C; Pelin, K; Kiiski, K				Sagath, Lydia; Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina; Pelin, Katarina; Kiiski, Kirsi			A custom ddPCR method for the detection of copy number variations in the nebulin triplicate region	PLOS ONE			English	Article							DROPLET DIGITAL PCR; SEGMENTAL DUPLICATIONS; MUTATION	The human genome contains repetitive regions, such as segmental duplications, known to be prone to copy number variation. Segmental duplications are highly identical and homologous sequences, posing a specific challenge for most mutation detection methods. The giant nebulin gene is expressed in skeletal muscle. It harbors a large segmental duplication region composed of eight exons repeated three times, the so-called triplicate region. Mutations in nebulin are known to cause nemaline myopathy and other congenital myopathies. Using our custom targeted Comparative Genomic Hybridization arrays, we have previously shown that copy number variations in the nebulin triplicate region are pathogenic when the copy number of the segmental duplication block deviates two or more copies from the normal number, which is three per allele. To complement our Comparative Genomic Hybridization arrays, we have established a custom Droplet Digital PCR method for the detection of copy number variations within the nebulin triplicate region. The custom Droplet Digital PCR assays allow sensitive, rapid, high-throughput, and cost-effective detection of copy number variations within this region and is ready for implementation a screening method for disease-causing copy number variations of the nebulin triplicate region. We suggest that Droplet Digital PCR may also be used in the study and diagnostics of other segmental duplication regions of the genome.	[Sagath, Lydia; Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina; Pelin, Katarina; Kiiski, Kirsi] Folkhalsan Res Ctr, Helsinki, Finland; [Sagath, Lydia; Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina; Pelin, Katarina; Kiiski, Kirsi] Univ Helsinki, Dept Med Genet, Medicum, Helsinki, Finland; [Pelin, Katarina] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Programme, Helsinki, Finland	Folkhalsan Research Center; University of Helsinki; University of Helsinki	Sagath, L; Kiiski, K (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.; Sagath, L; Kiiski, K (corresponding author), Univ Helsinki, Dept Med Genet, Medicum, Helsinki, Finland.	lydia.sagath@helsinki.fi; kirsi.kiiski@helsinki.fi		Pelin, Katarina/0000-0002-7040-7266; Lehtokari, Vilma-Lotta/0000-0002-8276-0972; Sagath, Lydia/0000-0002-6754-3830	Muscular Dystrophy UK [16NEM-PG36-0094]; Folkhaelsan Research Foundation [101003]; Finska Laekaresaellskapet; Magnus Ehrnrooth foundation	Muscular Dystrophy UK; Folkhaelsan Research Foundation; Finska Laekaresaellskapet; Magnus Ehrnrooth foundation	CWP received funding from Muscular Dystrophy UK (grant number 16NEM-PG36-0094, https://www.musculardystrophyuk.org), Folkhaelsan Research Foundation (grant number 101003, https://www.folkhalsan.fi/en/research), Finska Laekaresaellskapet (grant number N/A, https:// www.fls.fi/sallskapet/), Medicinska understoedsfoereningen Liv och Haelsa (grant numberN/A, http://www.livochhalsa.fi). KK received funding from Magnus Ehrnrooth foundation (grant number N/A, https://www. magnusehrnroothinsaatio.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bjorklund AK, 2010, J MOL BIOL, V402, P38, DOI 10.1016/j.jmb.2010.07.011; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; De Paolis E, 2021, CLIN CHIM ACTA, V513, P17, DOI 10.1016/j.cca.2020.12.001; Donner K, 2004, EUR J HUM GENET, V12, P744, DOI 10.1038/sj.ejhg.5201242; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Gohlke J, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012783; Huggett JF, 2020, CLIN CHEM, V66, P1012, DOI 10.1093/clinchem/hvaa125; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kiiski K, 2013, NEUROMUSCULAR DISORD, V23, P56, DOI 10.1016/j.nmd.2012.07.007; Kiiski K, 2016, EUR J HUM GENET, V24, P574, DOI 10.1038/ejhg.2015.166; Kiiski KJ, 2019, NEUROMUSCULAR DISORD, V29, P97, DOI 10.1016/j.nmd.2018.12.007; Lehtokari VL, 2014, HUM MUTAT, V35, P1418, DOI 10.1002/humu.22693; Park S, 2020, CLIN CHIM ACTA, V510, P787, DOI 10.1016/j.cca.2020.09.024; Pham J, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.285; Pu LR, 2018, GENOME RES, V28, P901, DOI 10.1101/gr.228718.117; Sagath L, 2021, NEUROMUSCULAR DISORD, V31, P539, DOI 10.1016/j.nmd.2021.03.006; Sagath Lydia, 2018, J Neuromuscul Dis, V5, P307, DOI 10.3233/JND-170298; Tskhovrebova L, 2017, SUBCELL BIOCHEM, V82, P285, DOI 10.1007/978-3-319-49674-0_10; Valipakka S, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000204; Verheul RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162467; Wang K, 1996, ADV BIOPHYS, V33, P123; Yin Xiao-Lin, 2010, Journal of Bioinformatics and Computational Biology, V8, P295, DOI 10.1142/S021972001000480X	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267793	10.1371/journal.pone.0267793	http://dx.doi.org/10.1371/journal.pone.0267793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576196	gold, Green Published			2022-12-26	WOS:000835262300004
J	Yang, L; Bu, SJ; Zhao, SX; Wang, N; Xiao, JX; He, F; Gao, X				Yang, Lu; Bu, Sijia; Zhao, Shengxue; Wang, Ning; Xiao, Jiaxin; He, Feng; Gao, Xuan			Transcriptome and physiological analysis of increase in drought stress tolerance by melatonin in tomato	PLOS ONE			English	Article							WATER-STRESS; SEEDLINGS; GROWTH; YIELD; ACID; ACCUMULATION; PARAMETERS; QUALITY; PLANTS; ROOT	Drought stress seriously affects tomato growth, yield and quality. Previous reports have pointed out that melatonin (MT) can alleviate drought stress damage to tomato. To better understand the possible physiological and molecular mechanisms, chlorophyll fluorescence parameters and leaf transcriptome profiles were analyzed in the "Micro Tom" tomato cultivar with or without melatonin irrigation under normal and drought conditions. Polyethylene glycol 6000 (PEG6000) simulated continuous drought treatment reduced plant height, but melatonin treatment improved plant growth rate. Physiological parameter measurements revealed that the drought-induced decreases in maximum efficiency of photosystem II (PSII) photochemistry, the effective quantum yield of PSII, electron transfer rate, and photochemical quenching value caused by PEG6000 treatment were alleviated by melatonin treatment, which suggests a protective effect of melatonin on PSII. Comparative transcriptome analysis identified 447, 3982, 4526 and 3258 differentially expressed genes (DEGs) in the comparative groups plus-melatonin vs. minus-melatonin (no drought), drought vs. no drought (minus-melatonin), drought vs. no drought (melatonin) and plus-melatonin vs. minus-melatonin (drought), respectively. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis revealed that DEGs in the four comparative groups were involved in multiple metabolic processes and closely related to hormone signal transduction and transcription factors. Transcriptome data revealed that melatonin changed the expression pattern of most hormone signal transduction related DEGs induced by drought, and improved plant drought resistance by down-regulating the expression of linoleic acid catabolic enzyme genes. These results provide new insights into a probable mechanism of the melatonin-induced protection of photosynthesis and enhancement of drought tolerance in tomato plants.	[Yang, Lu; Bu, Sijia; Zhao, Shengxue; Wang, Ning; Xiao, Jiaxin; He, Feng; Gao, Xuan] Anhui Normal Univ, Coll Life Sci, Key Lab Conservat & Utilizat Important Biol Resour, Wuhu, Anhui Province, Peoples R China	Anhui Normal University	Yang, L; Gao, X (corresponding author), Anhui Normal Univ, Coll Life Sci, Key Lab Conservat & Utilizat Important Biol Resour, Wuhu, Anhui Province, Peoples R China.	527288008@qq.com; gaoxuan@ahnu.edu.cn			Anhui Provincial Natural Science Foundation [KJ2019A0484]; Provincial Natural Science Research Program of Higher Education of Anhui province [2008085QC129];  [2008085MC77]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Provincial Natural Science Research Program of Higher Education of Anhui province; 	LY has been funded by the 17th Huo Yingdong Education Fund Project (171022), Anhui Provincial Natural Science Foundation (2008085QC129) and the Provincial Natural Science Research Program of Higher Education of Anhui province (KJ2019A0484). FH has been funded by Anhui Provincial Natural Science Foundation (2008085MC77). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2018, J PLANT NUTR, V41, P1734, DOI 10.1080/01904167.2018.1459688; Alam MN, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4588-y; Allakhverdiev SI, 2001, PLANT PHYSIOL, V125, P1842, DOI 10.1104/pp.125.4.1842; Arnao MB, 2018, ANN BOT-LONDON, V121, P195, DOI 10.1093/aob/mcx114; Arnao MB, 2015, J PINEAL RES, V59, P133, DOI 10.1111/jpi.12253; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BILGER W, 1991, PLANTA, V184, P226, DOI [10.1007/BF01102422, 10.1007/BF00197951]; Borek M, 2016, PHOTOSYNTHETICA, V54, P331, DOI 10.1007/s11099-016-0225-7; BRAY EA, 1990, PLANT CELL ENVIRON, V13, P531, DOI 10.1111/j.1365-3040.1990.tb01069.x; Byeon Y, 2014, J PINEAL RES, V56, P189, DOI 10.1111/jpi.12111; Chen YE, 2018, PHYSIOL PLANTARUM, V164, P349, DOI 10.1111/ppl.12737; Conti V, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8090336; Debnath B, 2020, ECOTOX ENVIRON SAFE, V200, DOI 10.1016/j.ecoenv.2020.110720; Ding F, 2018, MOLECULES, V23, DOI 10.3390/molecules23071605; Dodds GT, 1997, J AM SOC HORTIC SCI, V122, P491, DOI 10.21273/JASHS.122.4.491; Fleta-Soriano E, 2017, J AGRON CROP SCI, V203, P286, DOI 10.1111/jac.12201; Gao WY, 2018, MOLECULES, V23, DOI 10.3390/molecules23071580; Govind G., 2020, SALT DROUGHT STRESS, P315, DOI [10.1007/978-3-030-40277-8_12, DOI 10.1007/978-3-030-40277-8_12]; Hu ZC, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-0293-5; Hussain HA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00393; Ibrahim MFM, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9101276; Jahan MS, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1992-7; James D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00786; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Karaca P., 2019, International Journal of Vegetable Science, V25, P601; Korkmaz A, 2007, ACTA PHYSIOL PLANT, V29, P503, DOI 10.1007/s11738-007-0060-3; Lee HY, 2015, J PINEAL RES, V58, P291, DOI 10.1111/jpi.12214; Liang BW, 2018, ENVIRON EXP BOT, V155, P650, DOI 10.1016/j.envexpbot.2018.08.016; Liu CX, 2019, J AGR FOOD CHEM, V67, P6116, DOI 10.1021/acs.jafc.9b00058; Liu DD, 2019, MOLECULES, V24, DOI 10.3390/molecules24081514; Liu JL, 2015, PLANT GROWTH REGUL, V77, P317, DOI 10.1007/s10725-015-0066-6; Liu L, 2021, J PLANT GROWTH REGUL, V40, P1074, DOI 10.1007/s00344-020-10165-6; Liu QG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134753; Matsukura C, 2008, CURR GENOMICS, V9, P436, DOI 10.2174/138920208786241225; Murshed R, 2013, PHYSIOL MOL BIOL PLA, V19, P363, DOI 10.1007/s12298-013-0173-7; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nuruddin MM, 2003, HORTSCIENCE, V38, P1389, DOI 10.21273/HORTSCI.38.7.1389; Pan Y, 2012, PLANT CELL REP, V31, P349, DOI 10.1007/s00299-011-1170-3; Pervez M. A., 2009, Pakistan Journal of Agricultural Sciences, V46, P174; Shi HT, 2015, J PINEAL RES, V58, P335, DOI 10.1111/jpi.12219; Sivakumar R., 2016, Advances in Horticultural Science, V30, P3, DOI 10.13128/ahs-18696; Sun QQ, 2015, J EXP BOT, V66, P657, DOI 10.1093/jxb/eru332; Sun ZG, 2014, GANSU AGR SCI TECHNO, V12, P41; Wang K, 2019, PHYSIOL PLANTARUM, V165, P690, DOI 10.1111/ppl.12728; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang ML, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030218; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wang SiQi, 2020, Agricultural Research in the Arid Areas, V38, P243, DOI 10.7606/j.issn.1000-7601.2020.01.32; Wang YP, 2018, J EXP BOT, V69, P963, DOI 10.1093/jxb/erx473; Wu J, 2012, GENE, V509, P38, DOI 10.1016/j.gene.2012.08.002; Xu L, 2018, P NATL ACAD SCI USA, V115, pE4284, DOI 10.1073/pnas.1717308115; Xu W, 2016, J PINEAL RES, V61, P457, DOI 10.1111/jpi.12359; Yang L, 2020, TREES-STRUCT FUNCT, V34, P433, DOI 10.1007/s00468-019-01926-2; [杨再强 Yang Zaiqiang], 2016, [生态学报, Acta Ecologica Sinica], V36, P748; Yin LH, 2013, J PINEAL RES, V54, P426, DOI 10.1111/jpi.12038; Yuan XW, 2014, J EXP BOT, V65, P1637, DOI 10.1093/jxb/eru031; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhang L, 2011, PLANT MOL BIOL, V77, P17, DOI 10.1007/s11103-011-9788-7; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhao CF, 2021, PLANT PHYSIOL BIOCH, V168, P128, DOI 10.1016/j.plaphy.2021.09.044; Zhao HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05267-3; Zhou R, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1982-9; Zhou ZX, 2020, J PLANT BIOL, V63, P189, DOI 10.1007/s12374-020-09244-8	65	4	4	25	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267594	10.1371/journal.pone.0267594	http://dx.doi.org/10.1371/journal.pone.0267594			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580092	gold, Green Published, Green Submitted			2022-12-26	WOS:000835654800004
J	Bryan, C; Wei, XY; Wang, ZS; Yang, K				Bryan, Cameron; Wei, Xiaoying; Wang, Zhishuo; Yang, Kun			In vitro eradication of abasic site-mediated DNA-peptide/protein cross-links by Escherichia coli long-patch base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT BINDING; GLYCOSYLASE UDGX; EXONUCLEASE-III; ENDONUCLEASE-IV; COMPLEX; INTERACTS; REVEALS; LESIONS; ASSAY	Apurinic/apyrimidinic (AP or abasic) sites are among the most abundant DNA lesions. Numerous proteins within different organisms ranging from bacteria to human have been demonstrated to react with AP sites to form covalent Schiff base DNA-protein cross-links (DPCs). These DPCs are unstable due to their spontaneous hydrolysis, but the half-lives of these cross-links can be as long as several hours. Such long-lived DPCs are extremely toxic due to their large sizes, which physically block DNA replication. Therefore, these adducts must be promptly eradicated to maintain genome integrity. Herein, we used in vitro reconstitution experiments with chemically synthesized, stable, and site-specific Schiff base AP-peptide/protein cross-link analogs to demonstrate for the first time that this type of DPC can be repaired by Escherichia coli (E. coli) long-patch base excision repair. We demonstrated that the repair process requires a minimum of three enzymes and five consecutive steps, including: (1) 5'-DNA strand incision of the DPC by endonuclease IV; (2 to 4) strand-displacement DNA synthesis, removal of the 5'-deoxyribose phosphate-peptide/protein adduct-containing flap, and gap-filling DNA synthesis by DNA polymerase I; and (5) strand ligation by a ligase. We further demonstrated that endonuclease IV plays a major role in incising an AP-peptide cross-link within E. coli cell extracts. We also report that eradicating model AP-protein (11.2-36.1 kDa) DPCs is less efficient than that of an AP-peptide(10mer) cross-link, supporting the emerging model that proteolysis is likely required for efficient DPC repair.	[Bryan, Cameron; Wei, Xiaoying; Wang, Zhishuo; Yang, Kun] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Wei, Xiaoying] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Yang, K (corresponding author), Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA.	kun.yang@austin.utexas.edu		Bryan, Cameron/0000-0002-2303-8189	University of Texas at Austin	University of Texas at Austin	Start-up fund from the University of Texas at Austin.	Ahn WC, 2019, NAT CHEM BIOL, V15, P607, DOI 10.1038/s41589-019-0289-3; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Chan W, 2022, ANAL CHEM, V94, P803, DOI 10.1021/acs.analchem.1c03356; Chan W, 2019, ANAL CHEM, V91, P4987, DOI 10.1021/acs.analchem.8b04306; Chesner LN, 2021, DNA REPAIR, V97, DOI 10.1016/j.dnarep.2020.103026; Chesner LN, 2018, DNA REPAIR, V62, P18, DOI 10.1016/j.dnarep.2018.01.004; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Daley JM, 2010, MUTAT RES-REV MUTAT, V705, P217, DOI 10.1016/j.mrrev.2010.07.003; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; GENTIL A, 1990, BIOCHEM BIOPH RES CO, V173, P704, DOI 10.1016/S0006-291X(05)80092-0; Grosheva AS, 2017, NUCLEIC ACIDS RES, V45, P3833, DOI 10.1093/nar/gkx052; Halabelian L, 2019, NAT STRUCT MOL BIOL, V26, P607, DOI 10.1038/s41594-019-0246-6; Ham YH, 2020, CHEM RES TOXICOL, V33, P2739, DOI 10.1021/acs.chemrestox.0c00289; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; Ji SF, 2017, ANGEW CHEM INT EDIT, V56, P14130, DOI 10.1002/anie.201708286; Kelley MR, 2003, CANCER RES, V63, P549; Kitsera N, 2019, NUCLEIC ACIDS RES, V47, P8537, DOI 10.1093/nar/gkz558; Kosova AA, 2015, MUTAT RES-FUND MOL M, V779, P46, DOI 10.1016/j.mrfmmm.2015.06.005; KOW YW, 1989, BIOCHEMISTRY-US, V28, P3280, DOI 10.1021/bi00434a024; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kutuzov MM, 2015, BIOCHIMIE, V112, P10, DOI 10.1016/j.biochi.2015.02.010; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LJUNGQUIST S, 1976, J BACTERIOL, V126, P646, DOI 10.1128/JB.126.2.646-653.1976; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mazumder A, 1996, J BIOL CHEM, V271, P27330, DOI 10.1074/jbc.271.44.27330; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Mohni KN, 2019, CELL, V176, P144, DOI 10.1016/j.cell.2018.10.055; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; PRICE A, 1992, FEBS LETT, V300, P101, DOI 10.1016/0014-5793(92)80173-E; Pujari SS, 2018, CHEM COMMUN, V54, P6296, DOI 10.1039/c8cc01300d; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Ren MT, 2021, NUCLEIC ACIDS RES, V49, P257, DOI 10.1093/nar/gkaa1153; Rieger RA, 2006, MOL CELL PROTEOMICS, V5, P858, DOI 10.1074/mcp.M500224-MCP200; ROSA S, 1991, NUCLEIC ACIDS RES, V19, P5569, DOI 10.1093/nar/19.20.5569; Sczepanski JT, 2010, P NATL ACAD SCI USA, V107, P22475, DOI 10.1073/pnas.1012860108; Sung JS, 2001, J BIOL CHEM, V276, P2276, DOI 10.1074/jbc.M008147200; TAKEUCHI M, 1994, J BIOL CHEM, V269, P21907; Thompson PS, 2019, NAT STRUCT MOL BIOL, V26, P613, DOI 10.1038/s41594-019-0255-5; Tu J, 2019, NAT CHEM BIOL, V15, P615, DOI 10.1038/s41589-019-0290-x; Wang N, 2019, NUCLEIC ACIDS RES, V47, P10388, DOI 10.1093/nar/gkz744; Wang RX, 2018, BIOCHEMISTRY-US, V57, P3945, DOI 10.1021/acs.biochem.8b00493; Wang W, 2018, P NATL ACAD SCI USA, V115, pE2538, DOI 10.1073/pnas.1722050115; Wei XY, 2021, BBA-PROTEINS PROTEOM, V1869, DOI 10.1016/j.bbapap.2021.140669; Wickramaratne S, 2013, BIOCONJUGATE CHEM, V24, P1496, DOI 10.1021/bc400018u; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; YAJKO DM, 1975, P NATL ACAD SCI USA, V72, P688, DOI 10.1073/pnas.72.2.688; Yang K, 2019, CHEM RES TOXICOL, V32, P2118, DOI 10.1021/acs.chemrestox.9b00299; Yang K, 2018, P NATL ACAD SCI USA, V115, pE11212, DOI 10.1073/pnas.1813338115; Yang K, 2019, CHEMBIOCHEM, V20, P78, DOI 10.1002/cbic.201800559; You CJ, 2015, NAT PROTOC, V10, P1389, DOI 10.1038/nprot.2015.094; Yudkina AV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198480; Zharkov DO, 1998, BIOCHEMISTRY-US, V37, P12384, DOI 10.1021/bi981066y; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zhou CZ, 2012, J AM CHEM SOC, V134, P16734, DOI 10.1021/ja306858m	63	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102055	10.1016/j.jbc.2022.102055	http://dx.doi.org/10.1016/j.jbc.2022.102055			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35605665	gold, Green Published			2022-12-26	WOS:000818686700007
J	Li, XB; Yuan, RR; Wang, QX; Chai, SY; Zhang, ZY; Wang, Y; Huang, SH				Li, Xiaobing; Yuan, Rong-Rong; Wang, Qixia; Chai, Shouyu; Zhang, Zhengying; Wang, Yue; Huang, Shu-Hong			Brain-derived neurotrophic factor regulates LYN kinase-mediated myosin light chain kinase activation to modulate nonmuscle myosin II activity in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; ACTIN DYNAMICS; INHIBITION; MORPHOLOGY; MIGRATION; MOVEMENT; MOTORS	Myosins belong to a large superfamily of actin-dependent molecular motors. Nonmuscle myosin II (NM II) is involved in the morphology and function of neurons, but little is known about how NM II activity is regulated. Brain-derived neurotrophic factor (BDNF) is a prevalent neurotrophic factor in the brain that encourages growth and differentiation of neurons and synapses. In this study, we report that BDNF upregulates the phosphorylation of myosin regulatory light chain (MLC2), to increases the activity of NM II. The role of BDNF on modulating the phosphorylation of MLC2 was validated by using Western blotting in primary cultured hippocampal neurons. This result was confirmed by injecting BDNF into the dorsal hippocampus of mice and detecting the phosphorylation level of MLC2 by Western blotting. We further perform coimmunoprecipitation assay to confirm that this process depends on the activation of the LYN kinase through binding with tyrosine kinase receptor B, the receptor of BDNF, in a kinase activity-dependent manner. LYN kinase subsequently phosphorylates MLCK, further promoting the phosphorylation of MLC2. Taken together, our results suggest a new molecular mechanism by which BDNF regulates MLC2 activity, which provides a new perspective for further understanding the functional regulation of NM II in the nervous system.	[Li, Xiaobing; Wang, Qixia; Chai, Shouyu; Zhang, Zhengying; Wang, Yue; Huang, Shu-Hong] Shandong First Med Univ, Shandong Prov Hosp, Inst Basic Med, Jinan, Shandong, Peoples R China; [Yuan, Rong-Rong] Shandong Univ, Inst Basic Med, Jinan, Shandong, Peoples R China; [Wang, Yue; Huang, Shu-Hong] Shandong First Med Univ & Shandong Acad Med Sci, Med Sci & Technol Innovat Ctr, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, Y; Huang, SH (corresponding author), Shandong First Med Univ, Shandong Prov Hosp, Inst Basic Med, Jinan, Shandong, Peoples R China.; Wang, Y; Huang, SH (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Med Sci & Technol Innovat Ctr, Jinan, Shandong, Peoples R China.	wangyue@sdfmu.edu.cn; shuhonghuang@sdfmu.edu.cn	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		Shandong Provincial Natural Science Foundation, China [ZR2018MC008]; National Natural Science Foundation of China [81971088]; Innovation Project of Shandong Academy of Medical Sciences	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Shandong Academy of Medical Sciences	We thank all the peer reviewers for their opinions and suggestions. This study was supported by Shandong Provincial Natural Science Foundation, China (ZR2018MC008) , the National Natural Science Foundation of China (No. 81971088) , and The Innovation Project of Shandong Academy of Medical Sciences.	ADELSTEIN RS, 1981, J BIOL CHEM, V256, P7501; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Barry SM, 2017, NEUROPSYCHOPHARMACOL, V42, P1972, DOI 10.1038/npp.2017.114; Bhat P, 2009, MOL BIOL CELL, V20, P1795, DOI 10.1091/mbc.E08-10-1048; Bi AL, 2015, BRAIN STRUCT FUNCT, V220, P813, DOI 10.1007/s00429-013-0685-5; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; De Vincenti AP, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00135; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Gaidin SG, 2020, INT J NEUROSCI, V130, P363, DOI 10.1080/00207454.2019.1691205; Gavin CF, 2012, LEARN MEMORY, V19, P9, DOI 10.1101/lm.024042.111; Gonzalez MC, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00383; Hammer JA, 2013, J BIOL CHEM, V288, P28428, DOI 10.1074/jbc.R113.514497; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; ISEMURA M, 1991, CELL BIOL INT REP, V15, P965, DOI 10.1016/0309-1651(91)90146-A; ISHIKAWA T, 1988, MOL PHARMACOL, V33, P598; Jin Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00515; Kermani P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00455; Klapproth E, 2022, CELL SIGNAL, V90, DOI 10.1016/j.cellsig.2021.110203; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Malczynska Paulina, 2019, Postepy Biochem, V65, P2, DOI 10.18388/pb.2019_251; Mao Li-Min, 2017, Shengli Xuebao, V69, P657, DOI 10.13294/j.aps.2017.0067; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Notaras M, 2019, NEUROSCIENTIST, V25, P434, DOI 10.1177/1073858418810142; Popova NK, 2019, EXPERT OPIN THER TAR, V23, P227, DOI 10.1080/14728222.2019.1572747; Portugal CC, 2021, FEBS J, DOI 10.1111/febs.16197; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Trivedi N, 2011, CELL ADHES MIGR, V5, P42, DOI 10.4161/cam.5.1.13609; Ye ZH, 2022, J NEUROTRAUM, V39, P520, DOI 10.1089/neu.2021.0311; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200	35	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102054	10.1016/j.jbc.2022.102054	http://dx.doi.org/10.1016/j.jbc.2022.102054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35598826	Green Published, gold			2022-12-26	WOS:000816927100009
J	Delihas, N				Delihas, Nicholas			An ancestral genomic sequence that serves as a nucleation site for de novo gene birth	PLOS ONE			English	Article							DNA-POLYMERASE	The process of gene birth is of major interest with current excitement concerning de novo gene formation. We report a new and different mechanism of de novo gene birth based on the finding and the characteristics of a short non-coding sequence situated between two protein genes, termed a spacer sequence. This non-coding sequence is present in genomes of Mus musculus, the house mouse and Philippine tarsier, a primitive ancestral primate. The ancestral sequence is highly conserved during primate evolution with certain base pairs totally invariant from mouse to humans. By following the birth of the sequence of human lincRNA BCRP3 (BCR activator of RhoGEF and GTPase 3 pseudogene) during primate evolution, we find diverse genes, long non-coding RNA and protein genes (and sequences that do not appear to encode a gene) that all stem from the 3' end of the spacer, and all begin with a similar sequence. During primate evolution, part of the BCRP3 sequence initially formed in the Old World Monkeys and developed into different primate genes before evolving into the BCRP3 gene in humans. The gene developmental process consists of the initiation of DNA synthesis at spacer 3' ends, addition of a complex of tandem transposable elements and the addition of a segment of another gene. The findings support the concept of the spacer sequence as a starting site for DNA synthesis that leads to formation of different genes with the addition of other sequences. These data suggest a new process of de novo gene birth.	[Delihas, Nicholas] SUNY Stony Brook, Dept Microbiol & Immunol, Renaissance Sch Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Delihas, N (corresponding author), SUNY Stony Brook, Dept Microbiol & Immunol, Renaissance Sch Med, Stony Brook, NY 11794 USA.	Nicholas.delihas@stonybrrok.edu						Ahmad SF, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122714; Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; Carey KM, 2021, MOBILE DNA-UK, V12, DOI 10.1186/s13100-021-00232-4; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Delihas N, 2020, NON-CODING RNA, V6, DOI 10.3390/ncrna6030036; Delihas N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230236; Delihas N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195702; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Guerzoni D, 2016, GENOME BIOL EVOL, V8, P1222, DOI 10.1093/gbe/evw074; Kato T, 2012, CURR OPIN GENET DEV, V22, P221, DOI 10.1016/j.gde.2012.02.004; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Larson RT, 2019, TRAFFIC, V20, P961, DOI 10.1111/tra.12698; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Liang XG, 2004, BIOCHEMISTRY-US, V43, P13459, DOI 10.1021/bi0489614; Liu WH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4156-x; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Villanueva-Canas JL, 2017, GENOME BIOL EVOL, V9, P1886, DOI 10.1093/gbe/evx136; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; McGurk MP, 2018, GENOME RES, V28, P714, DOI 10.1101/gr.231472.117; Ogata N, 2007, BIOCHIMIE, V89, P702, DOI 10.1016/j.biochi.2006.12.011; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, P1; Rubino E, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.627007; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; Shatskikh AS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00312; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Stewart NB, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008314; Storer J, 2021, MOBILE DNA-UK, V12, DOI 10.1186/s13100-020-00230-y; Thakur J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094309; Van Oss SB, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008160; Vogt J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r80; Wang YL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00422; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Zinner Dietmar, 2015, Journal of East African Natural History, V104, P143	36	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267864	10.1371/journal.pone.0267864	http://dx.doi.org/10.1371/journal.pone.0267864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35552551	Green Published, Green Submitted, gold			2022-12-26	WOS:000868179400004
J	Fiorello, ML; Treweeke, AT; Macfarlane, DP; Megson, IL				Fiorello, Maria Luisa; Treweeke, Andrew T.; Macfarlane, David P.; Megson, Ian L.			Intermittent exposure of cultured endothelial cells to physiologically relevant fructose concentrations has a profound impact on nitric oxide production and bioenergetics	PLOS ONE			English	Article							HIGH GLUCOSE; OXIDATIVE STRESS; XANTHINE-OXIDASE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIETARY FRUCTOSE; PROTEIN-KINASE; MALONYL-COA; MECHANISMS; EXPRESSION	Hyperglycaemia is known to induce endothelial dysfunction and changes in metabolic function, which could be implicated in diabetes-induced cardiovascular disease. To date, however, little is known about the impact of physiologically relevant concentrations of fructose on endothelial cells. A novel in vitro model was devised to establish the impact of substitution of a small proportion of glucose with an equal concentration (0.1 mM or 1 mM) of fructose on EA.hy926 endothelial cells during periodic carbohydrate "meals" superimposed on a normoglycaemic (5.5 mM) background. Parallel experiments were conducted using meals consisting of normoglycaemic glucose, intermediate glucose (12.5 mM) or profound hyperglycaemia (25 mM), each delivered for 2 h, with and without substituted fructose over 50 h. Outcome measures included nitrite as a surrogate marker of the mediator of healthy endothelial function, nitric oxide (NO), and a range of bioenergetic parameters using a metabolic analyser. Despite its relatively low proportion of carbohydrate load, intermittent fructose induced a substantial reduction (approximately 90%) in NO generation in cells treated with either concentration of fructose. Cell markers of oxidative stress were not altered by this treatment regimen. However, the cells experienced a marked increase in metabolic activity induced by fructose, irrespective of the glucose concentration delivered simultaneously in the "meals". Indeed, glucose alone failed to induce any metabolic impact in this model. Key metabolic findings were a 2-fold increase in basal oxygen consumption rate and a similar change in extracellular acidification rate-a marker of glycolysis. Non-metabolic oxygen consumption also increased substantially in cells exposed to fructose. There was no difference between results with 0.1 mM fructose and those with 1 mM fructose. Low, physiologically relevant concentrations of fructose, delivered in a pattern that mimics mealtime consumption, had a profound impact on endothelial function and bioenergetics in an in vitro cell model. The results suggest that endothelial cells are exquisitely sensitive to circulating fructose; the potential ensuing dysfunction could have major implications for development of atherosclerotic disease associated with high fructose consumption.	[Fiorello, Maria Luisa; Treweeke, Andrew T.; Megson, Ian L.] Univ Highlands & Isl, Div Biomed Sci, Inverness, Scotland; [Macfarlane, David P.] Raigmore Hosp, Dept Diabet, NHS Highland, Inverness, Scotland	UHI Millennium Institute	Megson, IL (corresponding author), Univ Highlands & Isl, Div Biomed Sci, Inverness, Scotland.	ian.megson@uhi.ac.uk	Megson, Ian/K-2195-2012	Megson, Ian/0000-0001-8287-2459				Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; ANDERSON JW, 1989, DIABETES CARE, V12, P337, DOI 10.2337/diacare.12.5.337; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Baena M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26149; Bantle JP, 2009, J NUTR, V139, pS1263, DOI 10.3945/jn.108.098020; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; BOHANNON NV, 1980, J AM DIET ASSOC, V76, P555; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Chiu S, 2014, EUR J CLIN NUTR, V68, P416, DOI 10.1038/ejcn.2014.8; Cicero AFG, 2021, MED PRIN PRACT, V30, P122, DOI 10.1159/000512178; Cirillo P, 2015, J THROMB THROMBOLYS, V40, P444, DOI 10.1007/s11239-015-1243-1; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; CRAPO PA, 1980, DIABETES CARE, V3, P575, DOI 10.2337/diacare.3.5.575; Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y; DELARUE J, 1993, DIABETOLOGIA, V36, P338, DOI 10.1007/BF00400238; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dhar A., 2008, METABOLISM CLIN EXPT, P1211, DOI [10.1038/labinvest.2010.62, DOI 10.1038/LABINVEST.2010.62]; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Ferraris RP, 2018, ANNU REV NUTR, V38, P41, DOI 10.1146/annurev-nutr-082117-051707; Fiorello ML, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76505-4; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Gaby AR, 2005, ALTERN MED REV, V10, P294; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gaudreault N, 2008, MICROVASC RES, V75, P73, DOI 10.1016/j.mvr.2007.04.006; Gero D., 2018, ENDOTHELIAL DYSFUNCT, DOI [10.5772/intechopen.71433, DOI 10.5772/INTECHOPEN.71433]; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Hammad N, 2016, BBA-BIOENERGETICS, V1857, P1139, DOI 10.1016/j.bbabio.2016.03.034; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hernestal-Boman J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-152; Hirahatake KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026583; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jia GH, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0434-z; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/21976; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2; Liu TS, 2013, INFLAMM RES, V62, P697, DOI 10.1007/s00011-013-0623-2; MACDONALD I, 1978, AM J CLIN NUTR, V31, P1305, DOI 10.1093/ajcn/31.8.1305; Matsumoto S, 2003, FREE RADICAL RES, V37, P767, DOI 10.1080/1071576031000107344; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Miatello R, 2003, CELL MOL BIOL, V49, P945; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nair S, 2003, AM J GASTROENTEROL, V98, P466, DOI 10.1016/S0002-9270(02)05889-6; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Palanisamy N, 2013, BRIT J NUTR, V109, P1806, DOI 10.1017/S0007114512003819; Park KH, 2016, BIOCHEM CELL BIOL, V94, P337, DOI 10.1139/bcb-2015-0165; Pereira RM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040405; Piconi L, 2004, J THROMB HAEMOST, V2, P1453, DOI 10.1111/j.1538-7836.2004.00835.x; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Pircher A, 2016, ATHEROSCLEROSIS, V253, P247, DOI 10.1016/j.atherosclerosis.2016.08.011; Popov D., 2010, INT J DIABETES MELLI, V2, P189; Reddy Marpadga A, 2013, Subcell Biochem, V61, P435, DOI 10.1007/978-94-007-4525-4_19; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Saygin M, 2016, HUM EXP TOXICOL, V35, P194, DOI 10.1177/0960327115579431; Schlag G., 1990, SHOCK SEPSIS ORGAN F, P210; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Singh Raja B, 2002, Exp Clin Cardiol, V7, P40; Sotokawauchi A, 2019, DIABETES VASC DIS RE, V16, P556, DOI 10.1177/1479164119866390; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Tappy L, 2012, CLIN RES HEPATOL GAS, V36, P554, DOI 10.1016/j.clinre.2012.06.005; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Theytaz F, 2014, NUTRIENTS, V6, P2632, DOI 10.3390/nu6072632; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Wegner M, 2014, DIABETES RES CLIN PR, V105, P164, DOI 10.1016/j.diabres.2014.03.019; Whiting PH, 2008, BRIT J BIOMED SCI, V65, P71, DOI 10.1080/09674845.2008.11732800	80	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267675	http://dx.doi.org/10.1371/journal.pone.0267675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560114	gold, Green Published			2022-12-26	WOS:000835326900002
J	Galvan, FH; Liu, HH; Brooks, RA; Chen, YT; Lepe, RM				Galvan, Frank H.; Liu, Honghu; Brooks, Ronald A.; Chen, Ying-Tung; Mendoza Lepe, Ricardo			Using social and sexual networking mobile applications to promote HIV testing, medical care and prevention services among Latino men who have sex with men in Los Angeles County, California, USA	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; YOUNG MEN; RISK BEHAVIORS; UNITED-STATES; GRINDR; ACCEPTABILITY; ASSOCIATIONS; RECRUITMENT; SEEKING; GAY	HIV disproportionately affects Latinos versus Whites, with Latinos having higher rates of HIV. Additionally, many HIV-positive Latinos are unaware of their infection. Proyecto Protegete, an HIV prevention intervention developed for Latino men who have sex with men (MSM), used social and sexual networking mobile applications (apps) to recruit individuals for HIV testing and linkage to medical care and prevention services. This study occurred in Los Angeles County, California, USA from December 18, 2015 to April 22, 2017. The study's primary aim was to assess Proyecto Protegete's ability to successfully recruit Latino MSM involved in high-risk sexual activities. A secondary aim was to evaluate its capacity to promote HIV testing and linkage to HIV medical care and prevention services among this population by comparing it to two programs with similar samples. Comparisons using Fisher's Exact Test were conducted between Proyecto Protegete and the HIV testing program of the agency in which Proyecto Protegete was located and the County-funded HIV testing programs to compare the samples' rates of HIV-positive Latino MSM identified through HIV testing and linked to HIV medical care and prevention services. Participants were recruited through seven apps. In Proyecto Protegete, 9,573 individuals completed the screener, 4,657 were eligible, and 359 (7.7% of those eligible) enrolled. Among those enrolled, 79% reported anal sex without a condom in the previous twelve months; 51% reported anal sex under the influence of alcohol. The HIV positivity rates were as follows: Proyecto Protegete, 1.71%; the agency, 1.25% (p = .293, compared to Proyecto Protegete); and the County, 1.09% (p = .172, compared to Proyecto Protegete). The rates of those confirmed as new HIV-positives and linked to medical care within 30 days were as follows: Proyecto Protegete, 71.4%; the agency, 81.5% (p = .450, compared to Proyecto Protegete); and the County, 77.3% (p = .503, compared to Proyecto Protegete). Proyecto Protegete had a higher rate of linked referrals to prevention services than the agency's testing program (19.5% versus 8.3%, p < .001). Proyecto Protegete experienced successes in some areas but not in others. Future research should build on Proyecto Protegete's experiences to promote HIV-related services among Latino MSM.	[Galvan, Frank H.; Brooks, Ronald A.; Chen, Ying-Tung; Mendoza Lepe, Ricardo] Bienestar Human Serv Inc, Dept Res & Evaluat, Los Angeles, CA 90003 USA; [Liu, Honghu] Univ Calif Los Angeles, Sch Dent, Div Publ Hlth & Community Dent, Los Angeles, CA USA; [Liu, Honghu] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Liu, Honghu] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Brooks, Ronald A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brooks, RA (corresponding author), Bienestar Human Serv Inc, Dept Res & Evaluat, Los Angeles, CA 90003 USA.; Brooks, RA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA.	rabrooks@mednet.ucla.edu			California HIV/AIDS Research Program (CHRP) of the University of California Office of the President [TL13-BHS-584]; CHRP	California HIV/AIDS Research Program (CHRP) of the University of California Office of the President; CHRP	FHG received funding from the California HIV/AIDS Research Program (CHRP) (https:// www.californiaaidsresearch.org) of the University of California Office of the President under grant number, TL13-BHS-584, for the research project reported in this article. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of CHRP. We wish to express our gratitude to CHRP for their financial support of the study.	Gutierrez MA, 2018, SEX TRANSM INFECT, V94, P443, DOI 10.1136/sextrans-2017-053348; Aguirrebengoa OA, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.47.2001501; Badal HJ, 2018, AIDS BEHAV, V22, P1265, DOI 10.1007/s10461-017-1882-7; Baseman J., 2019, DATA INTERPRETATION; Biello KB, 2018, AIDS BEHAV, V22, P1158, DOI 10.1007/s10461-017-1972-6; Buckingham L, 2017, VACCINE, V35, P3498, DOI 10.1016/j.vaccine.2017.05.002; Burrell ER, 2012, AIDS BEHAV, V16, P1816, DOI 10.1007/s10461-012-0277-z; Cambiano V, 2018, LANCET INFECT DIS, V18, P85, DOI [10.1016/S1473-3099(17)30540-6, 10.1016/s1473-3099(17)30540-6]; Cao BL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3145-2; Cao BL, 2017, SEX TRANSM DIS, V44, P239, DOI [10.1097/OLQ.0000000000000575, 10.1097/olq.0000000000000575]; Card KG, 2017, SEX HEALTH, V14, P229, DOI 10.1071/SH16150; Centers for Disease Control and Prevention, 2021, DAT STAT; Centers for Disease Control and Prevention, 2019, TERMINOLOGY; Centers for Disease Control and Prevention, 2020, HIV SURVEILLANCE S, V25; Chan PA, 2018, SEX TRANSM DIS, V45, P462, DOI [10.1097/OLQ.0000000000000784, 10.1097/olq.0000000000000784]; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Chiou PY, 2021, J MED INTERNET RES, V23, DOI 10.2196/25031; Choi KWY, 2021, J SEX RES, V58, P785, DOI 10.1080/00224499.2021.1886227; Duevel JA, 2020, HEALTH ECON REV, V10, DOI 10.1186/s13561-020-00288-7; Duncan DT, 2018, AM J MENS HEALTH, V12, P292, DOI 10.1177/1557988316631964; Goedel WC, 2021, AIDS BEHAV, V25, P1619, DOI 10.1007/s10461-020-03078-8; Goedel WC, 2017, BEHAV MED, V43, P142, DOI 10.1080/08964289.2015.1121130; Goedel WC, 2016, SEX HEALTH, V13, P549, DOI 10.1071/SH16008; Goedel William C, 2015, JMIR Public Health Surveill, V1, pe4, DOI 10.2196/publichealth.4353; Grov C, 2016, AIDS EDUC PREV, V28, P378, DOI 10.1521/aeap.2016.28.5.378; Hermosa-Bosano C, 2021, ARCH SEX BEHAV, V50, P3011, DOI 10.1007/s10508-021-02093-7; Hermosa-Bosano C, 2021, ARCH SEX BEHAV, V50, P2995, DOI 10.1007/s10508-021-01921-0; Hill AO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209933; HIV Prevention Research Synthesis Project, 2021, COMP EV BAS INT BEST; HIV Prevention Research Synthesis Project, 2017, STYLE STRENGTH LIVIN; HIV Prevention Research Synthesis Project, 2020, NO EXCUSESSIN BUSCAR; Hoenigl M, 2020, CLIN INFECT DIS, V71, pE135, DOI 10.1093/cid/ciz1093; Hollingshead BM, 2020, HEALTH SOCIOL REV, V29, P264, DOI 10.1080/14461242.2020.1820366; Holloway IW, 2015, AIDS BEHAV, V19, pS112, DOI 10.1007/s10461-014-0989-3; Holloway IW, 2017, AIDS PATIENT CARE ST, V31, P517, DOI 10.1089/apc.2017.0082; Holloway IW, 2017, JAIDS-J ACQ IMM DEF, V74, P15, DOI 10.1097/QAI.0000000000001164; Holloway IW, 2014, AIDS BEHAV, V18, P285, DOI 10.1007/s10461-013-0671-1; Hong H, 2018, INT J STD AIDS, V29, P491, DOI 10.1177/0956462417738468; Huang E, 2016, AIDS EDUC PREV, V28, P341, DOI 10.1521/aeap.2016.28.4.341; Iribarren SJ, 2018, AIDS BEHAV, V22, P347, DOI 10.1007/s10461-017-1956-6; Kesten JM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7558-7; Kim DD, 2020, PHARMACOECONOMICS, V38, P1135, DOI 10.1007/s40273-020-00942-2; Krebs E, 2020, AIDS, V34, P447, DOI 10.1097/QAD.0000000000002455; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Martinez EZ, 2020, INT J STD AIDS, V31, P1161, DOI 10.1177/0956462420945940; Newcomb ME, 2016, JAIDS-J ACQ IMM DEF, V71, P200, DOI 10.1097/QAI.0000000000000819; Operario D, 2013, HEALTH PSYCHOL, V32, P932, DOI 10.1037/a0032760; Pena-Longobardo LM, 2019, EUR J HEALTH ECON, V20, P1207, DOI 10.1007/s10198-019-01087-6; Perez A, 2018, J IMMIGR MINOR HEALT, V20, P1261, DOI 10.1007/s10903-017-0682-5; Phillips G, 2016, LGBT HEALTH, V3, P225, DOI 10.1089/lgbt.2015.0122; Pitasi MA, 2021, MMWR-MORBID MORTAL W, V70, P1669, DOI 10.15585/mmwr.mm7048e1; Queiroz AAFLN, 2019, BRAZ J INFECT DIS, V23, P298, DOI 10.1016/j.bjid.2019.07.005; Rao S, 2016, MMWR-MORBID MORTAL W, V65, P1099, DOI 10.15585/mmwr.mm6540a2; Rendina HJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25055; Rendina HJ, 2014, AIDS BEHAV, V18, P41, DOI 10.1007/s10461-013-0573-2; Rogers MJ, 2021, J BONE JOINT SURG AM, V103, DOI 10.2106/JBJS.20.02126; Rosengren AL, 2016, SEX HEALTH, V13, P389, DOI 10.1071/SH15236; Shrestha RK, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25445; Smith LW, 2018, J MED INTERNET RES, V20, DOI 10.2196/10683; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Sun CJ, 2015, AIDS BEHAV, V19, P543, DOI 10.1007/s10461-014-0942-5; Sze WN, 2020, INT J DRUG POLICY, V75, DOI 10.1016/j.drugpo.2019.10.015; The White House, 2021, NAT HIV AIDS STRAT U; Ubrihien A, 2020, INT J STD AIDS, V31, P989, DOI 10.1177/0956462420927815; van Bilsen WPH, 2021, AIDS PATIENT CARE ST, V35, P204, DOI 10.1089/apc.2021.0024; Walker S, 2019, APPL HEALTH ECON HEA, V17, P577, DOI 10.1007/s40258-019-00481-8; Wei L, 2019, SEX TRANSM INFECT, V95, P496, DOI 10.1136/sextrans-2018-053902; Winetrobe H, 2014, AIDS CARE, V26, P1303, DOI 10.1080/09540121.2014.911811; Yang GL, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12573	69	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268406	10.1371/journal.pone.0268406	http://dx.doi.org/10.1371/journal.pone.0268406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560041	gold, Green Published			2022-12-26	WOS:000834668000010
J	Ha, SE; Jin, BYC; Jorgensen, BG; Zogg, H; Wei, L; Singh, R; Park, C; Kurahashi, M; Kim, S; Baek, G; Poudrier, SM; Lee, MY; Sanders, KM; Ro, S				Ha, Se Eun; Jin, Byungchang; Jorgensen, Brian G.; Zogg, Hannah; Wei, Lai; Singh, Rajan; Park, Chanjae; Kurahashi, Masaaki; Kim, Sei; Baek, Gain; Poudrier, Sandra M.; Lee, Moon Young; Sanders, Kenton M.; Ro, Seungil			Transcriptome profiling of subepithelial PDGFR alpha cells in colonic mucosa reveals several cell-selective markers	PLOS ONE			English	Article							AP-1; FIBROBLASTS; FIBROSIS; CXCL12; ROLES; MOUSE	Subepithelial platelet-derived growth factor receptor alpha (PDGFR alpha)(+) cells found in the colonic mucosal tissue come in close contact with epithelial cells, immune cells, neurons, capillaries, and lymphatic networks. Mucosal subepithelial PDGFR alpha(+) cells (MuP alpha C) are important regulators in various intestinal diseases including fibrosis and inflammation. However, the transcriptome of MuP alpha C has not yet been elucidated. Using Pdgfra-eGFP mice and flow cytometry, we isolated colonic MuP alpha C and obtained their transcriptome data. In analyzing the transcriptome, we identified three novel, and selectively expressed, markers (Adamdec1, Fin1, and Col6a4) found in MuP alpha C. In addition, we identified a unique set of MuP alpha C-enriched genetic signatures including groups of growth factors, transcription factors, gap junction proteins, extracellular proteins, receptors, cytokines, protein kinases, phosphatases, and peptidases. These selective groups of genetic signatures are linked to the unique cellular identity and function of MuP alpha C. Furthermore, we have added this MuP alpha C transcriptome data to our Smooth Muscle Genome Browser that contains the transcriptome data of jejunal and colonic smooth muscle cells (SMC), interstitial cells of Cajal (ICC), and smooth muscle resident PDGFR alpha(+) cells: (). This online resource provides a comprehensive reference of all currently known genetic transcripts expressed in primary MuP alpha C in the colon along with smooth muscle resident PDGFR alpha cells, SMC, and ICC in the murine colon and jejunum.	[Ha, Se Eun; Jin, Byungchang; Jorgensen, Brian G.; Zogg, Hannah; Wei, Lai; Singh, Rajan; Park, Chanjae; Kim, Sei; Baek, Gain; Poudrier, Sandra M.; Lee, Moon Young; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA; [Kurahashi, Masaaki] Univ Iowa, Dept Internal Med, Div Gastroenterol & Hepatol, Iowa City, IA USA; [Lee, Moon Young] Wonkwang Univ, Wonkwang Digest Dis Res Inst, Dept Physiol, Sch Med, Iksan, Chonbuk, South Korea; [Lee, Moon Young] Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Chonbuk, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Iowa; Wonkwang University; Wonkwang University	Ro, S (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA.	sro@med.unr.edu	Wei, Lai/GQH-9760-2022	Ha, Se Eun/0000-0001-6063-5559	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK094886, DK103055, DK091336, P01DK041315]	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Tsai-wei Shen, Ph.D. (LC Sciences) for the computational analysis of our RNA-seq data, and Duane Wiley (Computer System Administrator at UNR) for installation of Smooth Muscle Genome Browser.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bakogiannis C, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.09.013; Breland A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36607-6; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Cheng JW, 2014, CYTOKINE, V69, P277, DOI 10.1016/j.cyto.2014.06.007; Deckx S, 2018, MATRIX BIOL, V66, P110, DOI 10.1016/j.matbio.2017.09.002; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Furuya S, 2007, INT REV CYTOL, V264, P165; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Ha SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182265; Ha SE JB., 2021, J CROHN COLITIS; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hu X, 2018, EBIOMEDICINE, V34, P35, DOI 10.1016/j.ebiom.2018.07.021; Hu X, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0718-2; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Kurahashi M, 2013, AM J PHYSIOL-GASTR L, V304, pG823, DOI 10.1152/ajpgi.00001.2013; Lee MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176031; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; McCarthy N, 2020, NAT CELL BIOL, V22, P1033, DOI 10.1038/s41556-020-0567-z; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Nagasawa T, 2014, J MOL MED, V92, P433, DOI 10.1007/s00109-014-1123-8; Park C, 2015, J NEUROGASTROENTEROL, V21, P589, DOI 10.5056/jnm15063; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Roulis M, 2016, DIFFERENTIATION, V92, P116, DOI 10.1016/j.diff.2016.05.002; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Veschi V, 2020, ONCOGENE, V39, P987, DOI 10.1038/s41388-019-1047-4; Zhang T, 2020, BIOCHEM BIOPH RES CO, V527, P662, DOI 10.1016/j.bbrc.2020.04.156; Zuo CJ, 2018, CARDIOVASC RES, V114, P703, DOI 10.1093/cvr/cvy035	35	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0261743	http://dx.doi.org/10.1371/journal.pone.0261743			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560163	gold, Green Published			2022-12-26	WOS:000835326900022
J	Love, TM; Anaya, DA; Prime, MS; Ardolino, L; Ekinci, O				Love, Tara M.; Anaya, Daniel A.; Prime, Matthew S.; Ardolino, Luke; Ekinci, Okan			Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards	PLOS ONE			English	Article							GENOMICS; MODEL	Molecular tumor boards (MTBs) require specialized activities to leverage genomic data for therapeutic decision-making. Currently, there are no defined standards for implementing, executing, and tracking the impact of MTBs. This study describes the development and validation of ACTE-MTB, a tool to evaluate the maturity of an organization's MTB to identify specific areas that would benefit from process improvements and standardization. The ACTE-MTB maturity assessment tool is composed of 3 elements: 1) The ACTE-MTB maturity model; 2) a 59-question survey on MTB processes and challenges; and 3) a 5-level MTB maturity scoring algorithm. This tool was developed to measure MTB maturity in the categories of Access, Consultation, Technology, and Evidence (ACTE) and was tested on 20 MTBs spanning the United States, Europe, and Asia-Pacific regions. Validity testing revealed that the average maturity score was 3.3 out of 5 (+/- 0.1; range 2.0-4.3) with MTBs in academic institutions showing significantly higher overall maturity levels than in non-academic institutions (3.7 +/- 0.2 vs. 3.1 +/- 0.2; P = .018). While maturity scores for academic institutions were higher for Consultation, Technology, and Evidence domains, the maturity score for the Access domain did not significantly differ between the two groups, highlighting a disconnect between MTB operations and the downstream impact on ability to access testing and/or therapies. To our knowledge, ACTE-MTB is the first tool of its kind to enable structured, maturity assessment of MTBs in a universally-applicable manner. In the process of establishing construct validity of this tool, opportunities for further investigation and improvements were identified that address the key functional areas of MTBs that would likely benefit from standardization and best practice recommendations. We believe a unified approach to assessment of MTB maturity will help to identify areas for improvement at both the organizational and system level.	[Love, Tara M.; Ekinci, Okan] Roche Diagnost Corp, Roche Informat Solut, Santa Clara, CA 95050 USA; [Anaya, Daniel A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA; [Prime, Matthew S.] Roche Diagnost Corp, Roche Informat Solut, Basel, Switzerland; [Ardolino, Luke] Garvan Inst Med Res, Dept Med Oncol, Darlinghurst, NSW, Australia; [Ardolino, Luke] Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Ekinci, Okan] Univ Coll Dublin, Sch Med, Dublin, Ireland	Roche Holding; H Lee Moffitt Cancer Center & Research Institute; Garvan Institute of Medical Research; University of New South Wales Sydney; University College Dublin	Love, TM (corresponding author), Roche Diagnost Corp, Roche Informat Solut, Santa Clara, CA 95050 USA.	tara.love@roche.com		Love, Tara/0000-0002-6269-2669				Evans L., 2020, J CLIN ONCOL, V38, pe19200; Kato S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18613-3; Knepper TC, 2017, ONCOLOGIST, V22, P144, DOI 10.1634/theoncologist.2016-0195; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Liu YR, 2021, INT J MED INFORM, V156, DOI 10.1016/j.ijmedinf.2021.104610; Luchini C, 2020, TRENDS CANCER, V6, P738, DOI 10.1016/j.trecan.2020.05.008; Malone ER, 2020, GENOME MED, V12, DOI 10.1186/s13073-019-0703-1; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Mateo J, 2018, ANN ONCOL, V29, P1895, DOI 10.1093/annonc/mdy263; Mosele F, 2020, ANN ONCOL, V31, P1491, DOI 10.1016/j.annonc.2020.07.014; National Comprehensive Cancer Network, 2021, NON SMALL CELL LUNG; Orenstein EW, 2019, APPL CLIN INFORM, V10, P810, DOI 10.1055/s-0039-1697905; Rieke DT, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.18.00098; Singer F, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0680-0; Stockley TL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0364-2; Stoekle HC, 2018, SCI ENG ETHICS, V24, P307, DOI 10.1007/s11948-017-9880-8; Team C.P., 2006, CMMI FOR DEV; Tredan O, 2019, ANN ONCOL, V30, P757, DOI 10.1093/annonc/mdz080; Tsimberidou Apostolia-Maria, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00002; Tuxen IV, 2019, CLIN CANCER RES, V25, P1239, DOI 10.1158/1078-0432.CCR-18-1780; Voigt W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106743	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268477	10.1371/journal.pone.0268477	http://dx.doi.org/10.1371/journal.pone.0268477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560035	Green Published, gold			2022-12-26	WOS:000834668000001
J	Pepey, A; Obadia, T; Kim, S; Sovannaroth, S; Mueller, I; Witkowski, B; Vantaux, A; Souris, M				Pepey, Anais; Obadia, Thomas; Kim, Saorin; Sovannaroth, Siv; Mueller, Ivo; Witkowski, Benoit; Vantaux, Amelie; Souris, Marc			Mobility evaluation by GPS tracking in a rural, low-income population in Cambodia	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEMS; HUMAN MOVEMENT; TRANSMISSION	Global Positioning System (GPS) technology is an effective tool for quantifying individuals' mobility patterns and can be used to understand their influence on infectious disease transmission. In Cambodia, mobility measurements have been limited to questionnaires, which are of limited efficacy in rural environments. In this study, we used GPS tracking to measure the daily mobility of Cambodian forest goers, a population at high risk of malaria, and developed a workflow adapted to local constraints to produce an optimal dataset representative of the participants' mobility. We provide a detailed assessment of the GPS tracking and analysis of the data, and highlight the associated difficulties to facilitate the implementation of similar studies in the future.	[Pepey, Anais; Kim, Saorin; Witkowski, Benoit; Vantaux, Amelie] Inst Pasteurdu Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Obadia, Thomas] Inst Pasteur, Dept Paras & Insect Vectors, Infect Dis Epidemiol & Analyt, Paris, France; [Obadia, Thomas] Inst Pasteur, Dept Biol Computat, Hubde Bioinformat & Biostat, Paris, France; [Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control CNM, Phnom Penh, Cambodia; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Souris, Marc] UVE Aix Marseille Univ, UMR Unite Virus Emergents, IRD190, Inserm 1207,IHU5 Mediterranee Infect, Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Center Parasitology, Entomology & Malaria Control; Walter & Eliza Hall Institute; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pepey, A (corresponding author), Inst Pasteurdu Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	apepey@posteo.net		Pepey, Anais/0000-0002-8139-0578	National Institutes of Health program International Centres of Excellence for Malaria Research [1U19AI129392-01]; Pasteur Institute International Network Calmette and Yersin Ph.D. scholarship [212/18]	National Institutes of Health program International Centres of Excellence for Malaria Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pasteur Institute International Network Calmette and Yersin Ph.D. scholarship	This study was funded by the National Institutes of Health program International Centres of Excellence for Malaria Research, grant 1U19AI129392-01 "Understanding, tracking and eliminating malaria transmission in the Asia-Pacific Region". A.P. was funded by the Pasteur Institute International Network Calmette and Yersin Ph.D. scholarship, grant MHL/MJ/N degrees 212/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister-Tyrrell M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1792-1; Bharati K, 2013, INDIAN J MED RES, V137, P36; Caceres N, 2008, IET INTELL TRANSP SY, V2, P179, DOI 10.1049/iet-its:20080003; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cho GH, 2011, MED SCI SPORT EXER, V43, P365, DOI 10.1249/MSS.0b013e3181ebec3c; Duncan S, 2013, AM J PREV MED, V44, pE19, DOI 10.1016/j.amepre.2012.10.013; Enge P, 1999, P IEEE, V87, P3, DOI 10.1109/JPROC.1999.736338; Fornace KM, 2019, ELIFE, V8, DOI 10.7554/eLife.47602; Greenhouse Bryan, 2019, Gates Open Res, V3, P131, DOI 10.12688/gatesopenres.12897.1; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Hast M, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0183-y; Hii J, 2021, J INFECT DIS, V223, pS111, DOI 10.1093/infdis/jiab004; Hijmans R. J., 2016, GEOSPHERE SPHERICAL; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; McGranahan DA, 2018, ECOL EVOL, V8, P5649, DOI 10.1002/ece3.4094; Okami S, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00262; Paz-Soldan VA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002888; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Pepey A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12182972; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2020, R LANG ENV STAT COMP; Rossi G, 2018, CLIN INFECT DIS, V66, P1610, DOI 10.1093/cid/cix1064; Sandfort M, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03482-4; Schuessler N, 2009, TRANSPORT RES REC, P28, DOI 10.3141/2105-04; Searle KM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170046; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Thomson R, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3000-y; Tripura R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1703-5; Vantaux A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85628-1; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68; Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273; World Health Organization, 2019, COUNTR GREAT MEK ZER	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0266460	http://dx.doi.org/10.1371/journal.pone.0266460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559983	gold, Green Published			2022-12-26	WOS:000835326900007
J	Sufyan, MMA; Rehman, WU; Salam, T; Al-Salehi, AR; Ali, QE; Malik, AH				Sufyan, Mubarak Mohammed Al Ezzi; Rehman, Waheed Ur; Salam, Tabinda; Al-Salehi, Abdul Rahman; Ejaz Ali, Qazi; Haseeb Malik, Abdul			Distributed uplink cache for improved energy and spectral efficiency in B5G small cell network	PLOS ONE			English	Article							RESOURCE-ALLOCATION; DATA AGGREGATION; OPTIMIZATION; CHALLENGES; DELIVERY; STRATEGY	The advent of content-centric networks and Small Cell Networks (SCN) has resulted in the exponential growth of data for both uplink and downlink transmission. Data caching is considered one of the popular solutions to cater to the resultant challenges of network congestion and bottleneck of backhaul links in B5G networks. Caching for uplink transmission in distributed B5G scenarios has several challenges such as duplicate matching of contents, mobile station's unawareness about the cached contents, and the storage of large content size. This paper proposes a cache framework for uplink transmission in distributed B5G SCNs. Our proposed framework generates comprehensive lists of cache contents from all the Small Base Stations (SBSs) in the network to remove similar contents and assist uplink transmission. In addition, our framework also proposes content matching at a Mobile Station (MS) in contrast to an SBS, which effectively improves the energy and spectrum efficiency. Furthermore, large size contents are segmented and their fractions are stored in the distributed cache to improve the cache hit ratio. Our analysis shows that the proposed framework outperforms the existing schemes by improving the energy and spectrum efficiency of both access and core networks. Compared to the existing state of the art, our proposed framework improves the energy and spectrum efficiency of the access network by 41.28% and 15.58%, respectively. Furthermore, the cache hit ratio and throughput are improved by 9% and 40.00%, respectively.	[Sufyan, Mubarak Mohammed Al Ezzi; Rehman, Waheed Ur; Ejaz Ali, Qazi; Haseeb Malik, Abdul] Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan; [Salam, Tabinda] Shaheed Benazir Bhutto Women Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan; [Al-Salehi, Abdul Rahman] Int Islamic Univ, Dept Elect Engn, Islamabad, Pakistan	University of Peshawar; International Islamic University, Pakistan	Rehman, WU (corresponding author), Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan.	wahrehman@uop.edu.pk		Rehman, Waheed ur/0000-0002-6380-6787; Sufyan, Mubarak Mohammed Al-Ezzi/0000-0002-0443-6819				[Anonymous], CISCO ANN INTERNET R; Bernardini C, 2015, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2015.7417007; Bioglio V, 2015, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2015.7417697; Celebi H, 2019, IEEE T GREEN COMMUN, V3, P955, DOI 10.1109/TGCN.2019.2931700; Chang KC, 2020, IEEE ACCESS, V8, P32935, DOI 10.1109/ACCESS.2020.2973648; Chen Li-ming, 2009, Journal of China Universities of Posts and Telecommunications, V16, P121, DOI 10.1016/S1005-8885(08)60191-0; Chen LM, 2020, PHYS COMMUN-AMST, V42, DOI 10.1016/j.phycom.2020.101141; Christen P., 2012, DATA MATCHING, P23; Elshaer H, 2014, IEEE GLOB COMM CONF, P1798, DOI 10.1109/GLOCOM.2014.7037069; Furqan M, 2019, IEEE ACCESS, V7, P156907, DOI 10.1109/ACCESS.2019.2949272; Ge XH, 2015, IEEE T COMMUN, V63, P1019, DOI 10.1109/TCOMM.2015.2394386; He YX, 2020, ENERGIES, V13, DOI 10.3390/en13112693; Hou RH, 2020, COMPUT NETW, V172, DOI 10.1016/j.comnet.2020.107100; Hou RH, 2019, COMPUT COMMUN, V138, P11, DOI 10.1016/j.comcom.2018.12.004; Hua Y., 2020, DISTRIBUTED CACHING; Jia QM, 2017, IEEE CONF COMPUT, P468, DOI 10.1109/INFCOMW.2017.8116421; Karaliopoulos M, 2020, IEEE INT CONF COMM; Katz M, 2019, INT SYM WIRELESS COM, P714, DOI 10.1109/ISWCS.2019.8877155; Khan BS, 2019, CONSUM COMM NETWORK; Kuang SF, 2019, IEEE T VEH TECHNOL, V68, P7789, DOI 10.1109/TVT.2019.2924642; Li LY, 2018, IEEE COMMUN SURV TUT, V20, P1710, DOI 10.1109/COMST.2018.2820021; Li TX, 2018, IEEE CONF COMPUT, P492; Lin P, 2020, IEEE T VEH TECHNOL, V69, P5508, DOI 10.1109/TVT.2020.2981657; Liu CY, 2021, CHINA COMMUN, V18, P200, DOI 10.23919/JCC.2021.02.013; Liu D, 2017, IEEE T COMMUN, V65, P2699, DOI 10.1109/TCOMM.2017.2680447; Liu JB, 2017, IET COMMUN, V11, P477, DOI 10.1049/iet-com.2016.0680; Liu JY, 2020, IEEE INTERNET THINGS, V7, P1548, DOI 10.1109/JIOT.2019.2956554; Lu BW, 2020, PHYS COMMUN-AMST, V42, DOI 10.1016/j.phycom.2020.101162; Luo Y, 2019, IEEE ACCESS, V7, P12073, DOI 10.1109/ACCESS.2019.2891551; Mahboob S., 2021, DECENTRALIZED COLLAB; Mattera D, 2020, PHYS COMMUN-AMST, V39, DOI 10.1016/j.phycom.2019.100993; Nie T., 2020, 2020 IEEE 91 VEHICUL, P1; Nikolaos Thomos, 2019, Arxiv, DOI arXiv:1907.13516; Ostovar P, 2016, IEEE INT CONF MOB, P136, DOI [10.1109/MASS.2016.027, 10.1109/MASS.2016.22]; Papazafeiropoulos A, 2018, IEEE T WIREL COMMUN, V17, P8136, DOI 10.1109/TWC.2018.2874229; Qadri MY, 2009, EURASIP J EMBED SYST, DOI 10.1155/2009/725438; Rehman WU, 2020, IEEE ACCESS, V8, P49187, DOI 10.1109/ACCESS.2020.2974632; Ren DW, 2019, COMPUT NETW, V158, P1, DOI 10.1016/j.comnet.2019.04.026; Sadeghi A, 2019, INT CONF ACOUST SPEE, P4574, DOI 10.1109/ICASSP.2019.8682210; Salam T, 2019, IEEE ACCESS, V7, P41921, DOI 10.1109/ACCESS.2019.2906880; Salam T, 2018, IEEE ACCESS, V6, P4145, DOI 10.1109/ACCESS.2018.2791577; Salam T, 2017, SCI CHINA INFORM SCI, V60, DOI 10.1007/s11432-017-9186-6; Sboui L, 2019, IEEE WIREL COMMUN, V26, P168, DOI 10.1109/MWC.2019.1800161; Serbetci B, 2017, IEEE WCNC; Sharma SK, 2018, IEEE COMMUN LETT, V22, P1252, DOI 10.1109/LCOMM.2018.2810211; Sheng M, 2021, IEEE T WIREL COMMUN, V20, P2049, DOI 10.1109/TWC.2020.3038849; Shu P, 2020, PROCEEDINGS OF 2020 IEEE 4TH INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC 2020), P2441, DOI 10.1109/ITNEC48623.2020.9085078; Sloss A., 2004, ARM SYSTEM DEV GUID; Song F, 2019, IEEE T VEH TECHNOL, V68, P9162, DOI 10.1109/TVT.2019.2929839; Sufyan MMA, 2021, EURASIP J WIREL COMM, V2021, DOI 10.1186/s13638-021-02059-2; Sun Y, 2018, IEEE INTERNET COMPUT, V22, P52, DOI 10.1109/MIC.2018.112101645; Tamoor-ul-Hassan S, 2016, IEEE COMMUN LETT, V20, P1175, DOI 10.1109/LCOMM.2016.2543698; Teng L, 2019, IEEE COMMUN LETT, V23, P700, DOI 10.1109/LCOMM.2019.2896028; Tian F., 2020, 2020 IEEE WIRELESS C, P1; Tian F, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300313; Tokunaga K., 2016, 2016 IEEE INT S LOCA, P1; Wang Y.-T., 2019, INT C ADV INFORM NET, P725; Wu DP, 2020, J NETW COMPUT APPL, V149, DOI 10.1016/j.jnca.2019.102457; Wu H, 2019, 2019 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Wu XW, 2020, IEEE T COMMUN, V68, P3173, DOI 10.1109/TCOMM.2020.2970986; Wu XW, 2019, IEEE T WIREL COMMUN, V18, P4970, DOI 10.1109/TWC.2019.2931335; Xia JJ, 2020, EURASIP J WIREL COMM, V2020, DOI 10.1186/s13638-019-1612-0; Xie H., 2018, 2018 IEEE 87 VEH TEC, P1; Xu XZ, 2019, IEEE T WIREL COMMUN, V18, P5454, DOI 10.1109/TWC.2019.2936390; Xu Y., 2015, 2015 24 INT C COMPUT, P1; Yan Z, 2017, IEEE ACCESS, V5, P6791, DOI 10.1109/ACCESS.2017.2670598; Yang XN, 2021, ENG OPTIMIZ, V53, P1005, DOI 10.1080/0305215X.2020.1767098; Zhang CW, 2020, IEEE WCNC; Zhang HL, 2020, IEEE T GREEN COMMUN, V4, P497, DOI 10.1109/TGCN.2020.2988276; Zhang SB, 2019, IEEE T VEH TECHNOL, V68, P11260, DOI 10.1109/TVT.2019.2941115; Zhang X., 2018, 2018 IEEE INT C COMM, P1, DOI [10.1109/ICC.2018.8422883, 10.1109/ICC.2018.8422883.]; Zhang ZZ, 2018, IEEE ICC; Zhao JH, 2020, T EMERG TELECOMMUN T, V31, DOI 10.1002/ett.3804	73	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268294	10.1371/journal.pone.0268294	http://dx.doi.org/10.1371/journal.pone.0268294			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580094	Green Published, gold			2022-12-26	WOS:000886501700006
J	Wang, JK; He, Y; Chen, LL; Zhang, HX; Qi, XJ; Sun, L; Zhang, SF; Chen, J; Zhang, RH				Wang, Ji-Kai; He, Yue; Chen, Li-Li; Zhang, He-Xiang; Qi, Xiao-Juan; Sun, Liang; Zhang, Shuang-Feng; Chen, Jiang; Zhang, Rong-Hua			A population-based survey of the prevalence of self-reported acute gastrointestinal illness in Zhejiang Province, China	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; ECONOMIC BURDEN; HEALTH; FOOD; MAGNITUDE; COMMON; INCOME	Acute gastrointestinal illness (AGI) is a prevalent public health concern worldwide. This study investigated the magnitude, distribution and burden of self-reported AGI among residents of Zhejiang Province, China. A face-to-face household survey was conducted using a multi-stage stratified random sampling method in 10 counties in Zhejiang Province between July 2018 and June 2019. In total, 12,021 participants were recruited. The prevalence of AGI 28 days after standardization was 1.8% (95% confidence interval (CI), 1.6-2.1), with an incidence rate of 0.24 episodes of AGI per person-year and an estimated 14 million cases of AGI in Zhejiang Province. Univariate and multivariable analyses showed a higher AGI prevalence among people who performed housework and were unemployed in summer and autumn among respondents living in western or northern cities (p < 0.05). More than 50% of AGI cases were attributed to the consumption of contaminated food. The disease burden caused by AGI in Zhejiang Province was approximately 975 million Chinses yuan (CNY). These results indicated that the disease burden of AGI in Zhejiang Province should be addressed and highlights the need for an improved active surveillance system of foodborne diseases to assess the impact of AGI on society and health.	[Wang, Ji-Kai; He, Yue; Chen, Li-Li; Zhang, He-Xiang; Qi, Xiao-Juan; Sun, Liang; Zhang, Shuang-Feng; Chen, Jiang; Zhang, Rong-Hua] Zhejiang Prov Ctr Dis Control & Prevent, Dept Nutr & Food Safety, Hangzhou, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Chen, J; Zhang, RH (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Nutr & Food Safety, Hangzhou, Peoples R China.	jchen@cdc.zj.cn; rhzhang@cdc.zj.cn			National Health Commission Research Fund [WKJ-ZJ-1917]	National Health Commission Research Fund	We would like to thank the staffs of Center for Disease Control and Prevention in Jiaxing, Jinhua, Wenzhou, Quzhou and Zhoushan. Ethics approval and consent to participate Before taking part in the study, participants were informed about the contents of the study and about data protection. Written informed consent was obtained from all individual participants included in the study.	Adlam SB, 2011, EPIDEMIOL INFECT, V139, P302, DOI 10.1017/S0950268810000932; Aklilu Addis, 2015, BMC Res Notes, V8, P17, DOI 10.1186/s13104-014-0967-x; Berendes D, 2020, MMWR-MORBID MORTAL W, V68, P1201, DOI 10.15585/mmwr.mm6853a1; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Brar PK, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.PFS-0023-2018; Chacon L, 2021, AM J TROP MED HYG, V105, P1004, DOI 10.4269/ajtmh.21-0050; Chen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-456; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Roos AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229258; Dugee O, 2019, TROP MED INT HEALTH, V24, P715, DOI 10.1111/tmi.13231; Einarson TR, 2018, VALUE HEALTH, V21, P881, DOI 10.1016/j.jval.2017.12.019; Faour-Klingbeil D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010070; Feld LG, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3083; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hansdotter FI, 2015, SCAND J PUBLIC HEALT, V43, P540, DOI 10.1177/1403494815576787; Ho SC, 2010, EPIDEMIOL INFECT, V138, P982, DOI 10.1017/S0950268809991087; Hu BC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1780-4; Illiano P, 2020, FEBS J, V287, P833, DOI 10.1111/febs.15217; Kim KT, 2017, EUR J PUBLIC HEALTH, V27, P397, DOI 10.1093/eurpub/ckx055; King N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196990; Lau SYF, 2019, SCI TOTAL ENVIRON, V663, P793, DOI 10.1016/j.scitotenv.2019.01.403; Leddin D, 2020, J CLIN GASTROENTEROL, V54, P393, DOI 10.1097/MCG.0000000000001336; Li JQ, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04255-3; Li X, 2020, J AGR FOOD CHEM, V68, P14728, DOI 10.1021/acs.jafc.0c07378; Lin L, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003599; Lu Y, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-8117-y; Ma Xiaochen, 2019, Wei Sheng Yan Jiu, V48, P589; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Majowicz SE, 2004, EPIDEMIOL INFECT, V132, P607, DOI 10.1017/S0950268804002353; Martinovic T, 2016, J PROTEOMICS, V147, P226, DOI 10.1016/j.jprot.2016.04.029; McLinden T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-509; Montgomery H, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100447; Mullaney SB, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s0950268818003187, 10.1017/S0950268818003187]; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Patterson K, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH5141; Persuad Shamdeo, 2013, J Health Popul Nutr, V31, P57; Piglowski M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030477; Qu XY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196668; Rao CD, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2148; Rinninella E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102393; Rouger A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030050; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; Sang XL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-787; Save-Soderbergh M, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819002103; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Sell J, 2018, PRIMARY CARE, V45, P519, DOI 10.1016/j.pop.2018.05.008; Sheng LN, 2021, COMPR REV FOOD SCI F, V20, P738, DOI 10.1111/1541-4337.12671; Thomas MK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-307; Thomas MK, 2017, CAN J INFECT DIS MED, V2017, DOI 10.1155/2017/5956148; Tong Q, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140142; Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1; Uejio CK, 2014, AM J PUBLIC HEALTH, V104, P639, DOI 10.2105/AJPH.2013.301659; Wilking H, 2013, EPIDEMIOL INFECT, V141, P2365, DOI 10.1017/S0950268813000046; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; Wu P, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02268-6; Yezli S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11381-9; Yi M, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00908-z; Zeng J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111383; Zhou YJ, 2013, EPIDEMIOL INFECT, V141, P944, DOI 10.1017/S0950268812001331	60	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268717	10.1371/journal.pone.0268717	http://dx.doi.org/10.1371/journal.pone.0268717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584149	Green Published, gold			2022-12-26	WOS:000834613800008
J	Olney, SG; Chien, PT; Kearns, DB				Olney, Stephen G.; Chien, Peter; Kearns, Daniel B.			SmiA is a hybrid priming/scaffolding adaptor for the LonA protease in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWARMING DIFFERENTIATION; REGULATED PROTEOLYSIS; ESCHERICHIA-COLI; RECOGNITION; DEGRADATION; PROTEINS; YJBH; MECHANISM; SIGMA(S); MOTILITY	Regulatory proteolysis targets properly folded clients via a combination of cis-encoded degron sequences and trans-expressed specificity factors called adaptors. SmiA of Bacillus subtilis was identified as the first adaptor protein for the Lon family of proteases, but the mechanism of SmiAdependent proteolysis is unknown. Here, we develop a fluorescence-based assay to measure the kinetics of SmiAdependent degradation of its client SwrA and show that SmiA-SwrA interaction and the SwrA degron were both necessary, but not sufficient, for proteolysis. Consistent with a scaffolding adaptor mechanism, we found that stoichiometric excess of SmiA caused substrate-independent inhibition of LonA-dependent turnover. Furthermore, SmiA was strictly required even when SwrA levels were high suggesting that a local increase in substrate concentration mediated by the scaffold was not sufficient for proteolysis. Moreover, SmiA function could not be substituted by thermal denaturation of the substrate, consistent with a priming adaptor mechanism. Taken together, we conclude that SmiA functions via a mechanism that is a hybrid between scaffolding and priming models.	[Olney, Stephen G.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Chien, Peter] Univ Massachusetts Amherst, Dept Biochem & Mol Biol, Amherst, MA USA	Indiana University System; Indiana University Bloomington; University of Massachusetts System; University of Massachusetts Amherst	Kearns, DB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dbkearns@indiana.edu			National Institutes of Health [R35 GM130320, R35 GM131783]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by the National Institutes of Health grants R35 GM130320 (to P. C.) and R35 GM131783 (to D. B. K.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Chan CM, 2014, MOL MICROBIOL, V93, P426, DOI 10.1111/mmi.12671; Chan CM, 2012, MICROBIOL-SGM, V158, P1268, DOI 10.1099/mic.0.057661-0; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; GRANT GF, 1969, J BACTERIOL, V99, P116, DOI 10.1128/JB.99.1.116-124.1969; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur Eyal, 2013, Subcell Biochem, V66, P35, DOI 10.1007/978-94-007-5940-4_2; Gur E, 2012, PROTEIN SCI, V21, P268, DOI 10.1002/pro.2013; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hughes AC, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00659-17; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Jonas K, 2013, CELL, V154, P623, DOI 10.1016/j.cell.2013.06.034; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kommineni S, 2011, J BACTERIOL, V193, P2133, DOI 10.1128/JB.01350-10; Kuhlmann NJ, 2017, CURR OPIN MICROBIOL, V36, P118, DOI 10.1016/j.mib.2017.03.013; Kuroda A, 2006, BIOSCI BIOTECH BIOCH, V70, P325, DOI 10.1271/bbb.70.325; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Mahmoud SA, 2018, ANNU REV BIOCHEM, V87, P677, DOI 10.1146/annurev-biochem-062917-012848; Mordini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085065; Mukherjee S, 2015, P NATL ACAD SCI USA, V112, P250, DOI 10.1073/pnas.1417419112; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Puri N, 2017, MOL CELL, V66, P672, DOI 10.1016/j.molcel.2017.05.016; Ropelewska M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.585717; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Senesi S, 2004, J BACTERIOL, V186, P1158, DOI 10.1128/JB.186.4.1158-1164.2004; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Turgay K, 1998, EMBO J, V17, P6730; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zeinert RD, 2020, MOL CELL, V79, P758, DOI 10.1016/j.molcel.2020.07.011; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	54	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7								10.1016/j.jbc.2022.102045	http://dx.doi.org/10.1016/j.jbc.2022.102045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35595098	Green Published, gold			2022-12-26	WOS:000829549100012
J	He, WF; Qin, R; Gao, YH; Zhou, J; Wei, JJ; Liu, J; Hou, XF; Ma, HP; Xian, CJ; Li, XY; Chen, KM				He, Wen-Fang; Qin, Rong; Gao, Yu-Hai; Zhou, Jian; Wei, Juan-Juan; Liu, Jing; Hou, Xue-Feng; Ma, Hui-Ping; Xian, Cory J.; Li, Xue-Yan; Chen, Ke-Ming			The interdependent relationship between the nitric oxide signaling pathway and primary cilia in pulse electromagnetic field-stimulated osteoblastic differentiation	FASEB JOURNAL			English	Article						endothelial nitric oxide synthase; nitric oxide; osteogenic differentiation; primary cilia; pulsed electromagnetic fields	PROLIFERATION; MATURATION; CAMP	Pulsed electromagnetic fields (PEMFs) have long been recognized being safe and effective in treating bone fracture nonunion and osteoporosis. However, the mechanism of osteogenic action of PEMFs is still unclear. While primary cilia are reported to be a sensory organelle for PEMFs, and nitric oxide (NO) plays an indispensable role in osteogenic effect of PEMFs, the relationship between NO and primary cilia is unknown. In this study, effects of treatment with 50 Hz 0.6 mT PEMFs on osteogenic differentiation and mineralization, NO secretion, and ciliary location of specific proteins were examined in rat calvarial osteoblasts (ROBs) with normal or abrogated primary cilia. It was found that PEMFs stimulated the osteogenic differentiation by activating the NOS/NO/sGC/cGMP/PKG signaling pathway, which need the existence of primary cilia. All components of the signaling pathway including iNOS, eNOS, sGC, PKG-1, and PKG-2 were localized to primary cilia, and eNOS was phosphorylated inside the primary cilia. Besides, primary cilia were elongated significantly by PEMF treatment and changed dynamically with the activation NO/cGMP pathway. When the pathway was blocked by L-NAME, PEMFs could no longer elongate the primary cilia and stimulate the osteoblastic differentiation. Thus, this study for the first time observed activation of the NO/cGMP signaling pathway in ciliary compartment of osteoblasts, and PEMFs could not stimulate the osteoblastic differentiation if the NO signaling pathway was blocked or the ciliogenesis was inhibited. Our findings indicate the interdependent relationship between NO and primary cilia in the PEMF-promoted osteogenesis.	[He, Wen-Fang; Qin, Rong; Gao, Yu-Hai; Zhou, Jian; Wei, Juan-Juan; Liu, Jing; Hou, Xue-Feng; Ma, Hui-Ping; Chen, Ke-Ming] 940th Hosp Joint Logist Support Force, Peoples Liberat Army China, Fundamental Med Sci Res Labs, Lanzhou 730050, Peoples R China; [He, Wen-Fang; Li, Xue-Yan] Lanzhou Univ Technol, Sch Life Sci & Engn, Dept Bioengn, Lanzhou, Peoples R China; [He, Wen-Fang; Chen, Ke-Ming] Key Lab Stem Cells & Gene Drugs Gansu Prov, Lanzhou, Peoples R China; [Xian, Cory J.] Univ South Australia, UniSA Clin & Hlth Sci, Adelaide, SA, Australia	Lanzhou University of Technology; University of South Australia	Chen, KM (corresponding author), 940th Hosp Joint Logist Support Force, Peoples Liberat Army China, Fundamental Med Sci Res Labs, Lanzhou 730050, Peoples R China.; Li, XY (corresponding author), Lanzhou Univ Technol, Sch Life Sci & Engn, Lanzhou 730050, Peoples R China.	lixneyan@lut.cn; chenkm@lut.cn		zhou, jian/0000-0001-7211-1680; Liu, Jing/0000-0002-7005-611X; gao, yu hai/0000-0001-7845-3796	National Natural Science Foundation of China [81270963, 81770879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by project grants from the National Natural Science Foundation of China (Grant No. 81270963, 81770879).	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Bassett C A, 1978, Acta Orthop Belg, V44, P706; Bradley SA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5681036; Buerk Donald G., 2011, Critical Reviews in Biomedical Engineering, V39, P397, DOI 10.1615/CritRevBiomedEng.v39.i5.40; Cheng GZ, 2011, NITRIC OXIDE-BIOL CH, V25, P316, DOI 10.1016/j.niox.2011.05.009; Diniz P, 2002, NITRIC OXIDE-BIOL CH, V7, P18, DOI 10.1016/S1089-8603(02)00004-6; Falk N, 2015, CELLS-BASEL, V4, P500, DOI 10.3390/cells4030500; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Garland D E, 1999, J Spinal Cord Med, V22, P239; Gutierrez S, 2010, CELL PROLIFERAT, V43, P505, DOI 10.1111/j.1365-2184.2010.00700.x; Hannemann PEW, 2014, BONE JOINT J, V96B, P1070, DOI 10.1302/0301-620X.96B8.33767; Hofmann F, 2020, BIOL CHEM, V401, P447, DOI 10.1515/hsz-2019-0386; Jansen JHW, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-188; Johnson JLF, 2010, TRENDS CELL BIOL, V20, P435, DOI 10.1016/j.tcb.2010.05.005; Kalyanaraman H, 2018, NITRIC OXIDE-BIOL CH, V76, P62, DOI 10.1016/j.niox.2018.03.007; Kim SM, 2021, ANN NY ACAD SCI, V1487, P21, DOI 10.1111/nyas.14486; Li YH, 2020, AM J PHYSIOL-CELL PH, V318, pC73, DOI 10.1152/ajpcell.00273.2019; Maziarz A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0312-5; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Meskens M W, 1990, Acta Orthop Belg, V56, P483; Ota KT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011236; Pala R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120233; Petecchia L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13856; Saternos HC, 2018, NITRIC OXIDE-BIOL CH, V80, P108, DOI 10.1016/j.niox.2018.08.003; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schnoke M, 2007, J ORTHOP RES, V25, P933, DOI 10.1002/jor.20373; Shao X, 2021, AM J PHYSIOL-ENDOC M, V320, pE951, DOI 10.1152/ajpendo.00655.2020; Shao ZK, 2010, BRAIN RES, V1361, P67, DOI 10.1016/j.brainres.2010.09.011; Shi WG, 2017, J BIOL CHEM, V292, P20883, DOI 10.1074/jbc.M117.809517; Spasic M, 2017, EUR CELLS MATER, V33, P158, DOI 10.22203/eCM.v033a12; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Syed MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147588; TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Verghese E, 2011, CELL BIOL INT, V35, P909, DOI 10.1042/CBI20090154; Wang P, 2019, J CELL PHYSIOL, V234, P10588, DOI 10.1002/jcp.27734; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; We SR, 2013, RHEUMATOLOGY, V52, P815, DOI 10.1093/rheumatology/kes063; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhou J, 2019, J BONE MINER RES, V34, P1336, DOI 10.1002/jbmr.3704	43	0	0	7	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22376	10.1096/fj.202101577RR	http://dx.doi.org/10.1096/fj.202101577RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AQ	35616355	Green Accepted			2022-12-26	WOS:000800257900001
J	Noomuna, P; Hausman, JM; Sansoya, R; Kalfa, T; Risinger, M; Low, PS				Noomuna, Panae; Hausman, John M.; Sansoya, Ruhani; Kalfa, Theodosia; Risinger, Mary; Low, Philip S.			Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening	FASEB JOURNAL			English	Article						Band 3 tyrosine phosphorylation; calpain proteolysis; cleavage of PTP1B; phosphatase activity; PTP1B; sickle cells	RED-BLOOD-CELLS; THROMBIN GENERATION; HUMAN-ERYTHROCYTES; FREE HEMOGLOBIN; ENDOTHELIAL-CELLS; CALPAIN; BAND-3; MICROPARTICLES; DEOXYGENATION; PTP1B	Although both protein tyrosine phosphatases and kinases are constitutively active in healthy human red blood cells (RBCs), the preponderance of phosphatase activities maintains the membrane proteins in a predominantly unphosphorylated state. We report here that unlike healthy RBCs, proteins in sickle cells are heavily tyrosine phosphorylated, raising the question regarding the mechanism underpinning this tyrosine phosphorylation. Upon investigating possible causes, we observe that protein tyrosine phosphatase 1B (PTP1B), the major erythrocyte tyrosine phosphatase, is largely digested to a lower molecular weight fragment in sickle cells. We further find that the resulting truncated form of PTP1B is significantly less active than its intact counterpart, probably accounting for the intense tyrosine phosphorylation of Band 3 in sickle erythrocytes. Because this tyrosine phosphorylation of Band 3 promotes erythrocyte membrane weakening that causes release of both membrane vesicles and cell free hemoglobin that in turn initiates vaso-occlusive events, we conclude that cleavage of PTP1B could contribute to the symptoms of sickle cell disease. We further posit that methods to inhibit proteolysis of PTP1B could mitigate symptoms of the disease.	[Noomuna, Panae; Hausman, John M.; Sansoya, Ruhani; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Noomuna, Panae; Hausman, John M.; Low, Philip S.] Purdue Univ, Inst Drug Discovery, 720 Clin Dr, W Lafayette, IN 47907 USA; [Kalfa, Theodosia; Risinger, Mary] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Kalfa, Theodosia] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Low, PS (corresponding author), Purdue Univ, Inst Drug Discovery, 720 Clin Dr, W Lafayette, IN 47907 USA.	plow@purdue.edu		Hausman, John/0000-0002-5600-0304; Noomuna, Panae/0000-0001-7696-4488; Kalfa, Theodosia/0000-0002-0426-9686	NIH [GM24417-40]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by funds from the NIH (GM24417-40) (P.S.L.).	ADVANI R, 1992, BLOOD, V79, P1058; Alaarg A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00365; Atmis A, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.4681.4681; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bogdanova A, 2013, INT J MOL SCI, V14, P9848, DOI 10.3390/ijms14059848; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; Bragadin M, 2007, ANN NY ACAD SCI, V1095, P193, DOI 10.1196/annals.1397.023; Browning JA, 2007, BLOOD, V109, P2622, DOI 10.1182/blood-2006-03-001404; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; Ciana A, 2004, BIOELECTROCHEMISTRY, V62, P169, DOI 10.1016/j.bioelechem.2003.07.004; DANFORTH WH, 1962, P NATL ACAD SCI USA, V48, P1191, DOI 10.1073/pnas.48.7.1191; De Franceschi L, 2013, FASEB J, V27, P750, DOI 10.1096/fj.12-217836; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; DUMASWALA UJ, 1984, TRANSFUSION, V24, P490, DOI 10.1046/j.1537-2995.1984.24685066807.x; Ellory JC, 2007, BLOOD CELL MOL DIS, V39, P1, DOI 10.1016/j.bcmd.2007.02.011; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Fibach E, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.604738; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741; KAUL DK, 1993, BLOOD, V81, P2429; KAWASAKI H, 1993, ARCH BIOCHEM BIOPHYS, V305, P467, DOI 10.1006/abbi.1993.1448; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kucukal E, 2018, AM J HEMATOL, V93, P1050, DOI 10.1002/ajh.25159; Lon HK, 2019, CLIN PHARM DRUG DEV, V8, P290, DOI 10.1002/cpdd.598; Lorenz Ulrike, 2011, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1107s93; Ma YL, 2012, J PHYSIOL-LONDON, V590, P2095, DOI 10.1113/jphysiol.2012.229609; Merciris P, 2001, BLOOD, V98, P3121, DOI 10.1182/blood.V98.10.3121; Minetti G, 2004, BIOCHEM J, V377, P489, DOI 10.1042/BJ20031401; Noomuna P, 2020, BRIT J HAEMATOL, V190, P599, DOI 10.1111/bjh.16671; Parise Leslie V, 2003, Curr Hematol Rep, V2, P102; Picha KM, 2007, J BIOL CHEM, V282, P2911, DOI 10.1074/jbc.M610096200; Puchulu-Campanella E, 2016, P NATL ACAD SCI USA, V113, P13732, DOI 10.1073/pnas.1611904113; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SCHARFF O, 1981, ACTA BIOL MED GER, V40, P457; Siciliano A, 2010, BLOOD CELL MOL DIS, V44, P233, DOI 10.1016/j.bcmd.2010.02.007; Terra HTMB, 1998, AM J HEMATOL, V58, P224, DOI 10.1002/(SICI)1096-8652(199807)58:3<224::AID-AJH11>3.0.CO;2-9; Tiffert T., 2003, RED CELL MEMBRANE TR, P373, DOI DOI 10.1007/978-3-662-05181-8_15; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Wautier JL, 2013, CLIN HEMORHEOL MICRO, V53, P11, DOI 10.3233/CH-2012-1572; Whelihan MF, 2016, J THROMB HAEMOST, V14, P1941, DOI 10.1111/jth.13416; Zhang YX, 2017, J BIOL CHEM, V292, P407, DOI 10.1074/jbc.M116.766832	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22360	10.1096/fj.202100809RR	http://dx.doi.org/10.1096/fj.202100809RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5UG	35593742				2022-12-26	WOS:000797983400001
J	Shang, YL; Huang, J; Li, WD; Zhang, YA; Zhou, X; Shao, QQ; Tan, TC; Yin, S; Zhang, LR; Wang, SX				Shang, Yongliang; Huang, Ju; Li, Weidong; Zhang, Yanan; Zhou, Xu; Shao, Qiqi; Tan, Taicong; Yin, Shen; Zhang, Liangran; Wang, Shunxin			MEIOK21 regulates oocyte quantity and quality via modulating meiotic recombination	FASEB JOURNAL			English	Article						fertility; MEIOK21; meiosis; oocyte; recombination; synapsis	DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; SEXUAL-DIMORPHISM; FEMALE MEIOSIS; CROSSING-OVER; GERM-CELL; ANEUPLOIDY; INSIGHTS; REPAIR; SPO11	The reproductive life span of females is largely determined by the number and quality of oocytes. Previously, we identified MEIOK21 as a meiotic recombination regulator required for male fertility. Here, we characterize the important roles of MEIOK21 in regulating female meiosis and oocyte number and quality. MEIOK21 localizes at recombination sites as a component of recombination bridges in oogenesis like in spermatogenesis. Meiok21(-/-) female mice show subfertility. Consistently, the size of the primordial follicle pool in Meiok21(-/- )females is only similar to 40% of wild-type females because a great number of oocytes with defects in meiotic recombination and/or synapsis are eliminated. Furthermore, the numbers of primordial and growing follicles show a more marked decrease in an age-dependent manner compared with wild-type females. Further analysis shows Meiok21(-/- )oocytes also have reduced rates of germinal vesicle breakdown and the first polar body extrusion when cultured in vitro, indicating poor oocyte quality. Additionally, Meiok21(-/-) oocytes have more chromosomes bearing a single distally localized crossover (chiasmata), suggesting a possible defect in crossover maturation. Taken together, our findings indicate critical roles for MEIOK21 in ensuring the number and quality of oocytes in the follicles.	[Shang, Yongliang; Huang, Ju; Li, Weidong; Zhang, Yanan; Zhou, Xu; Shao, Qiqi; Tan, Taicong; Zhang, Liangran; Wang, Shunxin] Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, Jinan, Peoples R China; [Shang, Yongliang; Li, Weidong; Zhou, Xu; Shao, Qiqi; Zhang, Liangran] Shandong Univ, Adv Med Res Inst, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Shandong Prov Clin Res Ctr Reprod Hlth, Jinan, Peoples R China; [Yin, Shen] Qingdao Agr Univ, Coll Life Sci, Inst Reprod Sci, Qingdao, Peoples R China; [Zhang, Liangran] Shandong Normal Univ, Coll Life Sci, Shandong Prov Key Lab Anim Resistance Biol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Qingdao Agricultural University; Shandong Normal University	Wang, SX (corresponding author), Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, Jinan, Peoples R China.	shunxinwang@sdu.edu.cn			National Key Research and Development Program of China [2021YFC2700103, 2018YFC1003700]; National Natural Science Foundation of China [32070837, 31801203]; Taishan Scholars Youth Project of Shandong Province	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Youth Project of Shandong Province	This work was supported by the National Key Research and Development Program of China (2021YFC2700103 and 2018YFC1003700), National Natural Science Foundation of China (32070837, 31801203); Taishan Scholars Youth Project of Shandong Province.	Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Bolcun-Filas E, 2018, BIOL REPROD, V99, P112, DOI 10.1093/biolre/ioy021; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Brandsma I, 2019, CELL REP, V27, P3790, DOI 10.1016/j.celrep.2019.05.096; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Cahoon CK, 2019, CHROMOSOMA, V128, P199, DOI 10.1007/s00412-019-00692-x; Capalbo A, 2017, HUM REPROD UPDATE, V23, P706, DOI 10.1093/humupd/dmx026; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Dubois E, 2019, P NATL ACAD SCI USA, V116, P12400, DOI 10.1073/pnas.1901237116; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; El Yakoubi W, 2017, ADV EXP MED BIOL, V1002, P1, DOI 10.1007/978-3-319-57127-0_1; Felipe-Medina N, 2020, ELIFE, V9, DOI 10.7554/eLife.56996; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Gray S, 2016, ANNU REV GENET, V50, P175, DOI 10.1146/annurev-genet-120215-035111; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Huang CZ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.652407; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Hunter N, 2017, COLD SH Q B, V82, P235, DOI 10.1101/sqb.2017.82.035394; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jones KT, 2011, RESULTS PROBL CELL D, V53, P343, DOI 10.1007/978-3-642-19065-0_15; Kang R, 2018, MOL CELL, V69, P725, DOI 10.1016/j.molcel.2018.02.021; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Li M, 2020, J GENET GENOMICS, V47, P451, DOI 10.1016/j.jgg.2020.08.001; Li WD, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12809; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; Matsuzaki K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09190-1; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Pacheco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04851-z; Pan B, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-018-0445-8; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Qiao HY, 2018, MOL CELL, V72, P211, DOI 10.1016/j.molcel.2018.08.031; Qiao H, 2014, NAT GENET, V46, P194, DOI 10.1038/ng.2858; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Qu W, 2021, ASIAN J ANDROL, V23, P572, DOI 10.4103/aja202191; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Ribeiro J, 2016, CHROMOSOMA, V125, P265, DOI 10.1007/s00412-015-0552-7; Rinaldi VD, 2017, MOL CELL, V67, P1026, DOI 10.1016/j.molcel.2017.07.027; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Shang YL, 2020, NUCLEIC ACIDS RES, V48, P6624, DOI 10.1093/nar/gkaa406; Shi BL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007952; Takemoto K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107686; Tharp ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14055-8; Titus S, 2015, SEMIN REPROD MED, V33, P384, DOI 10.1055/s-0035-1567824; Wang C, 2017, CELL MOL LIFE SCI, V74, P2547, DOI 10.1007/s00018-017-2480-6; Wang JJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0492-2; Wang SX, 2021, ASIAN J ANDROL, V23, P562, DOI 10.4103/aja.aja_86_20; Wang SX, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800221; Wang SX, 2019, CELL, V177, P326, DOI 10.1016/j.cell.2019.02.021; Wang S, 2017, CELL, V168, P977, DOI 10.1016/j.cell.2017.02.002; Widger A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04850-0; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yan H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1208-3; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhang B, 2020, CELL DEATH DIFFER, V27, P2176, DOI 10.1038/s41418-020-0493-4; Zhang JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15954-x; Zhang JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08676-2; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zhang MJ, 2012, CELL MOL LIFE SCI, V69, P1279, DOI 10.1007/s00018-011-0867-3; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626; Zickler D, 2016, SEMIN CELL DEV BIOL, V54, P135, DOI 10.1016/j.semcdb.2016.02.024	79	0	0	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22357	10.1096/fj.202101950R	http://dx.doi.org/10.1096/fj.202101950R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9ZS	35593531				2022-12-26	WOS:000798270300001
J	Butler, JZ; Carson, M; Rios-Fetchko, F; Vargas, R; Cabrera, A; Gallegos-Castillo, A; LeSarre, M; Liao, M; Woo, K; Ellis, R; Liu, K; Burra, A; Ramirez, M; Doyle, B; Leung, L; Fernandez, A; Grumbach, K				Butler, Jonathan Z.; Carson, Mariam; Rios-Fetchko, Francine; Vargas, Roberto; Cabrera, Abby; Gallegos-Castillo, Angela; LeSarre, Monique; Liao, Michael; Woo, Kent; Ellis, Randi; Liu, Kirsten; Burra, Arun; Ramirez, Mario; Doyle, Brittney; Leung, Lydia; Fernandez, Alicia; Grumbach, Kevin			COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis	PLOS ONE			English	Article							UNITED-STATES	Background COVID-19 vaccination rates are lower among historically marginalized populations, including Black/African American and Latinx populations, threatening to contribute to already high COVID-19 morbidity and mortality disparities for these groups. We conducted a community-based participatory research study using qualitative methods to explore knowledge and beliefs about COVID-19 vaccination among Black/African American, Latinx, and Chinese American residents of the San Francisco Bay Area and assess their views on vaccination outreach and delivery strategies. Methods and findings Data were collected from January 14, 2021, to February 24, 2021, with adult residents (N = 109 [Female: N = 76; 70%]) in San Francisco. Focus groups (N = 10) and in-depth interviews (N = 25) were conducted among Black/African Americans (N = 35), Latinx (N = 40), and Chinese Americans (n = 34) in English, Spanish, Cantonese, or Mandarin. Themes were identified using grounded field theory, and included misinformation, mistrust of government and health institutions, and linguistic and other barriers to vaccine access. All three racial/ethnic groups had experiences with vaccine misinformation and information overload. Many African American and Latinx participants cited structural and interpersonal racism, and anti-immigrant discrimination, as factors reducing their trust in government and public health disseminated information and their willingness to be vaccinated. Participants expressed trust in community-based organizations, including faith-based organizations and community-run clinics. Participants often experienced barriers to vaccine access, such as transportation to drive-in sites, with Latinx and Chinese American groups also frequently citing language barriers. Conclusions Vaccine outreach strategies must acknowledge how longstanding systemic, institutional, and structural racism contributes to mistrust in government and health institutions and engage with and support trusted messengers from the community to eliminate cultural, linguistic, and other barriers to vaccine access.	[Butler, Jonathan Z.; Vargas, Roberto; Cabrera, Abby; Leung, Lydia; Grumbach, Kevin] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Carson, Mariam; Rios-Fetchko, Francine; Burra, Arun; Fernandez, Alicia] Univ Calif San Francisco, UCSF LatinX Ctr Excellence, Dept Med, San Francisco, CA 94143 USA; [Gallegos-Castillo, Angela] Inst Familiar Raza Inc, San Francisco, CA USA; [LeSarre, Monique; Ellis, Randi] Rafiki Coalit, San Francisco, CA USA; [Liao, Michael; Woo, Kent; Liu, Kirsten] NICOS Chinese Hlth Coalit, San Francisco, CA USA; [Ramirez, Mario] Stanford Univ, Stanford, CA 94305 USA; [Doyle, Brittney] Univ Calif San Francisco, UCSF Black Hlth Initiat, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Butler, JZ (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.	Jonathan.butler@ucsf.edu			National Institutes of Health, Community Engagement Alliance Against COVID-19 Disparities program [21-312-0217571-66106L]; National Center for Advancing Translational Sciences, National Institutes of Health, (UCSF-CTSI) [UL1 TR001872]	National Institutes of Health, Community Engagement Alliance Against COVID-19 Disparities program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health, (UCSF-CTSI)	This work was supported by the National Institutes of Health, Community Engagement Alliance Against COVID-19 Disparities program (21-312-0217571-66106L)(KG) https://covid19community.nih.gov/, the the National Center for Advancing Translational Sciences, National Institutes of Health, (UCSF-CTSI Grant Number UL1 TR001872)(KG) https://ncats.nih.gov/.The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. D. Joshi, 2021, medRxiv, DOI 10.1101/2021.02.25.21252402; Abraham P, 2021, ACAD RADIOL, V28, P893, DOI 10.1016/j.acra.2021.03.025; Allen JD, 2021, TRANSL BEHAV MED, V11, P785, DOI 10.1093/tbm/ibab014; Alsan M, 2021, ANN INTERN MED, V174, P484, DOI 10.7326/M20-6141; Bajaj SS, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMpv2035827; Balasuriya L, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.28575; Bibbins-Domingo Kirsten, 2021, JAMA Health Forum, V2, pe210213, DOI 10.1001/jamahealthforum.2021.0213; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Carson SL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.27582; Carson SL, 2020, J HEALTH CARE POOR U, V31, P1515, DOI 10.1353/hpu.2020.0112; Centers for Disease Control and Prec, 2021, DEM TRENDS PEOPL REC; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Cooper LA, 2020, J CLIN INVEST, V130, P5033, DOI 10.1172/JCI141562; Corbie-Smith Giselle, 2021, JAMA Health Forum, V2, pe210434, DOI 10.1001/jamahealthforum.2021.0434; Dickinson KL, 2021, HEALTH SECUR, V19, pS14, DOI 10.1089/hs.2021.0031; Garcia MA, 2021, J GERONTOL B-PSYCHOL, V76, pE75, DOI 10.1093/geronb/gbaa114; Grumbach K, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.1724; Grumbach K, 2021, JAMA INTERN MED, V181, P1008, DOI 10.1001/jamainternmed.2021.1445; Jimenez ME, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.17074; Kamal A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101121; Khubchandani Jagdish, 2021, Brain Behav Immun Health, V15, P100277, DOI 10.1016/j.bbih.2021.100277; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Knights F, 2021, BRIT J GEN PRACT, V71, pE583, DOI 10.3399/BJGP.2021.0028; Lockyer B, 2021, HEALTH EXPECT, V24, P1158, DOI 10.1111/hex.13240; MacNeil JR, 2021, MMWR-MORBID MORTAL W, V70, P651, DOI 10.15585/mmwr.mm7017e4; Mahmood F, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050584; Momplaisir F., 2021, CLIN INFECT DIS, V73, P1784, DOI [10.1093/cid/ciab102, DOI 10.1093/CID/CIAB102]; Muric G, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/30642; Nambi Ndugga LH., 2021, LASTEST DATA COVID 1; Osakwe ZT, 2022, AM J INFECT CONTROL, V50, P268, DOI 10.1016/j.ajic.2021.11.004; Rathore FA, 2020, J PAK MED ASSOC, V70, pS162, DOI 10.5455/JPMA.38; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; San Francisco City and County, 2021, COVID 19 VACC RAC AG; Seligman B, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003490; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weng Y., 2021, MEDRXIV; Woodhead C, 2022, ETHNIC HEALTH, V27, P1555, DOI [10.1080/13557858.2021.1936464, 10.1136/jech-2021-SSMabstracts.35]; Yang RH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040650	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0266397	10.1371/journal.pone.0266397	http://dx.doi.org/10.1371/journal.pone.0266397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35550627	Green Published, gold			2022-12-26	WOS:000868164600013
J	Patel, P; Raval, M; Manvar, A; Airao, V; Bhatt, V; Shah, PA				Patel, Priya; Raval, Mihir; Manvar, Aneka; Airao, Vishal; Bhatt, Vaibhav; Shah, Pranav			Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; PLGA NANOPARTICLES; PULMONARY DELIVERY; BLOCK-COPOLYMERS; MULTIDRUG-RESISTANCE; EPSILON-CAPROLACTONE; TISSUE DISTRIBUTION; GROWTH-INHIBITION; FORMULATION; OPTIMIZATION	Silibinin (SB) is shown to have an anticancer properties. However, its clinical therapeutic effects have been restricted due to its low water solubility and poor absorption after oral administration. The aim of this study was to develop SB-loaded PCL/Pluronic F68 nanoparticles for pulmonary delivery in the treatment of lung cancer. A modified solvent displacement process was used to make nanoparticles, which were then lyophilized to make inhalation powder, Nanoparticles were characterized with DSC, FTIR,SEM and In vitro release study. Further, a validated HPLC method was developed to investigate the Biodistribution study, pharmacokinetic parameters. Poly Caprolactone PCL / Pluronic F68 NPs showed the sustained release effect up to 48 h with an emitted (Mass median Aerodynamic diameter)MMAD and (Geometric size distribution)GSD were found to be 4.235 +/- 0.124 and 1.958 +/- 1.23 respectively. More specifically, the SB Loaded PCL/Pluronic F 68 NPs demonstrated long circulation and successful lung tumor-targeting potential due to their cancer-targeting capabilities. SB Loaded PCL/Pluronic F68 NPs significantly inhibited tumour growth in lung cancer-induced rats after inhalable administration. In a pharmacokinetics study, PCL/ Pluronic F68 NPs substantially improved SB bioavailability, with a more than 4-fold rise in AUC when compared to IV administration. These findings indicate that SB-loaded PCL/PluronicF68 nanoparticles may be a successful lung cancer therapy delivery system.	[Patel, Priya; Manvar, Aneka; Airao, Vishal] Saurashtra Univ, Dept Pharmaceut Sci, Rajkot, Gujarat, India; [Raval, Mihir] Sardar Patel Univ, Dept Pharmaceut Sci, Vallabh Vidyanagar, Gujarat, India; [Bhatt, Vaibhav] Gujarat Technol Univ, Sch Appl Sci & Technol, Ahmadabad, Gujarat, India; [Shah, Pranav] Uka Tarsadia Univ, Maliba Pharm Coll, Tarsadi, Gujarat, India	Saurashtra University; Sardar Patel University; Gujarat Technological University; UKA Tarsadia University	Patel, P (corresponding author), Saurashtra Univ, Dept Pharmaceut Sci, Rajkot, Gujarat, India.	pvpatel@sauuni.ac.in			Gujarat council on science and technology (GUJCOST), Department of Science &Technology, Government of Gujarat, Gandhinagar, India	Gujarat council on science and technology (GUJCOST), Department of Science &Technology, Government of Gujarat, Gandhinagar, India	PP have received a grant from Gujarat council on science and technology (GUJCOST), Department of Science &Technology, Government of Gujarat, Gandhinagar, India The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MH, 2021, AAPS PHARMSCITECH, V22, DOI 10.1208/s12249-021-02113-8; Ajiboye AL, 2018, DRUG DELIV TRANSL RE, V8, P1790, DOI 10.1007/s13346-017-0422-3; Al-Anati L, 2009, MOL NUTR FOOD RES, V53, P460, DOI 10.1002/mnfr.200800110; Al-Qadi S, 2012, J CONTROL RELEASE, V157, P383, DOI 10.1016/j.jconrel.2011.08.008; Alex MRA, 2011, EUR J PHARM SCI, V42, P11, DOI 10.1016/j.ejps.2010.10.002; Azarmi S, 2006, INT J PHARM, V319, P155, DOI 10.1016/j.ijpharm.2006.03.052; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Batrakova EV, 2003, PHARM RES-DORDR, V20, P1581, DOI 10.1023/A:1026179132599; Betancourt T, 2007, NANOMEDICINE-UK, V2, P219, DOI 10.2217/17435889.2.2.219; Bhatnagar S, 2013, PROTOPLASMA, V250, P919, DOI 10.1007/s00709-012-0478-3; Bhattacharya S, 2020, INT J BIOL MACROMOL, V151, P104, DOI 10.1016/j.ijbiomac.2020.02.151; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Bruinsmann FA, 2020, AAPS PHARMSCITECH, V21, DOI 10.1208/s12249-020-01723-y; Chalikwar SS, 2012, COLLOID SURFACE B, V97, P109, DOI 10.1016/j.colsurfb.2012.04.027; Chandolu Vijay, 2013, Curr Drug Discov Technol, V10, P170; Chang SH, 2018, BIOMACROMOLECULES, V19, P2302, DOI 10.1021/acs.biomac.8b00266; Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047; Chi CL, 2019, J NANOPART RES, V21, DOI 10.1007/s11051-019-4580-8; Dash TK, 2012, MOL PHARMACEUT, V9, P2365, DOI 10.1021/mp3001952; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; Din FU, 2017, INT J NANOMED, V12, P7291, DOI 10.2147/IJN.S146315; Dong M, 2012, EUR J PHARM BIOPHARM, V81, P478, DOI 10.1016/j.ejpb.2012.04.022; Du W, 2015, ONCOGENE, V34, P3215, DOI 10.1038/onc.2014.291; El-Samaligy MS, 2006, INT J PHARMACEUT, V308, P140, DOI 10.1016/j.ijpharm.2005.11.006; Elamanchili P, 2009, J PHARM SCI-US, V98, P945, DOI 10.1002/jps.21479; Elsewedy HS, 2020, DRUG DELIV, V27, P1134, DOI 10.1080/10717544.2020.1797237; Fonseca C, 2002, J CONTROL RELEASE, V83, P273, DOI 10.1016/S0168-3659(02)00212-2; Galindo-Rodriguez S, 2004, PHARM RES-DORDR, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be; Garbuzenko OB, 2010, P NATL ACAD SCI USA, V107, P10737, DOI 10.1073/pnas.1004604107; Golombek SK, 2018, ADV DRUG DELIVER REV, V130, P17, DOI 10.1016/j.addr.2018.07.007; Ha ES, 2019, MOLECULES, V24, DOI 10.3390/molecules24112180; Hammadi NI, 2017, PHARM RES-DORDR, V34, P1193, DOI 10.1007/s11095-017-2135-1; HiljanenVainio M, 1996, J APPL POLYM SCI, V59, P1281, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1281::AID-APP11>3.0.CO;2-9; Hogan FS, 2007, J SURG RES, V143, P58, DOI 10.1016/j.jss.2007.03.080; Huang JG, 2008, INT J PHARMACEUT, V356, P351, DOI 10.1016/j.ijpharm.2007.12.028; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2003, INT C HARMONIZATION; Jena GK, 2020, INDIAN J PHARM EDUC, V54, P349, DOI 10.5530/ijper.54.2.40; Joshi SA, 2010, EUR J PHARM BIOPHARM, V76, P189, DOI 10.1016/j.ejpb.2010.07.007; Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9; Kim JC, 2004, RADIOTHER ONCOL, V71, P213, DOI 10.1016/j.radonc.2004.03.006; Kim KY, 2007, NANOMED-NANOTECHNOL, V3, P103, DOI 10.1016/j.nano.2006.12.002; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Leardi R, 2009, ANAL CHIM ACTA, V652, P161, DOI 10.1016/j.aca.2009.06.015; Lemjabbar-Alaoui H, 2015, BBA-REV CANCER, V1856, P189, DOI 10.1016/j.bbcan.2015.08.002; Li JT, 1996, COLLOID SURFACE B, V7, P9, DOI 10.1016/0927-7765(96)01269-6; Li L, 2011, DRUG DEV IND PHARM, V37, P1170, DOI 10.3109/03639045.2011.563781; Ling YH, 2007, MOL PHARMACOL, V72, P248, DOI 10.1124/mol.107.034827; Liu DH, 2011, COLLOID SURFACE B, V85, P262, DOI 10.1016/j.colsurfb.2011.02.038; Liu XS, 2013, LANGMUIR, V29, P9138, DOI 10.1021/la401556k; Luo YC, 2010, CARBOHYD POLYM, V82, P942, DOI 10.1016/j.carbpol.2010.06.029; Ma GL, 2007, J APPL POLYM SCI, V104, P1895, DOI 10.1002/app.25866; Ma JKH., 1996, INHALATION AEROSOLS, P155; Mahaffey CM, 2007, CLIN LUNG CANCER, V8, P548, DOI 10.3816/CLC.2007.n.041; Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55; Mahboob T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65728-0; Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6; Mei L, 2009, J PHARM SCI-US, V98, P2040, DOI 10.1002/jps.21581; Minko T, 2005, J CONTROL RELEASE, V105, P269, DOI 10.1016/j.jconrel.2005.03.019; Minko T, 1998, J CONTROL RELEASE, V54, P223, DOI 10.1016/S0168-3659(98)00009-1; Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2; Mokhtari MJ, 2008, CELL BIOL INT, V32, P888, DOI 10.1016/j.cellbi.2008.03.019; Nguyen J, 2008, J GENE MED, V10, P1236, DOI 10.1002/jgm.1255; Nunthanid J., 2002, THAI B PHARM SCI, V8, P19; Paul P., 2018, NANOMEDICINE-UK, V13, P1; Paul P, 2018, NANOMEDICINE-UK, V13, P501, DOI 10.2217/nnm-2017-0291; PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110; Ravanfar R, 2016, FOOD CHEM, V199, P573, DOI 10.1016/j.foodchem.2015.12.061; Reich G, 1997, DRUG DEV IND PHARM, V23, P1191, DOI 10.3109/03639049709146156; Rizzardini M, 1998, HEPATOLOGY, V27, P703, DOI 10.1002/hep.510270311; Roa WH, 2011, J CONTROL RELEASE, V150, P49, DOI 10.1016/j.jconrel.2010.10.035; Rosen H, 2005, NAT REV DRUG DISCOV, V4, P381, DOI 10.1038/nrd1721; Seju U, 2011, ACTA BIOMATER, V7, P4169, DOI 10.1016/j.actbio.2011.07.025; Sharma D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/156010; Sharma G, 2003, ANTICANCER RES, V23, P2649; Singh B, 2005, CRIT REV THER DRUG, V22, P27, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20; Sinha B, 2012, DRUG DEV IND PHARM, V38, P171, DOI 10.3109/03639045.2011.592532; Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013; Suarez S, 2000, Respir Care, V45, P652; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Sun NY, 2008, POWDER TECHNOL, V182, P72, DOI 10.1016/j.powtec.2007.05.029; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Triplett MD, 2009, J NANOPART RES, V11, P601, DOI 10.1007/s11051-008-9402-3; Veni DK, 2020, INT J POLYM MATER PO, V69, P407, DOI 10.1080/00914037.2019.1570513; Wei Z, 2009, INT J PHARMACEUT, V376, P176, DOI 10.1016/j.ijpharm.2009.04.030; Wu WW, 2017, RSC ADV, V7, P54379, DOI 10.1039/c7ra10242a; Xu XM, 2011, INT J PHARMACEUT, V419, P52, DOI 10.1016/j.ijpharm.2011.07.012; Yamagata T, 2007, DRUG METAB DISPOS, V35, P1142, DOI 10.1124/dmd.106.014217; You YT, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00271; Zhao JF, 1999, CARCINOGENESIS, V20, P2101, DOI 10.1093/carcin/20.11.2101; Zhao JS, 2011, J TOXICOL ENV HEAL B, V14, P593, DOI 10.1080/10937404.2011.615113; Zou JJ, 2019, ARTIF CELL NANOMED B, V47, P3456, DOI 10.1080/21691401.2019.1626863	91	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267257	http://dx.doi.org/10.1371/journal.pone.0267257			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560136	Green Published, gold			2022-12-26	WOS:000835326900003
J	Xu, X; Wu, GY				Xu, Xin; Wu, Guangyu			Human C1orf27 protein interacts with ?(2A)-adrenergic receptor and regulates its anterograde transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; COUPLED RECEPTOR; ENDOPLASMIC-RETICULUM; ADRENERGIC-RECEPTOR; ALPHA(2)-ADRENERGIC RECEPTORS; MEMBRANE-TRAFFICKING; ANGIOTENSIN-II; EXPORT; MOTIF; LOCALIZATION	The molecular mechanisms underlying the anterograde surface transport of G protein-coupled receptors (GPCRs) after their synthesis in the endoplasmic reticulum (ER) are not well defined. In C. elegans, odorant response abnormal 4 has been implicated in the delivery of olfactory GPCRs to the cilia of chemosensory neurons. However, the function and regulation of its human homolog, C1orf27, in GPCR transport or in general membrane trafficking remain unknown. Here, we demonstrate that siRNA-mediated knockdown of C1orf27 markedly impedes the ER-to-Golgi export kinetics of newly synthesized alpha 2A-adrenergic receptor (alpha 2A-AR), a prototypic GPCR, with the half-time being prolonged by more than 65%, in mammalian cells in retention using the selective hooks assays. Using modified bioluminescence resonance energy transfer assays and ELISAs, we also show that C1orf27 knockdown significantly inhibits the surface transport of alpha 2AAR. Similarly, C1orf27 knockout by CRISPR-Cas9 markedly suppresses the ER-Golgi-surface transport of alpha 2A-AR. In addition, we demonstrate that C1orf27 depletion attenuates the export of beta 2-AR and dopamine D2 receptor but not of epidermal growth factor receptor. We further show that C1orf27 physically associates with alpha 2A-AR, specifically via its third intracellular loop and C terminus. Taken together, these data demonstrate an important role of C1orf27 in the trafficking of nascent GPCRs from the ER to the cell surface through the Golgi and provide novel insights into the regulation of the biosynthesis and anterograde transport of the GPCR family members.	[Xu, Xin; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu			National Institutes of Health [R35GM136397]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grant R35GM136397 to G. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Awabdh S, 2012, J NEUROSCI, V32, P14227, DOI 10.1523/JNEUROSCI.6329-11.2012; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chen CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004082; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Khater M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100805; Kim KA, 2003, J NEUROSCI, V23, P2075; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kunselman JM, 2021, CURR OPIN CELL BIOL, V71, P158, DOI 10.1016/j.ceb.2021.03.002; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lehman CW, 2005, GENOMICS, V85, P386, DOI 10.1016/j.ygeno.2004.11.009; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Li YW, 1998, J NEUROPHYSIOL, V79, P583, DOI 10.1152/jn.1998.79.2.583; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Pao CS, 2005, J BIOL CHEM, V280, P11052, DOI 10.1074/jbc.M412996200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Shiwarski DJ, 2019, MOL BIOL CELL, V30, P680, DOI 10.1091/mbc.E18-05-0292; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Shiwarski DJ, 2017, J NEUROSCI, V37, P3741, DOI 10.1523/JNEUROSCI.2923-16.2017; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Timmons SD, 2004, BRAIN RES, V1014, P184, DOI 10.1016/j.brainres.2004.04.025; Ulloa-Aguirre A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212329; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wei Z, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100517; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xu X, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103643; Zhang MX, 2019, TRAFFIC, V20, P110, DOI 10.1111/tra.12624; Zhang MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37921; Zhang MX, 2016, MOL CELL BIOL, V36, P1152, DOI 10.1128/MCB.00009-16; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	62	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102021	10.1016/j.jbc.2022.102021	http://dx.doi.org/10.1016/j.jbc.2022.102021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35551911	gold, Green Published			2022-12-26	WOS:000829588600003
J	Holm, M; Saraswat, M; Joenvaara, S; Seppo, A; Looney, RJM; Tohmola, T; Renkonen, J; Renkonen, R; Jarvinen, K				Holm, Matilda; Saraswat, Mayank; Joenvaara, Sakari; Seppo, Antti; Looney, R. John M.; Tohmola, Tiialotta; Renkonen, Jutta; Renkonen, Risto; Jarvinen, Kirsi			Quantitative glycoproteomics of human milk and association with atopic disease	PLOS ONE			English	Article							N-GLYCOPROTEOMICS; HUMAN COLOSTRUM; ALLERGY; ASTHMA	The prevalence of allergic diseases and asthma is increasing rapidly worldwide, with environmental and lifestyle behaviors implicated as a reason. Epidemiological studies have shown that children who grow up on farms are at lower risk of developing childhood atopic disease, indicating the presence of a protective "farm effect". The Old Order Mennonite (OOM) community in Upstate New York have traditional, agrarian lifestyles, a low rate of atopic disease, and long periods of exclusive breastfeeding. Human milk proteins are heavily glycosylated, although there is a paucity of studies investigating the milk glycoproteome. In this study, we have used quantitative glycoproteomics to compare the N-glycoprotein profiles of 54 milk samples from Rochester urban/suburban and OOM mothers, two populations with different lifestyles, exposures, and risk of atopic disease. We also compared N-glycoprotein profiles according to the presence or absence of atopic disease in the mothers and, separately, the children. We identified 79 N-glycopeptides from 15 different proteins and found that proteins including immunoglobulin A1, polymeric immunoglobulin receptor, and lactotransferrin displayed significant glycan heterogeneity. We found that the abundances of 38 glycopeptides differed significantly between Rochester and OOM mothers and also identified four glycopeptides with significantly different abundances between all comparisons. These four glycopeptides may be associated with the development of atopic disease. The findings of this study suggest that the differential glycosylation of milk proteins could be linked to atopic disease.	[Holm, Matilda; Saraswat, Mayank; Tohmola, Tiialotta; Renkonen, Jutta; Renkonen, Risto] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Holm, Matilda; Saraswat, Mayank; Joenvaara, Sakari; Tohmola, Tiialotta; Renkonen, Jutta; Renkonen, Risto] Helsinki Univ Hosp, Helsinki, Finland; [Seppo, Antti; Jarvinen, Kirsi] Univ Rochester, Golisano Childrens Hosp, Ctr Food Allergy, Dept Pediat,Div Allergy Immunol & Rheumatol,Sch Me, Rochester, NY 14642 USA; [Looney, R. John M.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Sch Med & Dent, Rochester, NY USA; [Holm, Matilda] KTH Royal Inst Technol, Dept Prot Sci, Div Cellular & Clin Prote, Stockholm, Sweden; [Holm, Matilda] Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, Solna, Sweden; [Saraswat, Mayank] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Rochester; University of Rochester; Royal Institute of Technology; Karolinska Institutet; Mayo Clinic	Jarvinen, K (corresponding author), Univ Rochester, Golisano Childrens Hosp, Ctr Food Allergy, Dept Pediat,Div Allergy Immunol & Rheumatol,Sch Me, Rochester, NY 14642 USA.	kirsi_jarvinen-seppo@URMC.Rochester.edu	saraswat, mayank/F-2985-2015	saraswat, mayank/0000-0002-5021-8150	National Center for Advancing Translational Sciences [R21 TR002516]; Founders' Distinguished Professorship in Pediatric Allergy; University of Rochester Clinical and Translational Science Institute; Environmental Health Sciences Center Pilot Award	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Founders' Distinguished Professorship in Pediatric Allergy; University of Rochester Clinical and Translational Science Institute; Environmental Health Sciences Center Pilot Award	This work was supported by the National Center for Advancing Translational Sciences [Grant Number R21 TR002516 to KJS and RJL]; Founders' Distinguished Professorship in Pediatric Allergy [KJ]; and Pilot Awards from University of Rochester Clinical and Translational Science Institute and Environmental Health Sciences Center Pilot Award [to RJL]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cao XY, 2018, FOOD FUNCT, V9, P1163, DOI 10.1039/c7fo01796k; Cao XY, 2017, J AGR FOOD CHEM, V65, P10360, DOI 10.1021/acs.jafc.7b04381; Elbert NJ, 2017, ALLERGY, V72, P1936, DOI 10.1111/all.13195; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Hettinga KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122234; Huang JC, 2017, ANAL BIOANAL CHEM, V409, P589, DOI 10.1007/s00216-016-0029-4; Jarvinen KM., 2016, ALLERGY IMMUNITY TOL, P235; Joenvaara S, 2008, GLYCOBIOLOGY, V18, P339, DOI 10.1093/glycob/cwn013; Joenvaara S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195006; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; Mange A, 2008, J CHROMATOGR B, V876, P252, DOI 10.1016/j.jchromb.2008.11.003; Martina C, 2016, ANN ALLERG ASTHMA IM, V117, P562, DOI 10.1016/j.anai.2016.08.023; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Niimi K, 2018, MUCOSAL IMMUNOL, V11, P643, DOI 10.1038/mi.2017.90; O'Donnell R, 2004, INT DAIRY J, V14, P1013, DOI 10.1016/j.idairyj.2004.04.004; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Phillips JT, 2020, ANN ALLERG ASTHMA IM, V124, P292, DOI 10.1016/j.anai.2019.12.019; Picariello G, 2008, PROTEOMICS, V8, P3833, DOI 10.1002/pmic.200701057; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Seppo AE, 2021, ALLERGY, V76, P3489, DOI 10.1111/all.14877; Steffen U, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13992-8; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Zhu J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081834	24	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267967	http://dx.doi.org/10.1371/journal.pone.0267967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559953	Green Published, gold			2022-12-26	WOS:000835326900021
J	Otambo, WO; Omondi, CJ; Ochwedo, KO; Onyango, PO; Atieli, H; Lee, MC; Wang, C; Zhou, GF; Githeko, AK; Githure, J; Ouma, C; Yan, GY; Kazura, J				Otambo, Wilfred Ouma; Omondi, Collince J.; Ochwedo, Kevin O.; Onyango, Patrick O.; Atieli, Harrysone; Lee, Ming-Chieh; Wang, Chloe; Zhou, Guofa; Githeko, Andrew K.; Githure, John; Ouma, Collins; Yan, Guiyun; Kazura, James			Risk associations of submicroscopic malaria infection in lakeshore, plateau and highland areas of Kisumu County in western Kenya	PLOS ONE			English	Article							DYNAMICS	BackgroundPersons with submicroscopic malaria infection are a major reservoir of gametocytes that sustain malaria transmission in sub-Saharan Africa. Despite recent decreases in the national malaria burden in Kenya due to vector control interventions, malaria transmission continues to be high in western regions of the country bordering Lake Victoria. The objective of this study was to advance knowledge of the topographical, demographic and behavioral risk factors associated with submicroscopic malaria infection in the Lake Victoria basin in Kisumu County. MethodsCross-sectional community surveys for malaria infection were undertaken in three eco-epidemiologically distinct zones in Nyakach sub-County, Kisumu. Adjacent regions were topologically characterized as lakeshore, hillside and highland plateau. Surveys were conducted during the 2019 and 2020 wet and dry seasons. Finger prick blood smears and dry blood spots (DBS) on filter paper were collected from 1,777 healthy volunteers for microscopic inspection and real time-PCR (RT-PCR) diagnosis of Plasmodium infection. Persons who were PCR positive but blood smear negative were considered to harbor submicroscopic infections. Topographical, demographic and behavioral risk factors were correlated with community prevalence of submicroscopic infections. ResultsOut of a total of 1,777 blood samples collected, 14.2% (253/1,777) were diagnosed as submicroscopic infections. Blood smear microscopy and RT-PCR, respectively, detected 3.7% (66/1,777) and 18% (319/1,777) infections. Blood smears results were exclusively positive for P. falciparum, whereas RT-PCR also detected P. malariae and P. ovale mono- and co-infections. Submicroscopic infection prevalence was associated with topographical variation (chi(2) = 39.344, df = 2, p<0.0001). The highest prevalence was observed in the lakeshore zone (20.6%, n = 622) followed by the hillside (13.6%, n = 595) and highland plateau zones (7.9%, n = 560). Infection prevalence varied significantly according to season (chi(2) = 17.374, df = 3, p<0.0001). The highest prevalence was observed in residents of the lakeshore zone in the 2019 dry season (29.9%, n = 167) and 2020 and 2019 rainy seasons (21.5%, n = 144 and 18.1%, n = 155, respectively). In both the rainy and dry seasons the likelihood of submicroscopic infection was higher in the lakeshore (AOR: 2.71, 95% CI = 1.85-3.95; p<0.0001) and hillside (AOR: 1.74, 95% CI = 1.17-2.61, p = 0.007) than in the highland plateau zones. Residence in the lakeshore zone (p<0.0001), male sex (p = 0.025), school age (p = 0.002), and living in mud houses (p = 0.044) increased the risk of submicroscopic malaria infection. Bed net use (p = 0.112) and occupation (p = 0.116) were not associated with submicroscopic infection prevalence. ConclusionTopographic features of the local landscape and seasonality are major correlates of submicroscopic malaria infection in the Lake Victoria area of western Kenya. Diagnostic tests more sensitive than blood smear microscopy will allow for monitoring and targeting geographic sites where additional vector interventions are needed to reduce malaria transmission.	[Otambo, Wilfred Ouma; Onyango, Patrick O.] Maseno Univ, Dept Zool, Kisumu, Kenya; [Otambo, Wilfred Ouma; Omondi, Collince J.; Ochwedo, Kevin O.; Atieli, Harrysone; Githure, John] Maseno Univ, Int Ctr Excellence Malaria Res, Tom Mboya Univ Coll, Homa Bay, Kenya; [Omondi, Collince J.; Ochwedo, Kevin O.] Univ Nairobi, Fac Sci & Technol, Dept Biol, Nairobi, Kenya; [Lee, Ming-Chieh; Wang, Chloe; Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA USA; [Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Ouma, Collins] Maseno Univ, Dept Biomed Sci & Technol, Kisumu, Kenya; [Kazura, James] Case Western Univ Reserve, Ctr Global Hlth & Dis, Cleveland, OH USA	Maseno University; Maseno University; University of Nairobi; University of California System; University of California Irvine; Kenya Medical Research Institute; Maseno University; Case Western Reserve University	Otambo, WO (corresponding author), Maseno Univ, Dept Zool, Kisumu, Kenya.; Otambo, WO (corresponding author), Maseno Univ, Int Ctr Excellence Malaria Res, Tom Mboya Univ Coll, Homa Bay, Kenya.	oumaotambo@gmil.com	Otambo, Wilfred/GZL-8494-2022; Ochwedo, Kevin Omondi/HDL-9048-2022; Ochwedo, Kevin Omondi/AAA-8860-2022	Otambo, Wilfred/0000-0003-3337-1206; Ochwedo, Kevin Omondi/0000-0002-4510-8344; Ochwedo, Kevin Omondi/0000-0002-4510-8344; Lee, Ming-Chieh/0000-0002-2462-6089; Wang, Xiaoming/0000-0003-1232-3125	National Institutes of Health [U19 AI129326, D43 TW001505]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the Nyakach Sub-County study participants for their participation in the study. We would like to express our gratitude to all of the field assistants, CHVs, and field and lab team members led by Charles Omboko, Polycarp Aduogo and Sally Mungoi who worked tirelessly to complete this project.	Agwu E, 2009, BRAZ J MICROBIOL, V40, P329, DOI [10.1590/S1517-83822009000200022, 10.1590/S1517-838220090002000022]; Ajayi IO, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.supp.2020.37.1.25738; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-241; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Cairns ME, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0839-4; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-40; County Government of Kisumu, 2018, KIS COUNT INT DEV PL; Dabaro D, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03641-1; Degefa T, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2098-z; Diiro GM, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1039-y; Essendi WM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2845-4; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hajison PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207207; Heuschen AK, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03872-2; Kamau A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2822-x; Khagayi S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2869-9; Kibret S, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0044-y; Kipruto EK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1848-2; Kleinschmidt I, 2018, LANCET INFECT DIS, V18, P640, DOI 10.1016/S1473-3099(18)30172-5; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Matsushita N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193693; Ministry of Health K, 2020, INT GUID MAN COVID 1; Monroe A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2638-9; Moshi IR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2550-8; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Mutero CM, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03464-6; National Malaria Control Programme, 2019, KEN MAL STRAT 2019 2; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndenga BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019473; Ng'ang'a PN, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11062-7; Nganga PN., 2019, MALARIA J, P1; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Ochwedo KO., 2021, MALARIA J, V20, P427; Orondo PW, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04833-z; Otambo WO, 2022, MALARIA J, V21, DOI 10.1186/s12936-022-04156-z; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2; Rek J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243303; Rovira-Vallbona E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005674; Selvaraj P, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3319-y; Shah MM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3547-z; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Smith JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180845; Soma DD, 2021, MALARIA J, V20, DOI 10.1186/s12936-020-03554-5; Stevenson JC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0944-4; Thomsen EK, 2017, J INFECT DIS, V215, P790, DOI 10.1093/infdis/jiw615; USAID, 2018, PRES MAL IN RWAND MA; Veron V, 2009, EXP PARASITOL, V121, P346, DOI 10.1016/j.exppara.2008.12.012; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; Wandiga SO, 2010, CLIMATIC CHANGE, V99, P473, DOI 10.1007/s10584-009-9670-7; Wanjala CL., 2010, MALARIA J, V9, P59; Weiss DJ, 2021, LANCET INFECT DIS, V21, P59, DOI 10.1016/S1473-3099(20)30700-3; WHO, 2019, GUID MAL VECT CONTR; World Health Organization,, 2020, TAIL MAL INT COVID 1; World Health Organization, 2013, WHO INFORMAL CONSULT; Zhao Y, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2398-y; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67; Zhou ZY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1482-4	59	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268463	10.1371/journal.pone.0268463	http://dx.doi.org/10.1371/journal.pone.0268463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576208	gold, Green Published			2022-12-26	WOS:000834668900004
J	Uddin, J; Ghazali, R; Abawajy, JH; Shah, HB; Husaini, NA; Zeb, A				Uddin, Jamal; Ghazali, Rozaida; Abawajy, Jemal H.; Shah, Habib; Husaini, Noor Aida; Zeb, Asim			Rough set based information theoretic approach for clustering uncertain categorical data	PLOS ONE			English	Article							CLASSIFICATION; ALGORITHM	MotivationMany real applications such as businesses and health generate large categorical datasets with uncertainty. A fundamental task is to efficiently discover hidden and non-trivial patterns from such large uncertain categorical datasets. Since the exact value of an attribute is often unknown in uncertain categorical datasets, conventional clustering analysis algorithms do not provide a suitable means for dealing with categorical data, uncertainty, and stability. Problem statementThe ability of decision making in the presence of vagueness and uncertainty in data can be handled using Rough Set Theory. Though, recent categorical clustering techniques based on Rough Set Theory help but they suffer from low accuracy, high computational complexity, and generalizability especially on data sets where they sometimes fail or hardly select their best clustering attribute. ObjectivesThe main objective of this research is to propose a new information theoretic based Rough Purity Approach (RPA). Another objective of this work is to handle the problems of traditional Rough Set Theory based categorical clustering techniques. Hence, the ultimate goal is to cluster uncertain categorical datasets efficiently in terms of the performance, generalizability and computational complexity. MethodsThe RPA takes into consideration information-theoretic attribute purity of the categorical-valued information systems. Several extensive experiments are conducted to evaluate the efficiency of RPA using a real Supplier Base Management (SBM) and six benchmark UCI datasets. The proposed RPA is also compared with several recent categorical data clustering techniques. ResultsThe experimental results show that RPA outperforms the baseline algorithms. The significant percentage improvement with respect to time (66.70%), iterations (83.13%), purity (10.53%), entropy (14%), and accuracy (12.15%) as well as Rough Accuracy of clusters show that RPA is suitable for practical usage. ConclusionWe conclude that as compared to other techniques, the attribute purity of categorical-valued information systems can better cluster the data. Hence, RPA technique can be recommended for large scale clustering in multiple domains and its performance can be enhanced for further research.	[Uddin, Jamal] Qurtuba Univ Sci & IT, Peshawar, Pakistan; [Ghazali, Rozaida] Univ Tun Hussien Onn Malaysia, Batu Pahat, Johor, Malaysia; [Abawajy, Jemal H.] Deakin Univ, Waurn Ponds Campus, Geelong, Australia; [Shah, Habib] King Khalid Univ, Asir, KSA, Saudi Arabia; [Husaini, Noor Aida] Tunku Abdul Rahman Univ Coll, Kuala Lumpur, Malaysia; [Zeb, Asim] Abbottabad Univ Sci & Technol, Abbottabad, Pakistan	Deakin University; King Khalid University; Tunku Abdul Rahman University College (TAR UC)	Uddin, J (corresponding author), Qurtuba Univ Sci & IT, Peshawar, Pakistan.	jamuddin1983@qurtuba.edu.pk	Uddin, Jamal/E-9927-2015	Uddin, Jamal/0000-0001-5618-8469; Ghazali, Rozaida/0000-0003-0119-0873; Shah, Habib/0000-0003-2078-6285	King Khalid University of Saudi Arabia [R.G.P.1/365/42]	King Khalid University of Saudi Arabia	The authors would like to thank the King Khalid University of Saudi Arabia for supporting this research under grant number R.G.P.1/365/42.	Abawajy JH, 2013, COMPUT METH PROG BIO, V112, P720, DOI 10.1016/j.cmpb.2013.08.002; Abawajy J, 2016, IEEE J BIOMED HEALTH, V20, P408, DOI 10.1109/JBHI.2014.2363177; Abawajy JH, 2014, IEEE T EMERG TOP COM, V2, P352, DOI 10.1109/TETC.2014.2316510; Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P1; Aggarwal CC, 2009, IEEE T KNOWL DATA EN, V21, P609, DOI 10.1109/TKDE.2008.190; Agresti A, 2007, INTRO CATEGORICAL DA; Aldana-Bobadilla E, 2015, ENTROPY-SWITZ, V17, P151, DOI 10.3390/e17010151; Amigo E, 2009, INFORM RETRIEVAL, V12, P461, DOI 10.1007/s10791-008-9066-8; Anaraki JR, 2013, 2013 5TH CONFERENCE ON INFORMATION AND KNOWLEDGE TECHNOLOGY (IKT), P301, DOI 10.1109/IKT.2013.6620083; Anquetil N., 1999, Sixth Working Conference on Reverse Engineering (Cat. No.PR00303), P235, DOI 10.1109/WCRE.1999.806964; Astel A, 2007, WATER RES, V41, P4566, DOI 10.1016/j.watres.2007.06.030; Bean C, 2008, INT J AUTOM COMPUT, V5, P90, DOI 10.1007/s11633-008-0090-3; Beaubouef T, 1998, INFORM SCIENCES, V109, P185, DOI 10.1016/S0020-0255(98)00019-X; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Chen LF, 2016, TOURISM MANAGE, V53, P197, DOI 10.1016/j.tourman.2015.10.001; Cheung LSL, 2007, PROC IEEE MICR ELECT, P806; Chowdhury MU, 2020, IEEE T CLOUD COMPUT, V8, P473, DOI 10.1109/TCC.2016.2567389; Christopher D Manning PR., 2009, INTRO INFORM RETRIEV; Dalic I., 2020, DECIS MAKING, V3, P80; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dharmarajan A, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND COMPUTING RESEARCH (ICCIC), P703; Dua A, 2018, IEEE GLOB COMM CONF; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Feng HH, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCE AND COMPUTATIONAL INTELLIGENCE (CSCI), VOL 1, P380, DOI 10.1109/CSCI.2014.71; Figueiredo Filho D.B., 2014, APPL MATH-US, V5, P2408, DOI [https://doi.org/10.4236/am.2014.515232, DOI 10.4236/AM.2014.515232]; Ganti V., 1999, P 5 ACM SIGKDD INT C, P73; Gao Y, 2017, AGR SYST, V154, P157, DOI 10.1016/j.agsy.2017.03.013; Gibson D, 2000, VLDB J, V8, P222, DOI 10.1007/s007780050005; Gordon Hunter M, 2012, ADV INFORM KNOWLEDGE, P129; Guha S, 1999, PROC INT CONF DATA, P512, DOI 10.1109/ICDE.1999.754967; Gupta K., 2011, INT J COMPUTER ELECT, V3, P845, DOI [10.7763/IJCEE.2011.V3.430, DOI 10.7763/IJCEE.2011.V3.430]; HAIMOV S, 1989, IEEE T GEOSCI REMOTE, V27, P606, DOI 10.1109/TGRS.1989.35943; Hassanein W., 2013, INT J DATABASE THEOR, V6, P53, DOI [10.14257/ijdta.2013.6.5.06, DOI 10.14257/IJDTA.2013.6.5.06]; Herawan T., 2010, INT J DATABASE THEOR, V3, P179; Herawan T, 2010, KNOWL-BASED SYST, V23, P220, DOI 10.1016/j.knosys.2009.12.003; Huang A., 2008, P 6 NZ COMP SCI RES, V4, P49; Huang H, 2019, IEEE ACCESS, V7, P12386, DOI 10.1109/ACCESS.2019.2893063; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Ivo Duntsch, 2015, ROUGH SET CLUSTERING; Jia XY, 2016, KNOWL-BASED SYST, V91, P204, DOI 10.1016/j.knosys.2015.05.017; Jyoti, 2013, INT J ADV RES IT ENG, V2, P30; Kim DW, 2004, PATTERN RECOGN LETT, V25, P1263, DOI 10.1016/j.patrec.2004.04.004; Kumar Prakash, 2009, International Journal of Rapid Manufacturing, V1, P189, DOI 10.1504/IJRAPIDM.2009.029382; Leung Y, 2008, INT J APPROX REASON, V47, P233, DOI 10.1016/j.ijar.2007.05.001; Li GX, 2022, IEEE T SYST MAN CY-S, V52, P3391, DOI 10.1109/TSMC.2021.3068759; Lin KP, 2018, IEEE ACCESS, V6, P11953, DOI 10.1109/ACCESS.2018.2809456; Lin TY., 2005, IMPACT PURITY MEASUR, V9th ed; Maqbool O, 2007, IEEE T SOFTWARE ENG, V33, P759, DOI 10.1109/TSE.2007.70732; Marin J, 2013, IEEE I CONF COMP VIS, P2592, DOI 10.1109/ICCV.2013.322; MATHIEU RG, 1993, IEEE T ENG MANAGE, V40, P283, DOI 10.1109/17.233190; Mazlack LJ, 2000, COMPUTER APPLICATIONS IN INDUSTRY AND ENGINEERING, P1; Mohebi E, 2009, 2009 FIRST ASIAN CONFERENCE ON INTELLIGENT INFORMATION AND DATABASE SYSTEMS, P82, DOI 10.1109/ACIIDS.2009.79; Naseem R., 2010, Proceedings 2010 Second International Conference on Computational Intelligence, Modelling and Simulation (CIMSiM 2010), P111, DOI 10.1109/CIMSiM.2010.34; Thao NX, 2018, ADV INTELL SYST, V672, P834, DOI 10.1007/978-981-10-7512-4_82; Ogihara M, 2004, P 21 INT C MACHINE L; Pamuar D., 2020, OPER RES ENG SCI THE, V3, P54, DOI [10.31181/oresta2003049p, DOI 10.31181/ORESTA2003049P]; Pandey N, 2017, INNOV SYST SOFTW ENG, V13, P279, DOI 10.1007/s11334-017-0294-1; Park IK, 2015, INFORM SYST, V48, P279, DOI 10.1016/j.is.2014.05.012; Park IK, 2015, INFORM SYST, V48, P289, DOI 10.1016/j.is.2014.06.008; Parmar D, 2007, DATA KNOWL ENG, V63, P879, DOI 10.1016/j.datak.2007.05.005; Parmar D, 2010, INT J PROD RES, V48, P3803, DOI 10.1080/00207540902942891; Pawlak Z, 2007, INFORM SCIENCES, V177, P3, DOI 10.1016/j.ins.2006.06.003; Peters G, 2006, PATTERN RECOGN, V39, P1481, DOI 10.1016/j.patcog.2006.02.002; Rahman M., 2012, INT J NEW COMPUTER A, V1, P683; Ramani G., 2013, INT J ADV RES COMPUT, V2, P1163; Reddy HV, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P500, DOI 10.1109/ICACCI.2013.6637222; Rissino Silvia, 2009, Data Mining and Knowledge Discovery in Real Life Applications, P35; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Russell S, 2009, ARTIFICIAL INTELLIGE; Sachdeva S, 2014, DOCUMENT CLUSTERING, P11693; Shelly DR, 2016, J GEOPHYS RES-SOL EA, V121, P8622, DOI 10.1002/2016JB013437; Tan P., 2006, INTRO DATA MINING; Trabelsi A, 2017, LNCS, V10350; Tripathy B. K., 2017, International Journal of Intelligent Systems and Applications, V9, P25, DOI 10.5815/ijisa.2017.08.03; Tripathy BK, 2016, RES J PHARM BIOL CHE, V7, P2787; Tripathy B. K., 2011, 2011 IEEE Recent Advances in Intelligent Computational Systems (RAICS 2011), P867, DOI 10.1109/RAICS.2011.6069433; Tripathy BK., 2011, ADV APPL SCI RES, V2, P314; Tuma Michael N., 2009, BUSINESS QUEST; Uddin J, 2021, COMPUTING, V103, P2061, DOI 10.1007/s00607-021-00950-w; Uddin J, 2017, ARTIF INTELL REV, V47, P145, DOI 10.1007/s10462-016-9478-6; Uddin J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0164803; Usman Qamar, 2013, P IEEE INT C SYST MA; Valdivia Garcia H., 2014, P 11 WORKING C MININ, P72; Voges K. E., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P1138, DOI 10.1109/HICSS.2012.510; Wang WG, 2013, GLOB CONGRESS INTELL, P11, DOI 10.1109/GCIS.2013.7; Wei W, 2019, INFORM FUSION, V48, P107, DOI 10.1016/j.inffus.2018.08.007; Wong KP, 2002, IEEE T NUCL SCI, V49, P200, DOI 10.1109/TNS.2002.998752; Wu SH, 2004, IEEE T INF TECHNOL B, V8, P5, DOI 10.1109/TITB.2004.824724; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Yanto ITR, 2016, ENG APPL ARTIF INTEL, V53, P41, DOI 10.1016/j.engappai.2016.01.026; Yanto ITR, 2011, INTELL DATA ANAL, V15, P465, DOI 10.3233/IDA-2011-0478; Zhang LB, 2013, 2013 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY - WORKSHOPS (WI-IAT), VOL 3, P245, DOI 10.1109/WI-IAT.2013.190; Zhao Y., 2001, CRITERION FUNCTIONS	93	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0265190	http://dx.doi.org/10.1371/journal.pone.0265190			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559954	Green Published, gold			2022-12-26	WOS:000835326900010
J	Prather, ER; Gavrilin, MA; Wewers, MD				Prather, Evan R.; Gavrilin, Mikhail A.; Wewers, Mark D.			The central inflammasome adaptor protein ASC activates the inflammasome after transition from a soluble to an insoluble state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECK-LIKE PROTEIN; HUMAN MONOCYTES; CELL-DEATH; CASPASE-1; MECHANISM; APOPTOSIS; RELEASE; MACROPHAGES; FAMILY	Apoptosis-associated speck-like protein containing a caspase recruitment domain (CARD) (ASC) is a 22 kDa protein that functions as the central adaptor for inflammasome assembly. ASC forms insoluble specks in monocytes undergoing pyroptosis, and the polymerization of ASC provides a template of CARDs that leads to proximity-mediated autoactivation of caspase-1 in canonical inflammasomes. However, specks are insoluble protein complexes, and solubility is typically important for protein function. Therefore, we sought to define whether ASC specks comprise active inflammasome complexes or are simply the end stage of exhausted ASC polymers. Using a THP-1 cell-lysing model of caspase-1 activation that is ASC dependent, we compared caspase-1 activation induced by preassembled insoluble ASC specks and soluble monomeric forms of ASC. Unexpectedly, after controlling for the concentration dependence of ASC oligomerization, we found that only insoluble forms of ASC promoted caspase-1 autocatalysis. This link to insolubility was recapitulated with recombinant ASC. We show that purified recombinant ASC spontaneously precipitated and was functional, whereas the maltose-binding protein-ASC fusion to ASC (promoting enhanced solubility) was inactive until induced to insolubility by binding to amylose beads. This functional link to insolubility also held true for the Y146A mutation of the CARD of ASC, which avoids insolubility and caspase-1 activation. Thus, we conclude that the role of ASC insolubility in inflammasome function is inextricably linked to its pyrin domain-mediated and CARD-mediated polymerizations. These findings will support future studies into the molecular mechanisms controlling ASC solubility.	[Prather, Evan R.; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA	Ohio State University	Gavrilin, MA (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA.	Mikhail.A.Gavrilin@gmail.com; Wewers.2@osu.edu			US National Institutes of Health [HL-076278]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by US National Institutes of Health grant (grant no.: HL-076278; to M. D. W.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Carty M, 2019, IMMUNITY, V50, P1412, DOI 10.1016/j.immuni.2019.04.005; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Compan V, 2015, J IMMUNOL, V194, P1261, DOI 10.4049/jimmunol.1301676; Conos SA, 2016, CELL DEATH DIFFER, V23, P1827, DOI 10.1038/cdd.2016.69; Diamond CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07081-3; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gavrilin MA, 2021, J IMMUNOL, V206, P1329, DOI 10.4049/jimmunol.2000969; Gavrilin MA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00461; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Nagar A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.752482; Nambayan RJT, 2019, J BIOL CHEM, V294, P439, DOI 10.1074/jbc.RA118.004407; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shamaa OR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142203; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Wewers MD, 1997, J IMMUNOL, V159, P5964; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	36	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102024	10.1016/j.jbc.2022.102024	http://dx.doi.org/10.1016/j.jbc.2022.102024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35568196	Green Published, gold			2022-12-26	WOS:000829588600002
J	Tian, Y; Sun, P; Liu, WX; Shan, LY; Hu, YT; Fan, HT; Shen, W; Liu, YB; Zhou, Y; Zhang, T				Tian, Yu; Sun, Peng; Liu, Wen-Xiang; Shan, Li-Ying; Hu, Yan-Ting; Fan, Hai-Tao; Shen, Wei; Liu, Yong-bin; Zhou, Yang; Zhang, Teng			Single-cell RNA sequencing of the Mongolia sheep testis reveals a conserved and divergent transcriptome landscape of mammalian spermatogenesis	FASEB JOURNAL			English	Article						developmental trajectories; mongolia Sheep; spermatogenesis; single-cell transcriptome	SPERMATOGONIAL STEM-CELLS; SEMINIFEROUS EPITHELIUM; CYCLE; EXPRESSION; DELETION; PATHWAY; COMPLEX; TEX101; ATLAS; MICE	Spermatogenesis is a highly coordinated and complex process, and is pivotal for transmitting genetic information between mammalian generations. In this study, we investigated the conservation, differences, and biological functions of homologous genes during spermatogenesis in Mongolia sheep, humans, cynomolgus monkey, and mice using single-cell RNA sequencing technology. We compared X chromosome meiotic inactivation events in Mongolia sheep, humans, cynomolgus monkey, and mice to uncover the concerted activity of X chromosome genes. Subsequently, we focused on the dynamics of gene expression, key biological functions, and signaling pathways at various stages of spermatogenesis in Mongolia sheep and humans. Additionally, the ligand-receptor networks of Mongolia sheep and humans in testicular somatic and germ cells at different developmental stages were mapped to reveal conserved germ cell-soma communication using single-cell resolution. These datasets provided novel information and insights to unravel the molecular regulatory mechanisms of Mongolia sheep spermatogenesis and highlight conservation in gene expression during spermatogenesis between Mongolia sheep and humans, providing a foundation for the establishment of a large mammalian disease model of male infertility.	[Tian, Yu; Sun, Peng; Liu, Wen-Xiang; Shan, Li-Ying; Hu, Yan-Ting; Fan, Hai-Tao; Liu, Yong-bin; Zhou, Yang; Zhang, Teng] Inner Mongolia Univ, Coll Life Sci, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot 010010, Peoples R China; [Sun, Peng] Inner Mongolia Med Univ, Coll Basic Med, Lab Microbiol & Immunol, Hohhot, Peoples R China; [Shen, Wei] Qingdao Agr Univ, Coll Life Sci, Inst Reprod Sci, Qingdao, Peoples R China; [Liu, Yong-bin] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia Medical University; Qingdao Agricultural University	Zhou, Y; Zhang, T (corresponding author), Inner Mongolia Univ, Coll Life Sci, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot 010010, Peoples R China.	zhouyang106@126.com; zhangteng428@163.com			National Natural Science Foundation of China [32000582, 31900595]; Science and Technology Major Project of Inner Mongolia Autonomous Region of China; State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock [2019ZD031, 2021ZD0048]; Major science and technology projects of Inner Mongolia [2020ZD0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project of Inner Mongolia Autonomous Region of China; State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock; Major science and technology projects of Inner Mongolia	This study was supported by the National Natural Science Foundation of China (32000582 to TZ; 31900595 to YZ), the Science and Technology Major Project of Inner Mongolia Autonomous Region of China to the State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock (2019ZD031 to TZ and 2021ZD0048 to YZ), the Major science and technology projects of Inner Mongolia (2020ZD0003 to YL)	Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655; Banin E, 2015, MOL THER, V23, P1423, DOI 10.1038/mt.2015.114; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Deng XX, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.557341; Ernst C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09182-1; Fainberg J., 2019, F1000RES, V8, P1; Fayomi AP, 2018, STEM CELL RES, V29, P207, DOI 10.1016/j.scr.2018.04.009; Franca LR, 1998, BIOL REPROD, V59, P1371, DOI 10.1095/biolreprod59.6.1371; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Guan YJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3385-8; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hochereau-de Reviers M T, 1987, J Reprod Fertil Suppl, V34, P101; Huang SS, 2017, ASIAN J ANDROL, V19, P619, DOI 10.4103/1008-682X.194420; Jia WY, 2017, LIFE SCI, V186, P1, DOI 10.1016/j.lfs.2017.07.025; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Lau XZ, 2020, DEV CELL, V54, P548, DOI 10.1016/j.devcel.2020.07.018; Li SY, 2017, MOL CELL, V68, P605, DOI 10.1016/j.molcel.2017.10.009; Liu ZS, 2019, NAT IMMUNOL, V20, P18, DOI 10.1038/s41590-018-0262-4; March MR, 2002, CONTRACEPTION, V65, P279, DOI 10.1016/S0010-7824(02)00296-2; Marshall GR, 1996, BIOL REPROD, V54, P1192, DOI 10.1095/biolreprod54.6.1192; Martianov I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32069; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Morton JD, 2013, INVEST OPHTH VIS SCI, V54, P389, DOI 10.1167/iovs.12-11088; Nayernia K, 2002, MOL CELL BIOL, V22, P3046, DOI 10.1128/MCB.22.9.3046-3052.2002; Nixon B, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00319; Olofsson SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121300; PANIAGUA R, 1987, ANAT EMBRYOL, V176, P225, DOI 10.1007/BF00310055; Pinnapureddy AR, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0327-5; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rolland AD, 2013, HUM REPROD, V28, P199, DOI 10.1093/humrep/des360; Sethi G, 2015, MOL CARCINOGEN, V54, P1772, DOI 10.1002/mc.22249; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; Staub C, 2018, ANIMAL, V12, pS27, DOI [10.1017/S1751731118000435, 10.1017/s1751731118000435]; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Wang X, 2020, ADV CLIN CHEM, V98, P51, DOI 10.1016/bs.acc.2020.02.003; Wang YT, 2012, J BIOL CHEM, V287, P34626, DOI 10.1074/jbc.M112.390401; Wood AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6467; WROBEL KH, 1995, ANN ANAT, V177, P19, DOI 10.1016/S0940-9602(11)80126-3; Wu Y, 2022, CURR ISSUES MOL BIOL, V44, P483, DOI 10.3390/cimb44020033; YANG H, 2021, FASEB J OFFICIAL PUB, V0035; Yu XW, 2021, ZOOL RES, V42, P401, DOI 10.24272/j.issn.2095-8137.2020.373; Zhang T, 2022, GUT, V71, P78, DOI 10.1136/gutjnl-2020-323347; Zhang T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006293; Zheng X, 2018, BIOCHEM BIOPH RES CO, V503, P572, DOI 10.1016/j.bbrc.2018.06.011; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003; Zhu FX, 2016, AM J HUM GENET, V99, P942, DOI 10.1016/j.ajhg.2016.08.004	60	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22348	10.1096/fj.202200152R	http://dx.doi.org/10.1096/fj.202200152R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1I2NA	35583907				2022-12-26	WOS:000797069600001
J	van Tienoven, TP; Glorieux, A; Minnen, J; Te Braak, P; Spruyt, B				van Tienoven, Theun Pieter; Glorieux, Anais; Minnen, Joeri; Te Braak, Petrus; Spruyt, Bram			Graduate students locked down? PhD students' satisfaction with supervision during the first and second COVID-19 lockdown in Belgium	PLOS ONE			English	Article							MOTIVATIONS; EXPERIENCES	Background Supervisor support is crucial for the successful and timely completion of the PhD and the largest contributor to PhD students' overall job satisfaction. The COVID-19 pandemic affected PhD students' life substantially through delayed experiments, missed timelines, running out of funding, change to online team- and supervisor meetings, mandatory working from home, and social confinement. Aim This contribution considers PhD students' satisfaction scores to reflect the extent to which PhD students felt supported by their supervisor during the COVID-19 pandemic so far and aims to investigate to what extent did PhD students' satisfaction with supervisor support changed over time. Method It uses two longitudinal two cohorts of wave 4 to 5 of the PhD Survey at a Belgian university. These cohorts are representative of two different ways the COVID-19 pandemic might have impacted doctoral research. Cohort 1 (n = 345) includes a pre-COVID measurement (April-May 2019) and a measurement immediately after the start of the abrupt lockdown in AprilMay 2020. Cohort 2 (n = 349) includes the measurement at the onset of the pandemic in 2020 and after a year with continuously changing containment policies (April-May 2021). The composite measure of satisfaction with supervisor support is based on six items with high internal consistency. Results No significant net effect of time was revealed. Instead within subject interactions with time showed that in cohort 1, PhD students at the start of their PhD trajectory and PhD students with family responsibilities reported lower supervisor satisfaction scores over time. In cohort 2, PhD students not pursuing academic careers reported lower satisfaction scores over time. Conclusion In times of crises, special attention needs to be paid to PhD students who are extra susceptible to uncertainties because of their junior status or personal situation, and especially those PhD students for whom doctoral research is not a trajectory to position themselves in academia.	[van Tienoven, Theun Pieter; Glorieux, Anais; Minnen, Joeri; Te Braak, Petrus; Spruyt, Bram] Vrije Univ Brussel, Sociol Dept, Res Grp TOR, Brussels, Belgium	Vrije Universiteit Brussel	van Tienoven, TP (corresponding author), Vrije Univ Brussel, Sociol Dept, Res Grp TOR, Brussels, Belgium.	t.p.van.tienoven@vub.be		Glorieux, Anais/0000-0002-8127-792X; van Tienoven, Theun Pieter/0000-0003-1532-254X; te Braak, Petrus/0000-0002-6534-6593; Spruyt, Bram/0000-0003-0573-724X				Akerlind G, 2017, STUD HIGH EDUC, V42, P1686, DOI 10.1080/03075079.2015.1118031; Zuniga-Gonzalez CA, 2021, REV ELECTRON CALID E, V12, P279, DOI 10.22458/caes.v12i2.3730; [Anonymous], 2002, HIGH EDUC RES DEV, V21, P41, DOI [10.1080/07294360220124648, DOI 10.1080/07294360220124648]; Aydemir D, 2020, BIOCHEM MOL BIOL EDU, V48, P428, DOI 10.1002/bmb.21351; Bedggood RE, 2012, STUD HIGH EDUC, V37, P825, DOI 10.1080/03075079.2010.549221; Borgeson E, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02727-3; Chan C, 2020, BRAIN BEHAV IMMUN, V88, P956, DOI 10.1016/j.bbi.2020.05.039; Cheng C, 2020, MOL PLANT, V13, P1229, DOI 10.1016/j.molp.2020.07.018; Craig L, 2021, FEM ECON, V27, P310, DOI 10.1080/13545701.2020.1831039; Dericks G, 2019, ASSESS EVAL HIGH EDU, V44, P1053, DOI 10.1080/02602938.2019.1570484; Donohue W.J., 2021, INT J DOCTORAL STUD, V16, P533, DOI [https://doi.org/10.28945/4818, DOI 10.28945/4818]; Elias S, 2021, CELL STEM CELL, V28, P802, DOI 10.1016/j.stem.2021.04.016; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Evans TM, 2018, NAT BIOTECHNOL, V36, P282, DOI 10.1038/nbt.4089; Glorieux A, 2021, DOING PHD RES COVID; Glorieux A, 2019, PHD SURVEY VUB 2019; Glorieux A, 2021, PHD SURVEY VUB 2021; Glorieux A, 2020, PHD SURVEY VUB 2020; Goldstone R, 2022, EDUC REV, V74, P422, DOI 10.1080/00131911.2021.1974348; Gunnarsson R, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-134; Haas N, 2022, J EXP POLIT SCI, V9, P1, DOI 10.1017/XPS.2020.34; Heidari E, 2021, J COMPUT ASSIST LEAR, V37, P1154, DOI 10.1111/jcal.12553; Hockey J, 1994, CAMB J EDUC, V24, P293, DOI DOI 10.1080/0305764940240211; Johnson R., 2020, RES SQUARE, DOI [10.21203/RS.3.RS-36330/V2, DOI 10.21203/RS.3.RS-36330/V2, 10.21203/rs.3.rs-36330/v2]; Lee A, 2008, STUD HIGH EDUC, V33, P267, DOI 10.1080/03075070802049202; Manzo LKC, 2020, DIALOGUES HUM GEOGR, V10, P120, DOI 10.1177/2043820620934268; McCallin A, 2012, TEACH HIGH EDUC, V17, P63, DOI 10.1080/13562517.2011.590979; Minello A, 2021, EUR SOC, V23, pS82, DOI 10.1080/14616696.2020.1809690; MOTUS, MOTUS RES PLATF 2016; Naylor R, 2016, ISS EDUC RES, V26, P351; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Omar HA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132313055; Paucsik M, 2022, STRESS HEALTH, V38, P891, DOI 10.1002/smi.3142; Paula JR, 2020, NAT ECOL EVOL, V4, P999, DOI 10.1038/s41559-020-1231-5; Pilbeam C, 2013, STUD HIGH EDUC, V38, P1472, DOI 10.1080/03075079.2011.636800; Shah Divyang, 2009, Indian J Occup Environ Med, V13, P77, DOI 10.4103/0019-5278.55123; Skakni I, 2018, STUD GRAD POSTDR EDU, V9, P197, DOI 10.1108/SGPE-D-18-00004; Stecker T, 2004, MED EDUC, V38, P465, DOI 10.1046/j.1365-2929.2004.01812.x; Suart C, 2021, FACETS, V6, P966, DOI 10.1139/facets-2020-0077; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Taylor RT, 2018, STUD HIGH EDUC, V43, P854, DOI 10.1080/03075079.2018.1438104; Ulku-Steiner B, 2000, J EDUC PSYCHOL, V92, P296, DOI 10.1037//0022-0663.92.2.296; van Rooij E, 2021, STUD CONTIN EDUC, V43, P48, DOI 10.1080/0158037X.2019.1652158; Varadarajan J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256687; Viglione G, 2020, NATURE, V581, P365, DOI 10.1038/d41586-020-01294-9; Zhao CM, 2007, J FURTH HIGH EDUC, V31, P263, DOI 10.1080/03098770701424983	46	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2022	17	5							e0268923	10.1371/journal.pone.0268923	http://dx.doi.org/10.1371/journal.pone.0268923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4W6TS	35605012	gold, Green Published			2022-12-26	WOS:000860293300001
J	ten Brink, DC; Martin-Hughes, R; Minnery, ME; Osborne, AJ; Schmidt, HMA; Dalal, S; Green, KE; Ramaurtarsing, R; Wilson, DP; Kelly, SL				ten Brink, Debra C.; Martin-Hughes, Rowan; Minnery, Mark E.; Osborne, Aaron J.; Schmidt, Heather-Marie A.; Dalal, Shona; Green, Kimberly E.; Ramaurtarsing, Reshmie; Wilson, David P.; Kelly, Sherrie L.			Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study	PLOS ONE			English	Article							PROGRAM; PREP; RISK	IntroductionMore than 70% of new HIV infections in Asia occurred in eight countries in 2020: Cambodia, China, India, Indonesia, Myanmar, Nepal, Thailand, and Vietnam-with a rising incidence among men who have sex with men (MSM). The World Health Organization (WHO) recommends pre-exposure prophylaxis (PrEP) for those at risk of acquiring HIV, yet wide-scale implementation of PrEP, on a daily or event-driven basis, has been limited in Asia. MethodsThe Optima HIV model was applied to examine the impact of scaling-up PrEP over five-years to cover an additional 15% of MSM compared with baseline coverage, a target deemed feasible by regional experts. Based on behavioral survey data, we assume that covering 15% of higher-risk MSM will cover 30% of all sexual acts in this group. Scenarios to compare the impact of generic-brand daily dosing of PrEP with generic event-driven dosing (15 days a month) were modelled from the start of 2022 to the end of 2026. Cost-effectiveness of generic versus branded PrEP was also assessed for China, the only country with an active patent for branded, higher cost PrEP. The impact on new HIV infections among the entire population and cost per HIV-related disability-adjusted life year (DALY) averted were estimated from the beginning of 2022 to the end of 2031 and from 2022 to 2051. ResultsIf PrEP were scaled-up to cover an additional 15% of MSM engaging in higher-risk behavior from the beginning of 2022 to the end of 2026 in the eight Asian countries considered, an additional 100,000 (66,000-130,000) HIV infections (17%) and 300,000 (198,000-390,000) HIV-related DALYs (3%) could be averted over the 2022 to 2031 period. The estimated cost per HIV-related DALY averted from 2022 to 2031 ranged from US$600 for event-driven generic PrEP in Indonesia to US$34,400 for daily branded PrEP in Thailand. Over a longer timeframe from 2022 to 2051, the cost per HIV-related DALY averted could be reduced to US$100-US$12,700. ConclusionPrEP is a critical tool to further reduce HIV incidence in highly concentrated epidemics. Implementing PrEP in Asia may be cost-effective in settings with increasing HIV prevalence among MSM and if PrEP drug costs can be reduced, PrEP could be more cost-effective over longer timeframes.	[ten Brink, Debra C.; Martin-Hughes, Rowan; Minnery, Mark E.; Osborne, Aaron J.; Wilson, David P.; Kelly, Sherrie L.] Burnet Inst, Melbourne, Vic, Australia; [Schmidt, Heather-Marie A.] United Nations Programme HIV AIDS, Reg Off Asia & Pacific, Bangkok, Thailand; [Schmidt, Heather-Marie A.; Dalal, Shona] WHO, Geneva, Switzerland; [Green, Kimberly E.] PATH, Hanoi, Vietnam; [Ramaurtarsing, Reshmie] Inst HIV Res & Innovat, Bangkok, Thailand; [Wilson, David P.] Monash Univ, Melbourne, Vic, Australia; [Wilson, David P.] Bill & Melinda Gates Fdn, Seattle, WA USA	Burnet Institute; World Health Organization; Monash University; Bill & Melinda Gates Foundation	ten Brink, DC (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	debra.tenbrink@burnet.edu.au		ten Brink, Debra/0000-0001-5938-6970				Access Campaign MSF, 2016, UNT WEB ANT PRIC RED; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Duong AT, 2014, JAIDS-J ACQ IMM DEF, V65, pE1, DOI 10.1097/QAI.0b013e3182a17d15; [Anonymous], 2017, Lancet, V390, pe38, DOI [10.1016/S0140-6736(17)32645-4, 10.1016/S0140-6736(17)32650-8, 10.1016/S0140-6736(17)32648-X, 10.1016/S0140-6736(17)32646-6, 10.1016/S0140-6736(17)32647-8, 10.1016/S0140-6736(17)32649-1]; [Anonymous], MULTICENTER REAL WOR; [Anonymous], 2020, VIIV HEALTHCARE ANNO; [Anonymous], 2018, APPROPRIATE MED OPTI; AVAC, 2019, GLOB PREP WATCH; Baral S, 2018, JMIR PUBLIC HLTH SUR, V4, P289, DOI 10.2196/publichealth.9321; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Cao WN, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08488-w; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Draper BL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21885; Durand-Zaleski I, 2018, AIDS, V32, P95, DOI [10.1097/QAD.0000000000001658, 10.1097/qad.0000000000001658]; Gannon S, 2018, PREP KEY POPULATIONS; Global Burden of Disease Collaborators, 2017, GLOBAL BURDEN DIS ST; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Hoornenborg E, 2017, AIDS, V31, P2179, DOI 10.1097/QAD.0000000000001627; Janamnuaysook R, 2021, SEX HEALTH, V18, P13, DOI 10.1071/SH20172; Kazemian P, 2020, CLIN INFECT DIS, V70, P633, DOI 10.1093/cid/ciz249; Kazibwe J., 2021, VALUE HEALTH; Kelly SL, 2018, LANCET HIV, V5, pE190, DOI 10.1016/S2352-3018(18)30024-9; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Korenromp EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170773; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Lau JYC, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25531; Li JH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3516-8; Luehring-Jones P, 2019, AIDS EDUC PREV, V31, P452, DOI 10.1521/aeap.2019.31.5.452; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Ministry of Health NCfHA Dermatology and STD., 2019, CONC NOT HIV PREEXP; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina J-M., INCIDENCE HIV INFECT; MOPE, 2017, SYNTH STOCKT REP NAT; National AIDS Control Organisation I-NIoMS, 2020, IND HIV EST 2019 REP; National Health Commission of the People's Republic of China, 2015, REP CHIN RES CHRON D; National team Cambodia U Optima Consortium for Decision Science, 2020, END AIDS EP CAMB; Ochalek J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000964; Phanuphak N, 2018, SEX HEALTH, V15, P542, DOI 10.1071/SH18065; Phillips AN, 2022, LANCET HIV, V9, pE353, DOI 10.1016/S2352-3018(22)00029-7; Siregar AYM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1098-3; Suraratdecha C, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25129; The World Bank Group, 2021, GDP CAP CURR US; Thin K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216774; UNAIDS, 2020, WORLD AIDS DAY REP; UNAIDS, 2018, GLOB AIDS UPD 2018 M; UNAIDS, 2021, UNAIDS DAT 2021 REF; UNAIDS, 2010, GLOB REP UNAIDS REP; van de Vijver DAMC, 2019, EUROSURVEILLANCE, V24, P30, DOI 10.2807/1560-7917.ES.2019.24.7.1800398; Son VH, 2019, JMIR PUBLIC HLTH SUR, V5, P276, DOI 10.2196/12451; Vu BN., 2018, SCALING PREP COMMUNI; WHO, GLOB PRIC REP MECH; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2020, PREEXP PROPH SERV TH; World Health Organization, 2019, EB1442019REC1 WHO; World Health Organization, COUNTR SPEC INP OUTP; Zhang L, 2019, AIDS BEHAV, V23, P523, DOI 10.1007/s10461-018-2205-3	60	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268240	http://dx.doi.org/10.1371/journal.pone.0268240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617169	Green Published, gold			2022-12-26	WOS:000835048800003
J	Wei, TH; Ye, BW; Wu, PS; Li, CP; Chao, Y; Lee, PC; Huang, YH; Lee, KC; Hou, MC				Wei, Tien-Hsin; Ye, Bing-Wei; Wu, Pei-Shan; Li, Chung-Pin; Chao, Yee; Lee, Pei-Chang; Huang, Yi-Hsiang; Lee, Kuei-Chuan; Hou, Ming-Chih			Outcomes of patients with malignant duodenal obstruction after receiving self-expandable metallic stents: A single center experience	PLOS ONE			English	Article							GASTRIC OUTLET OBSTRUCTION; PALLIATIVE TREATMENT; PANCREATIC-CANCER; PLACEMENT; GASTROJEJUNOSTOMY; MANAGEMENT; SURVIVAL	ObjectivesSelf-expandable metallic stent (SEMS) placement is a safe and effective palliative treatment for malignant gastric outlet obstruction; however, the clinical outcomes of gastric and duodenal stenoses may differ. This study aimed to investigate the clinical efficacy of SEMS placement and the predictors of clinical outcomes, specifically in malignant duodenal obstruction (MDO). MethodsBetween September 2009 and March 2021, 79 patients with MDO who received SEMS placement in our hospital were retrospectively enrolled. Patients were divided into three groups according to the obstruction levels: above-papilla group (type 1), papilla involved group (type 2), and below-papilla group (type 3). The clinical outcomes and predictors of survival and restenosis were analyzed. ResultsThe technical and clinical success rates were 97.5% and 80.5%, respectively. Among patients who had successful stent placement, stent restenosis occurred in 17 patients (22.1%). The overall median stent patency time was 103 days. The overall median survival time after stent placement was 116 days. There was no difference in the stent patency, or stent dysfunction and procedure-related adverse events among the three groups. A longer length of duodenal stenosis >= 4 cm was associated with poor prognosis (hazard ratio [HR] = 1.92, 95% confidence interval [CI] = 1.06-3.49, p = 0.032) and post-stent chemotherapy was associated with lower mortality (HR = 0.33; 95% CI = 0.17-0.63, p = 0.001). ConclusionSEMS is a safe and effective treatment for MDO. Chemotherapy after SEMS implantation improve the survival for these patients and a longer length of stenosis predicts higher mortality.	[Wei, Tien-Hsin] Taipei Municipal Gandau Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Wei, Tien-Hsin; Ye, Bing-Wei; Wu, Pei-Shan; Li, Chung-Pin; Chao, Yee; Lee, Pei-Chang; Huang, Yi-Hsiang; Lee, Kuei-Chuan; Hou, Ming-Chih] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Med, Taipei, Taiwan; [Ye, Bing-Wei] Taiwan Adventist Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Pei-Shan; Li, Chung-Pin; Lee, Pei-Chang; Huang, Yi-Hsiang; Lee, Kuei-Chuan; Hou, Ming-Chih] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Wu, Pei-Shan; Hou, Ming-Chih] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med Educ, Div Clin Skills Training, Taipei, Taiwan; [Chao, Yee] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wu, PS; Lee, KC (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Med, Taipei, Taiwan.; Wu, PS; Lee, KC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Wu, PS (corresponding author), Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan.	kclee2@vghtpe.gov.tw; pswu6@vghtpe.gov.tw			Taipei Veterans General Hospital [V110A-001, V110C-143]; Ministry of Science and Technology [MOST 110-2628-B-075 -016]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors gratefully acknowledge Mr. Dong-Ming Liao for his excellent technical assistance.	Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Boskoski I, 2010, ADV THER, V27, P691, DOI 10.1007/s12325-010-0061-2; Chang KB, 2020, J FORMOS MED ASSOC, V119, P238, DOI 10.1016/j.jfma.2019.05.002; Chiang NJ, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010097; Chiu KWH, 2015, EUR J GASTROEN HEPAT, V27, P1466, DOI 10.1097/MEG.0000000000000479; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Del Piano M, 2005, GASTROINTEST ENDOSC, V61, P421, DOI 10.1016/S0016-5107(04)02757-9; Ding NS, 2013, J ONCOL, V2013, DOI 10.1155/2013/167851; Dormann A, 2004, ENDOSCOPY, V36, P543, DOI 10.1055/s-2004-814434; Espinel J, 2006, SURG ENDOSC, V20, P1083, DOI 10.1007/s00464-005-0354-8; Espinel J, 2001, DIGEST DIS SCI, V46, P2322, DOI 10.1023/A:1012378509762; Hosono S, 2007, J GASTROENTEROL, V42, P283, DOI 10.1007/s00535-006-2003-y; Jeurnink SM, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-18; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Kaw M, 2003, SURG ENDOSC, V17, P646, DOI 10.1007/s00464-002-8527-1; Kim JH, 2007, GASTROINTEST ENDOSC, V66, P256, DOI 10.1016/j.gie.2006.12.017; Lillemoe KD, 1999, ANN SURG, V230, P322, DOI 10.1097/00000658-199909000-00005; Lopera JE, 2004, RADIOGRAPHICS, V24, P1561, DOI 10.1148/rg.246045033; Ly J, 2010, SURG ENDOSC, V24, P290, DOI 10.1007/s00464-009-0577-1; Mutignani M, 2007, ENDOSCOPY, V39, P440, DOI 10.1055/s-2007-966327; Oh SY, 2015, GASTROINTEST ENDOSC, V82, P460, DOI 10.1016/j.gie.2015.01.026; Piesman M, 2009, AM J GASTROENTEROL, V104, P2404, DOI 10.1038/ajg.2009.409; Roy A, 2012, SURG ENDOSC, V26, P3114, DOI 10.1007/s00464-012-2301-9; Salati M, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000206; Shah A, 2014, DIGEST DIS SCI, V59, P2294, DOI 10.1007/s10620-014-3170-y; Shitara K, 2020, JAMA ONCOL, V6, P1571, DOI 10.1001/jamaoncol.2020.3370; Tringali A, 2014, GASTROINTEST ENDOSC, V79, P66, DOI 10.1016/j.gie.2013.06.032; van Halsema EE, 2015, WORLD J GASTROENTERO, V21, P12468, DOI 10.3748/wjg.v21.i43.12468; van Heek NT, 2002, ACTA GASTRO-ENT BELG, V65, P171; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Wu CH, 2020, CANCER MANAG RES, V12, P10261, DOI 10.2147/CMAR.S273084; Ye BW, 2021, J CHIN MED ASSOC, V84, P346, DOI 10.1097/JCMA.0000000000000502; Ye BW, 2017, DIGEST DIS SCI, V62, P1286, DOI 10.1007/s10620-017-4534-x; Zou K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2772-5	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268920	10.1371/journal.pone.0268920	http://dx.doi.org/10.1371/journal.pone.0268920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3LQ	35613143	gold, Green Published			2022-12-26	WOS:000834666000011
J	Sweeney, P; Galliford, A; Kumar, A; Raju, D; Krishna, NB; Sutherland, E; Leo, CJ; Fisher, G; Lalitha, R; Muthuraj, L; Sigamani, G; Oehler, V; Synowsky, S; Shirran, SL; Gloster, TM; Czekster, CM; Kumar, P; Silva, RGD				Sweeney, Pamela; Galliford, Ashleigh; Kumar, Abhishek; Raju, Dinesh; Krishna, Naveen B.; Sutherland, Emmajay; Leo, Caitlin J.; Fisher, Gemma; Lalitha, Roopa; Muthuraj, Likith; Sigamani, Gladstone; Oehler, Verena; Synowsky, Silvia; Shirran, Sally L.; Gloster, Tracey M.; Czekster, Clarissa M.; Kumar, Pravin; Silva, Rafael G. da			Structure, dynamics, and molecular inhibition of the Staphylococcus aureus m(1)A22-tRNA methyltransferase TrmK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; BACILLUS-SUBTILIS; PROTEIN; COMPLEX; GENE; METHYLATION; REFINEMENT; DISCOVERY; BINDING; SYSTEM	The enzyme m(1)A22-tRNA methyltransferase (TrmK) catalyzes the transfer of a methyl group to the N1 of adenine 22 in bacterial tRNAs. TrmK is essential for Staphylococcus aureus survival during infection but has no homolog in mammals, making it a promising target for antibiotic development. Here, we characterize the structure and function of S. aureus TrmK (SaTrmK) using X-ray crystallography, binding assays, and molecular dynamics simulations. We report crystal structures for the SaTrmK apoenzyme as well as in complexes with methyl donor SAM and co-product product SAH. Isothermal titration calorimetry showed that SAM binds to the enzyme with favorable but modest enthalpic and entropic contributions, whereas SAH binding leads to an entropic penalty compensated for by a large favorable enthalpic contribution. Molecular dynamics simulations point to specific motions of the C-terminal domain being altered by SAM binding, which might have implications for tRNA recruitment. In addition, activity assays for SaTrmK-catalyzed methylation of A22 mutants of tRNA(Leu) demonstrate that the adenine at position 22 is absolutely essential. In silico screening of compounds suggested the multifunctional organic toxin plumbagin as a potential inhibitor of TrmK, which was confirmed by activity measurements. Furthermore, LC-MS data indicated the protein was covalently modified by one equivalent of the inhibitor, and proteolytic digestion coupled with LC-MS identified Cys92 in the vicinity of the SAM-binding site as the sole residue modified. These results identify a cryptic binding pocket of SaTrmK, laying a foundation for future structure-based drug discovery.	[Sweeney, Pamela; Galliford, Ashleigh; Sutherland, Emmajay; Leo, Caitlin J.; Fisher, Gemma; Oehler, Verena; Synowsky, Silvia; Shirran, Sally L.; Gloster, Tracey M.; Czekster, Clarissa M.; Silva, Rafael G. da] Univ St Andrews, Sch Biol Biomed Sci Res Complex, St Andrews, Scotland?; [Kumar, Abhishek; Raju, Dinesh; Krishna, Naveen B.; Lalitha, Roopa; Muthuraj, Likith; Sigamani, Gladstone; Kumar, Pravin] Kcat Enzymat Pvt Ltd, Bangalore, India	University of St Andrews	Silva, RGD (corresponding author), Univ St Andrews, Sch Biol Biomed Sci Res Complex, St Andrews, Scotland?.; Kumar, P (corresponding author), Kcat Enzymat Pvt Ltd, Bangalore, India.	pravin.k@kcat.co.in; rgds@st-andrews.ac.uk	Melo Czekster, Clarissa/G-9458-2012	Melo Czekster, Clarissa/0000-0002-7163-4057; Ravindra Raju, Dinesh/0000-0003-0657-1560; Sutherland, Emmajay/0000-0001-5150-4346; Guimaraes da Silva, Rafael/0000-0002-1308-8190; Shirran, Sally/0000-0003-3516-3507; kumar, Abhishek/0000-0003-0678-3387	Wellcome Trust Seed Award in Science [204821/Z/16/Z]]; University of St Andrews/Scottish Funding Council St Andrews Restarting Research Fund; Wellcome Trust Institutional Strategic Support Fund [208980/Z/17/Z]; Cunningham Trust PhD studentship [PhD-CT-18-41];  [204821/Z/16/Z]	Wellcome Trust Seed Award in Science(Wellcome Trust); University of St Andrews/Scottish Funding Council St Andrews Restarting Research Fund; Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Cunningham Trust PhD studentship; 	This work was supported by a Wellcome Trust Seed Award in Science [208980/Z/17/Z] to R. G. d. S.; a University of St Andrews/Scottish Funding Council St Andrews Restarting Research Fund to R. G. d. S.; and a Wellcome Trust Institutional Strategic Support Fund [204821/Z/16/Z] to the University of St Andrews. E. S. is the recipient of a Cunningham Trust PhD studentship (PhD-CT-18-41) .	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adusumilli R, 2017, METHODS MOL BIOL, V1550, P339, DOI 10.1007/978-1-4939-6747-6_23; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Antoine L, 2019, BIOCHIMIE, V164, P60, DOI 10.1016/j.biochi.2019.07.003; Benoni R, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13091722; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Boundy S, 2013, J BIOL CHEM, V288, P132, DOI 10.1074/jbc.M112.385138; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Date SV, 2014, J INFECT DIS, V209, P1542, DOI 10.1093/infdis/jit668; Degut C, 2019, NUCLEIC ACIDS RES, V47, P4736, DOI 10.1093/nar/gkz230; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong GP, 2020, ACS COMB SCI, V22, P422, DOI 10.1021/acscombsci.0c00077; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher G, 2018, BIOCHEMISTRY-US, V57, P4357, DOI 10.1021/acs.biochem.8b00559; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; HOLMES WM, 1992, J BIOL CHEM, V267, P13440; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Jamal MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087309; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Lee JH, 2022, CELL CHEM BIOL, V29, P476, DOI 10.1016/j.chembiol.2021.08.014; Mader U, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005962; Maruo S, 2013, ORG LETT, V15, P1556, DOI 10.1021/ol400335s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENICHI B, 1980, BIOCHEM BIOPH RES CO, V95, P461, DOI 10.1016/0006-291X(80)90760-3; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nitulescu G, 2019, DRUG DEVELOP RES, V80, P1136, DOI 10.1002/ddr.21599; Oerum S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010020; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Oleinikovas V, 2016, J AM CHEM SOC, V138, P14257, DOI 10.1021/jacs.6b05425; Peacock SJ, 2015, ANNU REV BIOCHEM, V84, P577, DOI 10.1146/annurev-biochem-060614-034516; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rondeau G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20451-9; Roovers M, 2008, NUCLEIC ACIDS RES, V36, P3252, DOI 10.1093/nar/gkn169; Santiago M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1361-3; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Selberg S, 2019, CELL REP, V26, P3762, DOI 10.1016/j.celrep.2019.02.100; Sreelatha T, 2009, J AGR FOOD CHEM, V57, P6090, DOI 10.1021/jf901760h; Sun GY, 2007, THEOR CHEM ACC, V117, P323, DOI 10.1007/s00214-006-0154-9; Szafranska AK, 2014, MBIO, V5, DOI 10.1128/mBio.01775-14; Ta HM, 2010, PROTEIN SCI, V19, P617, DOI 10.1002/pro.319; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; Tuley A, 2018, BIOCHEMISTRY-US, V57, P3326, DOI 10.1021/acs.biochem.8b00315; Valentino MD, 2014, MBIO, V5, DOI 10.1128/mBio.01729-14; Van Laer B, 2016, NUCLEIC ACIDS RES, V44, P940, DOI 10.1093/nar/gkv1369; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yu D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100270; Zhong W, 2019, ACS INFECT DIS, V5, P326, DOI 10.1021/acsinfecdis.8b00275	63	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102040	10.1016/j.jbc.2022.102040	http://dx.doi.org/10.1016/j.jbc.2022.102040			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35595101	Green Published, gold			2022-12-26	WOS:000829588600012
J	Obregon, D; Pederson, G; Taylor, A; Poveda, K				Obregon, Diana; Pederson, Grace; Taylor, Alan; Poveda, Katja			The pest control and pollinator protection dilemma: The case of thiamethoxam prophylactic applications in squash crops	PLOS ONE			English	Article							BEE APIS-MELLIFERA; PEPONAPIS-PRUINOSA; YIELD; PESTICIDE; POLLEN; NEONICOTINOIDS; CHRYSOMELIDAE; CLOTHIANIDIN; COLEOPTERA; RESIDUES	A major challenge in sustainable agriculture is finding solutions to manage crop-damaging pests such as herbivores while protecting beneficial organisms such as pollinators. Squash is a highly pollinator-dependent crop that is also attractive to herbivores like the striped cucumber beetle. While synthetic insecticides can provide control of insect pests, they can also affect non-target organisms such as pollinators. Thus, growers need to balance pest management with pollinator protection to ensure optimal yield. Thiamethoxam is a commonly used systemic insecticide that translocates throughout plants, leaving residues in nectar and pollen. The aim of this study was to evaluate whether there are uses of this insecticide that provides efficient pest control while minimizing pesticide pollinator exposure. Specifically, we tested how different prophylactic application methods (seed treatments, in-furrow applications, and early foliar sprays) of commercially available thiamethoxam products impact pest control, bee visitation, yield, and pesticide residues in flowers of squash crops. We found that among the different methods of thiamethoxam application, in-furrow application best prevented defoliation and resulted in the highest fruit weight and number. However, it also produced the most frequent and highest concentrations of thiamethoxam in nectar and pollen, reaching lethal levels for squash bees. Our study provides evidence that under current application methods, thiamethoxam does not provide a sustainable solution for squash growers and further research is required on more efficient pesticide delivery methods, as well as non-pesticide pest control measurements.	[Obregon, Diana; Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY USA; [Pederson, Grace] Cornell Univ, Biol Sci, Ithaca, NY USA; [Taylor, Alan] Cornell Univ, Dept Hort, Cornell AgriTech, Geneva, NY USA	Cornell University; Cornell University; Cornell University	Obregon, D (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY USA.	do265@cornell.edu			Federal Capacity Fund multistate project from the National Institute of Food and Agriculture (NIFA), United States, Department of Agriculture [NYC-139848]; Fulbright-MINCIENCIAS (Colombian Minister of Science, Technology, and Innovation) from Colombia; Department of Entomology at Cornell University	Federal Capacity Fund multistate project from the National Institute of Food and Agriculture (NIFA), United States, Department of Agriculture; Fulbright-MINCIENCIAS (Colombian Minister of Science, Technology, and Innovation) from Colombia; Department of Entomology at Cornell University	This research was funded by a Federal Capacity Fund multistate project received from the National Institute of Food and Agriculture (NIFA), United States, Department of Agriculture in the form of funds to KP [no. NYC-139848] and by a Fulbright-MINCIENCIAS (Colombian Minister of Science, Technology, and Innovation) in the form of a doctorate scholarship from Colombia to DO.The Grace H. Griswold fund (2022), from the Department of Entomology at Cornell University, provided the funds for the publication fee of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal I, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10110526; Agency UEP, 2020, CLOTH THIAM PROP INT; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Allen J. K. M. I., 2001, Journal of Vegetable Crop Production, V7, P83, DOI 10.1300/J068v07n02_08; Anderson NL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40031-9; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bredeson MM, 2015, J ECON ENTOMOL, V108, P2665, DOI 10.1093/jee/tov249; Brochu KK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58274-2; Brzozowski L, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.28; Burnham K, 2002, BAYESIAN DATA ANAL E, V2; Catarino R, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1550; Chan DSW, 2021, ENVIRON ENTOMOL, V50, P968, DOI 10.1093/ee/nvab045; Chan DSW, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83341-7; Chan DSW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47805-1; Coco AM, 2020, ENVIRON ENTOMOL, V49, P1316, DOI 10.1093/ee/nvaa116; Cowles R.S., 2017, J ENVIRON HORTIC, V35, P24, DOI DOI 10.24266/0738-2898-35.1.24; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; De Mendiburu F., 2014, AGRICOLAE STAT PROCE, DOI DOI 10.2307/2287932; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Ellers-Kirk CD, 2000, J ECON ENTOMOL, V93, P605, DOI 10.1603/0022-0493-93.3.605; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Gierer F, 2019, ENVIRON POLLUT, V249, P236, DOI 10.1016/j.envpol.2019.03.025; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Grout T, 2020, NEONICOTINOID INSECT; Haber AI, 2021, J INTEGR PEST MANAG, V12, DOI 10.1093/jipm/pmaa026; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hladun KR, 2009, ECOL ENTOMOL, V34, P144, DOI 10.1111/j.1365-2311.2008.01060.x; Hoffmann MP, 1996, HORTSCIENCE, V31, P439, DOI 10.21273/HORTSCI.31.3.439; HURD P D JR, 1974, Smithsonian Contributions to Zoology, P1; HURD PD, 1971, EVOLUTION, V25, P218, DOI 10.1111/j.1558-5646.1971.tb01874.x; Jasinski J, 2009, J ECON ENTOMOL, V102, P2255, DOI 10.1603/029.102.0630; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Li Y, 2018, CHEMOSPHERE, V207, P708, DOI 10.1016/j.chemosphere.2018.05.139; Lundin O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2243; Menail AH, 2020, ENTOMOL GEN, V40, P207, DOI 10.1127/entomologia/2020/0796; Motzke I, 2015, J APPL ECOL, V52, P261, DOI 10.1111/1365-2664.12357; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Osborne J L, 2019, J POLLINAT ECOL, V25; Otani T, 2007, SOIL SCI PLANT NUTR, V53, P86, DOI 10.1111/j.1747-0765.2007.00102.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rojas ES, 2015, PLANT DIS, V99, P564, DOI 10.1094/PDIS-10-14-1068-FE; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sharma A, 2016, HDB CUCURBITS, P329, DOI [10.1201/b19233-36, DOI 10.1201/B19233-36]; Simon-Delso N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03467-5; Smyth RR, 2010, BIOCONTROL, V55, P219, DOI 10.1007/s10526-009-9232-y; Stanley DA, 2015, NATURE, V528, P548, DOI 10.1038/nature16167; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Sutter L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2529; Team RC, 2016, R LANG ENV STAT COMP; TEPEDINO VJ, 1981, J KANSAS ENTOMOL SOC, V54, P359; Ternest JJ, 2020, J ECON ENTOMOL, V113, P872, DOI 10.1093/jee/toz346; Thomson VP, 2003, OECOLOGIA, V134, P167, DOI 10.1007/s00442-002-1102-6; Wagner DL, 2020, ANNU REV ENTOMOL, V65, P457, DOI 10.1146/annurev-ento-011019-025151; Welch Kara, 2019, BEN NEON INS US CUC; Welty C, 2009, CUCUMBER BEETLE MANA; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	62	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2022	17	5							e0267984	10.1371/journal.pone.0267984	http://dx.doi.org/10.1371/journal.pone.0267984			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6B4DN	35594241	gold, Green Published			2022-12-26	WOS:000881285600001
J	Zhang, M; Liu, J; Yin, ZZ; Zhang, L				Zhang, Ming; Liu, Jun; Yin, Zhenzhen; Zhang, Li			Phylogenetic and protein prediction analysis reveals the taxonomically diverse distribution of virulence factors in Bacillus cereus strains	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; WEB SERVER; TOXIN; CLYA; NHE; COMPONENT; SHEA	Bacillus cereus is a food contaminant with widely varying enterotoxic potential due to its virulence proteins. In this article, phylogenetic analysis of the amino acid sequences from the whole-genomes of 41 strains, evolutionary distance calculation of the amino acid sequences of the virulence genes, and functional and structural predictions of the virulence proteins were performed to reveal the taxonomically diverse distribution of virulence factors. The genome evolution of the strains showed a clustering trend based on the protein-coding virulence genes. The strains of B. cereus have evolved into non-toxic risk and toxic risk clusters with medium-high- and medium-low-risk subclusters. The evolutionary transfer distances of incomplete virulence genes relative to housekeeping genes were greater than those of complete virulence genes, and the distance values of HblACD were higher than those of nheABC and CytK among the complete virulence genes. Cytoplasmic localization was impossible for all the virulence proteins, and NheB, NheC, Hbl-B, and Hbl-L1 were predicted to be extracellular. Nhe and Hbl proteins except CytK had similar spatial structures. The predicted structures of Nhe and Hbl mainly showed 'head' and 'tail' domains. The 'head' of NheA and Hbl-B, including two alpha-helices separated by beta-tongue strands, might play a special role in the formation of Nhe trimers and Hbl trimers, respectively. The 'cap' of CytK, which includes two 'latches' with many beta-sheets, formed a beta-barrel structure with pores, and a 'rim' balanced the structure. The evolution of B. cereus strains showed a clustering tendency based on the protein-coding virulence genes, and the complete virulence-gene operon combination had higher relative genetic stability. The beta-tongue or latch associated with beta-sheet folding might play an important role in the binding of virulence structures and pore-forming toxins in B. cereus.	[Zhang, Ming; Liu, Jun; Yin, Zhenzhen] Nanfang Coll, Sch Yunkang Med & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Li] Liaoning Univ, Sch Life Sci, Shenyang, Liaoning, Peoples R China	Nanfang College, Guangzhou; Liaoning University	Yin, ZZ (corresponding author), Nanfang Coll, Sch Yunkang Med & Hlth, Guangzhou, Guangdong, Peoples R China.; Zhang, L (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang, Liaoning, Peoples R China.	837949196@qq.com; fmtzhangli@qq.com	zhang, ming/GPT-2393-2022; zhang, ming/ACV-2348-2022	Yin, Zhenzhen/0000-0001-9865-7876	Doctor foundation project of nanfang college guangzhou [2020BQ23]; Science and technology projects in guangzhou (2022-1980)	Doctor foundation project of nanfang college guangzhou; Science and technology projects in guangzhou (2022-1980)	The authors received "Doctor foundation project of nanfang college guangzhou (2020BQ23)" and "Science and technology projects in guangzhou (2022-1980)" fundings for this work.	Antropova N, 2021, BIORXIV, DOI [10.1101/2021.10.04.463034, DOI 10.1101/2021.10.04.463034]; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baum BR., 1989, Q REV BIOL, V64, P539, DOI DOI 10.1086/416571; Bazinet AL, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1020-1; Bhunia AK, 2008, FOODBORNE MICROBIAL; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bohm ME, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0529-4; Cardazzo B, 2008, APPL ENVIRON MICROB, V74, P850, DOI 10.1128/AEM.01495-07; Carroll LM, 2020, MBIO, V11, DOI 10.1128/mBio.00034-20; Phung D, 2012, ACTA CRYSTALLOGR F, V68, P1073, DOI 10.1107/S1744309112030813; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Didier A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165135; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Dietrich R, 2021, TOXINS, V13, DOI 10.3390/toxins13020098; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Ganash M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074748; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Jessberger N, 2019, TOXINS, V11, DOI 10.3390/toxins11050281; Jessberger N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00560; Jessberger N, 2014, TOXICON, V77, P49, DOI 10.1016/j.toxicon.2013.10.028; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kone KM, 2019, J FOOD PROTECT, V82, P1210, DOI 10.4315/0362-028X.JFP-19-006; Kovac J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2883-z; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lapidus A, 2008, CHEM-BIOL INTERACT, V171, P236, DOI 10.1016/j.cbi.2007.03.003; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pD458, DOI 10.1093/nar/gkaa937; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Liu Y, 2017, INT J SYST EVOL MICR, V67, P2499, DOI 10.1099/ijsem.0.001821; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14082; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peabody MA, 2016, NUCLEIC ACIDS RES, V44, pD663, DOI 10.1093/nar/gkv1271; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phelps RJ, 2002, APPL ENVIRON MICROB, V68, P3147, DOI 10.1128/AEM.68.6.3147-3151.2002; Rajkovic A, 2020, COMPR REV FOOD SCI F, V19, P1605, DOI 10.1111/1541-4337.12571; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Sharma A, 2018, CURR MICROBIOL, V75, P531, DOI 10.1007/s00284-017-1413-9; Stipcevic T, 2005, J DERMATOL SCI, V40, P141, DOI 10.1016/j.jdermsci.2005.08.005; Sugawara T, 2015, TOXICON, V108, P226, DOI 10.1016/j.toxicon.2015.09.033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thitiprasert S, 2021, ARCH MICROBIOL, V203, P3577, DOI 10.1007/s00203-021-02352-0; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson JR, 2011, BIOPHYS J, V101, P2679, DOI 10.1016/j.bpj.2011.09.054; Manno MAT, 2020, ANTON LEEUW INT J G, V113, P2223, DOI 10.1007/s10482-020-01494-3; Tourasse NJ, 2006, J APPL MICROBIOL, V101, P579, DOI 10.1111/j.1365-2672.2006.03087.x; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Webb MD, 2019, TRENDS FOOD SCI TECH, V93, P94, DOI 10.1016/j.tifs.2019.08.024; Worthy HL, 2021, TOXINS, V13, DOI 10.3390/toxins13040253; Zheng JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1206-5; Zuo GH, 2021, GENOM PROTEOM BIOINF, V19, P662, DOI 10.1016/j.gpb.2021.03.006; Zuo GH, 2015, GENOM PROTEOM BIOINF, V13, P321, DOI 10.1016/j.gpb.2015.08.004	57	0	0	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0262974	10.1371/journal.pone.0262974	http://dx.doi.org/10.1371/journal.pone.0262974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5R5AN	35588435	Green Published, gold			2022-12-26	WOS:000874523400001
J	Zhang, YJ; Yan, YX; Zhao, J; Gao, ZM				Zhang, Yu-Jun; Yan, Yu-Xin; Zhao, Juan; Gao, Zheng-Ming			CSCAHHO: Chaotic hybridization algorithm of the Sine Cosine with Harris Hawk optimization algorithms for solving global optimization problems	PLOS ONE			English	Article							HEURISTIC OPTIMIZATION; EVOLUTION; COLONY	Because of the No Free Lunch (NFL) rule, we are still under the way developing new algorithms and improving the capabilities of the existed algorithms. Under consideration of the simple and steady convergence capability of the sine cosine algorithm (SCA) and the fast convergence rate of the Harris Hawk optimization (HHO) algorithms, we hereby propose a new hybridization algorithm of the SCA and HHO algorithm in this paper, called the CSCAHHO algorithm henceforth. The energy parameter is introduced to balance the exploration and exploitation procedure for individuals in the new swarm, and chaos is introduced to improve the randomness. Updating equations is redefined and combined of the equations in the SCA and HHO algorithms. Simulation experiments on 27 benchmark functions and CEC 2014 competitive functions, together with 3 engineering problems are carried out. Comparisons have been made with the original SCA, HHO, Archimedes optimization algorithm (AOA), Seagull optimization algorithm (SOA), Sooty Tern optimization algorithm (STOA), Arithmetic optimizer (AO) and Chimp optimization algorithm (ChOA). Simulation experiments on either unimodal or multimodal, benchmark or CEC2014 functions, or real engineering problems all verified the better performance of the proposed CSAHHO, such as faster convergence rate, low residual errors, and steadier capability. Matlab code of this algorithm is shared in Gitee with the following address: https://gitee.com/yuj-zhang/cscahho.	[Zhang, Yu-Jun; Zhao, Juan] Jingchu Univ Technol, Sch Elect & Informat Engn, Jingmen, Peoples R China; [Yan, Yu-Xin] Jingchu Univ Technol, Acad Arts, Jingmen, Peoples R China; [Gao, Zheng-Ming] Jingchu Univ Technol, Sch Comp Engn, Jingmen, Peoples R China; [Gao, Zheng-Ming] Hubei Jingmen Ind Technol Res Inst, Inst Intelligent Informat Technol, Jingmen, Peoples R China	Jingchu University of Technology; Jingchu University of Technology; Jingchu University of Technology	Zhao, J (corresponding author), Jingchu Univ Technol, Sch Elect & Informat Engn, Jingmen, Peoples R China.	ajuan323@jcut.edu.cn	ZHAO, Juan/AAT-3268-2021; Zheng-Ming, GAO/U-2380-2019	ZHAO, Juan/0000-0001-7047-2001; Zheng-Ming, GAO/0000-0003-1566-7134; Zhang, Yujun/0000-0003-3016-8843	Jing Chu University of technology [TD202001]; National Training Program of Innovation and Entrepreneurship for Undergraduates [202111336006]; key research and development project of Jing men [2019YFZD009]; Provincial teaching reform research project of Hubei universities [2020683]	Jing Chu University of technology; National Training Program of Innovation and Entrepreneurship for Undergraduates; key research and development project of Jing men; Provincial teaching reform research project of Hubei universities	[1] The scientific research team project of Jing Chu University of technology with grant number TD202001. [2] National Training Program of Innovation and Entrepreneurship for Undergraduates with grant number 202111336006. [3] The key research and development project of Jing men with grant numbers 2019YFZD009. [4] Provincial teaching reform research project of Hubei universities with grant number 2020683.	Abdollahzadeh B, 2021, INT J INTELL SYST, V36, P5887, DOI 10.1002/int.22535; Abdollahzadeh B, 2021, COMPUT IND ENG, V158, DOI 10.1016/j.cie.2021.107408; Abdollahzadeh B, 2022, ENG COMPUT-GERMANY, V38, P1845, DOI 10.1007/s00366-021-01369-9; Abedinpourshotorban H, 2016, SWARM EVOL COMPUT, V26, P8, DOI 10.1016/j.swevo.2015.07.002; Abualigah L, 2021, COMPUT IND ENG, V157, DOI 10.1016/j.cie.2021.107250; Abualigah L, 2021, COMPUT METHOD APPL M, V376, DOI 10.1016/j.cma.2020.113609; Akdag O, 2021, NEURAL COMPUT APPL, V33, P1959, DOI 10.1007/s00521-020-05073-5; Al-Betar MA, 2021, EXPERT SYST APPL, V168, DOI 10.1016/j.eswa.2020.114243; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Askari Q, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105709; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/CEC.2007.4425083; Benyamin A, 2021, INT J INTELL SYST, V36, P1270, DOI 10.1002/int.22342; Chen H, 2020, FUTURE GENER COMP SY, V111, P175, DOI 10.1016/j.future.2020.04.008; Chen HL, 2020, APPL MATH COMPUT, V369, DOI 10.1016/j.amc.2019.124872; Cheraghalipour A, 2018, ENG APPL ARTIF INTEL, V72, P393, DOI 10.1016/j.engappai.2018.04.021; Dhiman G, 2019, ENG APPL ARTIF INTEL, V82, P148, DOI 10.1016/j.engappai.2019.03.021; Dhiman G, 2019, KNOWL-BASED SYST, V165, P169, DOI 10.1016/j.knosys.2018.11.024; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Erol OK, 2006, ADV ENG SOFTW, V37, P106, DOI 10.1016/j.advengsoft.2005.04.005; Fan Q, 2020, SOFT COMPUT, V24, P14825, DOI 10.1007/s00500-020-04834-7; Faramarzi A, 2020, EXPERT SYST APPL, V152, DOI 10.1016/j.eswa.2020.113377; Formato RA, 2007, PROG ELECTROMAGN RES, V77, P425, DOI 10.2528/PIER07082403; Frenzel J. F., 1993, IEEE Potentials, V12, P21, DOI 10.1109/45.282292; Gandomi AH, 2013, ENG COMPUT-GERMANY, V29, P17, DOI 10.1007/s00366-011-0241-y; Gao ZM, 2021, IEEE ACCESS, V9, P106317, DOI 10.1109/ACCESS.2021.3100365; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Ghafori S, 2022, ARCH COMPUT METHOD E, V29, P1569, DOI 10.1007/s11831-021-09624-4; Gharehchopogh FS, 2022, CLUSTER COMPUT, V25, P1981, DOI 10.1007/s10586-021-03304-5; Gharehchopogh FS, 2021, CONCURR COMP-PRACT E, V33, DOI 10.1002/cpe.6310; Gharehchopogh FS, 2022, EVOL INTELL, V15, P1777, DOI 10.1007/s12065-021-00590-1; Gharehchopogh FS, 2020, ARTIF INTELL REV, V53, P2265, DOI 10.1007/s10462-019-09733-4; Gharehchopogh FS, 2019, SWARM EVOL COMPUT, V48, P1, DOI 10.1016/j.swevo.2019.03.004; Gupta S, 2020, EXPERT SYST APPL, V158, DOI 10.1016/j.eswa.2020.113510; Hao C, 2019, EXPERT SYST APPL, V45, P50; Hashim FA, 2019, FUTURE GENER COMP SY, V101, P646, DOI 10.1016/j.future.2019.07.015; Heidari AA, 2019, FUTURE GENER COMP SY, V97, P849, DOI 10.1016/j.future.2019.02.028; Jia HM, 2021, EXPERT SYST APPL, V185, DOI 10.1016/j.eswa.2021.115665; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kaveh A, 2017, ADV ENG SOFTW, V110, P69, DOI 10.1016/j.advengsoft.2017.03.014; Khishe M, 2020, EXPERT SYST APPL, V149, DOI 10.1016/j.eswa.2020.113338; KOZA JR, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P194; Kumar M, 2018, FUTURE GENER COMP SY, V81, P252, DOI 10.1016/j.future.2017.10.052; Li S, 2018, EXPERT SYST APPL, V91, P63, DOI 10.1016/j.eswa.2017.08.038; Li SM, 2020, FUTURE GENER COMP SY, V111, P300, DOI 10.1016/j.future.2020.03.055; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2016, KNOWL-BASED SYST, V96, P120, DOI 10.1016/j.knosys.2015.12.022; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P495, DOI 10.1007/s00521-015-1870-7; Mohammadi-Balani A, 2021, COMPUT IND ENG, V152, DOI 10.1016/j.cie.2020.107050; Nayak DR, 2018, COMPUT ELECTR ENG, V68, P366, DOI 10.1016/j.compeleceng.2018.04.009; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Reddy KS, 2018, ARAB J SCI ENG, V43, P4041, DOI 10.1007/s13369-017-2790-x; Sabat A, 2021, ARAB J SCI ENG; Saremi S, 2017, ADV ENG SOFTW, V105, P30, DOI 10.1016/j.advengsoft.2017.01.004; Sarker RA, 2014, IEEE T EVOLUT COMPUT, V18, P689, DOI 10.1109/TEVC.2013.2281528; Shayanfar H, 2018, APPL SOFT COMPUT, V71, P728, DOI 10.1016/j.asoc.2018.07.033; Simon D, 2008, IEEE T EVOLUT COMPUT, V12, P702, DOI 10.1109/TEVC.2008.919004; Tan Y, 2010, LECT NOTES COMPUT SC, V6145, P355; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yang XS, 2020, J COMPUT SCI-NETH, V46, DOI 10.1016/j.jocs.2020.101104; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; Yazdani M, 2016, J COMPUT DES ENG, V3, P24, DOI 10.1016/j.jcde.2015.06.003; Zaman HRR, 2022, ENG COMPUT-GERMANY, V38, P2797, DOI 10.1007/s00366-021-01431-6; Zhang QY, 2017, NEUROCOMPUTING, V221, P123, DOI 10.1016/j.neucom.2016.09.068; Zhao J, 2021, J PHYS C SERIES, V1994; Zheng-Ming Gao, 2020, Journal of Physics: Conference Series, V1678, DOI 10.1088/1742-6596/1678/1/012079; Zhu W, 2020, IEEE ACCESS, V8, P61107, DOI 10.1109/ACCESS.2020.2981968	69	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0263387	10.1371/journal.pone.0263387	http://dx.doi.org/10.1371/journal.pone.0263387			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5J5UN	35588436	Green Published, gold			2022-12-26	WOS:000869106700001
J	Bossert, J; Mahler, C; Boltenhagen, U; Kaltenbach, A; Froehlich, D; Szecsenyi, J; Wensing, M; Joos, S; Klafke, N				Bossert, Jasmin; Mahler, Cornelia; Boltenhagen, Ursula; Kaltenbach, Anna; Froehlich, Daniela; Szecsenyi, Joachim; Wensing, Michel; Joos, Stefanie; Klafke, Nadja			Protocol for the process evaluation of a counselling intervention designed to educate cancer patients on complementary and integrative health care and promote interprofessional collaboration in this area (the CCC-Integrativ study)	PLOS ONE			English	Article							MEDICINE	BackgroundConducting a process evaluation is essential to understand how health interventions work in different healthcare settings. Particularly in the case of complex interventions, it is important to find out whether the intervention could be carried out as planned and which factors had a beneficial or hindering effect on its implementation. The aim of this study is to present the detailed protocol of the process evaluation embedded in the controlled implementation study CCC-Integrativ aiming to implement an interprofessional counselling program for cancer patients on complementary and integrative health care (CIH). MethodsThis mixed methods study will draw upon the "Consolidated Framework for Implementation Research" (CFIR) combined with the concept of "intervention fidelity" to evaluate the quality of the interprofessional counselling sessions, to explore the perspective of the directly and indirectly involved healthcare staff, as well as to analyze the perceptions and experiences of the patients. The qualitative evaluation phase consists of analyzing audio-recorded counselling sessions, as well as individual and group interviews with the involved persons. The quantitative evaluation phase applies questionnaires which are distributed before (T0), at the beginning (T1), in the middle (T2) and at the end (T3) of the intervention delivery. DiscussionThis protocol provides an example of how a process evaluation can be conducted parallel to a main study investigating and implementing a complex intervention. The results of this mixed methods research will make it possible to identify strengths and weaknesses of the team-based intervention, and to target more specifically the key factors and structures required to implement healthcare structures to meet patients' unmet needs in the context of CIH. To our knowledge, this study is the first applying the CFIR framework in the context of interprofessional CIH counselling, and its results are expected to provide comprehensive and multidisciplinary management of cancer patients with complex supportive healthcare needs.	[Bossert, Jasmin; Szecsenyi, Joachim; Wensing, Michel; Klafke, Nadja] Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Mahler, Cornelia; Boltenhagen, Ursula; Kaltenbach, Anna] Univ Hosp Tuebingen, Dept Nursing Sci, Tubingen, Germany; [Froehlich, Daniela; Joos, Stefanie] Univ Hosp Tuebingen, Inst Gen Practice & Interprofess Care, Tubingen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bossert, J (corresponding author), Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	Jasmin.Bossert@med.uni-heidelberg.de			Innovationsfonds of the Federal Joint Committee Berlin [01NVF18004]	Innovationsfonds of the Federal Joint Committee Berlin	This work was supported by the Innovationsfonds of the Federal Joint Committee Berlin 2019-2022 for the area "new forms of care" (funding years: October 2019 -March 2023). Grant number: 01NVF18004. The funder of the study has no influence on the study design, data collection, analysis, interpretation, and in writing the manuscript. Since this is a government grant, there is no commercial interest.	Arredondo P, 2004, J CLIN PSYCHOL, V60, P787, DOI 10.1002/jclp.20015; Beijers AJM, 2020, ANN ONCOL, V31, P131, DOI 10.1016/j.annonc.2019.09.006; Ben-Arye E, 2016, CANCER-AM CANCER SOC, V122, P598, DOI 10.1002/cncr.29796; Boon Heather S, 2007, BMC Womens Health, V7, P4, DOI 10.1186/1472-6874-7-4; Cidav Z, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-020-00993-1; Dahlke S, 2020, CAN J AGING, V39, P443, DOI 10.1017/S0714980819000539; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; du Pon E, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/5013142; Greenlee H, 2017, CA-CANCER J CLIN, V67, P195, DOI 10.3322/caac.21397; Hoffmann M, 2013, ONKOLOGIE INTERDISZI, P153; Kalder M, 2016, GEBURTSH FRAUENHEILK, V76, P150, DOI 10.1055/s-0042-100208; Kirk MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0437-z; Klafke N, 2017, ONCOL NURS FORUM, V44, pE223, DOI 10.1188/17.ONF.E223-E231; Klafke N, 2016, SUPPORT CARE CANCER, V24, P2341, DOI 10.1007/s00520-015-3038-5; Klafke N, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0538-4; Kuckartz U., 2016, METHODEN PRAXIS COMP; Lederle M., 2017, GESUNDHEITSWESEN, V79; Liekweg A, 2005, PHARM WORLD SCI, V27, P96, DOI 10.1007/s11096-004-5337-7; Mayring P., 2010, HDB QUALITATIVE FORS, P601, DOI [DOI 10.1007/978-3-531-92052-8_42, 10.1007/978-3-531-92052-8_42]; Ministerium fur Arbeit und Sozialordnung F, 2011, FRAUEN SENIOREN LAND; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Rew L, 2018, WESTERN J NURS RES, V40, P1843, DOI 10.1177/0193945917752092; Richards DA, 2015, COMPLEX INTERVENTION, P27; Safaeinili N, 2020, LEARN HEALTH SYST, V4, DOI 10.1002/lrh2.10201; Schaeffer D, 2012, LEHRBUCH PATIENTENBE; Shalom-Sharabi I, 2017, SUPPORT CARE CANCER, V25, P3181, DOI 10.1007/s00520-017-3726-4; Slaughter SE, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0320-3; Tashakkori A., 2009, SAGE HDB APPL SOCIAL, V2, P283, DOI DOI 10.4135/9781483348858.N9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Toomey E, 2021, PUBLIC HEALTH NUTR, V24, P2889, DOI 10.1017/S1368980020004954; Uwe F., 2007, QUALITATIVE SOZIALFO; Valentini J, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-055076; Varsi C, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.5091; Vitinius F., 2013, KOMPASS KONZEPTION I, V63, P482; Walther H., 2012, QM 2011 NACHBEFRAGUN; Willeboordse F, 2018, INT J CLIN PHARM-NET, V40, P550, DOI 10.1007/s11096-018-0615-y; Zill JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1027	37	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268091	http://dx.doi.org/10.1371/journal.pone.0268091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560173	gold, Green Published			2022-12-26	WOS:000835326900031
J	Huang, D; Chen, CW; Zuo, YX; Du, L; Liu, T; Abbott, GW; Hu, ZY				Huang, Dou; Chen, Changwei; Zuo, Yunxia; Du, Lei; Liu, Ting; Abbott, Geoffrey W.; Hu, Zhaoyang			Protective effect of remote liver ischemic postconditioning on pulmonary ischemia and reperfusion injury in diabetic and non-diabetic rats	PLOS ONE			English	Article							LUNG INJURY; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; SALVAGE KINASE; UP-REGULATION; HEART; DYSFUNCTION	Pulmonary ischemia and reperfusion (I/R) injury occurs in many clinical conditions and causes severe damage to the lungs. Diabetes mellitus (DM) predisposes to pulmonary I/R injury. We previously found that remote liver ischemia preconditioning protected lungs against pulmonary I/R injury. The aim of the present study was to investigate whether remote liver ischemic postconditioning (RLIPost) attenuates pulmonary damage induced by I/R injury in non-diabetic or diabetic rats. Male Sprague-Dawley rats were assigned into non-diabetic and diabetic groups. All rats except for the sham were exposed to 45 min of left hilum occlusion followed by 2 h of reperfusion. RLIPost was conducted at the onset of pulmonary reperfusion by four cycles of 5 min of liver ischemia and reperfusion. Lung injury was assessed by the wet/dry weight ratio, pulmonary oxygenation, histopathological changes, apoptosis and the expression of inflammatory cytokines. Reperfusion-associated protein phosphorylation states were determined. RLIPost offered strong pulmonary-protection in both non-diabetic and diabetic rats, as reflected in reduced water content and pulmonary structural damage, recovery of lung function, inhibition of apoptosis and inflammation after ischemia-reperfusion. RLIPost induced the activation of pulmonary STAT-3, a key component in the SAFE pathway, but not activation of the proteins in the RISK pathway, in non-diabetic rats. In contrast, RLIPost-induced pulmonary protection in diabetic lungs was independent of SAFE or RISK pathway activation. These results demonstrate that RLIPost exerts pulmonary protection against I/R-induced lung injury in non-diabetic and diabetic rats. The underlying mechanism for protection may be different in non-diabetic (STAT-3 dependent) versus diabetic (STAT-3 independent) rats.	[Huang, Dou; Chen, Changwei; Zuo, Yunxia; Du, Lei] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Huang, Dou; Chen, Changwei; Zuo, Yunxia; Du, Lei; Liu, Ting; Hu, Zhaoyang] Sichuan Univ, West China Hosp, Natl Local Joint Engn Res Ctr Translat Med Anesthe, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA USA	Sichuan University; Sichuan University; University of California System; University of California Irvine	Hu, ZY (corresponding author), Sichuan Univ, West China Hosp, Natl Local Joint Engn Res Ctr Translat Med Anesthe, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China.	zyhu@hotmail.com		Abbott, Geoffrey/0000-0003-4552-496X				An JQ, 2020, NEUROLOGY, V95, pE3355, DOI 10.1212/WNL.0000000000010884; Chen GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121971; den Hengst WA, 2010, AM J PHYSIOL-HEART C, V299, pH1283, DOI 10.1152/ajpheart.00251.2010; Donato M, 2021, MOL CELL BIOCHEM, V476, P3857, DOI 10.1007/s11010-021-04192-4; Harkin DW, 2002, J VASC SURG, V35, P1264, DOI 10.1067/mva.2002.121981; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hu ZY, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0537-3; Hu ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165123; Krishnadasan B, 2003, J THORAC CARDIOV SUR, V125, P261, DOI 10.1067/mtc.2003.16; Li C, 2014, ANESTHESIOLOGY, V121, P249, DOI 10.1097/ALN.0000000000000266; Luo NF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196186; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Morrison MI, 2017, J THORAC DIS, V9, P4084, DOI 10.21037/jtd.2017.09.09; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Noorbakhsh MF, 2015, IRAN J BASIC MED SCI, V18, P80; Peralta C, 2002, AM J PATHOL, V160, P2111, DOI 10.1016/S0002-9440(10)61160-1; Peters J, 2011, BASIC RES CARDIOL, V106, P507, DOI 10.1007/s00395-011-0187-7; Pitocco Dario, 2012, Rev Diabet Stud, V9, P23, DOI 10.1900/RDS.2012.9.23; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Schmidt MR, 2012, J CARDIOVASC MED, V13, P667, DOI 10.2459/JCM.0b013e328357bff2; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Simo R, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.225; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Song LL, 2017, J SURG RES, V216, P9, DOI 10.1016/j.jss.2017.03.024; Neto FJT, 2013, ACTA CIR BRAS, V28, P174, DOI 10.1590/S0102-86502013000300003; Tiengo A, 2008, DIABETES METAB, V34, P447, DOI 10.1016/j.diabet.2008.08.001; Waldow T, 2005, TRANSPL INT, V18, P198, DOI 10.1111/j.1432-2277.2004.00005.x; Wang CY, 2020, J CELL MOL MED, V24, P6670, DOI 10.1111/jcmm.15318; Wang DD, 2018, JACC-BASIC TRANSL SC, V3, P350, DOI 10.1016/j.jacbts.2018.01.005; Wider J, 2014, CARDIOVASC DIAGN THE, V4, P383, DOI 10.3978/j.issn.2223-3652.2014.10.05; Yang S, 2017, J APPL PHYSIOL, V122, P1095, DOI 10.1152/japplphysiol.00862.2016; Zhou L, 2019, FASEB J, V33, P9762, DOI 10.1096/fj.201802519R; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	35	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268571	http://dx.doi.org/10.1371/journal.pone.0268571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617238	Green Published, gold			2022-12-26	WOS:000835048800070
J	Kouno, T; Liu, X; Zhao, HY; Kisseleva, T; Cable, EE; Schnabl, B				Kouno, Tetsuya; Liu, Xiao; Zhao, Huayi; Kisseleva, Tatiana; Cable, Edward E.; Schnabl, Bernd			Selective PPAR delta agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; NEGATIVE FEEDBACK-REGULATION; ALPHA; FGF21; EXPRESSION; INDUCTION; REGULATOR; INHIBIT; CHOLANGITIS; METABOLISM	Peroxisome proliferator-activated receptor delta (PPAR delta) agonists have been shown to exert beneficial effects in liver disease and reduce total bile acid levels. The mechanism(s) whereby PPAR delta agonism reduces bile acid levels are, however, unknown, and therefore the aim of the present study was to investigate the molecular pathways responsible for reducing bile acid synthesis in hepatocytes, following treatment with the selective PPAR delta agonist, seladelpar. We show that administration of seladelpar to WT mice repressed the liver expression of cholesterol 7 alpha-hydroxylase (Cyp7a1), the rate-limiting enzyme for bile acid synthesis, and decreased plasma 7 alpha-hydroxy-4-cholesten-3-one (C4), a freely diffusible metabolite downstream of Cyp7a1. In primary mouse hepatocytes, seladelpar significantly reduced the expression of Cyp7a1 independent of the nuclear bile acid receptor, Farnesoid X receptor. In addition, seladelpar upregulated fibroblast growth factor 21 (Fgf21) in mouse liver, serum, and in cultured hepatocytes. We demonstrate that recombinant Fgf21 protein activated the cJun N-terminal kinase (JNK) signaling pathway and repressed Cyp7a1 gene expression in primary hepatocytes. The suppressive effect of seladelpar on Cyp7a1 expression was blocked by a JNK inhibitor as well as in the absence of Fgf21, indicating that Fgf21 plays an indispensable role in PPAR delta-mediated down-regulation of Cyp7a1. Finally, reduction of CYP7A1 expression by seladelpar was confirmed in primary human hepatocytes. In conclusion, we show that seladelpar reduces bile acid synthesis via an FGF21-dependent mechanism that signals at least partially through JNK to repress CYP7A1.	[Kouno, Tetsuya; Liu, Xiao; Zhao, Huayi; Schnabl, Bernd] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Liu, Xiao; Kisseleva, Tatiana] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Cable, Edward E.] CymaBay Therapeut, Newark, CA USA; [Schnabl, Bernd] VA San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Schnabl, B (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Schnabl, B (corresponding author), VA San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA.	beschnabl@health.ucsd.edu			National Institutes of Health [R01 AA24726, R37 AA020703, U01 AA026939, U01 AA026939-04S1]; Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [BX004594]; Biocodex Microbiota Foundation;  [R01DK101737];  [U01AA022614];  [R01DK099205];  [R01DK111866];  [R01AA028550];  [U01AA018663];  [U01AA029019];  [R01DK091183];  [R01DK09920]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; Biocodex Microbiota Foundation; ; ; ; ; ; ; ; ; 	This study was supported in part by National Institutes of Health grants R01 AA24726, R37 AA020703, U01 AA026939, and U01 AA026939-04S1, by Award Number BX004594 from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development and a Biocodex Microbiota Foundation Grant (to B. S.), R01DK101737, U01AA022614, R01DK099205, R01DK111866, R01AA028550, U01AA018663, U01AA029019, R01DK091183, and R01DK09920 (to Tatiana Kisseleva). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Brandl K, 2018, J HEPATOL, V69, P396, DOI 10.1016/j.jhep.2018.03.031; Chen MM, 2018, J ENDOCRINOL, V237, P139, DOI 10.1530/JOE-17-0727; Chiang John Y L, 2020, Liver Res, V4, P47, DOI 10.1016/j.livres.2020.05.001; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Chu HK, 2021, TRANSL RES, V227, P1, DOI 10.1016/j.trsl.2020.06.006; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Goetz R, 2012, MOL CELL BIOL, V32, P1944, DOI 10.1128/MCB.06603-11; Gottlieb A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111358; Harrison SA, 2020, HEPATOLOGY, V72, P1042; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jones D, 2017, LANCET GASTROENTEROL, V2, P716, DOI 10.1016/S2468-1253(17)30246-7; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kremer AE, 2022, LIVER INT, V42, P112, DOI 10.1111/liv.15039; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Li ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178580; Lily Z., 2019, HEPATOLOGY, V70, p807A; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Ma HY, 2020, J HEPATOL, V72, P946, DOI 10.1016/j.jhep.2019.12.016; Manieri E, 2020, P NATL ACAD SCI USA, V117, P16492, DOI 10.1073/pnas.2002672117; Marrapodi M, 2000, J LIPID RES, V41, P514; Mazuecos L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094624; Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200; Petrescu AD, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081846; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ravaux L, 2007, MOL CELL BIOL, V27, P8374, DOI 10.1128/MCB.00623-07; Sommars MA, 2019, ELIFE, V8, DOI 10.7554/eLife.43922; Trottier J, 2012, DIGEST LIVER DIS, V44, P303, DOI 10.1016/j.dld.2011.10.025; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Zarei M, 2016, DIABETES, V65, P3185, DOI 10.2337/db16-0155; Zhang J, 2017, EBIOMEDICINE, V15, P173, DOI 10.1016/j.ebiom.2016.12.016	37	1	1	7	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102056	10.1016/j.jbc.2022.102056	http://dx.doi.org/10.1016/j.jbc.2022.102056			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35605662	Green Published, gold			2022-12-26	WOS:000818686700002
J	Baksh, SS; Pratt, RE; Gomez, J; Dzau, VJ; Hodgkinson, CP				Baksh, Syeda Samara; Pratt, Richard E.; Gomez, Jose; Dzau, Victor J.; Hodgkinson, Conrad P.			A novel Cbx1, PurB, and Sp3 complex mediates long-term silencing of tissue- and lineage-specific genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; CARDIAC FIBROBLASTS; EXPRESSION; CARDIOMYOCYTES; REPRESSION; MYOCYTES; ELEMENT; ALPHA	miRNA-based cellular fate reprogramming offers an opportunity to investigate the mechanisms of long-term gene silencing. To further understand how genes are silenced in a tissue-specific manner, we leveraged our miRNA-based method of reprogramming fibroblasts into cardiomyocytes. Through screening approaches, we identified three proteins that were downregulated during reprogramming of fibroblasts into cardiomyocytes: heterochromatin protein Cbx1, transcriptional activator protein PurB, and transcription factor Sp3. We show that knockdown of Cbx1, PurB, and Sp3 was sufficient to induce cardiomyocyte gene expression in fibroblasts. Similarly, gene editing to ablate Cbx1, PurB, and Sp3 expression induced fibroblasts to convert into cardiomyocytes in vivo. Furthermore, high-throughput DNA sequencing and coimmunoprecipitation experiments indicated that Cbx1, PurB, and Sp3 also bound together as a complex and were necessary to localize nucleosomes to cardiomyocyte genes on the chromosome. Finally, we found that the expression of these genes led to nucleosome modification via H3K27me3 (trimethylated histone-H3 lysine-27) deposition through an interaction with the polycomb repressive PRC2 complex. In summary, we conclude that Cbx1, PurB, and Sp3 control cell fate by actively repressing lineage-specific genes.	[Baksh, Syeda Samara; Pratt, Richard E.; Dzau, Victor J.; Hodgkinson, Conrad P.] Duke Univ, Mandel Ctr Heart & Vasc Res, Med Ctr, Durham, NC 27708 USA; [Baksh, Syeda Samara; Pratt, Richard E.; Dzau, Victor J.; Hodgkinson, Conrad P.] Duke Univ, Duke Cardiovasc Res Ctr, Med Ctr, Durham, NC 27708 USA; [Gomez, Jose] Vanderbilt Univ, Dept Med, Clin Pharmacol Div, Med Ctr, Nashville, TN USA	Duke University; Duke University; Vanderbilt University	Hodgkinson, CP (corresponding author), Duke Univ, Mandel Ctr Heart & Vasc Res, Med Ctr, Durham, NC 27708 USA.; Hodgkinson, CP (corresponding author), Duke Univ, Duke Cardiovasc Res Ctr, Med Ctr, Durham, NC 27708 USA.	conrad.hodgkinson@duke.edu			National Institutes of Health [R01 HL131814-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-The work in this study was funded by the National Institutes of Health (grant no.: R01 HL131814-01A1) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa R, 2002, J BIOL CHEM, V277, P18979, DOI 10.1074/jbc.M201257200; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Anokye-Danso F, 2012, J CELL SCI, V125, P4179, DOI 10.1242/jcs.095968; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Burridge Paul W, 2015, Curr Protoc Hum Genet, V87, DOI 10.1002/0471142905.hg2103s87; Churko JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07333-4; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; Courey AJ, 2001, GENE DEV, V15, P2786; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Dal-Pra S, 2017, CIRC RES, V120, P1403, DOI 10.1161/CIRCRESAHA.116.308741; EVANS SM, 1994, MOL CELL BIOL, V14, P4269, DOI 10.1128/MCB.14.6.4269; Gupta M, 1998, MOL CELL BIOL, V18, P7243, DOI 10.1128/MCB.18.12.7243; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; Hodgkinson CP, 2018, J MOL CELL CARDIOL, V123, P64, DOI 10.1016/j.yjmcc.2018.08.024; Hodgkinson CP, 2018, STEM CELLS, V36, P1198, DOI 10.1002/stem.2833; Hu JB, 2021, MOL THER-NUCL ACIDS, V23, P55, DOI 10.1016/j.omtn.2020.10.034; Jayawardena T, 2014, METHODS MOL BIOL, V1150, P263, DOI 10.1007/978-1-4939-0512-6_18; Jayawardena TM, 2015, CIRC RES, V116, P418, DOI 10.1161/CIRCRESAHA.116.304510; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kang MH, 2020, BIOCHEM BIOPH RES CO, V533, P9, DOI 10.1016/j.bbrc.2020.08.104; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38815; Nam YJ, 2022, SEMIN CELL DEV BIOL, V122, P14, DOI 10.1016/j.semcdb.2021.06.020; Pavlovic BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33478-9; Petracovici A, 2021, MOL CELL, V81, P2625, DOI 10.1016/j.molcel.2021.03.038; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Sadahiro T, 2022, SEMIN CELL DEV BIOL, V122, P21, DOI 10.1016/j.semcdb.2021.06.019; Saxton DS, 2020, P NATL ACAD SCI USA, V117, P27493, DOI 10.1073/pnas.2004111117; Schlissel G, 2019, P NATL ACAD SCI USA, V116, P20605, DOI 10.1073/pnas.1911943116; Wang XW, 2021, METHODS MOL BIOL, V2239, P47, DOI 10.1007/978-1-0716-1084-8_4; Yuan T, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.650566	33	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102053	10.1016/j.jbc.2022.102053	http://dx.doi.org/10.1016/j.jbc.2022.102053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35605661	gold, Green Published			2022-12-26	WOS:000829588600005
J	Sarver, DC; Xu, C; Carreno, D; Arking, A; Terrillion, CE; Aja, S; Wong, GW				Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Terrillion, Chantelle E.; Aja, Susan; Wong, G. William			CTRP11 contributes modestly to systemic metabolism and energy balance	FASEB JOURNAL			English	Article						C1QL4; C1QTNF11; metabolism; obesity reversal; secreted hormone	ADIPOSE-TISSUE INFLAMMATION; FOOD-INTAKE; INSULIN SENSITIVITY; HEPATIC STEATOSIS; SECRETED PROTEIN; SKELETAL-MUSCLE; SEX-DIFFERENCES; RECEPTOR BAI3; FAMILY; OBESITY	C1q/TNF-related proteins (CTRP1-15) constitute a conserved group of secreted proteins of the C1q family with diverse functions. In vitro studies have shown that CTRP11/C1QL4 can inhibit adipogenesis, antagonize myoblast fusion, and promote testosterone synthesis and secretion. Whether CTRP11 is required for these processes in vivo remains unknown. Here, we show that knockout (KO) mice lacking CTRP11 have normal skeletal muscle mass and function, and testosterone level, suggesting that CTRP11 is dispensable for skeletal muscle development and testosterone production. We focused our analysis on whether this nutrient-responsive secreted protein plays a role in controlling sugar and fat metabolism. At baseline when mice are fed a standard chow, CTRP11 deficiency affects metabolic parameters in a sexually dimorphic manner. Only Ctrp11-KO female mice have significantly higher fasting serum ketones and reduced physical activity. In the refeeding phase following food withdrawal, Ctrp11-KO female mice have reduced food intake and increased metabolic rate and energy expenditure, highlighting CTRP11's role in fasting-refeeding response. When challenged with a high-fat diet to induce obesity and metabolic dysfunction, CTRP11 deficiency modestly exacerbates obesity-induced glucose intolerance, with more pronounced effects seen in Ctrp11-KO male mice. Switching to a low-fat diet after obesity induction results in greater fat loss in wild type relative to KO male mice, suggesting impaired response to obesity reversal and reduced metabolic flexibility in the absence of CTRP11. Collectively, our data provide genetic evidence for novel sex-dependent metabolic regulation by CTRP11, but note the overall modest contribution of CTRP11 to systemic energy homeostasis.	[Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Aja, Susan; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA; [Terrillion, Chantelle E.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA.	gwwong@jhmi.edu			HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), [DK084171]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK084171	Appari M, 2017, CIRC RES, V120, P66, DOI 10.1161/CIRCRESAHA.116.309398; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Cho Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg6069; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Hamoud N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06897-5; Han S, 2018, CIRC RES, V123, pE5, DOI 10.1161/CIRCRESAHA.118.312871; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Lahav R, 2021, AM J PHYSIOL-ENDOC M, V321, pE702, DOI 10.1152/ajpendo.00299.2021; Lei X, 2019, J BIOL CHEM, V294, P15638, DOI 10.1074/jbc.RA119.009230; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Li YX, 2019, FASEB J, V33, P9627, DOI 10.1096/fj.201900293RRR; Little HC, 2019, FASEB J, V33, P8666, DOI 10.1096/fj.201900520R; Liu F, 2017, MOL CELL BIOCHEM, V424, P57, DOI 10.1007/s11010-016-2842-7; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Masschelin PM, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01638; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Miller LR, 2017, FASEB J, V31, P29, DOI 10.1096/fj.201600781R; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Murayama MA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.607346; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Noda T, 2019, ANDROLOGY-US, V7, P644, DOI 10.1111/andr.12621; Park S, 2020, BIOL REPROD, V103, P195, DOI 10.1093/biolre/ioaa084; Park YK, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00554-16; Park YK, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00260-16; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Ressl S, 2015, STRUCTURE, V23, P688, DOI 10.1016/j.str.2015.01.019; Rodriguez S, 2019, FASEB J, V33, P14748, DOI 10.1096/fj.201901279R; Rodriguez S, 2021, AM J PHYSIOL-REG I, V320, pR19, DOI 10.1152/ajpregu.00139.2020; Rodriguez S, 2020, FASEB J, V34, P2657, DOI 10.1096/fj.201900558RR; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Sarver DC, 2021, FASEB J, V35, DOI 10.1096/fj.202100733RR; Sarver DC, 2020, AM J PHYSIOL-ENDOC M, V319, pE1084, DOI 10.1152/ajpendo.00448.2020; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tan AN, 2019, FASEB J, V33, P4893, DOI 10.1096/fj.201801620RR; Tan SY, 2020, AM J PHYSIOL-ENDOC M, V319, pE146, DOI 10.1152/ajpendo.00533.2019; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xia JY, 2018, DIABETOLOGIA, V61, P932, DOI 10.1007/s00125-017-4516-8; Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557; Youngstrom DW, 2020, J ORTHOP RES, V38, P996, DOI 10.1002/jor.24553; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Zuo AJ, 2020, J CELL MOL MED, V24, P2635, DOI 10.1111/jcmm.14982; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	77	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22347	10.1096/fj.202200189RR	http://dx.doi.org/10.1096/fj.202200189RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1H5ZA	35579659	hybrid, Green Published			2022-12-26	WOS:000796620600001
J	Laun, FB; Fuehres, T; Seuss, H; Mueller, A; Bickelhaupt, S; Stemmer, A; Benkert, T; Uder, M; Saake, M				Laun, Frederik B.; Fuehres, Tobit; Seuss, Hannes; Mueller, Astrid; Bickelhaupt, Sebastian; Stemmer, Alto; Benkert, Thomas; Uder, Michael; Saake, Marc			Flow-compensated diffusion encoding in MRI for improved liver metastasis detection	PLOS ONE			English	Article							SHORT-TIME EXPANSION; WEIGHTED MRI; HEPATIC METASTASES; LESION DETECTION; IMAGE QUALITY; MOTION; COEFFICIENT; ARTIFACT; NMR; BREATHHOLD	Magnetic resonance (MR) diffusion-weighted imaging (DWI) is often used to detect focal liver lesions (FLLs), though DWI image quality can be limited in the left liver lobe owing to the pulsatile motion of the nearby heart. Flow-compensated (FloCo) diffusion encoding has been shown to reduce this pulsation artifact. The purpose of this prospective study was to intra-individually compare DWI of the liver acquired with conventional monopolar and FloCo diffusion encoding for assessing metastatic FLLs in non-cirrhotic patients. Forty patients with known or suspected multiple metastatic FLLs were included and measured at 1.5 T field strength with a conventional (monopolar) and a FloCo diffusion encoding EPI sequence (single refocused; b-values, 50 and 800 s/mm(2)). Two board-certified radiologists analyzed the DWI images independently. They issued Likert-scale ratings (1 = worst, 5 = best) for pulsation artifact severity and counted the difference of lesions visible at b = 800 s/mm(2) separately for small and large FLLs (i.e., < 1 cm or > 1 cm) and separately for left and right liver lobe. Differences between the two diffusion encodings were assessed with the Wilcoxon signed-rank test. Both readers found a reduction in pulsation artifact in the liver with FloCo encoding (p < 0.001 for both liver lobes). More small lesions were detected with FloCo diffusion encoding in both liver lobes (left lobe: six and seven additional lesions by readers 1 and 2, respectively; right lobe: five and seven additional lesions for readers 1 and 2, respectively). Both readers found one additional large lesion in the left liver lobe. Thus, flow-compensated diffusion encoding appears more effective than monopolar diffusion encoding for the detection of liver metastases.	[Laun, Frederik B.; Fuehres, Tobit; Seuss, Hannes; Mueller, Astrid; Bickelhaupt, Sebastian; Uder, Michael; Saake, Marc] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Seuss, Hannes] Klinikum Forchheim Frank Schweiz gGmbH, Dept Radiol, Forchheim, Germany; [Stemmer, Alto; Benkert, Thomas] Siemens Healthcare GmbH, Erlangen, Germany	University of Erlangen Nuremberg; Siemens AG	Saake, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany.	marc.saake@uk-erlangen.de	Laun, Frederik Bernd/O-4810-2016	Laun, Frederik Bernd/0000-0002-9269-5609; Saake, Marc/0000-0003-3520-0312	Deutsche Forschungsgemeinschaft [DFG LA 2804/12-1, DFG LA 2804/15-1, DFG SA 4141/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding by the Deutsche Forschungsgemeinschaft is gratefully acknowledged (F.L.: DFG LA 2804/12-1, DFG LA 2804/15-1; M.S.: DFG SA 4141/1-1; https://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren A, 2016, NMR BIOMED, V29, P640, DOI 10.1002/nbm.3505; Aliotta E, 2018, MAGN RESON MED, V79, P663, DOI 10.1002/mrm.26709; Aliotta E, 2017, MAGN RESON MED, V77, P717, DOI 10.1002/mrm.26166; BROCKSTEDT S, 1995, ACTA RADIOL, V36, P662; Bruegel M, 2008, AM J ROENTGENOL, V191, P1421, DOI 10.2214/AJR.07.3279; Choi JS, 2013, J MAGN RESON IMAGING, V38, P109, DOI 10.1002/jmri.23949; Cives M, 2018, CA-CANCER J CLIN, V68, P471, DOI 10.3322/caac.21493; Coenegrachts K, 2007, BRIT J RADIOL, V80, P524, DOI 10.1259/bjr/33156643; Donato H, 2017, EUR J RADIOL, V93, P30, DOI 10.1016/j.ejrad.2017.05.028; Dreher C, 2020, INVEST RADIOL, V55, P285, DOI 10.1097/RLI.0000000000000639; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; FUJITA N, 1992, MAGNET RESON MED, V24, P109, DOI 10.1002/mrm.1910240112; Furuta A, 2014, EUR J RADIOL, V83, P1626, DOI 10.1016/j.ejrad.2014.06.003; Grebenkov DS, 2007, REV MOD PHYS, V79, P1077, DOI 10.1103/RevModPhys.79.1077; Ichikawa S, 2019, MAGN RESON MED SCI, V18, P225, DOI 10.2463/mrms.mp.2018-0085; Kandpal H, 2009, AM J ROENTGENOL, V192, P915, DOI 10.2214/AJR.08.1260; Koh DM, 2008, EUR RADIOL, V18, P903, DOI 10.1007/s00330-007-0847-z; Kwee TC, 2009, MAGN RESON MATER PHY, V22, P319, DOI 10.1007/s10334-009-0183-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laun FB, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00056; Laun FB, 2015, J MAGN RESON, V259, P10, DOI 10.1016/j.jmr.2015.07.003; Laun FB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048102; Liau J, 2012, J MAGN RESON IMAGING, V35, P318, DOI 10.1002/jmri.22816; MAKI JH, 1991, MAGNET RESON MED, V17, P95, DOI 10.1002/mrm.1910170114; McTavish S, 2022, MAGN RESON MATER PHY, V35, P827, DOI 10.1007/s10334-021-00981-6; Metens T, 2016, J MAGN RESON IMAGING, V43, P1100, DOI 10.1002/jmri.25089; Middione MJ, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4308; Moulin K, 2019, MAGN RESON MED, V81, P1521, DOI 10.1002/mrm.27490; Nasu K, 2006, RADIOLOGY, V239, P122, DOI 10.1148/radiol.2383041384; Ozaki M, 2013, J MAGN RESON IMAGING, V37, P172, DOI 10.1002/jmri.23796; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Pena-Nogales O, 2019, MAGN RESON MED, V81, P989, DOI 10.1002/mrm.27462; Rauh SS, 2020, MAGN RESON IMAGING, V67, P59, DOI 10.1016/j.mri.2019.12.011; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reynaud O, 2016, MAGN RESON MED, V76, P237, DOI 10.1002/mrm.25865; Riexinger A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239743; Saake M, 2021, INVEST RADIOL, V56, P579, DOI 10.1097/RLI.0000000000000776; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPISNIK J, 1981, PHYSICA B & C, V104, P350, DOI 10.1016/0378-4363(81)90182-0; Szczepankiewicz F, 2021, MAGN RESON MED, V85, P2117, DOI 10.1002/mrm.28551; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Tavakoli A, 2019, INVEST RADIOL, V54, P744, DOI 10.1097/RLI.0000000000000594; Wetscherek A, 2015, MAGN RESON MED, V74, P410, DOI 10.1002/mrm.25410; Xiang ZM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4604218; Zhang YX, 2019, MAGN RESON MED, V82, P302, DOI 10.1002/mrm.27735	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268843	http://dx.doi.org/10.1371/journal.pone.0268843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617260	Green Published, gold			2022-12-26	WOS:000835048800014
J	Sarker, AH; Hang, B				Sarker, Altaf H.; Hang, Bo			Tobacco-specific nitrosamine 1-(N-methyl-N-nitrosamino)-1-(3-pyridinyl)-4-butanal (NNA) causes DNA damage and impaired replication/transcription in human lung cells	PLOS ONE			English	Article							THIRDHAND-SMOKE; NICOTINE; ACTIVATION; SURFACES; EXPOSURE; PROTEIN	Thirdhand smoke (THS) is a newly described health hazard composed of toxicants, mutagens and carcinogens, including nicotine-derived tobacco specific nitrosamines (TSNAs), one of which is 1-(N-methyl-N-nitrosamino)-1-(3-pyridinyl)-4-butanal (NNA). Although TSNAs are generally potent carcinogens, the risk of NNA, which is specific to THS, is poorly understood. We recently reported that THS exposure-induced adverse impact on DNA replication and transcription with implications in the development of cancer and other diseases. Here, we investigated the role of NNA in THS exposure-induced harmful effects on fundamental cellular processes. We exposed cultured human lung epithelial BEAS-2B cells to NNA. The formation of DNA base damages was assessed by Long Amplicon QPCR (LA-QPCR); DNA double-strand breaks (DSBs) and NNA effects on replication and transcription by immunofluorescence (IF); and genomic instability by micronuclei (MN) formation. We found increased accumulation of oxidative DNA damage and DSBs as well as activation of DNA damage response pathway, after exposure of cells to NNA. Impaired S phase progression was also evident. Consistent with these results, we found increased MN formation, a marker of genomic instability, in NNA-exposed cells. Furthermore, ongoing RNA synthesis was significantly reduced by NNA exposure, however, RNA synthesis resumed fully after a 24h recovery period only in wild-type cells but not in those deficient in transcription-coupled nucleotide excision repair (TC-NER). Importantly, these cellular effects are common with the THS-exposure induced effects. Our findings suggest that NNA in THS could be a contributing factor for THS exposure-induced adverse health effect.	[Sarker, Altaf H.; Hang, Bo] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Sarker, AH (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	AHSarker@lbl.gov			University of California Tobacco Related Disease Research Program (UC-TRDRP) [26IR-0017, 28PT-0076]	University of California Tobacco Related Disease Research Program (UC-TRDRP)	We thank Drs. Priscilla Cooper, Susan Tsutakawa, Miaw-Sheue Tsai (LBNL), Tapas Hazra (UTMB, TX) for intellectual advice during the course of this study. We also thank Dr. Anirban Chakraborty (UTMB, TX) for primer design and sequence analysis for the LA-QPCR experiment.	ANDERSEN RA, 1989, J AGR FOOD CHEM, V37, P44, DOI 10.1021/jf00085a011; Bahl V, 2016, TOXICOL IN VITRO, V32, P220, DOI 10.1016/j.tiv.2015.12.007; Brown Buddy G, 2003, Nonlinearity Biol Toxicol Med, V1, P179, DOI 10.1080/15401420391434324; CRESPI CL, 1991, CARCINOGENESIS, V12, P1197, DOI 10.1093/carcin/12.7.1197; Destaillats H, 2006, ENVIRON SCI TECHNOL, V40, P1799, DOI 10.1021/es050914r; Dhall S, 2016, CLIN SCI, V130, P1269, DOI 10.1042/CS20160236; European Collaborative Action, 1993, P 6 INT C INDOOR AIR; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Gregersen LH, 2018, TRENDS BIOCHEM SCI, V43, P327, DOI 10.1016/j.tibs.2018.02.010; Groesser T, 2007, RADIAT RES, V168, P675, DOI 10.1667/RR0967.1; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hang B, 2018, CLIN SCI, V132, P475, DOI 10.1042/CS20171521; Hang B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050932; Hang B, 2014, ABSTR PAP AM CHEM S, V247; Hang B, 2013, MUTAGENESIS, V28, P381, DOI 10.1093/mutage/get013; Hang B, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/709521; HECHT SS, 1978, J NATL CANCER I, V60, P819, DOI 10.1093/jnci/60.4.819; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jacob P, 2017, CHEM RES TOXICOL, V30, P270, DOI 10.1021/acs.chemrestox.6b00343; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Lans H, 2019, NAT REV MOL CELL BIO, V20, P766, DOI 10.1038/s41580-019-0169-4; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Pankow JF, 2007, CANCER EPIDEM BIOMAR, V16, P584, DOI 10.1158/1055-9965.EPI-06-0762; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sarker AH, 2020, ENVIRON MOL MUTAGEN, V61, P635, DOI 10.1002/em.22372; Sarker AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090261; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Trego KS, 2016, MOL CELL, V61, P535, DOI 10.1016/j.molcel.2015.12.026; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Whitlatch A, 2019, NICOTINE TOB RES, V21, P1680, DOI 10.1093/ntr/nty153; Yu L, 2014, 20 ANN M SOC RES NIC	36	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267839	10.1371/journal.pone.0267839	http://dx.doi.org/10.1371/journal.pone.0267839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576221	gold, Green Published			2022-12-26	WOS:000835262300014
J	Sheikhi, F; Yousefian, N; Tehranipoor, P; Kowsari, Z				Sheikhi, Farnaz; Yousefian, Negar; Tehranipoor, Pardis; Kowsari, Zahra			Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran	PLOS ONE			English	Article								Estimating the basic reproduction number of a pandemic and the changes that appear on this value over time provide a good understanding of the contagious nature of the virus and efficiency of the controlling strategies. In this paper, we focus on studying the basic reproduction number (R-0) for two important variants of COVID-19 pandemic in Iran: Alpha and Delta variants. We use four different methods, three statistical models and one mathematical model, to compute R-0: Exponential Growth Rate (EGR), Maximum Likelihood (ML), Sequential Bayesian (SB), and time-dependent SIR model. Alpha variant of COVID-19 was active in Iran from March 10, 2021 until June 10, 2021. Our computations indicate that total R-0 of this variant according to EGR, ML, SB, and SIR model is respectively 0.9999 (95% CI: 0.9994-1), 1.046 (95% CI: 1.044-1.049), 1.06 (95% CI: 1.03-1.08), and 2.79 (95% CI: 2.77-2.81) in the whole active time interval. Moreover, during the time interval from April 3, 2021 to April 9, 2021 in which this variant was in its exponential growth in Iran, R-0 of Alpha variant in Iran according to SB, EGR, ML, and SIR model is respectively 2.26 (95% CI: 2.04-2.49), 2.64 (95% CI: 2.58-2.7), 11.38 (95% CI: 11.28-11.48), and 12.13 (95% CI: 12.12-12.14). Delta variant was active in Iran during the time interval from June 22, 2021 until September 22, 2021. Our computations show that during the time interval from July 3, 2021 to July 8, 2021 in which this variant was in its exponential growth in Iran, R-0 of Delta variant in Iran according to SB, EGR, ML, and SIR model is respectively 3 (95% CI: 2.34-3.66), 3.1 (95% CI: 3.02-3.17), 12 (95% CI: 11.89-12.12), and 23.3 (95% CI: 23.19-23.41). Further, total R-0 of Delta variant in Iran in the whole active time interval according to EGR, ML, SB, and SIR model is respectively 1.042 (95% CI: 1.04-1.043), 1.053 (95% CI: 1.051-1.055), 0.79 (95% CI: 0.63-0.95), and 5.65 (95% CI: 5.6-5.7). As the results show Delta variant was more severe than Alpha variant in Iran. Chasing the changes in R-0 during each variant shows that the controlling strategies applied were effective in controlling the virus spread.	[Sheikhi, Farnaz; Yousefian, Negar; Tehranipoor, Pardis; Kowsari, Zahra] KN Toosi Univ Technol, Fac Comp Engn, Tehran, Iran	K. N. Toosi University of Technology	Sheikhi, F (corresponding author), KN Toosi Univ Technol, Fac Comp Engn, Tehran, Iran.	f.sheikhi@kntu.ac.ir		Sheikhi, Farnaz/0000-0002-7695-6047				Alexandar S, 2021, INT J CLIN PHARM THE, V5, P83, DOI 10.1101/2021.06.20.21259195v1.full-text; Alimohamadi Yousef, 2020, J Prev Med Hyg, V61, pE304, DOI 10.15167/2421-4248/jpmh2020.61.3.1530; Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; [Anonymous], 2021, FRANCE24; Azimi Seyyedeh Sara, 2020, Med J Islam Repub Iran, V34, P95, DOI 10.34171/mjiri.34.95; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Blandenier E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249593; BourBour F, 2020, ARCH PHYSIOL BIOCHEM, DOI 10.1080/13813455.2020.1791188; Brede M., 2010, NETWORKS AN INTRO, V18, P241, DOI 10.1093/acprof:oso/9780199206650.001.0001/acprof-9780199206650; Burki T, 2021, LANCET, V397, P462, DOI 10.1016/S0140-6736(21)00298-1; Chen YC, 2020, IEEE T NETW SCI ENG, V7, P3279, DOI 10.1109/TNSE.2020.3024723; Chu J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249037; D. W. Eyre, 2021, medRxiv, DOI 10.1101/2021.09.28.21264260; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Dharmaratne S, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01411-0; Dhunagna HN, 2021, CLIN EPIDEMIOL GLOB, V9, P85, DOI 10.1016/j.cegh.2020.07.004; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Heesterbeek JAP, 1996, STAT NEERL, V50, P89, DOI [10.1111/j.1467-9574.1996.tb01482.x, DOI 10.1111/J.1467-9574.1996.TB01482.X]; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; ISNA, US; Jassat W, 2021, LANCET GLOB HEALTH, V9, pE1216, DOI 10.1016/S2214-109X(21)00289-8; Jewell BL, 2021, LANCET PUBLIC HEALTH, V6, pE267, DOI 10.1016/S2468-2667(21)00073-6; Krause PR, 2021, LANCET, V398, P1377, DOI 10.1016/S0140-6736(21)02046-8; Liu Q, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00915-3; Liu Y, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab124; Moghadas SM, 2021, CLIN INFECT DIS, V73, P2257, DOI 10.1093/cid/ciab079; Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147; Patel SKS, 2020, INDIAN J MICROBIOL, V60, P263, DOI 10.1007/s12088-020-00893-4; Pecoraro V, 2022, EUR J CLIN INVEST, V52, DOI 10.1111/eci.13706; Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0; Shah SRM, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101086; Statista, NUMB SARS COV 2 GAMM; Statista, NUMB SARS COV 2 ALPH; Statista, NUMB SARS COV 2 DELT; Statista, NUMB SARS COV 2 BET; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Thakur V, 2022, INFECTION, V50, P309, DOI 10.1007/s15010-021-01734-2; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; ULAS E, 2021, SULEYMAN DEMIREL NIV, P77, DOI [10.29233/sdufeffd.852222, DOI 10.29233/SDUFEFFD.852222]; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-35; WHO, 2020, NAM COR DIS COVID 19; WHO Director, WHO DIR GEN OP REM M; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, TRACK SARS COV 2 VAR; World Health Organization, LIST WHOS RESP COVID; World Health Organization, 2020, 1 WHO; Worldometers, COR CAS; Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050	52	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0265489	10.1371/journal.pone.0265489	http://dx.doi.org/10.1371/journal.pone.0265489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580114	Green Published, gold			2022-12-26	WOS:000835654800017
J	Ferreira, JC; Fadl, S; Rabeh, WM				Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.			Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; INDUCED DIMERIZATION; 3C-LIKE PROTEINASE; M-PRO; SARS; INHIBITOR; MECHANISM; DESIGN	3C-like protease (3CLpro) processes and liberates functional viral proteins essential for the maturation and infectivity of severe acute respiratory syndrome coronavirus 2, the virus responsible for COVID-19. It has been suggested that 3CLpro is catalytically active as a dimer, making the dimerization interface a target for antiviral development. Guided by structural analysis, here we introduced single amino acid substitutions at nine residues at three key sites of the dimer interface to assess their impact on dimerization and activity. We show that at site 1, alanine substitution of S1 or E166 increased by twofold or reduced relative activity, respectively. At site 2, alanine substitution of S10 or E14 eliminated activity, whereas K12A exhibited similar to 60% relative activity. At site 3, alanine substitution of R4, E290, or Q299 eliminated activity, whereas S139A exhibited 46% relative activity. We further found that the oligomerization states of the dimer interface mutants varied; the inactive mutants R4A, R4Q, S10A/C, E14A/ D/Q/S, E290A, and Q299A/E were present as dimers, demonstrating that dimerization is not an indication of catalytically active 3CLpro. In addition, present mostly as monomers, K12A displayed residual activity, which could be attributed to the conspicuous amount of dimer present. Finally, differential scanning calorimetry did not reveal a direct relationship between the thermodynamic stability of mutants with oligomerization or catalytic activity. These results provide insights on two allosteric sites, R4/E290 and S10/E14, that may promote the design of antiviral compounds that target the dimer interface rather than the active site of severe acute respiratory syndrome coronavirus 2 3CLpro.	[Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates		Rabeh, WM (corresponding author), New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates.	wael.rabeh@nyu.edu		rabeh, wael/0000-0001-6071-8581	New York University Abu Dhabi [ADC05]	New York University Abu Dhabi	This work was supported by New York University Abu Dhabi through research funds to the laboratory of Prof Rabeh in addition to the COVID-19 Facilitator Research Fund (grant number: ADC05) . This research was partially carried out using the Core Technology Platforms resources at New York University Abu Dhabi.	A. A.Golosov, 2020, bioRxiv, DOI 10.1101/2020.09.07.286344; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Aggarwal M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14753; Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Barrila J, 2010, BIOCHEMISTRY-US, V49, P4308, DOI 10.1021/bi1002585; Chang GG, 2010, MOLECULAR BIOLOGY OF THE SARS-CORONAVIRUS, P115, DOI 10.1007/978-3-642-03683-5_8; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chen S, 2008, J BIOCHEM, V143, P525, DOI 10.1093/jb/mvm246; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Douangamath A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18709-w; El-Baba TJ, 2020, ANGEW CHEM INT EDIT, V59, P23544, DOI 10.1002/anie.202010316; Ferreira GM, 2021, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2021.1970626; Ferreira JC, 2021, FASEB J, V35, DOI 10.1096/fj.202100994; Ferreira JC, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.692168; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Ho BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144865; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12; Kumar R, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00505-20; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Li QX, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081250; Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941; Lin PY, 2008, ARCH BIOCHEM BIOPHYS, V472, P34, DOI 10.1016/j.abb.2008.01.023; McCartney CSE, 2019, METHODS MOL BIOL, V1915, P39, DOI 10.1007/978-1-4939-8988-1_4; Nawaz MH, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171666; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Rabaan Ali A, 2020, Infez Med, V28, P174; Ramos-Guzman CA, 2021, ACS CATAL, V11, P4157, DOI 10.1021/acscatal.0c05522; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Simon L, 2010, J ORG CHEM, V75, P1831, DOI 10.1021/jo901503d; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Su HX, 2020, ACTA PHARMACOL SIN, V41, P1167, DOI 10.1038/s41401-020-0483-6; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Vuong W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18096-2; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Xia B, 2011, PROTEIN CELL, V2, P282, DOI 10.1007/s13238-011-1034-1; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07	58	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102023	10.1016/j.jbc.2022.102023	http://dx.doi.org/10.1016/j.jbc.2022.102023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35568197	gold, Green Published			2022-12-26	WOS:000829588600014
J	Krakovka, S; Ranjbarian, F; Lujan, LA; Saura, A; Larsen, NB; Jimenez-Gonzalez, A; Reggenti, A; Lujan, HD; Svard, SG; Hofer, A				Krakovka, Sascha; Ranjbarian, Farahnaz; Lujan, Lucas A.; Saura, Alicia; Larsen, Nicolai B.; Jimenez-Gonzalez, Alejandro; Reggenti, Anna; Lujan, Hugo D.; Svard, Staffan G.; Hofer, Anders			Giardia intestinalis thymidine kinase is a high-affinity enzyme crucial for DNA synthesis and an exploitable target for drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFRACTORY GIARDIASIS; ANTIGENIC VARIATION; METRONIDAZOLE; SALVAGE; PHARMACOKINETICS; ZIDOVUDINE; RESISTANCE; DIFFERENTIATION; LAMBLIA; PROTEIN	Giardiasis is a diarrheal disease caused by the unicellular parasite Giardia intestinalis, for which metronidazole is the main treatment option. The parasite is dependent on exogenous deoxyribonucleosides for DNA replication and thus is also potentially vulnerable to deoxyribonucleoside analogs. Here, we characterized the G. intestinalis thymidine kinase, a divergent member of the thymidine kinase 1 family that consists of two weakly homologous parts within one polypeptide. We found that the recombinantly expressed enzyme is monomeric, with 100-fold higher catalytic efficiency for thymidine compared to its second-best substrate, deoxyuridine, and is furthermore subject to feedback inhibition by dTTP. This efficient substrate discrimination is in line with the lack of thymidylate synthase and dUTPase in the parasite, which makes deoxy-UMP a dead-end product that is potentially harmful if converted to deoxy-UTP. We also found that the antiretroviral drug azidothymidine (AZT) was an equally good substrate as thymidine and was active against WT as well as metronidazole-resistant G. intestinalis trophozoites. This drug inhibited DNA synthesis in the parasite and efficiently decreased cyst production in vitro, which suggests that it could reduce infectivity. AZT also showed a good effect in G. intestinalis-infected gerbils, reducing both the number of trophozoites in the small intestine and the number of viable cysts in the stool. Taken together, these results suggest that the absolute dependency of the parasite on thymidine kinase for its DNA synthesis can be exploited by AZT, which has promise as a future medication effective against metronidazole-refractory giardiasis.	[Krakovka, Sascha; Jimenez-Gonzalez, Alejandro; Svard, Staffan G.] Uppsala Univ, Dept Cell & Mol Biol, BMC, Uppsala, Sweden; [Ranjbarian, Farahnaz; Reggenti, Anna; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Lujan, Lucas A.; Saura, Alicia; Lujan, Hugo D.] Univ Catolica Cordoba UCC, Ctr Invest & Desarrollo Immunol & Enfermedades In, Consejo Nacl Invest Cient & Tecn CONICET, Cordoba, Argentina; [Larsen, Nicolai B.] Statens Serum Inst, Copenhagen S, Denmark	Uppsala University; Umea University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Statens Serum Institut	Svard, SG (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Uppsala, Sweden.; Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	staffan.svard@icm.uu.se; anders.hofer@umu.se		Krakovka, Sascha/0000-0002-4757-1551; Jimenez-Gonzalez, Alejandro/0000-0003-3493-4154; Larsen, Nicolai Balle/0000-0001-5105-7056; Lujan, Lucas Agustin/0000-0003-4235-4301	Swedish Research Council [2019-01242, 201805814]; Fondo Para la Investigacion Cientifica y Tecnologica, Argentina [PICT-13469, PICT-2703]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [D4408]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Fondo Para la Investigacion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Swedish Research Council (2019-01242 to A. H. and 201805814 to S. G. S.), Fondo Para la Investigacion Cientifica y Tecnologica, Argentina (PICT-13469 and PICT-2703 to H. D. L.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (D4408 to H. D. L.).	ALDRITT SM, 1985, J EXP MED, V161, P437, DOI 10.1084/jem.161.3.437; Bartelt Luther A, 2015, F1000Prime Rep, V7, P62, DOI 10.12703/P7-62; BAUM KF, 1989, J BIOL CHEM, V264, P21087; Canete R, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2019.12.017; Caron Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101420; Carter ER, 2018, CLIN MICROBIOL INFEC, V24, P37, DOI 10.1016/j.cmi.2017.05.028; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Eckhardt B.J., 2017, INFECT DIS-NOR, P1293; Einarsson E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/j.mib.2016.07.019; Einarsson E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004571; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; Goolsby TA, 2018, INT J ANTIMICROB AG, V51, P319, DOI 10.1016/j.ijantimicag.2017.08.033; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hausen MA, 2006, EXP PARASITOL, V113, P135, DOI 10.1016/j.exppara.2005.12.009; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hendrickx S, 2019, PARASITOL RES, V118, P2743, DOI 10.1007/s00436-019-06443-2; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim N, 2009, NATURE, V459, P1150, DOI 10.1038/nature08033; KLECKER RW, 1987, CLIN PHARMACOL THER, V41, P407, DOI 10.1038/clpt.1987.49; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LAOWORAWIT P, 1993, MOL BIOCHEM PARASIT, V60, P37, DOI 10.1016/0166-6851(93)90026-T; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; Morch K, 2008, J INFECTION, V56, P268, DOI 10.1016/j.jinf.2008.01.013; Muller J, 2018, INT J PARASITOL-DRUG, V8, P271, DOI 10.1016/j.ijpddr.2018.04.008; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; PEREZREYES E, 1980, MOL PHARMACOL, V17, P239; Peters TE, 2021, TRAVEL MED INFECT DI, V43, DOI 10.1016/j.tmaid.2021.102090; POSNER MR, 1992, CANCER, V70, P2929, DOI 10.1002/1097-0142(19921215)70:12<2929::AID-CNCR2820701233>3.0.CO;2-W; Poulin R, 2015, PARASITOLOGY, V142, pS6, DOI 10.1017/S0031182013001674; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; RALPH ED, 1974, ANTIMICROB AGENTS CH, V6, P691, DOI 10.1128/AAC.6.6.691; Ranjbarian F, 2022, NUCLEIC ACIDS RES, V50, DOI 10.1093/nar/gkab1117; Ranjbarian F, 2012, J BIOL CHEM, V287, P17628, DOI 10.1074/jbc.M112.340059; Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141; Bachur TPR, 2008, BRAZ J INFECT DIS, V12, P115, DOI 10.1590/S1413-86702008000200004; Rogawski ET, 2017, J PEDIATR INFECT DIS, V6, P153, DOI 10.1093/jpids/piw082; SCHUPP DG, 1987, J PARASITOL, V73, P723, DOI 10.2307/3282401; Serradell MC, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00773-17; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Shaima SN, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8121186; Sorensen CG, 2020, J NEUROL, V267, P1, DOI 10.1007/s00415-018-9147-6; Sperling R, 1998, Infect Dis Obstet Gynecol, V6, P197, DOI 10.1155/S1064744998000404; Tejman-Yarden N, 2011, ANTIMICROB AGENTS CH, V55, P4643, DOI 10.1128/AAC.00384-11; UPCROFT JA, 1993, PARASITOL TODAY, V9, P187, DOI 10.1016/0169-4758(93)90144-5; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; WANG CC, 1983, J EXP MED, V158, P1703, DOI 10.1084/jem.158.5.1703; Wattanagoon Y, 2000, ANTIMICROB AGENTS CH, V44, P1986, DOI 10.1128/AAC.44.7.1986-1989.2000; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102	56	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102028	10.1016/j.jbc.2022.102028	http://dx.doi.org/10.1016/j.jbc.2022.102028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35568200	Green Published, gold			2022-12-26	WOS:000811813400005
J	Zhou, HY; Yang, DF; Cheng, HS; McCoy, MG; Perez-Cremades, D; Haemmig, S; Wong, D; Chen, L; Feinberg, MW				Zhou, Haoyang; Yang, Dafeng; Cheng, Henry S.; McCoy, Michael G.; Perez-Cremades, Daniel; Haemmig, Stefan; Wong, Danny; Chen, Lei; Feinberg, Mark W.			miR-181b regulates vascular endothelial aging by modulating an MAP3K3 signaling pathway	FASEB JOURNAL			English	Article						apoptosis; atherosclerosis; endothelium; microRNA; senescence	NF-KAPPA-B; CELLULAR SENESCENCE; OXIDATIVE STRESS; APOPTOSIS; ACTIVATION; CANCER; CELLS; MECHANISMS; EXPRESSION; BIOMARKER	Endothelial cell (EC) aging plays a vital role in the pathogenesis of cardiovascular disease (CVD). MicroRNAs have emerged as crucial regulators of target gene expression by inhibiting mRNA translation and/or promoting mRNA degradation. We identify an aging-related and oxidative stress-responsive microRNA, miR-181b, that inhibits endothelial cell apoptosis and senescence. In gain- or loss-of-function studies, miR-181b regulated the expression of key apoptosis markers (Bcl2, Bax, cleaved-Caspase3) and senescence markers (p16, p21, gamma H2AX) and the ratio of apoptotic cells (TUNEL-positive) and senescent cells (SA-beta gal-positive) in H2O2-induced ECs. Mechanistically, miR-181b targets MAP3K3 and modulates a MAP3K3/MKK/MAPK signaling pathway. MAP3K3 knockdown recapitulated the phenotype of miR-181b overexpression and miR-181b was dependent on MAP3K3 for regulating EC apoptosis and senescence. In vivo, miR-181b expression showed a negative correlation with increasing age in the mouse aorta. Endothelial-specific deficiency of miR-181a2b2 increased the target MAP3K3, markers of vascular senescence (p16, p21), and DNA double-strand breaks (gamma H2AX) in the aorta of aged mice. Collectively, this study unveils an important role of miR-181b in regulating vascular endothelial aging via an MAP3K3-MAPK signaling pathway, providing new potential therapeutic targets for antiaging therapy in CVD.	[Zhou, Haoyang; Yang, Dafeng; Cheng, Henry S.; McCoy, Michael G.; Perez-Cremades, Daniel; Haemmig, Stefan; Wong, Danny; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA; [Zhou, Haoyang; Yang, Dafeng; Chen, Lei] Cent South Univ, Dept Cardiol, Xiangya Hosp 2, Changsha, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central South University	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Yang, Dafeng/HIK-2106-2022	Yang, Dafeng/0000-0002-8320-8215; Feinberg, Mark/0000-0001-9523-3859; Perez-Cremades, Daniel/0000-0002-0969-8762	National Institutes of Health [HL115141, HL134849, HL148207, HL148355, HL153356]; American Heart Association [18SFRN33900144, 20SFRN35200163]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health (HL115141, HL134849, HL148207, HL148355, HL153356 to M.W.F.), and the American Heart Association (18SFRN33900144 and 20SFRN35200163 to M.W.F.)	Anton B, 2005, ANN NY ACAD SCI, V1057, P525, DOI 10.1196/annals.1356.040; Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Chamoli M, 2014, AGING CELL, V13, P641, DOI 10.1111/acel.12218; Chen H, 2010, SCI CHINA LIFE SCI, V53, P101, DOI 10.1007/s11427-010-0002-y; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Dangwal S, 2014, ANNU REV PHARMACOL, V54, P185, DOI 10.1146/annurev-pharmtox-011613-135957; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563; Ellinger-Ziegelbauer H, 1999, MOL CELL BIOL, V19, P3857; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gude NA, 2018, NAT REV CARDIOL, V15, P523, DOI 10.1038/s41569-018-0061-5; Guo SY, 2012, ONCOL REP, V27, P441, DOI 10.3892/or.2011.1509; Guo YM, 2017, AGING CELL, V16, P837, DOI 10.1111/acel.12615; Haemmig S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw1868; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001; Kuo LJ, 2008, IN VIVO, V22, P305; Lam JKW, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.23; Li DF, 2014, INT J CLIN EXP PATHO, V7, P7672; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Ling L, 2021, INFLAMMATION, V44, P1263, DOI 10.1007/s10753-020-01411-w; Liu B, 2019, EXP THER MED, V17, P1537, DOI 10.3892/etm.2019.7159; Liu J, 2014, BIOMED REP, V2, P7, DOI 10.3892/br.2013.199; Liu YQ, 2016, PROTEIN CELL, V7, P722, DOI 10.1007/s13238-016-0313-2; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Lv Y, 2020, MOL CELL BIOCHEM, V464, P193, DOI 10.1007/s11010-019-03660-2; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Munzel T, 2017, J AM COLL CARDIOL, V70, P212, DOI 10.1016/j.jacc.2017.05.035; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Pang XL, 2019, J CELL BIOCHEM, V120, P12822, DOI 10.1002/jcb.28553; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002; Ungvari Z, 2018, NAT REV CARDIOL, V15, P555, DOI 10.1038/s41569-018-0030-z; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang L, 2019, J CELL PHYSIOL, V234, P15206, DOI 10.1002/jcp.28162; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yang DF, 2022, ATHEROSCLEROSIS, V350, P9, DOI 10.1016/j.atherosclerosis.2022.04.010; Yang L, 2014, FEBS LETT, V588, P124, DOI 10.1016/j.febslet.2013.11.019; Yang XF, 2020, INT J MOL MED, V46, P1755, DOI 10.3892/ijmm.2020.4720; Zhi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109124; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179; Zhu FX, 2019, J CELL PHYSIOL, V234, P18963, DOI 10.1002/jcp.28536; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	70	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22353	10.1096/fj.202200046R	http://dx.doi.org/10.1096/fj.202200046R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5GG	35593587				2022-12-26	WOS:000797946600001
J	Moens, C; Muller, CJF; Bouwens, L				Moens, Celine; Muller, Christo J. F.; Bouwens, Luc			In vitro comparison of various antioxidants and flavonoids from Rooibos as beta cell protectants against lipotoxicity and oxidative stress-induced cell death	PLOS ONE			English	Article							GLUCOSE-INTOLERANCE; N-ACETYLCYSTEINE; ASPALATHIN; APOPTOSIS; SURVIVAL; OXYGEN; GENE; NRF2	Oxidative stress and lipotoxicity effects on pancreatic beta cells play a major role in the pathogenesis of type 2 diabetes (T2D). Flavonoids and antioxidants are under study for their cytoprotective effects and antidiabetic potential. In this study, we aimed to compare the protective effect of the Rooibos components aspalathin, isoorientin, 3-hydroxyphloretin (3-OH) and green Rooibos extract (GRT) itself, and exendin-4 and N-acetylcysteine (NAC) as reference molecules, against lipotoxicity and oxidative stress. The insulin-producing beta cell line INS1E was exposed to hydrogen peroxide or streptozotocin (STZ) to induce oxidative stress, and palmitate to induce lipotoxicity. Cell viability was assessed by a MTS cell viability assay. Antioxidant response and antiapoptotic gene expression was performed by qRT-PCR. Glucose transporter 2 (GLUT 2) transporter inhibition was assessed through 2-NBDG uptake. GRT and the flavonoids aspalathin and 3-hydroxyphloretin offered significant protection against oxidative stress and lipotoxicity. GRT downregulated expression of pro-apoptotic genes Txnip and Ddit3. The flavonoids aspalathin and 3-hydroxyphloretin also downregulated these genes and in addition upregulated expression of antioxidant response genes Hmox1, Nqo1 and Sod1. Isoorientin gave no cytoprotection. Cytoprotection by Rooibos components was significantly higher than by NAC or exendin-4. Rooibos components strongly protect INS1E beta cells against diabetogenic stress. Cytoprotection was associated with the upregulation of antioxidant response genes of the NRF2/KEAP1 pathway or suppression of the TXN system. The Rooibos molecules offered better protection against these insults than exendin-4 and NAC, making them interesting candidates as beta cell cytoprotectants for therapeutic or nutraceutical applications.	[Moens, Celine; Bouwens, Luc] Vrije Univ Brussel, Cell Differentiat Lab, Brussels, Belgium; [Muller, Christo J. F.] South African Med Res Council MRC, Biomed Res & Innovat Platform BRIP, Tygerberg, South Africa; [Muller, Christo J. F.] Stellenbosch Univ, Fac Med & Hlth Sci, Ctr Cardiometab Res Africa, Div Med Physiol, Stellenbosch, South Africa; [Muller, Christo J. F.] Univ Zululand, Dept Biochem & Microbiol, Kwa Dlangezwa, Empangeni, South Africa	Vrije Universiteit Brussel; Stellenbosch University; University of Zululand	Moens, C (corresponding author), Vrije Univ Brussel, Cell Differentiat Lab, Brussels, Belgium.	celine.moens@vub.de		Bouwens, Luc/0000-0001-5767-7002; Moens, Celine/0000-0002-4125-4950	BRIDGE Strategic Platform Grant from Innoviris-Brussels, "Personalized medicine in diabetes" (DiaType) [BRGIMP11]	BRIDGE Strategic Platform Grant from Innoviris-Brussels, "Personalized medicine in diabetes" (DiaType)	This research was funded by a BRIDGE Strategic Platform Grant from Innoviris-Brussels, "Personalized medicine in diabetes" (DiaType), grant number BRGIMP11.	Ajuwon OR, 2018, MOLECULES, V23, DOI 10.3390/molecules23123207; Al Nahdi AMT, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7054272; Al-Nahdi AM, 2018, CELL PHYSIOL BIOCHEM, V51, P201, DOI 10.1159/000495200; Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bao W., 2010, HUMAN GENOME EPIDEMI, V172; Baumel-Alterzon S, 2021, TRENDS ENDOCRIN MET, V32, P7, DOI 10.1016/j.tem.2020.11.002; Beekmann K, 2016, J AGR FOOD CHEM, V64, P1256, DOI 10.1021/acs.jafc.5b05456; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Falach-Malik A, 2016, AM J TRANSL RES, V8, P3744; Ghorbani A, 2019, BIOMED PHARMACOTHER, V111, P947, DOI 10.1016/j.biopha.2018.12.127; Grootaert C, 2016, J BIOMOL SCREEN, V21, P858, DOI 10.1177/1087057116653220; Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Himpe E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157604; Hosseini A, 2015, BRAZ J PHARM SCI, V51, P1, DOI 10.1590/S1984-82502015000100001; Johnson R, 2018, PLANTA MED, V84, DOI 10.1055/s-0044-100622; Johnson R, 2017, MOLECULES, V22, DOI 10.3390/molecules22020219; Joubert E, 2005, J AGR FOOD CHEM, V53, P10260, DOI 10.1021/jf051355a; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kim MH., 2017, TOXICOL APPL PHARM, P315; Krafczyk N, 2009, MOL NUTR FOOD RES, V53, P635, DOI 10.1002/mnfr.200800117; Kroon PA, 2004, AM J CLIN NUTR, V80, P15; Lablanche S, 2015, BBA-BIOENERGETICS, V1847, P629, DOI 10.1016/j.bbabio.2015.04.002; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lim JH, 2007, ARCH PHARM RES, V30, P1590, DOI 10.1007/BF02977329; Malik A, 2019, DRUG DES DEV THER, V13, P1501, DOI 10.2147/DDDT.S176698; Mangmool S, 2015, MOL ENDOCRINOL, V29, P583, DOI 10.1210/me.2014-1346; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Moens C, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201901009; Muller CJF, 2012, PHYTOMEDICINE, V20, P32, DOI 10.1016/j.phymed.2012.09.010; Muscogiuri G, 2013, DIABETES, V62, P4201, DOI 10.2337/db13-0314; Natalicchio A, 2013, DIABETOLOGIA, V56, P2456, DOI 10.1007/s00125-013-3028-4; Orlando P, 2019, MOLECULES, V24, DOI 10.3390/molecules24091713; Patel O, 2016, MOLECULES, V21, DOI 10.3390/molecules21111515; Roma LP, 2011, REDOX REP, V16, P173, DOI 10.1179/1351000211Y.0000000006; Sezik E, 2005, LIFE SCI, V76, P1223, DOI 10.1016/j.lfs.2004.07.024; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Song I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186480; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; Yeo SH, 2013, TOXICOL LETT, V219, P35, DOI 10.1016/j.toxlet.2013.02.013; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhitkovich A, 2019, CHEM RES TOXICOL, V32, P1318, DOI 10.1021/acs.chemrestox.9b00152; Zummo FP, 2017, DIABETES, V66, P1272, DOI 10.2337/db16-1009	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2022	17	5							e0268551	10.1371/journal.pone.0268551	http://dx.doi.org/10.1371/journal.pone.0268551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5H3YX	35580081	gold, Green Published			2022-12-26	WOS:000867618600002
J	Razavi, S; Farrokhnia, N; Davoody, N				Razavi, SeyedehMaryam; Farrokhnia, Nasim; Davoody, Nadia			Nurses' experience of using video consultation in a digital care setting and its impact on their workflow and communication	PLOS ONE			English	Article							NURSING-CARE; HEALTH-CARE; TELEMEDICINE; IMPLEMENTATION; TELEHEALTH; OUTCOMES; EHEALTH	Sweden as many other countries uses video consultation to increase patients' access to primary healthcare services particularly during the COVID-19 pandemic. Working in digital care settings and using new technologies, in this case video consultations, require learning new skills and adoption to new workflow. The aim of this study is to explore nurses' experience of using video consultation in a digital care setting and its impact on their workflow and communication. Fifteen semi-structured interviews were carried out with registered nurses recruited from a private digital healthcare provider. Interviews were recorded, transcribed, and analysed using an abductive approach. Nurses' workflow was modeled, and several categories and subcategories were identified: nurses' workflow (efficiency, flexibility, and information accessibility); communication (interaction with patients and interprofessional communication); user experience (change and development of the platform, challenges, and combining digital and physical care). Even though providing online care has its limitations, the nurses were positive towards using video consultations.	[Razavi, SeyedehMaryam; Davoody, Nadia] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Farrokhnia, Nasim] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Davoody, N (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden.	nadia.davoody@ki.se			Health Informatics Center at Karolinska Institute	Health Informatics Center at Karolinska Institute	The Health Informatics Center at Karolinska Institute has been supporting the project. The funding has not affected the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.	Alhajri N, 2021, JMIR MED INF, V9, DOI 10.2196/29251; Alsweed Fatimah, 2014, Int J Electron Healthc, V7, P287, DOI 10.1504/IJEH.2014.064328; [Anonymous], IS IT WORKS; [Anonymous], NATIONELL PATIENTOVE; Arnaert A, 2007, CAN J NURS RES, V39, P21; Barbosa ID, 2017, REV BRAS ENFERM, V70, P928, DOI 10.1590/0034-7167-2016-0142; Barney A, 2020, J ADOLESCENT HEALTH, V67, P164, DOI 10.1016/j.jadohealth.2020.05.006; Bengtsson L, KRY LAUNCHES DIGI PH; Blix M, 2018, DIGITALIZATION HLTH; Bombaci A, 2021, NEUROL SCI, V42, P9, DOI 10.1007/s10072-020-04783-x; Breton M, 2021, BMC FAM PRACT, V22, DOI 10.1186/s12875-021-01543-4; Breton Mylaine, 2021, Healthc Policy, V17, P73, DOI 10.12927/hcpol.2021.26576; Dahl-Popolizio S, 2020, INT J TELEREHABILITA, V12, P77, DOI 10.5195/ijt.2020.6328; De Weger E, 2013, J PSYCHIATR MENT HLT, V20, P448, DOI 10.1111/j.1365-2850.2012.01947.x; Dichmann Sorknaes A, 2016, STUD HEALTH TECHNOL, V225, P885, DOI 10.3233/978-1-61499-658-3-885; Dieperink KB, 2020, ANN ONCOL, V31, pS1125, DOI 10.1016/j.annonc.2020.08.2108; Donaghy E, 2019, BRIT J GEN PRACT, V69, pE586, DOI 10.3399/bjgp19X704141; Ekman B, 2019, INT J MED INFORM, V127, P134, DOI 10.1016/j.ijmedinf.2019.04.016; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20; Funderskov KF, 2019, J CLIN NURS, V28, P3966, DOI 10.1111/jocn.15004; Greenhalgh T, 2020, VIDEO CONSULTATIONS; Greenhalgh T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009388; Harvey J, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0869-x; Hensel JM, 2021, COUNS PSYCHOTHER RES, V21, P535, DOI 10.1002/capr.12372; Jeon E, 2015, STUD HEALTH TECHNOL, V210, P321, DOI 10.3233/978-1-61499-512-8-321; Jimenez-Rodriguez D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145112; Johansson AM, 2017, PRIM HEALTH CARE RES, V18, P73, DOI 10.1017/S1463423616000347; Kleinpell R, 2016, AM J CRIT CARE, V25, pE14, DOI 10.4037/ajcc2016808; Mirza NA, 2014, J ADV NURS, V70, P1980, DOI 10.1111/jan.12379; Monaghesh E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09301-4; Oh H, 2005, J MED INTERNET RES, V7; Oliveira-Hashiguchi TC., 2020, OECD HLTH WORKING PA, V116, DOI [10.1787/8-56ede7-en, DOI 10.1787/8-56EDE7-EN]; Ossebaard HC, 2016, INT J QUAL HEALTH C, V28, P415, DOI 10.1093/intqhc/mzw032; Primholdt Christensen Nina, 2018, J Particip Med, V10, pe11089, DOI 10.2196/11089; Randhawa RS, 2018, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423618000361; Rheuban KS, 2006, J TELEMED TELECARE, V12, P45, DOI 10.1258/135763306778393171; Ricciardi D, 2021, NEUROL SCI, V42, P4889, DOI 10.1007/s10072-021-05566-8; Rodrigues R. J., 2003, International Journal of Healthcare Technology and Management, V5, P335, DOI 10.1504/IJHTM.2003.004173; Rouleau Genevieve, 2017, J Med Internet Res, V19, pe122, DOI 10.2196/jmir.6686; Salisbury C, 2020, J MED INTERNET RES, V22, DOI 10.2196/19415; Santoro SL, 2021, AM J MED GENET C, V187, P70, DOI 10.1002/ajmg.c.31876; Scheuerlein H, 2012, LANGENBECK ARCH SURG, V397, P755, DOI 10.1007/s00423-012-0914-z; Sittig DF, 2015, COGNITIVE INFORM BIO, P59; Spina E, 2022, NEUROL SCI, P1, DOI [10.1007/s10072-021-05842-7, DOI 10.1007/S10072-021-05842-7]; Spina E, 2021, NEUROL SCI, V42, P3553, DOI 10.1007/s10072-021-05396-8; Sutherland AE., 2020, BMJ SUPPORT PALLIAT, V10, P271, DOI DOI 10.1136/bmjspcare-2020-002326; Tavares AI, 2018, INT J MED INFORM, V112, P104, DOI 10.1016/j.ijmedinf.2018.01.014; Thiyagarajan Arun, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101020; van Uden-Kraan CF, 2008, QUAL HEALTH RES, V18, P405, DOI 10.1177/1049732307313429; Wang Huan, 2021, Prim Health Care Res Dev, V22, pe48, DOI 10.1017/S1463423621000517; Whitworth B, 2009, HDB RES SOCIOTECHNIC	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2022	17	5							e0264876	10.1371/journal.pone.0264876	http://dx.doi.org/10.1371/journal.pone.0264876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Z9EN	35552539	Green Submitted, gold, Green Published			2022-12-26	WOS:000880268200001
J	Anyi, JN; Pouakam, AT; Amba, JC; Eric, F; Nizegha, PD; Momha, MB; Djopkop, L; Nzengwa, R				Anyi, Joseph Nkongho; Pouakam, Alexandra Tchamdjie; Amba, Jean Chills; Eric, Fongho; Nizegha, Platon Dongmo; Momha, Merlin Bodol; Djopkop, Landry; Nzengwa, Robert			Investigation of the macroscopic behaviour of laminates shells (MBLS) under varying loads using low order CSFE-sh FEM and the N-T's 2-D shell equations	PLOS ONE			English	Article							CYLINDRICAL-SHELLS; FINITE-ELEMENTS; PLATES	The target in this survey is to investigate deformations of laminates shells (DLS), due to asymmetric and axisymmetric loads, including several other loadings using N-T shell equations. We point out here, the contribution of the metric change in thickness for the analysis of static and linear behavior of laminated composite shells. To achieve this objective, we've applied N-T's shells equations on the same monolayer laminate composite shell and derive the law of MBLS. The macrostructure is analyzed under static loads and implemented using low order curved shell finite elements with shifted Lagrange (CSFE-sh). We tested this element on benchmarks found within the literature. The analysis of cylindrical and spherical shells subjected to uniform sinusoidal pressures and asymmetric pressures reveals excellent accuracy compared to others. The results found without any correction factor were compared with those obtained by the analytical method and other finite element models.	[Anyi, Joseph Nkongho; Pouakam, Alexandra Tchamdjie; Amba, Jean Chills; Eric, Fongho; Nizegha, Platon Dongmo; Momha, Merlin Bodol; Djopkop, Landry; Nzengwa, Robert] Univ Douala, Ecole Natl Super Polytech Douala, Lab E3M, Douala, Cameroon; [Anyi, Joseph Nkongho] Univ Buea Kumba, Dept Mech Engn, Higher Tech Teachers Training Coll, Kumba, Cameroon; [Anyi, Joseph Nkongho; Nzengwa, Robert] Natl Adv Sch Polytech Univ Yaounde I Cameroon, Dept Mech Engn, Yaounde, Cameroon		Anyi, JN (corresponding author), Univ Douala, Ecole Natl Super Polytech Douala, Lab E3M, Douala, Cameroon.; Anyi, JN (corresponding author), Univ Buea Kumba, Dept Mech Engn, Higher Tech Teachers Training Coll, Kumba, Cameroon.; Anyi, JN (corresponding author), Natl Adv Sch Polytech Univ Yaounde I Cameroon, Dept Mech Engn, Yaounde, Cameroon.	nkongho.anyi@ubuea.cm		Jean Chills, Amba/0000-0002-5801-1349				ALWAR M.C.N.R.S, 1991, COMPUTERS STRUCTURE, V41, P611; ALWAR RS, 1990, COMPOS STRUCT, V15, P215, DOI 10.1016/0263-8223(90)90032-A; Anyi JN, 2020, CURVED LAYER STRUCT, V7, P125, DOI 10.1515/cls-2020-0010; Anyi Joseph Nkongho R.N.A.J.C.A.N.C.V., 2016, MATH PROBL ENG, V12; Barbero E, 1989, GEN LAMINATE THEORY; Belytschko T, 2000, NONLINEAR FINITE ELE, V1st, DOI DOI 10.1055/S-2006-943830; Bogdanovich, 1966, MECH TEXT LAM COMP A; Carrera E, 2003, ARCH COMPUT METHOD E, V10, P215, DOI 10.1007/BF02736224; Carrera E, 2002, ARCH COMPUT METHOD E, V9, P87, DOI 10.1007/BF02736649; DISCIUVA M, 1993, COMPUT STRUCT, V47, P91, DOI 10.1016/0045-7949(93)90282-I; Ghugal YM, 2002, J REINF PLAST COMP, V21, P775, DOI [10.1177/073168402128988481, 10.1106/073168402025748]; Katili I.J.M.A.I.A.m.k.I., 2020, STRUCTURES COMPOSITE, DOI [10.1016/j.compositesa.2020.106009, DOI 10.1016/J.COMPOSITESA.2020.106009]; Katili I.J.M.J.B.A.I.I., 2018, COMPOS STRUCT, DOI [10.1016/j.compstruct.2017.12.006, DOI 10.1016/J.COMPSTRUCT.2017.12.006]; Kumar A, 2013, LAT AM J SOLIDS STRU, V10, P891; Mantari JL, 2011, COMPOS STRUCT, V94, P37, DOI 10.1016/j.compstruct.2011.07.020; Maria Cinefra, 2016, Applied Mechanics and Materials, V828, P215, DOI 10.4028/www.scientific.net/AMM.828.215; Mohamed M, 2015, ANAL MECANIQUE STRUC; Naceur S. S. D. C. J. B. H., 2013, MODELING DESIGN COMP; Nzengwa R, 1999, INT J SOLIDS STRUCT, V36, P5141, DOI 10.1016/S0020-7683(98)00165-6; PAGANO NJ, 1969, J COMPOS MATER, V3, P398, DOI 10.1177/002199836900300304; RAO KP, 1978, COMPUT METHOD APPL M, V15, P13, DOI 10.1016/0045-7825(78)90003-8; Reddy D R.J, 1991, COMPUT STRUCT, V41; Reddy J.N., 1984, ENERGY VARIATIONAL M; REN JG, 1989, COMPOS STRUCT, V11, P277, DOI 10.1016/0263-8223(89)90092-5; REN JG, 1987, COMPOS SCI TECHNOL, V29, P169, DOI 10.1016/0266-3538(87)90069-8; ROBBINS DH, 1993, INT J NUMER METH ENG, V36, P655, DOI 10.1002/nme.1620360407; Seide P., MECHANICS, P1980; SRINIVAS S, 1973, J SOUND VIB, V30, P495, DOI 10.1016/S0022-460X(73)80170-1; Tafla, 2007, EL FIN MIXT HYBR NAT; Timoshenko S.W.-K.S., 1959, THEORY PLATE SHELLS; Tornabene M.B.F, 2019, ADV STRUCTURED MAT, V110; Varadan K.B.T, 1991, COMPOS STRUCT, V1, P17; VARADAN TK, 1991, COMPOS STRUCT, V17, P141, DOI 10.1016/0263-8223(91)90067-9; Viola E, 2013, COMPOS STRUCT, V101, P59, DOI 10.1016/j.compstruct.2013.01.002; Zhang YX, 2009, COMPOS STRUCT, V88, P147, DOI 10.1016/j.compstruct.2008.02.014	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267480	http://dx.doi.org/10.1371/journal.pone.0267480			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560313	Green Published, gold			2022-12-26	WOS:000835326900028
J	Ichikawa, J; Kouta, M; Oogushi, M; Komori, M				Ichikawa, Junko; Kouta, Masaki; Oogushi, Masako; Komori, Makiko			Effects of room temperature and cold storage on the metabolic and haemostatic properties of whole blood for acute normovolaemic haemodilution	PLOS ONE			English	Article							PLATELET-AGGREGATION; REFRIGERATION; STATIONARY	BackgroundAcute normovolaemic haemodilution (ANH), as a blood-conservation technique, avoids the need for allogeneic blood transfusions. The historic practice of cold-storing type-O whole blood (WB) in military fields popularised the transfusion of refrigerated WB to treat acute bleeding. In this study, we compared the effects of room temperature (RT) and refrigeration up to 24 hours on the coagulation properties of WB for ANH. Materials and methodsEach WB sample, collected from 12 male volunteers, was divided into two parts, one stored at RT and the other refrigerated for 24 hours. Complete blood counts (CBC), blood gas levels, and coagulation profiles were measured, and rotational thromboelastometry (ROTEM) measurements were performed at the initial collection time point (baseline) and at 6, 12, and 24 hours after initial collection. ResultsThe preservation of platelet aggregation response induced by arachidonic acid and adenosine diphosphate was better in cold-stored WB compared to that in RT-stored WB. The platelet aggregation response induced by thrombin receptor-activating peptide 6 was significantly decreased in all samples after 24 hours of storage when compared with that at baseline. The lactate levels in WB stored at RT increased significantly after 6 hours of storage compared to that of cold-stored samples. There were no significant differences in CBC, coagulation parameters, and ROTEM variables between the cold-stored and RT-stored WB samples. ConclusionWB for ANH stored in the refrigerator showed better metabolic characteristics after 6 hours of storage and better aggregation response after 12 hours of storage than WB stored at RT.	[Ichikawa, Junko; Kouta, Masaki; Oogushi, Masako; Komori, Makiko] Tokyo Womens Med Univ Med Ctr East, Dept Anaesthesiol, Tokyo, Japan		Ichikawa, J (corresponding author), Tokyo Womens Med Univ Med Ctr East, Dept Anaesthesiol, Tokyo, Japan.	htwfx872@yahoo.co.jp			JSPS KAKENHI [16K10948]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI (Grant Number 16K10948).JI recived this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badlou BA, 2005, TRANSFUSION, V45, P214, DOI 10.1111/j.1537-2995.2004.04022.x; Baker JM, 2001, PLATELETS, V12, P333; BERTOLINI F, 1993, VOX SANG, V65, P194, DOI 10.1111/j.1423-0410.1993.tb02147.x; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Egidi MG, 2010, BLOOD TRANSFUS-ITALY, V8, pS73, DOI 10.2450/2010.012S; Faraday N, 1997, THROMB HAEMOSTASIS, V77, P748; Goodnough LT, 2002, VOX SANG, V83, P211, DOI 10.1111/j.1423-0410.2002.tb05304.x; Hazelton JP, 2019, J TRAUMA ACUTE CARE, V87, P1035, DOI 10.1097/TA.0000000000002471; HOLME S, 1995, BRIT J HAEMATOL, V91, P212, DOI 10.1111/j.1365-2141.1995.tb05272.x; Hornsey VS, 2008, VOX SANG, V95, P26, DOI 10.1111/j.1423-0410.2008.01052.x; Hughes JD, 2007, TRANSFUSION, V47, P2050, DOI 10.1111/j.1537-2995.2007.01429.x; Johnson L, 2016, TRANSFUSION, V56, P1807, DOI 10.1111/trf.13630; Ketter PM, 2019, TRANSFUSION, V59, P1479, DOI 10.1111/trf.15255; KOFOED KF, 1991, THROMB RES, V63, P549, DOI 10.1016/0049-3848(91)90180-5; Lozano ML, 1997, TRANSFUSION, V37, P368, DOI 10.1046/j.1537-2995.1997.37497265336.x; Lu SY, 2014, ANESTH ANALG, V118, P264, DOI 10.1213/ANE.0000000000000046; MANNO CS, 1991, BLOOD, V77, P930, DOI 10.1182/blood.V77.5.930.930; McRae HL, 2021, VOX SANG, V116, P190, DOI 10.1111/vox.13005; Meledeo MA, 2019, TRANSFUSION, V59, P1549, DOI 10.1111/trf.15164; Nair PM, 2021, TRANSFUSION, V61, pS68, DOI 10.1111/trf.16530; NESS PM, 1992, TRANSFUSION, V32, P226, DOI 10.1046/j.1537-2995.1992.32392213805.x; O'Neill EM, 1999, TRANSFUSION, V39, P488, DOI 10.1046/j.1537-2995.1999.39050488.x; Pidcoke HF, 2013, TRANSFUSION, V53, p137S, DOI 10.1111/trf.12048; Ranucci M, 2020, PLATELETS, V31, P88, DOI 10.1080/09537104.2019.1581920; Reddoch KM, 2014, SHOCK, V41, P54, DOI 10.1097/SHK.0000000000000082; Reddoch-Cardenas KM, 2019, TRANSFUS APHER SCI, V58, P16, DOI 10.1016/j.transci.2018.12.012; Solomon C, 2015, ANESTH ANALG, V121, P868, DOI 10.1213/ANE.0000000000000859; Tzounakas VL, 2016, TRANSFUSION, V56, P1274, DOI 10.1111/trf.13582; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019; Yazer MH, 2016, TRANSFUSION, V56, P596, DOI 10.1111/trf.13448	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267980	http://dx.doi.org/10.1371/journal.pone.0267980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560137	Green Published, gold			2022-12-26	WOS:000835326900013
J	Min, K; Choi, MA				Min, Kyungjin; Choi, Myung-Ae			Resource landscape, microbial activity, and community composition under wintering crane activities in the Demilitarized Zone, South Korea	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; CARBON; RHIZOSPHERE; ECOSYSTEMS; WATERFOWL; ABUNDANCE; ADDITIONS; PATTERN	Endangered cranes migrate to the Demilitarized Zone in Korea in search for habitat and food during winter. While cranes have the potential to influence soil biogeochemical processes via dropping, foraging, and walking, few studies have investigated ecological roles of migrating birds in the new habitat. Here, we explored how cranes alter resource landscape (the amount and quality of carbon) and microbial community in soil. We set up control (fenced, no crane access) and treatment (free crane activities) plots (n = 6, respectively) in a rice paddy, and collected soils at 0-15 cm three months after the crane migration. Soils were tested for total carbon, total nitrogen, water extractable organic carbon, and Diffuse Reflectance Infrared Fourier Transform Spectroscopy, along with microbial parameters (biomass, respiration, community composition). The wintering crane activity significantly increased total carbon and nitrogen contents, but decreased the ratio of CH (aliphatic) to COO (carboxylic) in soil. Also, both microbial biomass and respiration was greater in soils under crane activities. Bacterial and fungal community composition differed with or without crane activities, with treatment soils harboring more diverse microbial communities. Our results demonstrate that crane migration created a distinct system with altered resource landscape and microbial community, highlighting beneficial effects of migratory cranes on the soil biogeochemical processes in rice paddies. This study may help encourage more farmers, local governments, and the public to participate in crane conservation campaigns targeted at rice fields.	[Min, Kyungjin; Choi, Myung-Ae] Korea Adv Inst Sci & Technol, Ctr Anthropocene Studies, Daejeon, South Korea; [Min, Kyungjin] Univ Calif Merced, Dept Life & Environm Sci, Merced, CA 95343 USA	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Merced	Min, K (corresponding author), Univ Calif Merced, Dept Life & Environm Sci, Merced, CA 95343 USA.	kjmin.21@gmail.com		Min, Kyungjin/0000-0002-6189-6192	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2018R1A5A7025409, NRF-2019H1D3A1A01070116]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	We appreciate Kyung-Won Seo, Jong-Soo Choi, Yong-Bin Kim (local farmers of Cheorwon for allowing us to get access to the study site and perform field work. We are also grateful to Dr. Wook-Hyun Nahm for the help of field work, Dr. So-Jeong Kim for the access to the labs at Korea Institute of Geoscience and Mineral Resources, and Drs. Seonghwa Yoo and Kisup Lee for inviting us to the crane surveys	Artz RRE, 2006, SOIL BIOL BIOCHEM, V38, P2958, DOI 10.1016/j.soilbio.2006.04.017; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Bird JA, 2000, J APPL ECOL, V37, P728, DOI 10.1046/j.1365-2664.2000.00539.x; BirdLifeInternational, 2018, IUCN RED LIST THREAT, P2018, DOI [10.2305/IUCN.UK.2018-2.RLTS.T22692073A131927305.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T22692073A131927305.EN]; Blagodatskaya E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093282; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Cheng W. X., 2005, Roots and soil management: interactions between roots and the soil, P119; Choi Myung Ae, 2021, ECO, V25, P213, DOI 10.22734/ECO.25.1.202106.006; Chun lab, US; Davis KER, 2011, ENVIRON MICROBIOL, V13, P798, DOI 10.1111/j.1462-2920.2010.02384.x; Dessaux Y, 2016, TRENDS PLANT SCI, V21, P266, DOI 10.1016/j.tplants.2016.01.002; Edwards DP, 2015, CURR BIOL, V25, P2384, DOI 10.1016/j.cub.2015.07.063; Ellerbrock RH, 1999, PLANT SOIL, V213, P55, DOI 10.1023/A:1004511714538; Elphick CS, 2015, J ORNITHOL, V156, pS239, DOI 10.1007/s10336-015-1194-5; Environment M of, 2020, SEJONG; Environment" "Ministry of, 2020, CRAN HAB PROT SCHEM; ezbiocloud, EZBIOCLOUD APPS; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Firth AG, 2020, METHODSX, V7, DOI 10.1016/j.mex.2020.101036; Firth AG, 2020, AGR ECOSYST ENVIRON, V300, DOI 10.1016/j.agee.2020.106962; Freedman ZB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00259; Freedman ZB, 2015, SOIL BIOL BIOCHEM, V90, P275, DOI 10.1016/j.soilbio.2015.08.014; Fujioka M, 2010, WATERBIRDS, V33, P8, DOI 10.1675/063.033.s102; Go H., 2021, ANCHORAGE, P509; Graham EB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00214; Grandy A, 2008, BIOGEOCHEMISTRY, V91, P37, DOI 10.1007/s10533-008-9257-9; Hall SJ, 2018, BIOGEOCHEMISTRY, V140, P93, DOI [10.1007/s10533-018-0476-4, 10.1007/s10533-018-04]; Higuchi H, 1998, ECOL RES, V13, P273, DOI 10.1046/j.1440-1703.1998.00271.x; Higuchi Hiroyoshi, 2000, Global Environmental Research, V4, P123; 송관철, 2010, [Korean Journal of Environmental Agriculture, 한국환경농학회지], V29, P27; Kaiser M, 2005, GEODERMA, V127, P196, DOI 10.1016/j.geoderma.2004.12.002; Kameda K, 2006, HYDROBIOLOGIA, V567, P69, DOI 10.1007/s10750-006-0052-0; Kear J., 1961, WILDFOWL, V14, P72; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; KFEM, 2021, DRAM INCR 1200BN 330; Kim H., 2021, WINTER WATERBIRD CEN; 남형규, 2016, [Korean Journal of Environmental Agriculture, 한국환경농학회지], V35, P143, DOI 10.5338/KJEA.2016.35.2.16; Korea Meteorological Administration, US; Kremen C, 2015, ANN NY ACAD SCI, V1355, P52, DOI 10.1111/nyas.12845; Lee H., 2009, KOREAN J ENV BIOL, V27, P375; Lee J., 2010, CRANE; Lee SD, 2007, BIOL CONSERV, V138, P286, DOI 10.1016/j.biocon.2007.04.007; Malik AA, 2020, ISME J, V14, P1, DOI 10.1038/s41396-019-0510-0; Mao YJ, 2014, ENV MICROBIOL REP, V6, P293, DOI 10.1111/1758-2229.12152; Meine CD., 1996, BIRDS OF THE WORLD, DOI [10.2173/bow.watcra2.01, DOI 10.2173/BOW.WATCRA2.01]; Min K, 2021, SOIL BIOL BIOCHEM, V162, DOI 10.1016/j.soilbio.2021.108401; Min K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02083; Min K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825098; Min K, 2011, SOIL BIOL BIOCHEM, V43, P2461, DOI 10.1016/j.soilbio.2011.08.019; 유승화, 2011, [Korean Journal of Ornithology, 한국조류학회지], V18, P59; Prosser JI, 2015, NAT REV MICROBIOL, V13, P439, DOI 10.1038/nrmicro3468; R Core Team, US; Ryals R, 2014, SOIL BIOL BIOCHEM, V68, P52, DOI 10.1016/j.soilbio.2013.09.011; Slessarev EW, 2020, BIOGEOCHEMISTRY, V147, P307, DOI 10.1007/s10533-020-00645-y; Suseela V, 2016, FUNCT ECOL, V30, P1227, DOI 10.1111/1365-2435.12591; Tomassen HBM, 2005, CAN J BOT, V83, P1046, DOI 10.1139/B05-051; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; UNITE, US; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Whittinghill KA, 2012, ECOSYSTEMS, V15, P450, DOI 10.1007/s10021-012-9521-7; WWF (World Wide Fund for Nature), 2016, DMZ CHEORW CRAN FIEL; Yoo S., 2020, J ENV IMPACT ACCESS, P29; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zak DR, 2017, GLOBAL CHANGE BIOL, V23, P933, DOI 10.1111/gcb.13480; Zhang XC, 2019, SOIL BIOL BIOCHEM, V133, P83, DOI 10.1016/j.soilbio.2019.02.010; Zooniverse, ID COUT CRAN S KOR D	68	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268461	10.1371/journal.pone.0268461	http://dx.doi.org/10.1371/journal.pone.0268461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560038	Green Published, gold			2022-12-26	WOS:000834668000008
J	Ahmed, HGMD; Rizwan, M; Naeem, M; Khan, MA; Baloch, FS; Sun, SM; Chung, G				Ahmed, Hafiz Ghulam Muhu-Din; Rizwan, Muhammad; Naeem, Muhammad; Khan, Muhammad Ahsan; Baloch, Faheem Shehzad; Sun, Sangmi; Chung, Gyuhwa			Molecular characterization and validation of sunflower (Helianthus annuus L.) hybrids through SSR markers	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-STRUCTURE; INBRED LINES; MICROSATELLITE; PURITY; IDENTIFICATION; GENOTYPES	Genetic purity is a prerequisite for exploiting the potential of hybrids in cross-pollinated crops, such as sunflower. In this regard DNA-based study was conducted using 110 simple sequence repeat (SSR) markers to check the genetic purity of 23 parents and their 60 hybrids in sunflower. The polymorphism was shown in 92 markers with value 83.63%. The SSR markers ORS-453 and CO-306 showed the highest PIC values of 0.76 and 0.74, respectively. The primer ORS-453 amplified allele size of 310 base pairs (bp) for female parent L6 and 320 bp for L11, while for male parents, T1 and T2 had allele size 350 bp and 340 bp, respectively. The hybrids from these parents showed a similar size of alleles with parents, including hybrids L6xT1 (310 bp and 350 bp), L6xT2 (310 bp and 340 bp), and L11xT2 (320 bp and 340 bp). Similarly, the primer CO-306 amplified allele size 350 bp and 330 bp for female parents L6 and L11, respectively, while, allele size 300 bp and 310 bp for male parents T1 and T2, respectively. The hybrids' allele size was like the parents viz., L6xT1 (350 bp and 300 bp), L6xT2 (350 bp and 310 bp), and L11xT2 (330 bp and 310 bp). All 60 hybrids and their 23 parents were grouped into three main clusters (A, B and C) based upon DARWIN v.6.0 and STRUCTURE v.2.3 Bayesian analyses using genotypic data. Further, each main cluster was divided into two sub-divisions. Each sub-division showed the relatedness of parents and their hybrids, thus authenticating the genetic purity of hybrids. In conclusion, this study provides useful for accurate and effective identification of hybrids, which will help to improve seed genetic purity testing globally.	[Ahmed, Hafiz Ghulam Muhu-Din; Naeem, Muhammad] Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Plant Breeding & Genet, Bahawalpur, Pakistan; [Rizwan, Muhammad] Natl Inst Biotechnol & Genet Engn NIBGE, Agr Biotechnol Div, Faisalabad, Pakistan; [Khan, Muhammad Ahsan] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Baloch, Faheem Shehzad] Sivas Univ Sci & Technol, Fac Agr Sci & Technol, Sivas, Turkey; [Sun, Sangmi; Chung, Gyuhwa] Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea	Islamia University of Bahawalpur; Pakistan Institute of Engineering & Applied Science; University of Agriculture Faisalabad; Chonnam National University	Ahmed, HGMD (corresponding author), Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Plant Breeding & Genet, Bahawalpur, Pakistan.; Chung, G (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea.	ghulam.muhudin@iub.edu.pk; chung@chonnam.ac.kr		Ahmed, Hafiz GMD/0000-0001-9104-3791	"Cooperative Research Program for Agriculture Science and Technology Development," Rural Development Administration, Republic of Korea [PJ016650]	"Cooperative Research Program for Agriculture Science and Technology Development," Rural Development Administration, Republic of Korea	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science and Technology Development," Rural Development Administration, Republic of Korea in the form of funds to GC [Project No. PJ016650].	Ahmed HGMD, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0263263; Ahmed HGMD, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11081646; Ahmed HGMD, 2017, INT J AGRIC BIOL, V19, P1559, DOI 10.17957/IJAB/15.0463; Alekseevna RS, 2021, CASP J ENVIRON SCI, V19, P915, DOI DOI 10.22124/CJES.2021.5266; Ali MA, 2008, AUST J CROP SCI, V2, P141; [Anonymous], 2020, PAKISTAN ESO; Balalic I, 2009, THESIS; Bohra A, 2016, PLANT CELL REP, V35, P967, DOI 10.1007/s00299-016-1949-3; D, 2007, GENETIKA+, V39, P1; Darvishzadeh R, 2010, AFR J BIOTECHNOL, V9, P7280; Dehmer KJ, 1998, PLANT BREEDING, V117, P45, DOI 10.1111/j.1439-0523.1998.tb01446.x; Dimitrijevic A., 2010, Helia, V33, P191, DOI 10.2298/HEL1053191D; Dimitrijevic A, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02238; Dimitrijevic A, 2017, CROP BREED APPL BIOT, V17, P235, DOI 10.1590/1984-70332017v17n3a36; Dreisigacker S, 2013, LAB MANUAL ICAR CIMM; Duca M, 2013, BIOTECHNOL BIOTEC EQ, V27, P3772, DOI 10.5504/BBEQ.2013.0021; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Garayalde AF, 2011, ANN APPL BIOL, V158, P305, DOI 10.1111/j.1744-7348.2011.00465.x; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; HUNJE R., INDIAN SOC OILSEEDS, P40; Ibrar D, 2020, INT J AGRIC BIOL, V24, P51, DOI 10.17957/IJAB/15.1407; Iqbal A, 2011, GENET MOL RES, V10, P102, DOI 10.4238/vol10-1gmr918; Kapoor R, 2009, NEW BIOTECHNOL, V26, P239, DOI 10.1016/j.nbt.2009.09.003; Kempthorne O, 1957, INTRO GENETIC STAT; Liu LW, 2007, SCI HORTIC-AMSTERDAM, V115, P7, DOI 10.1016/j.scienta.2007.07.013; Lyu P, 2020, CURR BIOINFORM, V15, P889, DOI 10.2174/1574893615666200324134725; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadeem MA, 2018, BIOTECHNOL BIOTEC EQ, V32, P261, DOI 10.1080/13102818.2017.1400401; Naresh V, 2009, EUPHYTICA, V170, P347, DOI 10.1007/s10681-009-9995-3; Nyaligwa L, 2015, MAYDICA, V60; Pallavi HM, 2011, SEED SCI TECHNOL, V39, P259, DOI 10.2298/HEL1154059P; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rasoulzadeh Aghdam M, 2020, CROP BIOTECHNOLOGY, V10, P71; Rauf S, 2020, OCL OILS FAT CROP LI, V27, DOI 10.1051/ocl/2020042; Rauf S, 2019, ADVANCES IN PLANT BREEDING STRATEGIES: INDUSTRIAL AND FOOD CROPS, VOL 6, P637, DOI 10.1007/978-3-030-23265-8_16; Rizwan M, 2020, PAK J AGR SCI, V57, P101, DOI 10.21162/PAKJAS/20.8345; Sahin EC, 2018, OPEN LIFE SCI, V13, P319, DOI 10.1515/biol-2018-0039; Seiler GJ, 2017, CROP SCI, V57, P1083, DOI 10.2135/cropsci2016.10.0856; Setimela Peter S., 2016, South African Journal of Plant and Soil, V33, P141, DOI 10.1080/02571862.2015.1104737; Singh N, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0437-7; Tang SX, 2003, THEOR APPL GENET, V107, P6, DOI 10.1007/s00122-003-1233-0; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Yadav P, 2018, BIOCH MOL CHARACTERI; Yashitola J, 2002, CROP SCI, V42, P1369, DOI 10.2135/cropsci2002.1369; Yu JK, 2002, GENOME, V45, P652, DOI [10.1139/g02-025, 10.1139/G02-025]; Yue B, 2010, PLANT BREEDING, V129, P24, DOI 10.1111/j.1439-0523.2009.01661.x; Zeinalzadeh-Tabrizi H, 2018, MOL BIOL RES COMMUN, V7, P143, DOI 10.22099/mbrc.2018.30434.1340; Zia ZU, 2014, RUSS J GENET+, V50, P498, DOI 10.1134/S1022795414050147; Zimmer EA, 2015, J SYST EVOL, V53, P371, DOI 10.1111/jse.12174	50	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0267383	10.1371/journal.pone.0267383	http://dx.doi.org/10.1371/journal.pone.0267383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P7AY	35588423	gold, Green Published			2022-12-26	WOS:000855545600001
J	Tesfau, YB; Gebrehiwot, TG; Godefay, H; Kahsay, AB				Tesfau, Yemane Berhane; Gebrehiwot, Tesfay Gebregzabher; Godefay, Hagos; Kahsay, Alemayehu Bayray			Effect of health facility linkage with community using postnatal card on postnatal home visit coverage and newborn care practices in rural Ethiopia: A controlled quasi-experimental study design	PLOS ONE			English	Article							NEONATAL-MORTALITY; INTERVENTION; BANGLADESH; DEATHS; PERIOD; TRIAL	Background Postnatal home visit has the potential to improve maternal and newborn health, but it remains as a missed opportunity in many low-and middle-income countries. This study examines the effect of health extension worker administered postnatal card combined with health facility strengthening intervention on postnatal home visit coverage, newborn care practices, and knowledge of newborn danger signs in rural Ethiopia. Methods We employed quasi-experimental design using controlled before-and-after study in intervention and comparison districts of rural Tigray, northern Ethiopia. Training of health extension workers (HEWs) on postnatal home visit (PNHV), training of healthcare providers on maternal and newborn care, and capacity building of healthcare authorities on leadership, management and governance together with health system strengthening were the implemented interventions. Baseline (n = 705) and end line (n = 980) data were collected from mothers who delivered a year before the commencement of the actual data collection in the respective surveys. We used difference-in-differences (DiD) analysis to assess the effect of the intervention on PNHV coverage, essential newborn care practices and maternal knowledge of newborn danger signs. Results A total of 1685 (100%) mothers participated in this study. In all districts, more than 1/3(rd) of the mothers 633(37.57%) were in the age of 30-39 years. The difference-in-differences estimator showed an average of 23.5% increase in coverage of PNHVs within three days (DiD, p<0.001) and the provision of most postnatal contents significantly increased in the intervention district in the end line survey. The knowledge of at least three danger signs increased by 13.6% (p = 0.012).The DiD estimator showed an average of 27.6% increase to check the mothers for heavy bleeding (DiD, p = 0.011). This study also revealed that the checking of maternal blood pressure increased from 5.8% to 11.8% in the comparison districts and from 9.4% to 93.3% in the intervention district. The difference-in-differences estimator result showed a 9% difference in clean cord care practices among the participants (p = 0.025), 12.2% in skin to skin care (p = 0.022), and borderline significant increase in early initiation of breastfeeding (10.5%, p = 0.051). Conclusion We conclude that the intervention package was effective in improving the coverage of PNHV, increase in knowledge of newborn danger sign and essential newborn care practices. Hence, further strengthening the linkages between health facilities and community is imperative to improve the coverage of essential lifesaving maternal and newborn care services by HEWs at home.	[Tesfau, Yemane Berhane] Adigrat Univ, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Tesfau, Yemane Berhane; Gebrehiwot, Tesfay Gebregzabher; Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Godefay, Hagos] Tigray Reg Hlth Bur, Mekelle, Ethiopia	Mekelle University	Tesfau, YB (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Adigrat, Ethiopia.; Tesfau, YB (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia.	yemaneberhane12@gmail.com			Tigray regional health bureau	Tigray regional health bureau	The authors are grateful to the Tigray regional health bureau and the four district health offices for their facilitation and support of the fieldwork. Lastly, the authors would like to thank the data collectors and the study participants.	Adam MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104027; Aiga H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2788-4; Akibu M, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/8625437; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; Altaye DE, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1978-8; Alvarado R, 1999, STUD FAMILY PLANN, V30, P133, DOI 10.1111/j.1728-4465.1999.00133.x; [Anonymous], 2018, S E ZONE ADMNISTRATI; [Anonymous], 2014, WHO RECOMMENDATIONS; August F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0916-x; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barry D, 2014, J MIDWIFERY WOM HEAL, V59, pS44, DOI 10.1111/jmwh.12171; Batistatou E, 2014, STATA J, V14, P159, DOI 10.1177/1536867X1401400111; Beraki GG, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2694-8; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bulto GA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4583-7; Callaghan-Koru JA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-198; Central SA Program TD ICF Rockville M USA, 2019, ETH MIN DEM HLTH SUR; Chan G. J., 2021, Journal of Global Health Reports, V5, DOI 10.29392/001c.22125; Crigler L., 2013, SUPERVISION COMMUNIT; DiBari JN, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/530769; EDHS E., 2016, DHS PROGRAM ICF, V363, P364; Ekirapa E., 2017, RURAL UGANDA GLOBAL; EPHI I, 2019, ETH MIN DEM HLTH SUR; Gogia S, 2016, J PERINATOL, V36, pS54, DOI 10.1038/jp.2016.33; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Guenther T, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010808; Habib A., 2019, INT J COMMUNITY MED, V6, P4682, DOI DOI 10.18203/2394-6040.IJCMPH20195040; Hanson C, 2017, B WORLD HEALTH ORGAN, V95, P453, DOI 10.2471/BLT.16.175844; Hodgins S., 2017, POSTNATAL CARE FOCUS; Kananura RM, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1362826; Kerie MW., CONTRIBUTION HLTH SE; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Lee BX, 2016, J PUBLIC HEALTH POL, V37, pS13, DOI 10.1057/s41271-016-0002-7; Limenih Miteku Andualem, 2016, Int J Reprod Med, V2016, P7095352, DOI 10.1155/2016/7095352; McPherson R, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010422; Namazzi G, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1345495; Organization WH, 2012, INF M PROV HOM BAS C; Penfold S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-187; Probandari A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2490-y; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Shaban IA, 2018, HOME HEALTH CARE SER, V37, P247, DOI 10.1080/01621424.2018.1454865; Sinha LN., 2013, WPSAR, V5, P22; Sitrin D, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.23963; Somefun Oluwaseyi Dolapo, 2016, BMC Res Notes, V9, P21, DOI 10.1186/s13104-015-1823-3; Takai IU., 2015, SAHEL MED J, V18, P109, DOI DOI 10.4103/1118-8561.169282; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Tesfau YB, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03003-w; Tesfaye S, 2014, J MIDWIFERY WOM HEAL, V59, pS55, DOI 10.1111/jmwh.12168; Teshome M., 2018, HOME BASED NEONATAL; Tewodros Tegene, 2015, Clinics in Mother and Child Health, V12, P1000172; Timilsina S., 2015, SAUDI J MED PHARM PC, V1, P87; Tsawe M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0162-2; Ugboaja Joseph O, 2013, Niger Med J, V54, P45, DOI 10.4103/0300-1652.108895; Varma DS., 2013, J FAM WELFARE, V56, P31; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Waiswa P, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24584; Workineh YG, 2014, SCI J PUBLIC HLTH, V2, P169, DOI [10.11648/j.sjph.20140203.15, DOI 10.11648/J.SJPH.20140203.15]	61	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267686	10.1371/journal.pone.0267686	http://dx.doi.org/10.1371/journal.pone.0267686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552558	gold, Green Published			2022-12-26	WOS:000868164600028
J	Varas, S; Elorrieta, F; Vargas, C; Dintrans, PV; Castillo, C; Martinez, Y; Ayala, A; Maddaleno, M				Varas, Simon; Elorrieta, Felipe; Vargas, Claudio; Dintrans, Pablo Villalobos; Castillo, Claudio; Martinez, Yerko; Ayala, Andres; Maddaleno, Matilde			Factors associated with change in adherence to COVID-19 personal protection measures in the Metropolitan Region, Chile	PLOS ONE			English	Article							MASK	Personal protective measures such use of face masks, hand washing and physical distancing have proven to be effective in controlling the spread of the Covid-19 pandemic. However, adherence to these measures may have been relaxed over time. The objective of this work is to assess the change in adherence to these measures and to find factors that explain the change For this purpose, we conducted a survey in the Metropolitan Region of Chile in which we asked the adherence to these measures in August-September 2021 and retrospectively for 2020. With the answers obtained we fit a logistic regression model in which the response variable is the relaxation of each of the self-care preventive actions. The explanatory variables used are socio-demographic characteristics such as the age, sex, income, and vaccination status of the respondents. The results obtained show that there has been a significant decrease in adherence to the three personal protection measures in the Metropolitan Region of Chile. In addition, it was observed that younger people are more likely to relax these measures. The results show the importance of generating new incentives for maintaining adherence to personal protection measures.	[Varas, Simon; Elorrieta, Felipe; Vargas, Claudio; Ayala, Andres] Univ Santiago, Dept Matemat & Ciencia Comp, Santiago, Chile; [Dintrans, Pablo Villalobos; Castillo, Claudio; Martinez, Yerko; Maddaleno, Matilde] Univ Santiago, Fac Ciencias Med, Programa Ctr Salud Publ, Santiago, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile	Elorrieta, F (corresponding author), Univ Santiago, Dept Matemat & Ciencia Comp, Santiago, Chile.	felipe.elorrieta@usach.cl	Dintrans, Pablo Villalobos/AAM-6248-2020	Dintrans, Pablo Villalobos/0000-0002-2236-6447; Elorrieta, Felipe/0000-0002-1835-7433				Andrade EF, 2022, DEATH STUD, V46, P533, DOI 10.1080/07481187.2020.1809786; Ayala A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111058; Bante A, 2021, PATIENT PREFER ADHER, V15, P237, DOI 10.2147/PPA.S293647; Bazaid AS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243695; Beeckman M, 2020, APPL PSYCHOL-HLTH WE, V12, P1224, DOI 10.1111/aphw.12242; Castillo C, 2021, VACCINE-X, V9, DOI 10.1016/j.jvacx.2021.100114; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; de Bruin WB, 2021, J GERONTOL B-PSYCHOL, V76, pE24, DOI 10.1093/geronb/gbaa074; Ditekemena JD, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043356; Finger JAFF, 2021, TRENDS FOOD SCI TECH, V112, P847, DOI 10.1016/j.tifs.2021.03.016; Folmer CPR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257945; Gerhold L., 2020, COVID 19 RISK PERCEP, DOI [10.31234/osf.io/xmpk4, DOI 10.31234/OSF.IO/XMPK4]; GORERM, 2022, AL JUST DIG NEC CON; Han MFY, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.638831; Hills S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10379-7; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Junior A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031091; Machida M, 2020, INT J INFECT DIS, V96, P371, DOI 10.1016/j.ijid.2020.05.039; MacIntyre CR, 2021, INT J INFECT DIS, V106, P199, DOI 10.1016/j.ijid.2021.03.056; Mackay IM., 2020, VIROLOGY; Margraf J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243523; MinCiencia, 2022, DAT COVID19; MINSAL, 2020, GUIA AUT; Petherick A, 2021, NAT HUM BEHAV, V5, P1145, DOI 10.1038/s41562-021-01181-x; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Rahamim-Cohen D., 2021, MEDRXIV; Rosi A, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.646558; SUBTEL, 2022, SER EST SUBTEL; Beca-Martinez MT, 2022, TRANSBOUND EMERG DIS, V69, pE871, DOI 10.1111/tbed.14364; van den Broek-Altenburg E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250302; WHO, 2021, M REPORT; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; World Health Organization (WHO), 2020, PAND FAT REINV PUBL	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267413	10.1371/journal.pone.0267413	http://dx.doi.org/10.1371/journal.pone.0267413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551277	gold, Green Published			2022-12-26	WOS:000868164600024
J	Asri, A; Asri, V; Renerte, B; Follmi-Heusi, F; Leuppi, JD; Muser, J; Nuesch, R; Schuler, D; Fischbacher, U				Asri, Ankush; Asri, Viola; Renerte, Baiba; Follmi-Heusi, Franziska; Leuppi, Joerg D.; Muser, Juergen; Nuesch, Reto; Schuler, Dominik; Fischbacher, Urs			Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals	PLOS ONE			English	Article							INFLUENZA VACCINATION; HESITANCY; INTENTION; RISK; DETERMINANTS; ATTITUDES; CHILDREN; TRIAL; TIME	In many countries, the current vaccination rates are stagnating, to the extent that vaccine hesitancy-the delay or refusal to take recommended vaccinations-forms a major obstacle to ending the COVID-19 pandemic. This tendency is particularly concerning when observed among healthcare workers who are opinion leaders on medical matters for their patients and peers. Our study surveys 965 employees of two large Swiss hospitals and profiles vaccine-hesitant hospital employees using not only socio-demographic characteristics, but also a comprehensive set of standard behavioral preference measures: (i) Big-5 personality traits, (ii) risk-, time- and social preferences, and (iii) perceived prevailing social norms. Using multinomial probit models and linear probability models, we find that vaccine-hesitant hospital employees are less patient and less likely to perceive vaccination as the prevailing social norm-in addition to replicating previously published socio-demographic results. Our findings are robust to a range of model specifications, as well as individual and situational covariates. Our study thus offers actionable policy implications for tailoring public-health communications to vaccine-hesitant hospital employees.	[Asri, Ankush; Asri, Viola; Renerte, Baiba; Fischbacher, Urs] Univ Konstanz, Constance, Germany; [Asri, Ankush; Asri, Viola; Renerte, Baiba; Fischbacher, Urs] Thurgau Inst Econ, Kreuzlingen, Switzerland; [Renerte, Baiba] Univ Zurich, Zurich, Switzerland; [Follmi-Heusi, Franziska; Nuesch, Reto; Schuler, Dominik] Spital Schwyz, Schwyz, Switzerland; [Follmi-Heusi, Franziska] Univ St Gallen, Swiss Inst Int Econ & Appl Econ Res, St Gallen, Switzerland; [Leuppi, Joerg D.; Muser, Juergen] Kantonsspital Baselland, Liestal, Switzerland; [Leuppi, Joerg D.; Nuesch, Reto; Schuler, Dominik] Univ Basel, Basel, Switzerland	University of Konstanz; University of Zurich; University of St Gallen; Kantonsspital Baselland; University of Basel	Fischbacher, U (corresponding author), Univ Konstanz, Constance, Germany.; Fischbacher, U (corresponding author), Thurgau Inst Econ, Kreuzlingen, Switzerland.	urs.fischbacher@uni-konstanz.de	Fischbacher, Urs/H-2693-2014	Fischbacher, Urs/0000-0002-5115-8815; Asri, Viola/0000-0002-8531-285X; Renerte, Baiba/0000-0002-2229-2150; Muser, Juergen/0000-0002-7159-7380				Abul Kalam M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256496; Agarwal R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107873118; Agranov M, 2021, ECON LETT, V206, DOI 10.1016/j.econlet.2021.109979; Aharon AA, 2018, HUM VACC IMMUNOTHER, V14, P1618, DOI 10.1080/21645515.2018.1471305; Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; [Anonymous], 2020, 1 COVID 19 VACCINE A; Asri A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253621; Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601; Bocquier A, 2017, EXPERT REV VACCINES, V16, P1107, DOI 10.1080/14760584.2017.1381020; Bokemper SE, 2021, VACCINE, V39, P825, DOI 10.1016/j.vaccine.2020.12.048; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Cameron C., 2005, MICROECONOMETRICS US, P1056; Damnjanovic K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00735; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Di Gennaro F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030371; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Dube E, 2021, ANNU REV PUBL HEALTH, V42, P175, DOI 10.1146/annurev-publhealth-090419-102240; Falk A, 2018, Q J ECON, V133, P1645, DOI 10.1093/qje/qjy013; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]; Gates A., 2021, SYSTEMATIC REV FACTO; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Goodwin R, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-03986-2; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Graupensperger S, 2021, VACCINE, V39, P2060, DOI 10.1016/j.vaccine.2021.03.018; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; Head KJ, 2020, SCI COMMUN, V42, P698, DOI 10.1177/1075547020960463; Hotez P, 2021, NATURE, V592, P661, DOI 10.1038/d41586-021-01084-x; Jamison AM, 2019, SOC SCI MED, V221, P87, DOI 10.1016/j.socscimed.2018.12.020; Johnson MO, 2000, PERS INDIV DIFFER, V29, P459, DOI 10.1016/S0191-8869(99)00206-8; Joseph Bobby, 2016, Indian J Occup Environ Med, V20, P71, DOI 10.4103/0019-5278.197518; Jung H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2007538118; Kennedy J, 2019, EUR J PUBLIC HEALTH, V29, P512, DOI 10.1093/eurpub/ckz004; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Klevens RM, 2001, AM J PREV MED, V20, P41, DOI 10.1016/S0749-3797(01)00281-1; Kociolek LK, 2021, INFECT CONT HOSP EP, V42, P775, DOI 10.1017/ice.2021.58; Kose S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13917; Kuter BJ, 2021, VACCINE, V39, P1693, DOI 10.1016/j.vaccine.2021.02.029; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Ledda C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052703; Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Marti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172310; Mesch GS, 2015, AM J INFECT CONTROL, V43, P1161, DOI 10.1016/j.ajic.2015.06.031; Milkman KL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101165118; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Paterson P, 2016, VACCINE, V34, P6700, DOI 10.1016/j.vaccine.2016.10.042; Patty NJS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4879-2; Pulcini C, 2013, VACCINE, V31, P3943, DOI 10.1016/j.vaccine.2013.06.039; Qattan AMN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644300; Rieger MO, 2020, SOCIAL HLTH BEHAV, V3, P78, DOI [DOI 10.4103/SHB.SHB_39_20, 10.4103/SHB.SHB_39_20]; Robertson C, 2021, ECON LETT, V209, DOI 10.1016/j.econlet.2021.110097; Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Salovey P, 2003, BLACKW SER HLTH PSYC, P54; Schmelz K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104912118; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Schrading WA, 2021, ACAD EMERG MED, V28, P455, DOI 10.1111/acem.14236; Shaw J, 2021, CLIN INFECT DIS, V2021, pCIAB054, DOI [10.1093/cid/ciab054, DOI 10.1093/CID/CIAB054]; Shekhar R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020119; Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243; Sinclair S, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2021.1937832; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Suk JE., 2015, PLOS CURR-TREE LIFE, V7, DOI [10.1371/currents.outbreaks.49dba84ad4146de33706b1f131d7caa3, DOI 10.1371/CURRENTS.OUTBREAKS.49DBA84AD4146DE33706B1F131D7CAA3]; Thangaraju P, 2019, CUKUROVA MED J, V44, P1150, DOI 10.17826/cumj.514157; Thomson A, 2016, VACCINE, V34, P1018, DOI 10.1016/j.vaccine.2015.11.065; Timmermans DRM, 2005, VACCINE, V23, P3329, DOI 10.1016/j.vaccine.2005.01.075; Troiano G, 2021, PUBLIC HEALTH, V194, P245, DOI 10.1016/j.puhe.2021.02.025; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047; Wagner AL, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040155; Walkey AJ, 2021, JAMA-J AM MED ASSOC, V326, P766, DOI 10.1001/jama.2021.11048; Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482; Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021; Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279	78	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268775	http://dx.doi.org/10.1371/journal.pone.0268775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617200	gold, Green Published			2022-12-26	WOS:000835048800059
J	Bower, M; Donohoe-Bales, A; Smout, S; Ngyuen, AQH; Boyle, J; Barrett, E; Teesson, M				Bower, Marlee; Donohoe-Bales, Amarina; Smout, Scarlett; Ngyuen, Andre Quan Ho; Boyle, Julia; Barrett, Emma; Teesson, Maree			In their own words: An Australian community sample's priority concerns regarding mental health in the context of COVID-19	PLOS ONE			English	Article							PEOPLE; STIGMA; CARE	The COVID-19 pandemic has resulted in significant and unprecedented mental health impacts in Australia. However, there is a paucity of research directly asking Australian community members about their mental health experiences, and what they perceive to be the most important mental health issues in the context of the pandemic. This study utilises qualitative data from Alone Together, a longitudinal mixed-methods study investigating the effects of COVID-19 on mental health in an Australian community sample (N = 2,056). A total of 1,037 participants, ranging in sex (69.9% female), age (M = 40-49 years), state/territory of residence, and socioeconomic status, shared responses to two open-ended questions in the first follow up survey regarding their mental health experiences and priorities during COVID-19. Responses were analysed using thematic analysis. Participants described COVID-19 as primarily impacting their mental health through the disruption it posed to their social world and financial stability. A key concern for participants who reported having poor mental health was the existence of multiple competing barriers to accessing high quality mental health care. According to participant responses, the pandemic placed additional pressures on an already over-burdened mental health service system, leaving many without timely, appropriate support. Absent or stigmatising rhetoric around mental health, at both a political and community level, also prevented participants from seeking help. Insights gained from the present research provide opportunities for policymakers and health practitioners to draw on the expertise of Australians' lived experience and address priority issues through targeted policy planning. This could ultimately support a more responsive, integrated, and effective mental health system, during and beyond the COVID-19 pandemic.	[Bower, Marlee; Donohoe-Bales, Amarina; Smout, Scarlett; Ngyuen, Andre Quan Ho; Boyle, Julia; Barrett, Emma; Teesson, Maree] Univ Sydney, Matilda Ctr Res Mental Hlth & Subst Use, Sydney, NSW, Australia	University of Sydney	Bower, M (corresponding author), Univ Sydney, Matilda Ctr Res Mental Hlth & Subst Use, Sydney, NSW, Australia.	marlee.bower@sydney.edu.au		Smout, Scarlett/0000-0001-5879-442X; Barrett, Emma/0000-0003-0540-5691; Bower, Marlee/0000-0002-9818-1174	Henry Halloran Trust; LifeSpan Research Network, Faculty of Medicine and Health at the University of Sydney Seed Funding	Henry Halloran Trust; LifeSpan Research Network, Faculty of Medicine and Health at the University of Sydney Seed Funding	This work was supported by the Henry Halloran Trust under a Festival of Urbanism 2020 Grant (MB): https://www.sydney.edu.au/henry-halloran-trust/ This work was also supported by the LifeSpan Research Network, Faculty of Medicine and Health at the University of Sydney Seed Funding Grant (MB): https://www.sydney. edu.au/medicine-health/our-research/research-centres/lifespan-research-network.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	4World Health Organization and Calouste Gulbenkian Foundation, 2014, SOC DET MENT HLTH; AIHW, 2021, OLD AUSTR; [Anonymous], 2021, PFIZER PRESS RELEASE; Australian Bureau of Statistics, HOUS IMP COVID 19 SU; Australian Government Department of Health, BUDG 2021 22 2021; Beresford P, 2002, J MENT HLTH, V11, P581, DOI DOI 10.1080/09638230020023921; Bosc M, 2000, COMPR PSYCHIAT, V41, P63, DOI 10.1016/S0010-440X(00)90133-0; Bower M, 2021, INT J HOUS POLICY, DOI 10.1080/19491247.2021.1940686; Braun V., 2022, THEMATIC ANAL PRACTI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown N., 2021, NEWSCOMAU, V2021; Byrne L, 2020, J MENT HEALTH, V29, P243, DOI 10.1080/09638237.2020.1766002; Cruwys T, 2021, J AFFECT DISORDERS, V295, P316, DOI 10.1016/j.jad.2021.08.029; Dawel A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579985; Dockery L, 2015, PSYCHIAT RES, V228, P612, DOI 10.1016/j.psychres.2015.05.044; ENGEL GL, 1981, J MED PHILOS, V6, P101, DOI 10.1093/jmp/6.2.101; Everymind, 2020, REPORTING SUICIDE ME; Farrugia A, 2021, HEALTH SOCIOL REV, V30, P95, DOI 10.1080/14461242.2020.1789485; Fisher JRW, 2020, MED J AUSTRALIA, V213, P458, DOI 10.5694/mja2.50831; Griffiths D, 2021, J OCCUP REHABIL, V31, P455, DOI 10.1007/s10926-021-09958-7; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Haslam C, 2016, J AFFECT DISORDERS, V194, P188, DOI 10.1016/j.jad.2016.01.010; Honey A, 2021, COMMUNITY MENT HLT J, V57, P1255, DOI 10.1007/s10597-021-00871-0; Knox K, 2014, INT J SOC PSYCHIATR, V60, P533, DOI 10.1177/0020764013503149; Muldoon OT, 2019, EUR REV SOC PSYCHOL, V30, P311, DOI 10.1080/10463283.2020.1711628; National Mental Health Commission, 2019, MON MENT HLTH SUIC P; Nochaiwong S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89700-8; NVivo, 2018, NVIVO QUAL DAT AN SO; Olasoji M, 2017, J PSYCHIATR MENT HLT, V24, P403, DOI 10.1111/jpm.12399; Prins M, 2011, SOC PSYCH PSYCH EPID, V46, P1033, DOI 10.1007/s00127-010-0266-3; Productivity Commission, 2020, 95 PROD COMM MENT HL; Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P1086, DOI 10.3109/00048674.2011.621061; Rickwood D, 2005, ADV MENT HEALTH, V4, P218, DOI 10.5172/jamh.4.3.218; Rogers SL., 2020, PREPRINTS; Rossell SL, 2021, PSYCHIAT RES, V296, DOI 10.1016/j.psychres.2020.113660; Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333; Taquet M, 2021, LANCET PSYCHIAT, V8, P416, DOI 10.1016/S2215-0366(21)00084-5; World Health Organization, 2020, WHO REL GUID HELP CO	38	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268824	10.1371/journal.pone.0268824	http://dx.doi.org/10.1371/journal.pone.0268824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3R0QK	35588438	Green Published, gold			2022-12-26	WOS:000838625000003
J	Dublin, S; Idu, AR; Avalos, L; Cheetham, TCL; Easterling, T; Chen, L; Holt, VS; Nance, N; Bider-Canfield, ZE; Neugebauer, RM; Reynolds, K; Badon, S; Shortreed, S				Dublin, Sascha; Idu, Abisola R.; Avalos, Lyndsay; Cheetham, T. Craig L.; Easterling, Thomas; Chen, Lu; Holt, Victoria S.; Nance, Nerissa; Bider-Canfield, Zoe E.; Neugebauer, Romain M.; Reynolds, Kristi; Badon, Sylvia; Shortreed, Susan			Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study	PLOS ONE			English	Article							CHRONIC HYPERTENSION; LABETALOL; METHYLDOPA; COMPLICATIONS; VALIDITY; WOMEN; RISK; TERM	ObjectiveTo compare maternal and infant outcomes with different antihypertensive medications in pregnancy. DesignRetrospective cohort study. SettingKaiser Permanente, a large healthcare system in the United States. PopulationWomen aged 15-49 years with a singleton birth from 2005-2014 treated for hypertension. MethodsWe identified medication exposure from automated pharmacy data based on the earliest dispensing after the first prenatal visit. Using logistic regression, we calculated weighted outcome prevalences, adjusted odds ratios (aORs) and 95% confidence intervals, with inverse probability of treatment weighting to address confounding. Main outcome measuresSmall for gestational age, preterm delivery, neonatal and maternal intensive care unit (ICU) admission, preeclampsia, and stillbirth or termination at > 20 weeks. ResultsAmong 6346 deliveries, 87% with chronic hypertension, the risk of the infant being small for gestational age (birthweight < 10th percentile) was lower with methyldopa than labetalol (prevalence 13.6% vs. 16.6%; aOR 0.77, 95% CI 0.63 to 0.92). For birthweight < 3(rd) percentile the aOR was 0.57 (0.39 to 0.80). Compared with labetalol (26.0%), risk of preterm delivery was similar for methyldopa (26.5%; aOR 1.10 [0.95 to 1.27]) and slightly higher for nifedipine (28.5%; aOR 1.25 [1.06 to 1.46]) and other beta-blockers (31.2%; aOR 1.58 [1.07 to 2.23]). Neonatal ICU admission was more common with nifedipine than labetalol (25.9% vs. 23.3%, aOR 1.21 [1.02 to 1.43]) but not elevated with methyldopa. Risks of other outcomes did not differ by medication. ConclusionsRisk of most outcomes was similar comparing labetalol, methyldopa and nifedipine. Risk of the infant being small for gestational age was substantially lower for methyldopa, suggesting this medication may warrant further consideration.	[Dublin, Sascha; Idu, Abisola R.; Chen, Lu; Shortreed, Susan] Kaiser Permanente Washington, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98057 USA; [Dublin, Sascha; Holt, Victoria S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Avalos, Lyndsay; Nance, Nerissa; Neugebauer, Romain M.; Badon, Sylvia] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Cheetham, T. Craig L.] Chapman Univ, Sch Pharm, Irvine, CA USA; [Easterling, Thomas] Univ Washington, Dept Obstet & Gynecol, Seattle, WA USA; [Bider-Canfield, Zoe E.; Reynolds, Kristi] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA; [Shortreed, Susan] Univ Washington, Dept Biostat, Seattle, WA USA	Kaiser Permanente; University of Washington; University of Washington Seattle; Kaiser Permanente; Chapman University System; Chapman University; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Washington; University of Washington Seattle	Dublin, S (corresponding author), Kaiser Permanente Washington, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98057 USA.; Dublin, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	Sascha.Dublin@kp.org		Badon, Sylvia/0000-0002-2868-4067	National Institute on Child Health and Human Development [R01HD082141]; Group Health Foundation	National Institute on Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Group Health Foundation	SD received grant R01HD082141 from the National Institute on Child Health and Human Development, https://www.nichd.nih.gov/ LC was funded as a postdoctoral fellow by the Group Health Foundation (no grant number); this incarnation of the foundation no longer exists. Group Health is the former name of the healthcare system now known as Kaiser Permanente Washington. When Kaiser Permanente purchased Group Health, they placed money into a new foundation that is also called the Group Health Foundation. It has a URL but is not the entity that funded Dr. Chen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub4; American College of Obstetricians and Gynecologists' Committee on Practice BulletinsObstetrics, 2019, Obstet Gynecol, V133, pe26, DOI 10.1097/AOG.0000000000003020; Andrade SE, 2013, PHARMACOEPIDEM DR S, V22, P7, DOI 10.1002/pds.3319; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baldwin E, 2015, PHARMACOEPIDEM DR S, V24, P45, DOI 10.1002/pds.3728; Bateman BT, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2012.02.039, 10.1016/j.ajog.2011.07.030, 10.1016/j.ajog.2011.10.878]; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Chen L, 2020, PREGNANCY HYPERTENS, V19, P112, DOI 10.1016/j.preghy.2020.01.001; Chen L, 2019, AM J PERINAT, V36, P1045, DOI 10.1055/s-0038-1675619; Easterling T, 2019, LANCET, V394, P1011, DOI 10.1016/S0140-6736(19)31282-6; Hansen C, 2016, PHARMACOEPIDEM DR S, V25, P170, DOI 10.1002/pds.3919; Hernan M., 2020, CAUSAL INFERENCE WHA; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hoeltzenbein M, 2017, HYPERTENSION, V70, P201, DOI 10.1161/HYPERTENSIONAHA.117.09110; INNES A, 1992, J HUM HYPERTENS, V6, P211; Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001; Koebnick Corinna, 2012, Perm J, V16, P37; Lawrence JM, 2013, OBSTET GYNECOL, V121, P106, DOI [10.1097/AOG.0b013e318278ce86, http://10.1097/AOG.0b013e318278ce86]; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Lund Jennifer L, 2015, Curr Epidemiol Rep, V2, P221; Lydon-Rochelle MT, 2005, PAEDIATR PERINAT EP, V19, P460, DOI 10.1111/j.1365-3016.2005.00682.x; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Magee LA, 2016, BJOG-INT J OBSTET GY, V123, P1143, DOI 10.1111/1471-0528.13569; Magee LA, 2015, NEW ENGL J MED, V372, P2367, DOI 10.1056/NEJMc1503870; Motawea HKB, 2018, AM J PATHOL, V188, P2774, DOI 10.1016/j.ajpath.2018.08.011; Nakhai-Pour HR, 2010, BIRTH DEFECTS RES B, V89, P147, DOI 10.1002/bdrb.20238; National Institute for Health and Care Excellence, 2019, NICE GUIDELINE NG133; O'Callaghan JL, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010080; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Orbach H, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.011; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Petersen KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001185; Pocobelli G, 2018, OBSTET GYNECOL, V132, P859, DOI 10.1097/AOG.0000000000002780; Ray Joel G, 2001, BMC Pregnancy Childbirth, V1, P6, DOI 10.1186/1471-2393-1-6; Regitz-Zagrosek V, 2018, EUR HEART J, V39, P3165, DOI 10.1093/eurheartj/ehy340; Rezk M, 2020, HYPERTENS PREGNANCY, V39, P393, DOI 10.1080/10641955.2020.1791902; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SANDERS GL, 1979, BRIT J CLIN PHARMACO, V8, pS149, DOI 10.1111/j.1365-2125.1979.tb04771.x; Su CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053844; Swanson SA, 2017, EPIDEMIOLOGY, V28, P653, DOI 10.1097/EDE.0000000000000699; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1; WALLIN JD, 1983, AM J MED, V75, P87, DOI 10.1016/0002-9343(83)90140-7; Webster LM, 2017, HYPERTENSION, V70, P915, DOI 10.1161/HYPERTENSIONAHA.117.09972; Workalemahu T, 2020, HYPERTENSION, V75, P1117, DOI 10.1161/HYPERTENSIONAHA.119.14509; Zetterstrom K, 2005, ACTA OBSTET GYN SCAN, V84, P419, DOI 10.1111/j.0001-6349.2005.00508.x	50	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268284	10.1371/journal.pone.0268284	http://dx.doi.org/10.1371/journal.pone.0268284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576217	gold, Green Published			2022-12-26	WOS:000834668900006
J	Grant, E; Bucklain, F; Ginn, LE; Laity, PC; Ciani, BC; Bryant, HC				Grant, Emma; Bucklain, Fatma; Ginn, Lucy E.; Laity, Peter C.; Ciani, Barbara C.; Bryant, Helen C.			Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; STAT3; TRANSACTIVATION; APOPTOSIS; TARGET	Chemoresistance poses a great barrier to breast cancer treatment and is thought to correlate with increased matrix stiffness. We developed two-dimensional (2D) polyacrylamide (PAA) and three-dimensional (3D) alginate in vitro models of tissue stiffness that mimic the stiffness of normal breast and breast cancer. We then used these to compare cell viability in response to chemotherapeutic treatment. In both 2D and 3D we observed that breast cancer cell growth and size was increased at a higher stiffness corresponding to tumours compared to normal tissue. When chemotherapeutic response was measured, a specific differential response in cell viability was observed for gemcitabine in 2 of the 7 breast cancer cell lines investigated. MCF7 and T-47D cell lines showed gemcitabine resistance at 4 kPa compared to 500 Pa. These cell lines share a common phenotype of progesterone receptor (PGR) expression and, indeed, pre-treatment with the selective progesterone receptor modulator (SPRM) mifepristone abolished resistance to gemcitabine at high stiffness. Our data reveals that combined treatment with SPRMs may therefore help in reducing resistance to gemcitabine in stiffer breast tumours which are PGR positive.	[Grant, Emma; Bucklain, Fatma; Ginn, Lucy E.; Bryant, Helen C.] Univ Sheffield, Sheffield Inst Nucl Acids SInFoNiA, Dept Oncol & Metab, Acad Unit Mol Oncol, Sheffield, England; [Grant, Emma] Univ Sheffield, Krebs Inst, Ctr Membrane Interact & Dynam CMIAD, Dept Chem, Sheffield, England; [Laity, Peter C.; Ciani, Barbara C.] Nat Mat Grp, Dept Mat Sci & Engn, Sheffield, England	University of Sheffield; University of Sheffield	Bryant, HC (corresponding author), Univ Sheffield, Sheffield Inst Nucl Acids SInFoNiA, Dept Oncol & Metab, Acad Unit Mol Oncol, Sheffield, England.	h.bryant@sheffield.ac.uk		Ginn, Lucy/0000-0002-8673-339X	University of Sheffield; Team Verrico; Wellcome Trust [GR077544AIA]; European Union [713475]; King Abdul-Aziz University Scholarship	University of Sheffield; Team Verrico; Wellcome Trust(Wellcome Trust); European Union(European Commission); King Abdul-Aziz University Scholarship	HB, BC and EG were funded by The University of Sheffield (https://www.sheffield.ac.uk/) and Team Verrico (https://www.teamverrico.org/).Microscopy was funded by The Wellcome Trust (https://wellcome.org/) grant GR077544AIA. PL was funded by European Union's Horizon 2020 (https://ec.europa.eu/programmes/horizon2020/en/home) research and innovation programme under grant agreement no. 713475. FB was funded by a King Abdul-Aziz University Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Bell S, 2019, BIOPHYS J, V116, P551, DOI 10.1016/j.bpj.2018.12.020; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chung HH, 2014, J BIOL CHEM, V289, P2180, DOI 10.1074/jbc.M113.517896; ClinicalTrials.gov, 2020, MIF BREAST CANC PAT; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fragomeni SM, 2018, SURG ONCOL CLIN N AM, V27, P95, DOI 10.1016/j.soc.2017.08.005; Habiro A, 2004, BIOCHEM BIOPH RES CO, V316, P71, DOI 10.1016/j.bbrc.2004.02.017; Ioanou N, 2016, INT J ONCOL, V48, P908, DOI 10.3892/ijo.2016.3320; Jia YF, 2015, GENES DIS, V2, P299, DOI 10.1016/j.gendis.2015.07.003; Joyce MH, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00337; Kariagina A, 2008, CRIT REV EUKAR GENE, V18, P11, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.20; Lee JY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09755-0; Nelli F, 2013, INT J CLIN ONCOL, V18, P343, DOI 10.1007/s10147-012-0384-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Proietti CJ, 2011, STEROIDS, V76, P381, DOI 10.1016/j.steroids.2010.12.008; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Shynlova O, 2004, BIOL REPROD, V70, P986, DOI 10.1095/biolreprod.103.023648; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Truong TH, 2018, ENDOCRINOLOGY, V159, P3897, DOI 10.1210/en.2018-00831; Zhang J, 2015, INT J CANCER, V136, P204, DOI 10.1002/ijc.28966; Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268300	http://dx.doi.org/10.1371/journal.pone.0268300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617163	Green Accepted, gold, Green Published			2022-12-26	WOS:000835048800042
J	Szabolcs, M; Kapusi, F; Carrizo, S; Markovic, D; Freyhof, J; Cid, N; Cardoso, AC; Scholz, M; Kasperidus, HD; Darwall, WRT; Lengyel, S				Szabolcs, Marton; Kapusi, Felicia; Carrizo, Savrina; Markovic, Danijela; Freyhof, Jorg; Cid, Nuria; Cardoso, Ana Cristina; Scholz, Mathias; Kasperidus, Hans D.; Darwall, William R. T.; Lengyel, Szabolcs			Spatial priorities for freshwater biodiversity conservation in light of catchment protection and connectivity in Europe	PLOS ONE			English	Article							AREA-BASED CONSERVATION; RESERVE NETWORK; RIVER; BIOGEOGRAPHY; MANAGEMENT; SECURITY; THREATS; FISHES	Freshwater ecosystems host disproportionately high numbers of species relative to their surface area yet are poorly protected globally. We used data on the distribution of 1631 species of aquatic plant, mollusc, odonate and fish in 18,816 river and lake catchments in Europe to establish spatial conservation priorities based on the occurrence of threatened, range-restricted and endemic species using the Marxan systematic conservation planning tool. We found that priorities were highest for rivers and ancient lakes in S Europe, large rivers and lakes in E and N Europe, smaller lakes in NW Europe and karst/limestone areas in the Balkans, S France and central Europe. The a priori inclusion of well-protected catchments resulted in geographically more balanced priorities and better coverage of threatened (critically endangered, endangered and vulnerable) species. The a priori exclusion of well-protected catchments showed that priority areas that need further conservation interventions are in S and E Europe. We developed three ways to evaluate the correspondence between conservation priority and current protection by assessing whether a cathment has more (or less) priority given its protection level relative to all other catchments. Each method found that priority relative to protection was high in S and E Europe and generally low in NW Europe. The inclusion of hydrological connectivity had little influence on these patterns but decreased the coverage of threatened species, indicating a trade-off between connectivity and conservation of threatened species. Our results suggest that catchments in S and E Europe need urgent conservation attention (protected areas, restoration, management, species protection) in the face of imminent threats such as river regulation, dam construction, hydropower development and climate change. Our study presents continental-scale conservation priorities for freshwater ecosystems in ecologically meaningful planning units and will thus be important in freshwater biodiversity conservation policy and practice, and water management in Europe.	[Szabolcs, Marton; Kapusi, Felicia; Lengyel, Szabolcs] Inst Aquat Ecol, Ctr Ecol Res, Dept Tisza Res, ELKH, Debrecen, Hungary; [Carrizo, Savrina; Darwall, William R. T.] Global Species Programme, Freshwater Biodivers Unit, Int Union Conservat Nat, Cambridge, Cambs, England; [Markovic, Danijela] Osnabruck Univ Appl Sci, Osnabruck, Germany; [Freyhof, Jorg] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Cid, Nuria] Univ Barcelona, Fac Biol, Dept Ecol, Barcelona, Spain; [Cardoso, Ana Cristina] Inst Environm & Sustainabil, Joint Res Ctr, Water Resources Unit, European Commiss, Ispra, Italy; [Scholz, Mathias; Kasperidus, Hans D.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Barcelona; European Commission Joint Research Centre; EC JRC ISPRA Site; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Lengyel, S (corresponding author), Inst Aquat Ecol, Ctr Ecol Res, Dept Tisza Res, ELKH, Debrecen, Hungary.	lengyel.szabolcs@ecolres.hu		Scholz, Mathias/0000-0002-8463-9500; Cid, Nuria/0000-0002-9997-5523	'BioFresh' project [FP7-ENV-2008] [226874]; National Research, Development and Innovation Office of Hungary [K106133, K134391, GINOP 2.3.3-15-2016-00019]; Young Researcher Fellowship from the Hungarian Academy of Sciences	'BioFresh' project [FP7-ENV-2008]; National Research, Development and Innovation Office of Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); Young Researcher Fellowship from the Hungarian Academy of Sciences	This study was funded by the `BioFresh' project [FP7-ENV-2008, contract no. 226874]. FK, MS and SL were also supported by three grants from the National Research, Development and Innovation Office of Hungary [K106133, K134391, GINOP 2.3.3-15-2016-00019], and MS was supported by a Young Researcher Fellowship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Abellan P, 2007, AQUAT CONSERV, V17, P361, DOI 10.1002/aqc.778; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; American Fisheries Society (AFS), 2020, STAT WORLD AQ SCI SO; Ardron JA., 2008, MARXAN GOOD PRACTICE, DOI [10.1136/jnnp.2007.126045, DOI 10.1136/JNNP.2007.126045]; Balint M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031872; Ball I. R., 2009, SPATIAL CONSERVATION; Biofresh, 2013, FRESHWATER INFORM PL; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; Brum FT, 2017, P NATL ACAD SCI USA, V114, P7641, DOI 10.1073/pnas.1706461114; Carrizo SF, 2017, J APPL ECOL, V54, P1209, DOI 10.1111/1365-2664.12842; Collares-Pereira MJ, 2004, FISHERIES MANAG ECOL, V11, P303, DOI 10.1111/j.1365-2400.2004.00392.x; Cunningham CA, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02590-4; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Dolezsai A, 2015, BIODIVERS CONSERV, V24, P1403, DOI 10.1007/s10531-015-0864-1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; EEA, 2013, NAT 2000 END 2013; Esri [Environmental Systems Research Institute], 2010, ARCGIS 10 0; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Holland RA, 2012, BIOL CONSERV, V148, P167, DOI 10.1016/j.biocon.2012.01.016; INSPIRE, 2009, INSPIRE DAT SPEC COO; IUCN, 2013, IUCN RED LIST THREAT; IUCN and UNEP-WCMC, 2013, TECH REP; Keith P, 2000, BIOL CONSERV, V92, P265, DOI 10.1016/S0006-3207(99)00041-5; Lawrence DJ, 2011, CONSERV LETT, V4, P364, DOI 10.1111/j.1755-263X.2011.00185.x; Lehner B., 2012, HYDROBASINS GLOBAL W; LIGON FK, 1995, BIOSCIENCE, V45, P183, DOI 10.2307/1312557; Linke S, 2008, J APPL ECOL, V45, P1486, DOI 10.1111/j.1365-2664.2008.01520.x; Linke S., 2012, PRELIMINARY RESULTS; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Malnas K, 2011, J INSECT CONSERV, V15, P823, DOI 10.1007/s10841-011-9380-0; Markovic D, 2014, DIVERS DISTRIB, V20, P1097, DOI 10.1111/ddi.12232; Maxwell SL, 2020, NATURE, V586, P217, DOI 10.1038/s41586-020-2773-z; May ML, 2019, INSECTS, V10, DOI 10.3390/insects10030062; McIntyre PB, 2016, P NATL ACAD SCI USA, V113, P12880, DOI 10.1073/pnas.1521540113; Moilanen A, 2008, FRESHWATER BIOL, V53, P577, DOI 10.1111/j.1365-2427.2007.01906.x; Moilanen A, 2011, CONSERV LETT, V4, P383, DOI 10.1111/j.1755-263X.2011.00190.x; Nel JL, 2007, DIVERS DISTRIB, V13, P341, DOI 10.1111/j.1472-4642.2007.00308.x; Nel JL, 2011, FRESHWATER BIOL, V56, P106, DOI 10.1111/j.1365-2427.2010.02437.x; O'Hare MT, 2018, HYDROBIOLOGIA, V812, P1, DOI 10.1007/s10750-017-3190-7; Oikonomou A, 2014, HYDROBIOLOGIA, V738, P205, DOI 10.1007/s10750-014-1930-5; Postel S., 1997, Nature's services: societal dependence on natural ecosystems., P195; R Core Team, 2020, R LANG ENV STAT COMP; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rothley KD, 2005, ENVIRON MODEL ASSESS, V10, P107, DOI 10.1007/s10666-005-4697-2; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Thieme M, 2007, BIOL CONSERV, V135, P484, DOI 10.1016/j.biocon.2006.10.054; Vaughn CC, 2018, HYDROBIOLOGIA, V810, P15, DOI 10.1007/s10750-017-3139-x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zupan L, 2014, DIVERS DISTRIB, V20, P674, DOI 10.1111/ddi.12186	62	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267801	10.1371/journal.pone.0267801	http://dx.doi.org/10.1371/journal.pone.0267801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580083	Green Published, gold			2022-12-26	WOS:000835654800009
J	Fabris, L; Milani, C; Fiorotto, R; Mariotti, V; Kaffe, E; Seller, B; Sonzogni, A; Strazzabosco, M; Cadamuro, M				Fabris, Luca; Milani, Chiara; Fiorotto, Romina; Mariotti, Valeria; Kaffe, Eleanna; Seller, Barbara; Sonzogni, Aurelio; Strazzabosco, Mario; Cadamuro, Massimiliano			Dysregulation of the Scribble/YAP/beta-catenin axis sustains the fibroinflammatory response in a PKHD1(-/-) mouse model of congenital hepatic fibrosis	FASEB JOURNAL			English	Article						chronic cholangiopathy; congenital hepatic fibrosis; fibrocystin; Scribble; YAP	POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; YAP ACTIVATION; YAP/TAZ; LIVER; BILIARY; PROLIFERATION; CYSTOGENESIS; VERTEPORFIN; EXPRESSION	Congenital hepatic fibrosis (CHF), a genetic cholangiopathy characterized by fibropolycystic changes in the biliary tree, is caused by mutations in the PKHD1 gene, leading to defective fibrocystin (FPC), changes in planar cell polarity (PCP) and increased beta-catenin-dependent chemokine secretion. In this study, we aimed at understanding the role of Scribble (a protein involved in PCP), Yes-associated protein (YAP), and beta-catenin in the regulation of the fibroinflammatory phenotype of FPC-defective cholangiocytes. Immunohistochemistry showed that compared with wild type (WT) mice, in FPC-defective (Pkhd1(del4/del4)) mice nuclear expression of YAP/TAZ in cystic cholangiocytes, significantly increased and correlated with connective tissue growth factor (CTGF) expression and pericystic fibrosis, while Scribble expression on biliary cyst cells was markedly decreased. Cholangiocytes isolated from WT mice showed intense Scribble immunoreactivity at the membrane, but minimal nuclear expression of YAP, which conversely increased, together with CTGF, after small interfering RNA (siRNA) silencing of Scribble. In FPC-defective cholangiocytes, inhibition of YAP nuclear import reduced beta-catenin nuclear expression, and CTGF, integrin beta 6, CXCL1, and CXCL10 mRNA levels, whereas inhibition of beta-catenin signaling did not affect nuclear translocation of YAP. Notably, siRNA silencing of Scribble and YAP in WT cholangiocytes mimics the fibroinflammatory changes of FPC-defective cholangiocytes. Conditional deletion of beta-catenin in Pkhd1(del4/del4) mice reduced cyst growth, inflammation and fibrosis, without affecting YAP nuclear expression. In conclusion, the defective anchor of Scribble to the membrane facilitates the nuclear translocation of YAP and beta-catenin with gain of a fibroinflammatory phenotype. The Scribble/YAP/beta-catenin axis is a critical factor in the sequence of events linking the genetic defect to fibrocystic trait of cholangiocytes in CHF.	[Fabris, Luca; Mariotti, Valeria; Cadamuro, Massimiliano] Univ Padua, Dept Mol Med DMM, Padua, Italy; [Fabris, Luca; Cadamuro, Massimiliano] Univ Milano Bicocca, Int Ctr Digest Hlth ICDH, Milan, Italy; [Fabris, Luca; Fiorotto, Romina; Mariotti, Valeria; Kaffe, Eleanna; Strazzabosco, Mario] Yale Univ, Liver Ctr, Dept Internal Med, New Haven, CT 06517 USA; [Milani, Chiara; Seller, Barbara] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Sonzogni, Aurelio] ASST Papa Giovanni XXIII Hosp, Dept Pathol, Bergamo, Italy; [Mariotti, Valeria] Ist Sci San Raffaele, Div Neurosci, INSpe, Neuroimmunol Unit, Milan, Italy; [Kaffe, Eleanna] Yale Univ, Dept Immunobiol, New Haven, CT 06517 USA	University of Padua; University of Milano-Bicocca; Yale University; University of Milano-Bicocca; ASST Papa Giovanni XXIII; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University	Cadamuro, M (corresponding author), Univ Padua, Dept Mol Med DMM, Padua, Italy.; Strazzabosco, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Cedar St 333 Room LMP1080, New Haven, CT 06517 USA.; Cadamuro, M (corresponding author), Univ Padua, Dept Mol Med, Gabelli St 63, I-35121 Padua, Italy.	mario.strazzabosco@yale.edu; massimiliano.cadamuro@unipd.it	Cadamuro, Massimiliano/AAC-6169-2022	Cadamuro, Massimiliano/0000-0002-0899-7613; FABRIS, LUCA/0000-0001-8538-6317	Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; Project Cariplo 2014, Cariplo Foundation, Italy [2014-1099]; NIH [R01 DK096096, R01 DK101528]; Yale Liver Center award [NIH P30 DK034989]	Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; Project Cariplo 2014, Cariplo Foundation, Italy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center award	LF was supported by Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; CM and MC were supported by Project Cariplo 2014 (cod: 2014-1099), Cariplo Foundation, Italy; RF and MS were supported by NIH (R01 DK096096 and R01 DK101528). This project was supported in part by the Yale Liver Center award NIH P30 DK034989 Morphology and Cellular Molecular cores. The authors sincerely thank Prof. Paolo Simioni [General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padova, Italy] for the insightful suggestions and the critical revision of the manuscript.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Banales JM, 2009, HEPATOLOGY, V49, P160, DOI 10.1002/hep.22636; Cadamuro M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00115; Cadamuro M, 2016, CANCER RES, V76, P4775, DOI 10.1158/0008-5472.CAN-16-0188; Chen WS, 2015, BIOCHEM BIOPH RES CO, V466, P221, DOI 10.1016/j.bbrc.2015.09.012; Cohen J, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1609877; Cohen J, 2019, J CELL BIOL, V218, P1390, DOI 10.1083/jcb.201807216; Daulat AM, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800487; Daulat AM, 2017, TRENDS CANCER, V3, P113, DOI 10.1016/j.trecan.2017.01.001; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Di Benedetto A, 2016, ONCOTARGET, V7, P43188, DOI 10.18632/oncotarget.9668; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fabris L, 2019, NAT REV GASTRO HEPAT, V16, P497, DOI 10.1038/s41575-019-0156-4; Feng JT, 2016, ONCOTARGETS THER, V9, P5371, DOI 10.2147/OTT.S109979; Furu L, 2003, J AM SOC NEPHROL, V14, P2004, DOI 10.1097/01.ASN.0000078805.87038.05; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Ito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118336; Jiang Lu, 2017, Gene Expression, V17, P313, DOI 10.3727/105221617X15034976037343; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Locatelli L, 2016, HEPATOLOGY, V63, P965, DOI 10.1002/hep.28382; Lodillinsky C, 2016, ONCOGENE, V35, P344, DOI 10.1038/onc.2015.87; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Masyuk T, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100345; Masyuk TV, 2017, HEPATOLOGY, V66, P1197, DOI 10.1002/hep.29284; Masyuk TV, 2017, CURR DRUG TARGETS, V18, P950, DOI 10.2174/1389450116666150427161743; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Nagasawa-Masuda A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174633; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pinto C, 2018, BBA-MOL BASIS DIS, V1864, P1270, DOI 10.1016/j.bbadis.2017.07.024; Quinn HM, 2021, CANCER RES, V81, P2116, DOI 10.1158/0008-5472.CAN-20-2801; RUFFOLO RR, 1987, AM J MED SCI, V294, P244, DOI 10.1097/00000441-198710000-00005; Shome D, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4910280; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Veigel MC, 2009, PEDIATR RADIOL, V39, P317, DOI 10.1007/s00247-008-1070-z; Walter TJ, 2014, AM J PATHOL, V184, P1479, DOI 10.1016/j.ajpath.2014.01.030; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; Wang Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0606-1; Woollard JR, 2007, KIDNEY INT, V72, P328, DOI 10.1038/sj.ki.5002294; Xu DC, 2018, FASEB J, V32, P4394, DOI 10.1096/fj.201701376RR; Yonem O, 2007, WORLD J GASTROENTERO, V13, P1930, DOI 10.3748/wjg.v13.i13.1930; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang XY, 2017, INT J CLIN EXP PATHO, V10, P11968; Zheng HX, 2014, WORLD J GASTROENTERO, V20, P17092, DOI 10.3748/wjg.v20.i45.17092	52	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22364	10.1096/fj.202101924R	http://dx.doi.org/10.1096/fj.202101924R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5UL	35593740				2022-12-26	WOS:000797983900001
J	Farci, D; Haniewicz, P; de Sanctis, D; Iesu, L; Kereiche, S; Winterhalter, M; Piano, D				Farci, Domenica; Haniewicz, Patrycja; de Sanctis, Daniele; Iesu, Luca; Kereiche, Sami; Winterhalter, Mathias; Piano, Dario			The cryo-EM structure of the S-layer deinoxanthin-binding complex of Deinococcus radiodurans informs properties of its environmental interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; MICROSCOPE; RESOLUTION; UNIT; HPI	The radiation-resistant bacterium Deinococcus radiodurans is known as the world's toughest bacterium. The S-layer of D. radiodurans, consisting of several proteins on the surface of the cellular envelope and intimately associated with the outer membrane, has therefore been useful as a model for structural and functional studies. Its main proteinaceous unit, the S-layer deinoxanthin-binding complex (SDBC), is a hetero-oligomeric assembly known to contribute to the resistance against environmental stress and have porin functional features; however, its precise structure is unknown. Here, we resolved the structure of the SDBC at -2.5 angstrom resolution by cryo-EM and assigned the sequence of its main subunit, the protein DR_2577. This structure is characterized by a pore region, a massive beta-barrel organization, a stalk region consisting of a trimeric coiled coil, and a collar region at the base of the stalk. We show that each monomer binds three Cu ions and one Fe ion and retains one deinoxanthin molecule and two phosphoglycolipids, all exclusive to D. radiodurans. Finally, electrophysiological characterization of the SDBC shows that it exhibits transport properties with several amino acids. Taken together, these results highlight the SDBC as a robust structure displaying both protection and sieving functions that facilitates exchanges with the environment.	[Farci, Domenica; Haniewicz, Patrycja; Piano, Dario] Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Warsaw, Poland; [Farci, Domenica] Umea Univ, Dept Chem, Umea, Sweden; [de Sanctis, Daniele] European Synchrotron Radiat Facil ESRF, Struct Biol Grp, Grenoble, France; [Iesu, Luca; Piano, Dario] Univ Cagliari, Dept Life & Environm Sci, Lab Plant Physiol & Photobiol, Cagliari, Italy; [Kereiche, Sami] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Winterhalter, Mathias] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany	Warsaw University of Life Sciences; Umea University; European Synchrotron Radiation Facility (ESRF); University of Cagliari; Charles University Prague; Jacobs University	Farci, D; Piano, D (corresponding author), Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Warsaw, Poland.; Farci, D (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.; Piano, D (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Lab Plant Physiol & Photobiol, Cagliari, Italy.	dario.piano@unica.it; domenica.farci@umu.se	; de Sanctis, Daniele/G-9169-2015	Farci, Domenica/0000-0002-3691-2699; Iesu, Luca/0000-0002-4055-7909; Haniewicz, Patrycja/0000-0002-6298-7184; de Sanctis, Daniele/0000-0003-0391-8290	National Science Center (Poland); Sonata BIS 7 Program (2017) [PRO-2017/26/E/NZ1/00344]; Czech Science Foundation [1825144Y]; Harmonia 10 Program (2018) [PRO-2018/30/M/NZ1/00284]	National Science Center (Poland)(National Science Centre, Poland); Sonata BIS 7 Program (2017); Czech Science Foundation(Grant Agency of the Czech Republic); Harmonia 10 Program (2018)	This work was supported by the National Science Center (Poland) with the Sonata BIS 7 Program (2017) Grant PRO-2017/26/E/NZ1/00344 and the Harmonia 10 Program (2018) Grant PRO-2018/30/M/NZ1/00284 (both to D. P., D. F., and P. H.), the Czech Science Foundation Grant 1825144Y (to S. K.).	Adamec F, 2020, PHOTOCH PHOTOBIO SCI, V19, P495, DOI 10.1039/d0pp00031k; ANDERSON R, 1985, J BIOL CHEM, V260, P2219; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; BAUMEISTER W, 1986, J MOL BIOL, V187, P241, DOI 10.1016/0022-2836(86)90231-7; Bharat TAM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.59; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farci D, 2021, STRUCTURE, V29, P1279, DOI 10.1016/j.str.2021.06.014; Farci D, 2020, J BIOL CHEM, V295, P4224, DOI 10.1074/jbc.RA119.012174; Farci D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01450; Farci D, 2018, PHOTOCH PHOTOBIO SCI, V17, P81, DOI 10.1039/c7pp00240h; Farci D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00155; Farci D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00414; Farci D, 2014, BBA-BIOMEMBRANES, V1838, P1978, DOI 10.1016/j.bbamem.2014.02.014; Ferrara LGM, 2016, J MOL BIOL, V428, P4528, DOI 10.1016/j.jmb.2016.09.021; GENTNER NE, 1975, RADIAT RES, V61, P204, DOI 10.2307/3574039; Handing KB, 2018, NAT PROTOC, V13, P1062, DOI 10.1038/nprot.2018.018; HUANG Y, 1995, J BACTERIOL, V177, P2567, DOI 10.1128/jb.177.9.2567-2571.1995; HUANG Y, 1991, J BACTERIOL, V173, P457, DOI 10.1128/jb.173.2.457-462.1991; Kumar J, 2021, MICROB PHYSIOL, V31, P1, DOI 10.1159/000512018; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lister TE, 2001, LANGMUIR, V17, P2624, DOI 10.1021/la001448g; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Muller DJ, 1997, J STRUCT BIOL, V119, P149, DOI 10.1006/jsbi.1997.3878; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rothfuss H, 2006, MICROBIOL-SGM, V152, P2779, DOI 10.1099/mic.0.28971-0; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Singh PR, 2012, J PHYS CHEM B, V116, P4433, DOI 10.1021/jp2123136; Sleytr UB, 1997, TRENDS BIOTECHNOL, V15, P20, DOI 10.1016/S0167-7799(96)10063-9; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; YAN H, 1989, J BIOL CHEM, V264, P18667; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	37	3	3	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102031	10.1016/j.jbc.2022.102031	http://dx.doi.org/10.1016/j.jbc.2022.102031			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35577074	Green Published, gold			2022-12-26	WOS:000829588600004
J	Gao, XK; Bonzerato, CG; Wojcikiewicz, RJH				Gao, Xiaokong; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.			Binding of the erlin1/2 complex to the third intralumenal loop of IP(3)R1 triggers its ubiquitin-proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE; CANCER; RECEPTORS; CHANNELS; CA2+	Long-term activation of inositol 1,4,5-trisphosphate receptors (IP3Rs) leads to their degradation by the ubiquitin-proteasome pathway. The first and rate-limiting step in this process is thought to be the association of conformationally active IP3Rs with the erlin1/2 complex, an endoplasmic reticulum-located oligomer of erlin1 and erlin2 that recruits the E3 ubiquitin ligase RNF170, but the molecular determinants of this interaction remain unknown. Here, through mutation of IP3R1, we show that the erlin1/2 complex interacts with the IP3R1 intralumenal loop 3 (IL3), the loop between transmembrane (TM) helices 5 and 6, and in particular, with a region close to TM5, since mutation of amino acids D-2471 and R-2472 can specifically block erlin1/2 complex association. Surprisingly, we found that additional mutations in IL3 immediately adjacent to TM5 (e.g., D2465N) almost completely abolish IP3R1 Ca2+ channel activity, indicating that the integrity of this region is critical to IP3R1 function. Finally, we demonstrate that inhibition of the ubiquitin-activating enzyme UBE1 by the small-molecule inhibitor TAK-243 completely blocked IP3R1 ubiquitination and degradation without altering erlin1/2 complex association, confirming that association of the erlin1/2 complex is the primary event that initiates IP3R1 processing and that IP3R1 ubiquitination mediates IP3R1 degradation. Overall, these data localize the erlin1/2 complex-binding site on IP3R1 to IL3 and show that the region immediately adjacent to TM5 is key to the events that facilitate channel opening.	[Gao, Xiaokong; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Bonzerato, Caden/0000-0001-6380-8320				Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Baker JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0404-4; Baker MR, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02156-4; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Christianson JC, 2022, EMBO J, V41, DOI 10.15252/embj.2021109845; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; Daumke O, 2022, CELL RES, V32, P117, DOI 10.1038/s41422-021-00605-7; Fan GZ, 2018, CELL RES, V28, P1158, DOI 10.1038/s41422-018-0108-5; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kumari D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081185; Lemberg MK, 2021, MOL CELL, V81, P2507, DOI 10.1016/j.molcel.2021.05.004; Lesueur LL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.4; Lin QS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89402; Liu WG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082894; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Ma CY, 2022, CELL RES, V32, P176, DOI 10.1038/s41422-021-00598-3; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Mikoshiba Katsuhiko, 2015, Adv Biol Regul, V57, P217, DOI 10.1016/j.jbior.2014.10.001; Naranjo D, 2016, J GEN PHYSIOL, V148, P277, DOI 10.1085/jgp.201611625; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Prole DL, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035063; Schulman JJ, 2016, J BIOL CHEM, V291, P11820, DOI 10.1074/jbc.M115.711242; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Terry LE, 2020, J BIOL CHEM, V295, P18160, DOI 10.1074/jbc.RA120.015683; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wojcikiewicz Richard J H, 2018, Messenger (Los Angel), V6, P45, DOI 10.1166/msr.2018.1073; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Woll KA, 2022, PHYSIOL REV, V102, P209, DOI 10.1152/physrev.00033.2020; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Wright FA, 2018, J BIOL CHEM, V293, P15706, DOI 10.1074/jbc.RA118.004547; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Xu Q, 2004, MOL CANCER THER, V3, P1263; Zhu CC, 1999, J BIOL CHEM, V274, P3476, DOI 10.1074/jbc.274.6.3476	52	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102026	10.1016/j.jbc.2022.102026	http://dx.doi.org/10.1016/j.jbc.2022.102026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35568199	gold, Green Published			2022-12-26	WOS:000811243600005
J	Shi, RJ; Li, SW; Liu, PG; Zhang, SH; Wu, ZH; Wu, TH; Gong, SJ; Wan, Y				Shi, Ruijun; Li, Shuwei; Liu, Penggang; Zhang, Shuhui; Wu, Zhenhui; Wu, Tinghui; Gong, Shujuan; Wan, Yu			Identification of key genes and signaling pathways related to Hetian sheep wool density by RNA-seq technology	PLOS ONE			English	Article							HAIR-FOLLICLE; DIFFERENTIATION; CYCLE; MORPHOGENESIS; EXPRESSION; PROTEINS; PATTERNS; SKIN	Hetian sheep is a breed of sheep unique to the Hetian area of Xinjiang whose wool is used for producing blankets. Individual differences and hair follicle density are the key factors affecting wool production. Therefore, this study aimed to assess the Hetian sheep having different wool densities to statistically analyze the wool traits and hair follicle parameters. Furthermore, the transcriptome sequencing analysis was performed on the skins with different wool densities. The results showed that wool quantity and total hair follicle density of the high wool density sheep was significantly higher than low wool density sheep. The sheepskin with high wool density was found to grow more and finer wool than sheepskin with low wool density. A total of 1,452 differentially expressed genes were screened from the two sets of samples, including 754 upregulated and 698 downregulated genes. The differentially expressed genes were involved in the TGF-beta/BMP and MAPK signaling pathways related to hair growth. Eleven differentially expressed genes belonging to the KAPs and KIFs might affect the fineness of the wool. The key genes, like the TNF, MAP2K2, INHBA, FST, PTPN11, MAP3K7, KIT, and BMPR1A, were found to probably affect the growth and density of the wool. The qPCR verified eight genes related to the MAPK pathway whose gene expression trends were consistent with the transcriptome sequencing results. This study furnishes valuable resources for enhancing the quality and production of wool in the Hetian sheep.	[Shi, Ruijun; Li, Shuwei; Wu, Zhenhui; Wu, Tinghui; Gong, Shujuan; Wan, Yu] Tarim Univ, Coll Life Sci, Key Lab Protect & Utilizat Biol Resources Tarim, Alar, Peoples R China; [Liu, Penggang] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhang, Shuhui] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Tarim University; Yangzhou University; Shandong Agricultural University	Li, SW (corresponding author), Tarim Univ, Coll Life Sci, Key Lab Protect & Utilizat Biol Resources Tarim, Alar, Peoples R China.	yfzx_406@126.com		Shi, Ruijun/0000-0002-3070-4899	National Natural Science Foundation of China [31560685]; Postgraduate Research and Innovation Project [TDBSCX201905]; Southern Xinjiang Key Industry Innovation and Development Support Program [2021DB023]; Tarim Basin Biological Resources Conservation and Utilization Corps Key Laboratory Open Project [BRYB1906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Innovation Project; Southern Xinjiang Key Industry Innovation and Development Support Program; Tarim Basin Biological Resources Conservation and Utilization Corps Key Laboratory Open Project	This research was funded by National Natural Science Foundation of China(No. 31560685), Postgraduate Research and Innovation Project (No. TDBSCX201905), Southern Xinjiang Key Industry Innovation and Development Support Program (No. 2021DB023),Tarim Basin Biological Resources Conservation and Utilization Corps Key Laboratory Open Project (No. BRYB1906).	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Bertola DR, 2004, AM J MED GENET A, V130A, P378, DOI 10.1002/ajmg.a.30270; Bhat B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81471-6; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Cetera M, 2018, NAT CELL BIOL, V20, P541, DOI 10.1038/s41556-018-0082-7; Chen SJ, 2011, AGR SCI CHINA, V10, P595, DOI 10.1016/S1671-2927(11)60041-2; Ding HS, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07398-4; Doyle EK, 2021, ANIM FRONT, V11, P15, DOI 10.1093/af/vfab005; Eixarch H, 2020, NEUROTHERAPEUTICS, V17, P1988, DOI 10.1007/s13311-020-00885-8; Gong H, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060024; Guo HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169820; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; He N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231376; Kilsby AJ, 2013, CLIN DYSMORPHOL, V22, P64, DOI 10.1097/MCD.0b013e32835e8ce5; Lee J, 2012, SEMIN CELL DEV BIOL, V23, P906, DOI 10.1016/j.semcdb.2012.08.003; Li A, 2015, DEV DYNAM, V244, P905, DOI 10.1002/dvdy.24281; Li SM, 2020, GENE, V758, DOI 10.1016/j.gene.2020.144968; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Lin HY, 2013, DEV BIOL, V373, P394, DOI 10.1016/j.ydbio.2012.10.021; Lv XY, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061035; Lv XF, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061058; Mayer JA, 2008, AM J PATHOL, V173, P1339, DOI 10.2353/ajpath.2008.070920; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mishina Y, 2003, FRONT BIOSCI-LANDMRK, V8, pD855, DOI 10.2741/1097; Moore KE, 2015, J THERM BIOL, V47, P1, DOI 10.1016/j.jtherbio.2014.10.009; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nowaczyk MJM, 2014, CLIN GENET, V85, P138, DOI 10.1111/cge.12116; Ozturk OA, 2015, CELL REP, V13, P561, DOI 10.1016/j.celrep.2015.09.015; Ono S, 2013, EUR J DERMATOL, V23, P537, DOI 10.1684/ejd.2013.2074; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Popescu C, 2007, CHEM SOC REV, V36, P1282, DOI 10.1039/b604537p; Powell B C, 1997, EXS, V78, P59; Qiao X, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038589; Rippa AL, 2013, ACTA NATURAE, V5, P22, DOI 10.32607/20758251-2013-5-4-22-33; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Sayama K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011275; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Sotiropoulou PA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008383; Sulayman A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44600-w; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Wang H. Y., 2021, Braz. J. Biol., V81, P526, DOI 10.1590/1519-6984.224056; Wang JF, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020180; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang XS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14091; Xin SH, 2020, ARCH INSECT BIOCHEM, V105, DOI 10.1002/arch.21737; Xu HD, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.678667; Yang CH, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12569; Yang YJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/689756; Yuan SK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005253; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zhang YJ, 2020, GENOMICS, V112, P332, DOI 10.1016/j.ygeno.2019.02.013; Zhao BH, 2017, GENOME, V60, P1051, DOI 10.1139/gen-2017-0003; Zhao J, 2017, ANIM GENET, V48, P67, DOI 10.1111/age.12480	58	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2022	17	5							e0265989	10.1371/journal.pone.0265989	http://dx.doi.org/10.1371/journal.pone.0265989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6T2AH	35613128	Green Published, gold			2022-12-26	WOS:000893482100001
J	Kohno, M; Kamachi, T; Fukui, K				Kohno, Masahiro; Kamachi, Toshiaki; Fukui, Koji			Intermolecular binding between bulk water and dissolved gases in earth's magnetic field	PLOS ONE			English	Article							THERAPEUTIC ANTIOXIDANT; DIFFUSION; OXYGEN; ELECTRON; SPECTRUM; NITROGEN; NMR	Elucidation of the static states and dynamic behavior of oxygen and nitrogen dissolved in water is one of the most important issues in the life sciences. In the present study, experimental trials and theoretical calculations were performed based on the hypothesis that the dissolution of gas molecules in water is related to excitation by the Earth's magnetic field. Using quantum theories such as those used to describe electro magnetic resonance and nuclear magnetic resonance, this study investigated the states of oxygen, nitrogen and hydrogen dissolved in water. The results indicate that the Earth's magnetic field is involved in the bonding and dissociation of molecules at the gas-liquid interface. These calculations assessed the effect of a field strength of 1.0 x 10(-4) T and reproduced the influences of temperature changes on dissolved gas concentrations. Molecular interactions caused by electromagnetic properties and the external geomagnetic field were found to affect intermolar bonding associated with water cluster structures. It is concluded that the binding between molecules typically attributed to Coulomb coupling by magnetic charge and van der Waals forces results from excitation in the Earth's magnetic field.	[Kohno, Masahiro; Fukui, Koji] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Minuma Ku, Saitama, Japan; [Kamachi, Toshiaki] Tokyo Inst Technol, Dept Life Sci & Technol, Ookayama Meguro Ku, Tokyo, Japan	Shibaura Institute of Technology; Tokyo Institute of Technology	Fukui, K (corresponding author), Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Minuma Ku, Saitama, Japan.	koji@sic.shibaura-it.ac.jp	Kamachi, Toshiaki/C-4230-2015	Kamachi, Toshiaki/0000-0002-9720-0265; Fukui, Koji/0000-0003-2748-3228				[Anonymous], CHEM HDB FUNDAMENTAL, V5; Appelt S, 2006, NAT PHYS, V2, P105, DOI 10.1038/nphys211; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BENE GJ, 1980, PHYS REP, V58, P213, DOI 10.1016/0370-1573(80)90012-5; Boero M, 2007, J PHYS CHEM A, V111, P12248, DOI [10.1021/jp074356+, 10.1021/jp074356]; Borden WT, 2017, J AM CHEM SOC, V139, P9010, DOI 10.1021/jacs.7b04232; BUCKINGHAM AD, 1959, Q REV CHEM SOC, V13, P183, DOI 10.1039/qr9591300183; Carrington A., 1967, INTRO MAGNETIC RESON; COLPA JP, 1958, MOL PHYS, V1, P343, DOI 10.1080/00268975800100421; EPSTEIN PS, 1950, J CHEM PHYS, V18, P1505, DOI 10.1063/1.1747520; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FERRELL RT, 1967, J CHEM ENG DATA, V12, P111, DOI 10.1021/je60032a036; Froid B., 1953, TABLES DIELECTRIC CO; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Garbuio V, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/033101; Garrett BC, 2005, CHEM REV, V105, P355, DOI 10.1021/cr030453x; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; HIMMELBLAU DM, 1964, CHEM REV, V64, P527, DOI 10.1021/cr60231a002; James HM, 1938, ASTROPHYS J, V87, P438, DOI 10.1086/143936; Kohno M, 2011, J CLIN BIOCHEM NUTR, V49, P96, DOI 10.3164/jcbn.10-130; Liu JF, 2018, CHEM SCI, V9, P2065, DOI 10.1039/c7sc04205a; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Miyaji A, 2017, BIOCHEM BIOPH RES CO, V483, P178, DOI 10.1016/j.bbrc.2016.12.171; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Pettersson LGM, 2016, CHEM REV, V116, P7459, DOI 10.1021/acs.chemrev.6b00363; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; SHOSTAK SL, 1991, J CHEM PHYS, V94, P5875, DOI 10.1063/1.460471; STEPISNIK J, 1994, J MAGN RESON SER A, V107, P167, DOI 10.1006/jmra.1994.1064; Stepisnik J, 2006, NATURE, V439, P799, DOI 10.1038/439799a; Tawnes C.H., 1975, L MICROWAVE SPECTROS, P364; TINKHAM M, 1955, PHYS REV, V97, P951, DOI 10.1103/PhysRev.97.951; UENO S, 1994, J APPL PHYS, V75, P7177, DOI 10.1063/1.356686; WATANABE H, 1985, METROLOGIA, V21, P19, DOI 10.1088/0026-1394/21/1/005; Weiss HM, 2008, J CHEM EDUC, V85, P1218, DOI 10.1021/ed085p1218; Welil JA., 1994, ELECT PARAMAGNETIC R; Yoshihara A, 2003, EARTH PLANET SC LETT, V210, P219, DOI 10.1016/S0012-821X(03)00123-7	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267391	10.1371/journal.pone.0267391	http://dx.doi.org/10.1371/journal.pone.0267391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552552	Green Published, gold			2022-12-26	WOS:000868164600023
J	Majorina, MA; Veselova, VR; Melnik, BS				Majorina, Maria A.; Veselova, Victoria R.; Melnik, Bogdan S.			The influence of Pseudomonas syringae on water freezing and ice melting	PLOS ONE			English	Article							NUCLEATION; INHIBITION	Pseudomonas syringae is a widely spread plant pathogen known to have ice-nucleating proteins that serve as crystallization sites promoting ice growth at near-zero temperatures. Three temperatures that characterize water freezing and ice melting are (i) the freezing point of water, (ii) the temperature of coexistence of ice and water, and (iii) the melting point of ice. Here we show the influence of different concentrations of P. syringae on these three parameters. P. syringae appears to affect both the freezing point of water and the temperature of the coexistence of ice and water. Additionally, we propose a research technique for studying the freezing/melting process that is simple and requires no complex equipment.	[Majorina, Maria A.; Veselova, Victoria R.; Melnik, Bogdan S.] RAS, Inst Prot Res, Pushchino, Moscow Region, Russia	Russian Academy of Sciences	Melnik, BS (corresponding author), RAS, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Melnik, Bogdan/U-1988-2017	Melnik, Bogdan/0000-0002-9176-6452	Russian Science Foundation [21-14-00268]	Russian Science Foundation(Russian Science Foundation (RSF))	All the authors of this work was funded by Russian Science Foundation, grant number 21-14-00268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexei V. Finkelstein, 2020, Arxiv, DOI arXiv:2008.13682; Celik Y, 2010, P NATL ACAD SCI USA, V107, P5423, DOI 10.1073/pnas.0909456107; Cochet N, 2000, APPL MICROBIOL BIOT, V54, P153, DOI 10.1007/s002530000377; de Araujo GG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44283-3; DEVRIES AL, 1986, METHOD ENZYMOL, V127, P293; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; GOODNOW RA, 1990, APPL ENVIRON MICROB, V56, P2223, DOI 10.1128/AEM.56.7.2223-2227.1990; GURIANSHERMAN D, 1993, FASEB J, V7, P1338, DOI 10.1096/fasebj.7.14.8224607; Joly M, 2013, ATMOS ENVIRON, V70, P392, DOI 10.1016/j.atmosenv.2013.01.027; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; KNIGHT CA, 1989, SCIENCE, V245, P505, DOI 10.1126/science.245.4917.505; KOZLOFF LM, 1983, J BACTERIOL, V153, P222, DOI 10.1128/JB.153.1.222-231.1983; Kuiper MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05142; MAKI LR, 1974, APPL MICROBIOL, V28, P456, DOI 10.1128/AEM.28.3.456-459.1974; Pietsch RB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00318; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; SUZUKI M, 1993, CHEM PHARM BULL, V41, P942; SWEENEY TE, 1993, AM J PHYSIOL, V264, pR469, DOI 10.1152/ajpregu.1993.264.3.R469; Weng LD, 2016, LANGMUIR, V32, P9229, DOI 10.1021/acs.langmuir.6b02212; WOLBER P, 1989, TRENDS BIOCHEM SCI, V14, P179, DOI 10.1016/0968-0004(89)90270-3	20	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265683	10.1371/journal.pone.0265683	http://dx.doi.org/10.1371/journal.pone.0265683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551271	Green Published, gold			2022-12-26	WOS:000868164600007
J	Hafez, AM				Hafez, Abdulwahab M.			Risk assessment of resistance to diflubenzuron in Musca domestica: Realized heritability and cross-resistance to fourteen insecticides from different classes	PLOS ONE			English	Article							L. DIPTERA MUSCIDAE; HOUSE-FLY; FIELD STRAIN; LAMBDA-CYHALOTHRIN; GROWTH-REGULATORS; MOTH LEPIDOPTERA; FITNESS COST; POPULATIONS; FLIES; PYRIPROXYFEN	The Musca domestica L. is a well-known vector for a number of livestock and human diseases. One major challenge for maintaining effective control of this pest is its propensity to develop resistance to insecticides. This study utilized laboratory selection and realized heritability methods to examine the risk of resistance development to diflubenzuron in Musca domestica L. Cross-resistance (CR) to fourteen other insecticides was measured in diflubenzuron-selected (Diflu-SEL) strain which was selected for 20 generations. The resistance ratio (RR) of Diflu-SEL larvae to diflubenzuron increased from 30.33 in generation five (G(5)) to 182.33 in G(24) compared with the susceptible strain, while realized heritability (h(2)) was 0.08. The number of needed generations (G) for a tenfold increase in the median lethal concentration (LC50) for diflubenzuron ranged from 4 to 45 at h(2) values of 0.08, 0.18, and 0.28, at a slope of 1.51. At h(2) = 0.08 and slopes of 1.51, 2.51, and 3.51, the number of needed G for a tenfold increase in the LC50 ranged from 9 to 104. The level of CR shown by the Diflu-SEL strain to all other fourteen tested insecticides (insect growth regulators, organophosphates, and pyrethroids) was either absent or very low compared to the field population. The value of h(2) and the absent or low CR indicate potential successful management of resistance to diflubenzuron and recommend the use of the tested insecticides in rotation with diflubenzuron to control M. domestica.	[Hafez, Abdulwahab M.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Pesticides & Environm Toxicol Lab, Riyadh, Saudi Arabia	King Saud University	Hafez, AM (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Pesticides & Environm Toxicol Lab, Riyadh, Saudi Arabia.	hafez@ksu.edu.sa	Hafez, Abdulwahab/ABC-9703-2020	Hafez, Abdulwahab/0000-0003-4290-5548	Deanship of Scientific Research at King Saud University, Saudi Arabia [RG-1441-480]	Deanship of Scientific Research at King Saud University, Saudi Arabia	This project was funded by the Deanship of Scientific Research at King Saud University, Saudi Arabia, through the project number RG-1441-480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248693; Abbas N, 2021, J MED ENTOMOL, V58, P1779, DOI 10.1093/jme/tjab036; Abbas N, 2016, VET PARASITOL, V223, P71, DOI 10.1016/j.vetpar.2016.04.026; Abbas N, 2015, PAK J ZOOL, V47, P1663; Abbas N, 2015, PARASITOL RES, V114, P2629, DOI 10.1007/s00436-015-4467-2; Abbas N, 2015, J ECON ENTOMOL, V108, P826, DOI 10.1093/jee/tou057; Abbas N, 2015, PARASITOL RES, V114, P247, DOI 10.1007/s00436-014-4186-0; Abbas N, 2014, ECOTOXICOLOGY, V23, P791, DOI 10.1007/s10646-014-1217-7; Abbas N, 2014, PARASITOL RES, V113, P1343, DOI 10.1007/s00436-014-3773-4; Abbas N, 2012, PESTIC BIOCHEM PHYS, V103, P181, DOI 10.1016/j.pestbp.2012.05.001; Afzal MBS, 2020, PEST MANAG SCI, V76, P161, DOI 10.1002/ps.5488; Alam M, 2020, PESTIC BIOCHEM PHYS, V168, DOI 10.1016/j.pestbp.2020.104648; Banazeer A, 2019, PHYTOPARASITICA, V47, P531, DOI 10.1007/s12600-019-00753-y; Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263; Cetin H, 2006, J INSECT SCI, V6; Donahue WA, 2017, J ECON ENTOMOL, V110, P776, DOI 10.1093/jee/tow294; El-Guindy M. A., 1983, Pesticide Science, V14, P235, DOI 10.1002/ps.2780140305; FIRKO MJ, 1990, J ECON ENTOMOL, V83, P647, DOI 10.1093/jee/83.3.647; Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227; Grigoraki L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12103-1; Hafez AM., 2021, PARASIT VECTORS, V14, P1, DOI [10.1186/s13071-020-04505-4, DOI 10.1186/S13071-020-04505-4]; IRAC, 2020, IRAC MOD ACT CLASS S; James PJ, 2008, MED VET ENTOMOL, V22, P326, DOI 10.1111/j.1365-2915.2008.00753.x; Khan HAA, 2021, PARASITOL RES, V120, P435, DOI 10.1007/s00436-020-06998-5; Khan HAA, 2019, PEST MANAG SCI, V75, P2969, DOI 10.1002/ps.5409; Khan HAA, 2017, CHEMOSPHERE, V167, P308, DOI 10.1016/j.chemosphere.2016.10.018; Khan HAA, 2016, CHEMOSPHERE, V151, P133, DOI 10.1016/j.chemosphere.2016.02.077; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; Khan H, 2014, PESTIC BIOCHEM PHYS, V114, P38, DOI 10.1016/j.pestbp.2014.07.005; King BH, 2020, J MED ENTOMOL, V57, P511, DOI 10.1093/jme/tjz195; Kocisova A, 2004, BIOLOGIA, V59, P661; Kristensen M, 2003, J ECON ENTOMOL, V96, P1300, DOI 10.1603/0022-0493-96.4.1300; Lai TC, 2011, PEST MANAG SCI, V67, P1468, DOI 10.1002/ps.2201; Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019; LeOra S., 2003, POLOPLUS USERS GUIDE; Levot G, 2004, AUST J ENTOMOL, V43, P374, DOI 10.1111/j.1440-6055.2004.00394.x; Levot G. W., 2002, General and Applied Entomology, V31, P43; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Nielsen AA, 2011, J MED ENTOMOL, V48, P608, DOI 10.1603/ME11017; Saeed R, 2020, CROP PROT, V130, DOI 10.1016/j.cropro.2019.105069; Saeed R, 2020, PEST MANAG SCI, V76, P2645, DOI 10.1002/ps.5806; Shah RM, 2018, NEOTROP ENTOMOL, V47, P709, DOI 10.1007/s13744-018-0604-9; Shah RM, 2021, ENVIRON POLLUT, V278, DOI 10.1016/j.envpol.2021.116880; Shah RM, 2020, PEST MANAG SCI, V76, P1866, DOI 10.1002/ps.5716; Shah RM, 2017, PEST MANAG SCI, V73, P254, DOI 10.1002/ps.4296; Shah RM, 2015, ACTA TROP, V149, P32, DOI 10.1016/j.actatropica.2015.05.009; Shah RM, 2015, PARASITOL RES, V114, P487, DOI 10.1007/s00436-014-4206-0; Shah RM, 2015, ACTA TROP, V142, P149, DOI 10.1016/j.actatropica.2014.11.016; Su TY, 2021, J MED ENTOMOL, V58, P398, DOI 10.1093/jme/tjaa182; Su TY, 2014, J MED ENTOMOL, V51, P428, DOI 10.1603/ME13207; TABASHNIK BE, 1994, J ECON ENTOMOL, V87, P834, DOI 10.1093/jee/87.4.834; TABASHNIK BE, 1992, J ECON ENTOMOL, V85, P1551, DOI 10.1093/jee/85.5.1551; Tunaz Hasan, 2004, Turkish Journal of Agriculture and Forestry, V28, P377	53	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268261	http://dx.doi.org/10.1371/journal.pone.0268261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560149	gold, Green Published			2022-12-26	WOS:000835326900011
J	Hanumante, NA; Shastri, YA; Nisal, AA; Diwekar, UA; Cabezas, HA				Hanumante, Neeraj A.; Shastri, Yogendra A.; Nisal, Apoorva A.; Diwekar, Urmila A.; Cabezas, Heriberto A.			Integrated model for Food-Energy-Water (FEW) nexus to study global sustainability: The water compartments and water stress analysis	PLOS ONE			English	Article							DYNAMICS	Analysis of global sustainability is incomplete without an examination of the FEW nexus. Here, we modify the Generalized Global Sustainability Model (GGSM) to incorporate the global water system and project water stress on the global and regional levels. Five key water-consuming sectors considered here are agricultural, municipal, energy, industry, and livestock. The regions are created based on the continents, namely, Africa, Asia, Europe, North America, Oceania, and South America. The sectoral water use intensities and geographical distribution of the water demand were parameterized using historical data. A more realistic and novel indicator is proposed to assess the water situation: net water stress. It considers the water whose utility can be harvested, within economic and technological considerations, rather than the total renewable water resources. Simulation results indicate that overall global water availability is adequate to support the rising water demand in the next century. However, regional heterogeneity of water availability leads to high water stress in Africa. Africa's maximum net water stress is 140%, so the water demand is expected to be more than total exploitable water resources. Africa might soon cross the 100% threshold/breakeven in 2022. For a population explosion scenario, the intensity of the water crisis for Africa and Asia is expected to rise further, and the maximum net water stress would reach 149% and 97%, respectively. The water use efficiency improvement for the agricultural sector, which reduces the water demand by 30%, could help to delay this crisis significantly.	[Hanumante, Neeraj A.; Shastri, Yogendra A.] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Nisal, Apoorva A.; Diwekar, Urmila A.] Univ Illinois, Dept Ind Engn, Chicago, IL 60607 USA; [Diwekar, Urmila A.] Vishwamitra Res Inst, Crystal Lake, IL 60514 USA; [Cabezas, Heriberto A.] Univ Miskolc, Res Inst Appl Earth Sci, Miskolc, Hungary	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Miskolc	Diwekar, UA (corresponding author), Univ Illinois, Dept Ind Engn, Chicago, IL 60607 USA.; Diwekar, UA (corresponding author), Vishwamitra Res Inst, Crystal Lake, IL 60514 USA.	urmila@vri-custom.org	Nisal, Apoorva/GOP-1033-2022	Nisal, Apoorva/0000-0002-8469-9503; Hanumante, Neeraj/0000-0002-6693-0548; Diwekar, Urmila/0000-0002-0933-5865	Ministry of Human Resource Development, Government of India, through the SPARC [P1238]; Research Institute of Applied Earth Sciences of the University of Miskolc [GINOP-2.3.2-15-2016-00010]; European Union; European Structural and Investment Funds	Ministry of Human Resource Development, Government of India, through the SPARC; Research Institute of Applied Earth Sciences of the University of Miskolc; European Union(European Commission); European Structural and Investment Funds	NH, YS, UD acknowledge the support from the Ministry of Human Resource Development, Government of India, through the SPARC (project code: P1238). The research contribution by H. Cabezas was carried out in the GINOP-2.3.2-15-2016-00010 framework Development of enhanced engineering methods with the aim at utilization of subterranean energy resources"project at the Research Institute of Applied Earth Sciences of the University of Miskolc, the Szechenyi 2020 Plan, partially funded by the European Union, co-financed by the European Structural and Investment Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; D'Odorico P, 2018, REV GEOPHYS, V56, P456, DOI 10.1029/2017RG000591; Diwekar U., 2021, PLOS ONE UNPUB; FAO, 2021, GLOB MAP SALT AFF SO, DOI DOI 10.4135/9781412963855.N464; FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS, 2003, REV WORLD WAT RES CO; Food and Agriculture Organization of the United Nations (FAO), 2021, MET SDG 6; Food and Agriculture Organization of the United Nations (FAO), 2021, AQUASTAT MET TOT EXP; Food and Agriculture Organization of the United Nations (FAO), 2014, REP 31 SESS COMM FIS; Franz M, 2018, ENVIRON SCI POLICY, V90, P201, DOI 10.1016/j.envsci.2017.12.004; Gain AK, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124015; Gassert F., 2013, AQUEDUCT COUNTRY RIV; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Hoekstra A.Y., 2015, WATER FOOTPRINT IND, P221, DOI DOI 10.1016/B978-0-12-799968-5.00007-5; IEA, 2021, GLOB HYDR REV; Jekel, 2019, PWLF PYTHON LIB FITT, P15; Konapala G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16757-w; Maxmen A, 2018, NATURE, V554, P13, DOI 10.1038/d41586-018-01134-x; Meadows D.H., 1972, LIMITS GROWTH, P205; Mekonnen MM, 2015, ENVIRON SCI-WAT RES, V1, P285, DOI [10.1039/c5ew00026b, 10.1039/C5EW00026B]; Motesharrei S, 2014, ECOL ECON, V101, P90, DOI 10.1016/j.ecolecon.2014.02.014; Nie YL, 2019, SCI TOTAL ENVIRON, V659, P7, DOI 10.1016/j.scitotenv.2018.12.242; OECD, 1998, WAT CONS SUST WAT RE; Parks R.M., 2019, 29 GRANTH I; Randers J., 2018, TRANSFORMATION IS FE; Ritchie H., 2017, OUR WORLD DATA; Ritchie H., 2019, LAND USE; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Roser M, 2013, WORLD POPULATION GRO; Sadoff CW, 2020, NAT SUSTAIN, V3, P346, DOI 10.1038/s41893-020-0530-9; Scanlon BR, 2017, WATER RESOUR RES, V53, P3550, DOI 10.1002/2017WR020889; Terrapon-Pfaff JC, 2020, WATER-SUI, V12, DOI 10.3390/w12092482; UN, 2018, SUSTAINABLE DEV GOAL, DOI [10.1126/science.278.5339.827, DOI 10.1126/SCIENCE.278.5339.827]; UN-Water, 2018, SUSTAINABLE DEV GOAL; United Nations, 1999, WORLD 6 BILL; United Nations, UN WORLD WAT DEV REP; Wada Y, 2014, EARTH SYST DYNAM, V5, P15, DOI 10.5194/esd-5-15-2014; World Resources Institute, 2021, WAT STRESS COUNTR; Yeung HWC, 2015, ECON GEOGR, V91, P29, DOI 10.1111/ecge.12063	38	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0266554	http://dx.doi.org/10.1371/journal.pone.0266554			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559955	Green Published, gold			2022-12-26	WOS:000835326900025
J	Kathamuthu, GRA; Sridhar, RA; Baskaran, DA; Babu, SA				Kathamuthu, Gokul Raj A.; Sridhar, Rathinam A.; Baskaran, Dhanaraj A.; Babu, Subash A.			Dominant expansion of CD4(+), CD8(+) T and NK cells expressing Th1/Tc1/Type 1 cytokines in culture-positive lymph node tuberculosis	PLOS ONE			English	Article							IMMUNE-RESPONSES; DIAGNOSIS	Lymph node culture-positive tuberculosis (LNTB+) is associated with increased mycobacterial antigen-induced pro-inflammatory cytokine production compared to LN culture-negative tuberculosis (LNTB-). However, the frequencies of CD4(+), CD8(+) T cells and NK cells expressing Th1/Tc1/Type 1 (IFN gamma, TNF alpha, IL-2), Th17/Tc17/Type 17 (IL-17A, IL-17F, IL-22) cytokines and cytotoxic (perforin [PFN], granzyme [GZE] B, CD107a) markers in LNTB+ and LNTB- individuals are not known. Thus, we have studied the unstimulated (UNS) and mycobacterial antigen-induced frequencies of CD4(+), CD8(+) T and NK cells expressing Th1, Th17 cytokines and cytotoxic markers using flow cytometry. The frequencies of CD4(+), CD8(+) T and NK cells expressing cytokines and cytotoxic markers were not significantly different between LNTB+ and LNTB- individuals in UNS condition. In contrast, upon Mtb antigen stimulation, LNTB+ individuals are associated with significantly increased frequencies of CD4(+) T cells (PPD [IFN gamma, TNF alpha], ESAT-6 PP [IFN gamma, TNF alpha], CFP-10 PP [IFN gamma, TNF alpha, IL-2]), CD8(+) T cells (PPD [IFN gamma], ESAT-6 PP [IFN gamma], CFP-10 PP [TNF alpha]) and NK cells (PPD [IFN gamma, TNF alpha], ESAT-6 PP [IFN gamma, TNF alpha], CFP-10 PP [TNF alpha]) expressing Th1/Tc1/Type 1, but not Th17/Tc17/Type 17 cytokines and cytotoxic markers compared to LNTB- individuals. LNTB+ individuals did not show any significant alterations in the frequencies of CD4(+), CD8(+) T cells and NK cells expressing cytokines and cytotoxic markers compared to LNTB- individuals upon HIV Gag PP and P/I antigen stimulation. Increased frequencies of CD4(+), CD8(+) T and NK cells expressing Th1/Tc1/Type 1 cytokines among the LNTB+ group indicates that the presence of mycobacteria plays a dominant role in the activation of key correlates of immune protection or induces higher immunopathology.	[Kathamuthu, Gokul Raj A.; Babu, Subash A.] NIH, Int Ctr Excellence Res, NIRT, Chennai, India; [Kathamuthu, Gokul Raj A.; Baskaran, Dhanaraj A.] Natl Inst Res TB NIRT, Chennai, India; [Sridhar, Rathinam A.] Govt Stanley Med Hosp, Chennai, India; [Babu, Subash A.] Natl Inst Allergy & Infect Dis, NIH, Lab Parasit Dis, Bethesda, MD USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kathamuthu, GRA (corresponding author), NIH, Int Ctr Excellence Res, NIRT, Chennai, India.; Kathamuthu, GRA (corresponding author), Natl Inst Res TB NIRT, Chennai, India.	gokul.r@nirt.res.in	Babu, Subash/GXG-4746-2022					[Anonymous], 2021, INT J INFECT DIS; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Silva BDD, 2014, IMMUNOL LETT, V160, P23, DOI 10.1016/j.imlet.2014.03.009; Fontanilla JM, 2011, CLIN INFECT DIS, V53, P555, DOI 10.1093/cid/cir454; Ganchua SKC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007337; Kathamuthu GR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585293; Kathamuthu GR, 2019, TUBERCULOSIS, V118, DOI 10.1016/j.tube.2019.101856; Kathamuthu GR, 2019, AM J TROP MED HYG, V100, P1401, DOI 10.4269/ajtmh.18-0834; Kathamuthu GR, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00045-17, 10.1128/cvi.00045-17]; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Knox J, 2012, INTERN MED J, V42, P1029, DOI 10.1111/j.1445-5994.2012.02748.x; Kumar NP, 2014, TUBERCULOSIS, V94, P482, DOI 10.1016/j.tube.2014.06.007; Maji A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15214; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Polesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Zhang ZN, 2020, J COMPUT BIOL, V27, P121, DOI 10.1089/cmb.2019.0161	27	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0269109	http://dx.doi.org/10.1371/journal.pone.0269109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617254	Green Published, gold			2022-12-26	WOS:000835048800076
J	Rouault, AAJ; Buscaglia, P; Sebag, JA				Rouault, Alix A. J.; Buscaglia, Paul; Sebag, Julien A.			MRAP2 inhibits ?-arrestin recruitment to the ghrelin receptor by preventing GHSR1a phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETAGOGUE; PROTEINS; STOMACH; PEPTIDE	The melanocortin receptor accessory protein 2 (MRAP2) is essential for several physiological functions of the ghrelin receptor growth hormone secretagogue receptor 1a (GHSR1a), including increasing appetite and suppressing insulin secretion. In the absence of MRAP2, GHSR1a displays high constitutive activity and a weak G-protein-mediated response to ghrelin and readily recruits fl-arrestin. In the presence of MRAP2, however, G-protein-mediated signaling via GHSR1a is strongly dependent on ghrelin stimulation and the recruitment of fl-arrestin is significantly diminished. To better understand how MRAP2 modifies GHSR1a signaling, here we investigated the role of several phosphorylation sites within the C-terminal tail and third intracellular loop of GHSR1a, as well as the mechanism behind MRAP2-mediated inhibition of fl-arrestin recruitment. We show that Ser252 and Thr261 in the third intracellular loop of GHSR1a contribute to fl-arrestin recruitment, whereas the Cterminal region is not essential for fl-arrestin interaction. Additionally, we found that MRAP2 inhibits GHSR1a phosphorylation by blocking the interaction of GRK2 and PKC with the receptor. Taken together, these data suggest that MRAP2 alters GHSR1a signaling by directly impacting the phosphorylation state of the receptor and that the C-terminal tail of GHSR1a prevents rather than contribute to flarrestin recruitment.	[Rouault, Alix A. J.; Buscaglia, Paul; Sebag, Julien A.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Rouault, Alix A. J.; Buscaglia, Paul; Sebag, Julien A.] FOEDRC, Iowa City, IA 52242 USA; [Rouault, Alix A. J.; Buscaglia, Paul; Sebag, Julien A.] Pappajohn Biomed Inst, Iowa City, IA 52246 USA; [Rouault, Alix A. J.; Buscaglia, Paul; Sebag, Julien A.] Iowa Neurosci Inst, Iowa City, IA 52242 USA	University of Iowa	Sebag, JA (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.; Sebag, JA (corresponding author), FOEDRC, Iowa City, IA 52242 USA.; Sebag, JA (corresponding author), Pappajohn Biomed Inst, Iowa City, IA 52246 USA.; Sebag, JA (corresponding author), Iowa Neurosci Inst, Iowa City, IA 52242 USA.	Julien-sebag@uiowa.edu		Buscaglia, Paul/0000-0002-6080-2983; sebag, julien/0000-0002-8366-312X	NIDDK [R01DK115567]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant NIDDK R01DK115567	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bouzo-Lorenzo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22495; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Bruschetta G, 2018, MOL METAB, V18, P79, DOI 10.1016/j.molmet.2018.09.010; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chuang TT, 1996, J BIOL CHEM, V271, P28691, DOI 10.1074/jbc.271.45.28691; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Dezaki K, 2022, PEPTIDES, V148, DOI 10.1016/j.peptides.2021.170681; Gupta D, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101258; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Kahsai AW, 2018, CELL RES, V28, P783, DOI 10.1038/s41422-018-0067-x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Lilleness BM, 2016, CARDIOL REV, V24, P288, DOI 10.1097/CRD.0000000000000113; Madariaga-Mazon A, 2017, DRUG DISCOV TODAY, V22, P1719, DOI 10.1016/j.drudis.2017.07.002; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rouault AAJ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax4569; Rouault AAJ, 2017, BBA-MOL CELL RES, V1864, P2322, DOI 10.1016/j.bbamcr.2017.09.008; Rouault AAJ, 2017, BBA-MOL BASIS DIS, V1863, P2462, DOI 10.1016/j.bbadis.2017.05.008; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Seyedabadi M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020218; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Srisai D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00747-6; Stahl EL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102178118; Toth K, 2019, ACS PHARMACOL TRANSL, V2, P230, DOI 10.1021/acsptsci.9b00018; Verdinez JA, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.730417; Wang JL, 2021, MOL PHARMACOL, V100, P568, DOI 10.1124/molpharm.121.000359; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Wootten D, 2018, NAT REV MOL CELL BIO, V19, P638, DOI 10.1038/s41580-018-0049-3; Yin TC, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101216; Yuan MJ, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20203387	34	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102057	10.1016/j.jbc.2022.102057	http://dx.doi.org/10.1016/j.jbc.2022.102057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35605660	Green Published, gold			2022-12-26	WOS:000811243600003
J	Hofer, F; Schreyoegg, J; Stargardt, T				Hofer, Florian; Schreyogg, Jonas; Stargardt, Tom			Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; COPD; TELEHEALTH; MANAGEMENT; OUTCOMES; EXACERBATIONS; TELEMEDICINE; PREVALENCE; ALGORITHMS; ASTHMA	Introduction Chronic obstructive pulmonary disease (COPD) affects more than 6 million people in Germany. Monitoring the vital parameters of COPD patients remotely through telemonitoring may help doctors and patients prevent and treat acute exacerbations of COPD, improving patients' quality of life and saving costs for the statutory health insurance system. Objective To evaluate the effects from October 2012 until December 2015 of a structured home telemonitoring program implemented by a statutory health insurer in Germany. Methods We conducted a retrospective cohort study using administrative data. After building a balanced control group using Entropy Balancing, we calculated difference-in-difference estimators to account for time-invariant heterogeneity. We estimated differences in mortality rates using Cox regression and conducted subgroup and sensitivity analyses to check the robustness of the base case results. We observed each patient in the program for up to 3 years depending on his or her time of enrolment. Results Among patients in the telemonitoring cohort, we observed significantly higher inpatient costs due to COPD (Euro524.2, p<0,05; Euro434.6, p<0.05) and outpatient costs (102.5, p<0.01; 78.8 p<0.05) during the first two years of the program. Additional cost categories were significantly increased during the first year of telemonitoring. We also observed a significantly higher number of drug prescriptions during all three years of the observation period (2.0500, p < 0.05; 0.7260, p < 0.05; 3.3170, p < 0.01) and a higher number of outpatient contacts during the first two years (0.945, p<0.01, 0.683, p<0.05). Furthermore, we found significantly improved survival rates for participants in the telemonitoring program (HR 0.68, p<0.001). Conclusion On one hand, telemonitoring was associated with higher health care expenditures, especially in the first year of the program. For example, we were able to identify a statistically significant increase in inpatient costs due to COPD, outpatient contacts and drug prescriptions among individuals participating in the telemonitoring program. On the other hand, the telemonitoring program was accompanied by a survival benefit, which might be related to higher adherence rates, more intense treatment, or an improved understanding of COPD among these patients.	[Hofer, Florian; Schreyogg, Jonas; Stargardt, Tom] Univ Hamburg, Hamburg Ctr Hlth Econ HCHE, Hamburg, Germany	University of Hamburg	Stargardt, T (corresponding author), Univ Hamburg, Hamburg Ctr Hlth Econ HCHE, Hamburg, Germany.	tom.stargardt@uni-hamburg.de		Schreyogg, Jonas/0000-0001-8030-2161; Hofer, Florian/0000-0003-2532-0919	AOK Bayern	AOK Bayern	This project was funded by AOK Bayern and SHL Telemedizin.	Achelrod D, 2017, EUR J HEALTH ECON, V18, P869, DOI 10.1007/s10198-016-0834-x; Achelrod D, 2016, HEALTH POLICY, V120, P1029, DOI 10.1016/j.healthpol.2016.08.002; Alharbi Nouf Sahal, 2016, J Med Internet Res, V18, pe310; Ancochea J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00354-2018; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bashi N, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6571; Bashshur R L, 1995, Telemed J, V1, P19, DOI 10.1089/tmj.1.1995.1.19; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bolton CE, 2011, J EVAL CLIN PRACT, V17, P1216, DOI 10.1111/j.1365-2753.2010.01536.x; Brazauskas R, 2016, BIOL BLOOD MARROW TR, V22, P557, DOI 10.1016/j.bbmt.2015.12.005; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burton C, 2015, J TELEMED TELECARE, V21, P29, DOI 10.1177/1357633X14562733; Chatwin M, 2016, THORAX, V71, P305, DOI 10.1136/thoraxjnl-2015-207045; Cruz J, 2014, INT J MED INFORM, V83, P249, DOI 10.1016/j.ijmedinf.2014.01.008; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Esteban C, 2016, INT J CHRONIC OBSTR, V11, P2919, DOI 10.2147/COPD.S115350; Geldmacher H, 2008, DEUT MED WOCHENSCHR, V133, P2609, DOI 10.1055/s-0028-1105858; Global Initiative for Chronic Obstructive Lung Disease, US; Golbeck AL, 2011, J TELEMED TELECARE, V17, P273, DOI 10.1258/jtt.2011.100807; Hainmueller J, 2012, POLIT ANAL, V20, P25, DOI 10.1093/pan/mpr025; Hamad GA, 2016, HEALTH INFORM J, V22, P406, DOI 10.1177/1460458214564434; Kesten S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-129; Kirsch F, 2013, GESUNDHEITSWESEN, V75, P413, DOI 10.1055/s-0033-1333742; Klersy C, 2016, EUR J HEART FAIL, V18, P195, DOI 10.1002/ejhf.470; Kuo RN, 2011, MED CARE, V49, P1031, DOI 10.1097/MLR.0b013e31822ebe11; Lee SWH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12987-z; Marcus J., 2012, SSRN ELECT J, DOI [10.2139/ssrn.2166741, DOI 10.2139/SSRN.2166741]; Mehring M, 2014, RESP CARE, V59, P1123, DOI 10.4187/respcare.02748; Milkowska-Dymanowska J, 2018, INT J MED INFORM, V116, P46, DOI 10.1016/j.ijmedinf.2018.04.013; Pedone Claudio, 2015, Pneumonol Alergol Pol, V83, P476, DOI 10.5603/PiAP.2015.0077; Piga M, 2017, SEMIN ARTHRITIS RHEU, V47, P121, DOI 10.1016/j.semarthrit.2017.03.014; Pinnock H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6070; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rixon L, 2017, CLIN RESPIR J, V11, P459, DOI 10.1111/crj.12359; Rojahn K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155738; Rush KL, 2018, PATIENT EDUC COUNS, V101, P1310, DOI 10.1016/j.pec.2018.02.006; Sanchez-Morillo D, 2016, CHRON RESP DIS, V13, P264, DOI 10.1177/1479972316642365; Statistisches Bundesamt, 2011, AUSG BEV ZENS 2011, V39; Steventon A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009221; Vitacca M, 2018, THER ADV RESPIR DIS, V12, DOI 10.1177/1753465818754778; Walker PP, 2018, AM J RESP CRIT CARE, V198, P620, DOI 10.1164/rccm.201712-2404OC; Wootton R, 2012, J TELEMED TELECARE, V18, P211, DOI 10.1258/jtt.2012.120219; Yun JE, 2018, J CARD FAIL, V24, P19, DOI 10.1016/j.cardfail.2017.09.006	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267952	10.1371/journal.pone.0267952	http://dx.doi.org/10.1371/journal.pone.0267952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551546	Green Published, gold			2022-12-26	WOS:000868179400008
J	Memon, A; Bin Mustafa, MW; Anjum, W; Ahmed, A; Ullah, S; Altbawi, SMA; Jumani, TA; Khan, I; Hamadneh, NN				Memon, Ahsanullah; Bin Mustafa, Mohd Wazir; Anjum, Waqas; Ahmed, Ahsan; Ullah, Shafi; Altbawi, Saleh Masoud Abdallah; Jumani, Touqeer Ahmed; Khan, Ilyas; Hamadneh, Nawaf N.			Dynamic response and low voltage ride-through enhancement of brushless double-fed induction generator using Salp swarm optimization algorithm	PLOS ONE			English	Article							DESIGN; MPPT	A brushless double-fed induction generator (BDFIG) has shown tremendous success in wind turbines due to its robust brushless design, smooth operation, and variable speed characteristics. However, the research regarding controlling of machine during low voltage ride through (LVRT) need greater attention as it may cause total disconnection of machine. In addition, the BDFIG based wind turbines must be capable of providing controlled amount of reactive power to the grid as per modern grid code requirements. Also, a suitable dynamic response of machine during both normal and fault conditions needs to be ensured. This paper, as such, attempts to provide reactive power to the grid by analytically calculating the decaying flux and developing a rotor side converter control scheme accordingly. Furthermore, the dynamic response and LVRT capability of the BDFIG is enhanced by using one of the very intelligent optimization algorithms called the Salp Swarm Algorithm (SSA). To prove the efficacy of the proposed control scheme, its performance is compared with that of the particle swan optimization (PSO) based controller in terms of limiting the fault current, regulating active and reactive power, and maintaining the stable operation of the power system under identical operating conditions. The simulation results show that the proposed control scheme significantly improves the dynamic response and LVRT capability of the developed BDFIG based wind energy conversion system; thus proves its essence and efficacy.	[Memon, Ahsanullah; Bin Mustafa, Mohd Wazir; Anjum, Waqas; Altbawi, Saleh Masoud Abdallah] Univ Teknol Malaysia UTM, Fac Elect Engn, Sch Elect Engn, Skudai, Johor, Malaysia; [Memon, Ahsanullah; Jumani, Touqeer Ahmed] Mehran Univ Engn & Technol, Dept Elect Engn, SZAB Campus, Khairpur Mirs, Sindh, Pakistan; [Anjum, Waqas] Islamia Univ Bahawalpur, Dept Elect Engn, Bahawalpur, Pakistan; [Ahmed, Ahsan] Majmaah Univ, Coll Comp & Informat Sci, Dept Informat Technol, Al Majmaah, Saudi Arabia; [Ullah, Shafi] BUITEMS, Dept Comp Engn, Fac Informat & Commun Technol, Quetta, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Sci Al Zulfi, Dept Math, Al Majmaah, Saudi Arabia; [Hamadneh, Nawaf N.] Saudi Elect Univ, Coll Sci & Theoret Studies, Dept Basic Sci, Riyadh, Saudi Arabia	Universiti Teknologi Malaysia; Islamia University of Bahawalpur; Majmaah University; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Majmaah University; Saudi Electronic University	Memon, A (corresponding author), Univ Teknol Malaysia UTM, Fac Elect Engn, Sch Elect Engn, Skudai, Johor, Malaysia.; Memon, A (corresponding author), Mehran Univ Engn & Technol, Dept Elect Engn, SZAB Campus, Khairpur Mirs, Sindh, Pakistan.	memon.ahsanullah@graduate.utm.my	Altbawi, Saleh/GLT-0424-2022; Hamadneh, Nawaf/AAW-7128-2021	Altbawi, Saleh/0000-0003-4656-5333; Hamadneh, Nawaf/0000-0002-2170-2074				Duan QW, 2018, J POWER ELECTRON, V18, P817, DOI 10.6113/JPE.2018.18.3.817; Gholizadeh M, 2018, INT J ELEC POWER, V95, P1, DOI 10.1016/j.ijepes.2017.07.018; Hang CL, 2018, INT C ELECTR MACH SY, P1533, DOI 10.23919/ICEMS.2018.8549019; Hao JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242316; Huang JJ, 2018, INT J ELEC POWER, V98, P243, DOI 10.1016/j.ijepes.2017.12.005; Jumani TA, 2020, ENERGIES, V13, DOI 10.3390/en13164063; Jumani TA, 2018, ENERGIES, V11, DOI 10.3390/en11113191; Liu Y, 2018, APPL POWER ELECT CO, P1392, DOI 10.1109/APEC.2018.8341199; Long T, 2013, IEEE T ENERGY CONVER, V28, P502, DOI 10.1109/TEC.2013.2261818; Lu M, 2019, ENERGIES, V12, DOI 10.3390/en12020319; Memon A., 2021, INDONESIAN J ELECT E, V23, P650, DOI [10.11591/ijeecs.v23.i2.pp650-656, DOI 10.11591/IJEECS.V23.I2.PP650-656]; Memon A, 2021, INT T ELECTR ENERGY, V31, DOI 10.1002/2050-7038.13157; Memon A, 2021, ENERGIES, V14, DOI 10.3390/en14154461; Memon A, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10121413; Mirjalili S, 2017, ADV ENG SOFTW, V114, P163, DOI 10.1016/j.advengsoft.2017.07.002; Moghadasi A, 2016, RENEW SUST ENERG REV, V55, P823, DOI 10.1016/j.rser.2015.11.020; Mohammed OO, 2020, IEEE SYST J, V14, P1230, DOI 10.1109/JSYST.2019.2910554; Pereira RMM, 2018, ENERGIES, V11, DOI 10.3390/en11040885; Pura P, 2019, INT T ELECTR ENERGY, V29, DOI 10.1002/etep.2815; Shao SY, 2013, IEEE T IND ELECTRON, V60, P2465, DOI 10.1109/TIE.2012.2211313; Shipurkar U, 2017, IEEE T ENERGY CONVER, V32, P1611, DOI 10.1109/TEC.2017.2724204; Su M, 2018, ENERGIES, V11, DOI 10.3390/en11071883; Wang XW, 2017, IEEE T POWER ELECTR, V32, P8193, DOI 10.1109/TPEL.2016.2609461; Yang B, 2019, INT T ELECTR ENERGY, V29, DOI 10.1002/etep.2697; Yang B, 2019, J CLEAN PROD, V215, P1203, DOI 10.1016/j.jclepro.2019.01.150; Yang B, 2018, SOL ENERGY, V170, P31, DOI 10.1016/j.solener.2018.05.034; Yang B, 2018, ENERG CONVERS MANAGE, V159, P312, DOI 10.1016/j.enconman.2017.12.090; Yang B, 2017, ENERG CONVERS MANAGE, V133, P427, DOI 10.1016/j.enconman.2016.10.062; Zhang AL, 2020, IEEE T IND ELECTRON, V67, P7606, DOI 10.1109/TIE.2019.2944096; Zhang DY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221410; Zhang FG, 2019, IEEE T IND ELECTRON, V66, P631, DOI 10.1109/TIE.2018.2811379	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265611	10.1371/journal.pone.0265611	http://dx.doi.org/10.1371/journal.pone.0265611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551274	gold, Green Published			2022-12-26	WOS:000868164600006
J	Zhang, YX; Wu, JZ; Fu, Y; Yu, RR; Su, HC; Zheng, QS; Wu, H; Zhou, SQ; Wang, K; Zhao, J; Shen, SS; Xu, GF; Wang, L; Yan, C; Zou, XP; Lv, Y; Zhang, S				Zhang, Yixuan; Wu, Jianzhuang; Fu, Yao; Yu, Ranran; Su, Haochen; Zheng, Qisi; Wu, Hao; Zhou, Siqi; Wang, Kun; Zhao, Jing; Shen, Shanshan; Xu, Guifang; Wang, Lei; Yan, Chao; Zou, Xiaoping; Lv, Ying; Zhang, Shu			Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; MODIFIED-FOLFIRINOX; INDUCED APOPTOSIS; INCREASING ROS; ER STRESS; MITOCHONDRIA; AUTOPHAGY; INHIBITION; METABOLISM	Pancreatic cancer (PC) is a fatal disease with poor survival and limited therapeutic strategies. In this study, we identified Hesperadin as a potent anti-cancer compound against PC, from a high-throughput screening of a commercial chemical library associated with cell death. Hesperadin induced potent growth inhibition in PC cell lines and patient-derived tumor organoids in a dose- and time-dependent manner, with IC50 values in the nanomolar range. Cellular studies showed that Hesperadin caused mitochondria damage in PC cells, resulting in reactive oxygen species production, ER stress and apoptotic cell death. Transcriptomic analysis using RNA-sequencing data identified GADD45A as a potential target of Hesperadin. Mechanistic studies showed that Hesperadin could increase GADD45A expression in PC cells via ATF4, leading to apoptosis. Moreover, immunohistochemical staining of 92 PC patient samples demonstrated the correlation between ATF4 and GADD45A expression. PC xenograft studies demonstrated that Hesperadin could effectively inhibit the growth of PC cells in vivo. Together, these findings suggest that Hesperadin is a novel drug candidate for PC.	[Zhang, Yixuan; Wu, Hao; Zhao, Jing; Shen, Shanshan; Xu, Guifang; Wang, Lei; Zou, Xiaoping; Lv, Ying; Zhang, Shu] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Gastroenterol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Yixuan; Wu, Jianzhuang; Su, Haochen; Wu, Hao; Zhou, Siqi; Wang, Kun; Zhao, Jing; Shen, Shanshan; Xu, Guifang; Wang, Lei; Yan, Chao; Zou, Xiaoping; Lv, Ying; Zhang, Shu] Nanjing Univ, Inst Pancreatol, Nanjing, Peoples R China; [Wu, Jianzhuang; Yu, Ranran; Yan, Chao] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Fu, Yao] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Pathol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Su, Haochen] Nanjing Med Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Gastroenterol, Nanjing, Peoples R China; [Zheng, Qisi] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Clin Lab, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Siqi] Jiangsu Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Gastroenterol, Nanjing, Peoples R China; [Wang, Kun] Xuzhou Med Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Gastroenterol, Nanjing, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University; Nanjing University; Nanjing University; Jiangsu University; Nanjing University; Nanjing University; Xuzhou Medical University	Zou, XP; Lv, Y; Zhang, S (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Gastroenterol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zou, XP; Lv, Y; Zhang, S (corresponding author), Nanjing Univ, Inst Pancreatol, Nanjing, Peoples R China.	zouxp@nju.edu.cn; lvying@njglyy.com; zhangsgastro@nju.edu.cn		Fu, Yao/0000-0001-9864-1030	National Natural Science Foundation of China [81802396, 82072652]; Natural Science Foundation of Jiangsu Province [SBK2019022491, BK20180117]; General Project of Nanjing Medical Science and Technology Development Project [YKK17077]; Nanjing Science and Technology Development Plan Project [201715023]; Nanjing Medical Science and Technology Development Key Project [ZKX18022]; Nanjing Science and technology project [201911038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); General Project of Nanjing Medical Science and Technology Development Project; Nanjing Science and Technology Development Plan Project; Nanjing Medical Science and Technology Development Key Project; Nanjing Science and technology project	This work was supported by the National Natural Science Foundation of China (81802396 and 82072652), Natural Science Foundation of Jiangsu Province (SBK2019022491 and BK20180117), General Project of Nanjing Medical Science and Technology Development Project (YKK17077), Nanjing Science and Technology Development Plan Project (201715023), Nanjing Medical Science and Technology Development Key Project (ZKX18022), and Nanjing Science and technology project (201911038).	Aggarwal V, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110735; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen WQ, 2016, REDOX BIOL, V10, P78, DOI 10.1016/j.redox.2016.09.006; Chen X, 2021, NAT REV CANCER, V21, P71, DOI 10.1038/s41568-020-00312-2; Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.019; Cheng X, 2018, CANCER LETT, V431, P105, DOI 10.1016/j.canlet.2018.05.046; Chiu HY, 2020, ANTIOXID REDOX SIGN, V32, P309, DOI 10.1089/ars.2019.7898; Chuang KC, 2020, J DERMATOL SCI, V98, P152, DOI 10.1016/j.jdermsci.2020.03.009; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; DU J, 2021, CELL DEATH DIS, V12; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Harris IS, 2020, TRENDS CELL BIOL, V30, P440, DOI 10.1016/j.tcb.2020.03.002; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hu YL, 2019, ONCOGENE, V38, P731, DOI 10.1038/s41388-018-0478-7; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Li W, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0805-4; Li X, 2017, CANCER LETT, V406, P22, DOI 10.1016/j.canlet.2017.07.012; Li X, 2018, INT J BIOL SCI, V14, P1291, DOI 10.7150/ijbs.26776; Lin YN, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109249; Liu CY, 2020, ENVIRON TOXICOL, V35, P1100, DOI 10.1002/tox.22946; Liu S, 2017, REDOX BIOL, V13, P528, DOI 10.1016/j.redox.2017.06.007; Missiroli S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102943; Moore Alexandra, 2019, JAMA, V322, P1426, DOI 10.1001/jama.2019.14699; Nano M, 2019, CURR BIOL, V29, P3937, DOI 10.1016/j.cub.2019.09.041; Neoptolemos JP, 2018, NAT REV GASTRO HEPAT, V15, P332, DOI 10.1038/s41575-018-0005-x; Perillo B, 2020, EXP MOL MED, V52, P192, DOI 10.1038/s12276-020-0384-2; Rodic S, 2018, INT J CANCER, V142, P440, DOI 10.1002/ijc.31069; Sasaki K, 2020, BIOSCIENCE REP, V40; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva JM, 2009, NEUROBIOL DIS, V34, P357, DOI 10.1016/j.nbd.2009.02.005; Su MQ, 2018, INT J ONCOL, V53, P750, DOI 10.3892/ijo.2018.4402; Tempero MA, 2019, J NATL COMPR CANC NE, V17, P603, DOI 10.6004/jnccn.2019.5007; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Verfaillie T, 2013, CANCER LETT, V332, P249, DOI 10.1016/j.canlet.2010.07.016; Wang ZQ, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0367-7; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Xiong WP, 2016, MOL CANCER THER, V15, P412, DOI 10.1158/1535-7163.MCT-15-0703; Yang LX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02807-0; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151; Zhou SQ, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0218-z; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	47	0	0	6	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2022	41	25					3394	3408		10.1038/s41388-022-02328-4	http://dx.doi.org/10.1038/s41388-022-02328-4		MAY 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	2E6DK	35551503				2022-12-26	WOS:000794082100002
J	Luczynski, P				Luczynski, Piotr			Tsunamites versus tempestites: Various types of redeposited stromatoporoid beds in the Devonian of the Holy Cross Mountains (Poland), a case study from the Olowianka Quarry	PLOS ONE			English	Article							CARBONATE PLATFORM; SILURIAN BIOSTROME; FRASNIAN PLATFORM; PODOLIA UKRAINE; STORM DEPOSITS; SANDY TSUNAMI; GROWTH FORMS; WAVE-FORM; SEDIMENTARY; FACIES	The sedimentary history of two stromatoporoid accumulations - an allobiostrome and a parabiostrome-are studied in the shallow water carbonates of the Middle to Upper Devonian Kowala Formation in the Olowianka Quarry, Holy Cross Mountains, central Poland. Sedimentological and facies observations are accompanied by morphometrical and taphonomical analyses of redeposited stromatoporoid skeletons. Stromatoporoid features, including shape profile, latilaminae arrangement, surface character, dimensions, and preservation state, are interpreted in terms of their original growth habitats and susceptibility to exhumation and transport. Sedimentary features of the studied beds are interpreted with regards to the high-energy processes that lead to their deposition. In the allobiostrome, the original stromatoporoid habitat was located below storm wave base, in a calm setting characterised by a low and stable depositional rate and clear bottom waters. The large scale onshore redeposition of stromatoporoid skeletons from such a setting was only possible due to an extraordinary event causing erosion at considerable depths: a tsunami is the most probable explanation. The sedimentary and textural features of the allobiostromal accumulation, such as clast supported textures and lack of vertical sorting, point to a single act of deposition and high flow velocities, in agreement with the tsunami interpretation. In contrast, the parabiostromal stromatoporoid accumulation does not exhibit any features that would require a non-tempestitic explanation, the default and most probable interpretation of high energy facies interbedding shallow water lagoonal sediments. This comparison has shown that studies of variously developed stromatoporoid beds, and particularly the analysis of morphometric features of stromatoporoid skeletons, can provide a unique opportunity to identify palaeotsunamites, which commonly remain undetected in the sedimentary record, leading to underestimates of their abundance.	[Luczynski, Piotr] Univ Warsaw, Fac Geol, Warsaw, Poland	University of Warsaw	Luczynski, P (corresponding author), Univ Warsaw, Fac Geol, Warsaw, Poland.	Piotr.Luczynski@uw.edu.pl		Luczynski, Piotr/0000-0002-8507-5743	Faculty of Geology, University of Warsaw [501-0113-01-1130203]	Faculty of Geology, University of Warsaw	The study was financed from the funds of the Faculty of Geology, University of Warsaw. (geo. uw.edu.pl) Grant number 501-0113-01-1130203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biguenet M, 2021, SEDIMENT GEOL, V412, DOI 10.1016/j.sedgeo.2020.105806; Boesl F, 2020, SEDIMENTOLOGY, V67, P1393, DOI 10.1111/sed.12578; Boulvain F., 2008, 26 TH IAS REGIONAL M, V237, P21; Boulvain F, 2007, GEOL SOC SPEC PUBL, V275, P125, DOI 10.1144/GSL.SP.2007.275.01.09; Bourgeois J., 2009, SEA, V15, P53; Brill D, 2020, SEDIMENTOLOGY, V67, P1431, DOI 10.1111/sed.12586; BROADHURST F. M., 1966, NORSK GEOL TIDSSKR, V46, P401; Burchette T. V., 1981, SEPM SPEC PUBL, V30, P85; Chague-Goff C, 2010, MAR GEOL, V271, P67, DOI 10.1016/j.margeo.2010.01.010; Cocks LRM, 2006, GEOL SOC MEM, V32, P83, DOI 10.1144/GSL.MEM.2006.032.01.05; Copper Paul, 2002, P181; Costa PJM, 2020, SEDIMENTOLOGY, V67, P1189, DOI 10.1111/sed.12724; Czarnocki J., 1938, CARTE GEOLOGIQUE GEN; Da Silva AC, 2004, GEOL Q, V48, P253; Da Silva AC, 2012, BASIN RES, V24, P338, DOI 10.1111/j.1365-2117.2011.00526.x; Da Silva AC, 2011, LETHAIA, V44, P255, DOI 10.1111/j.1502-3931.2010.00240.x; Da Silva AC, 2011, PALAEONTOLOGY, V54, P883, DOI 10.1111/j.1475-4983.2011.01037.x; Dawson AG, 2000, PURE APPL GEOPHYS, V157, P875, DOI 10.1007/s000240050010; Dawson AG, 2007, SEDIMENT GEOL, V200, P166, DOI 10.1016/j.sedgeo.2007.01.002; Debowska U., 2004, PRZEGLAD GEOL, V52, P920; Einasto R., 1986, P65; Flugel E., 1992, Facies, V26, P167, DOI 10.1007/BF02539799; Fujiwara O, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P133, DOI 10.1016/B978-0-444-51552-0.00009-6; Fujiwara O, 2007, SEDIMENT GEOL, V200, P295, DOI 10.1016/j.sedgeo.2007.01.009; Gao Jianguo, 1997, P1651; Goff J, 2012, SEDIMENT GEOL, V243, P70, DOI 10.1016/j.sedgeo.2011.11.002; Goto K, 2009, POL J ENVIRON STUD, V18, P53; Goto K, 2007, SEDIMENT GEOL, V202, P821, DOI 10.1016/j.sedgeo.2007.09.004; Goto K, 2019, PROG EARTH PLANET SC, V6, DOI 10.1186/s40645-019-0265-2; Goto K, 2013, GEOLOGY, V41, P1139, DOI 10.1130/G34823.1; Goto K, 2010, EARTH-SCI REV, V102, P77, DOI 10.1016/j.earscirev.2010.06.005; Goto K, 2010, MAR GEOL, V269, P34, DOI 10.1016/j.margeo.2009.12.004; HARRINGTON RJ, 1987, J PALEONTOL, V61, P649, DOI 10.1017/S0022336000029012; Hoffman A., 1992, PRZEGLAD GEOL, V10, P606; Ikehara K., 2014, MAR GEOL, V349, P91; Ikehara K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87152-8; Jaffe BE, 2012, SEDIMENT GEOL, V282, P90, DOI 10.1016/j.sedgeo.2012.09.002; James N. P., 1992, FACIES MODELS RESPON, P323; Jan FGBL, 2007, SEDIMENT GEOL, V199, P1, DOI 10.1016/j.sedgeo.2006.12.007; Jarochowska E, 2015, SEDIMENT GEOL, V315, P14, DOI 10.1016/j.sedgeo.2014.10.012; Kaljo DL., 1983, T PALEONTOLOGICHESKO, V194, P45; Kazmierczak J., 1971, Palaeontologia Polonica, V26, P1; KAZMIERCZAK J, 1978, GEOL MAG, V115, P359, DOI 10.1017/S0016756800037377; KERSHAW S, 1990, PALAEONTOLOGY, V33, P681; Kershaw S, 1998, PALAEONTOLOGY, V41, P509; KERSHAW S, 1981, J PALEONTOL, V55, P1284; KERSHAW S, 1994, SEDIMENT GEOL, V89, P325, DOI 10.1016/0037-0738(94)90101-5; KERSHAW S, 1978, LETHAIA, V11, P233, DOI 10.1111/j.1502-3931.1978.tb01230.x; Kershaw S, 1999, PALAEOGEOGR PALAEOCL, V149, P313, DOI 10.1016/S0031-0182(98)00209-0; KERSHAW S, 1984, PALAEONTOLOGY, V27, P113; Kershaw Stephen, 1994, Facies, V31, P81, DOI 10.1007/BF02536934; Kershaw S, 2018, EARTH-SCI REV, V187, P53, DOI 10.1016/j.earscirev.2018.08.003; Kershaw Stephen, 2012, Treatise Online, V31, P1; Kershaw S, 2006, GFF, V128, P131, DOI 10.1080/11035890601282131; Kershaw S, 2013, J PALAEOGEOG-ENGLISH, V2, P163, DOI 10.3724/SP.J.1261.2013.00024; Konigshof P, 2006, FACIES, V52, P299, DOI 10.1007/s10347-005-0041-1; Konigshof P., 1991, Geologica et Palaeontologica, V25, P19; Kortekaas S, 2007, SEDIMENT GEOL, V200, P208, DOI 10.1016/j.sedgeo.2007.01.004; Kowalski WR., 1975, ANN SOC GEOL POL, V45, P45; Lecompte M., 1959, INT GEOL REV, V1, P1; Luczynski P, 2005, LETHAIA, V38, P143, DOI 10.1080/00241160510013268; Luczynski P, 1998, ACTA PALAEONTOL POL, V43, P653; Luczynski P., 2003, 22 IAS M SEDIMENTOLO, P109; Luczynski P, 2012, PRZ GEOL, V60, P598; Luczynski P, 2020, ACTA GEOL POL, V70, P311, DOI 10.24425/agp.2019.126460; Luczynski P, 2008, ACTA GEOL POL, V58, P303; Luczynski P, 2006, LETHAIA, V39, P339, DOI 10.1080/00241160600876735; Luczynski P, 2016, ACTA GEOL POL, V66, P281, DOI 10.1515/agp-2016-0014; Luczynski P, 2015, ACTA GEOL POL, V65, P297, DOI 10.1515/agp-2015-0013; Luczynski P, 2014, ACTA GEOL POL, V64, P261, DOI 10.2478/agp-2014-0014; Luczynski Piotr, 2003, Acta Geologica Polonica, V53, P19; Luczynski P, 2009, ACTA GEOL POL, V59, P319; Luczynski P, 2009, PALAEOGEOGR PALAEOCL, V271, P225, DOI 10.1016/j.palaeo.2008.10.017; Machel HG., 1994, FACIES, V30, P155, DOI DOI 10.1007/BF02536895; MEYER FO, 1981, SCIENCE, V213, P894, DOI 10.1126/science.213.4510.894; Mistiaen Bruno, 1994, Courier Forschungsinstitut Senckenberg, V172, P319; Moore A, 2011, PURE APPL GEOPHYS, V168, P1951, DOI 10.1007/s00024-011-0280-8; Morton RA, 2007, SEDIMENT GEOL, V200, P184, DOI 10.1016/j.sedgeo.2007.01.003; Nakanishi R, 2020, QUATERNARY SCI REV, V250, DOI 10.1016/j.quascirev.2020.106678; Narkiewicz M., 1990, GEOL Q, V34, P433; Nott J, 2003, J COASTAL RES, V19, P348; Paris R, 2010, MAR GEOL, V268, P43, DOI 10.1016/j.margeo.2009.10.011; Pas D, 2013, FACIES, V59, P969, DOI 10.1007/s10347-012-0351-z; Pratt BR, 2002, GEOLOGY, V30, P423, DOI 10.1130/0091-7613(2002)030<0423:SVTDIO>2.0.CO;2; Racki G, 2004, GEOL Q, V48, P83; Racki G., 1992, ACTA PALAEONTOL POL, V37, P87; Racki G, 2000, PRZEGLAD GEOL, V48, P65; Riding R., 1990, EUROPEAN FOSSIL REEF, V30, P41; Rubinowski Z, 1971, BIUL PANSTW I GEOL, V247, P1; Salerno Carlo, 2008, Zitteliana Reihe B, V27, P3; Sandstrom O, 2002, SEDIMENTOLOGY, V49, P379, DOI 10.1046/j.1365-3091.2002.00444.x; Shanmugam G, 2006, J SEDIMENT RES, V76, P718, DOI 10.2110/jsr.2006.073; Shiki T, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P1; Skompski S, 2008, FACIES, V54, P277, DOI 10.1007/s10347-007-0133-1; Stearn Colin W., 2010, Treatise Online, V10, P1; Stearn Colin W., 2010, Treatise Online, V9, P1; Stearn Colin W., 2010, Treatise Online, V8, P1; STEARN CW, 1994, LETHAIA, V27, P1, DOI 10.1111/j.1502-3931.1994.tb01547.x; Szczucinski W, 2006, POL J ENVIRON STUD, V15, P793; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; SZULCZEWSKI M, 1981, Acta Geologica Polonica, V31, P147; SZULCZEWSKI M, 1971, Acta Geologica Polonica, V21, P1; Szulczewski M, 1996, SEDIMENT GEOL, V106, P21, DOI 10.1016/0037-0738(95)00145-X; Szulczewski M., 1979, GUIDEBOOK 3 INT S FO, P5; Szulczewski M, 1977, PRZEGLAD GEOL, V8, P428; Szulczewski M., 1995, GEOL Q, V39, P471; Szulczewski M, 1968, ACTA GEOL POL, V17, P304; Takashimizu Y, 2000, SEDIMENT GEOL, V135, P231, DOI 10.1016/S0037-0738(00)00074-9; Vierek A., 2013, GEOLOGOS, V19, P257, DOI DOI 10.2478/logos-2013-0015; Vierek A, 2007, GEOL Q, V51, P307; Vierek A, 2011, PALAEOGEOGR PALAEOCL, V312, P1, DOI 10.1016/j.palaeo.2011.07.032; Ward S., 2011, ENCY EARTH SCI SERIE, P1473, DOI DOI 10.1007/978-90-481-8702-7; Webby B.D., 2011, Treatise Online, V25, P1; Weiss R, 2008, MAR GEOL, V250, P251, DOI 10.1016/j.margeo.2008.01.018; Wolniewicz P, 2021, LETHAIA, V54, P378, DOI 10.1111/let.12410; Wood R, 1995, PALAIOS, V10, P517, DOI 10.2307/3515091; Young GA, 2005, PALAEONTOLOGY, V48, P623, DOI 10.1111/j.1475-4983.2005.00480.x	117	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268349	10.1371/journal.pone.0268349	http://dx.doi.org/10.1371/journal.pone.0268349			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580129	gold, Green Published			2022-12-26	WOS:000886501700009
J	Song, S; DeMeo, NN; Almeida, DM; Majd, M; Engeland, CG; Graham-Engeland, JE				Song, Sunmi; DeMeo, Natasha N.; Almeida, David M.; Majd, Marzieh; Engeland, Christopher G.; Graham-Engeland, Jennifer E.			The longitudinal connection between depressive symptoms and inflammation: Mediation by sleep quality	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; HEALTH BEHAVIORS; SEX-DIFFERENCES; RISK; METAANALYSIS; MARKERS; DURATION; STRESS	Although there is a strong association between depressive symptoms and markers of inflammation, it remains unclear whether depressive symptoms at one point in life may predict inflammation later in life. Moreover, despite extant literature linking sleep with both depressive symptoms and inflammation, there is little research investigating poor sleep as a mechanism linking depressive symptoms with later inflammation. The links between depression and physical health can also vary by gender. In longitudinal analyses with data from the Midlife in the United States (MIDUS) study, we examined whether depressive symptoms were associated with inflammatory markers 11 years later and whether these associations were mediated by sleep disturbances or moderated by gender. Participants reported depressive symptoms and demographic information at baseline. At 11-year follow-up, the same participants (n = 968) reported depressive symptoms, sleep quality and duration using validated scale items, and provided a blood sample from which inflammatory markers interleukin-6 (IL-6) and C-reactive protein (CRP) were quantified. Actigraphy assessment of sleep was obtained in a subsample (n = 276). After adjusting for concurrent depressive symptoms and other relevant covariates, baseline depressive symptoms were associated with CRP 11 years later in the full sample, and with IL-6 among women. Subjective sleep quality mediated the association between depressive symptoms and CRP. Results suggest that depressive symptoms may be longitudinally associated with inflammation; however, directionality issues cannot be determined from the present work, particularly as inflammation markers (which might have been associated with baseline depressive symptoms) were not available at baseline. Findings further suggest that longitudinal associations between depressive symptoms and inflammation may potentially be explained by sleep and may reflect gender specific patterns.	[Song, Sunmi] Korea Univ, Grad Sch, Dept Hlth Sci, Seoul, South Korea; [DeMeo, Natasha N.; Engeland, Christopher G.; Graham-Engeland, Jennifer E.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16801 USA; [Almeida, David M.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA USA; [Majd, Marzieh] Rice Univ, Dept Psychol Sci, Houston, TX USA; [Engeland, Christopher G.] Penn State Univ, Coll Nursing, University Pk, PA USA	Korea University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Rice University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Graham-Engeland, JE (corresponding author), Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16801 USA.	jeg32@psu.edu		Graham-Engeland, Jennifer E./0000-0002-9940-2856; DeMeo, Natasha Nicole/0000-0002-0036-1469	John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; National Institute on Aging [P01AG020166]; Clinical and Translational Science Award [1UL1RR025011]; General Clinical Research Centers Program of the National Center for Research Resources, National Institutes of Health [M01-RR00865, M01RR023942]; Kligman Fellowship at the Pennsylvania State University; National Research Foundation of Korea(NRF) - Ministry of Education [NRF-2020R1A6A3A0110041011]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI21C0572]	John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical and Translational Science Award; General Clinical Research Centers Program of the National Center for Research Resources, National Institutes of Health; Kligman Fellowship at the Pennsylvania State University; National Research Foundation of Korea(NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	The Midlife in the United States study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development, and the longitudinal follow-up study was supported by a grant from the National Institute on Aging (P01AG020166). Support was also received from the following grants: 1UL1RR025011 (University of Wisconsin-Madison) from the Clinical and Translational Science Award, M01-RR00865 (University of California, Los Angeles), and M01RR023942 (Georgetown) from the General Clinical Research Centers Program of the National Center for Research Resources, National Institutes of Health. SS was supported by a Kligman Fellowship at the Pennsylvania State University and a postdoctoral fellow research award through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (NRF2020R1A6A3A0110041011) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI21C0572). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyo AA, 2000, CIRCULATION, V102, P1773; Bao YP, 2017, NEUROSCI BIOBEHAV R, V75, P257, DOI 10.1016/j.neubiorev.2017.01.032; Bauer ME, 2019, ANN NY ACAD SCI, V1437, P57, DOI 10.1111/nyas.13712; Bekhbat M, 2018, BRAIN BEHAV IMMUN, V67, P1, DOI 10.1016/j.bbi.2017.02.006; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Beurel E, 2020, NEURON, V107, P234, DOI 10.1016/j.neuron.2020.06.002; Bin YS, 2016, SLEEP, V39, P1629, DOI 10.5665/sleep.6078; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2021, SHORT SLEEP DUR US A; Copeland WE, 2012, BIOL PSYCHIAT, V71, P15, DOI 10.1016/j.biopsych.2011.09.023; Dannehl K, 2014, NEUROPSYCH DIS TREAT, V10, P1191, DOI [10.2147/NDT.S61640, 10.2140/NDT.361640]; de Jonge M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206495; DellaGioia N, 2010, NEUROSCI BIOBEHAV R, V34, P130, DOI 10.1016/j.neubiorev.2009.07.014; Derry HM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0618-5; Deverts DJ, 2010, PSYCHOSOM MED, V72, P734, DOI 10.1097/PSY.0b013e3181ec4b98; Duivis HE, 2011, AM J PSYCHIAT, V168, P913, DOI 10.1176/appi.ajp.2011.10081163; Eisenberger NI, 2009, NEUROIMAGE, V47, P881, DOI 10.1016/j.neuroimage.2009.04.040; Elovainio M, 2006, PSYCHOL MED, V36, P797, DOI 10.1017/S0033291706007574; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V31, P172, DOI 10.1016/j.bbi.2012.05.006; Fang H, 2019, J CELL MOL MED, V23, P2324, DOI 10.1111/jcmm.14170; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Graham-Engeland JE, 2018, BRAIN BEHAV IMMUN, V74, P222, DOI 10.1016/j.bbi.2018.09.011; Hales Craig M, 2020, NCHS Data Brief, P1; Hamer M, 2009, PSYCHONEUROENDOCRINO, V34, P1050, DOI 10.1016/j.psyneuen.2009.02.004; Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Ibarra-Coronado EG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/678164; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; Irwin MR, 2019, NAT REV IMMUNOL, V19, P702, DOI 10.1038/s41577-019-0190-z; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Jones DR, 2021, PSYCHONEUROENDOCRINO, V123, DOI 10.1016/j.psyneuen.2020.104892; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kiecolt-Glaser JK, 2015, AM J PSYCHIAT, V172, P1075, DOI 10.1176/appi.ajp.2015.15020152; Knight Erik L, 2020, Brain Behav Immun Health, V2, DOI 10.1016/j.bbih.2019.100013; Kohler-Forsberg O, 2017, BRAIN BEHAV IMMUN, V62, P344, DOI 10.1016/j.bbi.2017.02.020; Koponen H, 2010, WORLD J BIOL PSYCHIA, V11, P834, DOI 10.3109/15622975.2010.486842; Lee CH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01696; Levinson D, 2017, EUR NEUROPSYCHOPHARM, V27, pS448, DOI 10.1016/j.euroneuro.2016.09.514; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Livingston WS, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00059; Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355; Mac Giollabhui N, 2021, MOL PSYCHIATR, V26, P3302, DOI 10.1038/s41380-020-00867-4; MacKinnon D.R., 2013, OXFORD LIB PSYCHOL, V2, P338, DOI DOI 10.1093/0XF0RDHB/9780199934898.013.0016.MAGEAU; Maglione JE, 2012, J AM GERIATR SOC, V60, P635, DOI 10.1111/j.1532-5415.2012.03908.x; Majd M, 2020, FRONT NEUROENDOCRIN, V56, DOI 10.1016/j.yfrne.2019.100800; Matthews KA, 2018, SLEEP HEALTH, V4, P96, DOI 10.1016/j.sleh.2017.10.011; Matthews KA, 2010, BRAIN BEHAV IMMUN, V24, P96, DOI 10.1016/j.bbi.2009.08.005; McInnis CM, 2014, BRAIN BEHAV IMMUN, V42, P33, DOI 10.1016/j.bbi.2014.07.018; McIntyre RS, 2016, BIOL PSYCHIAT, V80, P9, DOI 10.1016/j.biopsych.2016.04.018; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Moieni M, 2015, NEUROPSYCHOPHARMACOL, V40, P1709, DOI 10.1038/npp.2015.17; Mojtabai R, 2006, PSYCHIAT SERV, V57, P631, DOI 10.1176/appi.ps.57.5.631; Motivala SJ, 2005, PSYCHOSOM MED, V67, P187, DOI 10.1097/01.psy.0000149259.72488.09; Musliner KL, 2016, J AFFECT DISORDERS, V192, P199, DOI 10.1016/j.jad.2015.12.030; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Niles AN, 2018, PSYCHONEUROENDOCRINO, V95, P149, DOI 10.1016/j.psyneuen.2018.05.035; Nowakowski S, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy049; Nutt David, 2008, Dialogues Clin Neurosci, V10, P329; O'Grady MA, 2010, J SOC CLIN PSYCHOL, V29, P949, DOI 10.1521/jscp.2010.29.9.949; Osimo EF, 2020, BRAIN BEHAV IMMUN, V87, P901, DOI 10.1016/j.bbi.2020.02.010; Patten SB, 2018, EPIDEMIOL PSYCH SCI, V27, P42, DOI 10.1017/S204579601600072X; Paudel M, 2013, SLEEP, V36, P1033, DOI 10.5665/sleep.2804; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reed DL, 2016, J CLIN SLEEP MED, V12, P263, DOI 10.5664/jcsm.5498; ROHDE P, 1990, J ABNORM PSYCHOL, V99, P264, DOI 10.1037/0021-843X.99.3.264; Rohleder N, 2019, PSYCHONEUROENDOCRINO, V105, P164, DOI 10.1016/j.psyneuen.2019.02.021; Roomruangwong C, 2020, J PSYCHOSOM RES, V135, DOI 10.1016/j.jpsychores.2020.110158; Ryff C., 2017, INTERUNIVERSITY CONS; Samanic CM, 2020, MMWR-MORBID MORTAL W, V69, P393, DOI 10.15585/mmwr.mm6914a1; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Shrivastava D, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.24983; Sin NL, 2015, HEALTH PSYCHOL, V34, P1154, DOI 10.1037/hea0000240; Slavich GM, 2019, PSYCHOPHARMACOLOGY, V236, P3063, DOI 10.1007/s00213-019-05326-9; Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011; van Tuijl LA, 2018, BEHAV RES THER, V107, P76, DOI 10.1016/j.brat.2018.06.001; Watters AJ, 2011, DEPRESS ANXIETY, V28, P703, DOI 10.1002/da.20854; Weinstein AA, 2010, BIOL PSYCHOL, V84, P228, DOI 10.1016/j.biopsycho.2010.01.016; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wiedlocha M, 2018, PROG NEURO-PSYCHOPH, V80, P217, DOI 10.1016/j.pnpbp.2017.04.026; Zuidersma M, 2013, INT J CARDIOL, V167, P2775, DOI 10.1016/j.ijcard.2012.07.002	88	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0269033	http://dx.doi.org/10.1371/journal.pone.0269033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617264	Green Published, gold			2022-12-26	WOS:000835048800044
J	Kanjanabuch, T; Nopsopon, T; Chatsuwan, T; Purisinsith, S; Johnson, DW; Udomsantisuk, N; Halue, G; Lorvinitnun, P; Puapatanakul, P; Pongpirul, K; Poonvivatchaikarn, U; Tatiyanupanwong, S; Chowpontong, S; Chieochanthanakij, R; Thamvichitkul, O; Treamtrakanpon, W; Saikong, W; Parinyasiri, U; Chuengsaman, P; Dandecha, P; Perl, J; Tungsanga, K; Eiam-Ong, S; Sritippayawan, S; Kantachuvesiri, S				Kanjanabuch, Talerngsak; Nopsopon, Tanawin; Chatsuwan, Tanittha; Purisinsith, Sirirat; Johnson, David W.; Udomsantisuk, Nibondh; Halue, Guttiga; Lorvinitnun, Pichet; Puapatanakul, Pongpratch; Pongpirul, Krit; Poonvivatchaikarn, Ussanee; Tatiyanupanwong, Sajja; Chowpontong, Saowalak; Chieochanthanakij, Rutchanee; Thamvichitkul, Oranan; Treamtrakanpon, Worapot; Saikong, Wadsamon; Parinyasiri, Uraiwan; Chuengsaman, Piyatida; Dandecha, Phongsak; Perl, Jeffrey; Tungsanga, Kriang; Eiam-Ong, Somchai; Sritippayawan, Suchai; Kantachuvesiri, Surasak		Advisory Board Peritoneal Dialysis; Nephrology Soc Thailand	Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS)	PLOS ONE			English	Article							FUNGAL PERITONITIS; MICROBIOLOGY; EXPERIENCE	Introduction We sought to evaluate the predictors and outcomes of mold peritonitis in patients with peritoneal dialysis (PD). Methods This cohort study included PD patients from the MycoPDICS database who had fungal peritonitis between July 2015-June 2020. Patient outcomes were analyzed by Kaplan Meier curves and the Log-rank test. Multivariable Cox proportional hazards model regression was used to estimating associations between fungal types and patients' outcomes. Results The study included 304 fungal peritonitis episodes (yeasts n = 129, hyaline molds n = 122, non-hyaline molds n = 44, and mixed fungi n = 9) in 303 patients. Fungal infections were common during the wet season (p < 0.001). Mold peritonitis was significantly more frequent in patients with higher hemoglobin levels, presentations with catheter problems, and positive galactomannan (a fungal cell wall component) tests. Patient survival rates were lowest for non-hyaline mold peritonitis. A higher hazard of death was significantly associated with leaving the catheter in-situ (adjusted hazard ratio [HR] = 6.15, 95%confidence interval [CI]: 2.86-13.23) or delaying catheter removal after the diagnosis of fungal peritonitis (HR = 1.56, 95%CI: 1.00-2.44), as well as not receiving antifungal treatment (HR = 2.23, 95%CI: 1.25-4.01) or receiving it for less than 2 weeks (HR = 2.13, 95%CI: 1.33-3.43). Each additional day of antifungal therapy beyond the minimum 14-day duration was associated with a 2% lower risk of death (HR = 0.98, 95%CI: 0.95-0.999). Conclusion Non-hyaline-mold peritonitis had worse survival. Longer duration and higher daily dosage of antifungal treatment were associated with better survival. Deviations from the 2016 ISPD Peritonitis Guideline recommendations concerning treatment duration and catheter removal timing were independently associated with higher mortality.	[Kanjanabuch, Talerngsak; Puapatanakul, Pongpratch; Tungsanga, Kriang; Eiam-Ong, Somchai] Dept Med, Div Nephrol, Bangkok, Thailand; [Kanjanabuch, Talerngsak] Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand; [Kanjanabuch, Talerngsak; Puapatanakul, Pongpratch] King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellent Ctr, Bangkok, Thailand; [Kanjanabuch, Talerngsak] Dialysis Policy & Practice Program Di3P, Bangkok, Thailand; [Nopsopon, Tanawin; Pongpirul, Krit] Dept Prevent & Social Med, Bangkok, Thailand; [Chatsuwan, Tanittha; Udomsantisuk, Nibondh] Dept Microbiol, Bangkok, Thailand; [Chatsuwan, Tanittha] Chulalongkorn Univ, Fac Med, Antimicrobial Resistance & Stewardship Res Unit, Bangkok, Thailand; [Purisinsith, Sirirat] Bangkok Metropolitan Adm, Hlth Dept, Bangkok, Thailand; [Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia; [Johnson, David W.] Translat Res Inst, Brisbane, Qld, Australia; [Halue, Guttiga] Phayao Hosp, Dept Med, Phayao, Thailand; [Lorvinitnun, Pichet] Sunpasitthiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Poonvivatchaikarn, Ussanee] Nakhon Pathom Hosp, Nephrol Clin, Nakhon Pathom, Thailand; [Tatiyanupanwong, Sajja] Chaiyaphum Hosp, Dept Internal Med, Nephrol Div, Chaiyaphum, Thailand; [Chowpontong, Saowalak] Phra Nakhon Si Ayutthaya Hosp, Dept Med, Div Nephrol, Phra Nakhon Si Ayutthaya, Thailand; [Chieochanthanakij, Rutchanee] Sawanpracharak Hosp, Dialysis Unit, Nakhon Sawan, Thailand; [Thamvichitkul, Oranan] Sisaket Hosp, Dialysis Unit, Sisaket, Thailand; [Treamtrakanpon, Worapot] Chaophraya Abhaibhubejhr Hosp, Dept Med, Prachin Buri, Thailand; [Saikong, Wadsamon] Mukdahan Hosp, Continuous Ambulatory Peritoneal Dialysis Clin, Mukdahan, Thailand; [Parinyasiri, Uraiwan] Songkhla Hosp, Dept Internal Med, Kidney Dis Clin, Songkhla, Thailand; [Chuengsaman, Piyatida] Banphaeo Hosp Publ Org, Banphaeo Dialysis Grp Bangkok, Bangkok, Thailand; [Dandecha, Phongsak] Prince Songkla Univ, Fac Med, Dept Internal Med, Div Nephrol, Hat Yai, Thailand; [Perl, Jeffrey] St Michaels Hosp, Toronto, ON, Canada; [Sritippayawan, Suchai] Mahidol Univ, Siriraj Hosp, Fac Med, Div Nephrol, Bangkok, Thailand; [Kantachuvesiri, Surasak] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Nephrol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; University of Queensland; Prince of Songkla University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Mahidol University; Mahidol University	Kanjanabuch, T (corresponding author), Dept Med, Div Nephrol, Bangkok, Thailand.; Kanjanabuch, T (corresponding author), Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand.; Kanjanabuch, T (corresponding author), King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellent Ctr, Bangkok, Thailand.; Kanjanabuch, T (corresponding author), Dialysis Policy & Practice Program Di3P, Bangkok, Thailand.	Talerngsak.K@chula.ac.th	Nopsopon, Tanawin/GOJ-7774-2022; Pongpirul, Krit/H-4064-2019; Johnson, David/F-2897-2011	Nopsopon, Tanawin/0000-0003-0428-973X; Pongpirul, Krit/0000-0003-3818-9761; Johnson, David/0000-0001-5491-3460	Thailand Science research and Innovation Fund Chulalongkorn University [CU_FRB65_hea (19) _026_30_07]; Chulalongkorn University, Thailand; National Research Council of Thailand [156/2560]; Thailand Research Foundation [IRG5780017]	Thailand Science research and Innovation Fund Chulalongkorn University; Chulalongkorn University, Thailand(Chulalongkorn University); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Thailand Research Foundation	This study was supported by the Thailand Science research and Innovation Fund Chulalongkorn University CU_FRB65_hea (19) _026_30_07, Chulalongkorn University, Thailand, the National Research Council of Thailand (156/2560), and Thailand Research Foundation (IRG5780017).	Abbott KC, 2001, NEPHRON, V89, P426, DOI 10.1159/000046115; Auricchio S, 2018, CLIN KIDNEY J, V11, P874, DOI 10.1093/ckj/sfy045; Boudville N, 2019, NEPHROL DIAL TRANSPL, V34, P2118, DOI 10.1093/ndt/gfy204; Caring for Australians with Renal Impairment (CARI), 2004, Nephrology (Carlton), V9 Suppl 3, pS78; Chamroensakchai T, 2020, KIDNEY INT REP, V5, P530, DOI 10.1016/j.ekir.2019.12.008; Chang TI, 2011, PERITON DIALYSIS INT, V31, P60, DOI 10.3747/pdi.2009.00057; Cho Y, 2017, SEMIN NEPHROL, V37, P66, DOI 10.1016/j.semnephrol.2016.10.008; Cho YJ, 2012, NEPHROL DIAL TRANSPL, V27, P2028, DOI 10.1093/ndt/gfr582; Dabas Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196196; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Goldie SJ, 1996, AM J KIDNEY DIS, V28, P86, DOI 10.1016/S0272-6386(96)90135-3; Hu SC, 2019, INFECTION, V47, P35, DOI 10.1007/s15010-018-1204-7; Hussain N, 2017, CURR CLIN MICROBIOL, V4, P106, DOI 10.1007/s40588-017-0062-x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Kanjanabuch T, 2021, KIDNEY INT REP, V6, P1118, DOI 10.1016/j.ekir.2021.01.010; Kanjanabuch T, 2022, PERITON DIALYSIS INT, V42, P83, DOI 10.1177/0896860821993950; Khan FY, 2011, J INFECT DEV COUNTR, V5, P646, DOI 10.3855/jidc.1519; Leelahavanichkul A, 2016, PERITON DIALYSIS INT, V36, P402, DOI 10.3747/pdi.2014.00235; Li PKT, 2016, PERITON DIALYSIS INT, V36, P481, DOI 10.3747/pdi.2016.00078; Lo SHK, 2003, PERITON DIALYSIS INT, V23, pS123; MICHEL C, 1994, AM J NEPHROL, V14, P113, DOI 10.1159/000168699; Miles R, 2009, KIDNEY INT, V76, P622, DOI 10.1038/ki.2009.202; Mujais S, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001916; Murray P. R., 2020, MED MICROBIOLOGY, V9th; Nadeau-Fredette AC, 2015, PERITON DIALYSIS INT, V35, P78, DOI 10.3747/pdi.2013.00179; Perl J, 2020, AM J KIDNEY DIS, V76, P42, DOI 10.1053/j.ajkd.2019.09.016; Prasad KN, 2004, J INFECTION, V48, P96, DOI 10.1016/S0163-4453(03)00119-1; Prasad N, 2005, PERITON DIALYSIS INT, V25, P207; Ram R, 2008, NEPHRON CLIN PRACT, V110, pC207, DOI 10.1159/000167867; Taskapan H, 2000, PERITON DIALYSIS INT, V20, P338; Wang AYM, 2000, AM J KIDNEY DIS, V36, P1183, DOI 10.1053/ajkd.2000.19833	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2022	17	5							e0268823	10.1371/journal.pone.0268823	http://dx.doi.org/10.1371/journal.pone.0268823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4W7AX	35609049	gold, Green Published			2022-12-26	WOS:000860312000001
J	Benach, J; Cash-Gibson, L; Rojas-Gualdron, DF; Padilla-Pozo, A; Fernandez-Gracia, J; Eguiluz, VM				Benach, Joan; Cash-Gibson, Lucinda; Rojas-Gualdron, Diego F.; Padilla-Pozo, Alvaro; Fernandez-Gracia, Juan; Eguiluz, Victor M.		COVID-SHINE Grp	Inequalities in COVID-19 inequalities research: Who had the capacity to respond?	PLOS ONE			English	Article							HEALTH INEQUALITIES; SCIENCE; OBLIGATIONS	The COVID-19 pandemic has been testing countries' capacities and scientific preparedness to actively respond and collaborate on a common global threat. It has also heightened awareness of the urgent need to empirically describe and analyze health inequalities to be able to act effectively. In turn, this raises several important questions that need answering: What is known about the rapidly emerging COVID-19 inequalities research field? Which countries and world regions have been able to rapidly produce research on this topic? What research patterns and trends have emerged, and how to these compared to the (pre-COVID-19) global health inequalities research field? Which countries have been scientifically collaborating on this important topic? Where are the scientific knowledge gaps, and indirectly where might research capacities need to be strengthened? In order to answer these queries, we analyzed the global scientific production (2020-2021) on COVID-19 associated inequalities by conducting bibliometric and network analyses using the Scopus database. Specifically, we analyzed the volume of scientific production per country (via author affiliations), its distribution by country income groups and world regions, as well as the inter-country collaborations within this production. Our results indicate that the COVID-19 inequalities research field has been highly collaborative; however, a number of significant inequitable research practices exist. When compared to the (pre-COVID-19) global health inequalities research field, similar inequalities were identified, however, several new dynamics and partnerships have also emerged that warrant further in-depth exploration. To ensure preparedness for future crises, and effective strategies to tackle growing social inequalities in health, investment in global health inequalities research capacities must be a priority for all.	[Benach, Joan; Cash-Gibson, Lucinda; Padilla-Pozo, Alvaro] Pompeu Fabra Univ, Res Grp Hlth Inequal Environm & Employment Condit, Barcelona, Spain; [Benach, Joan; Cash-Gibson, Lucinda; Padilla-Pozo, Alvaro] Pompeu Fabra Univ, Publ Policy Ctr JHU UPF PPC UPF BSM, Johns Hopkins Univ, Barcelona, Spain; [Benach, Joan] Univ Autonoma Madrid, Ecol Humanities Res Grp GHECO, Madrid, Spain; [Cash-Gibson, Lucinda] Pompeu Fabra Univ UPF, Barcelona Sch Management UPF BSM, Barcelona, Spain; [Rojas-Gualdron, Diego F.] CES Univ, Fac Med, Medellin, Colombia; [Fernandez-Gracia, Juan; Eguiluz, Victor M.] Inst Cross Disciplinary Phys & Complex Syst, Campus Univ Illes Balears, Palma De Mallorca, Islas Baleares, Spain	Pompeu Fabra University; Pompeu Fabra University; Autonomous University of Madrid; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Benach, J (corresponding author), Pompeu Fabra Univ, Res Grp Hlth Inequal Environm & Employment Condit, Barcelona, Spain.; Benach, J (corresponding author), Pompeu Fabra Univ, Publ Policy Ctr JHU UPF PPC UPF BSM, Johns Hopkins Univ, Barcelona, Spain.; Benach, J (corresponding author), Univ Autonoma Madrid, Ecol Humanities Res Grp GHECO, Madrid, Spain.	joan.benach@upf.edu	Eguíluz, Víctor M./B-9655-2008; Fernandez-Gracia, Juan/S-4344-2018	Eguíluz, Víctor M./0000-0003-1133-1289; Fernandez-Gracia, Juan/0000-0001-9728-7666; Rojas Gualdron, Diego Fernando/0000-0002-2293-0431; Padilla-Pozo, Alvaro/0000-0002-2110-5309	"la Caixa" Foundation [SR20-00386]; MCyE Project [PID2020-117029RB-I00]; ICREA; Direccio General de Politica Universitaria i Recerca from the government of the Balearic Islands through the postdoctoral program VicencMut	"la Caixa" Foundation(La Caixa Foundation); MCyE Project; ICREA(ICREA); Direccio General de Politica Universitaria i Recerca from the government of the Balearic Islands through the postdoctoral program VicencMut	This study is was funded by "la Caixa" Foundation under the project code SR20-00386, and also by the MCyE Project PID2020-117029RBI00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Joan Benach gratefully acknowledges the financial support by ICREA under the ICREA Academia programme. JFG acknowledges the supported of Direccio General de Politica Universitaria i Recerca from the government of the Balearic Islands through the postdoctoral program VicencMut.	Al-Mandhari A, 2021, E MEDITERR HEALTH J, V27, P217, DOI 10.26719/2021.27.3.217; Almeida-Filho N, 2003, AM J PUBLIC HEALTH, V93, P2037, DOI 10.2105/AJPH.93.12.2037; Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Benach J, 2022, J EPIDEMIOL COMMUN H, V76, P105, DOI 10.1136/jech-2021-217988; Benach J, 2021, INT J HEALTH SERV, V51, P50, DOI 10.1177/0020731420946594; Beran D, 2017, LANCET GLOB HEALTH, V5, pE567, DOI 10.1016/S2214-109X(17)30180-8; Bhakuni H, 2021, LANCET GLOB HEALTH, V9, pE1465, DOI 10.1016/S2214-109X(21)00301-6; Binagwaho A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2658; Cash-Gibson L, 2020, WHY SCI KNOWLEDGE HL, DOI [10.1186/s12961-020-00559-z, DOI 10.1186/S12961-020-00559-Z]; Cash-Gibson L, 2021, EVAL PROGRAM PLANN, V89, DOI 10.1016/j.evalprogplan.2021.101986; Cash-Gibson L, 2021, INT J HEALTH SERV, V51, P300, DOI 10.1177/0020731421993939; Cash-Gibson L, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00559-z; Cash-Gibson L, 2019, LANCET, V394, P29; Cash-Gibson L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191901; Collyer TA, 2020, SOC SCI MED, V264, DOI 10.1016/j.socscimed.2020.113330; Commission on Social Determinants of Health in the Eastern Mediterranean region Build Back Fairer, 2021, ACHIEVING HLTH EQUIT; Dahdouh-Guebas F, 2003, SCIENTOMETRICS, V56, P329, DOI 10.1023/A:1022374703178; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Ismail S., 2009, BIBLIOMETRICS TOOL S; Llop-Girones A, 2022, INT NURS REV, V69, P196, DOI 10.1111/inr.12722; Llop-Girones A, 2021, HUM RESOUR HEALTH, V19, DOI 10.1186/s12960-021-00651-7; Llop-Girones A, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0508-4; Maaravi Y, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.627559; Morton B, 2022, ANAESTHESIA, V77, P264, DOI 10.1111/anae.15597; Muntaner C, 2012, J URBAN HEALTH, V89, P915, DOI 10.1007/s11524-012-9699-1; Nabeth P, 2021, LANCET, V397, P1348, DOI 10.1016/S0140-6736(21)00679-6; Odjidja EN, 2021, LANCET GLOB HEALTH, V9, pE1365, DOI 10.1016/S2214-109X(21)00371-5; Olusanya BO, 2017, LANCET GLOB HEALTH, V5, pE869, DOI 10.1016/S2214-109X(17)30260-7; Pearce N, 2020, INT J EPIDEMIOL, V49, P1059, DOI 10.1093/ije/dyaa108; Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708; Peralta A, 2019, POPUL HEALTH METR, V17, DOI 10.1186/s12963-019-0183-y; Ribeiro KB, 2021, INT J EPIDEMIOL, V50, P732, DOI 10.1093/ije/dyab022; Santos B.D.S., 2014, EPISTEMOLOGIES S JUS, DOI DOI 10.4324/9781315634876; Waitzkin H, 2001, AM J PUBLIC HEALTH, V91, P1592, DOI 10.2105/AJPH.91.10.1592; Wang Panpan, 2021, J Biosaf Biosecur, V3, P4, DOI 10.1016/j.jobb.2020.12.002; White TM, 2021, EUR J PUBLIC HEALTH, V31, P1095, DOI 10.1093/eurpub/ckab066; World Bank, 2020, WORLD DEV IND	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0266132	10.1371/journal.pone.0266132	http://dx.doi.org/10.1371/journal.pone.0266132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551268	Green Published, Green Submitted, gold			2022-12-26	WOS:000868164600010
J	Winarto, H; Habiburrahman, M; Dorothea, M; Wijaya, A; Nuryanto, KH; Kusuma, F; Utami, TW; Anggraeni, TD				Winarto, Hariyono; Habiburrahman, Muhammad; Dorothea, Maya; Wijaya, Andrew; Nuryanto, Kartiwa Hadi; Kusuma, Fitriyadi; Utami, Tofan Widya; Anggraeni, Tricia Dewi			Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; PROSTATE-CANCER; ADOLESCENT KNOWLEDGE; ADVISORY-COMMITTEE; DECISION-MAKING; RISK BEHAVIORS; YOUNG-ADULTS; ACCEPTANCE; STUDENTS; POPULATION	Background Few studies explored Indonesian understanding of cervical cancer (CC) and the human papillomavirus (HPV) vaccination. We aimed to investigate the association between knowledge, attitudes, and practices (KAP) and socio-demographical influences related to HPV, CC, and vaccination among Indonesian urban citizens. Methods We conducted an online survey during March 2020-August 2021 using the Snowball sampling technique. The socio-demographic characteristic and KAP responses were collected via Google Forms from 400 respondents in Jakarta. The knowledge and attitudes were divided into HPV and CC (aspect 1) and HPV vaccination (aspect 2). Correlation between KAP scores was performed using Spearman's test, and multiple logistic regression analyses were conducted to determine KAP predictors. Results Indonesian urban citizens in Jakarta were found to have poor knowledge in individual aspects of the inquiry but moderate knowledge overall, good attitude in inquiry both in each aspect and overall, and unsatisfying practices. Overall, in the general population, men, and women respectively: 50.8%, 32.4%, and 53.6% had good knowledge; 82.0%, 75.2%, and 84.4% expressed positive attitude; and 30.3%, 15.2%, and 35.6% applied favorable practice regarding questions inquired. Knowledge was weakly correlated towards attitude (rho = 0.385) but moderately correlated with practice (rho = 0.485); attitude was moderately correlated with practice (rho = 0.577), all results: p<0.001. Significant odds ratio (OR) for predictors to good knowledge were female sex (OR = 2.99), higher education (OR = 2.91), and higher mother's education (OR = 2.15). Factors related to positive attitudes were higher mother's education (OR = 4.13), younger age (OR = 1.86), and better results in the knowledge inquiries (OR = 2.96). Factors that suggested better practices were female sex (OR = 2.33), being employed (OR = 1.68), excellent knowledge scores (OR = 4.56), and positive attitudes expressions (OR = 8.05). Having done one vaccination dose and intention to receive vaccines were significantly influenced by good KAP. Conclusions KAP had inter-association to successful CC and HPV prevention programs, and socio-demographical characteristics are critical to influencing better KAP.	[Winarto, Hariyono; Nuryanto, Kartiwa Hadi; Kusuma, Fitriyadi; Utami, Tofan Widya; Anggraeni, Tricia Dewi] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Dept Obstetr & Gynaecol, Div Gynecol Oncol,Fac Med, Greater Jakarta, Dki Jakarta, Indonesia; [Habiburrahman, Muhammad; Dorothea, Maya] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Fac Med, Greater Jakarta, Dki Jakarta, Indonesia; [Wijaya, Andrew] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Dept Obstetr & Gynaecol, Fac Med, Greater Jakarta, Dki Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia	Winarto, H (corresponding author), Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Dept Obstetr & Gynaecol, Div Gynecol Oncol,Fac Med, Greater Jakarta, Dki Jakarta, Indonesia.	hariyono.winarto@ui.ac.id	Winarto, Hariyono/AAD-4382-2022	Winarto, Hariyono/0000-0002-2081-9238; Habiburrahman, Muhammad/0000-0001-6372-8240; Dorothea, Maya/0000-0001-8400-5674				Abidi SH, 2018, INT J SURG, V52, P136, DOI 10.1016/j.ijsu.2018.02.050; Adejuyigbe FF, 2015, AFR J REPROD HEALTH, V19, P140; Adesina KT., 2018, KNOWLEDGE PRACTICE A, V13, P33; Ali AN., 2018, MOJ BIOEQUIVALENCE B, V5, P275; Almazrou S, 2020, J INFECT PUBLIC HEAL, V13, P584, DOI 10.1016/j.jiph.2019.09.002; Amoo EO., 2020, OPEN ACCESS MACED J, V8, P256; [Anonymous], 2018, Pediatr Dent, V40, P82; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Aswathy S, 2012, INDIAN J MED RES, V136, P205; Atashafrooz Fatemeh, 2016, Asian Pac J Cancer Prev, V17, P3953; Ayuningtyas D, 2018, HLTH SCI J INDONES, V9, P107, DOI DOI 10.22435/HSJI.V9I2.910; Bae JM, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015005; Baloch Z, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165254; Baloch Z, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.903370; Baskar K, 2020, J PHARM RES INT, V32, P95, DOI 10.9734/JPRI/2020/v32i1730672; Bastani R, 2011, CANCER EPIDEM BIOMAR, V20, P1463, DOI 10.1158/1055-9965.EPI-11-0267; Bathija G., 2016, IJCMPH, P2579; Belani HK, 2014, INT J DERMATOL, V53, pE486, DOI 10.1111/ijd.12401; Benavidez G, 2020, PUBLIC HEALTH, V182, P125, DOI 10.1016/j.puhe.2020.01.020; Bhatla N, 2020, J OBSTET GYNAECOL RE, V46, P1651, DOI 10.1111/jog.14345; Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614; Bianco A, 2013, J MED INTERNET RES, V15, P268, DOI 10.2196/jmir.2752; Biofarma, 2021, BIOFARMA BUMN; Bonar EE, 2017, AIDS BEHAV, V21, P2069, DOI 10.1007/s10461-016-1570-z; Boyce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043416; BPS-Statistics Indonesia, 2020, SUBDIREKTORAT STATIS, P1; BPS-Statistics Jakarta, 2021, PROVINSI DKI JAKARTA, P1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Bruni L., 2021, ICOIARC INF CENT HPV; Bruni L., 2019, ICOIARC INF CENT HPV; CDC, 2021, HPV VACCINATION RECO, P1; Chanprasertpinyo W, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04625; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chellapandian P, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01205-8; Cinar IO, 2019, ASIA-PAC J ONCOL NUR, V6, P300, DOI 10.4103/apjon.apjon_10_19; Clendinen C, 2016, VACCINE, V34, P5984, DOI 10.1016/j.vaccine.2016.09.042; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; Dahlgren M, 2020, ACTA ODONTOL SCAND, V78, P109, DOI 10.1080/00016357.2019.1655586; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Davila-Rodriguez Martha I, 2016, Asian Pac J Cancer Prev, V17, P4863; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Directorate of Statistical Dissemination, 2021, STAT YB IND, P1; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Eckert LO, 2020, OBSTET GYNECOL, V136, pE15, DOI 10.1097/AOG.0000000000004000; Egawa-Takata T, 2020, HUM VACC IMMUNOTHER, V16, P1653, DOI 10.1080/21645515.2019.1697107; Endarti Dwi, 2018, Asian Pac J Cancer Prev, V19, P1105; Ezat SWP, 2013, ASIAN PAC J CANCER P, V14, P2991, DOI 10.7314/APJCP.2013.14.5.2991; Falcaro M, 2021, LANCET, V398, P2084, DOI 10.1016/S0140-6736(21)02178-4; Feng SW, 2012, ASIA-PAC J PUBLIC HE, V24, P522, DOI 10.1177/1010539511415838; Fishman J, 2014, PEDIATRICS, V134, pE1049, DOI 10.1542/peds.2013-3454; Food and Drug Administration, 2018, FDA NEWS RELEASE; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Gamble HL, 2010, J PEDIATR PSYCHOL, V35, P704, DOI 10.1093/jpepsy/jsp108; Grandahl M., 2018, PARENTS KNOWLEDGE BE, P1; Guerrero AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2046-1; Handayani S., 2020, CERVICAL CANC RISK F, V22, P452; Heena H, 2019, J ONCOL, V2019, DOI 10.1155/2019/5423130; Hong Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-696; Internal Displacement Monitoring Centre, 2020, GLOBAL REPORT INTERN, P1; Jaspers L, 2011, VACCINE, V29, P7785, DOI 10.1016/j.vaccine.2011.07.107; Jradi H, 2019, VACCINE, V37, P530, DOI 10.1016/j.vaccine.2018.11.065; Juvanhol LL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3340-2; Kaarthigeyan K, 2012, INDIAN J MED PAEDIAT, V33, P7, DOI 10.4103/0971-5851.96961; Kementerian Kesehatan Republik Indonesia, 2017, KEMENTERIAN KESEHATA, P5; Kementerian Kesehatan RI, 2017, PERATURAN MENTERI KE, P162; Khatiwada M, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.616456; Kirchherr J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201710; Kombe AJK, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.552028; Kosen Soewarta, 2017, Asian Pac J Cancer Prev, V18, P2011, DOI 10.22034/APJCP.2017.18.7.2011; Lawson JS, 2020, INFECT AGENTS CANCER, V15, DOI 10.1186/s13027-020-00305-8; Lee M, 2021, AM J PREV MED, V60, P298, DOI 10.1016/j.amepre.2020.07.023; Lefkowitz ES, 2014, WOMEN HEALTH, V54, P487, DOI 10.1080/03630242.2014.903552; Leiros Gustavo J, 2005, BMC Urol, V5, P15, DOI 10.1186/1471-2490-5-15; Levin CE, 2015, VACCINE, V33, P2830, DOI 10.1016/j.vaccine.2015.02.052; Li SL, 2013, VACCINE, V31, P5785, DOI 10.1016/j.vaccine.2013.10.027; Lismidiati Wiwin, 2021, Asian Pac J Cancer Prev, V22, P471, DOI 10.31557/APJCP.2021.22.2.471; Liu YN, 2020, HUM VACC IMMUNOTHER, V16, P116, DOI 10.1080/21645515.2019.1638727; Martinez R, 2020, CITIES, V106, DOI 10.1016/j.cities.2020.102868; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Meites E, 2019, MMWR-MORBID MORTAL W, V68, P698, DOI [10.15585/mmwr.mm6832a3, 10.1111/ajt.15633]; Ministry of Manpower Indonesia, 2021, PERMENAKER NO 16 TAH; Moghoofei M, 2019, ASIA-PAC J CLIN ONCO, V15, pE59, DOI 10.1111/ajco.13124; Mohd Sopian Mastura, 2018, Asian Pac J Cancer Prev, V19, P1509, DOI 10.22034/APJCP.2018.19.6.1509; Naik DD., 2017, INT J COMMUNITY MED, V4, P400; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; Pedrana AE, 2020, SEX HEALTH, V17, P167, DOI 10.1071/SH18199; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Rahman TFNTA, 2019, INDIAN J MED PAEDIAT, V40, P193, DOI 10.4103/ijmpo.ijmpo_199_17; Raina SK, 2015, INDIAN J MED RES, V141, P127, DOI 10.4103/0971-5916.154519; Saha A, 2010, ASIAN PAC J CANCER P, V11, P1085; Sasidharanpillai Sabeena, 2021, Asian Pac J Cancer Prev, V22, P1351, DOI 10.31557/APJCP.2021.22.5.1351; Savas LS, 2012, AM J PREV MED, V43, pS490, DOI 10.1016/j.amepre.2012.09.003; Setiawan D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230359; Seven M, 2015, J PEDIATR ADOL GYNEC, V28, P382, DOI 10.1016/j.jpag.2014.11.005; Singh J, 2021, CLIN EPIDEMIOL GLOB, V9, P289, DOI 10.1016/j.cegh.2020.09.012; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07822; Skinner SR, 2017, SEX HEALTH, V14, P492, DOI [10.1071/SH16240, 10.1071/sh16240]; Smelov V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066630; Statistic Tutor, 2021, SPEARMANS CORRELATIO; Swapnajaswanth M, 2014, ASIAN PAC J CANCER P, V15, P6095, DOI 10.7314/APJCP.2014.15.15.6095; Swarnapriya K, 2015, Asian Pac J Cancer Prev, V16, P8473; Taylor ML, 2005, FAM MED, V37, P506; Thapa N, 2018, J GYNECOL ONCOL, V29, DOI 10.3802/jgo.2018.29.e57; The World Bank, 2021, GDP CURR US IND; Tung ILY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161846; UK Health Security Agency, 2021, HPV VACC GUID HEALTH; Uzunlar O, 2013, VACCINE, V31, P2191, DOI 10.1016/j.vaccine.2013.01.033; Wahidin M., 2021, INDONES J CANC, V15, P26; Wahidin M, 2012, ASIAN PAC J CANCER P, V13, P1709, DOI 10.7314/APJCP.2012.13.4.1709; Wallace SA, 2017, CULT DIVERS ETHN MIN, V23, P59, DOI 10.1037/cdp0000108; Waller J, 2012, BJOG-INT J OBSTET GY, V119, P26, DOI 10.1111/j.1471-0528.2011.03030.x; Whitaker NJ, 2013, PROSTATE, V73, P236, DOI 10.1002/pros.22562; Wibisono P, 2017, ANN ONCOL, V28, P90; Wijayanti KE, 2021, PREV MED REP, V24, DOI 10.1016/j.pmedr.2021.101651; Winarto H., 2019, The Open Public Health Journal, V12, P337; Wong LP, 2010, EUR J OBSTET GYN R B, V148, P90, DOI 10.1016/j.ejogrb.2009.10.002; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005; Worldometer, 2021, COR; Yam Pui Woo Angela, 2017, Asian Pac J Cancer Prev, V18, P1689, DOI 10.22034/APJCP.2017.18.6.1689; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14667; Yin BB, 2017, ONCOL LETT, V14, P1855, DOI 10.3892/ol.2017.6367; Yin Y, 2017, LANCET, V390, P1735, DOI 10.1016/S0140-6736(17)32606-5; Yu LL, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180447; Yu YB, 2019, ASIAN J ANDROL, V21, P375, DOI 10.4103/aja.aja_39_19; Zhang JM, 2017, J PAK MED ASSOC, V67, P209; Zhuang QY, 2016, SINGAP MED J, V57, P329, DOI 10.11622/smedj.2016108; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	130	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0266139	10.1371/journal.pone.0266139	http://dx.doi.org/10.1371/journal.pone.0266139			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552546	gold, Green Published			2022-12-26	WOS:000868164600011
J	Brouwer, AF; Campredon, LP; Walline, HM; Marinelli, BM; Goudsmit, CM; Thomas, TB; Delinger, RL; Lau, YK; Andrus, EC; Yost, ML; McCloskey, JK; Sullivan, TS; Mortensen, AS; Huang, SY; Murphy, K; Cheng, BN; Stanek, K; Nair, T; Carey, TE; Meza, R; Eisenberg, MC				Brouwer, Andrew F.; Campredon, Lora P.; Walline, Heather M.; Marinelli, Brittany M.; Goudsmit, Christine M.; Thomas, Trey B.; Delinger, Rachel L.; Lau, Yan Kwan; Andrus, Emily C.; Yost, Monica L.; McCloskey, Jodi K.; Sullivan, Taylor S.; Mortensen, Alex S.; Huang, Suiyuan; Murphy, Keith; Cheng, Bonnie; Stanek, Kayla; Nair, Thankam; Carey, Thomas E.; Meza, Rafael; Eisenberg, Marisa C.			Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; UNITED-STATES; RISK-FACTORS; BURDEN; TRENDS; EPIDEMIOLOGY; VACCINATION; CAVITY; RATES; WOMEN	We determined baseline oral and cervicogenital human papillomavirus (HPV) prevalence and determinants of infection in the Michigan HPV and Oropharyngeal Cancer (MHOC) study. We enrolled 394 college-age and older participants of both sexes in Ann Arbor, Michigan and the surrounding area. All participants provided an oral sample at baseline, and 130 females provided a cervicogenital sample. Samples were tested for 18 HPV genotypes using polymerase chain reaction (PCR) MassArray. Participants filled out sociodemographic and behavioral questionnaires. Prevalence ratios for HPV oral or cervicogenital prevalence by predictor variables were estimated in univariable log-binomial models. Analysis was conducted 2018-20. In the full cohort, baseline oral HPV prevalence was 10.0% for any detected genotype (among the 338 valid oral tests at baseline) and 6.5% for high-risk types, and cervicogenital prevalence was 20.0% and 10.8%, respectively (among the 130 first valid cervicogenital tests). Oral HPV prevalence did not vary by sex, with 10.5% of women and 9.0% of men having an infection. We found a high prevalence of oral and cervicogenital HPV infection in college-age participants reporting no lifetime sexual partners. Reporting a single recent partner was associated with a lower oral HPV prevalence (PR 0.39, 95% CI: 0.16, 0.96) than reporting no recent (but at least one ever) partner. No similar protective effect was seen for cervicogenital HPV. Both oral and cervicogenital prevalence increased with the number of recent partners for most sexual behaviors. We observed an ecological fallacy masking the direction of impact of vaccination on HPV prevalence in the full cohort compared to the college-aged and the age 23+ populations considered separately. Substance use was not significantly associated with oral or cervicogenital HPV infection. Many studies report substantially higher oral HPV infection prevalence in men than in women. That difference may not be uniform across populations in the US.	[Brouwer, Andrew F.; Campredon, Lora P.; Thomas, Trey B.; Delinger, Rachel L.; Lau, Yan Kwan; Andrus, Emily C.; Yost, Monica L.; McCloskey, Jodi K.; Sullivan, Taylor S.; Mortensen, Alex S.; Huang, Suiyuan; Murphy, Keith; Cheng, Bonnie; Stanek, Kayla; Meza, Rafael; Eisenberg, Marisa C.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Walline, Heather M.; Marinelli, Brittany M.; Goudsmit, Christine M.; Thomas, Trey B.; Nair, Thankam; Carey, Thomas E.] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Brouwer, AF (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	brouweaf@umich.edu		Brouwer, Andrew F./0000-0002-3779-5287	National Institutes for Health [U01CA182915]; Michigan Institute for Clinical & Health Research (CTSA) [UL1TR002240]	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical & Health Research (CTSA)	This work was supported by National Institutes for Health grant U01CA182915. Data management was supported by the Michigan Institute for Clinical & Health Research (CTSA grant UL1TR002240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, IARC MONOGRAPHS EVAL, V86; Brouwer AF, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-056502; Brouwer AF, 2019, PREV MED, V123, P288, DOI 10.1016/j.ypmed.2019.03.040; Brouwer AF, 2018, CANCER RES, V78, P3386, DOI 10.1158/0008-5472.CAN-17-3467; Brouwer AF, 2015, MATH BIOSCI, V270, P115, DOI 10.1016/j.mbs.2015.10.012; CDC, 2014, NAT HLTH NUTR EX SUR; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2019, JAMA-J AM MED ASSOC, V322, P977, DOI 10.1001/jama.2019.10508; Chaturvedi AK, 2018, J CLIN ONCOL, V36, P262, DOI 10.1200/JCO.2017.75.0141; Chaturvedi AK, 2016, ORAL ONCOL, V60, P61, DOI 10.1016/j.oraloncology.2016.06.006; Chaturvedi AK, 2014, J INFECT DIS, V210, P441, DOI 10.1093/infdis/jiu116; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; Cook RL, 2014, SEX TRANSM DIS, V41, P486, DOI 10.1097/OLQ.0000000000000159; D'Souza G, 2016, J INFECT DIS, V213, P1893, DOI 10.1093/infdis/jiw063; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; DNA Genotek Inc, 2017, ORAGENE RNA RE 100; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Eisenberg MC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021618; Gillison ML, 2012, VACCINE, V30, pF34, DOI 10.1016/j.vaccine.2012.05.070; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gravitt PE, 2013, J INFECT DIS, V207, P272, DOI 10.1093/infdis/jis660; Harper DM, 2008, VACCINE, V26, pA7, DOI 10.1016/j.vaccine.2008.01.013; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Paul P, 2021, J INFECT DIS, V223, P1423, DOI 10.1093/infdis/jiaa557; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; R Core Team, 2020, R LANG ENV STAT COMP; Schlecht NF, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14031; Serrano B, 2018, BEST PRACT RES CL OB, V47, P14, DOI 10.1016/j.bpobgyn.2017.08.006; Walline HM, 2013, JAMA OTOLARYNGOL, V139, P1320, DOI 10.1001/jamaoto.2013.5460	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268104	10.1371/journal.pone.0268104	http://dx.doi.org/10.1371/journal.pone.0268104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576195	gold, Green Published			2022-12-26	WOS:000835262300002
J	Issah, AN; Yeboah, D; Kpordoxah, MR; Boah, M; Mahama, AB				Issah, Abdul-Nasir; Yeboah, Daudi; Kpordoxah, Mary Rachael; Boah, Michael; Mahama, Abraham Bangamsi			Association between exposure to intimate partner violence and the nutritional status of women and children in Nigeria	PLOS ONE			English	Article							DOMESTIC VIOLENCE; MENTAL STRESS; RISK-FACTORS; HEALTH; MALNUTRITION; OBESITY; ETHIOPIA; UNDERNUTRITION; PREVALENCE; METABOLISM	BackgroundGlobally, intimate partner violence (IPV) epitomizes a greater proportion of the violence experienced by women, with more than a third of women (41.3%) in sub-Saharan Africa reporting IPV during their lifetime. This study examined the association between exposure to IPV and the nutritional status of women and their children in Nigeria. MethodsThe study analyzed secondary data obtained from the 2018 Nigeria Demographic and Health Survey. Data on women's lifetime experience of psychological, physical, and sexual IPV, as well as demographic and socioeconomic characteristics, were collected. We used regression models to determine the association between exposure to IPV and women and child nutrition indicators. A weighted sample of 4,391 women aged 15-49 years and 2,145 children 6-59 months were analyzed. ResultsThe lifetime experience of IPV in the study was 35.31% (95% CI: 33.35, 37.33), 30.43% (95% CI: 28.54, 32.38) experienced psychological IPV, 19.43% (95% CI: 17.79, 21.19) experienced physical IPV, and 6.03% (95% CI: 5.12, 7.09) experienced sexual IPV. After adjusting for a range of characteristics, maternal lifetime exposure to IPV was associated with underweight (ARRR = 0.63; 95% CI: 0.44, 0.91) and overweight/obesity (ARRR = 1.28; 95% CI: 1.04, 1.58). We also found that, children whose mothers experienced IPV were less likely to be underweight compared to their counterparts (ARRR = 0.69; 95% CI: 0.50, 0.96). ConclusionsOverall, IPV against women, particularly psychological, physical, and sexual IPV, is common in Nigeria and has an association with the nutritional status of affected women and their children. According to the study, women with a lifetime experience of IPV were more likely to be overweight. On the other hand, affected women's children were less likely to be underweight. A far-reaching effort is required to curb IPV against women, particularly policies, programs, and laws are needed to protect women and children from the unfavourable effects of IPV to reduce the prevalence and impact of such violence.	[Issah, Abdul-Nasir] Univ Dev Studies, Sch Publ Hlth, Dept Hlth Serv Policy Planning Management & Econ, Tamale, Ghana; [Yeboah, Daudi; Boah, Michael] Univ Dev Studies, Sch Publ Hlth, Dept Epidemiol Biostat & Dis Control, Tamale, Ghana; [Kpordoxah, Mary Rachael] Univ Dev Studies, Sch Publ Hlth, Dept Global & Int Hlth, Tamale, Ghana; [Mahama, Abraham Bangamsi] United Nations Childrens Fund UNICEF Nigeria Count, Abuja, Nigeria	University for Development Studies; University for Development Studies; University for Development Studies	Boah, M (corresponding author), Univ Dev Studies, Sch Publ Hlth, Dept Epidemiol Biostat & Dis Control, Tamale, Ghana.	mboah@uds.edu.gh		Boah, Michael/0000-0002-5660-2292				Abdulahi A, 2017, ETHIOP J HEALTH SCI, V27, P175, DOI 10.4314/ejhs.v27i2.10; Abebe Z, 2017, INT J PEDIAT, V2017, DOI 10.1155/2017/5367070; Abeway S, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/1078480; Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Adhikari RP, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00991-x; Adjah ESO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3041-x; Agbeko MP., 2013, OPEN OBES J, V5, P72, DOI [10.2174/1876823701305010072, DOI 10.2174/1876823701305010072]; Ahinkorah BO, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100601; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; Antai DE, 2008, RURAL REMOTE HEALTH, V8; Arulogun O., 2011, SIERRA LEONE J BIOME, V3, P43, DOI [10.4314/sljbr.v3i1.66650, DOI 10.4314/SLJBR.V3I1.66650]; Awerman JL, 2010, COMP BIOCHEM PHYS A, V156, P136, DOI 10.1016/j.cbpa.2010.01.010; Ayeni OB, 2022, VIOLENCE GEND, V9, P36, DOI 10.1089/vio.2021.0015; Balogun MO, 2012, WOMEN HEALTH, V52, P627, DOI 10.1080/03630242.2012.707171; Benebo FO, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0628-7; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Chai J, 2016, B WORLD HEALTH ORGAN, V94, P331, DOI 10.2471/BLT.15.152462; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Corica D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00187; Dake FAA, 2011, PUBLIC HEALTH NUTR, V14, P1285, DOI 10.1017/S1368980010002879; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; Diop-Sidibe N, 2006, SOC SCI MED, V62, P1260, DOI 10.1016/j.socscimed.2005.07.022; Doku DT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2033-6; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Estourgie-van Burk GF, 2006, TWIN RES HUM GENET, V9, P646, DOI 10.1375/twin.9.5.646; Ezeudu Charity Chinyere, 2019, Pan Afr Med J, V32, P14, DOI 10.11604/pamj.supp.2019.32.1.13287; Fentahun W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3180-0; Ferdos J, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00113916, 10.1590/0102-311x00113916]; Ferreira MD, 2015, CAD SAUDE PUBLICA, V31, P161, DOI 10.1590/0102-311X00192113; Fox A, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0457-y; Garoma S, 2012, J TROP PEDIATRICS, V58, P467, DOI 10.1093/tropej/fms018; Gewa CA, 2012, PUBLIC HEALTH NUTR, V15, P1029, DOI 10.1017/S136898001100245X; Hasan MT, 2016, AM J CLIN NUTR, V104, P1121, DOI 10.3945/ajcn.115.111773; Hindin M.J., 2008, INTIMATE PARTNER VIO; Kendall-Tackett KA, 2007, TRAUMA VIOLENCE ABUS, V8, P344, DOI 10.1177/1524838007304406; Khan MN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198833; Kiesswetter E, 2020, PUBLIC HEALTH NUTR, V23, P446, DOI 10.1017/S1368980019002271; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Klingelhafer SK, 2007, J HUM LACT, V23, P194, DOI 10.1177/0890334407300387; Kumar R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028972; Kumar S, 2005, BRIT J PSYCHIAT, V187, P62, DOI 10.1192/bjp.187.1.62; Kyrou I, 2006, ANN NY ACAD SCI, V1083, P77, DOI 10.1196/annals.1367.008; Laugero KD, 2001, J NEUROENDOCRINOL, V13, P827, DOI 10.1046/j.1365-2826.2001.00706.x; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P221, DOI 10.1177/1077801205285106; Mengesha Bewketu, 2014, BMC Res Notes, V7, P75, DOI 10.1186/1756-0500-7-75; Molini V, 2010, WORLD DEV, V38, P1012, DOI 10.1016/j.worlddev.2009.12.003; Nabaggala MS, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01286-5; National Population Commission ICF International, 2019, NIG DEM HLTH SURV 20; Neupane S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2698-5; Nshimyiryo A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6504-z; Okenwa-Emegwa L, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016667993; Ononokpono DN, 2014, HEALTH CARE WOMEN IN, V35, P973, DOI 10.1080/07399332.2014.924939; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Pressoir M, 2010, BRIT J CANCER, V102, P966, DOI 10.1038/sj.bjc.6605578; Rabasa C, 2016, CURR OPIN BEHAV SCI, V9, P71, DOI 10.1016/j.cobeha.2016.01.011; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Rahman M, 2012, AM J PUBLIC HEALTH, V102, P1336, DOI 10.2105/AJPH.2011.300396; Seematter G, 2000, AM J PHYSIOL-ENDOC M, V279, pE799, DOI 10.1152/ajpendo.2000.279.4.E799; Seematter G, 2002, OBES RES, V10, P49, DOI 10.1038/oby.2002.7; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Sobkoviak RM, 2012, SOC SCI MED, V74, P103, DOI 10.1016/j.socscimed.2011.10.024; Solomon MB, 2010, J NEUROENDOCRINOL, V22, P13, DOI 10.1111/j.1365-2826.2009.01933.x; Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030; Tenkorang EY, 2018, CHILD ABUSE NEGLECT, V79, P384, DOI 10.1016/j.chiabu.2018.02.027; Tigga P.L., 2016, J ANTHR, V2016, P1, DOI [10.1155/2016/6538235, DOI 10.1155/2016/6538235]; Tsedal DM, 2020, BMC NUTR, V6, DOI 10.1186/s40795-020-00354-7; Tuoyire Derek Anamaale, 2018, BMC Obes, V5, P8, DOI 10.1186/s40608-018-0186-4; Vizcarra Beatriz, 2004, Inj Control Saf Promot, V11, P125, DOI 10.1080/15660970412331292351; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization Violence against Women Prevalence Estimates, 2018, VIOLENCE WOMEN PREVA; Yount KM, 2011, J BIOSOC SCI, V43, P85, DOI 10.1017/S0021932010000441; Ziaei S, 2014, MATERN CHILD NUTR, V10, P347, DOI 10.1111/j.1740-8709.2012.00432.x	76	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268462	10.1371/journal.pone.0268462	http://dx.doi.org/10.1371/journal.pone.0268462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2YO	35550652	Green Published, gold			2022-12-26	WOS:000834632000001
J	Lei, XZ; Teng, WB; Fan, Y; Zhu, YK; Yao, LX; Li, YH; Zhu, SM				Lei, Xiuzhen; Teng, Wenbin; Fan, Ying; Zhu, Yeke; Yao, Liuxu; Li, Yuhong; Zhu, Shengmei			The protective effects of HIF-1 alpha activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis	PLOS ONE			English	Article							MORTALITY; TARGET	The integrity of the intestinal barrier is critical for protecting the host against the pathogen. The role of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in the intestinal barrier disfunction related to sepsis remained unclear. The purpose of the present study is to investigate the role of HIF-1 alpha on oxidative damage, the intestinal mucosal permeability, structural and morphological changes during sepsis. Twenty-four Sprague Dawley (SD) rats were randomly divided into four groups of 6 rats each: the sham group (sham), sepsis group (subjected to cecal ligation and perforation, CLP), sepsis + DMOG group (40 mg/kg of DMOG by intraperitoneal injection for 7 consecutive days before CLP), and sepsis + BAY 87-2243 group (9 mg/kg of BAY 87-2243 orally administered for 3 consecutive days before CLP). Sepsis increased plasma levels of inflammatory mediators, oxidative stress markers and HIF-1 alpha expression; caused pathological damage; increased permeability (P < 0.05); and decreased TJ protein expression in the intestinal mucosa of rats with sepsis (P < 0.05). The addition of DMOG up-regulated HIF-1 alpha, then decreased the plasma levels of inflammatory mediators, oxidative stress markers, alleviated pathological damage to the intestinal mucosa and decreased intestinal permeability (P < 0.05); while BAY 87-2243 treatment had the opposite effects. Our findings showed that HIF-1 alpha protects the intestinal barrier function of septic rats by inhibiting intestinal inflammation and oxidative damage, our results provide a novel insight for developing sepsis treatment.	[Lei, Xiuzhen; Teng, Wenbin; Fan, Ying; Zhu, Yeke; Zhu, Shengmei] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Yao, Liuxu] Shaoxing Univ, Shaoxing Peoples Hosp, Dept Anesthesiol, Zhejiang, Peoples R China; [Li, Yuhong] Zhejiang Shuren Univ, Shulan Hangzhou Hosp, Shulan Int Med Coll, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Shaoxing University; Zhejiang Shuren University	Zhu, SM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China.; Li, YH (corresponding author), Zhejiang Shuren Univ, Shulan Hangzhou Hosp, Shulan Int Med Coll, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China.	yuh_li@zju.edu.cn; smzhu20088@zju.edu.cn	li, Yu/HCI-9086-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022		Zhejiang Provincial Department of Science and Technology Fund [LY21H150001, LGF19H030011]; Zhejiang Provincial Health Committee Fund [2020KY329]	Zhejiang Provincial Department of Science and Technology Fund; Zhejiang Provincial Health Committee Fund	This study was supported by Zhejiang Provincial Department of Science and Technology Fund (grant number LY21H150001 and LGF19H030011), Zhejiang Provincial Health Committee Fund (grant number 2020KY329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur CM, 2019, TRANSFUSION, V59, P1233, DOI 10.1111/trf.15254; Bai ZL, 2018, J MOL NEUROSCI, V66, P428, DOI 10.1007/s12031-018-1165-4; Bao J, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/674875; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Coopersmith CM, 2018, INTENS CARE MED, V44, P1400, DOI 10.1007/s00134-018-5175-z; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Fitzpatrick SF, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00085; Fitzpatrick SF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01624; Goldim MP, 2019, MICROVASC RES, V123, P19, DOI 10.1016/j.mvr.2018.12.001; Hao ML, 2019, SPECTROCHIM ACTA A, V220, DOI 10.1016/j.saa.2019.05.009; Hegyi P, 2018, PHYSIOL REV, V98, P1983, DOI 10.1152/physrev.00054.2017; Hu QY, 2019, EBIOMEDICINE, V41, P497, DOI 10.1016/j.ebiom.2019.02.055; Hummitzsch L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1885-4; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471; Luo JL, 2018, J AM SOC NEPHROL, V29, P505, DOI 10.1681/ASN.2017030290; Mahendran VJ, 2018, CURR PHARM DESIGN, V24, P1518, DOI 10.2174/1381612824666180409093918; Montagnana M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.07.22; Muenchau S, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00553-18; Otani K, 2000, DIGEST DIS SCI, V45, P2313, DOI 10.1023/A:1005626622203; Park JW, 2004, J PHARMACOL SCI, V94, P221, DOI 10.1254/jphs.94.221; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pawlowska B, 2017, ADV CLIN EXP MED, V26, P1437, DOI 10.17219/acem/64883; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Saeedi BJ, 2015, MOL BIOL CELL, V26, P2252, DOI 10.1091/mbc.E14-07-1194; Salomao R, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198595, 10.1590/1414-431x20198595]; Schindler K, 2016, NEPHROL DIAL TRANSPL, V31, P1100, DOI 10.1093/ndt/gfv442; Shah Yatrik M, 2016, Mol Cell Pediatr, V3, P1, DOI 10.1186/s40348-016-0030-1; Shao T, 2018, J HEPATOL, V69, P886, DOI 10.1016/j.jhep.2018.05.021; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268	32	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268445	10.1371/journal.pone.0268445	http://dx.doi.org/10.1371/journal.pone.0268445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576220	Green Published, gold			2022-12-26	WOS:000834668900002
J	Pages, G; Dillmann, P; Vega, E; Berranger, M; Bauvais, S; Long, LC; Fluzin, P				Pages, Gaspard; Dillmann, Philippe; Vega, Enrique; Berranger, Marion; Bauvais, Sylvain; Long, Luc; Fluzin, Philippe			Vice-versa: The iron trade in the western Roman Empire between Gaul and the Mediterranean	PLOS ONE			English	Article							ICP-MS; SLAG INCLUSIONS; PROVENANCE; TOOL; PRODUCTS; ISOTOPES; BLOOMERY; FRANCE	Starting from the second century BC, with the fast expansion of the Roman Empire, iron production and consumption developed exponentially in north-western Europe. This rapid growth naturally led to an increase in trade, that still remains to be studied encompassing a broad scope, so as to not neglect long-distance exchanges. This is today possible by taking advantage of the progress made in the past 40 years in archaeology and archaeometallurgy. Cargoes of iron bars recovered from a group of 23 wrecks located off the coast of Saintes-Maries-de-la-Mer (Bouches-du-Rhone, France), opposite an old branch of the Rhone River, constitute a rich opportunity to examine this trade, by comparing the slag inclusions trapped in iron bars to primary slag from the six main ironmaking areas in Gaul. Based on a trace element analysis of these inclusions and this slag, we suggest that ships travelled down the Rhone carrying iron produced in Wallonia (Belgium), while others sailed up the Rhone transporting iron produced in Montagne Noire (Aude, France).	[Pages, Gaspard] MSH Mondes, Equipe Archeol Gaule & Monde Ant GAMA, CNRS, Archeol & Sci Antiqu,ArScAn,UMR7041, 21 Allee Univ, F-92023 Nanterre, France; [Dillmann, Philippe; Vega, Enrique; Bauvais, Sylvain] Univ Paris Saclay, CNRS, LAPA IRAMAT, NIMBE,CEA,CEA Saclay, F-91191 Gif Sur Yvette, France; [Berranger, Marion; Fluzin, Philippe] Univ Technol Belfort Montbeliard, CNRS, LMC IRAMAT, UMR7065, Montbeliard, France; [Long, Luc] Archeol Soc Mediterraneennes, Dept Rech Archeol Subaquat & Sous Marines DRASSM, ASM UMR 5140, F-34000 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Technologie de Belfort-Montbeliard (UTBM)	Pages, G (corresponding author), MSH Mondes, Equipe Archeol Gaule & Monde Ant GAMA, CNRS, Archeol & Sci Antiqu,ArScAn,UMR7041, 21 Allee Univ, F-92023 Nanterre, France.	gaspard.pages@cnrs.fr		Gaspard, Pages/0000-0002-5821-7849	French Ministry of Culture; CNRS; Communaute d'Universites et d'Etablissements Universite Paris Lumieres (ComUE UPL); European Union; Universite Paris 8	French Ministry of Culture; CNRS(Centre National de la Recherche Scientifique (CNRS)); Communaute d'Universites et d'Etablissements Universite Paris Lumieres (ComUE UPL); European Union(European Commission); Universite Paris 8	Research program entitled "Le fer antique et medieval du massif du Canigou (Pyrenees-Orientales, France)", directed by Gaspard Pages (CNRS -UMR7041 ArScAn), funded by the French Ministry of Culture and the CNRS. -Research program entitled "Appropriation, innovations et contro<^>le: le fer antique et me ' die ' val du massif du Canigou (Pyre ' ne ' es-Orientales, France)", directed by Gaspard Pages (CNRS UMR7041 ArScAn) and Catherine Verna (Universite ' Paris 8 -UMR7041 ArScAn), funded by the Communaute d'Universites et d'Etablissements Universite Paris Lumieres (ComUE UPL). -FEDER FERMAPYR European research program entitled "L'industrie du fer dans le massif des Pyre ' ne ' es (du Canigou au Couserans/Antiquite ' -milieu XVIIe s.)", directed by Gaspard Pages (CNRS -UMR7041 ArScAn) and Catherine Verna (Universite ' Paris 8 UMR7041 ArScAn), funded by the European Union, the CNRS and Universite ' Paris 8. Collective research program entitled "FANUM MARTIS (Nord, France)", directed by Raphae<spacing diaeresis>l Clotuche (INRAP -UMR7041 ArScAn), funded by the French Ministry of Culture. -ANR-DFG research program entitled "Circulation of Iron Products in the Iron-Age of eastern France and southern Germany (CIPIA)", directed by Philippe Dillmann (CNRS -IRAMAT-LMC-UMR5060) and Roland Schwab (Curt-Engelhorn-Zentrum Archa<spacing diaeresis> ometrie Germany). -Collective research program entitled "La me ' tallurgie du fer en Bourgogne-FrancheComte ' avant le haut fourneau. Organisation et circulation des productions", directed by Marion Berranger (CNRS -UM5060 -LMC-IRAMATUTBM), funded by the French Ministry of Culture and the CNRS. -Research program entitled "Carte arche ' ologique du littoral Camarguais (Bouches-duRho<^>ne, France)", directed by Luc Long (DRASSM UMR5140 ASM), funded by the French Ministry of Culture.	Baron S., 2011, REV ARCHE OLOGIQUE N, V44, P71, DOI DOI 10.3406/RAN.2011.1820; Berard E, 2020, J ANAL ATOM SPECTROM, V35, P2582, DOI 10.1039/d0ja00259c; Berranger M., 2019, GALLIA, V76, P165; Berranger M, 2017, ARCHEOSCIENCES-REV A, V41, P45, DOI 10.4000/archeosciences.4883; Bonenfant P., 1983, ACTES C FRANQUI, P235; Brauns M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229623; Brauns M, 2013, J ARCHAEOL SCI, V40, P841, DOI 10.1016/j.jas.2012.08.044; Cabboi S., 1995, COLL DOCUMENTS ARCHE, V51; Carignan J, 2001, GEOSTANDARD NEWSLETT, V25, P187, DOI 10.1111/j.1751-908X.2001.tb00595.x; Charlton MF, 2015, J ARCHAEOL SCI, V56, P210, DOI 10.1016/j.jas.2015.02.017; Coustures MP, 2003, ARCHAEOMETRY, V45, P599, DOI 10.1046/j.1475-4754.2003.00131.x; De Laet S.J., 1969, KLASSE LETTEREN, VXXXI, P3; De Nimal H., 1911, COLL EXTRAIT LIVRE E; Delque-Kolic E, 2017, RADIOCARBON, V59, P531, DOI 10.1017/RDC.2016.109; Denayer J., 2011, MINERAI FER WALLONIE; Denayer J., 2016, ANTHROPOLOGICA PRAEH, V126, P39; Dillmann P, 2007, J ARCHAEOL SCI, V34, P1810, DOI 10.1016/j.jas.2006.12.022; Dillmann P, 2017, J ARCHAEOL SCI, V87, P108, DOI 10.1016/j.jas.2017.10.002; Disser A, 2017, ARCHAEOMETRY, V59, P493, DOI 10.1111/arcm.12265; Disser A, 2014, J ARCHAEOL SCI, V42, P315, DOI 10.1016/j.jas.2013.10.034; Disser A., 2014, THESIS U TECHNOLOGIE; Disser A, 2020, J ARCHAEOL SCI-REP, V34, DOI 10.1016/j.jasrep.2020.102653; Domergue C., 2016, COLL REV ARCHEOLOG S, V43; Domergue C., 2018, INFRASTRUCTURE DISTR, P193; Domergue C., 2006, CELTES GAULOIS LARCH, P131; Domergue C., 2004, LARTISANAT METALLURG, V332, P129; Feugere M., 2000, IRON BLACKSMITHS TOO, P67; Firket A., 1982, CARTE NOTICE PRODUCT; Firket A., 1976, CARTE NOTICE PRODUCT; Gillard A., 1971, IND FER LOCALITES CO, V29; Gratuze B, 2001, J RADIOANAL NUCL CH, V247, P645, DOI 10.1023/A:1010623703423; Gratuze B, 1999, J ARCHAEOL SCI, V26, P869, DOI 10.1006/jasc.1999.0459; Hansotte G., 1963, B LINSTITUT ARCHEOLO, V76, P5; Houbrechts G., 2003, G OMORPHOLOGIE RELIE, V9-1, P3; Hure A., 1936, B SOCIETE DARCHEOLOG, V38, P33; L'Heritier M, 2020, MINERALS-BASEL, V10, DOI 10.3390/min10121131; L'Heritier M, 2016, NAT SCI ARCHAEOL, P213, DOI 10.1007/978-3-662-49894-1_14; Laval M., 1990, R31672DEXDAM90 BRGM; Leroy S, 2012, J ARCHAEOL SCI, V39, P1080, DOI 10.1016/j.jas.2011.11.025; Long L., 1985, 6 CONGRESO INT ARQUE, P93; Long L., 2002, AFRICA ROMANA, VXIV, P161; Long L., 1987, COLL CAESARODUNUM, VXXII, P149; Maillet GM, 2011, J SEDIMENT RES, V81, P138, DOI 10.2110/jsr.2011.8; Mairecolas M., 2010, QUELQUES JALONS PALL, V82, P139; Mangin M., 1992, COLL ANN LITTERAIRES, V38; Mangin M., 2004, COLL ARCHEOLOGIQUES; Marechal J.-F., 1998, B SOC NATL ANTIQUAIR, P239; Marechal J.-R., 1987, MINES METALLURGIE GA, P281; Mauer J., 1960, ANN DHISTOIRE LOCALE, V3, P99; Milot J, 2022, ARCHAEOMETRY, V64, P385, DOI 10.1111/arcm.12715; Milot J, 2016, J ARCHAEOL SCI, V76, P9, DOI 10.1016/j.jas.2016.10.003; Monguilan L., 1987, MINES METALLURGIE GA, VXXII, P171; Mut G., 2007, CARTE ARCHEOLOGIQUE, P141; Nelissen A., 1965, B SOCIETE ROYALE VIE, V6, P441; Pages G, 2011, J ARCHAEOL SCI, V38, P1234, DOI 10.1016/j.jas.2010.12.017; Pages G., 2014, GALLIA, V71, P47; Pages G., 2020, MARCH MATI RES PREMI, V563; Pietak J.-P., 2012, REV ARCHEOLOGIQUE LE, V61, P117; Polfer M., 2005, COLL MONOGRAPHIES IN, V28; Polfer Michel, 1999, ARTISANAT PRODUCTION, P45; Riccardi E., 2002, AFRICA ROMANA, V14, P1311; Rose T, 2019, J ARCHAEOL SCI, V101, P52, DOI 10.1016/j.jas.2018.11.005; Rothenhofer P., 2003, Z PAPYROLOGIE EPIGRA, V143, P277; Schwab R, 2006, ARCHAEOMETRY, V48, P433, DOI 10.1111/j.1475-4754.2006.00265.x; Tahon V., 1886, DOCUMENTS RAPPORTS S, V14, P794; Tchernia A., 2011, ROMAINS COMMERCE, P439, DOI [10.1016/j.arcped.2011.06.019, DOI 10.1016/J.ARCPED.2011.06.019]	66	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268209	10.1371/journal.pone.0268209	http://dx.doi.org/10.1371/journal.pone.0268209			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580132	gold, Green Published			2022-12-26	WOS:000835654800010
J	Salinas, SDD; Farra, YMM; Khoiy, KA; Houston, J; Lee, CH; Bellini, C; Amini, R				Salinas, Samuel D. D.; Farra, Yasmeen M. M.; Khoiy, Keyvan Amini; Houston, James; Lee, Chung-Hao; Bellini, Chiara; Amini, Rouzbeh			The role of elastin on the mechanical properties of the anterior leaflet in porcine tricuspid valves	PLOS ONE			English	Article							RIGHT-VENTRICULAR PRESSURE; MARFAN-SYNDROME; MOUSE MODEL; COLLAGEN; PROLAPSE; MANAGEMENT; GLAUCOMA; DISEASE	Elastin is present in the extracellular matrix (ECM) of connective tissues, and its mechanical properties are well documented. In Marfan syndrome, however, the inability to properly code for the protein fibrillin-1 prematurely leads to the degradation and loss of elastin fiber integrity in the ECM. In this study, the role of elastin in the ECM of the anterior leaflet of the tricuspid valve was investigated by examining the biomechanical behavior of porcine leaflets before and after the application of the enzyme elastase. Five loading protocols were applied to the leaflet specimens in two groups (elastase-treated and control samples). The mechanical response following elastase application yielded a significantly stiffer material in both the radial and circumferential directions. At a physiological level of stress (85 kPa), the elastase group had an average strain of 26.21% and 6.32% in the radial and circumferential directions, respectively, at baseline prior to elastase application. Following elastase treatment, the average strain was 5.28% and 0.97% in the radial and circumferential directions, respectively. No statistically significant change was found in the control group following sham treatment with phosphate-buffered saline (PBS). Two-photon microscopy images confirmed that after the removal of elastin, the collagen fibers displayed a loss of undulation. With a significant reduction in radial compliance, the ability to withstand physiological loads may be compromised. As such, an extracellular matrix that is structurally deficient in elastin may hinder normal tricuspid valve function.	[Salinas, Samuel D. D.; Farra, Yasmeen M. M.; Amini, Rouzbeh] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Salinas, Samuel D. D.; Khoiy, Keyvan Amini; Bellini, Chiara; Amini, Rouzbeh] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Houston, James] Middle Tennessee State Univ, Dept Psychol, Murfreesboro, TN USA; [Lee, Chung-Hao] Univ Oklahoma, Sch Aerosp & Mech Engn, Norman, OK USA; [Amini, Rouzbeh] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	Northeastern University; University System of Ohio; University of Akron; Middle Tennessee State University; University of Oklahoma System; University of Oklahoma - Norman; Northeastern University	Amini, R (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.; Amini, R (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.; Amini, R (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	r.amini@northeastern.edu	; Houston, James/None	Salinas, Samuel/0000-0002-5229-2290; Houston, James/0000-0002-2148-4302; Amini, Rouzbeh/0000-0003-3632-6195; Lee, Chung-Hao/0000-0002-8019-3329	American Heart Association [16SDG27770088]; National Science Foundation (NSF CAREER) [2049088]	American Heart Association(American Heart Association); National Science Foundation (NSF CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported in part by the American Heart Association (Grant No. 16SDG27770088, PI RA) and the National Science Foundation (NSF CAREER 2049088, PI RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini R, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026105; Avazmohammadi R, 2019, ANNU REV BIOMED ENG, V21, P417, DOI 10.1146/annurev-bioeng-062117-121129; Bhat SK, 2022, J MECH BEHAV BIOMED, V125, DOI 10.1016/j.jmbbm.2021.104959; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Carta L, 2009, ARTERIOSCL THROM VAS, V29, P2083, DOI 10.1161/ATVBAHA.109.193227; Chiang SJ, 2015, HEART, V101, P609, DOI 10.1136/heartjnl-2014-306198; Conn AR., 2000, TRUST REGION METHODS, DOI [10.1137/1.9780898719857, DOI 10.1137/1.9780898719857]; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; Delling FN, 2015, HEART, V101, P584, DOI 10.1136/heartjnl-2014-307229; Fata B, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026457; Federico S, 2008, MECCANICA, V43, P279, DOI 10.1007/s11012-007-9090-6; Ferruzzi J, 2011, CARDIOVASC RES, V92, P287, DOI 10.1093/cvr/cvr195; Fonck E, 2007, AM J PHYSIOL-HEART C, V292, pH2754, DOI 10.1152/ajpheart.01108.2006; FRIEDMAN BJ, 1984, J AM COLL CARDIOL, V4, P999, DOI 10.1016/S0735-1097(84)80062-5; Fung Y.C., 1993, BIOMECHANICS MECH PR; GEVA T, 1990, AM J CARDIOL, V65, P1230, DOI 10.1016/0002-9149(90)90979-B; Green EM, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0058; Gu XY, 2015, TEX HEART I J, V42, P30, DOI 10.14503/THIJ-13-3848; Helder MRK, 2014, J THORAC CARDIOV SUR, V148, P1020, DOI 10.1016/j.jtcvs.2014.06.046; Hill MR, 2012, J BIOMECH, V45, P762, DOI 10.1016/j.jbiomech.2011.11.016; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; HUMPHREY JD, 1987, BIOPHYS J, V52, P563, DOI 10.1016/S0006-3495(87)83245-9; Izquierdo N J, 1992, Trans Am Ophthalmol Soc, V90, P111; Jacobs NT, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023503; Jan NJ, 2018, ACTA BIOMATER, V72, P295, DOI 10.1016/j.actbio.2018.03.026; Jan NJ, 2017, INVEST OPHTH VIS SCI, V58, P3378, DOI 10.1167/iovs.17-21811; Jett S, 2018, J MECH BEHAV BIOMED, V87, P155, DOI 10.1016/j.jmbbm.2018.07.024; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Kheradvar A, 2015, ANN BIOMED ENG, V43, P833, DOI 10.1007/s10439-014-1209-z; Khoiy KA, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040126; Khoiy KA, 2018, J MECH BEHAV BIOMED, V78, P154, DOI 10.1016/j.jmbbm.2017.11.017; Khoiy KA, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034426; Kramer KE, 2019, ACTA BIOMATER, V96, P368, DOI 10.1016/j.actbio.2019.06.049; Lake SP, 2011, ANN BIOMED ENG, V39, P1891, DOI 10.1007/s10439-011-0298-1; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Mascherbauer J, 2010, EUR HEART J, V31, P2841, DOI 10.1093/eurheartj/ehq303; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Misfeld M, 2007, PHILOS T R SOC B, V362, P1421, DOI 10.1098/rstb.2007.2125; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pant AD, 2018, ACTA BIOMATER, V67, P248, DOI 10.1016/j.actbio.2017.11.040; Pant AD, 2018, INVEST OPHTH VIS SCI, V59, P4134, DOI 10.1167/iovs.18-24327; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; ROBERTS WC, 1982, AM HEART J, V104, P115, DOI 10.1016/0002-8703(82)90650-0; Ross CJ, 2021, ACTA BIOMATER, V135, P425, DOI 10.1016/j.actbio.2021.08.043; Ross CJ, 2020, BIOENGINEERING-BASEL, V7, DOI 10.3390/bioengineering7010025; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Salinas SD, 2020, J BIOMECH, V98, DOI 10.1016/j.jbiomech.2019.109462; Salinas SD, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6030070; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Schriefl AJ, 2015, ACTA BIOMATER, V17, P125, DOI 10.1016/j.actbio.2015.01.003; Schwaner SA, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039998; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; STARCHER BC, 1986, THORAX, V41, P577, DOI 10.1136/thx.41.8.577; Stevanella M, 2010, MED ENG PHYS, V32, P1213, DOI 10.1016/j.medengphy.2010.08.013; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; Pham T, 2017, ACTA BIOMATER, V54, P345, DOI 10.1016/j.actbio.2017.03.026; Tsamis Alkiviadis, 2013, J R Soc Interface, V10, P20121004, DOI 10.1098/rsif.2012.1004; Vassileva CM, 2012, J THORAC CARDIOV SUR, V143, P1043, DOI 10.1016/j.jtcvs.2011.07.004; Vesely I, 1998, J BIOMECH, V31, P115, DOI 10.1016/S0021-9290(97)00122-X; Wiltz D, 2013, CALCIFIC AORTIC VALV	63	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267131	http://dx.doi.org/10.1371/journal.pone.0267131			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560311	gold, Green Published			2022-12-26	WOS:000835326900004
J	Thiemann, R; Varney, S; Moskwa, NE; Lamar, J; Larsen, M; LaFlamme, S				Thiemann, Renee; Varney, Scott; Moskwa, Nicholas E.; Lamar, John; Larsen, Melinda; LaFlamme, Susan			Regulation of myoepithelial differentiation	PLOS ONE			English	Article							SALIVARY-GLANDS; STEM-CELLS; MORPHOGENESIS; YAP; PATHWAY; TAZ; DYSREGULATION; REGENERATION; PROGENITORS; EXPRESSION	The salivary gland can be permanently impaired by radiation treatment for head and neck cancers. Efforts at tissue regeneration have focused on saliva-producing acinar cells. However, myoepithelial cells are also critical to gland function, but mechanisms that regulate their differentiation are poorly defined. To study myoepithelial differentiation, we employed mSG-PAC1 murine salivary gland epithelial cells. We demonstrate that mSG-PAC1 spheroids exhibit phenotypic plasticity between pro-acinar and myoepithelial cell fates. Increased expression of pro-acinar/acinar or myoepithelial RNAs was identified from spheroids cultured under different media conditions by microarray followed by gene-set enrichment analysis. Spheroids cultured with different medium components expressed proteins typical of either acinar or myoepithelial cells, as detected by immunocytochemistry. We demonstrate that the pattern of TAZ expression in the epithelial compartment of the differentiating murine salivary gland correlates with the expression of the myoepithelial marker alpha-SMA, as is the case for TAZ expression in mSG-PAC1 spheroids. Our analysis also indicates that YAP/TAZ target genes are upregulated together with myoepithelial markers. Importantly, siRNA targeting of TAZ expression in mSG-PAC1 spheroids diminished the expression of myoepithelial markers. Our results in this in vitro cell model implicate TAZ signaling in myoepithelial differentiation.	[Thiemann, Renee; LaFlamme, Susan] Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA; [Varney, Scott] Albany Med Coll, Dept Surg, Albany, NY 12208 USA; [Moskwa, Nicholas E.; Larsen, Melinda] SUNY Albany, Dept Biol Sci, Albany, NY 12561 USA; [Lamar, John] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Thiemann, Renee] Catholic Cent High Sch, Troy, NY 12182 USA; [Varney, Scott] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19144 USA	Albany Medical College; Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; Jefferson University	LaFlamme, S (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA.	laflams@amc.edu		Moskwa, Nicholas/0000-0002-9819-9227; , John/0000-0001-5406-8391; Varney, Scott/0000-0001-9562-127X	National Institute of General Medical Sciences [R01-GM-51540]; National Institute of Dental & Craniofacial Research [R01-DE-027953]; National Institute of Dental & Craniofacial Research; National Institutes of Health	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health (https://www.nih.gov). R01 -GM-51540 to S.E.L. from National Institute of General Medical Sciences. R01-DE-027953 to M.L. from the National Institute of Dental & Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; Athwal HK, 2019, STEM CELL REP, V12, P366, DOI 10.1016/j.stemcr.2019.01.002; Aure MH, 2019, J DENT RES, V98, P1186, DOI 10.1177/0022034519864592; Barrows CML, 2020, TISSUE ENG PT A, V26, P1332, DOI [10.1089/ten.tea.2020.0184, 10.1089/ten.TEA.2020.0184]; Chang C, 2015, GENE DEV, V29, P1, DOI 10.1101/gad.253682.114; Chansaenroj A, 2021, TISSUE ENG PART B-RE, V27, P155, DOI [10.1089/ten.teb.2020.0149, 10.1089/ten.TEB.2020.0149]; Chitturi RT, 2015, J CLIN DIAGN RES, V9, pZE14, DOI 10.7860/JCDR/2015/11372.5707; De Rosa L, 2019, CELL REP, V27, P2036, DOI 10.1016/j.celrep.2019.04.055; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeSantis KA, 2017, ORGANOGENESIS, V13, P125, DOI 10.1080/15476278.2017.1358336; Eda H, 2008, BIOCHEM BIOPH RES CO, V366, P471, DOI 10.1016/j.bbrc.2007.11.140; Elbediwy A, 2016, BIOESSAYS, V38, P644, DOI 10.1002/bies.201600037; Emmerson E, 2018, GENESIS, V56, DOI 10.1002/dvg.23211; Emmerson E, 2017, ELIFE, V6, DOI 10.7554/eLife.26620; Enger TB, 2013, LAB INVEST, V93, P1203, DOI 10.1038/labinvest.2013.114; Garcia-Posadas L, 2020, AM J PATHOL, V190, P2067, DOI 10.1016/j.ajpath.2020.06.013; Gervais EM, 2016, ORGANOGENESIS, V12, P194, DOI 10.1080/15476278.2016.1252887; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hakim SG, 2002, ANTICANCER RES, V22, P4121; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hauser BR, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101838; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hosseini ZF, 2018, FGF2 DEPENDENT MESEN; Hu JKH, 2017, CELL STEM CELL, V21, P91, DOI 10.1016/j.stem.2017.03.023; Ikai K, 2020, FEBS LETT, V594, P3216, DOI 10.1002/1873-3468.13896; Kim JM, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.190785; Koslow M, 2019, STEM CELL RES, V41, DOI 10.1016/j.scr.2019.101608; Lombaert I, 2017, STEM CELLS, V35, P97, DOI 10.1002/stem.2455; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lu Y, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0485-0; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Makarenkova Helen P, 2015, Curr Mol Biol Rep, V1, P115; Matsumoto S, 2016, DEVELOPMENT, V143, P2311, DOI 10.1242/dev.134486; May AJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166363; Miyachi Y, 2021, GENES CELLS, V26, P714, DOI 10.1111/gtc.12879; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Ninche N, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.192807; O'Keefe KJ, 2020, J DENT RES, V99, P79, DOI 10.1177/0022034519889026; Patel N, 2011, DEV BIOL, V358, P156, DOI 10.1016/j.ydbio.2011.07.023; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pechoux C, 1999, DEV BIOL, V206, P88, DOI 10.1006/dbio.1998.9133; Raymond K, 2011, EMBO J, V30, P1896, DOI 10.1038/emboj.2011.113; REDMAN RS, 1994, MICROSC RES TECHNIQ, V27, P25, DOI 10.1002/jemt.1070270103; Sequeira SJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50060; Shubin AD, 2020, CELL TISSUE RES, V380, P487, DOI 10.1007/s00441-019-03157-w; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Song EAC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32343-z; SOULE HD, 1990, CANCER RES, V50, P6075; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymaniak AD, 2017, ELIFE, V6, DOI 10.7554/eLife.23499; Thiemann RF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47387-y; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wang SH, 2021, CELL, V184, P3702, DOI 10.1016/j.cell.2021.05.015; Weng PL, 2019, ORAL DIS, V25, P1837, DOI 10.1111/odi.13205; Weng PL, 2018, CELL REP, V24, P1464, DOI 10.1016/j.celrep.2018.07.016; Zhang DW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4165	58	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268668	10.1371/journal.pone.0268668	http://dx.doi.org/10.1371/journal.pone.0268668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617216	Green Published, gold			2022-12-26	WOS:000835048800046
J	Jiang, W; He, F; Ding, GM; Wu, JS				Jiang, Wu; He, Fan; Ding, Guoming; Wu, Junsong			Topoisomerase 1 inhibition modulates pyroptosis to improve recovery after spinal cord injury	FASEB JOURNAL			English	Article						camptothecin; neuroinflammation; pyroptosis; spinal cord injury; topoisomerase 1	NF-KAPPA-B; PROMOTES FUNCTIONAL RECOVERY; NLRP3 INFLAMMASOME; CELL-DEATH; TNF-ALPHA; NEURONAL DEATH; IN-VITRO; IL-1-BETA; ACTIVATION; EXPRESSION	Excessive neuroinflammation and neuronal loss contribute to mechanisms of spinal cord injury (SCI). Accumulating evidence has suggested that topoisomerase 1 (Top1) inhibition can suppress exacerbated immune responses and protect against lethal inflammation. Pyroptosis is a recently identified pro-inflammatory programmed mode of cell death. However, the effects and underlying mechanisms of Top1 inhibition in SCI remains unclear. Locomotor functional recovery in mice was evaluated through Basso Mouse Scale (BMS). Neuronal loss was evaluated by immunochemistry staining of NeuN. Pyroptosis was determined by immunofluorescence staining, western blot, flow cytometry, cell viability, and cytotoxicity assays. In the present study, we estimated the effects of chemical inhibition of Top1 in an SCI model. Administration of Top1 inhibitor camptothecin (CPT) to mice significantly improved locomotor functional recovery after SCI. Moreover, CPT reduced Top1 level, inhibited nucleotide-binding oligomerization domain-like receptor 3 (NLRP3) inflammasome activation and pyroptosis, attenuated proinflammatory cytokines levels, diminished the number of neutrophil and neuronal loss in mice. Furthermore, CPT in oxygen-glucose deprivation neurons down-regulated Top1 level, attenuated NLRP3 inflammasome activation, and suppressed pyroptosis and inflammatory response. Together, our findings indicate that inhibition of Top1 with CPT can inhibit pyroptosis, control neuroinflammation, and improve functional recovery after SCI.	[Jiang, Wu; Wu, Junsong] Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Wu; He, Fan; Ding, Guoming] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Orthoped, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Wu, JS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	drwujunsong@sina.com			Zhejiang Provincial Medical and Healthy Technology Project [2020KY699]; Zhejiang Provincial Pubilc Welfare Research Project [LGF20H060014]	Zhejiang Provincial Medical and Healthy Technology Project; Zhejiang Provincial Pubilc Welfare Research Project	Zhejiang Provincial Medical and Healthy Technology Project, Grant/Award Number: 2020KY699; Zhejiang Provincial Pubilc Welfare Research Project, Grant/Award Number: LGF20H060014	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-6; Burke SJ, 2014, MOL IMMUNOL, V62, P54, DOI 10.1016/j.molimm.2014.05.019; Chen J, 2019, NEUROSCIENCE, V408, P430, DOI 10.1016/j.neuroscience.2019.03.055; Chen S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00014; Cheng Zhijian, 2021, J NEURORESTORATOLOGY, V9, P106, DOI [DOI 10.26599/JNR.2021.9040009, 10.26599/JNR.2021.9040009]; Fan YX, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00426; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Fu HT, 2018, J NEUROTRAUM, V35, P2507, DOI 10.1089/neu.2017.5606; Guo XD, 2021, J NEURORESTORATOLOGY, V9, P31, DOI 10.26599/JNR.2021.9040003; He DW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.619761; Hsieh H, 2016, TOXICOL IN VITRO, V35, P24, DOI 10.1016/j.tiv.2016.05.003; Hu JL, 2017, NEUROBIOL DIS, V98, P25, DOI 10.1016/j.nbd.2016.11.006; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jin JJ, 2019, J SURG RES, V235, P83, DOI 10.1016/j.jss.2018.08.057; Kadioglu O, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00711; Kijima K, 2019, EBIOMEDICINE, V41, P659, DOI 10.1016/j.ebiom.2019.03.003; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lago N, 2018, BRAIN BEHAV IMMUN, V73, P416, DOI 10.1016/j.bbi.2018.06.002; Ledesma E, 2004, CYTOKINE, V26, P66, DOI 10.1016/j.cyto.2003.12.009; Lee JY, 2015, J NEUROTRAUM, V32, P633, DOI 10.1089/neu.2014.3527; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Leonard SC, 2017, ANTI-CANCER DRUG, V28, P1086, DOI 10.1097/CAD.0000000000000545; Li T, 2018, INT J NEUROSCI, V128, P778, DOI 10.1080/00207454.2018.1424154; Lin WP, 2016, SPINAL CORD, V54, P778, DOI 10.1038/sc.2016.20; Lin XL, 2019, EUR REV MED PHARMACO, V23, P1891, DOI 10.26355/eurrev_201903_17226; Liu LM, 2018, INT J ONCOL, V53, P1897, DOI 10.3892/ijo.2018.4531; Liu SC, 2016, TAIWAN J OBSTET GYNE, V55, P213, DOI 10.1016/j.tjog.2016.02.011; Liu T, 2019, J ALLERGY CLIN IMMUN, V144, P777, DOI 10.1016/j.jaci.2019.05.006; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.460; Lu FF, 2020, J CELL PHYSIOL, V235, P3207, DOI 10.1002/jcp.29268; Lu YH, 2016, BIOMATERIALS, V90, P27, DOI 10.1016/j.biomaterials.2016.03.003; Mazzone GL, 2017, NEUROSCIENCE, V343, P398, DOI 10.1016/j.neuroscience.2016.12.008; McKenzie BA, 2020, TRENDS NEUROSCI, V43, P55, DOI 10.1016/j.tins.2019.11.005; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Namjoo Z, 2018, J CELL BIOCHEM, V119, P10195, DOI 10.1002/jcb.27361; Oleszycka E, 2016, FEBS J, V283, P9, DOI 10.1111/febs.13546; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993; Riedlinger T, 2019, CANCERS, V11, DOI 10.3390/cancers11060883; Shi DL, 2019, NEUROSCI LETT, V694, P161, DOI 10.1016/j.neulet.2018.12.006; Silvestris N, 2014, INT J MOL SCI, V15, P15767, DOI 10.3390/ijms150915767; Slaets H, 2014, MOL NEUROBIOL, V50, P1142, DOI 10.1007/s12035-014-8795-5; Sun WJ, 2019, J PHYSIOL BIOCHEM, V75, P531, DOI 10.1007/s13105-019-00702-7; Tsai KD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060318; Wang S, 2019, INT IMMUNOPHARMACOL, V67, P458, DOI 10.1016/j.intimp.2018.12.019; Wang X, 2021, ARTHRITIS RHEUMATOL, V73, P1478, DOI 10.1002/art.41685; Wang YZ, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5556659; Wu JL, 2019, AGING DIS, V10, P1094, DOI 10.14336/AD.2019.0116; Xiao LX, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118130; Yang ZX, 2020, BIOCHEM BIOPH RES CO, V522, P61, DOI 10.1016/j.bbrc.2019.11.031; Yates AG, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02050-6; Yoshizaki S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1536-y; Yuin Ho JS., 2020, BIORXIV; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang DP, 2019, J NEUROSCI RES, V97, P645, DOI 10.1002/jnr.24385; Zhang SX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0543-8; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhang YX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1468-6; Zheng G, 2019, EBIOMEDICINE, V40, P643, DOI 10.1016/j.ebiom.2018.12.059; Zhou W, 2017, J NEUROPHYSIOL, V117, P2282, DOI 10.1152/jn.00936.2016; Zhu S, 2019, NEUROCHEM INT, V124, P141, DOI 10.1016/j.neuint.2019.01.003	68	1	1	9	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22294	10.1096/fj.202100713RR	http://dx.doi.org/10.1096/fj.202100713RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1H6IJ	35579890				2022-12-26	WOS:000796644900001
J	Gerlevik, U; Saygi, C; Cangul, H; Kutlu, A; Caralan, EF; Topcu, Y; Ozoren, N; Sezerman, OU				Gerlevik, Umut; Saygi, Ceren; Cangul, Hakan; Kutlu, Asli; Caralan, Erdal Firat; Topcu, Yasemin; Ozoren, Nesrin; Sezerman, Osman Ugur			Computational analysis of missense filamin-A variants, including the novel p.Arg484Gln variant of two brothers with periventricular nodular heterotopia	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; MOLECULAR-DYNAMICS; MOSAIC MUTATIONS; GENE CAUSE; FLNA; BINDING; CLASSIFICATION; MALFORMATIONS; DIMERIZATION; MIGRATION	Background Periventricular nodular heterotopia (PNH) is a cell migration disorder associated with mutations in Filamin-A (FLNA) gene on chromosome X. Majority of the individuals with PNHassociated FLNA mutations are female whereas liveborn males with FLNA mutations are very rare. Fetal viability of the males seems to depend on the severity of the variant. Splicing or severe truncations presumed loss of function of the protein product, lead to male lethality and only partial-loss-of-function variants are reported in surviving males. Those variants mostly manifest milder clinical phenotypes in females and thus avoid detection of the disease in females. Methods We describe a novel p.Arg484Gln variant in the FLNA gene by performing whole exome analysis on the index case, his one affected brother and his healthy non-consanguineous parents. The transmission of PNH from a clinically asymptomatic mother to two sons is reported in a fully penetrant classical X-linked dominant mode. The variant was verified via Sanger sequencing. Additionally, we investigated the impact of missense mutations reported in affected males on the FLNa protein structure, dynamics and interactions by performing molecular dynamics (MD) simulations to examine the disease etiology and possible compensative mechanisms allowing survival of the males. Results We observed that p.Arg484Gln disrupts the FLNa by altering its structural and dynamical properties including the flexibility of certain regions, interactions within the protein, and conformational landscape of FLNa. However, these impacts existed for only a part the MD trajectories and highly similar patterns observed in the other 12 mutations reported in the liveborn males validated this mechanism. Conclusion It is concluded that the variants seen in the liveborn males result in transient pathogenic effects, rather than persistent impairments. By this way, the protein could retain its function occasionally and results in the survival of the males besides causing the disease.	[Gerlevik, Umut; Kutlu, Asli; Sezerman, Osman Ugur] Acibadem Mehmet Ali Aydinlar Univ, Dept Biostatist & Bioinformat, Inst Hlth Sci, Istanbul, Turkey; [Saygi, Ceren; Ozoren, Nesrin] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Cangul, Hakan] Istanbul Medipol Univ, Ctr Genet Diag, Istanbul, Turkey; [Kutlu, Asli] Istinye Univ, Fac Engn & Nat Sci, Bioinformat & Genet, Istanbul, Turkey; [Topcu, Yasemin] Istanbul Medipol Univ, Fac Med, Dept Pediat Neurol, Istanbul, Turkey; [Sezerman, Osman Ugur] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Biostatist & Med Informat, Istanbul, Turkey; [Gerlevik, Umut] Univ Oxford, Dept Biochem, Oxford, England	Acibadem University; Bogazici University; Istanbul Medipol University; Istinye University; Istanbul Medipol University; Acibadem University; University of Oxford	Sezerman, OU (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Dept Biostatist & Bioinformat, Inst Hlth Sci, Istanbul, Turkey.; Sezerman, OU (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Biostatist & Med Informat, Istanbul, Turkey.	ugur.sezerman@acibadem.edu.tr	Gerlevik, Umut/AAI-9313-2020	Gerlevik, Umut/0000-0003-4288-6340; YENENLER-KUTLU, ASLI/0000-0002-9169-388X				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amberger JS, 2019, NUCLEIC ACIDS RES, V47, pD1038, DOI 10.1093/nar/gky1151; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Cannaerts E, 2018, BMC MED GENET BMC ME, V19, P1; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Davidchack RL, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3149788; Delgado J, 2019, BIOINFORMATICS, V35, P4168, DOI 10.1093/bioinformatics/btz184; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fergelot P, 2012, EUR J MED GENET, V55, P313, DOI 10.1016/j.ejmg.2012.01.018; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gerard-Blanluet M, 2006, AM J MED GENET A, V140A, P1041, DOI 10.1002/ajmg.a.31197; Gomez-Garre P, 2006, J MED GENET, V43, P232, DOI 10.1136/jmg.2004.029173; Guerrini R, 2004, NEUROLOGY, V63, P51, DOI 10.1212/01.WNL.0000132818.84827.4D; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hehr U, 2006, J MED GENET, V43, P541, DOI 10.1136/jmg.2005.038505; Himmel M, 2003, BIOCHEMISTRY-US, V42, P430, DOI 10.1021/bi026501+; Hommel AL, 2016, MUSCLE NERVE, V54, P794, DOI 10.1002/mus.25175; Hu JJ, 2017, HUM MOL GENET, V26, P1294, DOI 10.1093/hmg/ddx047; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Iwamoto DV, 2018, NAT STRUCT MOL BIOL, V25, P918, DOI 10.1038/s41594-018-0128-3; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Jardine PE, 1996, ARCH DIS CHILD, V74, P244, DOI 10.1136/adc.74.3.244; Jenkins ZA, 2018, HUM MUTAT, V39, P103, DOI 10.1002/humu.23355; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAMURO K, 1993, BRAIN DEV-JPN, V15, P237, DOI 10.1016/0387-7604(93)90073-H; Kapur RP, 2010, AM J SURG PATHOL, V34, P1528, DOI 10.1097/PAS.0b013e3181f0ae47; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kasper BS, 2013, AM J MED GENET A, V161A, P1323, DOI 10.1002/ajmg.a.35917; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; KOLAFA J, 1992, MOL SIMULAT, V9, P351, DOI 10.1080/08927029208049126; Kumar SU, 2020, MOLECULES, V25, DOI 10.3390/molecules25235543; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lange M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0331-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WY, 2017, EPILEPSY RES, V133, P33, DOI 10.1016/j.eplepsyres.2017.03.005; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Masurel-Paulet A, 2011, EUR J MED GENET, V54, P25, DOI 10.1016/j.ejmg.2010.09.010; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oegema R, 2013, AM J MED GENET A, V161, P2376, DOI 10.1002/ajmg.a.36109; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Parrini E, 2004, NEUROGENETICS, V5, P191, DOI 10.1007/s10048-004-0187-y; Parrini E, 2011, AM J MED GENET A, V155A, P1140, DOI 10.1002/ajmg.a.33880; Pelizzo G, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1460-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poussaint TY, 2000, PEDIATR RADIOL, V30, P748, DOI 10.1007/s002470000312; R Core Team, 2021, R LANGUAGE ENV STAT; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reinstein E, 2013, EUR J HUM GENET, V21, P494, DOI 10.1038/ejhg.2012.209; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Richmond T, 2000, GENOME BIOL, DOI [10.1186/gb-2000-1-1-reports223, DOI 10.1186/GB-2000-1-1-REPORTS223]; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; Sayers EW, 2020, NUCLEIC ACIDS RES, V48, pD84, DOI [10.1093/nar/gkz956, 10.1093/nar/gkaa1023]; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seo MD, 2009, PROTEINS, V75, P258, DOI 10.1002/prot.22336; Sethi R, 2014, J BIOL CHEM, V289, P8588, DOI 10.1074/jbc.M113.537456; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2003, NEUROLOGY, V60, P1033, DOI 10.1212/01.WNL.0000052689.03214.61; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sneha P, 2017, J CELL BIOCHEM, V118, P1900, DOI 10.1002/jcb.25920; Sole G, 2009, J NEUROL NEUROSUR PS, V80, P1394, DOI 10.1136/jnnp.2008.162263; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van Kogelenberg M, 2015, J MOL MED, V93, P773, DOI 10.1007/s00109-015-1261-7; Van Rossum G, 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	96	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2022	17	5							e0265400	10.1371/journal.pone.0265400	http://dx.doi.org/10.1371/journal.pone.0265400			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5V2HX	35613087	gold, Green Published			2022-12-26	WOS:000877056800001
J	Li, Y; Sun, D; Wang, KL; Liu, JW; Wang, Z; Liu, Y				Li, Yang; Sun, Dong; Wang, Kelai; Liu, Jingwei; Wang, Zhe; Liu, Yu			Postoperative avascular necrosis of the femoral head in pediatric femoral neck fractures	PLOS ONE			English	Article							LONG-TERM-FOLLOW; OPERATIVE TREATMENT; OPEN REDUCTION; HIP-FRACTURES; CHILDREN OPEN; RISK-FACTORS; FEMUR; ADOLESCENTS; ANATOMY; OSTEONECROSIS	This study aimed to evaluate the relevant factors of postoperative avascular necrosis of the femoral head (AVN) in children with femoral neck fracture. This study retrospectively analyzed the clinical data of 28 children with femoral neck fractures treated at our center between July 2016 and January 2019. The average age was 9.3 (range, 4.4-14) years with 75% male participants. Fracture classification was based on the Delbet classification: there were four, seven, 15, and two cases of type I, II, III, and IV fractures, respectively. Displacement degree was based on the Garden classification. Sixteen cases had insignificant displacement (Garden types I and II), six had medium displacement (Garden type III), and six had significant displacement (Garden type IV). There were six early (<= 24 hours) and 22 delayed (>24 hours) surgeries. Twenty-three patients had satisfactory reduction, and five had unsatisfactory reduction. The mean postoperative follow-up period was 15.7 (range, 12-36) months. Follow-up was evaluated using the Ratliff scoring standards. The correlation between age, fracture classification, displacement degree, surgery timing, reduction quality, and other factors and AVN occurrence was statistically analyzed. Among 28 children, AVN was found in six cases. There were statistically significant differences in displacement degree (P = 0.001) and reduction quality (P = 0.001), while the occurrence of AVN did not significantly differ with sex (P = 0.117), age distribution (P = 0.218), fracture classification (P = 0.438), surgery timing (P = 0.255), and mechanism of injury (P = 0.436). The results of logistic regression analysis showed that displacement degree was a relevant risk factor (P = 0.049, odds ratio [OR] = 8.391, 95% confidence interval [CI]: 1.004-70.117), while reduction quality was not (P = 0.075, OR = 14.536, 95% CI: 0.757-278.928). Although the development of AVN in children with femoral neck fractures may be related to many factors, the results of this research suggest that there is a significant correlation between displacement degree and AVN occurrence.	[Li, Yang; Sun, Dong; Wang, Kelai; Liu, Jingwei; Wang, Zhe; Liu, Yu] Shandong Univ, Dept Pediat Surg, Qilu Hosp, Jinan, Shandong, Peoples R China	Shandong University	Wang, KL (corresponding author), Shandong Univ, Dept Pediat Surg, Qilu Hosp, Jinan, Shandong, Peoples R China.	sddxqlyyxewkwkl@163.com						AlKhatib N, 2019, INT ORTHOP, V43, P677, DOI 10.1007/s00264-018-3998-4; Bali K, 2011, CLIN ORTHOP SURG, V3, P302, DOI 10.4055/cios.2011.3.4.302; Bukva B, 2015, INJURY, V46, pS44, DOI 10.1016/j.injury.2015.10.059; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Chen YP, 2020, ORTHOP SURG, V12, P639, DOI 10.1111/os.12629; CHUNG SMK, 1976, J BONE JOINT SURG AM, V58, P961, DOI 10.2106/00004623-197658070-00011; Colonna PC, 1928, ANN SURG, V88, P902, DOI 10.1097/00000658-192811000-00012; Dendane MA, 2010, ORTHOP TRAUMATOL-SUR, V96, P161, DOI [10.1016/j.otsr.2009.11.007, 10.1016/j.rcot.2010.02.004]; Dhammi IK, 2005, J ORTHOP SCI, V10, P173, DOI 10.1007/s00776-004-0875-3; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; FORLIN E, 1992, J PEDIATR ORTHOPED, V12, P164, DOI 10.1097/01241398-199203000-00004; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; Hajdu S, 2011, INT ORTHOP, V35, P883, DOI 10.1007/s00264-010-1039-z; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; Ju L, 2016, J PEDIATR ORTHOP B, V25, P459, DOI 10.1097/BPB.0000000000000339; LAM SF, 1971, J BONE JOINT SURG AM, VA 53, P1165, DOI 10.2106/00004623-197153060-00013; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Morsy HA, 2001, INJURY, V32, P45, DOI 10.1016/S0020-1383(00)00109-1; Nayeemuddin M, 2009, J PEDIATR ORTHOP B, V18, P314, DOI 10.1097/BPB.0b013e32832d5d5f; OVESEN O, 1989, ORTHOPEDICS, V12, P361; Panigrahi R, 2015, INT ORTHOP, V39, P1121, DOI 10.1007/s00264-015-2677-y; Pavone V, 2019, INJURY, V50, pS40, DOI 10.1016/j.injury.2019.01.043; Peterson Hamlet A, 2011, J Bone Joint Surg Am, V93, pe79, DOI 10.2106/JBJS.J.01714; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; Quick TJ, 2005, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000155372.65446.40; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Seeley MA, 2016, J AM ACAD ORTHOP SUR, V24, P516, DOI 10.5435/JAAOS-D-15-00237; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; Sokol Grzegorz, 2010, Chir Narzadow Ruchu Ortop Pol, V75, P300; Song KS, 2010, J BONE JOINT SURG BR, V92B, P1148, DOI 10.1302/0301-620X.92B8.24482; Spence D, 2016, J PEDIATR ORTHOPED, V36, P111, DOI 10.1097/BPO.0000000000000424; SWIONTKOWSKI MF, 1986, J TRAUMA, V26, P384, DOI 10.1097/00005373-198604000-00013; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; Wang WT, 2019, BONE JOINT J, V101B, P1160, DOI 10.1302/0301-620X.101B9.BJJ-2019-0275.R1; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161; Zheng JQ, 2021, J ARTHROPLASTY, V36, P62, DOI 10.1016/j.arth.2020.07.046	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0268058	10.1371/journal.pone.0268058	http://dx.doi.org/10.1371/journal.pone.0268058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551330	gold, Green Published			2022-12-26	WOS:000868179400017
J	Miller, L; Merino, DP; Baisley, K; Hayes, R				Miller, Lori; Prieto Merino, David; Baisley, Kathy; Hayes, Richard			Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; PARTICIPANTS EXPLANATIONS; DOUBLE-BLIND; VAGINAL GEL; INFECTION; WOMEN; TRANSMISSION; NONADHERENCE; PREDICTORS; CARRAGUARD	Background Interpretation of clinical trial results testing vaginal microbicide gels for HIV prevention depends on participant adherence. Prior to the era of antiretrovirals, microbicide trials collected adherence data via self-report, and trials typically reported trial population adherence as overall averages in primary results manuscripts. This study first sought to determine if different patterns of adherence from three trials of vaginal microbicide gels could be identified, using self-reported data and if so, how those patterns compare across trials. The second objective was to explore which individual-level factors were associated with different adherence patterns. Methods Data from the following three clinical trials of vaginal microbicides were used for this study: HIV Prevention Trials Network (HPTN) 035 testing PRO 2000 and Buffergel, the Microbicides Development Programme (MDP) 301 testing PRO 2000, and the Population Council's Carraguard study, testing Carraguard gel. Latent Class Analysis (LCA) was used to identify longitudinal patterns of adherence using self-reported data about gel use. Multinomial multivariable logistic regression was used to estimate relative risk-ratios for factors which were independently associated with different latent adherence trajectories within each trial, and compared across trials. Results Included in this analysis are 2,282 women from HPTN 035 (age 17-56 years), 6238 women from MDP 301 (age 16-75 years), and 6039 women from Carraguard (age 16-73 years). Using LCA, 3-4 different patterns of gel adherence were identified in each trial; these patterns were similar across the trials. Factors associated with adherence patterns were identified in all trials. Older age was associated with the adherence trajectory that consistently reported gel use in three trials. Participant-reported negative reaction of partners to the gel was associated with trajectories that reported less consistent adherence in two trials. A greater number of baseline-reported sex partners or sex acts was associated with trajectories which reported less consistent adherence in some trials. Trial site location was associated with membership of trajectories in all trials. Conclusion LCA was able to identify patterns of microbicide gel adherence in clinical trials that used self-reported data. Key factors associated with patterns of adherence in this study were participant age, clinical trial site location, and partner reaction to the study gel. These findings, in particular, age and perceived partner reaction to the method, are consistent with results from other clinical trials and programmatic rollout of biomedical HIV prevention methods for women in Africa. This study contributes to the body of evidence that women need more support to navigate power dynamics within their relationships with men so that they can successfully use HIV prevention methods.	[Miller, Lori; Prieto Merino, David; Baisley, Kathy; Hayes, Richard] London Sch Hyg & Trop Med, London, England; [Prieto Merino, David] Catholic Univ Murcia UCAM, Appl Stat Methods Med Res Grp, Murcia, Spain	University of London; London School of Hygiene & Tropical Medicine; Universidad Catolica de Murcia	Miller, L (corresponding author), London Sch Hyg & Trop Med, London, England.	Lori.Miller@alumni.lshtm.ac.uk		Hayes, Richard/0000-0002-1729-9892; Prieto-Merino, David/0000-0001-5001-0061	UK Economic and Social Research Council; National Institute of Allergy And Infectious Diseases of the National Institutes of Health [T32AI114398]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; European Union [MR/R010161/1]	UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission)	This study was supported by the UK Economic and Social Research Council. Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number T32AI114398. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. RH and KB receive funding from the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 programme supported by the European Union (Grant Ref: MR/R010161/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2020, ANNU REV MED, V71, P361, DOI 10.1146/annurev-med-090518-093731; Collins L.M., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Corneli AL, 2015, JAIDS-J ACQ IMM DEF, V68, P578, DOI 10.1097/QAI.0000000000000525; Crook AM, 2010, 18 INT AIDS C VIENN; Doggett EG, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20536; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Friedland BA, 2016, AIDS BEHAV, V20, P2565, DOI 10.1007/s10461-015-1123-x; Gombe MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227632; Gorbach PM, 2014, AIDS BEHAV, V18, P855, DOI 10.1007/s10461-013-0651-5; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Institute of Medicine,, 2008, METHODOLOGICAL CHALL; Jani N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246717; Kacanek D, 2013, JAIDS-J ACQ IMM DEF, V64, P400, DOI 10.1097/QAI.0b013e3182a6b0be; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lanham Michele, 2014, J Int AIDS Soc, V17, P19159, DOI 10.7448/IAS.17.3.19159; Lanza S, 2014, LCA STATA PLUGIN USE; Magazi B, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-88; Marrazzo J, 2013, 20 C RETR OPP INF AT; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mbewe L, 2020, AJAR-AFR J AIDS RES, V19, P93, DOI 10.2989/16085906.2020.1727932; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Miller L, 2020, JAIDS-J ACQ IMM DEF, V85, P458, DOI 10.1097/QAI.0000000000002463; Mitchell K, 2007, CULT HEALTH SEX, V9, P519, DOI 10.1080/13691050701432561; Montgomery E., MADRID HIV RES PREVE; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Nel A., 2016, C RETROVIRUSES OPPOR; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Pickett J, 2018, WHOSE CHOICE IS IT A; Quaife M, 2018, MED DECIS MAKING, V38, P120, DOI 10.1177/0272989X17729376; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Richardson BA, 2001, SEX TRANSM DIS, V28, P394, DOI 10.1097/00007435-200107000-00006; Roberts ST, 2020, AIDS BEHAV, V24, P1432, DOI 10.1007/s10461-019-02707-1; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Saethre E, 2013, MED ANTHROPOL Q, V27, P103, DOI 10.1111/maq.12018; Schroder KEE, 2003, ANN BEHAV MED, V26, P104, DOI 10.1207/S15324796ABM2602_03; Scorgie F, 2021, CULT HEALTH SEX, V23, P257, DOI 10.1080/13691058.2019.1703041; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; UNAIDS, 2011, GOOD PART PRACT GUID; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2015, AIDS, V29, P2161, DOI 10.1097/QAD.0000000000000801; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2009, JAIDS-J ACQ IMM DEF, V50, P419, DOI 10.1097/QAI.0b013e3181958511	46	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267011	10.1371/journal.pone.0267011	http://dx.doi.org/10.1371/journal.pone.0267011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551324	gold, Green Accepted, Green Published			2022-12-26	WOS:000868164600019
J	Kikuchi, K; Islam, R; Nishikitani, M; Sato, Y; Izukura, R; Yokota, F; Khan, NJ; Nessa, M; Ahmed, A; Morokuma, S; Nakashima, N				Kikuchi, Kimiyo; Islam, Rafiqul; Nishikitani, Mariko; Sato, Yoko; Izukura, Rieko; Yokota, Fumihiko; Khan, Nusrat Jahan; Nessa, Meherun; Ahmed, Ashir; Morokuma, Seiichi; Nakashima, Naoki			Women's health status before and during the COVID-19 pandemic in rural Bangladesh: A prospective longitudinal study	PLOS ONE			English	Article							MENTAL-HEALTH	The coronavirus disease (COVID-19) pandemic has widely spread worldwide since 2020. Several countries have imposed lockdown or stay-at-home policies to prevent the infection. Bangladesh experienced a lockdown from March 2020 to May 2020, and internal travel was restricted. Such long and strict confinement may impact women's health. Herein, we aimed to assess the impact of the COVID-19 pandemic on women's health by comparing their health status before and during the pandemic. We conducted a prospective longitudinal study in two zones in the Chhaygaon union, rural district Shariatpur, Bangladesh. The study population comprised non-pregnant women aged 15-49 years. We visited the household of all eligible women and invited them for health checkups. The survey staff examined their health status at the checkup camps and conducted questionnaire interviews. In total, 121 non-pregnant women received health checkups both from June 2019 to July 2019 and in October 2020, before and during the COVID-19 pandemic, respectively. Compared with those during the 2019 health checkup, the medians of body mass index, systolic blood pressure, and diastolic blood pressure were significantly higher (22.7 kg/m(2) to 23.6 kg/m(2); 110.0 mmHg to 111.0 mmHg; and 73.0 mmHg to 75.0 mmHg, respectively, p<0.05) during the 2020 health checkup. In contrast, urine glucose levels were significantly lower (10.1% to 3.4%, p = 0.021). The lack of physical activity and other inconvenience accumulation caused by the prolonged confinement might have affected their health status. This necessitates local health workers to promote physical activity to prevent health deterioration during the pandemic.	[Kikuchi, Kimiyo; Sato, Yoko; Morokuma, Seiichi] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka, Japan; [Islam, Rafiqul; Nishikitani, Mariko; Nakashima, Naoki] Kyushu Univ Hosp, Med Informat Ctr, Higashi Ku, Fukuoka, Japan; [Islam, Rafiqul; Khan, Nusrat Jahan] Grameen Commun, Global Commun Ctr, Dhaka, Bangladesh; [Sato, Yoko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Integrated Hlth Sci, Minami Ku, Hiroshima, Japan; [Izukura, Rieko] Kyushu Univ, Fac Med Sci, Dept Basic Med, Social Med, Higashi Ku, Fukuoka, Japan; [Yokota, Fumihiko] Kyushu Univ, Inst Asian & Oceanian Studies, Nishi Ku, Fukuoka, Japan; [Nessa, Meherun] Holy Family Red Crescent Med Coll & Hosp, Dhaka, Bangladesh; [Ahmed, Ashir] Kyushu Univ, Fac Informat Sci & Elect Engn, Dept Informat Sci & Technol, Fukuoka, Japan	Kyushu University; Hiroshima University; Kyushu University; Kyushu University; Kyushu University	Kikuchi, K (corresponding author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka, Japan.	kikuchi.kimiyo.715@kyushu-u.ac.jp			Telecommunications Advancement Foundation [JPJSBP120199959, JP21KK0169]	Telecommunications Advancement Foundation(Telecommunications Advancement Foundation)	We acknowledge the contributions of all the participating women and newborns and the staff at Grameen Communications. We would also like to thank Dr. Masuda Begum Sampa, Mr. Mokter Hossain, Ms. Ayesha Begum, as well as the research staff who helped in this study.	Aajal A, 2021, Ann Cardiol Angeiol (Paris), V70, P94, DOI 10.1016/j.ancard.2021.01.006; Ahmed F, 2021, FOOD POLICY, V101, DOI 10.1016/j.foodpol.2021.102066; Alam GMM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248120; [Anonymous], 2020, SOCIAL ISOLATION COV; Bonora BM, 2020, DIABETES THER, V11, P1369, DOI 10.1007/s13300-020-00829-7; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cecchetto C, 2021, APPETITE, V160, DOI 10.1016/j.appet.2021.105122; Cirillo M, 2021, J GYNECOL OBSTET HUM, V50, DOI 10.1016/j.jogoh.2021.102079; Coulthard H, 2021, APPETITE, V161, DOI 10.1016/j.appet.2020.105082; Di Dalmazi G, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001664; Fitbit, IMP COR GLOB ACT; Galali Y, 2021, FOOD SCI NUTR, V9, P2105, DOI 10.1002/fsn3.2179; Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1; Hermassi S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063093; Hossain FB, 2019, CLIN HYPERTENS, V25, DOI 10.1186/s40885-019-0134-8; Jontez NB, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041082; Kikuchi K, 2021, COMPUT METH PROG BIO, V207, DOI 10.1016/j.cmpb.2021.106156; Kreutz R, 2021, J HYPERTENS, V39, P1077, DOI 10.1097/HJH.0000000000002770; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Maffoni S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041117; Matsungo Tonderayi Mathew, 2020, BMJ Nutr Prev Health, V3, P205, DOI 10.1136/bmjnph-2020-000124; Menai M, 2017, HEALTH PROMOT PERSPE, V7, P190, DOI 10.15171/hpp.2017.34; Misra A, 2021, DIABETES METAB SYND, V15, P403, DOI 10.1016/j.dsx.2021.01.018; Nohara Y, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3705; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Ruissen MM, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2020-002035; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Tison GH, 2020, ANN INTERN MED, V173, P767, DOI 10.7326/M20-2665; UNICEF, 2022, WHO COR COVID 19 DAS	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0266141	http://dx.doi.org/10.1371/journal.pone.0266141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560141	gold, Green Published			2022-12-26	WOS:000835326900006
J	Naudin, L; Laredo, JLJ; Liu, Q; Corson, N				Naudin, Lois; Laredo, Juan Luis Jimenez; Liu, Qiang; Corson, Nathalie			Systematic generation of biophysically detailed models with generalization capability for non-spiking neurons	PLOS ONE			English	Article							NEURAL-NETWORK MODEL; DIFFERENTIAL EVOLUTION; PARAMETER-ESTIMATION; LOCAL INTERNEURONS; ACTION-POTENTIALS; ELEGANS; PHOTORECEPTOR; MOTORNEURONS; CONNECTOME; SIMULATION	Unlike spiking neurons which compress continuous inputs into digital signals for transmitting information via action potentials, non-spiking neurons modulate analog signals through graded potential responses. Such neurons have been found in a large variety of nervous tissues in both vertebrate and invertebrate species, and have been proven to play a central role in neuronal information processing. If general and vast efforts have been made for many years to model spiking neurons using conductance-based models (CBMs), very few methods have been developed for non-spiking neurons. When a CBM is built to characterize the neuron behavior, it should be endowed with generalization capabilities (i.e. the ability to predict acceptable neuronal responses to different novel stimuli not used during the model's building). Yet, since CBMs contain a large number of parameters, they may typically suffer from a lack of such a capability. In this paper, we propose a new systematic approach based on multi-objective optimization which builds general non-spiking models with generalization capabilities. The proposed approach only requires macroscopic experimental data from which all the model parameters are simultaneously determined without compromise. Such an approach is applied on three non-spiking neurons of the nematode Caenorhabditis elegans (C. elegans), a well-known model organism in neuroscience that predominantly transmits information through non-spiking signals. These three neurons, arbitrarily labeled by convention as RIM, AIY and AFD, represent, to date, the three possible forms of non-spiking neuronal responses of C. elegans.	[Naudin, Lois; Corson, Nathalie] Normandie Univ, Dept Appl Math, Le Havre, Normandie, France; [Laredo, Juan Luis Jimenez] Normandie Univ, Dept Comp Sci, Le Havre, Normandie, France; [Liu, Qiang] City Univ Hong Kong, Dept Neurosci, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Naudin, L (corresponding author), Normandie Univ, Dept Appl Math, Le Havre, Normandie, France.	lois.naudin@gmail.com	Jimenez Laredo, Juan Luis/F-8359-2014	Jimenez Laredo, Juan Luis/0000-0002-9416-2005; Naudin, Lois/0000-0003-2290-6666; Liu, Qiang/0000-0002-9232-1420	University of Le Havre Normandy; Kavli NSI Pilot Grant; NSF CRCNS grant [2113120]	University of Le Havre Normandy; Kavli NSI Pilot Grant; NSF CRCNS grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was partially supported by the University of Le Havre Normandy (https://www.univ-lehavre.fr/), and by the Kavli NSI Pilot Grant and NSF CRCNS grant (#2113120) to QL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; BRENNER S, 1974, GENETICS, V77, P71; Buhry L, 2008, 2008 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE - INTELLIGENT BIOMEDICAL SYSTEMS (BIOCAS), P173, DOI 10.1109/BIOCAS.2008.4696902; Buhry L, 2011, NEURAL COMPUT, V23, P2599, DOI 10.1162/NECO_a_00170; BURROWS M, 1988, J NEUROSCI, V8, P3085; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Costalago-Meruelo A, 2018, NEUROCOMPUTING, V290, P60, DOI 10.1016/j.neucom.2018.02.024; Das S, 2016, SWARM EVOL COMPUT, V27, P1, DOI 10.1016/j.swevo.2016.01.004; DAVIS RE, 1989, J NEUROSCI, V9, P403; DAVIS RE, 1989, J NEUROSCI, V9, P415; Dayan P, 2001, COMPUTATIONAL NEUROS; Destexhe A, 2012, SPR SER COMPUT NEURO, V8, P1, DOI 10.1007/978-0-387-79020-6; Dobosiewicz M, 2019, ELIFE, V8, DOI 10.7554/eLife.50566; Druckmann S., 2014, COMPUTING DENDRITE P, P465; Druckmann S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002133; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faumont S, 2006, J NEUROPHYSIOL, V95, P3665, DOI 10.1152/jn.00052.2006; Feoktistov V., 2004, Proceedings. 18th International Parallel and Distributed Processing Symposium; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Goaillard JM, 2021, ANNU REV NEUROSCI, V44, P335, DOI 10.1146/annurev-neuro-092920-121538; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Goodman MB, 2012, METHOD CELL BIOL, V107, P409, DOI 10.1016/B978-0-12-394620-1.00014-X; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iavarone E, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006753; Izhikevich E. M., 2007, DYNAMICAL SYSTEMS NE, DOI 10.7551/mitpress/2526.001.0001; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izquierdo Eduardo J., 2019, Current Opinion in Systems Biology, V13, P93, DOI 10.1016/j.coisb.2018.11.003; Kim J, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00008; Koch Christof, 1999, P1; Koch K, 2006, CURR BIOL, V16, P1428, DOI 10.1016/j.cub.2006.05.056; Kopell NJ, 2014, NEURON, V83, P1319, DOI 10.1016/j.neuron.2014.08.016; Kourennyi DE, 2004, J NEUROPHYSIOL, V92, P477, DOI 10.1152/jn.00606.2003; Kunert J, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052805; Kunert JM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005303; Lanza E, 2021, NEUROCOMPUTING, V430, P1, DOI 10.1016/j.neucom.2020.11.067; LAURENT G, 1989, J NEUROSCI, V9, P3019; LAURENT G, 1989, J NEUROSCI, V9, P3030; Le Cun Y., 2019, QUAND MACHINE APPREN; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Liu P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14818; Liu P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6155; Liu Q, 2018, CELL, V175, P57, DOI 10.1016/j.cell.2018.08.018; Lockery SR, 2009, NAT NEUROSCI, V12, P365, DOI 10.1038/nn0409-365; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maertens T, 2021, NEUROCOMPUTING, V427, P238, DOI 10.1016/j.neucom.2020.11.015; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Masoli S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00071; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Naudin L., 2021, HAL03494379; Naudin L., 2020, INT J NEURAL SYST; Nicoletti M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218738; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Olivares E., 2019, BIORXIV; Poirazi P, 2020, NAT REV NEUROSCI, V21, P303, DOI 10.1038/s41583-020-0301-7; Portegys TE, 2015, NEUROCOMPUTING, V168, P128, DOI 10.1016/j.neucom.2015.06.007; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Publio R, 2006, NEUROCOMPUTING, V69, P1020, DOI 10.1016/j.neucom.2005.12.037; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Rakowski F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00128; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Roberts A., 1981, NEURONES IMPULSES TH; Robic T, 2005, LECT NOTES COMPUT SC, V3410, P520; Saha I, 2014, ADV INTEL SOFT COMPU, V242, P529, DOI 10.1007/978-3-319-02309-0_58; Sakata K, 2004, NETWORK-COMP NEURAL, V15, P199, DOI 10.1088/0954-898X/15/3/003; Sakmann B., 2013, SINGLE CHANNEL RECOR; Sarma GP, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0382; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Szigeti B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00137; Wang DJ, 2017, COMPUT OPER RES, V79, P279, DOI 10.1016/j.cor.2016.04.024; Wicks SR, 1996, J NEUROSCI, V16, P4017; Willms AR, 1999, J COMPUT NEUROSCI, V6, P145, DOI 10.1023/A:1008880518515; Zheng MH, 2012, J NEUROSCI METH, V206, P78, DOI 10.1016/j.jneumeth.2012.01.002	78	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268380	10.1371/journal.pone.0268380	http://dx.doi.org/10.1371/journal.pone.0268380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560186	Green Submitted, Green Published, gold			2022-12-26	WOS:000834668000012
J	Smith, TJ; Tardu, M; Khatri, HR; Koutmou, KS				Smith, Tyler J.; Tardu, Mehmet; Khatri, Hem Raj; Koutmou, Kristin S.			mRNA and tRNA modification states influence ribosome speed and frame maintenance during poly(lysine) peptide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOBBLE NUCLEOSIDE MCM(5)S(2)U; ELONGATION-FACTOR TU; ESCHERICHIA-COLI; QUALITY-CONTROL; TRANSLATION; SITE; N-6-METHYLADENOSINE; DEGRADATION; POSITION; TRANSLOCATION	Ribosome speed is dictated by multiple factors including substrate availability, cellular conditions, and product (peptide) formation. Translation slows during the synthesis of cationic peptide sequences, potentially influencing the expression of thousands of proteins. Available evidence suggests that ionic interactions between positively charged nascent peptides and the negatively charged ribosome exit tunnel impede translation. However, this hypothesis was difficult to test directly because of inability to decouple the contributions of amino acid charge from mRNA sequence and tRNA identity/abundance in cells. Furthermore, it is unclear if other components of the translation system central to ribosome function (e.g., RNA modification) influence the speed and accuracy of positively charged peptide synthesis. In this study, we used a fully reconstituted Escherichia coli translation system to evaluate the effects of peptide charge, mRNA sequence, and RNA modifi- cation status on the translation of lysine-rich peptides. Comparison of translation reactions on poly(lysine)-encoding mRNAs conducted with either Lys-tRNA(Lys) or Val-tRNA(Lys) reveals that that amino acid charge, while important, only partially accounts for slowed translation on these transcripts. We further find that in addition to peptide charge, mRNA sequence and both tRNA and mRNA modification status influence the rates of amino acid addition and the ribosome's ability to maintain frame (instead of entering the -2, -1, and +1 frames) during poly(lysine) peptide synthesis. Our observations lead us to expand the model for explaining how the ribosome slows during poly(lysine) peptide synthesis and suggest that posttranscriptional RNA modifications can provide cells a mechanism to precisely control ribosome movements along an mRNA.	[Smith, Tyler J.; Tardu, Mehmet; Khatri, Hem Raj; Koutmou, Kristin S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Tardu, Mehmet] Istanbul Univ, Dept Biol, Istanbul, Turkey	University of Michigan System; University of Michigan; Istanbul University	Koutmou, KS (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	kkoutmou@umich.edu		Koutmou, Kristin/0000-0002-7763-9262	National Institutes of Health (NIGMS ) [R35 GM128836]; Research Corporation for Science Advancement (Cottrell Scholar Award); University of Michigan	National Institutes of Health (NIGMS )(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Corporation for Science Advancement (Cottrell Scholar Award); University of Michigan(University of Michigan System)	National Institutes of Health (NIGMS R35 GM128836) (K. S. K.) ; Research Corporation for Science Advancement (Cottrell Scholar Award) (K. S. K.) ; University of Michigan (start-up funds to K. S. K.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agirrezabala X, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700147; Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bekaert M, 2005, MOL CELL, V17, P61, DOI 10.1016/j.molcel.2004.12.009; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Chiabudini M, 2014, MOL CELL BIOL, V34, P4062, DOI 10.1128/MCB.00799-14; Choi J, 2018, ANNU REV BIOCHEM, V87, P421, DOI 10.1146/annurev-biochem-060815-014818; Choi J, 2016, NAT STRUCT MOL BIOL, V23, P110, DOI 10.1038/nsmb.3148; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Eyler DE, 2019, P NATL ACAD SCI USA, V116, P23068, DOI 10.1073/pnas.1821754116; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Guydosh NR, 2017, RNA, V23, P749, DOI 10.1261/rna.060418.116; Hanson G, 2018, RNA, V24, P1377, DOI 10.1261/rna.066787.118; Hoernes TP, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020084; Hoernes TP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07321-8; Ieong KW, 2021, NUCLEIC ACIDS RES, V49, P2684, DOI 10.1093/nar/gkab033; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Jacobs WM, 2017, P NATL ACAD SCI USA, V114, P11434, DOI 10.1073/pnas.1705772114; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Jones JD, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1586; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Karlsborn T, 2014, BIOCHEM BIOPH RES CO, V454, P441, DOI 10.1016/j.bbrc.2014.10.116; Kim HK, 2017, NUCLEIC ACIDS RES, V45, P2865, DOI 10.1093/nar/gkw1020; Kladwang W, 2020, BIOCHEMISTRY-US, V59, P2154, DOI 10.1021/acs.biochem.0c00020; Klimova M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw9049; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Leininger SE, 2021, BIOCHEMISTRY-US, V60, P3223, DOI 10.1021/acs.biochem.1c00507; Liao PY, 2008, NUCLEIC ACIDS RES, V36, P2619, DOI 10.1093/nar/gkn100; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu B., 2021, NAT COMMUN, V12, P5201; Liu Y, 2021, ANNU REV BIOCHEM, V90, P375, DOI 10.1146/annurev-biochem-071320-112701; Lorenz C, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020035; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Maehigashi T, 2014, P NATL ACAD SCI USA, V111, P12740, DOI 10.1073/pnas.1409436111; Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010; Monroe JG, 2021, METHOD ENZYMOL, V658, P379, DOI 10.1016/bs.mie.2021.06.011; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Ranjan N, 2017, J AM CHEM SOC, V139, P5857, DOI 10.1021/jacs.7b00727; Ranjan N, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1143076; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; ROSENBERG AH, 1993, J BACTERIOL, V175, P716, DOI 10.1128/JB.175.3.716-722.1993; Rozov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10457; Shi H, 2019, J AM CHEM SOC, V141, P19988, DOI 10.1021/jacs.9b10939; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sitron CS, 2020, ANNU REV BIOCHEM, V89, P417, DOI 10.1146/annurev-biochem-013118-110729; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0; Tesina P, 2020, EMBO J, V39, DOI 10.15252/embj.2019103365; Tsai TW, 2017, ACS CHEM BIOL, V12, P1629, DOI 10.1021/acschembio.7b00028; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; Yan SN, 2015, CELL, V160, P870, DOI 10.1016/j.cell.2015.02.003; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Yikilmaz E, 2014, BIOCHEMISTRY-US, V53, P5710, DOI 10.1021/bi500533x; You CJ, 2017, NUCLEIC ACIDS RES, V45, P9059, DOI 10.1093/nar/gkx515; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang Z, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0250	73	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2021	298	6							102039	10.1016/j.jbc.2022.102039	http://dx.doi.org/10.1016/j.jbc.2022.102039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3LM	35595100	Green Published, gold			2022-12-26	WOS:000816919900001
J	Ji, RP; Shi, QQ; Cao, YX; Zhang, JY; Zhao, CC; Zhao, HY; Sayyed, Y; Fu, L; Li, LY				Ji, Renpeng; Shi, Qianqian; Cao, Yixin; Zhang, Jingyue; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Fu, Li; Li, Lu-Yuan			Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; APOPTOSIS	The human rhomboid-5 homolog-1 (RHBDF1) is a multi-transmembrane protein present mainly on the endoplasmic reticulum. RHBDF1 has been implicated in the activation of epidermal growth factor receptor (EGFR)-derived cell growth signals and other activities critical to cellular responses to stressful conditions, but details of this activation mechanism are unclear. Here, we report a RHBDF1 mRNA transcript alternative splicing variant X6 (RHBDF1 X6 or RHX6) that antagonizes RHBDF1 activities. We found that while the RHBDF1 gene is marginally expressed in breast tumor-adjacent normal tissues, it is markedly elevated in the tumor tissues. In sharp contrast, the RHX6 mRNA represents the primary RHBDF1 variant in normal breast epithelial cells and tumor adjacent normal tissues but is diminished in breast cancer cells and tumors. We demonstrate that, functionally, RHX6 acts as an inhibitor of RHBDF1 activities. We show that artificially overexpressing RHX6 in breast cancer cells leads to retarded proliferation, migration, and decreased production of epithelial-mesenchymal transition-related adhesion molecules. Mechanically, RHX6 is able to inhibit the maturation of TACE, a protease that processes pro-TGF alpha, a pro-ligand of EGFR, and to prevent intracellular transportation of pro-TGF alpha to the cell surface. Additionally, we show that the production of RHX6 is under the control of the alternative splicing regulator RNA binding motif protein-4 (RBM4). Our findings suggest that differential splicing of the RHBDF1 gene transcript may have a regulatory role in the development of epithelial cell cancers.	[Ji, Renpeng; Cao, Yixin; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Li, Lu-Yuan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Shi, Qianqian; Zhang, Jingyue; Fu, Li] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Tianjin, Peoples R China; [Ji, Renpeng; Shi, Qianqian; Cao, Yixin; Zhang, Jingyue; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Fu, Li; Li, Lu-Yuan] Nankai Univ, Coll Pharm, Haihe Lab Cell Ecosyst, Tianjin Key Lab Mol Drug Res, Tianjin, Peoples R China	Nankai University; Tianjin Medical University; Nankai University	Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	liluyuan@nankai.edu.cn			National Natural Science Foundation of China, China [81874167, 82073064]; Haihe Laboratory of Cell Ecosystem Innovation Fund	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Haihe Laboratory of Cell Ecosystem Innovation Fund	Funding and addition information-This study was funded in part by grants from the National Natural Science Foundation of China, China (Grants 81874167 and 82073064 to L. Y. L.) and the Haihe Laboratory of Cell Ecosystem Innovation Fund.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; [Anonymous], 2014, CANCER DISCOV, V4, P1253, DOI 10.1158/2159-8290.CD-RW2014-198; Dulloo I, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190003; Freeman M, 2016, BIOCHEM SOC T, V44, P945, DOI 10.1042/BST20160035; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gao S, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00597-1; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kim HK, 2018, PFLUG ARCH EUR J PHY, V470, P995, DOI 10.1007/s00424-018-2136-x; Ladomery Michael, 2013, Int J Cell Biol, V2013, P463786, DOI 10.1155/2013/463786; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep11559; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li J, 2018, EBIOMEDICINE, V36, P229, DOI 10.1016/j.ebiom.2018.09.038; Maney SK, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5356; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Peng XM, 2018, FASEB J, V32, P5577, DOI 10.1096/fj.201800016R; Powles Joshua, 2018, F1000Res, V7, P139, DOI 10.12688/f1000research.13383.2; Qi YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11840; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Su CH, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00466-16; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Wang WY, 2020, MOL GENET GENOMICS, V295, P95, DOI 10.1007/s00438-019-01606-3; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yong HM, 2019, MED SCI MONITOR, V25, P4025, DOI 10.12659/MSM.914513; Yong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28222; Yuan HP, 2018, EXP CELL RES, V368, P24, DOI 10.1016/j.yexcr.2018.04.009; Zhang Y, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5555950; Zhou Z, 2014, CANCER RES, V74, P2719, DOI 10.1158/0008-5472.CAN-13-1027; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	36	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102033	10.1016/j.jbc.2022.102033	http://dx.doi.org/10.1016/j.jbc.2022.102033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35595096	Green Published, gold			2022-12-26	WOS:000829588600009
J	Atuhairwe, S; Gemzell-Danielsson, K; Atuyambe, L; Byamugisha, J; Tumwesigye, NM; Hanson, C				Atuhairwe, Susan; Gemzell-Danielsson, Kristina; Atuyambe, Lynn; Byamugisha, Josaphat; Tumwesigye, Nazarius Mbona; Hanson, Claudia			Exploring health care providers' experiences of and perceptions towards the use of misoprostol for management of second trimester incomplete abortion in Central Uganda	PLOS ONE			English	Article							SEEKING POSTABORTION CARE; PHYSICIANS; MIDWIVES; SAFETY	IntroductionWomen living in low- and middle-income countries still have limited access to quality second trimester post abortion care. We aim to explore health care providers' experiences of and perceptions towards the use of misoprostol for management of second trimester incomplete abortion. MethodsThis qualitative study used the phenomenology approach. We conducted 48 in-depth interviews for doctors and midwives at 14 public health facilities in central Uganda using a flexible interview guide. We used inductive content analysis and made code frequencies based on health care provider cadre, and health facility level and then abstracted themes from categories. ResultsWell trained midwives were perceived as competent to manage second trimester post abortion care stable patients, however doctor's supervision in case of complications was considered important. Sometimes, midwives were seen as offering better care than doctors given their stronger presence in the facilities. Misoprostol received unanimous support and viewed as: safe, effective, cheap, convenient, readily available, maintained patient privacy, and saved resources. Challenges faced included: side effects, prolonged hospital stay, treatment failure, inclination to surgical evacuation, heavy work load, inadequate space, lack of medical commodities, frequent staff rotations which affects the quality of patient care. To address these challenges, respondents coped by: giving patients psychological support, analgesics, close patient monitoring, staff mentorship, commitment to work, team work and patient involvement in care. ConclusionMisoprostol is perceived as an ideal uterine evacuation method for second trimester post abortion care of uncomplicated patients and trained midwives are considered competent managing these patients in a health facility setting with a back-up of a doctor. Health care providers require institutional and policy environment support for improved service delivery.	[Atuhairwe, Susan; Byamugisha, Josaphat] Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda; [Atuhairwe, Susan] Mulago Specialised Women & Neonatal Hosp, Dept Reprod Endocrinol & Infertil, Kampala, Uganda; [Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Atuyambe, Lynn] Makerere Univ Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Hanson, Claudia] Karolinska Inst, Global Publ Hlth, Stockholm, Sweden; [Hanson, Claudia] London Sch Hyg & Trop Med, Dept Dis control, London, England	Makerere University; Karolinska Institutet; Makerere University; Makerere University; Karolinska Institutet; University of London; London School of Hygiene & Tropical Medicine	Atuhairwe, S (corresponding author), Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda.; Atuhairwe, S (corresponding author), Mulago Specialised Women & Neonatal Hosp, Dept Reprod Endocrinol & Infertil, Kampala, Uganda.	atususan96@gmail.com	Visan, Delia/GXW-3349-2022	Atuhairwe, Susan/0000-0001-7904-5655	DELTAS Africa Initiative [DEL-15-011]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107742/Z/15/Z]; UK government	DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome Trust); UK government	This work was supported through the DELTAS Africa Initiative grant # DEL-15-011 to THRiVE-2 for SA. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA)<EM><STRONG> </STRONG></EM>and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust grant # 107742/Z/15/Z and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantjes CJ, 2018, CONTRACEPTION, V98, P77, DOI 10.1016/j.contraception.2018.03.014; [Anonymous], 2022, ABORTION CARE GUIDEL; Atuhairwe S, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-003274; Atuhairwe S, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3490-5; Baine SO, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0282-z; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Bearak J, 2020, LANCET GLOB HEALTH, V8, pE1152, DOI 10.1016/S2214-109X(20)30315-6; Chan WM, 2004, BRIT J OPHTHALMOL, V88, P968, DOI 10.1136/bjo.2003.039461; Cleeve A, 2019, MIDWIFERY, V77, P71, DOI 10.1016/j.midw.2019.06.004; Cleeve A, 2017, CULT HEALTH SEX, V19, P1286, DOI 10.1080/13691058.2017.1310297; Cleeve A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149172; Consortium PCP, PAC MODEL 2015; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Dah Talemoh, 2011, Afr J Reprod Health, V15, P42; Dahlgren L., 2004, QUALITATIVE METHODOL, DOI 10.1016/j.socscimed.2003.10.033; Dawson AJ, 2014, HEALTH POLICY PLANN, V29, P396, DOI 10.1093/heapol/czt026; Faundes A, 2020, BEST PRACT RES CL OB, V62, P101, DOI 10.1016/j.bpobgyn.2019.05.016; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Klingberg-Allvin M, 2015, LANCET, V385, P2392, DOI 10.1016/S0140-6736(14)61935-8; Kristiansen MB, 2021, ACTA OBSTET GYN SCAN, V100, P718, DOI 10.1111/aogs.14134; Loi UR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1502-2; Makenzius M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016157; Maternowska MC, 2015, REPROD HEALTH MATTER, V22, P16, DOI 10.1016/S0968-8080(14)43792-3; Ministry of Health U, 2011, REPROD HLTH DIVISION, VFourth; Ministry of Health Uganda, MED HLTH SERV DEL MO; Ngalame A, 2020, OPEN J OBSTET GYNECO, V10, P1295, DOI [10.4236/ojog.2020.1090119, DOI 10.4236/OJOG.2020.1090119]; Nkomazana O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135846; Nteziyaremye J., 2020, PRIMARY HLTH CARE OP, V10, P1; Osur J, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19649; Owolabi OO, 2019, LANCET GLOB HEALTH, V7, pE110, DOI 10.1016/S2214-109X(18)30404-2; Paul M, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.30283; Paul M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-28; Prada E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165812; Samnani AABA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0383-5; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schmiedhofer M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030915; statista, US; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Uganda Bureau of Statistics (UBOS), 2017, UG DEM HLTH SURV 201; USAID, 2012, POSTABORTION FAMILY; White Joanna, 2018, Etnográfica, V22, P643, DOI 10.4000/etnografica.6041; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268812	10.1371/journal.pone.0268812	http://dx.doi.org/10.1371/journal.pone.0268812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3R0QK	35587492	Green Accepted, gold, Green Published			2022-12-26	WOS:000838625000005
J	Ben-Sasson, A; Jacobs, K; Ben-Sasson, E				Ben-Sasson, Ayelet; Jacobs, Kayla; Ben-Sasson, Eli			The feasibility of a crowd-based early developmental milestone tracking application	PLOS ONE			English	Article							YOUNG-CHILDREN; DISORDERS; DELAYS	ObjectiveParents' tracking of developmental milestones can assist healthcare providers with early detection of developmental delays and appropriate referrals to early intervention. Crowdsourcing is one way to update the content and age data distribution of developmental checklists for parents and providers. This feasibility study examined which developmental milestones parents chose to track and what they added beyond traditional milestones, using the babyTRACKS crowd-based mobile app. MethodWe analyzed the developmental diaries of 3,832 children, registered in the babyTRACKS app at an average age of 9.3 months. Their parents recorded a median of 5 milestones per diary, selecting from the accumulating lists of age-appropriate milestones or authoring new milestones. The final database included 645 types of milestones; 89.15% were developmental, of which 43.6% were comparable to the Centers for Disease Control (CDC) milestones while the rest were crowd-authored. Milestones were categorized into developmental domains: Gross Motor, Fine Motor, Oral Motor, Self-Care, Cognitive, Language Comprehension, Speech, Non-Verbal Communication, Social, Emotional, and Regulation. ResultsOn average, the milestone domains of Gross Motor, Fine Motor, Cognitive and Social were the most added to diaries (20%-30% of a diary). Within the Cognitive, Speech and Language Comprehension domains there were significantly more CDC comparable versus crowd-authored milestones (29% versus 21%, 22% versus 10%, 8% versus 4%). In contrast, within the Regulation and Oral Motor domains there were more crowd versus CDC milestones (17% versus 3%, 9% versus 3%). Crowd-authored Speech milestones were significantly older by 7 months than CDC milestones. ConclusionTracking daily observations of child development provides a window into personally relevant milestones for the child and parent. The crowd of parents can independently track and add new milestones across main developmental domains. Regulation and Oral Motor development especially interest parents. Parents may be less aware of early progress in Language Comprehension and Speech; thus, these domains require more structured screening. Designing mobile early screening which is crowd-based engages parents as proactive partners in developmental tracking.	[Ben-Sasson, Ayelet] Univ Haifa, Fac Social Welf & Hlth Sci, Occupat Therapy Dept, Haifa, Israel; [Jacobs, Kayla] Technion, Fac Comp Sci, Haifa, Israel; [Ben-Sasson, Eli] StarkWare Ind Ltd, Netanya, Israel	University of Haifa; Technion Israel Institute of Technology	Ben-Sasson, A (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Occupat Therapy Dept, Haifa, Israel.	asasson@univ.haifa.ac.il		Ben-Sasson, Ayelet/0000-0003-2677-9414	Israeli Science Foundation [1501/14, 1435/18]; US-Israel Binational Science Foundation [2014-359]	Israeli Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	We thank the team members for their contribution to the babyTRACKS system project: Gal Agmon, Moriah Anouchi, Daniel Moran, Eden Saig, Naama Tzur, and Yocheved Zaltz.	[Anonymous], 2014, INTERACTIONS, DOI DOI https://doi.org/10.1145/2591689; Bagner DM, 2012, CLIN CHILD FAM PSYCH, V15, P113, DOI 10.1007/s10567-012-0110-2; Baker J, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/16085; Ben-Sasson A, P 2019 CHI C HUMAN F, P1; Ben-Sasson A, 2017, P 11 EAI INT C PERV, P110; Ben-Sasson A, 2020, HEALTH TECHNOL-GER, V10, P1079, DOI 10.1007/s12553-020-00457-y; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Brosch A., 2016, CHILD IS BORN INTERN, V43, P225, DOI [DOI 10.15804/TNER.2016.43.1.19, 10.15804/tner.2016.43.1.19]; cdc, CDCS DEV MIL; Crequit P, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9330; DeGangi GA, 2000, INF MENTAL HLTH J, V21, P156, DOI 10.1002/1097-0355(200007)21:3<156::AID-IMHJ2>3.0.CO;2-D; Dosman C, 2012, PAED CHILD HEALT-CAN, V17, P75, DOI 10.1093/pch/17.2.75; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Einboden R, 2013, HEALTH-LONDON, V17, P549, DOI 10.1177/1363459312472081; Glascoe F.P., 2011, PSYCHOL TEST ASSESSM, V53, P258; Glascoe FP., 2007, HDB INTELLECTUAL DEV, P353; Hagan J, 2017, BRIGHT FUTURES GUIDE; Johnson PR, 2019, JMIR PEDIATR PARENT, V2, DOI 10.2196/10814; Kanne SM, 2018, AUTISM RES, V11, P1038, DOI 10.1002/aur.1959; Kientz JA, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1713; Kitsao-Wekulo P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254621; Latipah E., 2020, UNIVERSAL J ED RES, V8, P4807, DOI [4817.10.13189/ujer.2020.081052, DOI 10.13189/UJER.2020.081052]; Lipkin PH, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3449; Maleka BK, 2016, TELEMED E-HEALTH, V22, P1013, DOI 10.1089/tmj.2016.0007; Moon RY, 2019, J MED INTERNET RES, V21, DOI 10.2196/14289; Morelli DL, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-16; Peacock-Chambers E, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1661; Pool JL, 2011, EDUC TRAIN AUTISM DE, V46, P267; Raspa M, 2015, J DEV BEHAV PEDIATR, V36, P575, DOI 10.1097/DBP.0000000000000205; Saldivar J, 2016, 2016 INTERNATIONAL CONFERENCE ON COLLABORATION TECHNOLOGIES AND SYSTEMS (CTS), P81, DOI [10.1109/CTS.2016.0033, 10.1109/CTS.2016.31]; Sand N, 2005, PEDIATRICS, V116, P174, DOI 10.1542/peds.2004-1809; Schmuckler MA, 2001, INFANCY, V2, P419, DOI 10.1207/S15327078IN0204_02; Sheldrick RC, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0374; Shelov SP, 2004, CARING YOUR BABY YOU; Sices L, 2003, J DEV BEHAV PEDIATR, V24, P409, DOI 10.1097/00004703-200312000-00002; Sices L., 2007, DEVELOPMENTAL SCREEN; Squires J., 2002, AGES STAGES QUESTION; Suh H, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P2279, DOI 10.1145/2556288.2557386; Thelen E, 2005, PSYCHOANAL DIALOGUES, V15, P255, DOI 10.1080/10481881509348831; Wazny K, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010502; Weitzman C, 2015, PEDIATRICS, V135, P384, DOI 10.1542/peds.2014-3716; Wilkinson CL, 2019, J DEV BEHAV PEDIATR, V40, P511, DOI 10.1097/DBP.0000000000000695	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268548	http://dx.doi.org/10.1371/journal.pone.0268548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617244	Green Published, gold			2022-12-26	WOS:000835048800049
J	de Souza, APG; Mota, CMD; Rosa, AGF; de Figueiredo, CJJ; Candeias, ALB				de Souza, Arthur Pimentel Gomes; Mota, Caroline Maria de Miranda; Rosa, Amanda Gadelha Ferreira; de Figueiredo, Ciro Jose Jardim; Candeias, Ana Lucia Bezerra			A spatial-temporal analysis at the early stages of the COVID-19 pandemic and its determinants: The case of Recife neighborhoods, Brazil	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; STATE	The outbreak of COVID-19 has led to there being a worldwide socio-economic crisis, with major impacts on developing countries. Understanding the dynamics of the disease and its driving factors, on a small spatial scale, might support strategies to control infections. This paper explores the impact of the COVID-19 on neighborhoods of Recife, Brazil, for which we examine a set of drivers that combines socio-economic factors and the presence of non-stop services. A three-stage methodology was conducted by conducting a statistical and spatial analysis, including clusters and regression models. COVID-19 data were investigated concerning ten dates between April and July 2020. Hotspots of the most affected regions and their determinant effects were highlighted. We have identified that clusters of confirmed cases were carried from a well-developed neighborhood to socially deprived areas, along with the emergence of hotspots of the case-fatality rate. The influence of age-groups, income, level of education, and the access to essential services on the spread of COVID-19 was also verified. The recognition of variables that influence the spatial spread of the disease becomes vital for pinpointing the most vulnerable areas. Consequently, specific prevention actions can be developed for these places, especially in heterogeneous cities.	[de Souza, Arthur Pimentel Gomes; Mota, Caroline Maria de Miranda; Rosa, Amanda Gadelha Ferreira] Univ Fed Pernambuco, Programa Posgrad Engn Prod, Recife, PE, Brazil; [Mota, Caroline Maria de Miranda] Univ Fed Pernambuco, Dept Engn Prod, Recife, PE, Brazil; [de Figueiredo, Ciro Jose Jardim] Univ Fed Rural Semi Arido, Dept Engn, Angicos, RN, Brazil; [Candeias, Ana Lucia Bezerra] Univ Fed Pernambuco, Dept Engn Cartograf, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal Rural do Semi-Arido (UFERSA); Universidade Federal de Pernambuco	Mota, CMD (corresponding author), Univ Fed Pernambuco, Programa Posgrad Engn Prod, Recife, PE, Brazil.; Mota, CMD (corresponding author), Univ Fed Pernambuco, Dept Engn Prod, Recife, PE, Brazil.	caroline.mota@ufpe.br		Candeias, Ana/0000-0002-9021-7603; Figueiredo, Ciro/0000-0002-0442-7939; Pimentel Gomes de Souza, Arthur/0000-0002-4745-6713; Rosa, Amanda Gadelha Ferreira/0000-0001-5466-8055	Universidade Federal de Pernambuco [UFPE- 06/2020]	Universidade Federal de Pernambuco	This research was partially supported by the Universidade Federal de Pernambuco (UFPE-06/2020) (website: https://www.ufpe.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Al Kindi KM, 2021, GEOSPATIAL HEALTH, V16, P145, DOI 10.4081/gh.2021.985; Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3; Ali T, 2021, J RISK RES, V24, P416, DOI 10.1080/13669877.2021.1881991; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Atinc G, 2012, ORGAN RES METHODS, V15, P57, DOI 10.1177/1094428110397773; Bambra Clare, 2020, J Epidemiol Community Health, V74, P964, DOI 10.1136/jech-2020-214401; Bartsch SM, 2021, AM J PREV MED, V60, P605, DOI 10.1016/j.amepre.2021.01.001; Boivin R, 2013, CAN J CRIMINOL CRIM, V55, P263, DOI 10.3138/cjccj.2012-E-06; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Buckingham-Jeffery E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4372-y; de Lima EEC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246808; Castro MC, 2021, SCIENCE, V372, P821, DOI 10.1126/science.abh1558; Chatterjee S., 2015, REGRESSION ANAL EXAM; Cuadros DF, 2020, HEALTH PLACE, V64, DOI 10.1016/j.healthplace.2020.102404; da Silva CFA., 2020, REV BRAS GEST O DESE, V16, P346; de Lima J, 2017, TRANSP RES PROC, V25, DOI 10.1016/j.trpro.2017.05.250; Quinino LRD, 2021, CIENC SAUDE COLETIVA, V26, P2171, DOI 10.1590/1413-81232021266.00642021; de Waal T, 2020, INT STAT REV, V88, P203, DOI 10.1111/insr.12352; Fatima M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052336; Fischer MM, 2011, SPRINGERBR REG SCI, P1, DOI 10.1007/978-3-642-21720-3; Florindo AA, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10123-7; Francis SS, 2020, EPIDEMIOLOGY, V31, P214, DOI 10.1097/EDE.0000000000001121; de Souza CDF, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00743-x; G1, 2020, G1; Gao YD, 2021, ALLERGY, V76, P428, DOI 10.1111/all.14657; Garcia MLT, 2021, QUAL SOC WORK, V20, P356, DOI 10.1177/1473325020981753; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gomes DS, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001843; Huang XC, 2021, GEOHEALTH, V5, DOI 10.1029/2020GH000358; Huang ZC, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10080519; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; IBGE, 2016, CENS 2010; IBGE, 2020, CID EST; Iyanda AE, 2020, J INFECT PUBLIC HEAL, V13, P1438, DOI 10.1016/j.jiph.2020.07.006; JENKS GF, 1971, ANN ASSOC AM GEOGR, V61, P217, DOI 10.1111/j.1467-8306.1971.tb00779.x; Kameda K, 2021, CAD SAUDE PUBLICA, V37, DOI [10.1590/0102-311X00277420, 10.1590/0102-311x00277420]; Kang JY, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00229-x; Kerr L, 2020, CIENC SAUDE COLETIVA, V25, P4099, DOI 10.1590/1413-812320202510.2.28642020; Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Kwok CYT, 2021, SCI TOTAL ENVIRON, V764, DOI 10.1016/j.scitotenv.2020.144455; Lak A, 2021, SUSTAIN CITIES SOC, V72, DOI 10.1016/j.scs.2021.103034; Li B, 2021, SUSTAIN CITIES SOC, V66, DOI 10.1016/j.scs.2020.102685; Li MX, 2021, J BUS RES, V126, P472, DOI 10.1016/j.jbusres.2020.12.037; Liu C, 2021, SUSTAIN CITIES SOC, V74, DOI 10.1016/j.scs.2021.103144; Lyu JL, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109842; Ma Q., 2021, BMC INFECT DIS, V21, P1, DOI [10.1186/s12879-020-05706-z, DOI 10.1186/S12879-020-05706-Z]; Maiti A, 2021, SUSTAIN CITIES SOC, V68, DOI 10.1016/j.scs.2021.102784; Mansour S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102627; Middya AI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86987-5; Moore JP, 2021, JAMA-J AM MED ASSOC, V325, P821, DOI 10.1001/jama.2021.1114; Bermudi PMM, 2021, TRAVEL MED INFECT DI, V39, DOI 10.1016/j.tmaid.2020.101945; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Oluyomi AO, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041495; Pereira DVS, 2017, INT J OFFENDER THER, V61, P1570, DOI 10.1177/0306624X15623282; Pereira DVE, 2016, SOC INDIC RES, V125, P19, DOI 10.1007/s11205-014-0836-y; PHS, 2020, PERN COV 19; PNUD, IDHM MUN 2010; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, VVolume 5, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Roberts KA, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.598400; SEPLAG, 2020, COVID 19 MUND BRAS P; Shi X, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/29693; Siddiqi HK, 2021, TRENDS CARDIOVAS MED, V31, P1, DOI 10.1016/j.tcm.2020.10.005; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; Sigler T, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00707-2; Silverman B. W., 1986, DENSITY ESTIMATION S, DOI DOI 10.1007/978-1-4899-3324-9; Simsek S, 2021, OMEGA-INT J MANAGE S, V100, DOI 10.1016/j.omega.2020.102296; SIS, 2020, SINT IND SOC 2020; Sun YR, 2021, SCI TOTAL ENVIRON, V758, DOI 10.1016/j.scitotenv.2020.143595; Vantaggi B, 2008, INT J APPROX REASON, V49, P701, DOI 10.1016/j.ijar.2008.07.005; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang JJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147561; Weinstein B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020604; Wheeler DC., 2010, GEOGRAPHICALLY WEIGH, P461; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Wu X, 2021, ENVIRON SCI POLLUT R, V28, P43732, DOI 10.1007/s11356-021-13653-8; Xiong YZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113903; Yao YP, 2021, INT J HEALTH GEOGR, V20, DOI 10.1186/s12942-021-00270-4; Yu XH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145246; Zheng AR, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10090627	82	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268538	10.1371/journal.pone.0268538	http://dx.doi.org/10.1371/journal.pone.0268538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580093	gold, Green Published			2022-12-26	WOS:000886501700007
J	Denk, J; Burmester, A; Kandziora, M; Clement, M				Denk, Janis; Burmester, Alexa; Kandziora, Michael; Clement, Michel			The impact of COVID-19 on music consumption and music spending	PLOS ONE			English	Article							RECORDED MUSIC; VARIABLES; ONLINE	COVID-19 induced restrictions ordered by governments around the world have been an exogenous shock to the music industry, which we divide into two affected groups: 1) live music events and 2) recorded music. While the impact on live music events is rather obvious, it is unclear how the current pandemic is affecting the recorded music market. Hence, we study consumers' pre- and post-pandemic shifts in consumer spending (in euros) and music consumption (in hours) across live music events, as well as the digital and physical submarkets of recorded music, in the world's fourth largest music market, Germany. Relying on an online bi-annual panel capturing five waves between winter 2018/19 and winter 2020/21, we find that the COVID-19 pandemic is accelerating the continuous trend towards digitalization of the music landscape with premium streaming being the biggest beneficiary. However, total monthly consumer spending on music decreased by more than 45% compared to pre-pandemic, with live music events and physical sales being the most severely affected. Surprisingly, music consumption in hours also decreased during the lockdown even though consumers spent more time at home.	[Denk, Janis; Burmester, Alexa; Kandziora, Michael; Clement, Michel] Univ Hamburg, Inst Mkt, Hamburg Business Sch, Hamburg, Germany; [Burmester, Alexa] Kuhne Logist Univ, Dept Leadership & Management, Hamburg, Germany	University of Hamburg; Kuhne Logistics University	Clement, M (corresponding author), Univ Hamburg, Inst Mkt, Hamburg Business Sch, Hamburg, Germany.	michel.clement@uni-hamburg.de	Burmester, Alexa/AAG-4462-2020; Clement, Michel/GQQ-1785-2022	Burmester, Alexa B./0000-0001-5000-688X; Clement, Michel/0000-0001-6769-6709	City of Hamburg	City of Hamburg	City of Hamburg and all major music initiatives in Germany Musikstudie Mr. Michael Kandziora	Aguiar L, 2016, INF ECON POLICY, V34, P27, DOI 10.1016/j.infoecopol.2016.01.003; Aly-Tovar R, 2020, J CULT ECON, V44, P255, DOI 10.1007/s10824-019-09358-z; BAMF, 2020, ASYL MIGRATION INTEG; Bello P, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00855-1; Black GC, 2007, POP MUSIC SOC, V30, P149, DOI 10.1080/03007760701267698; Bundeszentrale fur politische Bildung, 2020, KATH EV KIRCH NACH B; BVMI, 2018, BUNDESVERBAND MUSIKI; Cabedo-Mas A, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.606180; Carlson E, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.647756; Clarke PM, 2008, J HEALTH ECON, V27, P1275, DOI 10.1016/j.jhealeco.2008.05.012; Clement M., 2021, STUDIE ZUKUNFT MUSIK; Datta H, 2018, MARKET SCI, V37, P5, DOI 10.1287/mksc.2017.1051; Economist The., 2020, ECONOMIST 0327; FEDERACAO INTERNACIONAL DA INDUSTRIA FONOGRAFICA (IFPI), 2020, GLOB MUS REP 2020; Federal Association of the Events Industry, 2017, BDV; Fink LK, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00858-y; Hall, 2020, WORLD EC FORUM; HALVORSEN R, 1980, AM ECON REV, V70, P474; Handke C, 2016, J CULT ECON, V40, P227, DOI 10.1007/s10824-015-9251-8; Handke C, 2012, INF ECON POLICY, V24, P15, DOI 10.1016/j.infoecopol.2012.01.009; Hurwitz ER, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.648413; IFPI, 2021, ENG MUS; Kubler R, 2021, J CULT ECON, V45, P295, DOI 10.1007/s10824-020-09391-3; Leight E., 2020, ROLLING STONE 0330; Maarten Buis, 2017, FMLOGIT STAT MOD FIT; Magaudda P, 2011, J CONSUM CULT, V11, P15, DOI 10.1177/1469540510390499; Mayfield G., 2020, VARIETY 0327; Millman E, 2020, ROLLING STONE 0318; Montoro-Pons JD, 2011, J CULT ECON, V35, P19, DOI 10.1007/s10824-010-9130-2; Mullahy John, 2015, J Econom Method, V4, P71, DOI 10.1515/jem-2012-0006; Nguyen GD, 2014, J CULT ECON, V38, P315, DOI 10.1007/s10824-013-9208-8; OECD, 2020, OECD EC OUTLOOK, DOI [10.1787/34ffc900-en, DOI 10.1787/34FFC900-EN]; OECD, 2020, TERRITORIAL IMPACT C, DOI DOI 10.1787/0CCAFA0B-EN; Papies D, 2011, J ACAD MARKET SCI, V39, P777, DOI 10.1007/s11747-010-0230-5; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; PwC, 2019, GERM ENT MED OUTL 20; Rewindo, 2014, BUNDESVERBAND MUSIKI; Sachs Goldman., 2020, GOLDMAN SACHS EQUITY; Sim J, 2022, MARKET SCI, V41, P19, DOI 10.1287/mksc.2021.1321; STIGLER GJ, 1977, AM ECON REV, V67, P76; UN Regional Information Centre, 2021, RAD PROV SOL COVID 1; Vandenberg F, 2021, EUR SOC, V23, pS141, DOI 10.1080/14616696.2020.1818271; Varadi J, 2021, CENTRAL EUROPEAN J E, V3, P1, DOI [10.37441/cejer/2021/3/1/9345, DOI 10.37441/CEJER/2021/3/1/9345]; Waldfogel J, 2012, J LAW ECON, V55, P715, DOI 10.1086/665824; Yeung T.Y.-C., 2020, COVID EC VETTED REAL, P154, DOI [10.2139/ssrn.3678606, DOI 10.2139/SSRN.3678606]; Ziv N, 2022, PSYCHOL MUSIC, V50, P475, DOI 10.1177/03057356211003326	46	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0267640	http://dx.doi.org/10.1371/journal.pone.0267640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560113	Green Published, gold			2022-12-26	WOS:000835326900014
J	Garcon, A; Vexler, J; Budker, D; Kramer, S				Garcon, Antoine; Vexler, Julian; Budker, Dmitry; Kramer, Stefan			Deep neural networks to recover unknown physical parameters from oscillating time series	PLOS ONE			English	Article							UNCERTAINTY	Deep neural networks are widely used in pattern-recognition tasks for which a human-comprehensible, quantitative description of the data-generating process, cannot be obtained. While doing so, neural networks often produce an abstract (entangled and non-interpretable) representation of the data-generating process. This may be one of the reasons why neural networks are not yet used extensively in physics-experiment signal processing: physicists generally require their analyses to yield quantitative information about the system they study. In this article we use a deep neural network to disentangle components of oscillating time series. To this aim, we design and train the neural network on synthetic oscillating time series to perform two tasks: a regression of the signal latent parameters and signal denoising by an Autoencoder-like architecture. We show that the regression and denoising performance is similar to those of least-square curve fittings with true latent-parameters initial guesses, in spite of the neural network needing no initial guesses at all. We then explore various applications in which we believe our architecture could prove useful for time-series processing, when prior knowledge is incomplete. As an example, we employ the neural network as a preprocessing tool to inform the least-square fits when initial guesses are unknown. Moreover, we show that the regression can be performed on some latent parameters, while ignoring the existence of others. Because the Autoencoder needs no prior information about the physical model, the remaining unknown latent parameters can still be captured, thus making use of partial prior knowledge, while leaving space for data exploration and discoveries.	[Garcon, Antoine; Vexler, Julian; Budker, Dmitry; Kramer, Stefan] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Garcon, Antoine; Budker, Dmitry] GSI Helmholtzzentrum Schwerionenforsch GmbH, Helmholtz Inst, Mainz, Germany; [Budker, Dmitry] Univ Calif Berkeley, Dept Phys, Berkeley, CA USA	Johannes Gutenberg University of Mainz; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; University of California System; University of California Berkeley	Garcon, A (corresponding author), Johannes Gutenberg Univ Mainz, Mainz, Germany.; Garcon, A (corresponding author), GSI Helmholtzzentrum Schwerionenforsch GmbH, Helmholtz Inst, Mainz, Germany.	garcon@uni-mainz.de		Vexler, Julian/0000-0002-8336-1447	Cluster of Excellence PRISMA+ - German Research Foundation (DFG) within the German Excellence Strategy [39083149]; European Research Council (ERC) [695405]; DFG Reinhart Koselleck project; Emergent AI Center; Carl-Zeiss-Stiftung	Cluster of Excellence PRISMA+ - German Research Foundation (DFG) within the German Excellence Strategy(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); DFG Reinhart Koselleck project(German Research Foundation (DFG)); Emergent AI Center; Carl-Zeiss-Stiftung	This work was supported in part by the Cluster of Excellence PRISMA+ funded by the German Research Foundation (DFG) within the German Excellence Strategy (Project ID 39083149), by the European Research Council (ERC) under the European Union Horizon 2020 research and innovation program (project Dark-OST, grant agreement No 695405), and by the DFG Reinhart Koselleck project. A.G. acknowledges funding from the Emergent AI Center funded by the Carl-Zeiss-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54119-9; Bishop Christopher M., 2006, PATTERN RECOGNITION; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; D'Agnolo RT, 2019, PHYS REV D, V99, DOI 10.1103/PhysRevD.99.015014; Daw A, ARXIV171011431; Ding YK, 2020, IEEE COMPUT SOC CONF, P22, DOI 10.1109/CVPRW50498.2020.00010; Farina M, 2020, PHYS REV D, V101, DOI 10.1103/PhysRevD.101.075021; Gao SY, 2019, PR MACH LEARN RES, V89; Garcon A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4539; Gondara L, 2016, INT CONF DAT MIN WOR, P241, DOI [10.1109/ICDMW.2016.102, 10.1109/ICDMW.2016.0041]; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guest D, 2018, ANNU REV NUCL PART S, V68, P161, DOI 10.1146/annurev-nucl-101917-021019; Hanin B., 2018, ADV NEURAL INFORM PR, P582; Higgins Irina, 2017, INT C LEARN REPR ICL, P1; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Kabir HMD, 2018, IEEE ACCESS, V6, P36218, DOI 10.1109/ACCESS.2018.2836917; Kasiviswanathan KS, 2017, STOCH ENV RES RISK A, V31, P1659, DOI 10.1007/s00477-016-1369-5; Li T, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P292; Maas AL, 2017, COMPUT SPEECH LANG, V41, P195, DOI 10.1016/j.csl.2016.06.007; Masia-Roig H, 2020, PHYS DARK UNIVERSE, V28, DOI 10.1016/j.dark.2020.100494; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; Strutz T., 2016, DATA FITTING UNCERTA; Tremblay J, 2018, IEEE COMPUT SOC CONF, P1082, DOI 10.1109/CVPRW.2018.00143; Ver Steeg G, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P5151; Worswick SG, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5218; Wu T, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.191302	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268439	10.1371/journal.pone.0268439	http://dx.doi.org/10.1371/journal.pone.0268439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560322	Green Submitted, Green Published, gold			2022-12-26	WOS:000834668000009
J	Gomes, MT; Palasiewicz, K; Gadiyar, V; Lahey, K; Calianese, D; Birge, RB; Ucker, DS				Gomes, Marta T.; Palasiewicz, Karol; Gadiyar, Varsha; Lahey, Kevin; Calianese, David; Birge, Raymond B.; Ucker, David S.			Phosphatidylserine externalization by apoptotic cells is dispensable for specific recognition leading to innate apoptotic immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMPAIRED UPTAKE; NECROTIC CELLS; MICE LACKING; CLEARANCE; DEATH; MACROPHAGES; PHAGOCYTOSIS; CASPASES; INDUCTION	Surface determinants newly expressed by apoptotic cells that are involved in triggering potent immunosuppressive responses, referred to as "innate apoptotic immunity (IAI)" have not been characterized fully. It is widely assumed, often implicitly, that phosphatidylserine, a phospholipid normally cloistered in the inner leaflet of cells and externalized specifically during apoptosis, is involved in triggering IAI, just as it plays an essential role in the phagocytic recognition of apoptotic cells. It is notable, however, that the triggering of IAI in responder cells is not dependent on the engulfment of apoptotic cells by those responders. Contact between the responder and the apoptotic target, on the other hand, is necessary to elicit IAI. Previously, we demonstrated that exposure of protease-sensitive determinants on the apoptotic cell surface are essential for initiating IAI responses; exposed glycolytic enzyme molecules were implicated in particular. Here, we report our analysis of the involvement of externalized phosphatidylserine in triggering IAI. To analyze the role of phosphatidylserine, we employed a panel of target cells that either externalized phosphatidylserine constitutively, independently of apoptosis, or did not, as well as their WT parental cells that externalized the phospholipid in an apoptosis-dependent manner. We found that the externalization of phosphatidylserine, which can be fully uncoupled from apoptosis, is neither sufficient nor necessary to trigger the profound immunomodulatory effects of IAI. These results reinforce the view that apoptotic immunomodulation and phagocytosis are dissociable and further underscore the significance of protein determinants localized to the cell surface during apoptosis in triggering innate apoptotic immunity.	[Gomes, Marta T.; Palasiewicz, Karol; Ucker, David S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Gadiyar, Varsha; Lahey, Kevin; Calianese, David; Birge, Raymond B.] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Ucker, David S.] Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Indianapolis, IN 46202 USA; [Palasiewicz, Karol] Loyola Univ, Stritch Sch Med, Dept Surg, Maywood, IL 60153 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Loyola University Chicago	Ucker, DS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.; Ucker, DS (corresponding author), Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Indianapolis, IN 46202 USA.	duck@uic.edu		Lahey, Kevin/0000-0002-9105-4471	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program [201923/2014-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M. T. G. received support from a fellowship (No. 201923/2014-9) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bozelli JC, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183241; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chang SH, 2002, EXP CELL RES, V277, P15, DOI 10.1006/excr.2002.5539; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Davies SP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00044; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferguson TA, 2003, IMMUNOL REV, V193, P111, DOI 10.1034/j.1600-065X.2003.00042.x; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Giampazolias E, 2017, NAT CELL BIOL, V19, P1116, DOI 10.1038/ncb3596; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Ke FFS, 2018, CELL, V173, P1217, DOI 10.1016/j.cell.2018.04.036; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Legrand AJ, 2019, MOL CELL, V76, P232, DOI 10.1016/j.molcel.2019.09.006; Lorent JH, 2020, NAT CHEM BIOL, V16, P644, DOI 10.1038/s41589-020-0529-6; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; McArthur K, 2018, TRENDS CELL BIOL, V28, P475, DOI 10.1016/j.tcb.2018.02.003; McDonald PP, 1999, J IMMUNOL, V163, P6164; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2021, CURR OPIN IMMUNOL, V68, P1, DOI 10.1016/j.coi.2020.07.007; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Pattabiraman G, 2017, AGING CELL, V16, P585, DOI 10.1111/acel.12589; Pattabiraman G, 2017, MICROB PATHOGENESIS, V105, P218, DOI 10.1016/j.micpath.2017.02.036; Pattabiraman G, 2016, MECH AGEING DEV, V157, P44, DOI 10.1016/j.mad.2016.07.008; Penberthy KK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15191-1; Powers MJ, 2019, P NATL ACAD SCI USA, V116, P17147, DOI 10.1073/pnas.1902026116; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; TUCKER KA, 1987, BLOOD, V70, P372; Ucker DS, 2016, CELL DEATH DIFFER, V23, P990, DOI 10.1038/cdd.2016.17; Ucker DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00241; Ucker DS, 2012, J BIOL CHEM, V287, P10325, DOI 10.1074/jbc.M111.314971; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	78	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102034	10.1016/j.jbc.2022.102034	http://dx.doi.org/10.1016/j.jbc.2022.102034			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35588784	gold, Green Published			2022-12-26	WOS:000818686700001
J	Sairin, MA; Abd Aziz, S; Mun, CY; Khaled, AY; Rokhani, FZ				Amat Sairin, Masyitah; Abd Aziz, Samsuzana; Yoke Mun, Chan; Khaled, Alfadhl Yahya; Rokhani, Fakhrul Zaman			Analysis and prediction of the major fatty acids in vegetable oils using dielectric spectroscopy at 5-30 MHz	PLOS ONE			English	Article							INFRARED-SPECTROSCOPY; EDIBLE OILS; OLIVE OIL; DIFFERENTIATION; LARD; PALM; BEEF; FTIR	A dielectric spectroscopy method was applied to determine major fatty acids composition in vegetable oils. Dielectric constants of vegetable oils were measured in the frequency range of 5-30 MHz. After data pre-treatment, prediction models were constructed using partial least squares (PLS) regression between dielectric spectral values and the fatty acids compositions measured by gas chromatography. Generally, the root means square error of validation (RMSECV) was less than 11.23% in the prediction of individual fatty acids. The determination coefficient (R-2) between predicted and measured oleic, linoleic, mono-unsaturated, and poly-unsaturated fatty acids were 0.84, 0.77, 0.84, and 0.84, respectively. These results indicated that dielectric spectroscopy coupled with PLS regression could be a promising method for predicting major fatty acid composition in vegetable oils and has the potential to be used for in-situ monitoring systems of daily consumption of dietary fatty acids.	[Amat Sairin, Masyitah; Abd Aziz, Samsuzana; Rokhani, Fakhrul Zaman] Univ Putra Malaysia UPM, Fac Engn, Serdang, Selangor, Malaysia; [Abd Aziz, Samsuzana] Univ Putra Malaysia UPM, Smart Farming Technol Res Ctr, Serdang, Selangor, Malaysia; [Yoke Mun, Chan] Univ Putra Malaysia UPM, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Khaled, Alfadhl Yahya] Univ Wisconsin, Coll Agr & Life Sci, Dept Hort, Madison, WI USA; [Rokhani, Fakhrul Zaman] Univ Putra Malaysia UPM, MyAgeing Res Inst, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; University of Wisconsin System; University of Wisconsin Madison; Universiti Putra Malaysia	Rokhani, FZ (corresponding author), Univ Putra Malaysia UPM, Fac Engn, Serdang, Selangor, Malaysia.; Rokhani, FZ (corresponding author), Univ Putra Malaysia UPM, MyAgeing Res Inst, Serdang, Selangor, Malaysia.	fzr@upm.edu.my	; Rokhani, Fakhrul Zaman/L-2896-2016	Abd Aziz, Samsuzana/0000-0003-0777-8344; Rokhani, Fakhrul Zaman/0000-0001-6449-8184	Malaysian Ministry of Higher Education [01-01-20-2247FR]	Malaysian Ministry of Higher Education	Funding was provided by the Malaysian Ministry of Higher Education (www.mohe.gov.my) through the Fundamental Research Grant Scheme under the Grant No. [01-01-20-2247FR], awarded to FZR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. the oil, fatty composition	Agilent, 2008, AG 16452A LIQ TEST F; Ahmad Nizar NN, 2016, GRASAS ACEITES, V67, P2; Akkaya MR, 2018, J FOOD SCI TECH MYS, V55, P2318, DOI 10.1007/s13197-018-3150-x; [Anonymous], 2021, TOP 8 OLIVE OIL COOK; [Anonymous], 2021, TOP 10 BEST SUNFLOWE; Armenta S, 2010, CRIT REV FOOD SCI, V50, P567, DOI 10.1080/10408390802606790; Brody T., 1999, CALCIUM PHOSPHATE NU; Buehler DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018592; Bumbrah G.S., 2016, EGYPT J FORENSIC SCI, V6, P209, DOI [10.1016/j.ejfs.2015.06.001, DOI 10.1016/J.EJFS.2015.06.001]; Centers for Medicare & Medicaid Services, 2018, INTROD MULTIVAR CALI; Dahimi O., 2014, J FOOD PHARM SCI, V2, P27; Datta AK, 2005, FOOD SCI, V144, P501; DEMAN JM, 1983, J AM OIL CHEM SOC, V60, P91, DOI 10.1007/BF02540900; Dong W, 2013, J RAMAN SPECTROSC, V44, P1739, DOI 10.1002/jrs.4386; Dortmund Data Bank, 2021, DIEL CONST AIR DORTM; FAO, 2021, NUTR GUID STAND SCH; FAO (Food and Agriculture Organization of the United Nations) WHO (World Health Organization), 1994, FATS OILS HUM HLTH R; Fasina OO, 2008, LWT-FOOD SCI TECHNOL, V41, P1501, DOI 10.1016/j.lwt.2007.09.012; Hamdan K, 2015, T ASABE, V58, P227; Hernandez-Martinez M, 2013, LWT-FOOD SCI TECHNOL, V52, P12, DOI 10.1016/j.lwt.2013.01.001; Hollas J.M., 2004, MODERN SPECTROSCOPY; Houston, 2016, DESP FDA PHAS OUT PA; Hu LZ, 2008, J FOOD ENG, V88, P151, DOI 10.1016/j.jfoodeng.2007.12.035; Hui YH., 2005, BAILEYS IND OIL FAT, V6; Indrasti D, 2010, FOOD CHEM, V122, P1273, DOI 10.1016/j.foodchem.2010.03.082; Karunathilaka SR., 2016, J AGR FOOD CHEM, P1; Karupaiah T, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0301-9; Lasch P, 2012, CHEMOMETR INTELL LAB, V117, P100, DOI 10.1016/j.chemolab.2012.03.011; Lizhi H, 2010, J FOOD ENG, V96, P167, DOI 10.1016/j.jfoodeng.2009.06.045; Lucas A, 2008, INT DAIRY J, V18, P595, DOI 10.1016/j.idairyj.2007.12.001; Lunn J, 2006, NUTR BULL, V31, P178, DOI 10.1111/j.1467-3010.2006.00571.x; Maggio RM, 2009, FOOD CHEM, V114, P1549, DOI 10.1016/j.foodchem.2008.11.029; Man YBC, 2011, J AM OIL CHEM SOC, V88, P187, DOI 10.1007/s11746-010-1659-x; Mba O, 2014, IND CROP PROD, V61, P472, DOI 10.1016/j.indcrop.2014.07.037; Mohamad F., 2015, INVESTIGATION INTERD, V0; Moller A, 2011, DANISH FOOD INFORMAT, P1; National Research Council US, 2003, NUTR REQ NONH PRIM; Nizar NNA, 2013, J OLEO SCI, V62, P459, DOI 10.5650/jos.62.459; Nurjuliana M, 2011, J AM OIL CHEM SOC, V88, P75, DOI 10.1007/s11746-010-1655-1; Parker T, 2014, TRAC-TREND ANAL CHEM, V57, P147, DOI 10.1016/j.trac.2014.02.006; Perez-Juan M, 2010, FOOD RES INT, V43, P1416, DOI 10.1016/j.foodres.2010.04.006; Popescu R, 2015, FOOD CONTROL, V48, P84, DOI 10.1016/j.foodcont.2014.04.046; Randolph Timothy W., 2006, Cancer Biomarkers, V2, P135; Rohman A., 2012, International Food Research Journal, V19, P475; Sairin MA, 2017, CORRELATION SPECTRAL; Sairin MM., 2015, POTENTIAL DIELECTRIC; Shapaval V, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-86; Sierra V, 2008, MEAT SCI, V78, P248, DOI 10.1016/j.meatsci.2007.06.006; Sindhu R., 2015, IND BIOREFINERIES WH, P575, DOI [10.1016/B978-0-444-63453-5.00019-7, DOI 10.1016/B978-0-444-63453-5.00019-7]; Singh Meharban, 2005, Indian Journal of Pediatrics, V72, P239, DOI 10.1007/BF02859265; Sneddon J., 2002, ADV ATOMIC SPECTROSC, V1, P438; Society JOC, 1996, STANDARD METHODS ANA; Velioglu SD, 2016, J AM OIL CHEM SOC, V93, P627, DOI 10.1007/s11746-016-2808-7; Yang H, 2005, FOOD CHEM, V93, P25, DOI 10.1016/j.foodchem.2004.08.039; Yanty N. A. M., 2014, International Food Research Journal, V21, P277; Yuan JJ, 2013, FOOD CHEM, V138, P1657, DOI 10.1016/j.foodchem.2012.11.096	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268827	http://dx.doi.org/10.1371/journal.pone.0268827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617210	gold, Green Published			2022-12-26	WOS:000835048800045
J	Beauvais, DM; Nelson, SE; Adams, KM; Stueven, NA; Jung, OS; Rapraeger, AC				Beauvais, DeannaLee M.; Nelson, Scott E.; Adams, Kristin M.; Stueven, Noah A.; Jung, Oisun; Rapraeger, Alan C.			Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; TYROSINE KINASE; TETRASPANIN CD151; INTEGRIN ALPHA-3-BETA-1; DNA-REPLICATION; MAP KINASE; CROSS-TALK; C-ABL; HEAD	Epidermal growth factor receptor (EGFR) is a causal factor in carcinoma, yet many carcinoma patients are resistant to EGFR inhibitors. Potential insight into this resistance stems from prior work that showed EGFR in normal epithelial cells docks to the extracellular domain of the plasma membrane proteoglycan syndecan-4 (Sdc4) engaged with alpha 3 beta 1 and alpha 6 beta 4 integrins. We now report that this receptor complex is modified by the recruitment of syndecan-2 (Sdc2), the Recepteur d'Origine Nantais (RON) tyrosine kinase, and the cellular signaling mediator Abelson murine leukemia viral oncogene homolog 1 (ABL1) in triple-negative breast carcinoma and head and neck squamous cell carcinoma, where it contributes to EGFR kinase-independent proliferation. Treatment with a peptide mimetic of the EGFR docking site in the extracellular domain of Sdc4 (called SSTNEGFR) disrupts the entire complex and causes a rapid, global arrest of the cell cycle. Normal epithelial cells do not recruit these additional receptors to the adhesion mechanism and are not arrested by SSTNEGFR. Although EGFR docking with Sdc4 in the tumor cells is required, cell cycle progression does not depend on EGFR kinase. Instead, progression depends on RON kinase, activated by its incorporation into the complex. RON activates ABL1, which suppresses p38 mitogen-activated protein kinase and prevents a p38-mediated signal that would otherwise arrest the cell cycle. These findings add to the growing list of receptor tyrosine kinases that support tumorigenesis when activated by their association with syndecans at sites of matrix adhesion and identify new potential targets for cancer therapy.	[Beauvais, DeannaLee M.; Nelson, Scott E.; Adams, Kristin M.; Stueven, Noah A.; Jung, Oisun; Rapraeger, Alan C.] Univ Wisconsin Madison, Univ Wisconsin Carbone Canc Ctr, Dept Human Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Univ Wisconsin Madison, Univ Wisconsin Carbone Canc Ctr, Dept Human Oncol, Madison, WI 53706 USA.	rapraeger@humonc.wisc.edu			National Institutes of Health [R01-CA163662, R01-DE028341]; UW School of Medicine and Public Health; UW Carbone Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW School of Medicine and Public Health; UW Carbone Cancer Center	This work was supported by funds from the National Institutes of Health to A. C. R. (R01-CA163662, R01-DE028341) and funds in support of head and neck cancer research to A. C. R. from the UW School of Medicine and Public Health and the UW Carbone Cancer Center. The con-tent is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beauvais DM, 2016, CANCER RES, V76, P4981, DOI 10.1158/0008-5472.CAN-16-0232; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Carvalho FM, 2010, CLINICS, V65, P1033, DOI 10.1590/S1807-59322010001000019; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Choi Y, 2015, J BIOL CHEM, V290, P16943, DOI 10.1074/jbc.M114.611798; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dent P, 1999, MOL BIOL CELL, V10, P2493, DOI 10.1091/mbc.10.8.2493; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Grandis JR, 1997, ONCOGENE, V15, P409, DOI 10.1038/sj.onc.1201188; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gryp JL, 2012, CELL CYCLE, V11, P3917, DOI 10.4161/cc.22394; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Harlow E., 1988, ANTIBODIES LAB MANUA; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jung O, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.5; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Keller J, 2013, BRIT J CANCER, V109, P482, DOI 10.1038/bjc.2013.321; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Oh ES, 2004, MOL CELLS, V17, P181; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Park JW, 2014, RADIOTHER ONCOL, V113, P337, DOI 10.1016/j.radonc.2014.08.026; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; RONSIN C, 1993, ONCOGENE, V8, P1195; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Saxena M, 2017, NAT MATER, V16, P775, DOI [10.1038/NMAT4893, 10.1038/nmat4893]; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; SCHMIDTULLRICH RK, 1994, INT J RADIAT ONCOL, V29, P813, DOI 10.1016/0360-3016(94)90570-3; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2002, J CELL SCI, V115, P1161; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang HY, 2015, J BIOL CHEM, V290, P26103, DOI 10.1074/jbc.M115.679084; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yu PT, 2012, INT J CANCER, V131, P1744, DOI 10.1002/ijc.27447; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zhao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029416; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	65	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102029	10.1016/j.jbc.2022.102029	http://dx.doi.org/10.1016/j.jbc.2022.102029			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35569509	Green Published, gold			2022-12-26	WOS:000829588600013
J	Buel, GR; Dang, HQ; Asara, JM; Blenis, J; Mutvei, AP				Buel, Gwen R.; Dang, Huy Q.; Asara, John M.; Blenis, John; Mutvei, Anders P.			Prolonged deprivation of arginine or leucine induces PI3K/ Akt-dependent reactivation of mTORC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAG GTPASES; GROWTH-FACTOR; INSULIN; PROTEIN; MECHANISM; AUTOPHAGY; COMPLEX; PHOSPHORYLATION; SUFFICIENCY; ACTIVATION	The mechanistic target of rapamycin complex 1 (mTORC1) is a serine/threonine kinase complex that promotes anabolic processes including protein, lipid, and nucleotide synthesis, while suppressing catabolic processes such as macroautophagy. mTORC1 activity is regulated by growth factors and amino acids, which signal through distinct but integrated molecular pathways: growth factors largely signal through the PI3K/Aktdependent pathway, whereas the availabilities of amino acids leucine and arginine are communicated to mTORC1 by the Rag-GTPase pathway. While it is relatively well described how acute changes in leucine and arginine levels affect mTORC1 signaling, the effects of prolonged amino acid deprivation remain less well understood. Here, we demonstrate that prolonged deprivation of arginine and/or leucine leads to reactivation of mTORC1 activity, which reaches activation levels similar to those observed in nutrient-rich conditions. Surprisingly, we find that this reactivation is independent of the regeneration of amino acids by canonical autophagy or proteasomal degradation but is dependent on PI3K/Akt signaling. Together, our data identify a novel crosstalk between the amino acid and PI3K/Akt signaling pathways upstream of mTORC1. These observations extend our understanding of the role of mTORC1 in growth-related diseases and indicate that dietary intervention by removal of leucine and/or arginine may be an ineffective therapeutic approach.	[Buel, Gwen R.] Harvard Med Sch, Programs Biol & Biomed Sci, Boston, MA USA; [Buel, Gwen R.; Blenis, John] Weill Cornell Med Coll, Meyer Canc Ctr, Dept Pharmacol, New York, NY 10021 USA; [Buel, Gwen R.; Blenis, John] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Dang, Huy Q.; Mutvei, Anders P.] Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden; [Asara, John M.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Cornell University; Harvard University; Harvard Medical School; Uppsala University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Blenis, J (corresponding author), Weill Cornell Med Coll, Meyer Canc Ctr, Dept Pharmacol, New York, NY 10021 USA.; Blenis, J (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Mutvei, AP (corresponding author), Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden.	jblenis@med.cornell.edu; anders.mutvei@igp.uu.se		Buel, Gwen/0000-0003-2917-3055	Swedish Research Council [2020-01126]; Swedish Cancer Society [21 0437 JIA, 20 1188 Pj]; Magnus Bergvall foundation; National Institutes of Health [F31 CA173942, R01 GM051405]; Ake Wibergs foundation; Lars Hierta's Memory Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvall foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ake Wibergs foundation; Lars Hierta's Memory Foundation	This work was supported by grants from The Swedish Research Council (2020-01126), The Swedish Cancer Society (21 0437 JIA, 20 1188 Pj), Ake Wibergs foundation, Lars Hierta's Memory Foundation and Magnus Bergvall foundation to A. P. M., National Institutes of Health F31 CA173942 to G. R. B., and National Institutes of Health R01 GM051405 to J. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang CC, 2012, ORAL ONCOL, V48, P1227, DOI 10.1016/j.oraloncology.2012.06.004; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kang JS, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00439-x; KAWASE T, 1995, ARCH ORAL BIOL, V40, P921, DOI 10.1016/0003-9969(95)00061-S; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kelly MP, 2012, BRIT J CANCER, V106, P324, DOI 10.1038/bjc.2011.524; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Melick CH, 2020, GENES-BASEL, V11, DOI 10.3390/genes11090989; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Mutvei AP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15156-5; Nakashima N, 1999, GENETICS, V152, P853; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Yao Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030051; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	41	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102030	10.1016/j.jbc.2022.102030	http://dx.doi.org/10.1016/j.jbc.2022.102030			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35577075	Green Published, gold			2022-12-26	WOS:000816927100001
J	Shaheen, A; Alam, SM; Azam, F; Saleem, SA; Khan, M; Hasan, SS; Liaquat, A				Shaheen, Abida; Alam, Syed Mahboob; Azam, Fahad; Saleem, Salman Ahmad; Khan, Moosa; Hasan, Syed Saud; Liaquat, Afrose			Lack of impact of OCTN1 gene polymorphisms on clinical outcomes of gabapentinoids in Pakistani patients with neuropathic pain	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; RENAL CLEARANCE; PHARMACOKINETICS; PREGABALIN; INVOLVEMENT; METFORMIN; SLC22A4	Background and objectiveGabapentinoids are the first-line drugs for neuropathic pain. These drugs are the substrate of organic cation transporter (OCTN1) for renal excretion and absorption across the intestinal epithelium. Gabapentinoids exhibit wide interindividual variability in daily dosage and therapeutic efficacy which makes titration regimens prolonged for optimal efficacy. The present study aimed to investigate the possible influence of the single nucleotide polymorphism (SNP) of OCTN1 on therapeutic efficacy and safety of gabapentinoids in neuropathic pain patients of the Pakistani population. MethodsFour hundred and twenty-six patients were enrolled in the study. All participants were genotyped for OCTN1 rs1050152 and rs3792876 by PCR-RFLP method and followed up for eight weeks. The therapeutic outcomes of gabapentinoids, reduction in pain score, inadequate or complete lack of response, adverse events (AEs) in responders and discontinuation of treatment on account of AEs were recorded for all patients. ResultsThere was no significant association of genotypes and alleles of both SNPs on the clinical response of gabapentinoids (P > 0.05). Similarly, significant differences were not found in the reduction of pain scores and AEs among different genotypes in the responders. The present study has reported the association of OCTN1 rs1050152 and rs3792876 polymorphisms with clinical outcomes of gabapentinoids for the first time in the real-world clinical setting. ConclusionOur results suggest a lack of influence of OCTN1 genetic variants in the determination of clinical response to gabapentinoids in patients with neuropathic pain in the Pakistani population. These findings signify the role of renal functions in predicting the interindividual variability to therapeutic responsiveness of gabapentinoids.	[Shaheen, Abida; Azam, Fahad] Shifa Tameer Emillat Univ, Shifa Coll Med, Dept Pharmacol & Therapeut, Islamabad, Pakistan; [Alam, Syed Mahboob] JPMC, Basic Med Sci Inst, Dept Pharmacol & Therapeut, Karachi, Pakistan; [Saleem, Salman Ahmad] Shifa Int Hosp, Dept Pain Clin, Islamabad, Pakistan; [Khan, Moosa] Shaheed Zulfiqar Ali Bhutto Med Univ, Dept Pharmacol & Therapeut, Islamabad, Pakistan; [Hasan, Syed Saud] Dow Univ Hlth Sci, Dow Med Coll, Dept Pharmacol & Therapeut, Karachi, Pakistan; [Liaquat, Afrose] Shifa Tameer Emillat Univ, Shifa Coll Med, Dept Biochem, Islamabad, Pakistan	Shifa College of Medicine; Dow University of Health Sciences; Shifa College of Medicine	Shaheen, A (corresponding author), Shifa Tameer Emillat Univ, Shifa Coll Med, Dept Pharmacol & Therapeut, Islamabad, Pakistan.	abida.scm@stmu.edu.pk		Liaquat, Afrose/0000-0001-6410-6953; Shaheen, Abida/0000-0001-8977-9820	Shifa Tameer-e-Millat University, Islamabad [514-363-2015]	Shifa Tameer-e-Millat University, Islamabad	This research was supported by Shifa Tameer-e-Millat University, Islamabad [Ref: IRB#514-363-2015]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA., 2019, AM J IMMUNOLOGY, V15, P10, DOI [10.3844/ajisp.2019.10.18, DOI 10.3844/AJISP.2019.10.18]; Akamine T, 2015, J PHARMACOL EXP THER, V354, P65, DOI 10.1124/jpet.115.223891; BLUM RA, 1994, CLIN PHARMACOL THER, V56, P154, DOI 10.1038/clpt.1994.118; Bockbrader HN, 2010, CLIN PHARMACOKINET, V49, P661, DOI 10.2165/11536200-000000000-00000; Costa ACC, 2021, BRIT J CLIN PHARMACO, V87, P1981, DOI 10.1111/bcp.14594; Dickens D, 2013, BIOCHEM PHARMACOL, V85, P1672, DOI 10.1016/j.bcp.2013.03.022; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Fujita S, 2019, J NEUROCHEM, V148, P373, DOI 10.1111/jnc.14607; Futatsugi A, 2016, J PHARM PHARMACOL, V68, P1160, DOI 10.1111/jphp.12574; Hou X, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0222-x; Ieiri I, 2006, EXPERT OPIN DRUG MET, V2, P651, DOI 10.1517/17425255.2.5.651; Lauschke VM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101714; Li J, 2018, ACTA ENDOCRINOL-BUCH, V14, P294, DOI 10.4183/aeb.2018.294; Nakamichi N, 2013, J PHARM SCI-US, V102, P3407, DOI 10.1002/jps.23595; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pochini L, 2019, SLAS DISCOV, V24, P89, DOI 10.1177/2472555218812821; Randinitis EJ, 2003, J CLIN PHARMACOL, V43, P277, DOI 10.1177/0091270003251119; Shaheen A, 2021, BASIC CLIN PHARMACOL, V128, DOI 10.1111/bcpt.13534; Shoji S, 2011, BRIT J CLIN PHARMACO, V72, P63, DOI 10.1111/j.1365-2125.2011.03932.x; Tamai I, 2004, MOL PHARMACEUT, V1, P57, DOI 10.1021/mp0340082; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Urban TJ, 2008, CLIN PHARMACOL THER, V83, P416, DOI 10.1038/sj.clpt.6100271; Waller S, 2006, GUT, V55, P809, DOI 10.1136/gut.2005.084574; Yamamoto PA, 2019, BASIC CLIN PHARMACOL, V124, P266, DOI 10.1111/bcpt.13126; Yeh YC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0242467; Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0266559	http://dx.doi.org/10.1371/journal.pone.0266559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35559956	Green Published, gold			2022-12-26	WOS:000835326900018
J	Wang, SS; Xiong, EH; Bhadra, S; Ellington, AD				Wang, Siyuan S.; Xiong, Erhu; Bhadra, Sanchita; Ellington, Andrew D.			Developing predictive hybridization models for phosphorothioate oligonucleotides using high-resolution melting	PLOS ONE			English	Article							DOUBLE-HELIX FORMATION; THERMODYNAMIC PARAMETERS; DNA; STABILITY; STACKING; RNA	The ability to predict nucleic acid hybridization energies has been greatly enabling for many applications, but predictive models require painstaking experimentation, which may limit expansion to non-natural nucleic acid analogues and chemistries. We have assessed the utility of dye-based, high-resolution melting (HRM) as an alternative to UV-Vis determinations of hyperchromicity in order to more quickly acquire parameters for duplex stability prediction. The HRM-derived model for phosphodiester (PO) DNA can make comparable predictions to previously established models. Using HRM, it proved possible to develop predictive models for DNA duplexes containing phosphorothioate (PS) linkages, and we found that hybridization stability could be predicted as a function of sequence and backbone composition for a variety of duplexes, including PS:PS, PS:PO, and partially modified backbones. Individual phosphorothioate modifications destabilize helices by around 0.12 kcal/mol on average. Finally, we applied these models to the design of a catalytic hairpin assembly circuit, an enzyme-free amplification method used for nucleic acid-based molecular detection. Changes in PS circuit behavior were consistent with model predictions, further supporting the addition of HRM modeling and parameters for PS oligonucleotides to the rational design of nucleic acid hybridization.	[Wang, Siyuan S.; Xiong, Erhu; Bhadra, Sanchita; Ellington, Andrew D.] Univ Texas Austin, Coll Nat Sci, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Xiong, Erhu] South China Normal Univ, Sch Life Sci, Guangzhou, Peoples R China	University of Texas System; University of Texas Austin; South China Normal University	Ellington, AD (corresponding author), Univ Texas Austin, Coll Nat Sci, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Wang, Siyuan Stella/0000-0001-8249-6553	John Templeton Foundation [54466]; National Science Foundation Graduate Research Fellowship [DGE-1610403]; Welch Foundation [F-1654]; National Natural Science Foundation of China [21904042]; China Scholarship Council [201606130011]	John Templeton Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	S.S.W. received funding support from the John Templeton Foundation (54466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.templeton.org S.S.W. received funding support from the National Science Foundation Graduate Research Fellowship (DGE-1610403). The funders had no role in study design, data collection and analysis, decision to publish, or<EM><STRONG> </STRONG></EM>preparation of the manuscript. www.nsfgrfp.org S. S.W. and S.B. received funding support from the Welch Foundation (F-1654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. welch1.org E.X. received funding support from the National Natural Science Foundation of China (No. 21904042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.nsfc.gov.cn E.X. received funding support from the China Scholarship Council (No. 201606130011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.chinesescholarshipcouncil.com.	Aung-Htut MT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49385-6; Bhadra S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku074; Boczkowska M, 2002, BIOCHEMISTRY-US, V41, P12483, DOI 10.1021/bi026225z; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Cai S, 2018, ANAL CHEM, V90, P8290, DOI 10.1021/acs.analchem.8b02062; Carlucci M, 2009, BIOCHEMISTRY-US, V48, P10882, DOI 10.1021/bi901506f; Chen YJ, 2015, NAT NANOTECHNOL, V10, P748, DOI [10.1038/NNANO.2015.195, 10.1038/nnano.2015.195]; CROTHERS DM, 1964, J MOL BIOL, V9, P1, DOI 10.1016/S0022-2836(64)80086-3; DEMESMAEKER A, 1995, ACCOUNTS CHEM RES, V28, P366, DOI 10.1021/ar00057a002; DEVOE H, 1962, J MOL BIOL, V4, P500; DOKTYCZ MJ, 1995, J BIOL CHEM, V270, P8439, DOI 10.1074/jbc.270.15.8439; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gray DM, 1997, BIOPOLYMERS, V42, P783, DOI 10.1002/(SICI)1097-0282(199712)42:7<783::AID-BIP4>3.0.CO;2-P; GRAY DM, 1970, BIOPOLYMERS, V9, P223, DOI 10.1002/bip.1970.360090207; Hong F, 2017, CHEM REV, V117, P12584, DOI 10.1021/acs.chemrev.6b00825; Hoshika S, 2019, SCIENCE, V363, P884, DOI 10.1126/science.aat0971; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Jiang Yu Sherry, 2014, Angew Chem Int Ed Engl, V53, P1845, DOI 10.1002/anie.201307418; Jiang Y, 2013, J AM CHEM SOC, V135, P7430, DOI 10.1021/ja4023978; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Li BL, 2012, ANAL CHEM, V84, P8371, DOI 10.1021/ac301944v; Li BL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr504; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Owczarzy R, 2005, BIOPHYS CHEM, V117, P207, DOI 10.1016/j.bpc.2005.05.006; Owczarzy R, 1997, BIOPOLYMERS, V44, P217, DOI 10.1002/(SICI)1097-0282(1997)44:3<217::AID-BIP3>3.0.CO;2-Y; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia J., 2000, SPECTROPHOTOMETRY SP, P329; Simmel FC, 2019, CHEM REV, V119, P6326, DOI 10.1021/acs.chemrev.8b00580; SPITZER S, 1988, NUCLEIC ACIDS RES, V16, P11691, DOI 10.1093/nar/16.24.11691; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; SUGIMOTO N, 1994, NUCLEOS NUCLEOT, V13, P1311, DOI 10.1080/15257779408012153; TINOCO I, 1971, NATURE, V230, P362, DOI 10.1038/230362a0; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Wang J, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/5318935; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	43	0	0	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268575	10.1371/journal.pone.0268575	http://dx.doi.org/10.1371/journal.pone.0268575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584176	Green Published, gold			2022-12-26	WOS:000834613800004
J	Chen, JN; Li, XH; Zeng, P; Zhang, XJ; Bi, KF; Lin, CH; Jiang, JJ; Diao, HY				Chen, Jianing; Li, Xuehui; Zeng, Ping; Zhang, Xujun; Bi, Kefan; Lin, Chenhong; Jiang, Jingjing; Diao, Hongyan			Lamina propria interleukin 17 A aggravates natural killer T-cell activation in autoimmune hepatitis	FASEB JOURNAL			English	Article						autoimmune hepatitis; interleukin 17 A; lamina propria; natural killer T cells	MAIT CELLS; LIVER-INJURY; RECOGNITION; SALMONELLA; MECHANISM; CYTOKINE; IL-17	Autoimmune hepatitis is an interface hepatitis characterized by the progressive destruction of the liver parenchyma, the cause of which is still obscure. Interleukin (IL)-17A is a major driver of autoimmunity, which can be produced by innate immune cells against several intracellular pathogens. Here, we investigated the involvement of IL-17A in a mice model of immune-mediated hepatitis with the intestine exposed to Salmonella typhimurium. Our results showed more severe Concanavalin (Con) A-induced liver injury and gut microbiome dysbiosis when the mice were treated with a gavage of S. typhimurium. Then, the natural killer (NK) T cells were overactivated by the accumulated IL-17A in the liver in the Con A and S. typhimurium administration group. IL-17A could activate NKT cells by inducing CD178 expression via IL-4/STAT6 signaling. Furthermore, via the portal tract, the laminae propria mucosal-associated invariant T (MAIT)-cell-derived IL-17A could be the original driver of NKT cell overactivation in intragastric administration of S. typhimurium and Con A injection. In IL-17A-deficient mice, Con A-induced liver injury and NKT cell activation were alleviated. However, when AAV-sh-mIL-17a was used to specifically knock down IL-17A in liver, it seemed that hepatic IL-17a knock down did not significantly influence the liver injury. Our results suggested that, under Con A-induction, laminae propria MAIT-derived IL-17A activated hepatic NKT, and this axis could be a therapeutic target in autoimmune liver disease.	[Chen, Jianing; Li, Xuehui; Zeng, Ping; Zhang, Xujun; Bi, Kefan; Lin, Chenhong; Jiang, Jingjing; Diao, Hongyan] Zhejiang Univ, Natl Clin Res Ctr Infect Dis, Coll Med,Collaborat Innovat Ctr Diag & Treatment, Affiliated Hosp 1,State Key Lab Diag & Treatment, Hangzhou 310003, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Diao, HY (corresponding author), Zhejiang Univ, Natl Clin Res Ctr Infect Dis, Coll Med,Collaborat Innovat Ctr Diag & Treatment, Affiliated Hosp 1,State Key Lab Diag & Treatment, Hangzhou 310003, Peoples R China.	diaohy@zju.edu.cn			National Key Research and Development Program of China [2021YFA1301100, 2018YFC2000500]; Key Research & Development Plan of Zhejiang Province [2019C04005]; Research Project of Jinan Microecological Biomedicine Shandong Laboratory [JNL-2022012B]; National Natural Science Foundation of China [81700499]	National Key Research and Development Program of China; Key Research & Development Plan of Zhejiang Province; Research Project of Jinan Microecological Biomedicine Shandong Laboratory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China (2021YFA1301100, 2018YFC2000500), Key Research & Development Plan of Zhejiang Province (2019C04005), Research Project of Jinan Microecological Biomedicine Shandong Laboratory (JNL-2022012B), the National Natural Science Foundation of China (No. 81700499).	Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Awad W, 2018, IMMUNOL CELL BIOL, V96, P588, DOI 10.1111/imcb.12017; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen JN, 2014, SCI REP-UK, V4, DOI 10.1038/srep07259; Chen XY, 2019, LAB INVEST, V99, P37, DOI 10.1038/s41374-018-0134-4; Chen YL, 2014, IMMUNOLOGY, V141, P388, DOI 10.1111/imm.12201; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Cheng J, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2441634; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Davies A, 2004, J IMMUNOL, V172, P6828, DOI 10.4049/jimmunol.172.11.6828; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Haga K, 2016, J GASTROEN HEPATOL, V31, P965, DOI 10.1111/jgh.13242; Hardie C, 2016, EBIOMEDICINE, V14, P65, DOI 10.1016/j.ebiom.2016.11.021; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kunzmann LK, 2020, HEPATOLOGY, V72, P1310, DOI 10.1002/hep.31140; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lantz O, 2018, IMMUNOL CELL BIOL, V96, P564, DOI 10.1111/imcb.1034; Liberal R, 2021, LANCET GASTROENTEROL, V6, P315, DOI 10.1016/S2468-1253(20)30328-9; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Renand A, 2020, J HEPATOL, V73, P1379, DOI 10.1016/j.jhep.2020.05.053; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tedesco D, 2018, GASTROENTEROLOGY, V154, P2178, DOI 10.1053/j.gastro.2018.02.019; Trebicka J, 2021, J HEPATOL, V75, pS67, DOI 10.1016/j.jhep.2020.11.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vierling JM, 2020, HEPATOLOGY, V72, P753, DOI 10.1002/hep.31407; Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523; Yadav J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00514; Yin YS, 2013, ISME J, V7, P615, DOI 10.1038/ismej.2012.128; You ZR, 2021, HEPATOLOGY, V74, P847, DOI 10.1002/hep.31739; Zhang YY, 2019, BIOMED PHARMACOTHER, V110, P692, DOI 10.1016/j.biopha.2018.12.025; Zhao N, 2011, J IMMUNOL, V187, P5007, DOI 10.4049/jimmunol.1101315	40	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22346	10.1096/fj.202101734RRR	http://dx.doi.org/10.1096/fj.202101734RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1I2MF	35583908				2022-12-26	WOS:000797067500001
J	Zhao, JY; Xie, W; Yang, ZC; Zhao, M; Ke, T; Xu, CQ; Li, H; Chen, QY; Wang, QK				Zhao, Jinyan; Xie, Wen; Yang, Zhongcheng; Zhao, Miao; Ke, Tie; Xu, Chengqi; Li, Hui; Chen, Qiuyun; Wang, Qing K.			Identification and characterization of a special type of subnuclear structure: AGGF1-coated paraspeckles	FASEB JOURNAL			English	Article						AGGF1; alternative splicing; NONO; paraspeckle; PSF; SFPQ	KLIPPEL-TRENAUNAY-SYNDROME; NONCODING RNA NEAT1; ANGIOGENIC FACTOR; AGGF1 ACTS; TRANSCRIPTION; EXPRESSION; PROTEIN; SFPQ; SUBPOPULATION; SPECIFICATION	AGGF1 is an angiogenic factor with G-Patch and FHA domains 1 described by our group. Gain-of-function mutations in AGGF1 cause Klippel-Trenaunay syndrome, whereas somatic loss-of-function mutations cause cancer. Paraspeckles are small membraneless subnuclear structures with a diameter of 0.5-1 mu m, and composed of lncRNA NEAT1 as the scaffold and three core RNA-binding proteins NONO, PSPC1, and PSF. Here, we show that AGGF1 is a key regulatory and structural component of paraspeckles that induces paraspeckle formation, forms an outside rim of paraspeckles, wraps around the NONO/PSF/PSPC1/NEAT1 core, and regulates the size and number of paraspeckles. AGGF1-paraspeckles are larger (>1 mu m) than conventional paraspeckles. RNA-FISH in combination with immunostaining shows that AGGF1, NONO, and NEAT1_2 co-localize in 20.58% of NEAT1_2-positive paraspeckles. Mechanistically, AGGF1 interacts with NONO, PSF, and HNRNPK, and upregulates NEAT1_2, a longer, 23 kb NEAT1 transcript with a key role in regulation of paraspeckle size and number. RNA-immunoprecipitation shows that AGGF1 interacts with NEAT1, which may be another possible mechanism underlying the formation of AGGF1-paraspeckles. NEAT1_2 knockdown reduces the number and size of AGGF1-paraspeckles. Functionally, AGGF1 regulates alternative RNA splicing as it decreases the exon skipping/inclusion ratio in a CD44 model. AGGF1 is also localized in some nuclear foci without NEAT1 or NONO, suggesting that AGGF1 is an important liquid-liquid phase separation (LLPS) driver for other types of AGGF1-positive nuclear condensates (referred to as AGGF1-bodies). Our results identify a special type of AGGF1-coated paraspeckles and provide important insights into the formation, structure, and function of paraspeckles.	[Zhao, Jinyan; Xie, Wen; Yang, Zhongcheng; Zhao, Miao; Ke, Tie; Xu, Chengqi; Li, Hui; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan, Peoples R China; [Chen, Qiuyun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan, Peoples R China.; Chen, QY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	chenq_2003@yahoo.com; qingwang118@qq.com		Wang, Qing Kenneth/0000-0002-2235-6572; Zhao, Jinyan/0000-0002-8125-0516; Xu, Chengqi/0000-0002-4269-6830	National Natural Science Foundation of China [31430047, 81630002, 81872116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31430047, 81630002 and 81872116	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; An HY, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0658-x; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barra J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz9072; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen LY, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2582416; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Duvignaud JB, 2016, BIOCHEMISTRY-US, V55, P2553, DOI 10.1021/acs.biochem.5b01240; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Hirose T, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1545; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Huang CJ, 2016, AGING-US, V8, P3356, DOI 10.18632/aging.101125; Huang J, 2018, J BIOL CHEM, V293, P6593, DOI 10.1074/jbc.RA117.001451; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kessler Sonja M, 2019, Cell Physiol Biochem, V52, P787, DOI 10.33594/000000055; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Li SF, 2018, GENES DIS, V5, P27, DOI 10.1016/j.gendis.2017.11.003; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Li Z, 2020, CIRC RES, V126, P471, DOI 10.1161/CIRCRESAHA.119.315769; Liu LL, 2011, MOL ENDOCRINOL, V25, P1197, DOI 10.1210/me.2010-0517; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Lu YR, 2019, EUR REV MED PHARMACO, V23, P10785, DOI 10.26355/eurrev_201912_19781; Ma YL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0799-3; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; McCluggage F, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000245; Misteli T, 2000, J CELL SCI, V113, P1841; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Peng WZ, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1020-x; Pisani G, 2019, NON-CODING RNA RES, V4, P128, DOI 10.1016/j.ncrna.2019.11.002; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sawyer IA, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1514; Si WX, 2021, CANCER LETT, V497, P28, DOI 10.1016/j.canlet.2020.10.014; Simchovitz A, 2019, FASEB J, V33, P11223, DOI 10.1096/fj.201900830R; Simko EAJ, 2020, NUCLEIC ACIDS RES, V48, P7421, DOI 10.1093/nar/gkaa475; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tu JF, 2017, ONCOTARGET, V8, P111623, DOI 10.18632/oncotarget.22880; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; VISA N, 1993, EUR J CELL BIOL, V60, P308; Wang Y, 2020, ESSAYS BIOCHEM, V64, P875, DOI 10.1042/EBC20200010; West JA, 2016, J CELL BIOL, V214, P817, DOI 10.1083/jcb.201601071; Wu Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0908-z; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Yamazaki T, 2018, MOL CELL, V70, P1038, DOI 10.1016/j.molcel.2018.05.019; Yao HH, 2017, MED SCI MONITOR, V23, P1286, DOI 10.12659/MSM.903248; Yao YF, 2019, DIABETES, V68, P1635, DOI 10.2337/db18-1178; Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w; Yu Y., 2022, J BIOL CHEM, V298; Zan J, 2021, CELL MOL GASTROENTER, V12, P465, DOI 10.1016/j.jcmgh.2021.02.010; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhang X, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6474-7	70	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22366	10.1096/fj.202101690RR	http://dx.doi.org/10.1096/fj.202101690RR			26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35608889				2022-12-26	WOS:000800641200002
J	Chen, YQ; Zhou, S; Wan, KR; Yu, L; Zhao, CC; Deng, HT; Ou, QJ; Qin, JY; Hu, JB; Hou, ZL				Chen, Yaqi; Zhou, Sha; Wan, Kairui; Yu, Long; Zhao, Chongchong; Deng, Haiteng; Ou, Qingjian; Qin, Jiayi; Hu, Junbo; Hou, Zhenlin			RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2	ONCOGENE			English	Article							ENDORIBONUCLEASE G3BP; MDM2; RADIOTHERAPY; BIOGENESIS; RESISTANCE; PROMOTES; KINASES; CELLS	RIO Kinase 1 (RIOK1) is involved in various pathologies, including cancer. However, the role of RIOK1 in radioresistance of colorectal cancer (CRC) remains largely unknown. In this study, we reported that RIOK1 was overexpressed in rectal cancer tissue with weaker tumor regression after neoadjuvant chemoradiotherapy (neoCRT). Moreover, higher RIOK1 expression predicted a poor prognosis in patients with rectal cancer. Blockade of RIOK1 using Toyocamycin, a pharmacological inhibitor of RIOK1, or by knocking down its expression, decreased the resistance of CRC cells to radiotherapy in vitro and in vivo. A mechanistic study revealed that RIOK1 regulates radioresistance by suppressing the p53 signaling pathway. Furthermore, we found that RIOK1 and Ras-GAP SH3 domain binding protein 2 (G3BP2) interact with each other. RIOK1 phosphorylates G3BP2 at Thr226, which increases the activity of G3BP2. RIOK1-mediated phosphorylation of G3BP2 facilitated ubiquitination of p53 by murine double minute 2 protein (MDM2). Altogether, our study revealed the clinical significance of RIOK1 in CRC, and therapies targeting RIOK1 might alleviate the CRC tumor burden in patients.	[Chen, Yaqi; Wan, Kairui; Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Hosp, GI Canc Res Inst, Wuhan 430030, Peoples R China; [Zhou, Sha] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China; [Yu, Long; Ou, Qingjian; Qin, Jiayi; Hou, Zhenlin] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Colorectal Surg, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China; [Zhao, Chongchong; Deng, Haiteng] Tsinghua Univ, Prot Chem & Prote Facil, Technol Ctr Prot Res, Beijing 100084, Peoples R China	Huazhong University of Science & Technology; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Tsinghua University	Hou, ZL (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Colorectal Surg, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China.	houzl@sysucc.org.cn		Yu, Long/0000-0003-1045-5407; Deng, Haiteng/0000-0001-9496-1280; Wan, Kairui/0000-0001-5991-5334	China Postdoctoral Science Foundation [2019M663289]; Natural Science Foundation of Guangdong Province [2019A1515110144, 2021A1515111014]; National Natural Science Foundation of China [81572725]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China Postdoctoral Science Foundation (No. 2019M663289), Natural Science Foundation of Guangdong Province (Nos. 2019A1515110144 and 2021A1515111014) and National Natural Science Foundation of China (No. 81572725).	Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Baker B, 2012, SURG ONCOL, V21, pE103, DOI 10.1016/j.suronc.2012.03.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Ferreira-Cerca S, 2014, NUCLEIC ACIDS RES, V42, P8635, DOI 10.1093/nar/gku542; Gal J, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00052-19; Gu XY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0308-x; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Hinata N, 2003, UROL RES, V31, P387, DOI 10.1007/s00240-003-0355-9; Hong HQ, 2018, ACTA PHARMACOL SIN, V39, P184, DOI 10.1038/aps.2017.58; Hong XH, 2018, ELIFE, V7, DOI 10.7554/eLife.29511; Hu S, 2015, AM J CANCER RES, V5, P651; Huang QH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.586025; Huang QH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01214; Iacovella MG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7643; Kim BM, 2015, INT J MOL SCI, V16, P26880, DOI 10.3390/ijms161125991; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Kong XH, 2021, ONCOL LETT, V22, DOI 10.3892/ol.2021.12922; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Li JQ, 2015, J CELL PHYSIOL, V230, P2318, DOI 10.1002/jcp.24994; Line A, 2002, CANCER IMMUNOL IMMUN, V51, P574, DOI 10.1007/s00262-002-0322-2; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Prentzell MT, 2021, CELL, V184, P655, DOI 10.1016/j.cell.2020.12.024; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Singleton DC, 2015, ONCOGENE, V34, P4713, DOI 10.1038/onc.2014.396; Sun Y, 2019, ONCOGENE, V38, P4856, DOI 10.1038/s41388-019-0762-1; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Weinberg F, 2017, EBIOMEDICINE, V20, P79, DOI 10.1016/j.ebiom.2017.04.015; Williams AB, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026070; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; Xie J, 2018, THERANOSTICS, V8, P650, DOI 10.7150/thno.21963; Yang PX, 2017, J GASTROEN HEPATOL, V32, P837, DOI 10.1111/jgh.13606	43	1	1	7	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2022	41	25					3433	3444		10.1038/s41388-022-02352-4	http://dx.doi.org/10.1038/s41388-022-02352-4		MAY 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	2E6DK	35589951				2022-12-26	WOS:000799459800002
J	Elbon, CE; LeCleir, GR; Tuttle, MJ; Jurgensen, SK; Demas, TG; Keller, CJ; Stewart, T; Buchan, A				Elbon, Claire E.; LeCleir, Gary R.; Tuttle, Matthew J.; Jurgensen, Sophie K.; Demas, Thomas G.; Keller, Christian J.; Stewart, Tina; Buchan, Alison			Microbiomes and Planctomycete diversity in large-scale aquaria habitats	PLOS ONE			English	Article							AMMONIUM-OXIDIZING BACTERIA; ANAMMOX BACTERIA; NITROGEN REMOVAL; GENES; MICROORGANISMS; BIOREACTOR; OXIDATION; SEWAGE; KEGG	In commercial large-scale aquaria, controlling levels of nitrogenous compounds is essential for macrofauna health. Naturally occurring bacteria are capable of transforming toxic nitrogen species into their more benign counterparts and play important roles in maintaining aquaria health. Nitrification, the microbially-mediated transformation of ammonium and nitrite to nitrate, is a common and encouraged process for management of both commercial and home aquaria. A potentially competing microbial process that transforms ammonium and nitrite to dinitrogen gas (anaerobic ammonium oxidation [anammox]) is mediated by some bacteria within the phylum Planctomycetes. Anammox has been harnessed for nitrogen removal during wastewater treatment, as the nitrogenous end product is released into the atmosphere rather than in aqueous discharge. Whether anammox bacteria could be similarly utilized in commercial aquaria is an open question. As a first step in assessing the viability of this practice, we (i) characterized microbial communities from water and sand filtration systems for four habitats at the Tennessee Aquarium and (ii) examined the abundance and anammox potential of Planctomycetes using culture-independent approaches. 16S rRNA gene amplicon sequencing revealed distinct, yet stable, microbial communities and the presence of Planctomycetes (similar to 1-15% of library reads) in all sampled habitats. Preliminary metagenomic analyses identified the genetic potential for multiple complete nitrogen metabolism pathways. However, no known genes diagnostic for the anammox reaction were found in this survey. To better understand the diversity of this group of bacteria in these systems, a targeted Planctomycete-specific 16S rRNA gene-based PCR approach was used. This effort recovered amplicons that share <95% 16S rRNA gene sequence identity to previously characterized Planctomycetes, suggesting novel strains within this phylum reside within aquaria.	[Elbon, Claire E.; LeCleir, Gary R.; Tuttle, Matthew J.; Jurgensen, Sophie K.; Buchan, Alison] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Demas, Thomas G.; Keller, Christian J.; Stewart, Tina] Tennessee Aquarium, Chattanooga, TN USA; [Elbon, Claire E.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Jurgensen, Sophie K.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	University of Tennessee System; University of Tennessee Knoxville; University System of Georgia; Georgia Institute of Technology; Louisiana State University System; Louisiana State University	Buchan, A (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	abuchan@utk.edu		Buchan, Alison/0000-0001-7420-985X; LeCleir, Gary/0000-0002-0228-7557; Jurgensen, Sophie/0000-0001-5399-510X; Tuttle, Matthew/0000-0002-4582-2097	Tennessee Aquarium, Incorporated	Tennessee Aquarium, Incorporated	Funds to support this work were provided to A.B. by the Tennessee Aquarium, Incorporated.	Abeliovich A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P861, DOI 10.1007/0-387-30745-1_41; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amano T, 2007, MICROBES ENVIRON, V22, P232, DOI 10.1264/jsme2.22.232; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bellucci M, 2011, METHOD ENZYMOL, V496, P269, DOI 10.1016/B978-0-12-386489-5.00011-7; Burns AS, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01250-18; Chen WJ, 2020, ENVIRON SCI POLLUT R, V27, P18661, DOI 10.1007/s11356-020-08432-w; Cooper EA, 1921, BIOCHEM J, V15, P513, DOI 10.1042/bj0150513; Damashek J, 2018, ESTUAR COAST, V41, P626, DOI 10.1007/s12237-017-0306-2; De Vrieze J, 2018, ENVIRON MICROBIOL, V20, P1991, DOI 10.1111/1462-2920.14269; Ganesan S, 2020, BIORESOURCE TECHNOL, V296, DOI 10.1016/j.biortech.2019.122341; Gonzalez-Martinez A, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny031; Grossart HP, 2020, LIMNOL OCEANOGR, V65, pS2, DOI 10.1002/lno.11382; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kim JH, 2019, ENVIRON TOXICOL PHAR, V67, P73, DOI 10.1016/j.etap.2019.02.001; Lackner S, 2014, WATER RES, V55, P292, DOI 10.1016/j.watres.2014.02.032; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lynch JB, 2019, SCIENCE, V365, P1405, DOI 10.1126/science.aay0240; Ma B, 2016, BIORESOURCE TECHNOL, V200, P981, DOI 10.1016/j.biortech.2015.10.074; Meng FG, 2017, WATER RES, V114, P151, DOI 10.1016/j.watres.2017.02.006; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Oshiki M, 2013, MICROBES ENVIRON, V28, P436, DOI 10.1264/jsme2.ME13077; Paerl HW, 2002, ANTON LEEUW INT J G, V81, P487, DOI 10.1023/A:1020561422706; Pajares S, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00739; Patin NV, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00179-18; Proctor L, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0620-y; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shi XF, 2014, J WATER PROCESS ENG, V1, P121, DOI 10.1016/j.jwpe.2014.04.003; Tal Y, 2006, APPL ENVIRON MICROB, V72, P2896, DOI 10.1128/AEM.72.4.2896-2904.2006; Teng Y, 2019, PEDOSPHERE, V29, P283, DOI 10.1016/S1002-0160(18)60061-X; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Van Bonn W, 2015, ZOO BIOL, V34, P360, DOI 10.1002/zoo.21220; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; van Niftrik L, 2012, MICROBIOL MOL BIOL R, V76, P585, DOI 10.1128/MMBR.05025-11; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Wilmes P, 2009, CURR OPIN MICROBIOL, V12, P310, DOI 10.1016/j.mib.2009.03.004; Wu N, 2018, CHEMOSPHERE, V208, P460, DOI 10.1016/j.chemosphere.2018.06.012; Zheng DD, 1996, APPL ENVIRON MICROB, V62, P4504, DOI 10.1128/AEM.62.12.4504-4513.1996; Zhu YG, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.105059; Zorz J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00281	49	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267881	10.1371/journal.pone.0267881	http://dx.doi.org/10.1371/journal.pone.0267881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551553	Green Published, gold			2022-12-26	WOS:000868179400005
J	Lunn, RB; Blackwell, BF; DeVault, TL; Fernandez-Juricic, E				Lunn, Ryan B.; Blackwell, Bradley F.; DeVault, Travis L.; Fernandez-Juricic, Esteban			Can we use antipredator behavior theory to predict wildlife responses to high-speed vehicles?	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; AGE-RELATED DIFFERENCES; RISK-ASSESSMENT; ESCAPE BEHAVIOR; PREDATOR RECOGNITION; INDIVIDUAL VARIATION; QUANTILE REGRESSION; ENERGY-EXPENDITURE; LIMITED ATTENTION; NUCLEUS ROTUNDUS	Animals seem to rely on antipredator behavior to avoid vehicle collisions. There is an extensive body of antipredator behavior theory that have been used to predict the distance/time animals should escape from predators. These models have also been used to guide empirical research on escape behavior from vehicles. However, little is known as to whether antipredator behavior models are appropriate to apply to an approaching high-speed vehicle scenario. We addressed this gap by (a) providing an overview of the main hypotheses and predictions of different antipredator behavior models via a literature review, (b) exploring whether these models can generate quantitative predictions on escape distance when parameterized with empirical data from the literature, and (c) evaluating their sensitivity to vehicle approach speed using a simulation approach wherein we assessed model performance based on changes in effect size with variations in the slope of the flight initiation distance (FID) vs. approach speed relationship. The slope of the FID vs. approach speed relationship was then related back to three different behavioral rules animals may rely on to avoid approaching threats: the spatial, temporal, or delayed margin of safety. We used literature on birds for goals (b) and (c). Our review considered the following eight models: the economic escape model, Blumstein's economic escape model, the optimal escape model, the perceptual limit hypothesis, the visual cue model, the flush early and avoid the rush (FEAR) hypothesis, the looming stimulus hypothesis, and the Bayesian model of escape behavior. We were able to generate quantitative predictions about escape distance with the last five models. However, we were only able to assess sensitivity to vehicle approach speed for the last three models. The FEAR hypothesis is most sensitive to high-speed vehicles when the species follows the spatial (FID remains constant as speed increases) and the temporal margin of safety (FID increases with an increase in speed) rules of escape. The looming stimulus effect hypothesis reached small to intermediate levels of sensitivity to high-speed vehicles when a species follows the delayed margin of safety (FID decreases with an increase in speed). The Bayesian optimal escape model reached intermediate levels of sensitivity to approach speed across all escape rules (spatial, temporal, delayed margins of safety) but only for larger (> 1 kg) species, but was not sensitive to speed for smaller species. Overall, no single antipredator behavior model could characterize all different types of escape responses relative to vehicle approach speed but some models showed some levels of sensitivity for certain rules of escape behavior. We derive some applied applications of our findings by suggesting the estimation of critical vehicle approach speeds for managing populations that are especially susceptible to road mortality. Overall, we recommend that new escape behavior models specifically tailored to high-speeds vehicles should be developed to better predict quantitatively the responses of animals to an increase in the frequency of cars, airplanes, drones, etc. they will face in the next decade.	[Lunn, Ryan B.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Blackwell, Bradley F.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Sandusky, OH USA; [DeVault, Travis L.] Univ Georgia, Savannah River Ecol Lab, Jackson, SC USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Department of Energy (DOE); Savannah River Ecology Laboratory	Lunn, RB (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	rlunn@purdue.edu		Lunn, Ryan/0000-0001-9998-3200	USDA Wildlife Services; FAA [APH-HQ-19-0122]; USDA/WS/NWRC; Purdue [20-7439-1452CA]; U.S. Department of Energy [DE-EM0005228]	USDA Wildlife Services; FAA; USDA/WS/NWRC; Purdue; U.S. Department of Energy(United States Department of Energy (DOE))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Contributions by B. F. Blackwell were in part supported by the interagency agreement between the USDA Wildlife Services and the FAA (APH-HQ-19-0122). R.B. Lunn and E. Ferna ' ndez-Juricic, were in part supported by the cooperative agreement between the USDA/WS/NWRC and Purdue (20-7439-1452CA). Contributions by T.L. DeVault were partially supported by the U.S. Department of Energy under award #DE-EM0005228 to the University of Georgia Research Foundation.	Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Allan JR., 2001, 2001 BIRD STRIKE COM, P2; Anderson A, 2015, TRANSPORT RES D-TR E, V38, P49, DOI 10.1016/j.trd.2015.04.027; Armel KC, 2008, JUDGM DECIS MAK, V3, P396; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Bernard GE, 2018, LANDSCAPE URBAN PLAN, V178, P276, DOI 10.1016/j.landurbplan.2018.06.006; Bernhardt GE, 2010, IBIS, V152, P830, DOI 10.1111/j.1474-919X.2010.01043.x; Blackwell BF, 2004, J WILDLIFE MANAGE, V68, P725, DOI 10.2193/0022-541X(2004)068[0725:EOALLI]2.0.CO;2; Blackwell BF, 2019, PEERJ, V7, DOI 10.7717/peerj.8164; Blackwell BF, 2019, J WILDLIFE MANAGE, V83, P893, DOI 10.1002/jwmg.21650; Blackwell BF, 2016, ANIM BEHAV, V120, P245, DOI 10.1016/j.anbehav.2016.07.013; Blackwell BF, 2013, WILDL MANAGE CONSERV, P11; Blackwell BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109988; Blackwell BF, 2012, J APPL ECOL, V49, P758, DOI 10.1111/j.1365-2664.2012.02165.x; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Blumstein DT, 2016, CURR OPIN BEHAV SCI, V12, P24, DOI 10.1016/j.cobeha.2016.08.006; Blumstein DT, 2016, ANIM BEHAV, V120, P255, DOI 10.1016/j.anbehav.2016.05.012; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Bonenfant M, 1996, BEHAV ECOL, V7, P299, DOI 10.1093/beheco/7.3.299; Briffa M, 2013, ANIM BEHAV, V86, P47, DOI 10.1016/j.anbehav.2013.04.009; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Brown GE, 2013, BEHAV ECOL SOCIOBIOL, V67, P43, DOI 10.1007/s00265-012-1422-4; Bushnell PJ, 1998, PSYCHOPHARMACOLOGY, V138, P231, DOI 10.1007/s002130050668; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cardenas YL, 2005, ANIM BEHAV, V70, P1395, DOI 10.1016/j.anbehav.2005.03.022; Caro Tim, 2005, pXIII; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Chivers DP, 2014, GLOBAL CHANGE BIOL, V20, P515, DOI 10.1111/gcb.12291; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conover M., 2001, Resolving human-wildlife conflicts: the science of wildlife damage management; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; Cooper Jr W. E., 2015, ESCAPING PREDATORS I; Cooper WE, 2003, CAN J ZOOL, V81, P979, DOI 10.1139/Z03-079; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; William EC, 2006, ETHOLOGY, V112, P858, DOI 10.1111/j.1439-0310.2006.01240.x; Cooper WE, 2015, ADV STUD BEHAV, V47, P147, DOI 10.1016/bs.asb.2015.02.002; Cooper WE, 2014, BEHAV ECOL, V25, P44, DOI 10.1093/beheco/art083; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CURIO E, 1988, AM NAT, V131, P825, DOI 10.1086/284824; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DeVault TL, 2018, CAN J ZOOL, V96, P441, DOI 10.1139/cjz-2017-0142; DeVault TL, 2017, J ZOOL, V301, P17, DOI 10.1111/jzo.12385; DeVault TL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2188; DeVault TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087944; Dolan T, 2010, BRAIN BEHAV EVOLUT, V75, P111, DOI 10.1159/000305025; Dommes A, 2012, ACCIDENT ANAL PREV, V44, P42, DOI 10.1016/j.aap.2010.12.012; Doppler MS, 2015, CONDOR, V117, P165, DOI 10.1650/CONDOR-14-157.1; Dukas R, 2000, BEHAV ECOL, V11, P502, DOI 10.1093/beheco/11.5.502; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Elvidge CK, 2013, OECOLOGIA, V172, P69, DOI 10.1007/s00442-012-2478-6; Ensminger AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111854; Fernandez-Juricic E, 2001, ENVIRON CONSERV, V28, P263, DOI 10.1017/S0376892901000273; Ferrari MCO, 2010, BEHAV ECOL, V21, P532, DOI 10.1093/beheco/arq023; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Frid A, 2002, CONSERV ECOL, V6; Frost BJ., 2004, TIME TO CONTACT, V135, P13, DOI DOI 10.1016/S0166-4115(04)80004-9; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Garvey PM, 2020, TRENDS ECOL EVOL, V35, P990, DOI 10.1016/j.tree.2020.07.007; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Goller B, 2018, PEERJ, V6, DOI 10.7717/peerj.5404; Griffin AS, 2001, ANIM BEHAV, V62, P577, DOI 10.1006/anbe.2001.1781; Guay Patrick-Jean, 2014, Victorian Naturalist (Blackburn), V131, P150; Gulbransen D, 2006, ETHOLOGY, V112, P1056, DOI 10.1111/j.1439-0310.2006.01265.x; Hemmi JM, 2009, P R SOC B, V276, P4381, DOI 10.1098/rspb.2009.1452; Highcock L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095179; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Holm L, 2008, J VISION, V8, DOI 10.1167/8.4.14; Holmern T, 2016, BEHAV ECOL, V27, P1432, DOI 10.1093/beheco/arw052; Javurkova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032522; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kirk E. Christopher, 2004, P539; Kokko H, 2007, MODELLING FOR FIELD BIOLOGISTS AND OTHER INTERESTING PEOPLE, P1, DOI 10.1017/CBO9780511811388; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Lethlean H, 2017, LANDSCAPE URBAN PLAN, V159, P42, DOI 10.1016/j.landurbplan.2016.08.020; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2015, BIOL REV, V90, P60, DOI 10.1111/brv.12093; Lobjois R, 2007, ACCIDENT ANAL PREV, V39, P934, DOI 10.1016/j.aap.2006.12.013; Lobjois R, 2013, ACCIDENT ANAL PREV, V53, P166, DOI 10.1016/j.aap.2012.12.028; Lobjois R, 2009, ACCIDENT ANAL PREV, V41, P259, DOI 10.1016/j.aap.2008.12.001; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2014, J WILDLIFE MANAGE, V78, P763, DOI 10.1002/jwmg.721; MCGARIGAL K, 1991, WILDLIFE MONOGR, P1; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Miksis-Olds JL, 2007, J ACOUST SOC AM, V121, P3011, DOI 10.1121/1.2713555; Mukherjee Shomen, 2013, Canadian Field-Naturalist, V127, P229; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nudds RL, 2000, J EXP BIOL, V203, P1561; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; Quinn JL, 2005, BEHAVIOUR, V142, P1377, DOI 10.1163/156853905774539391; Quinn JL, 2005, ANIM BEHAV, V69, P1285, DOI 10.1016/j.anbehav.2004.10.007; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Rodriguez-Prieto I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1937, DOI 10.1007/s00265-010-1004-2; Ronald KL, 2017, BIOL OPEN, V6, P1771, DOI 10.1242/bio.028282; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Samia DSM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119906; Samia DSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113134; Samia DSM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0016; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Sengui Zheng., 2012, R PACKAGE VERSION 10; STALMASTER MV, 1978, J WILDLIFE MANAGE, V42, P506, DOI 10.2307/3800811; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Sutton NM, 2018, AM NAT, V192, P321, DOI 10.1086/698692; Swarthout ECH, 2001, J WILDLIFE MANAGE, V65, P312, DOI 10.2307/3802910; Team R.C, R LANG ENV STAT COMP; Transportation RT., 2020, FEDERAL AVIATION ADM; Tyrrell LP., 2015, ESCAPING PREDATORS I, P322; Tyrrell LP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03231; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Wann JP, 2011, PSYCHOL SCI, V22, P429, DOI 10.1177/0956797611400917; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wu LQ, 2005, EUR J NEUROSCI, V22, P2325, DOI 10.1111/j.1460-9568.2005.04397.x; Xiao Q, 2006, BRAIN RES BULL, V68, P322, DOI 10.1016/j.brainresbull.2005.09.003; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	132	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267774	10.1371/journal.pone.0267774	http://dx.doi.org/10.1371/journal.pone.0267774			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551549	Green Published, Green Submitted, gold			2022-12-26	WOS:000868164600032
J	Kang, N; Koh, E; Lee, JY; Song, WJ; Choi, DC; Lee, BJ				Kang, Noeul; Koh, Eunsil; Lee, Jin-Young; Song, Woo-Jung; Choi, Dong-Chull; Lee, Byung-Jae			Cut-off value for exercise-induced bronchoconstriction based on the features of the airway obstruction	PLOS ONE			English	Article							INDUCED BRONCHOSPASM; INDIRECT CHALLENGES; ASTHMA; CHILDREN; FEV1; FLOW	The current cut-off value for diagnosing exercise-induced bronchoconstriction (EIB) in adults-percent fall in FEV1 (Delta FEV1) >= 10% after exercise challenge test (ECT)-has low specificity and weak evidences. Therefore, this study aimed to identify the cut-off value for EIB that provides the highest diagnostic sensitivity and specificity. Participants who underwent the ECT between 2007 and 2018 were categorized according to Delta FEV1: definite EIB (Delta FEV1 >= 15%), borderline (10% <= Delta FEV1 < 15%), and normal (Delta FEV1 < 10%). Distinct characteristics of the definite EIB group were identified and explored in the borderline EIB group. A receiver operating characteristic curve was plotted to determine the optimal cut-off value. Of 128 patients, 60 were grouped as the definite EIB group, 23 as the borderline group, and 45 as the normal group. All participants were men, with a median age of 20 years (interquartile range [IQR:] 19-23 years). The definite EIB group exhibited wheezing on auscultation (P < 0.001), Delta FEV1/FVC >= 10% (P < 0.001), and Delta FEF25-75% >= 25% (P < 0.001) compared to other groups. Eight (8/23, 34.8%) patients in the borderline group had at least one of these features, but the trend was more similar to that of the normal group than the definite EIB group. A cut-off value of Delta FEV1 >= 13.5% had a sensitivity of 98.5% and specificity of 93.5% for EIB. Wheezing on auscultation, Delta FEV1/FVC >= 10%, and Delta FEF25-75% >= 25% after ECT may be useful for the diagnosis of EIB, particularly in individuals with a Delta FEV1 of 10-15%. For EIB, a higher cut-off value, possibly Delta FEV1 >= 13.5%, should be considered as the diagnostic criterion.	[Kang, Noeul; Koh, Eunsil; Choi, Dong-Chull; Lee, Byung-Jae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Allergy, Seoul, South Korea; [Lee, Jin-Young] Samsung Med Ctr, Hlth Promot Ctr, Seoul, South Korea; [Song, Woo-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center	Lee, BJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Allergy, Seoul, South Korea.	leebj@skku.edu		Kang, Noeul/0000-0003-0925-3891				Anderson SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-120; Anderson SD, 2010, CHEST, V138, p25S, DOI 10.1378/chest.10-0116; BECK KC, 1994, AM J RESP CRIT CARE, V149, P352, DOI 10.1164/ajrccm.149.2.8306029; Buchvald F, 2005, CHEST, V128, P1964, DOI 10.1378/chest.128.4.1964; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Cockcroft D, 2009, ANN ALLERG ASTHMA IM, V103, P363, DOI 10.1016/S1081-1206(10)60353-5; Cockcroft DW, 2003, CLIN REV ALLERG IMMU, V24, P19, DOI 10.1385/CRIAI:24:1:19; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; CUSTOVIC A, 1994, CHEST, V105, P1127, DOI 10.1378/chest.105.4.1127; Duong M, 2008, CHEST, V133, P404, DOI 10.1378/chest.07-2048; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Fonseca-Guedes CHF, 2003, PEDIATR PULM, V36, P49, DOI 10.1002/ppul.10309; Fuentes C, 2011, J ASTHMA, V48, P729, DOI 10.3109/02770903.2011.594139; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Godfrey S, 1999, EUR RESPIR J, V14, P659, DOI 10.1034/j.1399-3003.1999.14c28.x; Holzer K, 2002, J ALLERGY CLIN IMMUN, V110, P374, DOI 10.1067/mai.2002.127784; Industry, 2002, GF EX IND BRONCH EIB; KATTAN M, 1978, J PEDIATR-US, V92, P718, DOI 10.1016/S0022-3476(78)80135-8; Koh YI, 2002, CLIN EXP ALLERGY, V32, P532, DOI 10.1046/j.0954-7894.2002.01353.x; Lipworth BJ, 1997, THORAX, V52, P1036, DOI 10.1136/thx.52.12.1036; Manoharan A, 2015, LUNG, V193, P47, DOI 10.1007/s00408-014-9674-6; MARINI JJ, 1979, AM REV RESPIR DIS, V120, P1069; Marseglia GL, 2007, ALLERGY ASTHMA PROC, V28, P74, DOI 10.2500/aap.2007.28.2920; MCFADDEN ER, 1994, NEW ENGL J MED, V330, P1362, DOI 10.1056/NEJM199405123301907; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Parsons JP, 2007, MED SCI SPORT EXER, V39, P1487, DOI 10.1249/mss.0b013e3180986e45; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Rundell KW, 2008, J ALLERGY CLIN IMMUN, V122, P238, DOI 10.1016/j.jaci.2008.06.014; Rundell KW, 2001, MED SCI SPORT EXER, V33, P208; Sallaoui Ridha, 2009, BMC Pulm Med, V9, P8, DOI 10.1186/1471-2466-9-8; SHIM CS, 1983, ARCH INTERN MED, V143, P890, DOI 10.1001/archinte.143.5.890; SINCLAIR DG, 1995, EUR RESPIR J, V8, P1314, DOI 10.1183/09031936.95.08081314; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Weiler JM, 2007, J ALLERGY CLIN IMMUN, V119, P1349, DOI 10.1016/j.jaci.2007.02.041; Weiler JM, 2016, J ALLERGY CLIN IMMUN, V138, P1292, DOI 10.1016/j.jaci.2016.05.029; Weiler JM, 2014, J ALLER CL IMM-PRACT, V2, P275, DOI 10.1016/j.jaip.2013.11.001	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268969	http://dx.doi.org/10.1371/journal.pone.0268969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617173	Green Published, gold			2022-12-26	WOS:000835048800004
J	Sitthiyotha, T; Klaewkla, M; Krusong, K; Pichyangkura, R; Chunsrivirot, S				Sitthiyotha, Thassanai; Klaewkla, Methus; Krusong, Kuakarun; Pichyangkura, Rath; Chunsrivirot, Surasak			Computational design of Lactobacillus Acidophilus alpha-L-rhamnosidase to increase its structural stability	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BACILLUS-CIRCULANS XYLANASE; SWISS-MODEL; BIOCHEMICAL-CHARACTERIZATION; SELECTIVE DERHAMNOSYLATION; ASPERGILLUS-TERREUS; CHAIN-LENGTH; PURIFICATION; THERMOSTABILIZATION; IMMOBILIZATION	alpha-L-rhamnosidase catalyzes hydrolysis of the terminal alpha-L-rhamnose from various natural rhamnoglycosides, including naringin and hesperidin, and has various applications such as debittering of citrus juices in the food industry and flavonoid derhamnosylation in the pharmaceutical industry. However, its activity is lost at high temperatures, limiting its usage. To improve Lactobacillus acidophilus alpha-L-rhamnosidase stability, we employed molecular dynamics (MD) to identify a highly flexible region, as evaluated by its root mean square fluctuation (RMSF) value, and computational protein design (Rosetta) to increase rigidity and favorable interactions of residues in highly flexible regions. MD results show that five regions have the highest flexibilities and were selected for design by Rosetta. Twenty-one designed mutants with the best Delta Delta G at each position and Delta Delta G < 0 REU were simulated at high temperature. Eight designed mutants with Delta RMSF of highly flexible regions lower than -10.0% were further simulated at the optimum temperature of the wild type. N88Q, N202V, G207D, Q209M, N211T and Y213K mutants were predicted to be more stable and could maintain their native structures better than the wild type due to increased hydrogen bond interactions of designed residues and their neighboring residues. These designed mutants are promising enzymes with high potential for stability improvement.	[Sitthiyotha, Thassanai; Klaewkla, Methus; Krusong, Kuakarun; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Unit, Bangkok, Thailand; [Pichyangkura, Rath] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Unit, Bangkok, Thailand.	surasak.ch@chula.ac.th			ARDA [CRP6405031560]; Agricultural Research Development Agency (Public Organization) of Thailand	ARDA; Agricultural Research Development Agency (Public Organization) of Thailand	This research project was financially supported by Agricultural Research Development Agency (Public Organization) of Thailand or "ARDA" grant number CRP6405031560.	Amber C., 2018, AMBER 2018 REFERENCE; [Anonymous], 1995, FOOD SCI TECHNOL INT, DOI [10.3136/fsti9596t9798.1.29, DOI 10.3136/FSTI9596T9798.1.29]; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ayutthaya PPN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198484; Beekwilder J, 2009, APPL ENVIRON MICROB, V75, P3447, DOI 10.1128/AEM.02675-08; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Busto MD, 2007, FOOD CHEM, V104, P1177, DOI 10.1016/j.foodchem.2007.01.033; CALDINI C, 1994, ENZYME MICROB TECH, V16, P286, DOI 10.1016/0141-0229(94)90168-6; Charoenwongpaiboon T, 2020, ACS OMEGA, V5, P28001, DOI 10.1021/acsomega.0c03521; Charoenwongpaiboon T, 2019, RSC ADV, V9, P14957, DOI 10.1039/c9ra02137j; Charoenwongpaiboon T, 2019, CARBOHYD POLYM, V209, P111, DOI 10.1016/j.carbpol.2018.12.078; Chen J, 2013, J BIOTECHNOL, V164, P354, DOI 10.1016/j.jbiotec.2013.01.021; Chen R, 2016, PHARM BIOL, V54, P3203, DOI 10.1080/13880209.2016.1216131; Cui ZL, 2006, ACTA CRYSTALLOGR F, V62, P646, DOI 10.1107/S174430910601904X; Daniel RM, 2013, FEBS LETT, V587, P2738, DOI 10.1016/j.febslet.2013.06.027; Di Lazzaro A, 2001, J MOL CATAL B-ENZYM, V11, P307, DOI 10.1016/S1381-1177(00)00152-1; Fei BJ, 2013, J IND MICROBIOL BIOT, V40, P457, DOI 10.1007/s10295-013-1260-z; Fujimoto Z, 2013, J BIOL CHEM, V288, P12376, DOI 10.1074/jbc.M113.460097; Gallego MV, 2001, J FOOD SCI, V66, P204, DOI 10.1111/j.1365-2621.2001.tb11317.x; Ghofrani S, 2015, EUR J PHARMACOL, V764, P195, DOI 10.1016/j.ejphar.2015.07.001; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GRAUMLICH TR, 1986, J AGR FOOD CHEM, V34, P402, DOI 10.1021/jf00069a004; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guillotin L, 2019, ACS OMEGA, V4, P1916, DOI 10.1021/acsomega.8b03186; Ichinose H, 2013, BIOSCI BIOTECH BIOCH, V77, P213, DOI 10.1271/bbb.120735; Joo JC, 2011, J BIOTECHNOL, V151, P56, DOI 10.1016/j.jbiotec.2010.10.002; Joo JC, 2010, J BIOTECHNOL, V146, P31, DOI 10.1016/j.jbiotec.2009.12.021; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Kanjanatanin P, 2019, INT J BIOL MACROMOL, V140, P1239, DOI 10.1016/j.ijbiomac.2019.08.151; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klaewkla M, 2021, J PHYS CHEM B, V125, P5766, DOI 10.1021/acs.jpcb.1c02016; Klaewkla M, 2020, INT J BIOL MACROMOL, V160, P252, DOI 10.1016/j.ijbiomac.2020.05.102; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li LJ, 2021, BIOTECHNOL BIOENG, V118, P3409, DOI 10.1002/bit.27758; Li SF, 2021, BIOTECHNOL BIOENG, V118, P4441, DOI 10.1002/bit.27913; Liu XY, 2017, BIOTECHNOLOGY OF MICROBIAL ENZYMES: PRODUCTION, BIOCATALYSIS AND INDUSTRIAL APPLICATIONS, P267, DOI 10.1016/B978-0-12-803725-6.00011-X; Loshbaugh AL, 2020, PROTEINS, V88, P206, DOI 10.1002/prot.25790; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mamonova TB, 2013, BBA-PROTEINS PROTEOM, V1834, P854, DOI 10.1016/j.bbapap.2013.02.011; Manissorn J, 2020, ACS CHEM BIOL, V15, P3235, DOI 10.1021/acschembio.0c00791; Manzanares P, 1997, FEMS MICROBIOL LETT, V157, P279, DOI 10.1016/S0378-1097(97)00487-4; Mokmak W, 2014, CHEM BIOL DRUG DES, V84, P450, DOI 10.1111/cbdd.12334; Mokmak W, 2013, J MOL MODEL, V19, P521, DOI 10.1007/s00894-012-1565-2; Monti D, 2004, BIOTECHNOL BIOENG, V87, P763, DOI 10.1002/bit.20187; Pachl P, 2018, ACTA CRYSTALLOGR D, V74, P1078, DOI 10.1107/S2059798318013049; Parra-Cruz R, 2018, J PHYS CHEM B, V122, P8526, DOI 10.1021/acs.jpcb.8b05926; Punnatin P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229734; Puri M, 1996, CRIT REV BIOTECHNOL, V16, P145, DOI 10.3109/07388559609147419; Raveendran S, 2018, FOOD TECHNOL BIOTECH, V56, P16, DOI 10.17113/ftb.56.01.18.5491; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Scaroni E, 2002, LETT APPL MICROBIOL, V34, P461, DOI 10.1046/j.1472-765X.2002.01115.x; Sitthiyotha T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94873-3; Sitthiyotha T, 2020, J PHYS CHEM B, V124, P10930, DOI 10.1021/acs.jpcb.0c07890; Sitthiyotha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204915; Soria F, 2002, BIOSCI BIOTECH BIOCH, V66, P1442, DOI 10.1271/bbb.66.1442; Wangpaiboon K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063229; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608; Yu HS, 2004, PROCESS BIOCHEM, V39, P861, DOI 10.1016/S0032-9592(03)00196-1; Zverlov VV, 2000, MOL MICROBIOL, V35, P173, DOI 10.1046/j.1365-2958.2000.01691.x	63	0	0	8	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268953	10.1371/journal.pone.0268953	http://dx.doi.org/10.1371/journal.pone.0268953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3LQ	35613129	gold, Green Published			2022-12-26	WOS:000834666000010
J	Zhang, XX; Xie, HY; Iaea, D; Khelashvili, G; Weinstein, H; Max, FR				Zhang, Xiaoxue; Xie, Hengyi; Iaea, David; Khelashvili, George; Weinstein, Harel; Max, Frederick R.			Phosphatidylinositol phosphates modulate interactions between the StarD4 sterol trafficking protein and lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC RECYCLING COMPARTMENT; CHOLESTEROL TRAFFICKING; PLASMA-MEMBRANE; TRANSPORT; BINDING; DOMAIN; ER; 4-PHOSPHATE; MECHANISM; DYNAMICS	There is substantial evidence for extensive nonvesicular sterol transport in cells. For example, lipid transfer by the steroidogenic acute regulator-related proteins (StarD) containing a StarT domain has been shown to involve several pathways of nonvesicular trafficking. Among the soluble StarT domain-containing proteins, StarD4 is expressed in most tissues and has been shown to be an effective sterol transfer protein. However, it was unclear whether the lipid composition of donor or acceptor membranes played a role in modulating StarD4-mediated transport. Here, we used fluorescence-based assays to demonstrate a phosphatidylinositol phosphate (PIP)-selective mechanism by which StarD4 can preferentially extract sterol from liposome membranes containing certain PIPs (especially, PI(4,5)P2 and to a lesser degree PI(3,5)P2). Monophosphorylated PIPs and other anionic lipids had a smaller effect on sterol transport. This enhancement of transport was less effective when the same PIPs were present in the acceptor membranes. Furthermore, using molecular dynamics (MD) simulations, we mapped the key interaction sites of StarD4 with PIP-containing membranes and identified residues that are important for this interaction and for accelerated sterol transport activity. We show that StarD4 recognizes membrane-specific PIPs through specific interaction with the geometry of the PIP headgroup as well as the surrounding membrane environment. Finally, we also observed that StarD4 can deform membranes upon longer incubations. Taken together, these results suggest a mechanism by which PIPs modulate cholesterol transfer activity via StarD4.	[Zhang, Xiaoxue; Iaea, David; Max, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Xie, Hengyi; Khelashvili, George; Weinstein, Harel] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Max, Frederick R.] Rockefeller Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [Max, Frederick R.] Mem Sloan Kettering Canc Ctr, Triinst Chem Biol Program, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center	Max, FR (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.; Weinstein, H (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.; Max, FR (corresponding author), Rockefeller Univ, Weill Cornell Med Coll, New York, NY 10065 USA.	haw2002@med.cornell.edu; frmaxfie@med.cornell.edu		Xie, Hengyi/0000-0001-5712-2058; Maxfield, Frederick/0000-0003-4396-8866	DOE Office of Science User Facility [DE-AC0500OR22725]; COVID-19 HPC Consortium	DOE Office of Science User Facility(United States Department of Energy (DOE)); COVID-19 HPC Consortium	Access to the following computational re-sources is gratefully acknowledged: the Oak Ridge Leadership Computing Facility (INCITE allocations BIP109) at the Oak Ridge National Laboratory, which is a DOE Office of Science User Facility supported under Contract DE-AC0500OR22725 and the RPI Artificial Intelligence Multiprocessing Optimized System (AiMOS) system accessed through an award from the COVID-19 HPC Consortium (https://covid19-hpc-consortium.org/) , which is a unique private-public effort to bring together government, industry, and academic leaders volunteering free compute time and resources in support of COVID-19 research.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Blanchette-Mackie E. J., 1998, INTRACELLULAR CHOLES; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Dikiy I, 2013, BIOMOL NMR ASSIGN, V7, P245, DOI 10.1007/s12104-012-9419-5; Dittman JS, 2017, TRENDS BIOCHEM SCI, V42, P90, DOI 10.1016/j.tibs.2016.11.004; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Gallegos AM, 2001, BIOCHEMISTRY-US, V40, P6493, DOI 10.1021/bi010217l; Garbarino J, 2012, J LIPID RES, V53, P2716, DOI 10.1194/jlr.M032227; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Iaea D. B., 2014, CHOLESTEROL TRANSPOR, P173; Iaea DB, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158609; Iaea DB, 2017, MOL BIOL CELL, V28, P1111, DOI 10.1091/mbc.E16-07-0499; Iaea DB, 2015, BIOCHEMISTRY-US, V54, P4623, DOI 10.1021/acs.biochem.5b00618; Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/BSE0570043, 10.1042/bse0570043]; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Khelashvili G, 2008, BIOPHYS J, V94, P2580, DOI 10.1529/biophysj.107.120667; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2012, BIOCHEMISTRY-US, V51, P7685, DOI 10.1021/bi300833z; Khelashvili G, 2010, ANN REP COMP CHEM, V6, P237, DOI 10.1016/S1574-1400(10)06012-3; Khelashvili G, 2009, BIOPHYS J, V97, P1626, DOI 10.1016/j.bpj.2009.07.006; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Maxfield F.R., 2013, ENCY BIOPHYSICS, P1289, DOI [10.1007/978-3-642-16712-6_651, DOI 10.1007/978-3-642-16712-6_651]; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Menon AK, 2016, BBA-MOL CELL BIOL L, V1861, P755, DOI 10.1016/j.bbalip.2016.05.004; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mobius W, 2003, TRAFFIC, V4, P222; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rodriguez-Agudo D, 2011, BBA-MOL CELL BIOL L, V1811, P597, DOI 10.1016/j.bbalip.2011.06.028; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandhu J, 2018, CELL, V175, P514, DOI 10.1016/j.cell.2018.08.033; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wijdeven RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11808; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yaworsky DC, 2005, J BIOL CHEM, V280, P2045, DOI 10.1074/jbc.M410937200; Zhang XX, 2018, BIOCHEMISTRY-US, V57, P1868, DOI 10.1021/acs.biochem.7b01190; Zhang XX, 2017, BIOCHEMISTRY-US, V56, P376, DOI 10.1021/acs.biochem.6b01016	61	0	0	5	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102058	10.1016/j.jbc.2022.102058	http://dx.doi.org/10.1016/j.jbc.2022.102058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35605664	Green Published, gold			2022-12-26	WOS:000829549100007
J	Yan, JM; Liu, QH; Tang, Q; Zhang, JH; Jing, XD; Xia, Y; Xu, Y; Li, JH; Li, YP; He, JH				Yan, Jiamin; Liu, Qinhui; Tang, Qin; Zhang, Jinhang; Jing, Xiandan; Xia, Yan; Xu, Ying; Li, Jiahui; Li, Yanping; He, Jinhan			Mesencephalic astrocyte-derived neurotrophic factor alleviates non-alcoholic steatohepatitis induced by Western diet in mice	FASEB JOURNAL			English	Article						inflammation response; lipid accumulation; mesencephalic astrocyte-derived neurotrophic factor; non-alcoholic steatohepatitis; nuclear factor-kappa B; sterol regulatory element binding protein 1	NF-KAPPA-B; LIVER-INJURY; MANF; INFLAMMATION; METABOLISM	Excessive lipid accumulation, inflammation, and fibrosis in the liver are the major characteristics of non-alcoholic steatohepatitis (NASH). Mesencephalic astrocyte-derived neurotrophic factor (MANF) plays an important role in metabolic homeostasis, raising the possibility that it is involved in NASH. Here, we reduced and increased MANF levels in mice in order to explore its influence on hepatic triglyceride homeostasis, inflammation, and fibrosis during NASH progression. The MANF expression was decreased in Western diet-induced NASH mice. In vivo, liver-specific MANF knockout exacerbated hepatic lipid accumulation, inflammation, and fibrosis of mice induced by Western diet, while liver-specific MANF overexpression mitigated these NASH pathogenic features. In vitro, knocking down MANF in primary hepatocyte cultures aggravated hepatic steatosis and inflammation, which MANF overexpression markedly attenuated. Studies in vitro and in vivo suggested that MANF regulated hepatic lipid synthesis by modulating SREBP1 expression. Inhibiting SREBP1 in primary hepatocytes blocked lipid accumulation after MANF knockdown. MANF overexpression reversed LXRs agonist GW3965 induced SREBP1 and LIPIN1 expression. MANF decreased the expression of pro-inflammatory cytokines by inhibiting NF-kappa B phosphorylation. These results suggest that MANF can protect against NASH by regulating SREBP1 expression and NF-kappa B signaling.	[Yan, Jiamin; Zhang, Jinhang; Xia, Yan; Xu, Ying; Li, Jiahui; He, Jinhan] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Dept Pharm, Chengdu, Peoples R China; [Yan, Jiamin; Liu, Qinhui; Tang, Qin; Zhang, Jinhang; Jing, Xiandan; Xia, Yan; Xu, Ying; Li, Jiahui; Li, Yanping; He, Jinhan] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Clin Pharm & Adverse Drug React, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Li, YP; He, JH (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Clin Pharm & Adverse Drug React, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, Dept Pharm, West China Hosp, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	liyanping_512@163.com; jinhanhe@scu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [82025007, 81930020, 81873662, 81870599]; Sichuan Province [2021YJ0458]; West China Hospital of Sichuan University [2020HXBH095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province; West China Hospital of Sichuan University(Sichuan University)	National Natural Science Foundation of China, Grant/Award Number: 82025007, 81930020, 81873662 and 81870599; Research funding from Sichuan Province, Grant/Award Number: 2021YJ0458; Post--Doctor Research Project, West China Hospital of Sichuan University, Grant/Award Number: 2020HXBH095	Alkhouri N, 2012, J HEPATOL, V57, P1312, DOI 10.1016/j.jhep.2012.07.027; Azzu V, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101210; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bindesboll C, 2016, BIOCHEM J, V473, P899, DOI 10.1042/BJ20151077; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658; Danilova T, 2019, DIABETES, V68, P66, DOI 10.2337/db17-1149; Friedman SL, 2022, HEPATOLOGY, V75, P473, DOI 10.1002/hep.32285; Hall Z, 2017, HEPATOLOGY, V65, P1165, DOI 10.1002/hep.28953; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; He M, 2020, WORLD J GASTROENTERO, V26, P1029, DOI 10.3748/wjg.v26.i10.1029; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Huang CY, 2021, FREE RADICAL BIO MED, V169, P110, DOI 10.1016/j.freeradbiomed.2021.04.008; Jantti M, 2020, CELL TISSUE RES, V382, P83, DOI 10.1007/s00441-020-03263-0; Jin KP, 2020, THERANOSTICS, V10, P5290, DOI 10.7150/thno.42658; Kihira Y, 2020, MOL MED REP, V22, P559, DOI 10.3892/mmr.2020.11076; Kim Y, 2017, TRANSL RES, V188, P1, DOI 10.1016/j.trsl.2017.06.010; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Lim JO, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101626; Liu J, 2020, HEPATOLOGY, V71, P1262, DOI 10.1002/hep.30917; Liu W, 2022, DIABETES, V71, P60, DOI 10.2337/db21-0240; Ma XH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03762-0; Neuschwander-Tetri BA, 2020, GASTROENTEROLOGY, V158, P1984, DOI 10.1053/j.gastro.2020.01.051; Orlandi P, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14100995; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Sato K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092180; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Sousa-Victor P, 2019, NAT METAB, V1, P276, DOI 10.1038/s42255-018-0023-6; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takahashi S, 2020, J BIOL CHEM, V295, P4733, DOI 10.1074/jbc.RA119.011913; Tang Q, 2022, TRENDS ENDOCRIN MET, V33, P236, DOI 10.1016/j.tem.2022.01.001; Tokushige K, 2021, J GASTROENTEROL, V56, P951, DOI 10.1007/s00535-021-01796-x; Voutilainen MH, 2015, FEBS LETT, V589, P3739, DOI 10.1016/j.febslet.2015.09.031; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang P, 2021, FREE RADICAL BIO MED, V162, P283, DOI 10.1016/j.freeradbiomed.2020.10.028; Wang XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091476; Wu T, 2021, J EXP MED, V218, DOI 10.1084/jem.20201203; Yagi T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101810; Yang W, 2014, J NEUROL SCI, V344, P129, DOI 10.1016/j.jns.2014.06.042; Yang Y, 2021, LIVER INT, V41, P623, DOI 10.1111/liv.14697; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yu XG, 2020, J PATHOL, V252, P358, DOI 10.1002/path.5530; Yu Y, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6467679; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhang GR, 2021, BIOCHEM BIOPH RES CO, V550, P197, DOI 10.1016/j.bbrc.2021.02.123; Zhao YC, 2022, HEPATOLOGY, V75, P939, DOI 10.1002/hep.32165	47	0	0	8	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22349	10.1096/fj.202101975R	http://dx.doi.org/10.1096/fj.202101975R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1F4UF	35567505				2022-12-26	WOS:000795164400001
J	Yu, ZY; Lu, Y; Li, Y; An, Y; Wang, B				Yu, Zhaoyu; Lu, Yao; Li, Yong; An, Yan; Wang, Bo			A one-step foraminoplasty via a large trephine in percutaneous endoscopic transforaminal discectomy for the treatment of lumbar disc herniation	PLOS ONE			English	Article							SURGICAL TECHNIQUE; COMPLICATIONS	Background Transforaminal percutaneous endoscopic lumbar discectomy (PELD) is a widely used basic technique for lumbar disc herniation (LDH) with advantages including causing less trauma and fast recovery. The secure, efficient, and rapid enlargement of the intervertebral foramen is a key step in PELD procedures. However, the conventional multi-step trephine system for foraminoplasty involves complicated surgical procedures. In this study, we reported an improved one-step foraminoplasty via a large trephine with simplified surgical procedures, reduced radiation exposure, and shortened operative time. Methods 70 LDH patients who underwent PELD were retrospectively reviewed in this study. The conventional multi-step trephine system was used for foraminoplasty in 35 patients in the multistep (MS) group, and the single large trephine was used in the other 35 patients in the onestep (OS) group. Indicators including the operative time, the time to establish the working cannula, intraoperative fluoroscopy times, the radiation dose, and postoperative complications were compared between the MS and OS group. Results The operative time and the time to establish the working cannula in the OS group was significantly shorter than that in the MS group (P < 0.01); intraoperative fluoroscopy times and the radiation dose in the OS group were significantly smaller than those in the MS group (P < 0.01). There was no statistical difference in the incidence of postoperative complications between the two groups (P > 0.05). The postoperative VAS scores and ODI scores (2 days and 3 months after the surgery) were significantly lower than the preoperative scores in both groups (P < 0.01), and there was no statistical difference in VAS scores or ODI scores between the two groups at the same time points (P > 0.05). Conclusions The one-step foraminoplasty via a single large trephine is an optimized technique evolving from the conventional multi-step foraminoplasty, showing significant superiority in simplified operation, shorted operative time, and reduced radiation exposure.	[Yu, Zhaoyu] Guangzhou Univ Chinese Med, Clin Med Coll 2, Guangzhou, Peoples R China; [Yu, Zhaoyu; Lu, Yao; Li, Yong] Guangdong Prov Hosp Tradit Chinese Med, Zhuhai Branch, Zhuhai, Peoples R China; [An, Yan; Wang, Bo] Beijing Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	An, Y; Wang, B (corresponding author), Beijing Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China.	ay_jstspine@vip.163.com; drwangbo@pku.edu.cn		Zhaoyu, Yu/0000-0001-6479-2543				Ahn Y, 2019, PAIN PHYSICIAN, V22, P295; Ahn Y, 2014, NEUROSURGERY, V75, P124, DOI 10.1227/NEU.0000000000000361; Bao BX, 2019, ORTHOP SURG, V11, P1093, DOI 10.1111/os.12559; Choi KC, 2017, WORLD NEUROSURG, V106, P484, DOI 10.1016/j.wneu.2017.07.035; Eun SS, 2018, J NEUROL SURG PART A, V79, P163, DOI 10.1055/s-0037-1608837; Fan GX, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006684; Fiani Brian, 2021, Surg Neurol Int, V12, P222, DOI 10.25259/SNI_153_2021; He SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011240; Hoogland T, 2006, SPINE, V31, pE890, DOI 10.1097/01.brs.0000245955.22358.3a; Knight MTN, 2014, INT J SPINE SURG, V8, DOI 10.14444/1021; Lin YP, 2020, ANN PALLIAT MED, V9, P3923, DOI 10.21037/apm-20-1956; Liu C, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049902; Pan MM, 2020, PAIN PHYSICIAN, V23, P49; Sairyo K, 2018, J ORTHOP SCI, V23, P229, DOI 10.1016/j.jos.2017.10.015; Uchikado Hisaaki, 2020, J Spine Surg, V6, P405, DOI 10.21037/jss.2019.10.07; Wu PH, 2020, NEUROSPINE, V17, pS20, DOI 10.14245/ns.2040116.058; Wu RH, 2019, WORLD NEUROSURG, V124, pE633, DOI 10.1016/j.wneu.2018.12.169; Yeung AT, 2002, SPINE, V27, P722, DOI 10.1097/00007632-200204010-00009; Yin JJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020709; Yu Y, 2020, ORTHOP SURG, V12, P1277, DOI 10.1111/os.12740; Zhou CL, 2018, PAIN PHYSICIAN, V21, pE105	21	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2022	17	5							e0268564	10.1371/journal.pone.0268564	http://dx.doi.org/10.1371/journal.pone.0268564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6H4YE	35609055	Green Published, gold			2022-12-26	WOS:000885446300001
J	Gaikwad, UN; Bose, O; Padhi, A; Jindal, A; Nagpure, K; Bhargava, A; Das, P				Gaikwad, Ujjwala Nitin; Bose, Oshrika; Padhi, Abhishek; Jindal, Atul; Nagpure, Keshao; Bhargava, Anudita; Das, Padma			A retrospective observational insight into COVID-19 exposures resulting from personal protective equipment (PPE) breaches	PLOS ONE			English	Article								Background Healthcare workers (HCWs) stand the risk of acquiring infection directly, while attending to patients or indirectly while handling and testing patient specimens. Considering this, the present study was planned to assess Personal Protective Equipment (PPE) breaches and exposures among HCWs working in COVID-19 wards/ screening areas and to evaluate their COVID-19 positivity rates post-exposure concerning the level of exposure, type of PPE breach, and the cadre of HCWs exposed in COVID-19 wards. Methods This retrospective cross-sectional study involved the analysis of all instances of PPE breaches which occurred during a period of nine months from June 2020 to February 2021 at a tertiary care level hospital in Central India. The analysis included all exposures involving any cadre of HCWs that occurred while handling the patients or while doffing the contaminated PPE in COVID -19 wards. Results A total of 347 PPE breaches were analyzed from the available records of the Hospital Infection Control team repository. Amongst the 347 breaches, 268 (77.2%) were classified as low-risk exposures and 79 (22.8%) as high-risk exposures. Cadre wise distribution of high and low-risk exposures revealed that, PPE breaches occurred most commonly in the category of nursing officers (n = 174, 50.1%). Among all of the breaches, 15.2% of high-risk exposures and 2.6% of low-risk exposures resulted in COVID-19 positivity with a cumulative positivity of 5.4%. Collectively, non-mask related breaches accounted for the majority (63.2%) of the positive COVID-19 cases. Conclusion Appropriate use of PPE by HCWs is vital for their protection. However, breaches in the use of PPE may occur while managing COVID-19 patients due to physical and mental exhaustion among HCWs resulting from work overload. Early identification and appropriate management of HCWs with high-risk exposures can help prevent transmission to other hospital staff and patients, thus preserving resources and workforce.	[Gaikwad, Ujjwala Nitin; Bose, Oshrika; Padhi, Abhishek; Bhargava, Anudita; Das, Padma] All India Inst Med Sci, Dept Microbiol, Raipur, Chhatisgarh, India; [Jindal, Atul] All India Inst Med Sci, Dept Pediat, Raipur, Chhatisgarh, India; [Nagpure, Keshao] All India Inst Med Sci, Dept Gen Med, Raipur, Chhatisgarh, India	All India Institute of Medical Sciences (AIIMS) Raipur; All India Institute of Medical Sciences (AIIMS) Raipur; All India Institute of Medical Sciences (AIIMS) Raipur	Gaikwad, UN (corresponding author), All India Inst Med Sci, Dept Microbiol, Raipur, Chhatisgarh, India.	ujugaikwad@aiimsraipur.edu.in	Jindal, Atul/AAE-8673-2020	Jindal, Atul/0000-0002-0504-1077; Gaikwad, Ujjwala/0000-0002-9869-2839				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], INT INF PREV CONTR R; Avo C, 2020, J HOSP INFECT, V106, P208, DOI 10.1016/j.jhin.2020.06.024; Biswas VP, 2020, BBC NEWS 0413; Centers for Diseases Control and Prevention, 2020, COR DIS 2019 COVID 1; Centre for Disease Control and Prevention, RISK ASS HEALTHC WOR; Chou R, 2022, ANN INTERN MED, V175, pW8, DOI 10.7326/M21-4294; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Gohil SK, 2021, ANTIMICROB RESIST IN, V10, DOI 10.1186/s13756-021-01031-5; Jacob JT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1283; Ministry of Health and Family Welfare Government of India, GUID RAT US PERS PRO; Ministry of Health and Family Welfare Government of India, UPD ADV MAN HLTH CAR; Ortega R, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMvcm2014809; Pandrowala A, 2021, INDIAN PEDIATR, V58, P568, DOI 10.1007/s13312-021-2243-1; Papoutsi E, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00195-2020; Patel Manali, 2021, J Assoc Physicians India, V69, P11; Peng J, 2020, J HOSP INFECT, V105, P106, DOI 10.1016/j.jhin.2020.02.020; World Health Organization, MOD TRANSM VIR CAUS; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2022	17	5							e0268582	10.1371/journal.pone.0268582	http://dx.doi.org/10.1371/journal.pone.0268582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5H3YX	35580133	gold, Green Published			2022-12-26	WOS:000867618600001
J	Nakano, Y; Watari, T; Adachi, K; Watanabe, K; Otsuki, K; Amano, Y; Takaki, Y; Onigata, K				Nakano, Yasuhisa; Watari, Takashi; Adachi, Kazuya; Watanabe, Kenji; Otsuki, Kazuya; Amano, Yu; Takaki, Yuji; Onigata, Kazumichi			Survey of potentially inappropriate prescriptions for common cold symptoms in Japan: A cross-sectional study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; PATIENT-SATISFACTION; PREVENTION; COUGH; COST	Background Common cold is among the main reasons patients visit a medical facility. However, few studies have investigated whether prescriptions for common cold in Japan comply with domestic and international evidence. Objective To determine whether prescriptions for common cold complied with domestic and international evidence. Methods This cross-sectional study was conducted between October 22, 2020, and January 16, 2021. Patients with cold symptoms who visited the two dispensing pharmacies and met the eligibility criteria were interviewed. Main outcome measure The pharmacists at each store and a physician classified the patients into two groups: the potentially inappropriate prescribing group and the appropriate prescribing group. Results Of the 150 selected patients, 14 were excluded and 136 were included in the analysis. Males accounted for 44.9% of the total study population, and the median patient age was 34 years (interquartile range [IQR], 27-42). The prevalence rates of potentially inappropriate prescriptions and appropriate prescriptions were 89.0% and 11.0%, respectively and the median drug costs were 602.0 yen (IQR, 479.7-839.2) [$5.2 (IQR, 4.2-7.3)] and 406.7 yen (IQR, 194.5-537.2) [$3.5 (IQR, 1.7-4.7)], respectively. The most common potentially inappropriate prescriptions were the prescription of oral cephem antibacterial agents to patients who did not have symptoms of bacterial infections (50.4%) and beta 2 stimulants to those who did not have respiratory symptoms due to underlying disease or history (33.9%). Conclusions Approximately 90% of prescriptions for common cold symptoms in the area were potentially inappropriate. Our findings could contribute to the monitoring of the use of medicines for the treatment of common cold symptoms.	[Nakano, Yasuhisa; Otsuki, Kazuya; Amano, Yu; Onigata, Kazumichi] Shimane Univ, Fac Med, Matsue, Shimane, Japan; [Watari, Takashi] Shimane Univ, Gen Med Ctr, Matsue, Shimane, Japan; [Watari, Takashi] Univ Michigan Hlth Syst, Div Hosp Med, Ann Arbor, MI 48109 USA; [Adachi, Kazuya; Watanabe, Kenji; Takaki, Yuji] Midori Pharm Co Ltd, Matsue, Shimane, Japan; [Onigata, Kazumichi] Shimane Univ Hosp, Postgrad Clin Training Ctr, Matsue, Shimane, Japan	Shimane University; Shimane University; University of Michigan System; University of Michigan; Shimane University	Watari, T (corresponding author), Shimane Univ, Gen Med Ctr, Matsue, Shimane, Japan.; Watari, T (corresponding author), Univ Michigan Hlth Syst, Div Hosp Med, Ann Arbor, MI 48109 USA.	wataritari@gmail.com			National Academic Research Grant Funds (JSPS KAKENHI) [20H03913]	National Academic Research Grant Funds (JSPS KAKENHI)	YES T.W. is supported by grants from the National Academic Research Grant Funds (JSPS KAKENHI: 20H03913). The sponsor of the study had no role in the study design, data collection, analysis, or preparation of the manuscript.	Allan GM, 2014, CAN MED ASSOC J, V186, P190, DOI 10.1503/cmaj.121442; Arroll B, 2005, RESP MED, V99, P1477, DOI 10.1016/j.rmed.2005.09.039; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Blaiss MS, 2015, CURR MED RES OPIN, V31, P1527, DOI 10.1185/03007995.2014.1002558; BRADLEY CP, 1992, BRIT MED J, V304, P294, DOI 10.1136/bmj.304.6822.294; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cannon Katrina T, 2006, Am J Geriatr Pharmacother, V4, P134, DOI 10.1016/j.amjopharm.2006.06.010; Cazzola M, 2020, RESP MED, V164, DOI 10.1016/j.rmed.2020.105904; Deckx L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009612.pub2; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Douma Joeri A J, 2015, Ned Tijdschr Geneeskd, V159, pA9132; Ebihara S, 2008, RESP MED, V102, P1497, DOI 10.1016/j.rmed.2008.03.005; Fashner J, 2012, AM FAM PHYSICIAN, V86, P153; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Fernandez-Liz E, 2008, BRIT J CLIN PHARMACO, V65, P407, DOI 10.1111/j.1365-2125.2007.03029.x; FIXEN DR, 2019, PHARM TODAY, V25, P42; Higashi T, 2009, INTERNAL MED, V48, P1369, DOI 10.2169/internalmedicine.48.1893; Horiguchi Takahiko, 2007, Allergol Int, V56, P263, DOI 10.2332/allergolint.O-06-473; Huntington Mark K, 2013, S D Med, V66, P136; Ida H, 1997, CLIN THER, V19, P215, DOI 10.1016/S0149-2918(97)80111-7; ISHIBASHI Y, 1987, J FAM PRACTICE, V25, P83; Issa I, 2014, WORLD J GASTROENTERO, V20, P17788, DOI 10.3748/wjg.v20.i47.17788; Jungersen Mikkel, 2014, Microorganisms, V2, P92, DOI 10.3390/microorganisms2020092; Katona G, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0084-5; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kirkpatrick GL, 1996, PRIMARY CARE, V23, P657, DOI 10.1016/S0095-4543(05)70355-9; Komagamine Junpei, 2017, BMC Res Notes, V10, P728, DOI 10.1186/s13104-017-3070-2; Lee CC, 2018, J AM COLL CARDIOL, V72, P1369, DOI 10.1016/j.jacc.2018.06.067; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Murai Mitsuya, 2005, BMC Med Educ, V5, P33, DOI 10.1186/1472-6920-5-33; Muscat DM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033126; Nino-Serna LF, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3260; O'Mahony D, 2008, AGE AGEING, V37, P138, DOI 10.1093/ageing/Afm189; Onda M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007581; Sato D, 2021, INFECT CONT HOSP EP, V42, P280, DOI 10.1017/ice.2020.427; Satomura K, 2005, AM J PREV MED, V29, P302, DOI 10.1016/j.amepre.2005.06.013; Scaglione Francesco, 2019, Clin Med Insights Ear Nose Throat, V12, p1179550618821930, DOI 10.1177/1179550618821930; Shikamura Y, 2016, YAKUGAKU ZASSHI, V136, P1263, DOI 10.1248/yakushi.16-00024; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; Sterrantino C, 2016, ACTA MEDICA PORT, V29, P164, DOI 10.20344/amp.7526; Tamura G, 2007, RESP MED, V101, P1895, DOI 10.1016/j.rmed.2007.05.001; Tsutsumi M, 2017, J GEN FAM MED, V18, P336, DOI 10.1002/jgf2.81; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419; Ziegler TR, 1996, NUTRITION, V12, pS68, DOI 10.1016/S0899-9007(96)00019-6	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265874	10.1371/journal.pone.0265874	http://dx.doi.org/10.1371/journal.pone.0265874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552542	Green Published, gold			2022-12-26	WOS:000868164600009
J	Paul, P; Saha, R				Paul, Pintu; Saha, Ria			Is maternal autonomy associated with child nutritional status? Evidence from a cross-sectional study in India	PLOS ONE			English	Article							WOMENS EMPOWERMENT; HEALTH-CARE; DOMESTIC VIOLENCE; DECISION-MAKING; MALNUTRITION; PREVALENCE; MARRIAGE; IMPACT	Despite India's steady economic growth over recent the period, the burden of childhood malnutrition persists, contributing to higher neonatal and infant mortality. There is limited evidence available to contextualise mothers' crucial role in childcare practices and health status in the Indian context. This study attempts to assess the association between maternal autonomy and the nutritional status of children under five. We used samples of 38,685 mother-child pairs from the fourth round of the National Family Health Survey (NFHS-4), conducted in 2015-16. We considered three widely used indicators of child nutrition as outcome variables: stunting, wasting, and underweight. Maternal autonomy (measured from three dimensions: household decision-making, freedom of physical movement, and access to economic resources/control over assets) was the key predictor variable, and various child demographics, maternal, and household characteristics were considered control variables. Stepwise binary logistic regression models were performed to examine the association. Of study participants, 38%, 21%, and 35% of children were stunted, wasted, and underweight, respectively. Our results (models 1 to 4) indicate that mothers with greater autonomy were significantly associated with lower odds of malnourished children. After controlling for all potential confounding variables (in model 5), maternal autonomy had a statistically insignificant association with children's stunting (Odds ratio [OR]: 0.93; 95% confidence interval [CI]: 0.87, 1.00) and wasting (OR: 0.92; 95% CI: 0.85, 1.00). However, a significant relationship (though marginally) was retained with underweight (OR: 0.94; 95% CI: 0.88, 0.99). In addition, socio-demographic characteristics such as child age, birth order, maternal education, maternal BMI, place of residence and household wealth quintile were found to be strong predictors of child nutritional status. Future policies should not only inform women's empowerment programmes but also emphasise effective interventions toward improving female educational attainment and nutritional status of women, as well as addressing socioeconomic inequalities in order to combat the persistent burden of childhood malnutrition in India.	[Paul, Pintu] Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India; [Saha, Ria] Medway Council, Chatham, Kent, England	Jawaharlal Nehru University, New Delhi	Paul, P (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India.	pintupaul383@gmail.com	Paul, Pintu/AAR-6371-2021	Paul, Pintu/0000-0002-6727-6082; Saha, Ria/0000-0002-0286-1985				Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; Arulampalam W., 2016, SSRN ELECT J, DOI [https://doi.org/10.2139/ssrn.2742569, DOI 10.2139/SSRN.2742569]; Bassani DG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-491; Bellamy C., 1998, STATE WORLDS CHILDRE; Bhagowalia P, 2012, WHAT DIMENSIONS WOME; Bharati S, 2011, ASIA-PAC J PUBLIC HE, V23, P324, DOI 10.1177/1010539511403455; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Carlson GJ, 2015, MATERN CHILD NUTR, V11, P452, DOI 10.1111/mcn.12113; Chilinda ZB, 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Correia MITD, 2014, J AM MED DIR ASSOC, V15, P544, DOI 10.1016/j.jamda.2014.05.011; Cunningham K, 2015, MATERN CHILD NUTR, V11, P1, DOI 10.1111/mcn.12125; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; DOAN RM, 1993, SOC SCI MED, V36, P297, DOI 10.1016/0277-9536(93)90013-T; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Engle PL, 1999, WORLD DEV, V27, P1309, DOI 10.1016/S0305-750X(99)00059-5; Fall C, 2009, INDIAN J MED RES, V130, P593; Hashemi SM, 1996, WORLD DEV, V24, P635, DOI 10.1016/0305-750X(95)00159-A; Hossain B, 2020, APPL ECON, V52, P1566, DOI 10.1080/00036846.2019.1676873; IIPS, NATL FAMILY HLTH SUR; Imai KS, 2014, WORLD DEV, V62, P88, DOI 10.1016/j.worlddev.2014.05.001; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; International Institute for Population Sciences (IIPS) and ICF, 2015, NATL FAMILY HLTH SUR; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Jensen R., 2003, GENDER DEV, V11, P9, DOI DOI 10.1080/741954311; Jones R, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100475; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kamiya Y, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0567-3; Kar BR, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-31; Khan J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76884-8; Khan J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5873-z; Kishor S., 1997, SEM FEM EMP DEM PROC; Mahmud S, 2012, WORLD DEV, V40, P610, DOI 10.1016/j.worlddev.2011.08.003; Mallick R, 2022, GEOJOURNAL, V87, P2019, DOI 10.1007/s10708-020-10347-5; Mihrete TS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-102; Mondal D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243553; Paul P, 2019, PUBLIC HEALTH, V177, P95, DOI 10.1016/j.puhe.2019.08.008; Paul P, 2019, CHILD YOUTH SERV REV, V100, P16, DOI 10.1016/j.childyouth.2019.02.033; Poudel S, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.817717; Rahman MM, 2015, ASIA-PAC J PUBLIC HE, V27, P509, DOI 10.1177/1010539514568710; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Saaka M, 2020, J NUTR SCI, V9, DOI 10.1017/jns.2020.30; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sethuraman K, 2006, FOOD NUTR BULL, V27, P128, DOI 10.1177/156482650602700204; Shafiq A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224499; Shroff M, 2009, MATERN CHILD NUTR, V5, P64, DOI 10.1111/j.1740-8709.2008.00161.x; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Singh S, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1093-0; Smith Lisa C., 2003, Food and Nutrition Bulletin, V24, P287; Sunny Jose, 2018, Economic and Political Weekly, V53, P63; Swaminathan S, 2019, LANCET CHILD ADOLESC, V3, P855, DOI 10.1016/S2352-4642(19)30273-1; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization (WHO), 2010, NUTRLANDACAPE INF SY, P1; Yaya S, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-019-0129-8	56	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2022	17	5							e0268126	10.1371/journal.pone.0268126	http://dx.doi.org/10.1371/journal.pone.0268126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2O1VP	35544582	gold, Green Published			2022-12-26	WOS:000818854500044
J	Berihun, G; Adane, M; Walle, Z; Abebe, M; Alemnew, Y; Natnael, T; Andualem, A; Ademe, S; Tegegne, B; Teshome, D; Berhanu, L				Berihun, Gete; Adane, Metadel; Walle, Zebader; Abebe, Masresha; Alemnew, Yeshiwork; Natnael, Tarikuwa; Andualem, Atsedemariam; Ademe, Sewunet; Tegegne, Belachew; Teshome, Daniel; Berhanu, Leykun			Access to and challenges in water, sanitation, and hygiene in healthcare facilities during the early phase of the COVID-19 pandemic in Ethiopia: A mixed-methods evaluation	PLOS ONE			English	Article							PREVENTION PRACTICES; DETERMINANT FACTORS; WASH	BackgroundInadequate water, sanitation, and hygiene (WASH) in healthcare facilities (HCFs) have an impact on the transmission of infectious diseases, including COVID-19 pandemic. But, there is limited data on the status of WASH facilities in the healthcare settings of Ethiopia. Therefore, this study aimed to assess WASH facilities and related challenges in the HCFs of Northeastern Ethiopia during the early phase of COVID-19 pandemic. MethodsAn institution-based cross-sectional study was conducted from July to August 2020. About 70 HCFs were selected using a simple random sampling technique. We used a mixed approach of qualitative and quantitative study. The quantitative data were collected by an interviewer-administered structured questionnaire and observational checklist, whereas the qualitative data were collected using a key-informant interview from the head of HCFs, janitors, and WASH coordinator of the HCFs. The quantitative data were entered in EpiData version 4.6 and exported to Statistical Package for Social Sciences (SPSS) version 25.0 for data cleaning and analysis. The quantitative data on access to WASH facilities was reported using WHO ladder guidelines, which include no access, limited access, and basic access, whereas the qualitative data on challenges to WASH facilities were triangulated with the quantitative result. ResultsFrom the survey of 70 HCFs, three-fourths 53 (75.7%) were clinics, 12 (17.2%) were health centers, and 5 (7.1%) were hospitals. Most (88.6%) of the HCFs had basic access to water supply. The absence of a specific budget for WASH facilities, non-functional water pipes, the absence of water-quality monitoring systems, and frequent water interruptions were the major problems with water supply, which occurred primarily in clinics and health centers. Due to the absence of separate latrine designated for disabled people, none of the HCFs possessed basic sanitary facilities. Half (51.5%) of the HCFs had limited access to sanitation facilities. The major problems were the absence of separate latrines for healthcare workers and clients, as well as female and male staffs, an unbalanced number of functional latrines for the number of clients, non-functional latrines, poor cleanliness and misuse of the latrine. Less than a quarter of the HCFs 15 (21.4%) had basic access to handwashing facilities, while half 35 (50%) of the HCFs did not. The lack of functional handwashing facilities at expected sites and misuse of the facilities around the latrine, including theft of supplies by visitors, were the two most serious problems with hygiene facilities. ConclusionDespite the fact that the majority of HCFs had basic access to water, there were problems in their sanitation and handwashing facilities. The lack of physical infrastructure, poor quality of facilities, lack of separate budget to maintain WASH facilities, and inappropriate utilization of WASH facilities were the main problems in HCFs. Further investigation should be done to assess the enabling factors and constraints for the provision, use, and maintenance of WASH infrastructure at HCFs.	[Berihun, Gete; Adane, Metadel; Abebe, Masresha; Natnael, Tarikuwa; Berhanu, Leykun] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia; [Walle, Zebader; Alemnew, Yeshiwork] Debre Tabor Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Tabor, Ethiopia; [Alemnew, Yeshiwork] Wollo Univ, Coll Nat Sci, Dept Biol, Dessie, Ethiopia; [Andualem, Atsedemariam; Ademe, Sewunet; Tegegne, Belachew] Wollo Univ, Coll Med & Hlth Sci, Dept Nursing, Dessie, Ethiopia; [Teshome, Daniel] Wollo Univ, Coll Med & Hlth Sci, Dept Anat, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Berihun, G (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	geteberihun@gmail.com	Adane, Metadel/AFQ-9478-2022; Teshome, Daniel/AAD-1584-2022	Adane, Metadel/0000-0002-7039-4768; Teshome, Daniel/0000-0002-9124-3045; Walle, Zebader/0000-0001-5361-5226				Ababa A., 2014, FEDERAL DEMOCRATIC R; Abalkhail A, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9121627; Adane M, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-021-12362-8; Andualem A, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0259851; Angrup A, 2020, INDIAN J MED MICROBI, V38, P139, DOI 10.4103/ijmm.IJMM_20_125; Ashinyo ME, 2021, J WATER SANIT HYG DE, V11, P398, DOI 10.2166/washdev.2021.254; Asnake D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241270; Baye K, 2020, COVID 19 PREVENTION; Belete ZW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250145; Berhanu L, 2021, J MULTIDISCIP HEALTH, V14, P1843, DOI 10.2147/JMDH.S321456; Berihun G, 2021, PATIENT PREFER ADHER, V15, P1795, DOI 10.2147/PPA.S324564; Berihun G, 2021, J MULTIDISCIP HEALTH, V14, P2123, DOI 10.2147/JMDH.S322495; Cronk R, 2018, INT J HYG ENVIR HEAL, V221, P409, DOI 10.1016/j.ijheh.2018.01.004; De Wandel D, 2010, AM J CRIT CARE, V19, P230, DOI 10.4037/ajcc2010892; Gine-Garriga R, 2021, SCI TOTAL ENVIRON, V795, DOI 10.1016/j.scitotenv.2021.148789; Guo A, 2017, AM J TROP MED HYG, V97, P1033, DOI 10.4269/ajtmh.17-0208; Hassen SL, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/2643531; Hirai M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115641; Howard G, 2020, J WATER HEALTH, V18, P613, DOI 10.2166/wh.2020.162; Huttinger A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2460-4; Jemal B, 2021, SAGE OPEN MED, V9, DOI 10.1177/20503121211034389; Jemal K, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/6021870; Kanyangarara M, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06515-z; Kayiwa D, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09895-9; Keleb A, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.782705; Khader YS, 2017, INT J HEALTH CARE Q, V30, P645, DOI 10.1108/IJHCQA-10-2016-0156; Kilpatrick C., 2011, INT J INFECT CONTROL, V7, DOI [10.3396/ijic.V7i2.011.11, DOI 10.3396/IJIC.V7I2.011.11]; Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132; Lopez J, 2020, GLOB HEALTH-SCI PRAC, V8, P256, DOI [10.9745/GHSP-D-19-00413, 10.9745/GHSPD-19-00413]; Mangiza N.M., 2020, WATER SANITATION HYG; McGriff JA, 2020, AM J TROP MED HYG, V103, P1762, DOI 10.4269/ajtmh.20-0638; Mulogo EM, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/5403795; Mushi V, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00236-5; Mwai J, 2022, INT HEALTH, V14, P597, DOI 10.1093/inthealth/ihab077; Odagiri M, 2018, AM J TROP MED HYG, V99, P546, DOI 10.4269/ajtmh.18-0044; Ogunsola FT, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00747-0; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Organization WH, 2015, WATER SANITATION HYG; Patel LN, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005833; Sambo L., 2003, TOOLS ASSESSING OPER; Tamene A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256086; Taye EB, 2022, CLIN EPIDEMIOL GLOB, V14, DOI 10.1016/j.cegh.2022.100993; Walle Z, 2021, J MULTIDISCIP HEALTH, V14, P2287, DOI 10.2147/JMDH.S325127; World Health Organization, GLOB PROGR REP WAT S; World Health Organization, 2018, WHO REC INTR CAR POS, P2018; World Health Organization, WATER SANITATION HYG; World Health Organization UNICEF, 2020, WATER SANITATION HYG; World Health Organization (WHO) and the United Nations Children's Fund, 2019, WASH HLTH CAR FAC GL	48	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268272	http://dx.doi.org/10.1371/journal.pone.0268272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560168	Green Published, gold			2022-12-26	WOS:000835326900029
J	Costa, A; Santa-Cruz, F; Araujo, RLC; Leitao, G; Figueiredo, JL; Ferraz, AAB				Costa, Adriano; Santa-Cruz, Fernando; Araujo, Raphael L. C.; Leitao, Glauber; Figueiredo, Jose-Luiz; Ferraz, Alvaro A. B.			Analysis of cathepsin S expression in gastric adenocarcinoma and in Helicobacter pylori infection	PLOS ONE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; CANCER	BackgroundRecent experimental studies have suggested a potential link between cathepsin S (CTTS) and gastric adenocarcinoma progression. Herein, we aimed to evaluate the expression of CTTS in gastric adenocarcinoma in patients who underwent curative-intent surgical resection. MethodsThis was a cross-sectional study that included two groups: gastric adenocarcinoma (n = 42) and gastritis (n = 50). The gastritis group was then subdivided into H. pylori-positive (n = 25) and H. pylori-negative (n = 25) groups. Gastric tissue samples were analysed to determine CTTS expression through immunohistochemistry. Samples were obtained by oesophagogastroduodenoscopy or surgical specimens. ResultsIn patients with gastritis, the age ranged from 18 to 78 years. Among them, 34% were male, and 66% were female. In patients with gastric adenocarcinoma, the age ranged from 37 to 85 years. Among them, 50% were male. When comparing the expression of CTTS between the two groups, only 16% of the gastritis samples had an expression higher than 25%. Alternatively, among patients with gastric adenocarcinoma, 19% had expression between 25-50%, 14.3% between 51-75%, and 26.2% had expression higher than 75% (p < 0.001). In the gastritis group, CTTS expression was significantly higher in patients with a positive test for H. pylori than negative test for H. pylori: 87.5% and 38.5%, respectively (p<0.001). There was no statistically significant association between CTTS positivity and clinicopathological variables, including tumour staging, histological type, angiolymphatic invasion, recurrence, current status and death. ConclusionCTTS expression is higher in gastric adenocarcinoma samples. Patients with gastritis due to H. pylori also show a higher expression of CTTS than patients with negative results for this bacterium.	[Costa, Adriano; Leitao, Glauber] Hosp Clin Fed Univ Pernambuco HC UFPE, Oncol Unit, Recife, PE, Brazil; [Costa, Adriano; Santa-Cruz, Fernando] Univ Fed Pernambuco, Postgrad Surg, Recife, PE, Brazil; [Araujo, Raphael L. C.] Univ Fed Sao Paulo UNIFESP, Dept Digest Surg, Sao Paulo, SP, Brazil; [Figueiredo, Jose-Luiz; Ferraz, Alvaro A. B.] Univ Fed Pernambuco, Dept Surg, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pernambuco	Costa, A (corresponding author), Hosp Clin Fed Univ Pernambuco HC UFPE, Oncol Unit, Recife, PE, Brazil.; Costa, A (corresponding author), Univ Fed Pernambuco, Postgrad Surg, Recife, PE, Brazil.	adrianocacosta@gmail.com	da Costa, Adriano Carneiro/AEB-0960-2022; Araujo, Raphael/N-4775-2017	da Costa, Adriano Carneiro/0000-0002-5248-2705; Araujo, Raphael/0000-0002-7834-5944				Ahn HJ, 2015, WORLD J GASTRO ONCOL, V7, P455, DOI 10.4251/wjgo.v7.i12.455; Amedei A, 2014, INTERN EMERG MED, V9, P303, DOI 10.1007/s11739-012-0867-9; Chen SY, 2017, ONCOTARGET, V8, P41690, DOI 10.18632/oncotarget.16677; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Da Costa AC, 2020, MOL CLIN ONCOL, V12, P99, DOI 10.3892/mco.2019.1958; Dixon BREA, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00363-19; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hamalisto S, 2016, CURR OPIN CELL BIOL, V39, P69, DOI 10.1016/j.ceb.2016.02.009; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Liu WL, 2016, ONCOTARGET, V7, P28124, DOI 10.18632/oncotarget.8582; PLEBANI M, 1995, DIGEST DIS SCI, V40, P2473, DOI 10.1007/BF02063258; Rudzinska M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143602; Talieri M, 2004, CANCER LETT, V205, P97, DOI 10.1016/j.canlet.2003.09.033; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wilkinson RDA, 2015, BIOL CHEM, V396, P867, DOI 10.1515/hsz-2015-0114; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268836	http://dx.doi.org/10.1371/journal.pone.0268836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617240	Green Published, gold			2022-12-26	WOS:000835048800030
J	Hahn, L; Parent, LE; Paviani, AC; Feltrim, AL; Wamser, AF; Rozane, DE; Ender, MM; Grando, DL; Moura-Bueno, JM; Brunetto, G				Hahn, Leandro; Parent, Leon-Etienne; Paviani, Angela Cristina; Feltrim, Anderson Luiz; Wamser, Anderson Fernando; Rozane, Danilo Eduardo; Ender, Marcos Matos; Grando, Douglas Luiz; Moura-Bueno, Jean Michel; Brunetto, Gustavo			Garlic (Allium sativum) feature-specific nutrient dosage based on using machine learning models	PLOS ONE			English	Article							NITROGEN-FERTILIZATION; PHYSICAL-PROPERTIES; CORN RESPONSE; PHOSPHORUS; STICS; CLASSIFICATION; CALIBRATION; GROWTH; RATES; YIELD	Brazil presents large yield gaps in garlic crops partly due to nutrient mismanagement at local scale. Machine learning (ML) provides powerful tools to handle numerous combinations of yield-impacting factors that help reducing the number of assumptions about nutrient management. The aim of the current study is to customize fertilizer recommendations to reach high garlic marketable yield at local scale in a pilot study. Thus, collected 15 nitrogen (N), 24 phosphorus (P), and 27 potassium (K) field experiments conducted during the 2015 to 2017 period in Santa Catarina state, Brazil. In addition, 61 growers' observational data were collected in the same region in 2018 and 2019. The data set was split into 979 experimental and observational data for model calibration and into 45 experimental data (2016) to test ML models and compare the results to state recommendations. Random Forest (RF) was the most accurate ML to predict marketable yield after cropping system (cultivar, preceding crops), climatic indices, soil test and fertilization were included features as predictor (R-2 = 0.886). Random Forest remained the most accurate ML model (R-2 = 0.882) after excluding cultivar and climatic features from the prediction-making process. The model suggested the application of 200 kg N ha(-1) to reach maximum marketable yield in a test site in comparison to the 300 kg N ha(-1) set as state recommendation. P and K fertilization also seemed to be excessive, and it highlights the great potential to reduce production costs and environmental footprint without agronomic loss. Garlic root colonization by arbuscular mycorrhizal fungi likely contributed to P and K uptake. Well-documented data sets and machine learning models could support technology transfer, reduce costs with fertilizers and yield gaps, and sustain the Brazilian garlic production.	[Hahn, Leandro] Agr Res & Rural Extens Agcy Santa Catarina Epagri, Cacador Expt Stn, Cacador, SC, Brazil; [Parent, Leon-Etienne; Feltrim, Anderson Luiz; Wamser, Anderson Fernando] Laval Univ, Dept Soils & Agrifood Engn, Quebec City, PQ, Canada; [Parent, Leon-Etienne; Grando, Douglas Luiz; Moura-Bueno, Jean Michel; Brunetto, Gustavo] Univ Fed Santa Maria, Dept Soil, Santa Maria, RS, Brazil; [Paviani, Angela Cristina] Govt Adm Ctr, Execut Secretariat Environm, Florianopolis, SC, Brazil; [Rozane, Danilo Eduardo] State Univ Paulista Julio Mesquita Filho, Campus Registro, Sao Paulo, Brazil; [Ender, Marcos Matos] Univ Alto Vale Rio Peixe, Cacador, SC, Brazil	Laval University; Universidade Federal de Santa Maria (UFSM)	Moura-Bueno, JM (corresponding author), Univ Fed Santa Maria, Dept Soil, Santa Maria, RS, Brazil.	bueno.jean1@gmail.com		HAHN, LEANDRO/0000-0002-1796-9761	Santa Catarina State Agricultural Research and Rural Extension Agency [6312106, 001/2016]; Natural Sciences and Engineering Research Council of Canada [NSERC-2254]; Alto Vale do Rio do Peixe University [FAP 001/2015e 001/2016]	Santa Catarina State Agricultural Research and Rural Extension Agency; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alto Vale do Rio do Peixe University	this articlewas supported financiallybySantaCatarinaStateAgriculturalResearchandRuralExtensionAgency,Epagri(SeplanN.6312106)and Alto Vale do Rio do Peixe University (edital FAP 001/2015e 001/2016) and the NaturalSciencesand Engineering ResearchCouncilofCanada(NSERC-2254). The fundershad no role in 13 study design, data collection and analysis, decisionto publish,or preparationof the manuscript.	Al-Karaki GN, 2002, J PLANT NUTR, V25, P747, DOI 10.1081/PLN-120002956; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alves B., 2021, GARLIC CROP PRODUCTI; Amorim JRD, 2002, PESQUI AGROPECU BRAS, V37, P167, DOI 10.1590/S0100-204X2002000200008; Barber S.A, 1995, SOIL NUTR BIOAVAILAB, V2nd ed.; Betemps D. L., 2020, Agronomy, V10, DOI 10.3390/agronomy10060900; Botelho Gloria R., 2019, Cienc. suelo, V37, P51; Brisson N, 1998, AGRONOMIE, V18, P311, DOI 10.1051/agro:19980501; Bull LT, 2004, SCI AGR, V61, P516, DOI 10.1590/S0103-90162004000500009; Buso GSC, 2008, GENET MOL RES, V7, P534, DOI 10.4238/vol7-2gmr451; Comissao de Quimica e Fertilidade do Solo CQFS-RS/SC, 2016, MAN CAL AD EST RIO G, V11th; Cope JT., 1973, SOIL TESTING PLANT A, P35; Coulibali Z, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230888; CQFS RS/SC, COMMISSAO QUIMICA FE; Dahnke W. C., 1990, Soil testing and plant analysis., P45; Dalhat MH., 2018, ASIAN FOOD SCI J, V3, P1, DOI [10.9734/AFSJ/2018/43165, DOI 10.9734/AFSJ/2018/43165]; de Paula BV, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9081049; deResende JTV., 2013, BRAS, V31, P157, DOI [10.1590/S0102-05362013000100025, DOI 10.1590/S0102-05362013000100025]; DEWIT CT, 1992, AGR SYST, V40, P125, DOI 10.1016/0308-521X(92)90018-J; dos Santos LPD, 2017, J PLANT NUTR, V40, P624, DOI 10.1080/01904167.2016.1240201; EPAGRI, 2020, EP DOC, V310; Fante L, 2012, J FOOD ENG, V108, P436, DOI 10.1016/j.jfoodeng.2011.08.024; Faria P, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11040731; Fortin JG, 2010, COMPUT ELECTRON AGR, V73, P126, DOI 10.1016/j.compag.2010.05.011; Gaskin JW, 2020, RENEW AGR FOOD SYST, V35, P550, DOI 10.1017/S1742170519000152; Golubkina N, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020279; Gonzalez M. Q., 2016, American Journal of Plant Sciences, V7, P469, DOI 10.4236/ajps.2016.73041; Government of Canada, 2018, COOL WAV DAYS COOL S; Hahn L, 2020, REV BRAS CIENC SOLO, V44, DOI 10.36783/18069657rbcs20190067; IBGE, 2021, PROD AGR LAV TEMP; Inglis PW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228485; Jego G, 2015, INT J APPL EARTH OBS, V41, P11, DOI 10.1016/j.jag.2015.04.013; Jego G, 2013, FIELD CROP RES, V151, P65, DOI 10.1016/j.fcr.2013.07.003; Kyveryga PM, 2007, AGRON J, V99, P1048, DOI 10.2134/agronj2006.0339; Kyveryga PM, 2007, AGRON J, V99, P1057, DOI 10.2134/agronj2006.0340; Lajili A, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11030432; Neto AJD, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111467; Liu LW, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11040771; Luengo RFA., 1999, CLASSIFICACAO HORTAL; Macedo FS, 2011, CIENC RURAL, V41, P379, DOI 10.1590/S0103-84782011000300003; Maksimovic J, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11010141; Mallarino AP, 2003, SOIL SCI SOC AM J, V67, P1928, DOI 10.2136/sssaj2003.1928; Marodin JC, 2020, HORTIC BRAS, V38, P295, DOI [10.1590/s0102-053620200309, 10.1590/S0102-053620200309]; Melsted SW., 1984, SOIL TESTING MADISON, P1, DOI [10.2134/asaspecpub29.c1, DOI 10.2134/ASASPECPUB29.C1]; Michuda A, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11010149; Moretti CL, 2005, ACTA HORTIC, P317, DOI 10.17660/ActaHortic.2005.688.46; Morris TF, 2018, AGRON J, V110, P1, DOI 10.2134/agronj2017.02.0112; Munson R. D., 1990, Soil testing and plant analysis., P359; Nelson LA., 1984, SOIL TESTING CORRELA, P19; Nowaki RHD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00825; Orst B, 2015, 19 C BRAS AGR AGR SE; Parent S-E., 2020, WHY WE SHOULD USE BA; Parent SE, 2021, NEXTJOURNAL; Parent SE, 2020, AGRON J, V112, P2176, DOI 10.1002/agj2.20115; PECK TR, 1990, COMMUN SOIL SCI PLAN, V21, P1165, DOI 10.1080/00103629009368297; Cunha MLP, 2016, REV BRAS CIENC SOLO, V40, DOI 10.1590/18069657rbcs20140771; Piva J. T., 2017, Revista de Ciencias Agroveterinarias, V16, P239, DOI 10.5965/223811711632017239; Santos Flavia Cristina dos, 2008, Rev. Bras. Ciênc. Solo, V32, P1661, DOI 10.1590/S0100-06832008000400031; Shao YN, 2012, FOOD BIOPROCESS TECH, V5, P100, DOI 10.1007/s11947-009-0267-y; Silva FC., 2009, MANUAL ANALISES QUIM, V2; Soil Survey Staff, 2014, KEYS SOIL TAXONOMY, V12th, DOI DOI 10.1109/TIP.2005.854494; Tedesco MJ., 1995, ANAL SOILS PLANTS OT, V2nd; Trani PE., 2008, BRAS, V26, P330, DOI [10.1590/S0102-05362008000300008, DOI 10.1590/S0102-05362008000300008]; Tremblay N, 2012, AGRON J, V104, P1658, DOI 10.2134/agronj2012.0184; Zhang CL, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10070972	65	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268516	10.1371/journal.pone.0268516	http://dx.doi.org/10.1371/journal.pone.0268516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580085	Green Published, gold			2022-12-26	WOS:000886501700008
J	Jensen, KH; Stalder, AK; Wernersson, R; Roloff-Handschin, TC; Hansen, DH; Groenen, PMA				Jensen, Klaus Hojgaard; Stalder, Anna Katharina; Wernersson, Rasmus; Roloff-Handschin, Tim-Christoph; Hansen, Daniel Hvidberg; Groenen, Peter M. A.			A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; GENE ONTOLOGY; DISEASE; ALS; ASSOCIATIONS; PATHOGENESIS; ENVIRONMENT; EXPRESSION; MUTATIONS	BackgroundDespite the discovery of familial cases with mutations in Cu/Zn-superoxide dismutase (SOD1), Guanine nucleotide exchange C9orf72, TAR DNA-binding protein 43 (TARDBP) and RNA-binding protein FUS as well as a number of other genes linked to Amyotrophic Lateral Sclerosis (ALS), the etiology and molecular pathogenesis of this devastating disease is still not understood. As proteins do not act alone, conducting an analysis of ALS at the system level may provide new insights into the molecular biology of ALS and put it into relationship to other neurological diseases. MethodsA set of ALS-associated genes/proteins were collected from publicly available databases and text mining of scientific literature. We used these as seed proteins to build protein-protein interaction (PPI) networks serving as a scaffold for further analyses. From the collection of networks, a set of core modules enriched in seed proteins were identified. The molecular biology of the core modules was investigated, as were their associations to other diseases. To assess the core modules' ability to describe unknown or less well-studied ALS biology, they were queried for proteins more recently associated to ALS and not involved in the primary analysis. ResultsWe describe a set of 26 ALS core modules enriched in ALS-associated proteins. We show that these ALS core modules not only capture most of the current knowledge about ALS, but they also allow us to suggest biological interdependencies. In addition, new associations of ALS networks with other neurodegenerative diseases, e.g. Alzheimer's, Huntington's and Parkinson's disease were found. A follow-up analysis of 140 ALS-associated proteins identified since 2014 reveals a significant overrepresentation of new ALS proteins in these 26 disease modules. ConclusionsUsing protein-protein interaction networks offers a relevant approach for broadening the understanding of the biological context of known ALS-associated genes. Using a bottom-up approach for the analysis of protein-protein interaction networks is a useful method to avoid bias caused by over-connected proteins. Our ALS-enriched modules cover most known biological functions associated with ALS. The presence of recently identified ALS-associated proteins in the core modules highlights the potential for using these as a scaffold for identification of novel ALS disease mechanisms.	[Jensen, Klaus Hojgaard; Wernersson, Rasmus; Hansen, Daniel Hvidberg] Intom A S, Copenhagen, Denmark; [Stalder, Anna Katharina; Roloff-Handschin, Tim-Christoph] Univ Hosp Basel, Basel, Switzerland; [Wernersson, Rasmus] Tech Univ Denmark, DTU Hlth Technol, Lyngby, Denmark; [Groenen, Peter M. A.] Idorsia Pharmaceut Ltd, Allschwil, Switzerland	University of Basel; Technical University of Denmark; Idorsia Pharmaceuticals Ltd	Wernersson, R (corresponding author), Intom A S, Copenhagen, Denmark.; Wernersson, R (corresponding author), Tech Univ Denmark, DTU Hlth Technol, Lyngby, Denmark.; Groenen, PMA (corresponding author), Idorsia Pharmaceut Ltd, Allschwil, Switzerland.	rwe@intomics.com; peter.groenen@idorsia.com		Groenen, Peter/0000-0002-8172-1752; Jensen, Klaus Hojgaard/0000-0003-3234-6068; Wernersson, Rasmus/0000-0003-4417-9842; Roloff, Tim-Christoph/0000-0003-3435-4723	Actelion Pharmaceuticals Ltd.; Idorsia Pharmaceutical Ltd.; Intomics A/S; Idorsia Pharmaceuticals	Actelion Pharmaceuticals Ltd.; Idorsia Pharmaceutical Ltd.; Intomics A/S; Idorsia Pharmaceuticals	The study was partially funded by Actelion Pharmaceuticals Ltd. and Idorsia Pharmaceutical Ltd. with Intomics A/S providing additional computational analyses. The funders provided support in the form of salaries for authors DHH, KHL, RWE (Intomics A/S) and AS, TCRH, PG (Idorsia Pharmaceuticals), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALSgene, US; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; [Anonymous], GAD FULL DATA SET; [Anonymous], INBIO KNOW TEXT MINI; [Anonymous], 2017, NUCL ACIDS RES, DOI DOI 10.1093/NAR/GKW1108; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00423, 10.3339/fncel.2015.00423]; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Balendra R, 2018, NAT REV NEUROL, V14, P544, DOI 10.1038/s41582-018-0047-2; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Capponi S, 2016, HUM MUTAT, V37, P1202, DOI 10.1002/humu.23062; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Boer EMJ, 2021, J NEUROL NEUROSUR PS, V92, P86, DOI 10.1136/jnnp-2020-322983; De Vos KJ, 2017, NEUROBIOL DIS, V105, P283, DOI 10.1016/j.nbd.2017.02.004; Diaz-Ortiz ME, 2020, TRENDS GENET, V36, P152, DOI 10.1016/j.tig.2019.12.002; Dodge JC, 2015, P NATL ACAD SCI USA, V112, P8100, DOI 10.1073/pnas.1508767112; Dorn T, 2018, EMBO J, V37, DOI 10.15252/embj.201798133; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Ebert D, 2003, J NEUROSCI, V23, P5928; Fogarty MJ, 2018, BRAIN RES BULL, V140, P318, DOI 10.1016/j.brainresbull.2018.05.023; Gascon E, 2014, J NEUROGENET, V28, P30, DOI 10.3109/01677063.2013.876021; Guo WT, 2018, CELL STRESS, V2, P14, DOI 10.15698/cst2018.01.120; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Henriques A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05313-0; Iaconelli J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071605; Iglesias V, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00314; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kalmar B, 2014, PHARMACOL THERAPEUT, V141, P40, DOI 10.1016/j.pharmthera.2013.08.003; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kim Y, 2012, SAF HEALTH WORK, V3, P243, DOI 10.5491/SHAW.2012.3.4.243; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; MalaCards, US; Mao YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172246; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; McAlary L, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00262; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Morgan S, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.017; National Library of Medicine, US; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oberstadt M, 2018, MOL NEUROBIOL, V55, P3143, DOI 10.1007/s12035-017-0543-1; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Porta S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06548-9; Rahmati S, 2017, NUCLEIC ACIDS RES, V45, pD419, DOI 10.1093/nar/gkw1082; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Soo KY, 2015, ACTA NEUROPATHOL, V130, P679, DOI 10.1007/s00401-015-1468-2; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Su FC, 2016, JAMA NEUROL, V73, P803, DOI 10.1001/jamaneurol.2016.0594; Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Verma A, 2013, NEUROL INDIA, V61, P107, DOI 10.4103/0028-3886.111109; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wall DP, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-50; Wang DW, 2015, ONCOTARGET, V6, P37098, DOI 10.18632/oncotarget.5776; Wang J, 2008, NEUROBIOL AGING, V29, P586, DOI 10.1016/j.neurobiolaging.2006.11.009; Webster CP, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00123; Weeks SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18874-x; Wills AM, 2014, LANCET, V383, P2065, DOI 10.1016/S0140-6736(14)60222-1; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Yedavalli VS, 2018, J CLIN IMAG SCI, V8, DOI 10.4103/jcis.JCIS_40_18; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528	76	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268159	10.1371/journal.pone.0268159	http://dx.doi.org/10.1371/journal.pone.0268159			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576218	gold, Green Published, Green Submitted			2022-12-26	WOS:000835262300003
J	Sendekie, AK; Teshale, AB; Tefera, YG				Sendekie, Ashenafi Kibret; Teshale, Achamyeleh Birhanu; Tefera, Yonas Getaye			Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia	PLOS ONE			English	Article							TREATMENT REGIMEN; CLINICAL-TRIAL; BASAL INSULIN; RISK-FACTORS; THERAPY; MANAGEMENT; GLARGINE; HYPERGLYCEMIA; ATORVASTATIN; METFORMIN	BackgroundThough many trials had examined the effectiveness of taking insulin with or without oral agents, there are limited real-world data, particularly among patients with type 2 diabetes mellitus (T2DM) in the resource limited settings. This study aimed to examine level of glycemic control among patients with T2DM after initiation of insulin and factors associated with poor glycemic control. MethodsAn analysis of retrospective medical records of patients with T2DM who initiated insulin due to uncontrolled hyperglycemia by oral agents was conducted from 2015-2020 in the University of Gondar Comprehensive Specialized Hospital. Difference in median fasting plasma glucose (FPG) before and after insulin initiations was examined by a Wilcoxon signed-rank test. Kruskal Wallis test was performed to explore difference in the median level of FPG among treatment groups. A logistic regression model was also used to identify associated factors of poor glycemic control after insulin initiation. Statistical significance was declared at p < 0.05. ResultsOf 424 enrolled patients with T2DM, 54.7% were males and the mean age was 59.3 +/- 9.3 years. A Wilcoxon signed-rank test showed that there was significant deference in FPG before and after insulin initiation (P < 0.001). A declining trend of blood glucose was observed during the 1-year follow-up period of post-initiation. However, majority of the participants did not achieve target glucose levels. Participants who had higher FPG and systolic blood pressure (SBP) before insulin initiation were found more likely to have poor glycemic control after insulin initiation. Similarly, patients who received atorvastatin compared with simvastatin were found to have poor glycemic control in the post-period of initiation (P = 0.04). Premixed insulin was associated with a lower likelihood of poor glycemic control than neutral protamine Hagedorn (NPH) insulin (P < 0.001). ConclusionFollowing insulin initiation, a significant change in glycemic level and declining trend of FPG was observed during a 1-year follow-up period. However, the majority of patients still had a poorly controlled glycemic level. Appropriate management focusing on predictors of glycemic control would be of a great benefit to achieve glycemic control.	[Sendekie, Ashenafi Kibret; Tefera, Yonas Getaye] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia; [Teshale, Achamyeleh Birhanu] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar	Sendekie, AK (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia.	ashukib02@yahoo.com	Teshale, Achamyeleh/HHN-8416-2022; Sendekie, Ashenafi Kibret/GRX-8487-2022	Sendekie, Ashenafi Kibret/0000-0001-5982-853X				Abdi H, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.65600; Al-Rasheedi AA, 2015, INT J HEALTH SCI-IJH, V9, P345; American Diabetes Association, 2018, Diabetes Care, V41, pS55, DOI 10.2337/dc18-S006; [Anonymous], 2010, World Health Statistics 2010; Best JD, 2012, DIABETES CARE, V35, P1165, DOI 10.2337/dc11-1307; Blak BT, 2012, DIABETIC MED, V29, pE13, DOI 10.1111/j.1464-5491.2012.03586.x; Blonde L, 2018, DIABETES THER, V9, P1347, DOI 10.1007/s13300-018-0413-5; Bolli GB, 2011, DIABETES CARE, V34, pS220, DOI 10.2337/dc11-s224; Bretzel RG, 2009, DIABETES CARE, V32, pS260, DOI 10.2337/dc09-S319; Broz J, 2019, DIABETES THER, V10, P663, DOI 10.1007/s13300-019-0584-8; Broz J, 2018, DIABETES THER, V9, P1897, DOI 10.1007/s13300-018-0485-2; Cappon G, 2019, DIABETES METAB J, V43, P383, DOI 10.4093/dmj.2019.0121; Caturano A, 2022, EUR REV MED PHARMACO, V26, P1068, DOI 10.26355/eurrev_202202_28093; Caturano A, 2021, DIABETES RES CLIN PR, V178, DOI 10.1016/j.diabres.2021.108959; Caturano A, 2019, JAMA-J AM MED ASSOC, V322, P1312, DOI 10.1001/jama.2019.11489; Cui JY, 2018, J CLIN PHARM THER, V43, P556, DOI 10.1111/jcpt.12690; Curtis Bradley, 2014, J Med Econ, V17, P21, DOI 10.3111/13696998.2013.862538; Defeudis G, 2022, DIABETES-METAB RES, V38, DOI 10.1002/dmrr.3494; Defeudis G, 2018, HORM-INT J ENDOCRINO, V17, P113, DOI 10.1007/s42000-018-0005-9; Donner T, 2012, J CLIN ENDOCR METAB, V97, P1405, DOI 10.1210/jc.2011-2202; Evans M., 2010, BRIT J DIABETES VASC, V10, P178, DOI 10.1177/1474651410370659; Gentile S, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/7153087; Goodall G, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-19; Hajos TRS, 2011, DIABETIC MED, V28, P1096, DOI 10.1111/j.1464-5491.2011.03329.x; Hemmingsen B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1771; Hollander P, 2015, J DIABETES COMPLICAT, V29, P1266, DOI 10.1016/j.jdiacomp.2015.05.022; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jabbar A, 2019, DIABETES RES CLIN PR, V149, P18, DOI 10.1016/j.diabres.2019.01.017; Janka HU, 2005, DIABETES CARE, V28, P254, DOI 10.2337/diacare.28.2.254; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kakade A.A., 2018, INTEGR OBES DIABETES, V4, DOI [10.15761/iod.1000209, DOI 10.15761/IOD.1000209]; Karl D, 2012, DIABETIC MED, V29, P933, DOI 10.1111/j.1464-5491.2012.03640.x; Khunti K, 2016, DIABETES OBES METAB, V18, P401, DOI 10.1111/dom.12626; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Li GW, 2019, DIABETES CARE, V42, P507, DOI 10.2337/dc18-1965; Liu GX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00639; Lundby-Christensen L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008376; Mata-Cases M, 2017, J DIABETES, V9, P34, DOI 10.1111/1753-0407.12373; Minutolo R, 2006, J HYPERTENS, V24, P1655, DOI 10.1097/01.hjh.0000239303.93872.31; Mudaliar S, 2013, INT J CLIN PRACT, V67, P876, DOI 10.1111/ijcp.12154; Pinchevsky Y, 2015, JEMDSA, V20, P81, DOI 10.1080/16089677.2015.1056468; Pollock RF, 2011, CURR DIABETES REV, V7, P61, DOI 10.2174/157339911794273892; Raz I, 2013, DIABETES CARE, V36, P1779, DOI 10.2337/dc13-0512; Reusch JEB, 2017, JAMA-J AM MED ASSOC, V317, P1015, DOI 10.1001/jama.2017.0241; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Salvetti A, 1993, Drugs, V46 Suppl 2, P149; Sasso FC, 1999, METABOLISM, V48, P1346, DOI 10.1016/S0026-0495(99)90141-5; Sasso FC, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01343-1; Sasso FC, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3106056; Simsek S, 2012, DIABETIC MED, V29, P628, DOI 10.1111/j.1464-5491.2011.03553.x; Smith RJ, 2010, J CLIN ENDOCR METAB, V95, P1566, DOI 10.1210/jc.2009-1966; Spollett GR, 2012, J AM ACAD NURSE PRAC, V24, P249, DOI 10.1111/j.1745-7599.2012.00721.x; Sun H, 2022, DIABETES RES CLIN PR, V183, DOI 10.1016/j.diabres.2021.109119; Tam HL, 2010, ATHEROSCLEROSIS, V209, P173, DOI 10.1016/j.atherosclerosis.2009.08.031; Vos RC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006992.pub2; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Zeru MA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01256-9	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268639	http://dx.doi.org/10.1371/journal.pone.0268639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617250	Green Published, gold			2022-12-26	WOS:000835048800029
J	Sonis, J; Pathman, DE; Read, S; Gaynes, BN				Sonis, Jeffrey; Pathman, Donald E.; Read, Susan; Gaynes, Bradley N.			A national study of moral distress among US internal medicine physicians during the COVID-19 pandemic	PLOS ONE			English	Article							STRESS; DEPRESSION; DILEMMAS; VALIDITY; ANXIETY; CARE	BackgroundThere have been no studies to date of moral distress during the COVID-19 pandemic in national samples of U.S. health workers. The purpose of this study was to determine, in a national sample of internal medicine physicians (internists) in the U.S.: 1) the intensity of moral distress; 2) the predictors of moral distress; 3) the outcomes of moral distress. MethodsWe conducted a national survey with an online panel of internists, representative of the membership of the American College of Physicians, the largest specialty organization of physicians in the United States, between September 21 and October 8, 2020. Moral distress was measured with the Moral Distress Thermometer, a one-item scale with a range of 0 ("none") to 10 ("worst possible"). Outcomes were measured with short screening scales. ResultsThe response rate was 37.8% (N = 810). Moral distress intensity was low (mean score = 2.4, 95% CI, 2.2-2.6); however, 13.3% (95% CI, 12.1% - 14.5%) had a moral distress score greater than or equal to 6 ("distressing"). In multiple linear regression models, perceived risk of death if infected with COVID-19 was the strongest predictor of higher moral distress (beta (standardized regression coefficient) = 0.26, p < .001), and higher perceived organizational support (respondent belief that their health organization valued them) was most strongly associated with lower moral distress (beta = -0.22, p < .001). Controlling for other factors, high levels of moral distress, but not low levels, were strongly associated (adjusted odds ratios 3.0 to 11.5) with screening positive for anxiety, depression, posttraumatic stress disorder, burnout, and intention to leave patient care. ConclusionsThe intensity of moral distress among U.S. internists was low overall. However, the 13% with high levels of moral distress had very high odds of adverse mental health outcomes. Organizational support may lower moral distress and thereby prevent adverse mental health outcomes.	[Sonis, Jeffrey] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27599 USA; [Sonis, Jeffrey; Pathman, Donald E.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; [Pathman, Donald E.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Read, Susan] Amer Coll Physicians, Res Ctr, Philadelphia, PA USA; [Gaynes, Bradley N.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Gaynes, Bradley N.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; American College of Physicians; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sonis, J (corresponding author), Univ N Carolina, Dept Social Med, Chapel Hill, NC 27599 USA.; Sonis, J (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA.	jsonis@med.unc.edu						Baele CA, 2021, J ADV NURS, V77, P4120, DOI 10.1111/jan.14923; Borges LM, 2020, J CONTEXT BEHAV SCI, V17, P95, DOI 10.1016/j.jcbs.2020.06.006; British Medical Association, 2021, MOR DISTR MOR INJ RE; Cacchione PZ, 2020, CLIN NURS RES, V29, P215, DOI 10.1177/1054773820920385; Cohen J, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106263; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Corley MC, 2001, J ADV NURS, V33, P250, DOI 10.1046/j.1365-2648.2001.01658.x; Dal Grande E, 2015, AM J EPIDEMIOL, V182, P544, DOI 10.1093/aje/kwv080; Diamond D., 2021, WASH POST; Donkers MA, 2021, BMC MED ETHICS, V22, DOI 10.1186/s12910-021-00641-3; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; Epstein Elizabeth G, 2019, AJOB Empir Bioeth, V10, P113, DOI 10.1080/23294515.2019.1586008; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2002, SURVEY NONRESPONSE, P289; Giannetta N, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103767; Hesselink G, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06555-5; Hines SE, 2020, AM J IND MED, V63, P830, DOI 10.1002/ajim.23157; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Jameton A., 1984, NURSING PRACTICE ETH, DOI 10.1002/chp.4760040110; Koepsell TD, 2014, EPIDEMIOLOGIC METHOD; Kok N, 2021, CRIT CARE MED, V49, P419, DOI 10.1097/CCM.0000000000004865; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kurtessis JN, 2017, J MANAGE, V43, P1854, DOI 10.1177/0149206315575554; Lake ET, 2022, J ADV NURS, V78, P799, DOI 10.1111/jan.15013; Lamiani G, 2017, J HEALTH PSYCHOL, V22, P51, DOI 10.1177/1359105315595120; Meese KA, 2021, J HEALTHC MANAG, V66, P304, DOI 10.1097/JHM-D-20-00288; Miljeteig I, 2021, NURS ETHICS, V28, P66, DOI 10.1177/0969733020981748; Morley Georgina, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc047; Muthen B., 2010, MPLUS USERS GUIDE; Nemati R, 2021, WORK, V70, P1039, DOI 10.3233/WOR-210558; NEWMAN TB, 1991, EPIDEMIOLOGY, V2, P383, DOI 10.1097/00001648-199109000-00014; Norman SB, 2021, DEPRESS ANXIETY, V38, P1007, DOI 10.1002/da.23205; O'Neal L, 2021, INT J EMERG MED, V14, DOI 10.1186/s12245-021-00341-0; Petrisor C, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9101377; Plouffe RA., 2021, EUR J PSYCHOTRAUMATO, V12, P1984667, DOI [10.1080/20008198.2021.1984667, DOI 10.1080/20008198.2021.1984667]; Rodriguez-Ruiz E, 2022, CRIT CARE MED, V50, pE487, DOI 10.1097/CCM.0000000000005434; Romero-Garcia M, 2022, INTENS CRIT CARE NUR, V70, DOI 10.1016/j.iccn.2022.103206; Sasso L, 2016, NURS ETHICS, V23, P523, DOI 10.1177/0969733015574926; Schneider JN, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.775204; Sellers FS., 2021, WASHINGTON POST 0818; Shanock LR, 2019, PSYCHOL-MANAG J, V22, P168, DOI 10.1037/mgr0000088; Sheppard KN, 2022, J NURS CARE QUAL, V37, P28, DOI 10.1097/NCQ.0000000000000596; Silverman HJ, 2021, NURS ETHICS, V28, P1137, DOI 10.1177/09697330211003217; Sonis J, 2021, GEN HOSP PSYCHIAT, V71, P142, DOI 10.1016/j.genhosppsych.2021.05.004; Spilg EG, 2022, BMC PSYCHIATRY, V22, DOI 10.1186/s12888-021-03637-w; Tian X, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/0046958021996499; West CP, 2012, J GEN INTERN MED, V27, P1445, DOI 10.1007/s11606-012-2015-7; Williams ES, 2001, HEALTH CARE MANAGE R, V26, P7, DOI 10.1097/00004010-200101000-00002; Williams Roger D, 2020, J Health Serv Psychol, V46, P65, DOI 10.1007/s42843-020-00011-4; Wilson CA, 2022, INT J MENT HEALTH NU, V31, P111, DOI 10.1111/inm.12942; Wocial LD, 2020, J GEN INTERN MED, V35, P1405, DOI 10.1007/s11606-020-05652-1; Wocial LD, 2013, J ADV NURS, V69, P167, DOI 10.1111/j.1365-2648.2012.06036.x; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	54	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268375	10.1371/journal.pone.0268375	http://dx.doi.org/10.1371/journal.pone.0268375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MS	35576206	gold, Green Published			2022-12-26	WOS:000834668900005
J	Zilli, J; Schaenzer, A; Buettner, K; Kressin, M; Schmidt, MJ				Zilli, Jessica; Schaenzer, Anne; Buettner, Kathrin; Kressin, Monika; Schmidt, Martin J.			Quantitative and qualitative evaluation of the hippocampal cytoarchitecture in adult cats with regard to the pathological diagnosis of hippocampal sclerosis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; ASTROCYTES; NEURONS; SUBPOPULATION; EXPRESSION; MICROGLIA; DENSITIES; LESIONS; AXIS; AGE	Cats are known to be affected by hippocampal sclerosis, potentially causing antiseizure drug(s) resistance. In order to lay the foundation for a standardized, systematic classification and diagnosis of this pathology in cats, this prospective study aimed at evaluating normal reference values of cellular densities and the cytoarchitecture of the feline hippocampus. Three transverse sections (head, body and tail) of each left hippocampus were obtained from 17 non-epileptic cats of different brachycephalic and mesocephalic breeds and age classes (range: 3-17 years). Histological (hematoxylin and eosin, Nissl) and immunohistochemical (NeuN, GFAP) staining was performed to investigate neuron and astroglial cell populations, as well as the layer thickness of the pyramidal cell layer and granule cell layer. Significant differences in neuronal density (in CA2-CA4 and the granule cell layer) and layer thickness (in CA1-CA3 and the granule cell layer) were evidenced throughout the longitudinal hippocampal axis (p<0.05); on the other hand, the astrocyte density did not differ. Moreover, reference ranges were defined for these parameters in the pyramidal cell layer and in the granule cell layer. The findings did not differ according to breed or age. In veterinary medicine these parameters have not been evaluated in cats so far. As surgical treatment may become a therapeutic option for cats with temporal lobe epilepsy, estimating normal values of the hippocampal cytoarchitecture will help in the standardized histopathological examination of resected hippocampal specimens to reach a diagnosis of hippocampal sclerosis.	[Zilli, Jessica; Schmidt, Martin J.] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Hessen, Germany; [Schaenzer, Anne] Justus Liebig Univ, Inst Neuropathol, Giessen, Hessen, Germany; [Buettner, Kathrin] Justus Liebig Univ, Inst Biomath, Giessen, Hessen, Germany; [Kressin, Monika] Justus Liebig Univ, Inst Vet Anat Histol & Embryol, Giessen, Hessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Zilli, J (corresponding author), Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Hessen, Germany.	Jessica.Zilli@vetmed.uni-giessen.de		Zilli, Jessica/0000-0003-4112-6518				BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Blumcke I, 2012, BRAIN PATHOL, V22, P347, DOI 10.1111/j.1750-3639.2012.00584.x; Chambers JK, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0258-3; Colombo M, 1998, J NEUROPHYSIOL, V80, P1002, DOI 10.1152/jn.1998.80.2.1002; DAM AM, 1979, NEUROPATH APPL NEURO, V5, P249, DOI 10.1111/j.1365-2990.1979.tb00624.x; DEVANEY KO, 1984, GERONTOLOGY, V30, P100, DOI 10.1159/000212615; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel Jerome Jr, 2003, Epilepsy Curr, V3, P37, DOI 10.1046/j.1535-7597.2003.03201.x; Hasegawa D, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.719455; Jinno S, 2007, GLIA, V55, P1334, DOI 10.1002/glia.20552; Jinno S, 2010, HIPPOCAMPUS, V20, P829, DOI 10.1002/hipo.20685; Keller D, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00083; KITAMURA T, 1987, BRAIN RES, V423, P189, DOI 10.1016/0006-8993(87)90839-0; Kitz S, 2017, J VET INTERN MED, V31, P633, DOI 10.1111/jvim.14699; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kuwabara T, 2010, EPILEPSY RES, V92, P85, DOI 10.1016/j.eplepsyres.2010.08.010; LING EA, 1973, J COMP NEUROL, V149, P73, DOI 10.1002/cne.901490105; Matiasek K, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0467-9; Mayhew TM, 1996, J ANAT, V188, P1; MOSER E, 1993, J NEUROSCI, V13, P3916; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pakozdy A, 2014, J VET INTERN MED, V28, P255, DOI 10.1111/jvim.12297; Pakozdy A, 2013, J VET INTERN MED, V27, P212, DOI 10.1111/jvim.12026; Pakozdy A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P399, DOI 10.1016/B978-0-12-804066-9.00029-8; Pakozdy A, 2011, J FELINE MED SURG, V13, P687, DOI 10.1016/j.jfms.2011.05.014; RICKMANN M, 1995, NEUROSCI LETT, V186, P13, DOI 10.1016/0304-3940(95)11269-3; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; SHEFER V F, 1977, Neuroscience and Behavioral Physiology, V8, P236, DOI 10.1007/BF01184064; SHIMADA M, 1992, J ANAT, V180, P89; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Vogt AH, 2010, J AM ANIM HOSP ASSOC, V46, P70, DOI 10.5326/0460070; Wagner E, 2014, BRAIN PATHOL, V24, P607, DOI 10.1111/bpa.12147; Wahle AM, 2014, J VET INTERN MED, V28, P182, DOI 10.1111/jvim.12250; Walz W, 1998, NEUROSCI LETT, V257, P127, DOI 10.1016/S0304-3940(98)00813-1; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wu Y, 2005, NEUROCHEM INT, V46, P565, DOI 10.1016/j.neuint.2005.01.002; Zilli J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244892	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268010	http://dx.doi.org/10.1371/journal.pone.0268010			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560321	Green Published, gold			2022-12-26	WOS:000835326900017
J	Bois, A; Tervil, B; Moreau, A; Vienne-Jumeau, A; Ricard, D; Oudre, L				Bois, Alexandre; Tervil, Brian; Moreau, Albane; Vienne-Jumeau, Alienor; Ricard, Damien; Oudre, Laurent			A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis	PLOS ONE			English	Article							FATIGUE; WALKING; IMPACT; EDSS	In the past few years, light, affordable wearable inertial measurement units have been providing to clinicians and researchers the possibility to quantitatively study motor degeneracy by comparing gait trials from patients and/or healthy subjects. To do so, standard gait features can be used but they fail to detect subtle changes in several pathologies including multiple sclerosis. Multiple sclerosis is a demyelinating disease of the central nervous system whose symptoms include lower limb impairment, which is why gait trials are commonly used by clinicians for their patients' follow-up. This article describes a method to compare pairs of gait signals, visualize the results and interpret them, based on topological data analysis techniques. Our method is non-parametric and requires no data other than gait signals acquired with inertial measurement units. We introduce tools from topological data analysis (sublevel sets, persistence barcodes) in a practical way to make it as accessible as possible in order to encourage its use by clinicians. We apply our method to study a cohort of patients suffering from progressive multiple sclerosis and healthy subjects. We show that it can help estimate the severity of the disease and also be used for longitudinal follow-up to detect an evolution of the disease or other phenomena such as asymmetry or outliers.	[Bois, Alexandre; Tervil, Brian; Vienne-Jumeau, Alienor; Ricard, Damien; Oudre, Laurent] Univ Paris Saclay, Ctr Borelli, CNRS, ENS Paris Saclay, Gif Sur Yvette, France; [Bois, Alexandre; Tervil, Brian; Vienne-Jumeau, Alienor; Ricard, Damien; Oudre, Laurent] Univ Paris, Ctr Borelli, CNRS, Paris, France; [Moreau, Albane; Vienne-Jumeau, Alienor; Ricard, Damien] Hop Instruct Armees Percy, Serv Neurol, Serv St Armees, Clamart, France; [Ricard, Damien] Ecole St Armees, Ecole Val De Grace, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Bois, A (corresponding author), Univ Paris Saclay, Ctr Borelli, CNRS, ENS Paris Saclay, Gif Sur Yvette, France.; Bois, A (corresponding author), Univ Paris, Ctr Borelli, CNRS, Paris, France.	alexandre.bois@ens-paris-saclay.fr		Tervil, Brian/0000-0002-7275-2717; Bois, Alexandre/0000-0003-2765-7961				Angelini L, 2020, J NEUROL, V267, P2897, DOI 10.1007/s00415-020-09928-8; Ben Mansour K, 2015, Comput Methods Biomech Biomed Engin, V18, P1996, DOI 10.1080/10255842.2015.1069553; Boissonnat J.-D., 2018, GEOMETRIC TOPOLOGICA, V57; Buckley C, 2019, GAIT POSTURE, V71, P289, DOI 10.1016/j.gaitpost.2018.06.166; Chazal F, 2012, ARXIV; Chazal F, 2014, GEOMETRIAE DEDICATA, V173, P193, DOI 10.1007/s10711-013-9937-z; Chazal F, 2009, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY (SCG'09), P237, DOI 10.1145/1542362.1542407; Chen YR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255584; Cohen-Steiner D, 2007, DISCRETE COMPUT GEOM, V37, P103, DOI 10.1007/s00454-006-1276-5; Cox M.A., 2008, HDB DATA VISUALIZATI, P315; Dindin Meryll, 2020, Advances in Artificial Intelligence. 33rd Canadian Conference on Artificial Intelligence, Canadian AI 2020. Proceedings. Lecture Notes in Artificial Intelligence. Subseries of Lecture Notes in Computer Science (LNAI 12109), P177, DOI 10.1007/978-3-030-47358-7_17; Dorrity MW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15351-4; Dot T, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20071939; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Emrani S, 2014, IEEE SIGNAL PROC LET, V21, P459, DOI 10.1109/LSP.2014.2305700; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Galea MP, 2017, NEUROREHABILITATION, V40, P277, DOI 10.3233/NRE-161413; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jung S, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20195625; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Learmonth YC, 2013, MULT SCLER J, V19, P1784, DOI 10.1177/1352458513483890; Liparoti M, 2019, MULT SCLER RELAT DIS, V29, P100, DOI 10.1016/j.msard.2019.01.028; Majumder S, 2020, INT CONF ACOUST SPEE, P1210, DOI 10.1109/ICASSP40776.2020.9054747; Mariani B., 2012, EPFL; Meyer-Moock S, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-58; Muller R, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02361-y; Muller R, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21124001; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; NOSEWORTHY JH, 1994, ANN NEUROL, V36, pS80, DOI 10.1002/ana.410360718; Novak D, 2013, MED ENG PHYS, V35, P1713, DOI 10.1016/j.medengphy.2013.07.003; Oudre L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18114033; Pau M, 2017, GAIT POSTURE, V58, P307, DOI 10.1016/j.gaitpost.2017.08.023; Perea JA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0645-6; Rugard M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252486; Sakaue S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15194-z; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Salch A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255859; Seversky LM, 2016, IEEE COMPUT SOC CONF, P1014, DOI 10.1109/CVPRW.2016.131; Stolz BJ, 2017, CHAOS, V27, DOI 10.1063/1.4978997; Tong JG, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11041834; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vasudevan R., 2011, IFAC P VOLUMES, V44, P3292, DOI [10.3182/20110828-6-IT-1002.03807, DOI 10.3182/20110828-6-IT-1002.03807]; Venkataraman V, 2016, IEEE IMAGE PROC, P4150, DOI 10.1109/ICIP.2016.7533141; Vienne A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00817; Vienne-Jumeau A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00261; Vienne-Jumeau A, 2020, ANN PHYS REHABIL MED, V63, P138, DOI 10.1016/j.rehab.2019.07.004; Vienne-Jumeau A, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19143089; Wang Y, 2018, ANN APPL STAT, V12, P1506, DOI 10.1214/17-AOAS1119; Yan Y, 2022, IEEE SENS J; Yan Y, 2020, IEEE ACCESS, V8, P96363, DOI 10.1109/ACCESS.2020.2996667; Yan Y, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072006	53	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268475	10.1371/journal.pone.0268475	http://dx.doi.org/10.1371/journal.pone.0268475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560328	Green Published, gold			2022-12-26	WOS:000834668000005
J	Idrees, A; Qadir, ZA; Afzal, A; Ranran, Q; Li, J				Idrees, Atif; Qadir, Ziyad Abdul; Afzal, Ayesha; Ranran, Qiu; Li, Jun			Laboratory efficacy of selected synthetic insecticides against second instar invasive fall armyworm, Spodoptera frugiperda (Lepidoptera: Noctuidae) larvae	PLOS ONE			English	Article							GATED CHLORIDE CHANNEL; POINT MUTATION; GENETIC-BASIS; RESISTANCE; SUSCEPTIBILITY; TOXICITY; MAIZE; FIELD	Maize is the most essential crop of China and its productivity has been recently endangered by the fall armyworm (FAW), Spodoptera frugiperda. Chemical pesticides are one of the most important strategies for managing FAW on a short-term basis. The seven synthetic insecticides including novel and conventional belong to four chemical group, spinetoram and spinosad (spinosyns), lambda-cyhalothrin, cypermethrin and bifenthrin (pyrethroids), abamectin (avermectins), broflinilide (diamides), were assessed for their efficiency in causing mortality to second instar S. frugiperda larvae at 24, 48 and 72 h post-treatment at five different serial concentrations (10 to 0.625 mg liter(-1)). The second instar S. frugiperda larvae were susceptible to the tested synthetic insecticides, however, the toxicity index of synthetic insecticides was estimated based on lethal concentration 50 (LC50), while, LC50 was calculated from the data of larval mortality. The broflanilide and abamectin proved to be the most toxic having the highest toxicity index of 100 and 78.29%, respectively, followed by cypermethrin and bifenthrin were showed toxicity index of 75.47 and 66.89%, respectively. The LC50 values were 0.606 and 0.774 mg liter(-1) for broflanilide and abamectin, respectively, followed by cypermethrin and bifenthrin were showed LC50 values of 0.803 and 0.906 mg liter(-1) at 72 h post-treatment. Rest of the other synthetic insecticides were showed moderate toxicity index of 42.11 to 62.09%, based on LC50 values were 1.439 to 0.976 mg liter(-1) at 72 h post-treatment. The efficiency of synthetic insecticides was increased by increasing concentration level and exposure time. The screened synthetic insecticides among seven insecticides perhaps, provide basis for the development of novel insecticides for controlling S. frugiperda population after further research to evaluate and validate the laboratory results in the field.	[Idrees, Atif; Afzal, Ayesha; Ranran, Qiu; Li, Jun] Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utiliz, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Peoples R China; [Qadir, Ziyad Abdul] Honeybee Res Inst, Natl Agr Res Ctr, Islamabad, Pakistan; [Qadir, Ziyad Abdul] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE USA; [Afzal, Ayesha] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; National Agricultural Research Council - Pakistan; University of Delaware; University of Lahore	Li, J (corresponding author), Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utiliz, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Peoples R China.	junl@giabr.gd.cn	Idrees, Atif/A-9644-2016; Idrees, Atif/ABG-2285-2021	Idrees, Atif/0000-0001-9819-0831; Idrees, Atif/0000-0001-9819-0831; Afzal, Ayesha/0000-0003-4069-0512	Key-Area Research and Development Program of Guangdong Province [2020B020223004]; GDAS Special Project of Science and Technology Development [2020GDASYL-20200301003, 2020GDASYL-20200104025]; Agricultural scientific research and technology promotion project of Guangdong Province [2021KJ260]	Key-Area Research and Development Program of Guangdong Province; GDAS Special Project of Science and Technology Development; Agricultural scientific research and technology promotion project of Guangdong Province	We would like to thank Hafiz Azhar Ali Khan guided the experiment analysis.	Abu Bakar M, 2018, PAK J ZOOL, V50, P857, DOI 10.17582/journal.pjz/2018.50.3.857.861; Acharya S., 2020, TROPICAL AGROBIODIVE, V1, P82, DOI [10.26480/TRAB.02.2020.82.85, DOI 10.26480/TRAB.02.2020.82.85]; Adams A, 2016, J ECON ENTOMOL, V109, P2411, DOI 10.1093/jee/tow210; Akhtar ZR, 2020, SPAN J AGRIC RES, V18, DOI 10.5424/sjar/2020183-15241; Assefa Y, 2019, INT J TROP INSECT SC, V39, P73, DOI 10.1007/s42690-019-00018-5; Bakar M. A., 2019, Pakistan Journal of Agricultural Research, V32, P566, DOI 10.17582/journal.pjar/2019/32.4.566.571; Bashir M.H., 2016, J ENTOMOL ZOOL STUD, V4, P611; Bateman ML, 2021, J APPL ENTOMOL, V145, P384, DOI 10.1111/jen.12856; Belay DK, 2012, FLA ENTOMOL, V95, P476, DOI 10.1653/024.095.0232; Bengyella L, 2021, PHYTOPARASITICA, V49, P1, DOI 10.1007/s12600-020-00862-z; do Nascimento ARB, 2016, PEST MANAG SCI, V72, P810, DOI 10.1002/ps.4057; Boaventura D, 2020, PEST MANAG SCI, V76, P47, DOI 10.1002/ps.5505; Cai P, 2017, BIOL CONTROL, V108, P89, DOI 10.1016/j.biocontrol.2017.02.006; Chimweta M, 2020, INT J PEST MANAGE, V66, P142, DOI 10.1080/09670874.2019.1577514; Cook DR, 2004, FLA ENTOMOL, V87, P433, DOI 10.1653/0015-4040(2004)087[0433:FALPON]2.0.CO;2; Daves CA., 2009, AMT, V34, P1, DOI [DOI 10.4182/AMT.2009.F43, 10.4182/amt.2009.F43]; Day R., 2017, Outlooks on Pest Management, V28, P196, DOI 10.1564/v28_oct_02; Deshmukh S, 2020, FLA ENTOMOL, V103, P221, DOI 10.1653/024.103.0211; Freeman G.H., 1985, BIOMETRICS, V41, DOI [10.2307/2530673, DOI 10.2307/2530673]; Gu XH, 2018, BIOL CONTROL, V122, P101, DOI 10.1016/j.biocontrol.2018.04.002; [郭井菲 Guo Jingfei], 2018, [植物保护, Plant Protection], V44, P1; Gutierrez-Moreno R, 2019, J ECON ENTOMOL, V112, P792, DOI 10.1093/jee/toy372; Hardke JT, 2011, FLA ENTOMOL, V94, P272, DOI 10.1653/024.094.0221; He LM, 2021, J INTEGR AGR, V20, P804, DOI 10.1016/S2095-3119(20)63334-2; [何莉梅 He Limei], 2020, [植物保护, Plant Protection], V46, P28; Idrees A, 2017, APPL ECOL ENV RES, V15, P1883, DOI 10.15666/aeer/1504_18831899; Idrees A, 2021, INSECTS, V12, DOI 10.3390/insects12111044; Jia HR, 2021, J INTEGR AGR, V20, P685, DOI 10.1016/S2095-3119(20)63281-6; Jing DP, 2020, INSECT SCI, V27, P780, DOI 10.1111/1744-7917.12700; Kasoma C, 2021, J CROP IMPROV, V35, P111, DOI 10.1080/15427528.2020.1802800; Kim J, 2021, PEST MANAG SCI, V77, P3145, DOI 10.1002/ps.6350; Kong FF, 2021, TOXICS, V9, DOI 10.3390/toxics9020020; Kulye M, 2021, INSECTS, V12, DOI 10.3390/insects12080758; Kumela T, 2019, INT J PEST MANAGE, V65, P1, DOI 10.1080/09670874.2017.1423129; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Luo MJ, 2018, PEST MANAG SCI, V74, P2842, DOI 10.1002/ps.5074; Mahmood R., 2021, PAK J ZOOL, V53, P1173, DOI 10.17582/journal.pjz/20200219080258; Maruthadurai R, 2020, PHYTOPARASITICA, V48, P15, DOI 10.1007/s12600-019-00771-w; Nakao T, 2016, BIOORGAN MED CHEM, V24, P372, DOI 10.1016/j.bmc.2015.08.008; Navik O, 2021, CROP PROT, V143, DOI 10.1016/j.cropro.2021.105536; Ndolo D, 2019, OUTLOOKS PEST MANAGE, V30, P267, DOI DOI 10.1564/V30_DEC_08; Okuma DM, 2018, PEST MANAG SCI, V74, P1441, DOI 10.1002/ps.4829; Qadir ZA, 2021, INSECTS, V12, DOI 10.3390/insects12111032; Ren H, 2021, SCI TOTAL ENVIRON, V763, DOI [10.1016/j.scitotenv.2020.143035, 10.1016/j.scitutenv.2020.143035]; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; Sartiami D, 2020, IOP C SER EARTH ENV, V468, DOI 10.1088/1755-1315/468/1/012021; Song YL, 2021, INT J CLIMATOL, V41, pE2851, DOI 10.1002/joc.6885; Susanto A., 2021, Research on Crops, V22, P652, DOI 10.31830/2348-7542.2021.114; Tang T, 2021, PEST MANAG SCI, V77, P1262, DOI 10.1002/ps.6139; Toepfer S, 2021, J PEST SCI, V94, P1075, DOI 10.1007/s10340-021-01359-2; Udayakumar A, 2021, J PLANT DIS PROTECT, V128, P775, DOI 10.1007/s41348-020-00401-2; Usmani KA, 2001, J ECON ENTOMOL, V94, P868, DOI 10.1603/0022-0493-94.4.868; Veres A, 2020, ENVIRON SCI POLLUT R, V27, P29867, DOI 10.1007/s11356-020-09279-x; Wang X, 2016, INSECT MOL BIOL, V25, P116, DOI 10.1111/imb.12204; Womack ED, 2020, J ECON ENTOMOL, V113, P956, DOI 10.1093/jee/toz357; Wu JZ, 2021, J INTEGR AGR, V20, P289, DOI 10.1016/S2095-3119(20)63244-0; [徐蓬军 Xu Pengjun], 2019, [植物保护, Plant Protection], V45, P61; Yang X.L., 2019, YUNNAN AGR, V1, P72; [杨现明 Yang Xianming], 2020, [植物保护, Plant Protection], V46, P10; Yeboah S, 2021, CROP PROT, V145, DOI 10.1016/j.cropro.2021.105612; You NS, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00827-9; Zhang DD, 2021, J INTEGR AGR, V20, P764, DOI 10.1016/S2095-3119(20)63288-9; Zhang HH, 2019, B ENTOMOL RES, V109, P236, DOI 10.1017/S0007485318000470; Zhang HH, 2019, COMP BIOCHEM PHYS B, V231, P11, DOI 10.1016/j.cbpb.2019.01.017; Zhao YX, 2020, PESTIC BIOCHEM PHYS, V168, DOI 10.1016/j.pestbp.2020.104623	65	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0265265	10.1371/journal.pone.0265265	http://dx.doi.org/10.1371/journal.pone.0265265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2BO	35576188	Green Published, gold			2022-12-26	WOS:000835262300005
J	O'Donnell, A; Pham, N; Battisti, L; Epstein, R; Nunes, D; Sawinski, D; Lodi, S				O'Donnell, Adrienne; Pham, Nathan; Battisti, Leandra; Epstein, Rachel; Nunes, David; Sawinski, Deirdre; Lodi, Sara			Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection	PLOS ONE			English	Article							DISEASE; RISK; ASSOCIATION; THERAPY; HCV; SAFETY; HIV	BackgroundDirect-acting antivirals (DAA) are highly effective at treating Hepatitis C virus (HCV) infection, with a cure rate >95%. However, the effect of DAAs on kidney function remains debated. MethodsWe analyzed electronic health record data for DAA-naive patients with chronic HCV infection engaged in HCV care at Boston Medical Center between 2014 and 2018. We compared the following hypothetical interventions using causal inference methods: 1) initiation of DAA and 2) no DAA initiation. For patients with normal kidney function at baseline (eGFR>90 ml/min/1.73m(2)), we estimated and compared the risk for reaching Stage 3 chronic kidney disease (CKD) (eGFR <= 60 ml/min/1.73m(2)) under each intervention. For patients with baseline CKD Stages 2-4 (15<eGFR <= 90 ml/min/1.73m(2)), we estimated and compared the mean change in eGFR at 2 years after baseline under each intervention. We used the parametric g-formula to adjust our estimates for baseline and time-varying confounders. ResultsFirst, among 1390 patients with normal kidney function at baseline the estimated 2-year risk difference (95% CI) of reaching Stage 3 CKD for DAA initiation versus no DAA was -1% (-3, 2). Second, among 733 patients with CKD Stage 2-4 at baseline the estimated 2-year mean difference in change in eGFR for DAA initiation versus no DAA therapy was -3 ml/min/1.73m(2) (-8, 2). ConclusionsWe found no effect of DAA initiation on kidney function, independent of baseline renal status. This suggests that DAAs may not be nephrotoxic; furthermore, in the short-term, HCV clearance may not improve CKD.	[O'Donnell, Adrienne; Lodi, Sara] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA; [Pham, Nathan] Univ Washington, Dept Gastroenterol, Seattle, WA USA; [Battisti, Leandra] Boston Med Ctr, Departmentof Pharm, Boston, MA USA; [Epstein, Rachel] Boston Univ, Dept Med, Sect Infect Dis, Sch Med, Boston, MA USA; [Epstein, Rachel] Boston Univ, Dept Pediat, Sect Infect Dis, Sch Med, Boston, MA USA; [Nunes, David] Boston Univ, Evans Dept Med, Sch Med, Boston, MA USA; [Sawinski, Deirdre] Weill Cornell Med Coll, Nephrol & Transplant Div, New York, NY USA	Boston University; University of Washington; University of Washington Seattle; Boston Medical Center; Boston University; Boston University; Boston University; Cornell University	O'Donnell, A (corresponding author), Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA.	aodonnel@bu.edu		O'Donnell, Adrienne/0000-0002-8491-9246	Providence/Boston Center for AIDS Research [P30AI042853]; Early Career Catalyst Award from idea hub at the Boston University School of Public Health; Charles A. King Trust Postdoctoral Research Fellowship	Providence/Boston Center for AIDS Research; Early Career Catalyst Award from idea hub at the Boston University School of Public Health; Charles A. King Trust Postdoctoral Research Fellowship	This work was supported by Providence/Boston Center for AIDS Research [grant number P30AI042853] (to SL), an Early Career Catalyst Award from idea hub at the Boston University School of Public Health (to SL) and The Charles A. King Trust Postdoctoral Research Fellowship (to RE).	Barsoum RS, 2017, J ADV RES, V8, P113, DOI 10.1016/j.jare.2016.07.004; Butt AA, 2018, ALIMENT PHARM THER, V48, P35, DOI 10.1111/apt.14799; Cacoub P, 2021, NEW ENGL J MED, V384, P1038, DOI 10.1056/NEJMra2033539; Calner P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218388; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Driedger M, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020436; Epstein RL, 2021, HEPATOL COMMUN, V5, P1543, DOI 10.1002/hep4.1748; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Janjua NZ, 2018, INT J DRUG POLICY, V55, P31, DOI 10.1016/j.drugpo.2018.02.001; Lee JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100790; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu Chen-Hua, 2022, Clin Gastroenterol Hepatol, DOI 10.1016/j.cgh.2022.01.050; Liu CH, 2020, J HEPATOL, V72, P839, DOI 10.1016/j.jhep.2019.11.014; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Lodi S, 2015, LANCET HIV, V2, pE335, DOI 10.1016/S2352-3018(15)00108-3; Logan R., GFORMULA 30 THE PARA; Loustaud-Ratti V, 2016, WORLD J HEPATOL, V8, P123, DOI 10.4254/wjh.v8.i2.123; Medeiros T, 2018, J CLIN PHARM THER, V43, P707, DOI 10.1111/jcpt.12697; Molnar MZ, 2015, HEPATOLOGY, V61, P1495, DOI 10.1002/hep.27664; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; Negro F, 2014, J HEPATOL, V61, pS69, DOI 10.1016/j.jhep.2014.08.003; Okubo T, 2018, HEPATOL INT, V12, P133, DOI 10.1007/s12072-018-9859-9; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Robins JM, 2009, CH CRC HANDB MOD STA, P553; Satapathy SK, 2012, HEPATOL INT, V6, P369, DOI 10.1007/s12072-011-9284-9; Saxena V, 2016, LIVER INT, V36, P807, DOI 10.1111/liv.13102; Schneeweiss S, 2019, ANN INTERN MED, V170, P398, DOI 10.7326/M18-3079; Sise ME, 2020, KIDNEY INT, V97, P193, DOI 10.1016/j.kint.2019.04.030; Sperring H, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720969554; Su FH, 2012, AM J KIDNEY DIS, V60, P553, DOI 10.1053/j.ajkd.2012.04.003; Taubman SL, 2009, INT J EPIDEMIOL, V38, P1599, DOI 10.1093/ije/dyp192; Trooskin SB, 2015, CLIN INFECT DIS, V61, P1825, DOI 10.1093/cid/civ677; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, CHRON HEP C VIR INF; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Wheeler DC, 2018, KIDNEY INT SUPPL, V8, P91, DOI 10.1016/j.kisu.2018.06.001; Young JG, 2011, STAT BIOSCI, V3, P119, DOI 10.1007/s12561-011-9040-7; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Zullig LL, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4349-x	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268478	10.1371/journal.pone.0268478	http://dx.doi.org/10.1371/journal.pone.0268478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560032	Green Published, gold			2022-12-26	WOS:000834668000003
J	Takahashi, K; Miyazato, I; Maeda, S; Takahashi, L				Takahashi, Keisuke; Miyazato, Itsuki; Maeda, Satoshi; Takahashi, Lauren			Designing transformer oil immersion cooling servers for machine learning and first principle calculations	PLOS ONE			English	Article								A transfomer oil immersion cooling server is designed and constructed for machine learning applications and first principle calculations that are carried out for materials-related research. CPU, motherboard, random access memory, hard disk drive, solid state drive, graphic card, and the power supply unit are submerged into the transformer oil in order to cool the entire system. Benchmark tests reveal that overall performance is improved while performance times for multicore calculations are dramatically improved. Furthermore, calculation times for machine learning with large data sets and density functional theory calculations are shortened during single core calculations. Thus, a transformer oil immersion cooling server is proposed to be an alternative cooling system used for improving the performance of first principle calculations and machine learning.	[Takahashi, Keisuke; Miyazato, Itsuki; Maeda, Satoshi; Takahashi, Lauren] Hokkaido Univ, Dept Chem, Sapporo, Japan; [Maeda, Satoshi] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Japan	Hokkaido University; Hokkaido University	Takahashi, K (corresponding author), Hokkaido Univ, Dept Chem, Sapporo, Japan.	keisuke.takahashi@sci.hokudai.ac.jp	Takahashi, Keisuke/Q-3874-2019; Maeda, Satoshi/H-3613-2014	Takahashi, Keisuke/0000-0002-9328-1694; Maeda, Satoshi/0000-0001-8822-1147	Japan Science and Technology Agency (JST); Core Research for Evolutional Science and Technology (CREST) [JPMJCR17P2]; Exploratory Research for Advanced Technology (ERATO) [JPMJER1903]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Exploratory Research for Advanced Technology (ERATO)(Japan Science & Technology Agency (JST))	This study was funded by the Japan Science and Technology Agency (JST) in the form of a Core Research for Evolutional Science and Technology (CREST) grant to KT (No. JPMJCR17P2) and in the form of a Exploratory Research for Advanced Technology (ERATO) grant to SM (JPMJER1903). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; [Anonymous], GEEKBENCH 5; [Anonymous], TRANSFORMER OIL A EN; Blaha P., 2001, WIEN2K; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Curtarolo S, 2013, NAT MATER, V12, P191, DOI [10.1038/nmat3568, 10.1038/NMAT3568]; Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Mortensen JJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035109; Mounet N, 2018, NAT NANOTECHNOL, V13, P246, DOI 10.1038/s41565-017-0035-5; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ramprasad R, 2017, NPJ COMPUT MATER, V3, DOI 10.1038/s41524-017-0056-5; Takahashi K, 2016, DALTON T, V45, P10497, DOI 10.1039/c6dt01501h; Nguyen TN, 2021, ACS CATAL, V11, P1797, DOI 10.1021/acscatal.0c04629	15	0	0	9	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0266880	10.1371/journal.pone.0266880	http://dx.doi.org/10.1371/journal.pone.0266880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580082	Green Published, gold			2022-12-26	WOS:000835654800002
J	Dogan, AE; Hamid, SM; Yildirim, AD; Yildirim, Z; Sen, G; Riera, CE; Gottlieb, RA; Erbay, E				Dogan, Asli E.; Hamid, Syed M.; Yildirim, Asli D.; Yildirim, Zehra; Sen, Ganes; Riera, Celine E.; Gottlieb, Roberta A.; Erbay, Ebru			PACT establishes a posttranscriptional brake on mitochondrial biogenesis by promoting the maturation of miR-181c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUIDE STRAND SELECTION; BINDING PROTEIN PACT; ADIPOSE-TISSUE; BEIGE FAT; BROWN; DICER; COLD; COACTIVATOR; TRBP; THERMOGENESIS	The double-stranded RNA-dependent protein kinase activating protein (PACT), an RNA-binding protein that is part of the RNA-induced silencing complex, plays a key role in miR-mediated translational repression. Previous studies showed that PACT regulates the expression of various miRs, selects the miR strand to be loaded onto RNA-induced silencing complex, and determines proper miR length. Apart from PACT's role in mediating the antiviral response in immune cells, what PACT does in other cell types is unknown. Strikingly, it has also been shown that cold exposure leads to marked downregulation of PACT protein in mouse brown adipose tissue (BAT), where mitochondrial biogenesis and metabolism play a central role. Here, we show that PACT establishes a posttranscriptional brake on mitochondrial biogenesis (mitobiogenesis) by promoting the maturation of miR-181c, a key suppressor of mitobiogenesis that has been shown to target mitochondrial complex IV subunit I (Mtco1) and sirtuin 1 (Sirt1). Consistently, we found that a partial reduction in PACT expression is sufficient to enhance mitobiogenesis in brown adipocytes in culture as well as during BAT activation in mice. In conclusion, we demonstrate an unexpected role for PACT in the regulation of mitochondrial biogenesis and energetics in cells and BAT.	[Dogan, Asli E.; Hamid, Syed M.; Yildirim, Zehra] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Dogan, Asli E.; Yildirim, Asli D.; Yildirim, Zehra] Bilkent Univ, Natl Nanotechnol Ctr, Dept Mol Biol & Genet, Ankara, Turkey; [Sen, Ganes] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA; [Riera, Celine E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Ctr Neural Sci & Med, Los Angeles, CA 90048 USA; [Riera, Celine E.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Dept Neurol, Los Angeles, CA 90048 USA; [Riera, Celine E.; Erbay, Ebru] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gottlieb, Roberta A.; Erbay, Ebru] Cedars Sinai Med Ctr, Smidt Heart Inst, Dept Cardiol, Los Angeles, CA 90048 USA; [Erbay, Ebru] Altos Labs, Bay Area Inst, Redwood City, CA 94065 USA	Cedars Sinai Medical Center; Ihsan Dogramaci Bilkent University; Cleveland Clinic Foundation; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Erbay, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.; Erbay, E (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Dept Cardiol, Los Angeles, CA 90048 USA.; Erbay, E (corresponding author), Altos Labs, Bay Area Inst, Redwood City, CA 94065 USA.	ebru.erbay@cshs.org		Riera, Celine/0000-0003-3535-3407; Yildirim, Asli Dilber/0000-0002-5654-3093; Dogan, Asli/0000-0003-1546-7191; Yildirim, Zehra/0000-0003-3132-8984	National Institutes of Health [R01HL149972]; Cedars-Sinai Medical Center Institutional Support	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Medical Center Institutional Support	This work was supported by the National Institutes of Health Grant R01HL149972 (E. E.) and Cedars-Sinai Medical Center Institutional Support (E. E.).	Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Andres AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89303; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; BARNETT SA, 1989, BIOL REV, V64, P317, DOI 10.1111/j.1469-185X.1989.tb00679.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chou CF, 2014, DIABETES, V63, P2949, DOI 10.2337/db13-1901; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Dabo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16089-8; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096820; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; dos Santos CO, 2018, PARKINSONISM RELAT D, V48, P93, DOI 10.1016/j.parkreldis.2017.12.015; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gottlieb RA, 2016, CELL CALCIUM, V60, P88, DOI 10.1016/j.ceca.2016.04.006; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hu F, 2015, DIABETES, V64, P2056, DOI 10.2337/db14-1117; Huot ME, 2012, MOL CELL, V46, P187, DOI 10.1016/j.molcel.2012.02.007; Indrieri A, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708734; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Ladomery MR, 2011, INT J MOL EPIDEMIOL, V2, P253; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39794; Liu WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003626; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2020, EMBO REP, V21, DOI 10.15252/embr.201947929; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Lui PY, 2017, J IMMUNOL, V199, P1846, DOI 10.4049/jimmunol.1601493; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Noland CL, 2013, RNA, V19, P639, DOI 10.1261/rna.037424.112; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Oliverio M, 2016, NAT CELL BIOL, V18, P328, DOI 10.1038/ncb3316; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodriguez-Ortiz CJ, 2014, J ALZHEIMERS DIS, V42, P1229, DOI 10.3233/JAD-140204; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shamsi F, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00205; Siang DTC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14001-8; Singh M, 2012, J CELL BIOCHEM, V113, P2754, DOI 10.1002/jcb.24152; Singh M, 2009, J MOL BIOL, V385, P457, DOI 10.1016/j.jmb.2008.10.068; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Thomou T, 2017, NATURE, V545, P252, DOI 10.1038/nature22319; Trajkovski M, 2013, TRENDS ENDOCRIN MET, V24, P442, DOI 10.1016/j.tem.2013.05.002; Tufanli O, 2017, P NATL ACAD SCI USA, V114, pE1395, DOI 10.1073/pnas.1621188114; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Wilson RC, 2015, MOL CELL, V57, P397, DOI 10.1016/j.molcel.2014.11.030; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu D, 2017, DIABETES, V66, P2987, DOI 10.2337/db17-0655; Zhang HB, 2015, EMBO REP, V16, P1378, DOI 10.15252/embr.201540837; Zhao MW, 2019, ENVIRON TOXICOL, V34, P699, DOI 10.1002/tox.22736	72	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102050	10.1016/j.jbc.2022.102050	http://dx.doi.org/10.1016/j.jbc.2022.102050			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35598827	gold, Green Published			2022-12-26	WOS:000818686700005
J	Chen, WW; Li, YQ; Steinhoff, M; Zhang, WH; Buddenkotte, J; Buhl, T; Zhu, RK; Yan, XR; Lu, ZP; Xiao, S; Wang, JF; Meng, JH				Chen, Weiwei; Li, Yanqing; Steinhoff, Martin; Zhang, Wenhao; Buddenkotte, Joerg; Buhl, Timo; Zhu, Renkai; Yan, Xinrong; Lu, Zhiping; Xiao, Song; Wang, Jiafu; Meng, Jianghui			The PLAUR signaling promotes chronic pruritus	FASEB JOURNAL			English	Article						atopic dermatitis; OSM; OSMR; PLAUR; Serpin E1; toll-like receptor	ATOPIC-DERMATITIS; ONCOSTATIN-M; RECEPTOR 2; EXPRESSION; ITCH; KERATINOCYTES; ACTIVATION; INFLAMMATION; MECHANISMS; UROKINASE	Chronic itch is a complex sensation of the skin frequently associated with skin diseases, such as atopic dermatitis (AD) and psoriasis. Although Serpin E1 is implicated in chronic itch, its receptor and signaling pathways involved in itch are not known. In this study, the clinical relevance of a putative Serpin E1 receptor PLAUR to chronic itch, and the neuro-cutaneous Serpin E1-PLAUR signaling are explored. We found that PLAUR is overexpressed in skin specimens of human lesional AD and lesional psoriasis, and sensory neurons innervating MC903-induced AD-like murine skin. Murine PLAUR(+) sensory neurons responded to Serpin E1, resulting in enrichment of numerous itch- and inflammation-related genes and their protein release. PLAUR resides in TLR2(+) neurons and Serpin E1 stimulus led to transcriptional upregulation of TLR2 and its co-signaling proteins. Agonists of TLR2 propagated itch-related gene transcription including BNP, OSM, and PAR2. OSM induced acute itch in mice and promoted G-CSF and IL-8 release from human keratinocytes. Serpin E1 inhibitor reduced MC903-induced itch, epidermal hyperplasia, immunocyte infiltration, and resulted in lower transcription/expression levels of Serpin E1 and OSM. Taken together, the PLAUR-TLR2-OSM signaling promotes skin-nerve communication, cutaneous inflammation, and itch, all feeding into an aggravation of AD and exaggerated itch circuits.	[Chen, Weiwei; Li, Yanqing; Zhang, Wenhao; Zhu, Renkai; Yan, Xinrong; Lu, Zhiping; Xiao, Song] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Dept Dermatol & Venereol, Doha, Qatar; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med Qatar, Dept Dermatol, Doha, Qatar; [Steinhoff, Martin] Qatar Univ, Coll Med, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med, Dept Dermatol, New York, NY USA; [Buhl, Timo] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Wang, Jiafu] Dublin City Univ, Fac Sci & Hlth, Sch Biotechnol, Dublin 9, Ireland; [Meng, Jianghui] Dublin City Univ, Fac Sci & Hlth, Natl Inst Cellular Biotechnol, Dublin 9, Ireland	Henan University; Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University; Cornell University; University of Gottingen; Dublin City University; Dublin City University	Wang, JF (corresponding author), Dublin City Univ, Fac Sci & Hlth, Sch Biotechnol, Dublin 9, Ireland.; Meng, JH (corresponding author), Dublin City Univ, Fac Sci & Hlth, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	jiafu.wang@dcu.iess; Jianghui.meng@dcu.ie	Buhl, Timo/AFP-7298-2022	xiao, song/0000-0003-2254-9486; Meng, Jianghui/0000-0002-3107-4200; Buddenkotte, Joerg/0000-0002-2394-3269; Wang, Jiafu/0000-0002-3654-4400	Henan University (HENU); Science Foundation Ireland (SFI) [15/SIRG/3508T]; Sanofi (Sanofi US)	Henan University (HENU); Science Foundation Ireland (SFI)(Science Foundation Ireland); Sanofi (Sanofi US)	Henan University (HENU), Grant/Award Number: Double-first class funding; Science Foundation Ireland (SFI), Grant/Award Number: 15/SIRG/3508T; Sanofi (Sanofi US), Grant/Award Number: Type 2 Innovation Grant	Akiyama T., 2014, MECH TREATMENT; Amarbayasgalan T, 2013, INT ARCH ALLERGY IMM, V160, P63, DOI 10.1159/000339666; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Bando T, 2006, NEUROSCIENCE, V142, P1263, DOI 10.1016/j.neuroscience.2006.07.009; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Braz JM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021386118; Cevikbas F, 2020, PHYSIOL REV, V100, P945, DOI 10.1152/physrev.00017.2019; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; Czekay RP, 2009, J CELL PHYSIOL, V220, P655, DOI 10.1002/jcp.21806; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Huang JT, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108233; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kasraie S, 2011, ALLERGY, V66, P845, DOI 10.1111/j.1398-9995.2011.02545.x; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Larkin C, 2021, J ALLERGY CLIN IMMUN, V147, P1110, DOI 10.1016/j.jaci.2020.09.028; Meng J, 2016, CURR RES TRANSL MED, V64, P203, DOI 10.1016/j.retram.2016.08.006; Meng JH, 2020, BRIT J PHARMACOL, V177, P1025, DOI 10.1111/bph.14952; Meng JH, 2019, J INVEST DERMATOL, V139, P2324, DOI 10.1016/j.jid.2019.04.017; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Nakayama T, 2001, INT IMMUNOL, V13, P95, DOI 10.1093/intimm/13.1.95; Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200; Niebuhr M, 2009, ALLERGY, V64, P1580, DOI 10.1111/j.1398-9995.2009.02050.x; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pastore S, 1997, J CLIN INVEST, V99, P3009, DOI 10.1172/JCI119496; Shin HY, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113177; Simone TM, 2014, ADV WOUND CARE, V3, P281, DOI 10.1089/wound.2013.0512; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Sun LX, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/1824624; Tseng PY, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe3037; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Voisin T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022087118; Wang F, 2021, CELL, V184, P422, DOI 10.1016/j.cell.2020.12.033; Wang F, 2020, IMMUNITY, V52, P753, DOI 10.1016/j.immuni.2020.04.008; Wang TT, 2020, NEUROSCIENCE, V429, P245, DOI 10.1016/j.neuroscience.2020.01.010; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9; Xiao S, 2021, BRAIN BEHAV IMMUN, V98, P28, DOI 10.1016/j.bbi.2021.08.211; Yosipovitch G, 2013, DERMATOL THER, V26, P83, DOI 10.1111/dth.12033	48	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22368	10.1096/fj.202200079R	http://dx.doi.org/10.1096/fj.202200079R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9LJ	35596683	Green Published			2022-12-26	WOS:000798232900001
J	Li, K; Ji, X; Seeley, R; Lee, WC; Shi, Y; Song, FF; Liao, XY; Song, C; Huang, XB; Rux, D; Cao, J; Luo, XJ; Anderson, SM; Huang, W; Long, FX				Li, Ke; Ji, Xing; Seeley, Rebecca; Lee, Wen-Chih; Shi, Yu; Song, Fangfang; Liao, Xueyang; Song, Chao; Huang, Xiaobin; Rux, Danielle; Cao, Ju; Luo, Xiaoji; Anderson, Steven M.; Huang, Wei; Long, Fanxin			Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis	FASEB JOURNAL			English	Article						articular cartilage; diabetes; Glut1; glycolysis; osteoarthritis	CHONDROCYTES; PROTEOGLYCAN; TRANSPORT; PROTEIN	Osteoarthritis (OA) is the leading joint disease characterized by cartilage destruction and loss of mobility. Accumulating evidence indicates that the incidence and severity of OA increases with diabetes, implicating systemic glucose metabolism in joint health. However, a definitive link between cellular metabolism in articular cartilage and OA pathogenesis is not yet established. Here, we report that in mice surgically induced to develop knee OA through destabilization of medial meniscus (DMM), expression of the main glucose transporter Glut1 is notably reduced in joint cartilage. Inducible deletion of Glut1 specifically in the Prg4-expressing articular cartilage accelerates cartilage loss in DMM-induced OA. Conversely, forced expression of Glut1 protects against cartilage destruction following DMM. Moreover, in mice with type I diabetes, both Glut1 expression and the rate of glycolysis are diminished in the articular cartilage, and the diabetic mice exhibit more severe cartilage destruction than their nondiabetic counterparts following DMM. The results provide proof of concept that boosting glucose metabolism in articular chondrocytes may ameliorate cartilage degeneration in OA.	[Li, Ke; Luo, Xiaoji; Huang, Wei] Chongqing Med Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Li, Ke; Ji, Xing; Seeley, Rebecca; Lee, Wen-Chih; Shi, Yu; Song, Fangfang; Liao, Xueyang; Song, Chao; Huang, Xiaobin; Rux, Danielle; Long, Fanxin] Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19104 USA; [Cao, Ju] Chongqing Med Univ, Dept Lab Med, Affiliated Hosp 1, Chongqing, Peoples R China; [Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA	Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Chongqing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Long, FX (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Suite 902,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	longf1@chop.edu			China Scholarship Council (CSC) [201908500129]; National Natural Science Foundation of China (NSFC) [81902293]	China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	China Scholarship Council (CSC), Grant/Award Number: 201908500129; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902293	Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Boer CG, 2021, CELL, V184, P4784, DOI 10.1016/j.cell.2021.07.038; Cieza A, 2020, LANCET, V396, P2006, DOI 10.1016/S0140-6736(20)32340-0; Decker RS, 2017, DEV BIOL, V426, P56, DOI 10.1016/j.ydbio.2017.04.006; Decker RS, 2015, CURR OSTEOPOROS REP, V13, P407, DOI 10.1007/s11914-015-0290-z; Dubey NK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103021; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gupta RC, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00192; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hollander JM, 2019, CURR OSTEOPOROS REP, V17, P59, DOI 10.1007/s11914-019-00506-0; Juel NG, 2018, SCAND J RHEUMATOL, V47, P325, DOI 10.1080/03009742.2017.1397189; Karner CM, 2016, J BIOL CHEM, V291, P13028, DOI 10.1074/jbc.M115.708578; Lee SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07316-5; Lee WC, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108108; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; Mobasheri A, 2002, CELL BIOL INT, V26, P297, DOI 10.1006/cbir.2001.0850; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; Shikhman AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE980, DOI 10.1152/ajpendo.00243.2003; Shikhman AR, 2001, J IMMUNOL, V167, P7001, DOI 10.4049/jimmunol.167.12.7001; Smeriglio P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax2332; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Veronese N, 2019, SEMIN ARTHRITIS RHEU, V49, P9, DOI 10.1016/j.semarthrit.2019.01.005; WAINE H, 1961, Tufts Folia Med, V7, P13; Wang CC, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00153-1; Wang CC, 2018, J ORTHOP TRANSL, V12, P66, DOI 10.1016/j.jot.2017.12.004; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205	36	1	1	7	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22377	10.1096/fj.202200485R	http://dx.doi.org/10.1096/fj.202200485R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35608871				2022-12-26	WOS:000800641200004
J	Wang, XS; Jespers, W; de Waal, JJ; Wolff, KAN; van Uden, L; IJzerman, AP; van Westen, GJP; Heitman, LH				Wang, Xuesong; Jespers, Willem; de Waal, Just J.; Wolff, Kim A. N.; van Uden, Liedeke; IJzerman, Adriaan P.; van Westen, Gerard J. P.; Heitman, Laura H.			Cancer-related somatic mutations alter adenosine A(1) receptor pharmacology-A focus on mutations in the loops and C-terminus	FASEB JOURNAL			English	Article						adenosine A(1) receptor; cancer; G protein-coupled receptors; mutations; yeast system	PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR LOOP; STRUCTURAL DIVERSITY; KEY ROLE; ADENOSINE-A1-RECEPTOR; PATHWAY; ANTAGONIST; ACTIVATION; EXPRESSION; CARCINOMA	G protein-coupled receptors (GPCRs) are known to be involved in tumor progression and metastasis. The adenosine A(1) receptor (A(1)AR) has been detected to be over-expressed in various cancer cell lines. However, the role of A(1)AR in tumor development is not yet well characterized. A series of A(1)AR mutations were identified in the Cancer Genome Atlas from cancer patient samples. In this study, we have investigated the pharmacology of mutations located outside of the 7-transmembrane domain by using a "single-GPCR-one-G protein" yeast system. Concentration-growth curves were obtained with the full agonist CPA for 12 mutant receptors and compared to the wild-type hA(1)AR. Most mutations located at the extracellular loops (EL) reduced the levels of constitutive activity of the receptor and agonist potency. For mutants at the intracellular loops (ILs) of the receptor, an increased constitutive activity was found for mutant receptor L211R(5.69), while a decreased constitutive activity and agonist response were found for mutant receptor L113F(34.51). Lastly, mutations identified on the C-terminus did not significantly influence the pharmacological function of the receptor. A selection of mutations was also investigated in a mammalian system. Overall, similar effects on receptor activation compared to the yeast system were found with mutations located at the EL, but some contradictory effects were observed for mutations located at the IL. Taken together, this study will enrich the insight of A(1)AR structure and function, enlightening the consequences of these mutations in cancer. Ultimately, this may provide potential precision medicine in cancer treatment.	[Wang, Xuesong; Jespers, Willem; de Waal, Just J.; Wolff, Kim A. N.; van Uden, Liedeke; IJzerman, Adriaan P.; van Westen, Gerard J. P.; Heitman, Laura H.] Leiden Acad Ctr Drug Res, Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Heitman, Laura H.] Oncode Inst, Leiden, Netherlands		van Westen, GJP; Heitman, LH (corresponding author), Leiden Acad Ctr Drug Res, Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	gerard@lacdr.leidenuniv.nl; l.h.heitman@lacdr.leidenuniv.nl	van Westen, Gerard/HHZ-3762-2022		China Scholarship Council (CSC); NWO | Stichting voor de Technische Wetenschappen (STW) [14410]	China Scholarship Council (CSC)(China Scholarship Council); NWO | Stichting voor de Technische Wetenschappen (STW)	China Scholarship Council (CSC); NWO | Stichting voor de Technische Wetenschappen (STW), Grant/Award Number: Veni #14410	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Borea PA, 2017, BRIT J PHARMACOL, V174, P1945, DOI 10.1111/bph.13763; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cheng RKY, 2017, STRUCTURE, V25, P1275, DOI 10.1016/j.str.2017.06.012; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dastjerdi MN, 2016, RES PHARM SCI, V11, P303, DOI 10.4103/1735-5362.189301; de Ligt RAF, 2005, EUR J PHARMACOL, V510, P1, DOI 10.1016/j.ejphar.2005.01.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Glukhova A, 2017, CELL, V168, P867, DOI 10.1016/j.cell.2017.01.042; Guo D, 2018, BRIT J PHARMACOL, V175, P1719, DOI 10.1111/bph.14184; Heitman LH, 2009, J MED CHEM, V52, P926, DOI 10.1021/jm8014052; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Johnston JB, 2001, ANN NEUROL, V49, P650, DOI 10.1002/ana.1007; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lappano R, 2012, ACTA PHARMACOL SIN, V33, P351, DOI 10.1038/aps.2011.183; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Liu H, 2020, CANCER CELL, V37, P324, DOI 10.1016/j.ccell.2020.02.006; Liu R, 2015, BIOCHEM PHARMACOL, V95, P290, DOI 10.1016/j.bcp.2015.04.005; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Ma HY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.636373; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Merighi S, 2001, BRIT J PHARMACOL, V134, P1215, DOI 10.1038/sj.bjp.0704352; Mirza A, 2005, CANCER BIOL THER, V4, P1355, DOI 10.4161/cbt.4.12.2196; MORO O, 1993, J BIOL CHEM, V268, P22273; Nasrollahi-Shirazi S, 2020, MOL PHARMACOL, V98, P250, DOI 10.1124/molpharm.120.000003; Navarro G, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0247-4; Nguyen ATN, 2016, MOL PHARMACOL, V90, P703, DOI 10.1124/mol.116.105007; Nguyen ATN, 2016, MOL PHARMACOL, V90, P715, DOI 10.1124/mol.116.105015; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Peeters MC, 2012, BIOCHEM PHARMACOL, V84, P76, DOI 10.1016/j.bcp.2012.03.008; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Peeters MC, 2011, FASEB J, V25, P632, DOI 10.1096/fj.10-164319; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Saito M, 2010, CANCER LETT, V290, P211, DOI 10.1016/j.canlet.2009.09.011; Sek K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123837; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stoy H, 2015, GENES DIS, V2, P108, DOI 10.1016/j.gendis.2015.02.005; Synowitz M, 2006, CANCER RES, V66, P8550, DOI 10.1158/0008-5472.CAN-06-0365; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang JN, 2019, J PHYS CHEM B, V123, P6462, DOI 10.1021/acs.jpcb.9b04867; Wang XS, 2020, EUR J PHARMACOL, V880, DOI 10.1016/j.ejphar.2020.173126; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yang X, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114144; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zamani Rarani M., 2020, INT ELECT J MED, V9, P14; Zhou YH, 2017, CELL PHYSIOL BIOCHEM, V43, P733, DOI 10.1159/000481557	60	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22358	10.1096/fj.202200203RR	http://dx.doi.org/10.1096/fj.202200203RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35604751	Green Published			2022-12-26	WOS:000800641200001
J	Liu, W; Guo, ZQ; Jiang, F; Liu, GW; Wang, D; Ni, ZS				Liu, Wei; Guo, Zhiqing; Jiang, Feng; Liu, Guangwei; Wang, Dong; Ni, Zishun			Improved WOA and its application in feature selection	PLOS ONE			English	Article							WHALE OPTIMIZATION ALGORITHM; SALP SWARM ALGORITHM; CLASSIFICATION; SYSTEM	Feature selection (FS) can eliminate many redundant, irrelevant, and noisy features in high-dimensional data to improve machine learning or data mining models' prediction, classification, and computational performance. We proposed an improved whale optimization algorithm (IWOA) and improved k-nearest neighbors (IKNN) classifier approaches for feature selection (IWOAIKFS). Firstly, WOA is improved by using chaotic elite reverse individual, probability selection of skew distribution, nonlinear adjustment of control parameters and position correction strategy to enhance the search performance of the algorithm for feature subsets. Secondly, the sample similarity measurement criterion and weighted voting criterion based on the simulated annealing algorithm to solve the weight matrix M are proposed to improve the KNN classifier and improve the evaluation performance of the algorithm on feature subsets. The experimental results show: IWOA not only has better optimization performance when solving benchmark functions of different dimensions, but also when used with IKNN for feature selection, IWOAIKFS has better classification and robustness.	[Liu, Wei; Guo, Zhiqing; Jiang, Feng; Ni, Zishun] Liaoning Tech Univ, Coll Sci, Fuxing, Liaoning, Peoples R China; [Liu, Guangwei; Wang, Dong] Liaoning Tech Univ, Coll Mines, Fuxing, Liaoning, Peoples R China	Liaoning Technical University; Liaoning Technical University	Guo, ZQ (corresponding author), Liaoning Tech Univ, Coll Sci, Fuxing, Liaoning, Peoples R China.	mathgzq@gmail.com			National Natural Science Foundation of China [51974144, 51874160]; Project of Liaoning Provincial Department of Education [LJKZ0340]; Discipline Innovation Team of Liaoning Technical University [LNTU20TD-01, LNTU20TD-07]; Key Scientific and Technological Project For Liaoning Province [2021JH1/10400011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Liaoning Provincial Department of Education; Discipline Innovation Team of Liaoning Technical University; Key Scientific and Technological Project For Liaoning Province	This study was funded by the National Natural Science Foundation of China [51974144; 51874160], the Project of Liaoning Provincial Department of Education [LJKZ0340], and the Discipline Innovation Team of Liaoning Technical University [LNTU20TD-01; LNTU20TD-07] in the form of funds to WL. This study was also supported by the Jie Bang Gua Shuai'(Take The Lead) of Key Scientific and Technological Project For Liaoning Province in the form of funds to GL [2021JH1/10400011].	Abdel-Basset M, 2020, EXPERT SYST APPL, V139, DOI 10.1016/j.eswa.2019.112824; Abdollahzadeh B, 2021, INT J INTELL SYST, V36, P5887, DOI 10.1002/int.22535; Abdollahzadeh B, 2021, COMPUT IND ENG, V158, DOI 10.1016/j.cie.2021.107408; Abualigah L, 2021, COMPUT IND ENG, V157, DOI 10.1016/j.cie.2021.107250; Abualigah L, 2021, COMPUT METHOD APPL M, V376, DOI 10.1016/j.cma.2020.113609; Agrawal P, 2021, IEEE ACCESS, V9, P26766, DOI 10.1109/ACCESS.2021.3056407; Agrawal RK, 2020, APPL SOFT COMPUT, V89, DOI 10.1016/j.asoc.2020.106092; Ahmad SR, 2015, 2015 SCIENCE AND INFORMATION CONFERENCE (SAI), P222, DOI 10.1109/SAI.2015.7237148; Al-Tashi Q, 2019, IEEE ACCESS, V7, P39496, DOI 10.1109/ACCESS.2019.2906757; Alweshah M, 2022, NEURAL COMPUT APPL, V34, P11267, DOI 10.1007/s00521-020-05210-0; Arora S, 2019, EXPERT SYST APPL, V116, P147, DOI 10.1016/j.eswa.2018.08.051; Asuncion A, 2007, UCI MACHINE LEARNING; Azzalini A, 2005, SCAND J STAT, V32, P159, DOI 10.1111/j.1467-9469.2005.00426.x; Bai Ll, 2020, APPL SOFT COMPUT, V92, DOI 10.1016/j.asoc.2020.106245; Bennasar M, 2015, EXPERT SYST APPL, V42, P8520, DOI 10.1016/j.eswa.2015.07.007; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dash M., 1997, Intelligent Data Analysis, V1; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Eid Heba F., 2018, International Journal of Computer Information Systems and Industrial Management Applications, V10, P174; Emary E, 2016, NEUROCOMPUTING, V213, P54, DOI 10.1016/j.neucom.2016.03.101; Emary E, 2016, NEUROCOMPUTING, V172, P371, DOI 10.1016/j.neucom.2015.06.083; Faris H, 2018, NEURAL COMPUT APPL, V30, P2355, DOI 10.1007/s00521-016-2818-2; Faris H, 2018, KNOWL-BASED SYST, V154, P43, DOI 10.1016/j.knosys.2018.05.009; Faris H, 2016, LECT NOTES ARTIF INT, V9875, P498, DOI 10.1007/978-3-319-45243-2_46; Ghoneim SSM, 2021, IEEE ACCESS, V9, P78324, DOI 10.1109/ACCESS.2021.3083593; Guha R, 2020, SOFT COMPUT, V24, P12821, DOI 10.1007/s00500-020-05183-1; Hafez AI, 2016, PROCEEDINGS OF THE 2016 INTERNATIONAL SYMPOSIUM ON INNOVATIONS IN INTELLIGENT SYSTEMS AND APPLICATIONS (INISTA); Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hecht-Nielsen R., 1992, IEEE T NEURAL NETWOR, p65e93, DOI [10.1016/B978-0-12-741252-8.50010-8, DOI 10.1016/B978-0-12-741252-8.50010-8, 10.1109/IJCNN.1989.118638, DOI 10.1109/IJCNN.1989.118638]; Heidari AA, 2019, FUTURE GENER COMP SY, V97, P849, DOI 10.1016/j.future.2019.02.028; Hussien Abdelazim G., 2019, Recent Trends in Signal and Image Processing. ISSIP 2017. Advances in Intelligent Systems and Computing (AISC 727), P79, DOI 10.1007/978-981-10-8863-6_9; Hussien A G, 2018, IEEE 8 INT C INTELLI, P166, DOI DOI 10.1109/INTELCIS.2017.8260031; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Jia HM, 2021, EXPERT SYST APPL, V185, DOI 10.1016/j.eswa.2021.115665; Kaur S, 2020, ENG APPL ARTIF INTEL, V90, DOI 10.1016/j.engappai.2020.103541; Khaire UM, 2022, IETE TECH REV, V39, P286, DOI 10.1080/02564602.2020.1843554; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krithiga R., 2020, MICROPROCESS MICROSY, DOI [DOI 10.1016/J.MICPRO.2020.103451, 10.1016/j. micpro.2020.103451]; Kumar L, 2021, NAT COMPUT, V20, P39, DOI 10.1007/s11047-019-09769-z; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu H., 2012, FEATURE SELECTION KN, V454; Mafarja M, 2021, INT J PARALLEL EMERG, V36, P80, DOI 10.1080/17445760.2019.1617866; Mafarja M, 2020, FUTURE GENER COMP SY, V112, P18, DOI 10.1016/j.future.2020.05.020; Mafarja M, 2020, COGN COMPUT, V12, P150, DOI 10.1007/s12559-019-09668-6; Mafarja M, 2018, KNOWL-BASED SYST, V145, P25, DOI 10.1016/j.knosys.2017.12.037; Mafarja M, 2018, APPL SOFT COMPUT, V62, P441, DOI 10.1016/j.asoc.2017.11.006; Mafarja MM, 2017, NEUROCOMPUTING, V260, P302, DOI 10.1016/j.neucom.2017.04.053; Manbari Z, 2019, EXPERT SYST APPL, V124, P97, DOI 10.1016/j.eswa.2019.01.016; McCallum A., 1998, AAAI 98 WORKSH LEARN; Mirjalili S, 2017, ADV ENG SOFTW, V114, P163, DOI 10.1016/j.advengsoft.2017.07.002; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P495, DOI 10.1007/s00521-015-1870-7; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mohammadzadeh H, 2021, COMPUT INTELL-US, V37, P176, DOI 10.1111/coin.12397; Moorthy RS, 2019, LECT NOTE DATA ENG, V26, P1291, DOI 10.1007/978-3-030-03146-6_151; Naruei I, 2022, ENG COMPUT-GERMANY, V38, P3025, DOI 10.1007/s00366-021-01438-z; Neggaz N, 2020, EXPERT SYST APPL, V152, DOI 10.1016/j.eswa.2020.113364; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ramanujam K. S., 2019, J COMPUT THEOR NANOS, V16, P384; Saidala RK, 2017, 2017 2ND INTERNATIONAL CONFERENCE FOR CONVERGENCE IN TECHNOLOGY (I2CT), P626; Sayed GI, 2018, J CLASSIF, V35, P300, DOI 10.1007/s00357-018-9261-2; Sayed GI, 2017, ADV INTELL SYST, V536, P306, DOI 10.1007/978-3-319-48490-7_36; Seif Z, 2015, ENG APPL ARTIF INTEL, V37, P293, DOI 10.1016/j.engappai.2014.09.009; Seth JK, 2016, PROCEEDINGS OF THE 10TH INDIACOM - 2016 3RD INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT, P3735; Shuaib M, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0394-7; Thara L., 2018, INT J PURE APPL MATH, V119, P337; Tizhoosh HR, 2006, International Conference on Computational Intelligence for Modelling, Control & Automation Jointly with International Conference on Intelligent Agents, Web Technologies & Internet Commerce, Vol 1, Proceedings, P695, DOI 10.1109/cimca.2005.1631345; Too JW, 2021, NEURAL COMPUT APPL, V33, P16229, DOI 10.1007/s00521-021-06224-y; Too J, 2020, CONNECT SCI, V32, P406, DOI 10.1080/09540091.2020.1741515; Too J, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8101130; Too J, 2018, COMPUTERS, V7, DOI 10.3390/computers7040058; Tubishat M, 2019, APPL INTELL, V49, P1688, DOI 10.1007/s10489-018-1334-8; Vijayanand R, 2020, IEEE ACCESS, V8, P56847, DOI 10.1109/ACCESS.2020.2978035; Wang JH, 2021, COGN COMPUT, V13, P1297, DOI 10.1007/s12559-021-09933-7; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xu H, 2018, PROCEEDINGS OF THE 2018 IEEE 4TH INTERNATIONAL SYMPOSIUM ON WIRELESS SYSTEMS WITHIN THE INTERNATIONAL CONFERENCES ON INTELLIGENT DATA ACQUISITION AND ADVANCED COMPUTING SYSTEMS (IDAACS-SWS), P10; Zamani H., 2016, INT J COMPUT SCI INF, DOI [DOI 10.13140/RG.2.2.29065.88161, 10.13140/RG.2.2.29065.88161]; Zhao WG, 2019, KNOWL-BASED SYST, V163, P283, DOI 10.1016/j.knosys.2018.08.030; Zheng YF, 2019, IEEE ACCESS, V7, P14908, DOI 10.1109/ACCESS.2018.2879848	81	1	1	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0267041	10.1371/journal.pone.0267041	http://dx.doi.org/10.1371/journal.pone.0267041			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6D9LS	35588402	Green Published, gold			2022-12-26	WOS:000883006100001
J	Sadef, Y; Javed, T; Javed, R; Mahmood, A; Alwahibi, MS; Elshikh, MS; AbdelGawwa, MR; Alhaji, JH; Rasheed, RA				Sadef, Yumna; Javed, Tayyaba; Javed, Rimsha; Mahmood, Adeel; Alwahibi, Mona S.; Elshikh, Mohamed S.; AbdelGawwa, Mohamed Ragab; Alhaji, Jawaher Haji; Rasheed, Rabab Ahmed			Nutritional status, antioxidant activity and total phenolic content of different fruits and vegetables' peels	PLOS ONE			English	Article							MANGO PEEL; CAPACITY; KERNEL; HEALTH	The present study assessed nutritional status, antioxidant activity, and total phenolic content in fruits, i.e., mango (Mangifera indica), apple (Malus domestica), and vegetable, i.e., bottle gourd (Lagenaria siceraria), and ridge gourd (Luffa acutangula) peels. The antioxidant activity and total phenolic content (TPC) were evaluated by using methanol extracts along with 2, 2-diphenyl-1-picrylhydrazyl (DPPH), Folin-Ciocalteu (FC) assay, respectively having Butylated hydroxytoluene (BHT) and Gallic acid (GA) as standard. The TPC and antioxidant activity in the peels ranged from 20 mg GAE/g to 525 mg GAE/g and 15.02% to 75.95%, respectively, which revealed that investigated fruit and vegetable peels are rich source of phytochemical constituents. Bottle gourd peels exhibited the highest value of DPPH compared to the rest of the peels included in the study. Likewise, mango peels had the highest TPC as compared to the rest of the fruit peels. This research showed that the utilization of agricultural wastes should be promoted at commercial level to achieve the nutritional benefit at zero cost and minimize the generation of biological waste.	[Sadef, Yumna; Javed, Tayyaba] Univ Punjab, Coll Earth & Environm Sci, Lahore, Pakistan; [Javed, Rimsha; Mahmood, Adeel] GC Women Univ Sialkot, Dept Environm Sci, Sialkot, Pakistan; [Alwahibi, Mona S.; Elshikh, Mohamed S.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [AbdelGawwa, Mohamed Ragab] Int Univ Sarajevo, Fac Engn & Nat Sci, Genet & Bioengn, Sarajevo, Bosnia & Herceg; [Alhaji, Jawaher Haji] King Saud Univ, Coll Appl Studies & Community Serv, Dept Hlth Sci, Riyadh, Saudi Arabia; [Rasheed, Rabab Ahmed] King Salman Int Univ, Fac Med, Histol & Cell Biol Dept, South Sinai, Egypt	University of Punjab; King Saud University; King Saud University; King Salman International University	Mahmood, A (corresponding author), GC Women Univ Sialkot, Dept Environm Sci, Sialkot, Pakistan.	adilqau5@gmail.com	Alwhibi, Mona/M-7398-2019; alhaji, jwaher Haji/GVS-0003-2022; Rasheed, Rabab/AAC-6230-2022	Alwhibi, Mona/0000-0002-3420-1164; alhaji, jwaher Haji/0000-0001-7473-3037; Rasheed, Rabab/0000-0002-1960-1792	King Saud University, Riyadh, Saudi Arabia [RSP2021/173]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	The authors extend their appreciation to the Researchers supporting project number (RSP2021/173), King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S., 2015, GLOB J MULTISTUD, V4, P302; Aina V. O., 2012, Advance Journal of Food Science & Technology, V4, P445; Ali S., 2015, PAKISTAN J AGR RES V, V28; Ditta HMA, 2021, INT J PHYTOREMEDIAT, V23, P1231, DOI 10.1080/15226514.2021.1889965; Arumugam R., 2011, ASIAN J EXP BIOL SCI, V2, P246; Ashoush I. S., 2011, World Journal of Dairy & Food Sciences, V6, P35; Asif A, 2016, TRENDS FOOD SCI TECH, V53, P102, DOI 10.1016/j.tifs.2016.05.004; Aziz NAA, 2012, J SCI FOOD AGR, V92, P557, DOI 10.1002/jsfa.4606; Baiano A, 2014, MOLECULES, V19, P14821, DOI 10.3390/molecules190914821; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Farooq M, 2018, J AGR FOOD CHEM, V66, P8887, DOI 10.1021/acs.jafc.8b02924; Habauzit V, 2012, THER ADV CHRONIC DIS, V3, P87, DOI 10.1177/2040622311430006; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Heng MY, 2017, FOOD CHEM, V221, P1388, DOI 10.1016/j.foodchem.2016.11.015; Horwitz W., 2000, OFFICIAL METHODS ANA; Hung SF, 2016, J FOOD DRUG ANAL, V24, P83, DOI 10.1016/j.jfda.2015.08.004; Hussain MK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254602; Ijaz M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13158535; Jahurul MHA, 2015, FOOD CHEM, V183, P173, DOI 10.1016/j.foodchem.2015.03.046; Kalpna R, 2011, J MED PLANTS RES, V5, P63; Kulisic T, 2004, FOOD CHEM, V85, P633, DOI 10.1016/j.foodchem.2003.07.024; Leyva-Corral J, 2016, LWT-FOOD SCI TECHNOL, V65, P228, DOI 10.1016/j.lwt.2015.07.073; Majeed A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230720; Maqsood A., 2013, J FOOD AGRIC ENVIRON, V11, P168; Miletic N, 2014, CZECH J FOOD SCI, V32, P360, DOI 10.17221/166/2013-CJFS; Morais DR, 2015, FOOD RES INT, V77, P392, DOI 10.1016/j.foodres.2015.08.036; Mukhtar A, 2010, J ANIM PLANT SCI, V20, P253; Nithya TG., 2016, ASIAN J PHARM CLIN R, V9, P200; Nweze C.C., 2015, INT J SCI ENV TECHNO, V4, P17; Nwofia G. E., 2012, Pakistan Journal of Nutrition, V11, P848; Pem D, 2015, IRAN J PUBLIC HEALTH, V44, P1309; Romelle FD., 2016, EURO J FOOD SCI TECH, V4, P12, DOI DOI 10.2527/JAS2012-5761.; Saeed MK., 2010, PHARMACOLOGYONLINE, V1, P252; Sai Srinivas SH., 2017, INT J AGR ENV BIORES, V2, P136; Shah K A, 2010, Pharmacogn Rev, V4, P42, DOI 10.4103/0973-7847.65325; Sogi DS, 2013, FOOD CHEM, V141, P2649, DOI 10.1016/j.foodchem.2013.05.053; Southon S, 2000, FOOD RES INT, V33, P211, DOI 10.1016/S0963-9969(00)00036-3; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Sultana B, 2012, J FOOD SCI, V77, pC849, DOI 10.1111/j.1750-3841.2012.02807.x; Vasco C, 2008, FOOD CHEM, V111, P816, DOI 10.1016/j.foodchem.2008.04.054; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307	41	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265566	10.1371/journal.pone.0265566	http://dx.doi.org/10.1371/journal.pone.0265566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35552543	Green Published, gold			2022-12-26	WOS:000868164600005
J	Shimamoto, Y; Sanuki, M; Kurita, S; Ueki, M; Kuwahara, Y; Matsumoto, A				Shimamoto, Yoko; Sanuki, Michiyoshi; Kurita, Shigeaki; Ueki, Masaya; Kuwahara, Yoshie; Matsumoto, Ayumu			Factors affecting prolonged time to extubation in patients given remimazolam	PLOS ONE			English	Article							MIDAZOLAM; PHARMACOKINETICS; METAANALYSIS; VARIABILITY; DESFLURANE; TOLERANCE; AVERAGE; YOUNG	PurposeTo analyze the cause of prolonged recovery from general anesthesia with remimazolam. MethodsWe studied 65 patients under general anesthesia with remimazolam. According to time to extubation, patients were divided into short period (SP) (n = 34, < 15 min) and long period (LP) (n = 31, >= 15 min) groups. Variables affecting time to extubation such as age, sex, height, body weight, body mass index (BMI), plasma albumin concentration, ASA class, duration of surgery, and total duration of general anesthesia, and total dose of remimazolam were compared between SP and LP groups. At the end of remimazolam infusion and upon extubation, predictive remimazolam concentrations were calculated using pharmacokinetic/pharmacodynamic three compartment modeling. ResultsLP group showed significantly higher BMI, older age, and lower plasma albumin concentration compared with those of SP group. Logistic regression analysis showed that the probability of time to extubation of >= 15 min was higher in patients with BMI greater than 22.0 kg/m(2) (AUC 0.668, 95% CI 0.533-0.803), ages older than 79.0 years (AUC 0.662, 95% CI 0.526-0.798), and plasma albumin concentrations lower than 3.60 g/dl (AUC 0.720, 95% CI 0.593-0.847). LP group showed significantly lower predicted remimazolam concentration than SP group upon extubation despite no difference in concentration between both groups at the end of infusion. Pharmacological analysis estimates that LP group is more sensitive to remimazolam than SP group through amplified responses. ConclusionsLower remimazolam doses should be considered for the overweight patients, elderly, and those with lower plasma albumin concentration.	[Shimamoto, Yoko; Sanuki, Michiyoshi; Kurita, Shigeaki; Ueki, Masaya; Kuwahara, Yoshie; Matsumoto, Ayumu] NHO Kure Med Ctr, Dept Anesthesiol, Kure, Hiroshima, Japan; [Matsumoto, Ayumu] Hiroshima Univ, Grad Sch Biomedical& Hlth Sci, Dept Anesthesiol & Crit Care, Hiroshima, Japan	Hiroshima University	Shimamoto, Y (corresponding author), NHO Kure Med Ctr, Dept Anesthesiol, Kure, Hiroshima, Japan.	shimamoto.yoko.px@mail.hosp.go.jp		, dao ben ye zi/0000-0002-3355-0661				Agoliati A, 2010, ANESTH ANALG, V110, P1433, DOI 10.1213/ANE.0b013e3181d58052; Antonik LJ, 2012, ANESTH ANALG, V115, P274, DOI 10.1213/ANE.0b013e31823f0c28; Bertz RJ, 1997, J PHARMACOL EXP THER, V281, P1317; Bouillon T, 1998, ANESTHESIOLOGY, V89, P557, DOI 10.1097/00000542-199809000-00002; Dexter F, 2010, ANESTH ANALG, V110, P570, DOI 10.1213/ANE.0b013e3181b5dcb7; Doi M., 2014, NIHONN RINSYO MASUI, V34, P860, DOI DOI 10.2199/JJSCA.34.860; Ihmsen H, 2004, BRIT J CLIN PHARMACO, V57, P153, DOI 10.1046/j.1365-2125.2003.01964.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kilpatrick GJ, 2007, ANESTHESIOLOGY, V107, P60, DOI 10.1097/01.anes.0000267503.85085.c0; Kilpatrick GJ, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.690875; Lohmer LL, 2020, J CLIN PHARMACOL, V60, P505, DOI 10.1002/jcph.1552; Loscalzo LM, 2008, EUR J PHARMACOL, V580, P306, DOI 10.1016/j.ejphar.2007.11.011; Minto CF, 2000, ANESTHESIOLOGY, V92, P1603, DOI 10.1097/00000542-200006000-00017; Platten HP, 1998, CLIN PHARMACOL THER, V63, P552, DOI 10.1016/S0009-9236(98)90106-0; Schuttler J, 2020, ANESTHESIOLOGY, V132, P636, DOI 10.1097/ALN.0000000000003103; Sun GC, 2008, BRIT J ANAESTH, V101, P632, DOI 10.1093/bja/aen251; US Food and Drug Administration, BYF HIGHL PRESCR INF; VINIK HR, 1989, ANESTH ANALG, V69, P213; Wanderer JP, 2018, ANESTH ANALG, V126, P1241, DOI 10.1213/ANE.0000000000002732; Yamamoto T, 2021, J ANESTH, V35, P322, DOI 10.1007/s00540-021-02915-x; Zhou J, 2020, J CLIN ANESTH, V66, DOI 10.1016/j.jclinane.2020.109899	21	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268568	10.1371/journal.pone.0268568	http://dx.doi.org/10.1371/journal.pone.0268568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584094	gold, Green Published			2022-12-26	WOS:000834613800010
J	Mano, S; Hayashi, Y; Hikino, K; Otomo, M; Kanai, M; Nishimura, M				Mano, Shoji; Hayashi, Yasuko; Hikino, Kazumi; Otomo, Masayoshi; Kanai, Masatake; Nishimura, Mikio			Ubiquitin-conjugating activity by PEX4 is required for efficient protein transport to peroxisomes in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATEWAY BINARY VECTORS; IMPORT RECEPTOR PEX5P; HIGHER MOLECULAR-MASS; TARGETING SIGNAL; FUNCTIONAL-CHARACTERIZATION; CARBOXY-TERMINUS; PTS1 RECEPTOR; IDENTIFICATION; GENE; BIOGENESIS	Protein transport to peroxisomes requires various proteins, such as receptors in the cytosol and components of the transport machinery on peroxisomal membranes. The Arabidopsis apem (aberrant peroxisome morphology) mutant apem7 shows decreased efficiency of peroxisome targeting signal 1-dependent protein transport to peroxisomes. In apem7 mutants, peroxisome targeting signal 2-dependent protein transport is also disturbed, and plant growth is repressed. The APEM7 gene encodes a protein homologous to peroxin 4 (PEX4), which belongs to the ubiquitin-conjugating (UBC) protein family; however, the UBC activity of Arabidopsis PEX4 remains to be investigated. Here, we show using electron microscopy and immunoblot analysis using specific PEX4 antibodies and in vitro transcription/translation assay that PEX4 localizes to peroxisomal membranes and possesses UBC activity. We found that the substitution of proline with leucine by apem7 mutation alters ubiquitination of PEX4. Furthermore, substitution of the active-site cysteine residue at position 90 in PEX4, which was predicted to be a ubiquitin-conjugation site, with alanine did not restore the apem7 phenotype. Taken together, these findings indicate that abnormal ubiquitination in the apem7 mutant alters ubiquitin signaling during the process of protein transport, suggesting that the UBC activity of PEX4 is indispensable for efficient protein transport to peroxisomes.	[Mano, Shoji; Hikino, Kazumi; Kanai, Masatake; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Hayashi, Yasuko; Otomo, Masayoshi] Niigata Univ, Grad Sch Sci & Technol, Ikarashi, Niigata, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Niigata University	Mano, S (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.; Mano, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	mano@nibb.ac.jp		Nishimura, Mikio/0000-0001-7960-9721	Japan Society for the Promotion of Science KAKENHI grant [20059035, 22112523, 17K07457, 20K06711, 17K07467]	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 20059035, 22112523, 17K07457, and 20K06711; to S. M.; and 17K07467; to Y. H.).	Asano T, 2004, PLANT J, V38, P448, DOI 10.1111/j.1365-313X.2004.02057.x; Baker A, 2016, BIOCHEM SOC T, V44, P783, DOI 10.1042/BST20160036; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CRANE DI, 1994, J BIOL CHEM, V269, P21835; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Fan JL, 2005, PLANT PHYSIOL, V139, P231, DOI 10.1104/pp.105.066811; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Gonzalez KL, 2018, P NATL ACAD SCI USA, V115, pE3163, DOI 10.1073/pnas.1721279115; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Goto-Yamada S, 2015, PLANT CELL PHYSIOL, V56, P1264, DOI 10.1093/pcp/pcv081; Goto-Yamada S, 2014, PLANT CELL PHYSIOL, V55, P482, DOI 10.1093/pcp/pcu017; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; Gurvitz A, 2001, MOL GENET GENOMICS, V265, P276, DOI 10.1007/s004380000412; Hasan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00261; Hayashi H, 1998, J BIOL CHEM, V273, P8301, DOI 10.1074/jbc.273.14.8301; Hayashi M, 1999, PLANT CELL PHYSIOL, V40, P263, DOI 10.1093/oxfordjournals.pcp.a029537; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hayashi M, 1997, PLANT CELL PHYSIOL, V38, P759, DOI 10.1093/oxfordjournals.pcp.a029233; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hayashi Y, 2001, PROTOPLASMA, V218, P83, DOI 10.1007/BF01288364; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kao YT, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0605-3; Kaplan CP, 2001, BBA-MOL CELL RES, V1539, P173, DOI 10.1016/S0167-4889(01)00091-X; KATO A, 1995, PLANT MOL BIOL, V27, P377, DOI 10.1007/BF00020191; Kato A, 1998, PLANT CELL PHYSIOL, V39, P186, DOI 10.1093/oxfordjournals.pcp.a029356; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Mano S, 2005, VITAM HORM, V72, P111, DOI 10.1016/S0083-6729(05)72004-5; Mano S, 2004, PLANT J, V38, P487, DOI 10.1111/j.1365-313X.2004.02063.x; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Mural RV, 2013, PLANT CELL, V25, P3615, DOI 10.1105/tpc.113.117093; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Philip N, 2007, P NATL ACAD SCI USA, V104, P7845, DOI 10.1073/pnas.0611601104; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Prestele J, 2010, P NATL ACAD SCI USA, V107, P14915, DOI 10.1073/pnas.1009174107; Rinaldi MA, 2017, PLANT PHYSIOL, V174, P2231, DOI 10.1104/pp.17.00548; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schumann U., 1999, Plant Physiology, V120, P339, DOI 10.1104/pp.120.1.339; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Tanaka Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1795, DOI 10.1271/bbb.130405; van der Klei IJ, 1998, EMBO J, V17, P3608, DOI 10.1093/emboj/17.13.3608; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; Wimmer C, 1998, PLANT J, V16, P453, DOI 10.1046/j.1365-313x.1998.00320.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Zhou BJ, 2017, PLANT PHYSIOL, V173, P1371, DOI 10.1104/pp.16.01190; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101	75	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102038	10.1016/j.jbc.2022.102038	http://dx.doi.org/10.1016/j.jbc.2022.102038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35595097	gold, Green Published			2022-12-26	WOS:000811813400006
J	Camacho-Valdez, V; Rodiles-Hernandez, R; Navarrete-Gutierrez, DA; Valencia-Barrera, E				Camacho-Valdez, Vera; Rodiles-Hernandez, Rocio; Navarrete-Gutierrez, Dario A.; Valencia-Barrera, Emmanuel			Tropical wetlands and land use changes: The case of oil palm in neotropical riverine floodplains	PLOS ONE			English	Article							ECOSYSTEM SERVICES; WATER-QUALITY; FLOOD PLAINS; BIODIVERSITY; PLANTATIONS; EXPANSION; LANDSCAPES; IMPACT; DEFORESTATION; CONSEQUENCES	Oil palm plantations are expanding in Latin America due to the global demand for food and biofuels, and much of this expansion has occurred at expense of important tropical ecosystems. Nevertheless, there is limited knowledge about effects on aquatic ecosystems near to oil palm-dominated landscapes. In this study, we used Landsat 7 ETM+, Landsat 8 OLI imagery and high-resolution images in Google Earth to map the current extent of oil palm plantations and determined prior land use land cover (LULC) in the Usumacinta River Basin as a case-study site. In addition, we assess the proximity of the crop with aquatic ecosystems distributed in the Usumacinta floodplains and their potential effects. Based on our findings, the most significant change was characterized by the expansion of oil palm crop areas mainly at expenses of regional rainforest and previously intervened lands (e.g. secondary vegetation and agriculture). Although aquatic ecosystem class (e.g. rivers, lagoons and channels) decreased in surface around 3% during the study period (2001-2017), the change was not due to the expansion of oil palm lands. However, we find that more than 50% of oil palm cultivations are near (between 500 and 3000 m) to aquatic ecosystems and this could have significant environmental impacts on sediment and water quality. Oil palm crops tend to spatially concentrate in the Upper Usumacinta ecoregion (Guatemala), which is recognized as an area of important fish endemism. We argue that the basic information generated in this study is essential to have better land use decision-making in a region that is relative newcomer to oil palm boom.	[Camacho-Valdez, Vera] CONACYT Colegio Frontera Sur, Dept Conservac Biodiversidad, San Cristobal Las Casas, Chiapas, Mexico; [Rodiles-Hernandez, Rocio] Colegio Frontera Sur, Dept Conservac Biodiversidad, San Cristobal Las Casas, Chiapas, Mexico; [Navarrete-Gutierrez, Dario A.; Valencia-Barrera, Emmanuel] Colegio Frontera Sur, Dept Observac & Estudio Tierra, San Cristobal Las Casas, Chiapas, Mexico	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR)	Camacho-Valdez, V (corresponding author), CONACYT Colegio Frontera Sur, Dept Conservac Biodiversidad, San Cristobal Las Casas, Chiapas, Mexico.	vcamacho@ecosur.mx		Camacho, Vera/0000-0001-7596-9586	Conectividad y Diversidad Funcional de la Cuenca del rio Usumacinta [FID-ECOSUR-784-1004]	Conectividad y Diversidad Funcional de la Cuenca del rio Usumacinta	Conectividad y Diversidad Funcional de la Cuenca del rio Usumacinta"(FID-ECOSUR-784-1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Abram NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095388; Abrams J, 2019, SOC NATUR RESOUR, V32, P548, DOI 10.1080/08941920.2018.1544678; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Alonso-Fradejas A., 2011, INT C GLOB LAND GRAB; Alonso-Fradejas A, 2012, CAN J DEV STUD, V33, P509, DOI 10.1080/02255189.2012.743455; Avendano C., 2019, EFFECTS LAND USE WAT; Benami E, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa270; Bennett A, 2018, WORLD DEV, V109, P29, DOI 10.1016/j.worlddev.2018.04.001; Bock K, 2018, AQUAT ECOL SER, V8, P413, DOI 10.1007/978-3-319-73250-3_21; Cabrera J., 2002, AMBIENTE CONFLICTO C, P1; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castellanos-Navarrete A, 2021, J RURAL STUD, V81, P294, DOI 10.1016/j.jrurstud.2020.10.047; Castellanos-Navarrete A, 2018, J AGRAR CHANGE, V18, P132, DOI 10.1111/joac.12195; Castellanos-Navarrete A, 2015, J PEASANT STUD, V42, P791, DOI 10.1080/03066150.2015.1016920; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Cazzanelli M, 2021, HYDROBIOLOGIA, V848, P773, DOI 10.1007/s10750-020-04468-8; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Clay J., 2004, WORLD AGR ENV COMMOD, P203; Comte I, 2012, ADV AGRON, V116, P71, DOI 10.1016/B978-0-12-394277-7.00003-8; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; Cunha EJ, 2015, ECOL INDIC, V52, P422, DOI 10.1016/j.ecolind.2014.12.024; Damon A., 2013, LANKESTERIANA; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; De Leon E., 2012, REV OBSERVATORIO EC; de Souza ALT, 2013, FOREST ECOL MANAG, V298, P12, DOI 10.1016/j.foreco.2013.02.022; Drescher J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0275; Eastman J.R, 2003, GUIDE GIS IMAGE PROC, V14, P239; Eigenbrod F, 2011, P ROY SOC B-BIOL SCI, V278, P3201, DOI 10.1098/rspb.2010.2754; Elias DJ, 2020, J BIOGEOGR, V47, P2483, DOI 10.1111/jbi.13941; Euler M, 2017, WORLD DEV, V93, P219, DOI 10.1016/j.worlddev.2016.12.019; Fernandes JD, 2014, HYDROBIOLOGIA, V724, P175, DOI 10.1007/s10750-013-1732-1; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agriculture Organization Statistics Division (FAOSTAT), 2014, PROD; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Garcia E., 1998, CLIMAS 1 1000000, V1; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Graya CL, 2014, BASIC APPL ECOL, V15, P693, DOI 10.1016/j.baae.2014.09.009; Gucker B, 2009, FRESHWATER BIOL, V54, P2069, DOI 10.1111/j.1365-2427.2008.02069.x; Guerena A., 2013, POWER OIL PALM LAND; Hamann R., 1996, ROUNDTABLE M HELD SA; Hervas A, 2020, REG ENVIRON CHANGE, V20, DOI 10.1007/s10113-020-01630-9; Hervas A, 2019, J PEASANT STUD, V46, P115, DOI 10.1080/03066150.2017.1351435; Hornung LK, 2019, ECOSYST PEOPLE, V15, P214, DOI 10.1080/26395916.2019.1656287; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; IMA (Indonesian Ministry of Agriculture), 2010, AR PROD CAT PROD PAL; Junk W.J., 1990, P491; Koh LP, 2008, BIOL CONSERV, V141, P2450, DOI 10.1016/j.biocon.2008.08.005; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Kolb M, 2012, GEOGR J, V178, P147, DOI 10.1111/j.1475-4959.2011.00431.x; Krishna V, 2017, AGR ECON-BLACKWELL, V48, P639, DOI 10.1111/agec.12363; Kubitza C, 2018, HUM ECOL, V46, P107, DOI 10.1007/s10745-017-9965-7; Kumar M., 2018, REMOTE SENS APPL SOC, V10, P224, DOI [DOI 10.1016/J.RSASE.2018.04.002, 10.1016/j.rsase.2018.04.002]; Lo M, 2020, BIOSCIENCE, V70, P404, DOI 10.1093/biosci/biaa021; Lord S., 2006, INT PLANT C HIGH PRO; Luke SH, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1827; Mahler T, 2019, ELGAR STUD LAW REG, P1, DOI [10.1007/s11356-019-04563-x, 10.4337/9781786435149]; March Mifsut I.y., 2010, CUENCAS HIDROGR FICA, P193; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Mateo-Sagasta J., 2013, FAO WATER REPORTS, V40; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; MEA, 2003, ECOSYSTEMS HUMAN WEL; Merten J, 2016, ECOL SOC, V21, DOI 10.5751/ES-08214-210205; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mingorria Sara, 2014, Environment Development and Sustainability, V16, P841, DOI 10.1007/s10668-014-9530-0; Mitsch W.J., 2015, ECOSYSTEM SERVICES W; Mitsch WJ, 2000, ECOL ECON, V35, P25, DOI 10.1016/S0921-8009(00)00165-8; O'Hare MT, 2018, HYDROBIOLOGIA, V812, P1, DOI 10.1007/s10750-017-3190-7; Obidzinski K, 2012, ECOL SOC, V17, DOI 10.5751/ES-04775-170125; Olaleye V. F., 2005, International Journal of Zoological Research, V1, P15; Pardon L, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0353-2; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Qaim M, 2020, ANNU REV RESOUR ECON, V12, P321, DOI 10.1146/annurev-resource-110119-024922; Quezada ML, 2014, REG ENVIRON CHANGE, V14, P1139, DOI 10.1007/s10113-013-0548-x; R Core Team, 2021, R LANGUAGE ENV STAT; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Rodiles-Hernandez M.R., 2018, REV MEX BIODIVERS, V89, P1; Sanchez A.J., 2005, BIODIVERSIDAD ESTADO; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Schindler S, 2014, LANDSCAPE ECOL, V29, P229, DOI 10.1007/s10980-014-9989-y; Schrier-Uijl A.P., 2013, ENV SOCIAL IMPACTS O; Selfa T, 2015, ENVIRON MANAGE, V56, P1315, DOI 10.1007/s00267-015-0535-8; Sheaves M, 2018, AGR ECOSYST ENVIRON, V262, P1, DOI 10.1016/j.agee.2018.04.011; Sheil Douglas, 2009, 51 CIFOR; Simova P., 2017, BIRDS USEFUL INDICAT, P37; Stone R, 2007, SCIENCE, V317, P1491, DOI 10.1126/science.317.5844.1491; Sumarga E, 2016, ECOL SOC, V21, DOI 10.5751/ES-08490-210252; Tan KT, 2009, RENEW SUST ENERG REV, V13, P420, DOI 10.1016/j.rser.2007.10.001; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 2010, RIVER RES APPL, V26, P76, DOI 10.1002/rra.1328; Tomscha SA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1728; Tung Petronella G. Ah, 2009, American Journal of Applied Sciences, V6, P1788, DOI 10.3844/ajassp.2009.1788.1799; Uning R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125077; USDA (United States Department of Agriculture), 2009, IND PALM OIL PROD GR; Van der Ploeg S., 2010, TEEB VALUATION DATAB; Varkkey H, 2013, WETLANDS, V33, P679, DOI 10.1007/s13157-013-0423-z; Verchot L.V., 2010, REDUCING FORESTRY EM; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Wahid MB, 2005, PLANT PROD SCI, V8, P288, DOI 10.1626/pps.8.288; Wang CJ, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20060398; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Yule CM, 2009, J N AM BENTHOL SOC, V28, P404, DOI 10.1899/07-161.1	105	1	1	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0266677	10.1371/journal.pone.0266677	http://dx.doi.org/10.1371/journal.pone.0266677			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35550633	gold, Green Published			2022-12-26	WOS:000868164600015
J	Kitayama, M; Unoki, T; Matsuda, Y; Matsuishi, Y; Kawai, Y; Iida, Y; Teramoto, M; Tatsuno, J; Hamamoto, M				Kitayama, Mio; Unoki, Takeshi; Matsuda, Yui; Matsuishi, Yujiro; Kawai, Yusuke; Iida, Yasuo; Teramoto, Mio; Tatsuno, Junko; Hamamoto, Miya			Development and initial validation of the Japanese healthy work environment assessment tool for critical care settings	PLOS ONE			English	Article							INTRACLASS CORRELATION-COEFFICIENTS; COMMUNICATION; NURSES	Aim This study aims to translate the Healthy Work Environment Assessment Tool (HWE-AT) into Japanese and evaluate its validity and reliability. Design and methods The authors followed the guidelines for scale translation, adaptation, and validation in cross-cultural healthcare research. After translation and back-translation, a series of pilot studies were conducted to assess comprehensibility. Subsequently, an expert panel established the content validity. Content validity was calculated using the content validity index (CVI). Finally, we verified the construct validity and calculated the test-retest reliability. Results The updated HWE-AT achieved sufficient comprehensibility after conducting the two pilot tests. Content validity was calculated using the scale-level CVI/average and all the items were 1.00. The content validity indices CFI and RMSEA were 0.918 and 0.082, respectively. Intraclass correlation coefficients for all dimensions ranged from 0.618 to 0.903, indicating acceptable test-retest reliability. Our findings suggest that the Japanese version of the HWE-AT has good validity and reliability.	[Kitayama, Mio] Kanazawa Med Univ Hosp, Nursing Dept, Uchinada, Ishikawa, Japan; [Unoki, Takeshi] Sapporo City Univ, Sch Nursing, Sapporo, Hokkaido, Japan; [Matsuda, Yui] Univ Miami, Sch Nursing & Hlth Studies, Coral Gables, FL USA; [Matsuishi, Yujiro] Sei Roka Kango Daigaku, Neurosci Nursing, Tokyo, Japan; [Kawai, Yusuke] Fujita Hlth Univ Hosp, Dept Nursing, Toyoake, Aichi, Japan; [Iida, Yasuo] Kanazawa Med Univ, Div Gen Educ Nat Sci Math, Uchinada, Ishikawa, Japan; [Teramoto, Mio] Columbia Univ, Teachers Coll, New York, NY 10027 USA; [Tatsuno, Junko] Kokura Mem Hosp, Nursing Dept, Kokura, Japan; [Hamamoto, Miya] Tosei Gen Hosp, Nursing Dept, Seto, Japan	Kanazawa Medical University; University of Miami; Fujita Health University; Kanazawa Medical University; Columbia University; Columbia University Teachers College; Kokura Memorial Hospital; Tosei General Hospital	Kitayama, M (corresponding author), Kanazawa Med Univ Hosp, Nursing Dept, Uchinada, Ishikawa, Japan.	mimio-f@kanazawa-med.ac.jp		Matsuda, Yui/0000-0003-4936-1504				American Association of Critical are Nurses, AACN HLTH WORK ENV A; American Association of Critical Care Nurses, 2009, AACN HLTH WORK ENV A; American Association of Critical-Care Nurses, 2005, AM J CRIT CARE, DOI 10.4037/ajcc2005.14.3.187; Beth U, 2019, FINDINGS IMPLICATION, V39, P67, DOI [10.4037/ccn2019605, DOI 10.4037/CCN2019605]; Chatzittofis A, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.707293; Cohen J, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106263; Connor JA, 2018, AM J CRIT CARE, V27, P363, DOI 10.4037/ajcc2018179; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Hoe SiuLoon., 2008, J APPL QUANTITATIVE, V3, P76; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huddleston P, 2016, J NURS ADMIN, V46, P373, DOI 10.1097/NNA.0000000000000361; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Kelly L, 2017, AACN ADV CRIT CARE, V28, P351, DOI 10.4037/aacnacc2017283; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; Kitchin Rob, 2016, P I MECH ENG C-J MEC, V3, p205395171663113, DOI [10.1177/001316447403400115, DOI https://doi.org/10.1177/0025802420918487, 10.1177/2053951716631130, DOI 10.1177/0954406219850598]; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kyriazos T., 2018, PSYCHOLOGY, V9, DOI [10.4236/psych.2018.98126, DOI 10.4236/PSYCH.2018.98126]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Manojlovich M, 2007, AM J CRIT CARE, V16, P536; Manojlovich M, 2009, AM J CRIT CARE, V18, P21, DOI 10.4037/ajcc2009353; Maskey R, 2018, ASIAN J SHIPPING LOG, V34, P91, DOI 10.1016/j.ajsl.2018.06.006; Massoudi A.H., 2017, J BUSINESS MANAGEMEN, V19, P35, DOI [10.9790/487X-1901033542, DOI 10.9790/487X-1901033542]; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; McHugh MD, 2016, MED CARE, V54, P74, DOI 10.1097/MLR.0000000000000456; Munro CL, 2020, AM J CRIT CARE, V29, P4, DOI 10.4037/ajcc2020940; Olds DM, 2017, INT J NURS STUD, V74, P155, DOI 10.1016/j.ijnurstu.2017.06.004; Sezgin D, 2021, INT NURS REV, DOI 10.1111/inr.12740; Shah M, 2021, CLIN J ONCOL NURS, V25, P69, DOI 10.1188/21.CJON.69-75; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Thing R, 2010, WHO HLTH WORKPLACE F; Yusoff M.S.B., 2019, RESOURCE, V11, P49, DOI [10.21315/eimj2019.11.2.6, DOI 10.21315/EIMJ2019.11.2.6]; Zou GY, 2012, STAT MED, V31, P3972, DOI 10.1002/sim.5466	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0268124	10.1371/journal.pone.0268124	http://dx.doi.org/10.1371/journal.pone.0268124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2GE	35552559	Green Published, gold			2022-12-26	WOS:000868181100001
J	Marquez, LK; Ingiliz, P; Boesecke, C; Krznaric, I; Schewe, K; Lutz, T; Mauss, S; Christensen, S; Rockstroh, JK; Jain, S; He, F; Wertheim, JO; Martin, NK				Marquez, Lara K.; Ingiliz, Patrick; Boesecke, Christoph; Krznaric, Ivanka; Schewe, Knud; Lutz, Thomas; Mauss, Stefan; Christensen, Stefan; Rockstroh, Jurgen K.; Jain, Sonia; He, Feng; Wertheim, Joel O.; Martin, Natasha K.			Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; POSITIVE MEN; BISEXUAL MEN; HIGH-RISK; INFECTION; GAY; TRANSMISSION; EPIDEMIC; BEHAVIOR	Background Prior to direct-acting antivirals (DAAs), HCV incidence rose among men who have sex with men (MSM) living with HIV infection in Germany despite high hepatitis C virus (HCV) treatment rates. We establish a HCV elimination modeling framework to evaluate whether existing treatment rates can achieve the World Health Organization (WHO) incidence target among MSM living with HIV in Germany. Methods To evaluate progress towards HCV elimination in Germany, we adapted a previously published HCV transmission model among MSM living with diagnosed HIV. We modelled HCV incidence and prevalence until 2030 (relative to 2015) under existing treatment and DAA scale-up and explored potential impacts of disruptions in treatment and behavioral risk reduction due to the COVID-19 pandemic. Results Continuing current treatment rates will result in stable HCV incidence among MSM living with HIV in Germany between 2015-2030. The WHO HCV incidence target is achievable under DAA scale-up to 100% treatment combined with treatment of those previously diagnosed and untreated (at a rate of 15%/year) and would result in greater reductions with early treatment (3 vs 6 months) reducing incidence from 4.0/100person-years to 0.8/100person-years by 2030. A 12-month disruption to HCV treatment (20% reduction) and risk behaviors (25%,50%,75% reduction) during the COVID-19 pandemic would result in a 15% relative increase in total HCV incidence in 2030 compared to that expected under the status quo. Conclusions HCV elimination among MSM living with HIV in Germany requires further DAA scale-up among those newly diagnosed combined with efforts to treat those previously diagnosed but untreated. Prospective monitoring will establish whether Germany is on track for HCV microelimination.	[Marquez, Lara K.; Wertheim, Joel O.; Martin, Natasha K.] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Ingiliz, Patrick; Krznaric, Ivanka] Ctr Infectiol, Berlin, Germany; [Ingiliz, Patrick] Henri Mondor Hosp, Hepatol Dept, INSERM U955, Creteil, France; [Boesecke, Christoph; Rockstroh, Jurgen K.] Univ Bonn, Dept Med, Bonn, Germany; [Schewe, Knud] ICH Studyctr, Hamburg, Germany; [Lutz, Thomas] Infektiologikum, Frankfurt, Germany; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Christensen, Stefan] CIM Munster, Munster, Germany; [Christensen, Stefan] Muenster Univ Hosp, Dept Gastroenterol & Hepatol, Munster, Germany; [Jain, Sonia; He, Feng] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn; University of Munster; University of California System; University of California San Diego	Marquez, LK (corresponding author), Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA.; Ingiliz, P (corresponding author), Ctr Infectiol, Berlin, Germany.; Ingiliz, P (corresponding author), Henri Mondor Hosp, Hepatol Dept, INSERM U955, Creteil, France.	lkusnezo@health.uscd.edu; p_ingiliz@web.de			Gilead [IN-DE-987-4637, INFR-980-6332]; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA); Ruth L. Kirschstein Institutional National Research Service Award; T32 Postdoctoral fellowship in Substance abuse, HIV, and Related Infections [T32 DA023356]; Fogarty International Center of the National Institutes of Health; University of California Global Health Institute [D43TW009343]; National Institute of Allergy and Infectious Diseases [R01 AI135992]	Gilead(Gilead Sciences); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ruth L. Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Postdoctoral fellowship in Substance abuse, HIV, and Related Infections; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by Gilead (PI: Patrick Ingiliz, grant numbers IN-DE-987-4637, INFR-980-6332) (url: https://urldefense.com/v3/__ https://www.gilead.com/__;!!LLK065n_VXAQ! 23TxhSkx7A5mo3pmlA6ob408Bh5zcfkyn7lQUI_ 3fV82aNCwgCrdgBXCkgoXgwZz4ac$). LKM was supported by the National Institutes of Health (NIH) and National Institute on Drug Abuse (NIDA; https://nida.nih.gov/) Ruth L. Kirschstein Institutional National Research Service Award, T32 Postdoctoral fellowship in Substance abuse, HIV, and Related Infections (PI: Steffanie Strathdee, grant number T32 DA023356) and by the Fogarty International Center of the National Institutes of Health (url: https://www.fic.nih.gov/) and the University of California Global Health Institute under Award Number D43TW009343 (url: https://ucghi.universityofcalifornia.edu/uc-global-healthinstitute).JOW acknowledges funding from the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (url: https://www.niaid.nih.gov/) under Award Number: R01 AI135992.	an der Heiden M., 2019, EPIDEMIOLOGISCHES B, P483; [Anonymous], 2019, EPIDEMIOLOGY REPORT; Boerekamps A, 2018, CLIN INFECT DIS, V66, P1360, DOI 10.1093/cid/cix1007; Boesecke C, 2020, CROI ABSTRACT; Boesecke C, CROI C; Boesecke C, 2016, INFECTION, V44, P93, DOI 10.1007/s15010-015-0856-9; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Davies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055373; Esser S, 2017, J DTSCH DERMATOL GES, V15, P421, DOI 10.1111/ddg.13217; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Garvey LJ, 2021, CLIN INFECT DIS, V72, P233, DOI 10.1093/cid/ciaa021; Gillespie D, 2021, SEX TRANSM INFECT, V97, P85, DOI 10.1136/sextrans-2020-054598; Graf C, 2020, EASL; Hammoud MA, 2021, JAIDS-J ACQ IMM DEF, V86, P22, DOI 10.1097/QAI.0000000000002514; Hammoud MA, 2020, JAIDS-J ACQ IMM DEF, V85, P309, DOI 10.1097/QAI.0000000000002462; Hyndman I, 2021, SEX TRANSM INFECT, V97, P521, DOI 10.1136/sextrans-2020-054768; Ingiliz P., 2021, CROI ABSTRACT, V442; Ingiliz P, 2020, PROGRAM ABSTRACTS C; Ingiliz P, 2020, CLIN INFECT DIS, V71, P1248, DOI 10.1093/cid/ciz949; Ingiliz P, 2017, J HEPATOL, V66, P282, DOI 10.1016/j.jhep.2016.09.004; Jansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142515; Jin FY, 2021, LANCET GASTROENTEROL, V6, P39, DOI 10.1016/S2468-1253(20)30303-4; Martin NK, 2019, J INFECT DIS, V220, P1635, DOI 10.1093/infdis/jiz367; Martin NK, 2016, CLIN INFECT DIS, V62, P1072, DOI 10.1093/cid/ciw075; Mascolini M, 2021, 18 EUROPEAN AIDS C A; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Public Health England, 2019, HIV UK ZER HIV TRANS; Public Health England, 2020, HLTH PROTECTION REPO, V14; Reyniers T, 2021, SEX TRANSM INFECT, V97, P414, DOI 10.1136/sextrans-2020-054756; Robert Koch-Institut, 2015, EPIDEMIOLOGISCHES B, V45; Schmidt AJ, 2016, INT J DRUG POLICY, V38, P4, DOI 10.1016/j.drugpo.2016.09.007; Schmidt D, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10088-7; Scott N, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25059; Shakeri A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071314; Steininger K, 2017, J VIRAL HEPATITIS, V24, P832, DOI 10.1111/jvh.12707; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; UNAIDS, 2018, GERM COUNTR DAT; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; van Santen DK, 2017, J HEPATOL, V67, P255, DOI 10.1016/j.jhep.2017.03.038; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization (WHO), GLOB HLTH SECT STRAT; Wyles DL, 2016, CLIN INFECT DIS, V63, pS3, DOI 10.1093/cid/ciw219; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Yin Z, 2014, HIV UK 2014 REPORT D	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267853	10.1371/journal.pone.0267853	http://dx.doi.org/10.1371/journal.pone.0267853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35551326	Green Published, gold			2022-12-26	WOS:000868179400003
J	Martinsen, EMH; Eagan, TML; Wiker, HG; Leiten, EO; Husebo, GR; Knudsen, KS; Tangedal, S; Sanseverino, W; Paytuvi-Gallart, A; Nielsen, R				Martinsen, Einar M. H.; Eagan, Tomas M. L.; Wiker, Harald G.; Leiten, Elise O.; Husebo, Gunnar R.; Knudsen, Kristel S.; Tangedal, Solveig; Sanseverino, Walter; Paytuvi-Gallart, Andreu; Nielsen, Rune			A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease	PLOS ONE			English	Article							BRONCHOSCOPY; FUNGI	Background Few studies have examined the stability of the pulmonary mycobiome. We report longitudinal changes in the oral and pulmonary mycobiome of participants with and without COPD in a large-scale bronchoscopy study (MicroCOPD). Methods Repeated sampling was performed in 30 participants with and 21 without COPD. We collected an oral wash (OW) and a bronchoalveolar lavage (BAL) sample from each participant at two time points. The internal transcribed spacer 1 region of the ribosomal RNA gene cluster was PCR amplified and sequenced on an Illumina HiSeq sequencer. Differences in taxonomy, alpha diversity, and beta diversity between the two time points were compared, and we examined the effect of intercurrent antibiotic use. Results Sample pairs were dominated by Candida. We observed less stability in the pulmonary taxonomy compared to the oral taxonomy, additionally emphasised by a higher Yue-Clayton measure in BAL compared to OW (0.69 vs 0.22). No apparent effect was visually seen on taxonomy from intercurrent antibiotic use or participant category. We found no systematic variation in alpha diversity by time either in BAL (p-value 0.16) or in OW (p-value 0.97), and no obvious clusters on bronchoscopy number in PCoA plots. Pairwise distance analyses showed that OW samples from repeated sampling appeared more stable compared to BAL samples using the Bray-Curtis distance metric (p-value 0.0012), but not for Jaccard. Conclusion Results from the current study propose that the pulmonary mycobiome is less stable than the oral mycobiome, and neither COPD diagnosis nor intercurrent antibiotic use seemed to influence the stability.	[Martinsen, Einar M. H.; Eagan, Tomas M. L.; Wiker, Harald G.; Leiten, Elise O.; Husebo, Gunnar R.; Tangedal, Solveig; Nielsen, Rune] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Eagan, Tomas M. L.; Husebo, Gunnar R.; Knudsen, Kristel S.; Tangedal, Solveig; Nielsen, Rune] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Wiker, Harald G.] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Sanseverino, Walter; Paytuvi-Gallart, Andreu] Sequentia Biotech SL, Barcelona, Spain	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Martinsen, EMH (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	einar.martinsen@uib.no	Paytuvi-Gallart, Andreu/E-3967-2019; Eagan, Tomas Mikal/P-3554-2014; Martinsen, Einar Marius Hjellestad/Q-8731-2018	Paytuvi-Gallart, Andreu/0000-0002-0958-6592; Sanseverino, Walter/0000-0003-3324-5912; Eagan, Tomas Mikal/0000-0001-8725-9960; Martinsen, Einar Marius Hjellestad/0000-0001-7368-2549; Knudsen, Kristel Svalland/0000-0001-5129-3892; Wiker, Harald Gotten/0000-0001-9452-243X	Helse Vest; GlaxoSmithKline; Bergen Medical Research Foundation; Endowment of Timber Merchant A. Delphin and Wife through the Norwegian Medical Association	Helse Vest; GlaxoSmithKline(GlaxoSmithKline); Bergen Medical Research Foundation; Endowment of Timber Merchant A. Delphin and Wife through the Norwegian Medical Association	The MicroCOPD study was funded by unrestricted grants and fellowships from Helse Vest, GlaxoSmithKline, Bergen Medical Research Foundation, and the Endowment of Timber Merchant A. Delphin and Wife through the Norwegian Medical Association. No specific grant or award numbers exist for the specific funding. The MicroCOPD funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sequentia Biotech SL provided support in the form of salaries for authors Walter Sanseverino and Andreu Paytuvi '-Gallart, but not study design or data collection. All funding of data collection and laboratory analyses were from the MicroCOPD Study. Walter Sanseverino and Andreu Paytuvi ' Gallart both contributed to interpretation of results, and preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	[Anonymous], 2017, PNEUMOLOGIE, V71, P9; [Anonymous], NUCL; Bafadhel M, 2014, EUR RESPIR J, V43, P64, DOI 10.1183/09031936.00162912; BAKKE PS, 1991, THORAX, V46, P863, DOI 10.1136/thx.46.12.863; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Bokulich NA, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00219-18; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Froslev TG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01312-x; Gronseth Rune, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00019-2017; Gronseth R, 2014, EUR CLIN RESPIR J, V1, DOI 10.3402/ecrj.v1.26196; Kramer R, 2015, J CLIN MICROBIOL, V53, P2900, DOI 10.1128/JCM.01094-15; Krause A, 1997, AM J RESP CRIT CARE, V155, P1793, DOI 10.1164/ajrccm.155.5.9154894; Krause R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155033; Liu HY, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01163; Martinsen EMH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248967; Monteiro-da-Silva F, 2014, MED MYCOL, V52, P496, DOI 10.1093/mmy/myu027; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; R Core Team, 2021, R LANGUAGE ENV STAT; Rivers Adam R, 2018, F1000Res, V7, P1418, DOI 10.12688/f1000research.15704.1; STANDIFORD TJ, 1991, CHEST, V99, P1529, DOI 10.1378/chest.99.6.1529; StataCorp, 2021, STATA STAT SOFTWARE; Su J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130736; Tiew PY, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02050-2020; UNITE Community, 2019, UNITE QIIME RELEASE, DOI [10.15156/BIO/786335, DOI 10.15156/BIO/786335]; UNITE Community, 2019, UNITE QIIME REL FUNG, DOI [10.15156/BIO/786345, DOI 10.15156/BIO/786349]; UNITE Community, 2019, UNITE QIIME RELEASE, DOI [10.15156/BIO/786350, DOI 10.15156/BIO/786350]; Urbanska KM., 1997, RESTOR ECOL, DOI DOI 10.15156/BIO/786349; Usyk M, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00488-17; Vandenborght LE, 2019, ERS MONOGR, V83, P88, DOI 10.1183/2312508X.10015918; Weaver D, 2019, CURR FUNGAL INFECT R, V13, P109, DOI 10.1007/s12281-019-00347-5; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267195	10.1371/journal.pone.0267195	http://dx.doi.org/10.1371/journal.pone.0267195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551278	Green Published, gold			2022-12-26	WOS:000868164600020
J	Sereda, AD; Kazakova, AS; Dmitrenko, VV; Kolbasov, DV				Sereda, Alexey D.; Kazakova, Anna S.; Dmitrenko, Viktor V.; Kolbasov, Denis, V			Search for additional tests for immunobiological evaluation of the candidate vaccines against African swine fever	PLOS ONE			English	Article							VIRUS; NEUTROPHILS; IMMUNITY; PIGS; PROTECTION	The spread of African swine fever (ASF) in Eurasia has forced a return to the development of live vaccines based on naturally or experimentally attenuated strains of the virus including those resulting from genetic manipulations. This process includes evaluation of the immunomodulating properties of the vaccines. In this report we provide our assessment of two tests for immunobiological evaluation of a candidate live vaccine against ASF from the attenuated ASF virus (ASFV) strain KK-202: (i) investigation of the effect of the attenuated ASFV strain KK-202 on the protectiveness of the vaccine ASFV strain FK-32/135 and a vaccine against classical swine fever (CSF) from the strain LK-VNIIVViM; (ii) determination of the phagocytic activity of blood neutrophils in pigs inoculated with ASFV strains differing in virulence. A simultaneous or sequential inoculation of attenuated strain KK-202 (seroimmunotype II) and vaccine strain FK-32/135 (seroimmunotype IV) into pigs resulted in the loss of protection against the virulent strain France-32 (seroimmunotype IV). Following the simultaneous or sequential inoculations of the ASFV strain KK-202 and the CSF virus (CSFV) vaccine produced from the strain LK-VNIIVViM, the neutralizing antibody titers against the CSFV observed in the experimental groups (after vaccination and after the challenge infection with the virulent CSFV strain Shimen) were not different from those found in animals of the control group. The phagocytic activity of blood neutrophils was shown to increase from 30% in the norm to 50%-94% depending on the virulence of the ASFV strains inoculated into pigs. The results of this work demonstrate the ability of the attenuated ASFV strains to modulate the development of the cellular link of protective immunity without negative impact on the humoral immune response. The informative value of the described immunobiological tests in vivo and in vitro seems to be a more preferable alternative in comparison to the commonly used in vitro tests, which do not always correlate with the development of protection against ASF.	[Sereda, Alexey D.; Kazakova, Anna S.; Dmitrenko, Viktor V.; Kolbasov, Denis, V] Fed Res Ctr Virol & Microbiol FRCVM, Volginsky, Vladimir Region, Russia	Federal Research Center for Virology & Microbiology	Sereda, AD; Kazakova, AS (corresponding author), Fed Res Ctr Virol & Microbiol FRCVM, Volginsky, Vladimir Region, Russia.	sereda-56@mail.ru; annakazakova85@gmail.com			Ministry of Science and Higher Education of the Russian Federation [0451-2019-0005]	Ministry of Science and Higher Education of the Russian Federation	This work was supported by a subsidy from the Ministry of Science and Higher Education of the Russian Federation 0451-2019-0005. (http://government.ru/en/department/388/events/).A.D.S.and D.V.K. received this grant. NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2018, J GEN VIROL, V99, P613, DOI 10.1099/jgv.0.001049; [Anonymous], 2005, 2857390 GOST; Ashmarin IP., 1975, RAPID METHODS STAT P, V2nd Ed; Ballester M, 2010, J VIROL METHODS, V168, P38, DOI 10.1016/j.jviromet.2010.04.013; Belyaeva A. S., 2016, Immunologiya, V37, P129, DOI 10.18821/0206-4952-2016-37-2-129-133; Blome S, 2017, VET MICROBIOL, V206, P10, DOI 10.1016/j.vetmic.2017.01.001; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cadenas-Fernandez E, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030171; Carrasco L, 1996, VET RES, V27, P55; Chander V, 2014, ANIM HEALTH RES REV, V15, P87, DOI 10.1017/S1466252314000024; Chen WY, 2020, SCI CHINA LIFE SCI, V63, P623, DOI 10.1007/s11427-020-1657-9; Global African Swine Fever Research Alliance (GARA), 2018, GAP AN REP; Golnar AJ, 2019, VECTOR-BORNE ZOONOT, V19, P512, DOI 10.1089/vbz.2018.2387; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JENSEN MH, 1981, ACTA VET SCAND, V22, P85; Karalova E. M., 2012, Voprosy Virusologii, V57, P27; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Leitao A, 2001, J GEN VIROL, V82, P513, DOI 10.1099/0022-1317-82-3-513; Liess B., DIAGNOSIS EPIZOOTIOL, V1976, P187; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; Makarov VV., 1995, VESTNIK RUSSIAN AGR, V6, P60; Manso Ribeiro J., 1963, Bulletin de l'Office International des Epizooties, V60, P921; MARTINS CLV, 1994, VET IMMUNOL IMMUNOP, V43, P99, DOI 10.1016/0165-2427(94)90125-2; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Monteagudo PL, 2017, J VIROL, V91, DOI [10.1128/JVI.01058-17, 10.1128/jvi.01058-17]; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; National Research Council, 2011, GUIDE CARE USE LAB A, VEighth Edition, DOI [10.17226/12910, DOI 10.17226/12910]; NORLEY SG, 1984, RES VET SCI, V37, P255, DOI 10.1016/S0034-5288(18)31917-9; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; O'Donnell V, 2017, J VIROL, V91, DOI 10.1128/JVI.01760-16; OIE ASF 2019: World Organization for Animal Health (OIE), 2019, MANUAL DIAGNOSTIC TE, V8th Ed; OIE CSF, 2019, MANUAL DIAGNOSTIC TE; Pan I. C., 1987, African swine fever, P81; PAN IC, 1970, P SOC EXP BIOL MED, V134, P367, DOI 10.3181/00379727-134-34794; Sanchez-Cordon PJ, 2017, ANTIVIR RES, V138, P1, DOI 10.1016/j.antiviral.2016.11.021; Sanchez-Vizcaino JM, 2019, DIS SWINE 11, P443, DOI DOI 10.1002/9781119350927.CH25; Sereda A. D., 2015, Sel'skokhozyaistvennaya Biologiya, P709, DOI 10.15389/agrobiology.2015.6.709rus; SEREDA AD, 1992, VOP VIRUSOL+, V37, P168; Sereda AD, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9040274; Takamatsu HH, 2013, VIRUS RES, V173, P110, DOI 10.1016/j.virusres.2012.11.009; Zhesterev VI, 2007, Pat, Patent No. [RU2332234C1, 2332234]	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0265819	10.1371/journal.pone.0265819	http://dx.doi.org/10.1371/journal.pone.0265819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551531	Green Published, gold			2022-12-26	WOS:000868164600008
J	Behailu, Y; Hussen, S; Alemayehu, T; Mengistu, M; Fenta, DA				Behailu, Yeshareg; Hussen, Siraj; Alemayehu, Tsegaye; Mengistu, Mulugeta; Fenta, Demissie Assegu			Prevalence, determinants, and antimicrobial susceptibility patterns of Campylobacter infection among under-five children with diarrhea at Governmental Hospitals in Hawassa city, Sidama, Ethiopia. A cross-sectional study	PLOS ONE			English	Article							JEJUNI OUTBREAK; SPP.; IDENTIFICATION; EPIDEMIOLOGY; RESISTANCE; CHICKENS; CLIMATE; KAMPALA; HUMANS; SHEEP	Background Campylobacteriosis, is a zoonotic bacterial disease observed with a rising worldwide. It is becoming the most commonly recognized cause of bacterial gastroenteritis in under-five mortality in recent years. This study was done to determine the prevalence and determinants of Campylobacter infection among under-fives with acute watery diarrhea. Methods This institutional-based cross-sectional study was conducted at governmental and private health institutions in Hawassa city. All outpatient under-five children who met the inclusion criteria from April 2021 to August 2021 were enrolled in this study. Demographic and clinical data were obtained using a standardized data collection tool. Stool samples were collected from each participant with a sterile container and inoculated on a campylobacter agar media. The isolates were identified by using biochemical tests and a disc diffusion technique was performed to determine the antimicrobial sensitivity patterns of the isolates. Data were entered and analyzed using SPSS version 21. Descriptive and Logistic regression analysis was applied to determine the determinants of Campylobacter infection. P-value <0.05 was considered statistically significant. Results A total of 235 under-five children were enrolled in this study with a 100% response rate. Of these 130 (55.3%) and 105(44.7%) were males and females respectively with the age range of 2 months to 60 months with the mean age of 25 months. The majority of the 150 (63.2%) were rural residents. Of 235 under-fives with acute watery diarrhea, 16 (6.8%) patients were found to have Campylobacter infection with (95% CI, 3.8-10.2%). Consumption of pasteurized milk (AOR: 0.12; 95% CI 0.02-0.75, P<0.05), presence of domestic animals like cats, hens, and cows (AOR: 0.09: 95% CI 0.01-0.67, P<0.05), absence of handwashing practice before food preparation (AOR: 3.63, 95% CI 1.15-11.46, P<0.05) showed significant association with campylobacter infection. The antimicrobial susceptibility patterns of the isolated bacteria were 100% sensitivity to Azithromycin, Chloramphenicol, and Gentamicin, however; it was 100% resistant to Cephalothin. The associations of socio-demographic, environmental, and behavioral factors were compared and consumption of unpasteurized milk, the presence of domestic animal like the cat was significantly associated. Conclusion Campylobacter infection showed a comparatively low prevalence in under-fives with acute watery diarrhea. In this study contact with cats, consumption of unpasteurized milk were associated with Campylobacter infection. The treatment approach of Campylobacter infection must consider the sensitivity profile of antibiotics as indicated in the study. We, therefore, recommend further studies to determine the species responsible for Campylobacter infection with other co-morbidities and the susceptibility pattern for each species to indicate appropriate antibiotic therapy.	[Behailu, Yeshareg; Hussen, Siraj; Alemayehu, Tsegaye; Mengistu, Mulugeta; Fenta, Demissie Assegu] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Sidama, Ethiopia	Hawassa University	Fenta, DA (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Sidama, Ethiopia.	demissieasegu@yahoo.com		Assegu, Demissie/0000-0003-3914-838X				A dJM, 2019, ON HLTH APPR ART INS; Abdiwahab Hashi, 2016, Open Journal of Preventive Medicine, V6, P233; Abebe G, 2017, DATA BRIEF, V14, P371, DOI 10.1016/j.dib.2017.07.052; Addis T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259602; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; [Anonymous], I CALS PERFORMANCE S; Asrat D, 1999, ETHIOPIAN MED J, V37, P71; Beatty M E, 2009, East Afr Med J, V86, P387; Blaser AR, 2015, CURR OPIN CRIT CARE, V21, P142, DOI 10.1097/MCC.0000000000000188; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Chan M, 2012, LANCET, V379, P2119, DOI 10.1016/S0140-6736(12)60908-8; Chiyangi H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2232-0; Deogratias AP, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-17; Diriba K, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-020-00474-7; Elhadidy M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227833; Enany ME, 2018, PAK J PHARM SCI, V31, P1865; Francois R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006200; Gedamu G, 2017, QUAL PRIM CARE, V25, P199; Getnet Beyene, 2004, Ethiopian Journal of Health Development, V18, P185; Gill CJ, 2017, LANCET INFECT DIS, V17, P884, DOI 10.1016/S1473-3099(17)30336-5; Gillespie IA, 2008, EPIDEMIOL INFECT, V136, P1717, DOI 10.1017/S0950268808000319; Gwimi P. B., 2015, International Journal of One Health, V1, P1, DOI 10.14202/ijoh.2015.1-5; Hald B, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0192-9; Hassan A, 2007, J CHINESE CLIN MED, V2, P445; Hassan W.M., 2019, AM J BIOMED SCI RES, V3, P460, DOI [DOI 10.34297/AJBSR.2019.03.000717, 10.34297/AJBSR.2019.03.000717]; Ifeadike C. O., 2014, Tropical Journal of Medical Research, V17, P10; Ioannidis A, CAMPYLOBACTER INFECT, P109; Jonsson ME, 2012, PREV VET MED, V107, P95, DOI 10.1016/j.prevetmed.2012.05.002; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kabayiza JC, 2014, PEDIATR INFECT DIS J, V33, P1037, DOI 10.1097/INF.0000000000000448; Karikari AB, 2017, OPEN J MED MICROBIOL, V7, P1; Khalili M, 2013, MATERNAL KNOWLEDGE P; Komba EVG, 2015, ZOONOSES PUBLIC HLTH, V62, P557, DOI 10.1111/zph.12185; Lengerh A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-82; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Lopes GV, 2021, MICROB PATHOGENESIS, V161, DOI 10.1016/j.micpath.2021.105265; Mackenjee M K, 1984, Ann Trop Paediatr, V4, P183; Mason J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059663; Melese A, 2021, CAMPYLOBACTER JEJUNI; Mirgissa Kaba, 2000, Ethiopian Journal of Health Development, V14, P77; Montgomery MP, 2018, MMWR-MORBID MORTAL W, V67, P1032, DOI 10.15585/mmwr.mm6737a3; Mossong J, 2016, SCI REP-UK, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Mshana SE, 2009, AFR HEALTH SCI, V9, P201; Mulatu Getamesay, 2014, Ethiop J Health Sci, V24, P101, DOI 10.4314/ejhs.v24i2.1; Murray P.R., 1995, MANUAL CLIN MICROBIO; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Platts-Mills JA, 2014, CURR OPIN INFECT DIS, V27, P444, DOI 10.1097/QCO.0000000000000091; Pyra M, 2012, EPIDEMIOL INFECT, V140, P2087, DOI 10.1017/S0950268812000441; Qu M, 2019, J INFECT DEV COUNTR, V13, P1086, DOI 10.3855/jidc.11408; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P1620; Randremanana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044533; Saeed A, 2015, J MED MICROBIOL, V64, P432, DOI 10.1099/jmm.0.000043; Sakran W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62744-y; Samie A, 2007, J HEALTH POPUL NUTR, V25, P406; Sangare L., 2012, African Journal of Clinical and Experimental Microbiology, V13, P106, DOI 10.4314/ajcem.v13i2.9; Sindhi S, 2020, INT J CURR MICROBIOL, V9, P3319; Soofi Sajid Bashir, 2011, J Infect Public Health, V4, P12, DOI 10.1016/j.jiph.2010.10.001; Tafa Belay, 2014, Int J Bacteriol, V2014, P560617, DOI 10.1155/2014/560617; Wanyenya I, 2004, J FOOD PROTECT, V67, P1957, DOI 10.4315/0362-028X-67.9.1957; Worku W, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262308; Zachariah OH, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05788-3; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]	64	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2022	17	5							e0266976	10.1371/journal.pone.0266976	http://dx.doi.org/10.1371/journal.pone.0266976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2O1VP	35544554	gold, Green Published			2022-12-26	WOS:000818854500020
J	An, J; Kong, H				An, Jinho; Kong, Hyunseok			Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats	PLOS ONE			English	Article							MODEL; DIHYDROTESTOSTERONE; EPIDEMIOLOGY; STRESS; THYMUS; LEVEL; ACID; SIZE	Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels for inducing benign prostatic hyperplasia more conveniently than that for testosterone propionate. We conducted two-part studies to determine the optimal dosage and dosing cycle for efficient and stable induction of benign prostatic hyperplasia using testosterone undecanoate. In the injection dosage substudy, single testosterone undecanoate dose (125, 250, 500, 750, or 1000 mg/kg body weight) was administered, and the optimal concentration was determined for 8weeks by measuring changes in testosterone, dihydrotestosterone, and 5-alpha reductase levels. And then, testosterone undecanoate was administered at the optimal dose at intervals of 1, 2, 3, or 4 weeks for 12weeks to induce benign prostatic hyperplasia. The injection dosage substudy showed dose-dependently higher and more stable levels of testosterone in groups administrated testosterone undecanoate than in groups administered testosterone propionate. In the injection cycle substudy, testosterone undecanoate-administered group stably maintained high levels of testosterone, dihydrotestosterone, and 5-alpha reductase compared with testosterone propionate-administered group for the same injection cycle; moreover, the prostate measurements, an important sign of benign prostatic hyperplasia, were significantly increased. Based on these two substudies, we determined the optimal conditions for inducing benign prostatic hyperplasia stably and more conveniently than that for testosterone propionate. This study suggests an extended application of testosterone undecanoate for inducing benign prostatic hyperplasia that can improve research reliability considering the half-life of testosterone as well as injection dosage and concentration.	[An, Jinho] Sahmyook Univ, Coll Pharm, Seoul, South Korea; [An, Jinho; Kong, Hyunseok] Sahmyook Univ, Coll PADAM Nat Mat Res Inst, Seoul, South Korea; [Kong, Hyunseok] Sahmyook Univ, Coll Anim Biotechnol & Resource, Seoul, South Korea	Sahmyook University; Sahmyook University; Sahmyook University	Kong, H (corresponding author), Sahmyook Univ, Coll PADAM Nat Mat Res Inst, Seoul, South Korea.; Kong, H (corresponding author), Sahmyook Univ, Coll Anim Biotechnol & Resource, Seoul, South Korea.	hskong0813@gmail.com			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1F1A1063286]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1F1A1063286). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriyie DK, 2014, J ETHNOPHARMACOL, V157, P90, DOI 10.1016/j.jep.2014.09.007; Arruzazabala MD, 2007, J PHARM PHARMACOL, V59, P995, DOI 10.1211/jpp.59.7.0012; Bartsch G, 2000, EUR UROL, V37, P367, DOI 10.1159/000020181; Behre HM, 1999, EUR J ENDOCRINOL, V140, P414, DOI 10.1530/eje.0.1400414; Callies F, 2003, EXP CLIN ENDOCR DIAB, V111, P203, DOI 10.1055/s-2003-40464; Cantlay A., 2015, INNOVAIT ED INSPIR G, V8, P238, DOI [10.1177/1755738014568038, DOI 10.1177/1755738014568038]; Carson C, 2003, UROLOGY, V61, P2, DOI 10.1016/S0090-4295(03)00045-1; Cordaro M, 2017, TOXICOL APPL PHARM, V329, P231, DOI 10.1016/j.taap.2017.06.005; Davidyan A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240278; Devlin CM, 2021, BJU INT, V127, P389, DOI 10.1111/bju.15229; Egan KB, 2016, UROL CLIN N AM, V43, P289, DOI 10.1016/j.ucl.2016.04.001; HARA C, 1981, PHYSIOL BEHAV, V27, P243, DOI 10.1016/0031-9384(81)90264-X; Huang JJ, 2016, EUR J PHARMACOL, V791, P473, DOI 10.1016/j.ejphar.2016.09.009; Jena AK, 2016, J ETHNOPHARMACOL, V190, P33, DOI 10.1016/j.jep.2016.05.052; Kassabian VS, 2003, LANCET, V361, P60, DOI 10.1016/S0140-6736(03)12164-2; Kim YN, 2013, NUTR RES PRACT, V7, P172, DOI 10.4162/nrp.2013.7.3.172; Lee B, 2009, KEY ENG MATER, V396-398, P209, DOI 10.4028/www.scientific.net/KEM.396-398.209; Lee SWH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06628-8; Li YZ, 2021, PROSTATE, V81, P1135, DOI 10.1002/pros.24208; Lim KB, 2017, ASIAN J UROL, V4, P148, DOI 10.1016/j.ajur.2017.06.004; Miller J, 2009, CLIN INTERV AGING, V4, P251; Minh TD, 2021, J ETHNOPHARMACOL, V279, DOI 10.1016/j.jep.2021.114388; Mozayani A., 2011, SPRINGER SCI BUSINES, V656; Nieschlag E, 2019, EUR J ENDOCRINOL, V180, pR201, DOI 10.1530/EJE-19-0071; Park HK, 2017, SAUDI J BIOL SCI, V24, P1555, DOI 10.1016/j.sjbs.2015.10.020; Rizzuti A., 2022, URO, V2, P30, DOI [10.3390/uro2010005, DOI 10.3390/URO2010005]; Sayed RH, 2016, TOXICOL APPL PHARM, V311, P52, DOI 10.1016/j.taap.2016.09.024; Shin IS, 2012, FOOD CHEM TOXICOL, V50, P884, DOI 10.1016/j.fct.2012.01.007; Waites GMH, 2003, FERTIL STERIL, V80, P1, DOI 10.1016/S0015-0282(03)00577-6; Wang C, 2016, EXP CELL RES, V345, P125, DOI 10.1016/j.yexcr.2015.03.026; Wang LP, 2021, MAR DRUGS, V19, DOI 10.3390/md19120652; Wang YR, 2017, CHIN J NAT MEDICINES, V15, P341, DOI 10.1016/S1875-5364(17)30054-7; WHO Special Programme of Research Development and Research Training in Human, 1990, REPROD WORKSHOP C AN; Wu XY, 2017, TOXICOL LETT, V265, P9, DOI 10.1016/j.toxlet.2016.11.011; Xu DH, 2014, ENVIRON TOXICOL PHAR, V37, P679, DOI 10.1016/j.etap.2014.02.001; Zivkovic I, 2005, ACTA HISTOCHEM, V106, P449, DOI 10.1016/j.acthis.2004.11.002	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268695	10.1371/journal.pone.0268695	http://dx.doi.org/10.1371/journal.pone.0268695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584179	gold, Green Published			2022-12-26	WOS:000834613800003
J	Kopanchuk, S; Vavers, E; Veiksina, S; Ligi, K; Zvejniece, L; Dambrova, M; Rinken, A				Kopanchuk, Sergei; Vavers, Edijs; Veiksina, Santa; Ligi, Kadri; Zvejniece, Liga; Dambrova, Maija; Rinken, Ago			Intracellular dynamics of the Sigma-1 receptor observed with super-resolution imaging microscopy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; EXPRESSION; BINDING; MODULATOR; CHAPERONE; DISTINCT; SYSTEM; DRUGS; ASSAY; SITES	Sigma-1 receptor (Sig1R) is an endoplasmic reticulum (ER)-related membrane protein, that forms heteromers with other cellular proteins. As the mechanism of action of this chaperone protein remains unclear, the aim of the present study was to detect and analyze the intracellular dynamics of Sig1R in live cells using super-resolution imaging microscopy. For that, the Sig1R-yellow fluorescent protein conjugate (Sig1R-YFP) together with fluorescent markers of cell organelles were transfected into human ovarian adenocarcinoma (SK-OV-3) cells with BacMam technology. Sig1R-YFP was found to be located mainly in the nuclear envelope and in both tubular and vesicular structures of the ER but was not detected in the plasma membrane, even after activation of Sig1R with agonists. The super-resolution radial fluctuations approach (SRRF) performed with a highly inclined and laminated optical sheet (HILO) fluorescence microscope indicated substantial overlap of Sig1R-YFP spots with KDEL-mRFP, slight overlap with pmKate2-mito and no overlap with the markers of endosomes, peroxisomes, lysosomes, or caveolae. Activation of Sig1R with (+)-pentazocine caused a time-dependent decrease in the overlap between Sig1R-YFP and KDEL-mRFP, indicating that the activation of Sig1R decreases its colocalization with the marker of vesicular ER and does not cause comprehensive translocations of Sig1R in cells.	[Kopanchuk, Sergei; Veiksina, Santa; Ligi, Kadri; Rinken, Ago] Univ Tartu, Inst Chem, Tartu, Estonia; [Vavers, Edijs; Zvejniece, Liga; Dambrova, Maija] Latvian Inst Organ Synth, Riga, Latvia; [Vavers, Edijs; Dambrova, Maija] Riga Stradins Univ, Riga, Latvia	University of Tartu; Latvian Institute of Organic Synthesis; Riga Stradins University	Rinken, A (corresponding author), Univ Tartu, Inst Chem, Tartu, Estonia.; Vavers, E (corresponding author), Latvian Inst Organ Synth, Riga, Latvia.; Vavers, E (corresponding author), Riga Stradins Univ, Riga, Latvia.	ago.rinken@ut.ee; edijs.vavers@farm.osi.lv	; Kopanchuk, Sergei/H-4256-2018	Vavers, Edijs/0000-0003-1322-1307; Kopanchuk, Sergei/0000-0003-1756-9327; Rinken, Ago/0000-0002-7238-749X; Zvejniece, Liga/0000-0003-4576-2386	SV- Estonian Research Council [PSG230, 1.1.1.2/VIAA/2/18/376]; EV -COST action [CA 18133 ERNEST]	SV- Estonian Research Council(Estonian Research Council); EV -COST action	SV-Estonian Research Council grant (PSG230) EV-European Regional Development Fund Project No. 1.1.1.2/VIAA/2/18/376 "Sigma chaperone protein as a novel drug target" AR, EV -COST action CA 18133 ERNEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.589810; Abate C, 2016, EUR J MED CHEM, V108, P577, DOI 10.1016/j.ejmech.2015.12.014; Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Balasuriya D, 2014, J BIOL CHEM, V289, P32353, DOI 10.1074/jbc.M114.603506; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Carter SD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9572; Chenouard N, 2013, IEEE T PATTERN ANAL, V35, P2736, DOI 10.1109/TPAMI.2013.97; Corbett AD, 2018, OPT EXPRESS, V26, P21887, DOI 10.1364/OE.26.021887; Culley S, 2018, NAT METHODS, V15, P263, DOI [10.1038/NMETH.4605, 10.1038/nmeth.4605]; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; De Zitter E, 2019, NAT METHODS, V16, P707, DOI 10.1038/s41592-019-0462-3; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; Friesland M, 2013, J VIROL, V87, P6377, DOI 10.1128/JVI.03557-12; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gustafsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12471; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hoelzel CA, 2020, CHEMBIOCHEM, V21, P1935, DOI 10.1002/cbic.202000037; Holloway G, 2015, J GEN VIROL, V96, P3519, DOI 10.1099/jgv.0.000294; Hong WC, 2020, J PHARMACOL EXP THER, V373, P290, DOI 10.1124/jpet.119.262790; Jiang LL, 2020, AGING-US, V12, P9041, DOI 10.18632/aging.103166; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Laasfeld T, 2021, NANOSCALE, V13, P2436, DOI 10.1039/d0nr06737g; Laasfeld T, 2017, BIOTECHNIQUES, V63, P161, DOI 10.2144/000114595; Lagache T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03053-x; Laine RF, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/ab0261; Lavogina D, 2021, METHODS MOL BIOL, V2268, P179, DOI 10.1007/978-1-0716-1221-7_12; Lee IT, 2008, EUR J PHARMACOL, V578, P123, DOI 10.1016/j.ejphar.2007.09.020; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Martin P, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.106989; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mavlyutov TA, 2017, ONCOTARGET, V8, P51317, DOI 10.18632/oncotarget.17906; Mazina O, 2015, METHODS MOL BIOL, V1272, P65, DOI 10.1007/978-1-4939-2336-6_5; Mazina O, 2012, J BIOMOL SCREEN, V17, P1096, DOI 10.1177/1087057112449862; Vela JM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.582310; Min JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04577; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Reinart-Okugbeni R, 2012, EUR J MED CHEM, V55, P255, DOI 10.1016/j.ejmech.2012.07.025; Reis G, 2022, LANCET GLOB HEALTH, V10, pE36, DOI 10.1016/S2214-109X(21)00448-4; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Schermelleh L, 2019, NAT CELL BIOL, V21, P72, DOI 10.1038/s41556-018-0251-8; Schmidt HR, 2019, TRENDS PHARMACOL SCI, V40, P636, DOI 10.1016/j.tips.2019.07.006; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sharma N, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101299; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Soulez F, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1735, DOI 10.1109/ISBI.2012.6235915; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Toufik B, 2012, ADVANCES IN WAVELET THEORY AND THEIR APPLICATIONS IN ENGINEERING, PHYSICS AND TECHNOLOGY, P395; van Unen J, 2015, MOL PHARMACOL, V88, P589, DOI 10.1124/mol.115.098897; Wong AYC, 2016, MOL PHARMACOL, V90, P238, DOI 10.1124/mol.116.104018; Yano H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01356; Yano H, 2018, NEUROPHARMACOLOGY, V133, P264, DOI 10.1016/j.neuropharm.2018.01.042; Zhemkov V, 2021, ELIFE, V10, DOI 10.7554/eLife.65192; Zvejniece L, 2014, BRIT J PHARMACOL, V171, P761, DOI 10.1111/bph.12506	64	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268563	10.1371/journal.pone.0268563	http://dx.doi.org/10.1371/journal.pone.0268563			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L2RP	35584184	Green Published, gold			2022-12-26	WOS:000834613800002
J	Kotthoff, I; Kundrotas, PJ; Vakser, IA				Kotthoff, Ian; Kundrotas, Petras J.; Vakser, Ilya A.			DOCKGROUND membrane protein-protein set	PLOS ONE			English	Article							RECOGNITION	Membrane proteins are significantly underrepresented in Protein Data Bank despite their essential role in cellular mechanisms and the major progress in experimental protein structure determination. Thus, computational approaches are especially valuable in the case of membrane proteins and their assemblies. The main focus in developing structure prediction techniques has been on soluble proteins, in part due to much greater availability of the structural data. Currently, structure prediction of protein complexes (protein docking) is a well-developed field of study. However, the generic protein docking approaches are not optimal for the membrane proteins because of the differences in physicochemical environment and the spatial constraints imposed by the membranes. Thus, docking of the membrane proteins requires specialized computational methods. Development and benchmarking of the membrane protein docking approaches has to be based on high-quality sets of membrane protein complexes. In this study we present a new dataset of 456 non-redundant alpha helical binary interfaces. The set is significantly larger and more representative than the previously developed sets. In the future, it will become the basis for the development of docking and scoring benchmarks, similar to the ones for soluble proteins in the Dockground resource .	[Kotthoff, Ian; Kundrotas, Petras J.; Vakser, Ilya A.] Univ Kansas, Computat Biol Program, Lawrence, KS 66045 USA	University of Kansas	Kundrotas, PJ; Vakser, IA (corresponding author), Univ Kansas, Computat Biol Program, Lawrence, KS 66045 USA.	pkundro@ku.edu; vakser@ku.edu			NIH [R01GM074255]; NSF [DBI1917263]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This study was supported by NIH grant R01GM074255 and NSF grant DBI1917263 (IAV, PJK, IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishchenko I, 2017, PROTEINS, V85, P470, DOI 10.1002/prot.25183; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Hartuv E, 2000, INFORM PROCESS LETT, V76, P175, DOI 10.1016/S0020-0190(00)00142-3; Hurwitz N, 2016, BIOINFORMATICS, V32, P2444, DOI 10.1093/bioinformatics/btw184; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaczor AA, 2013, MOL INFORM, V32, P717, DOI 10.1002/minf.201200150; Kirys T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0672-3; Koukos PI, 2018, J MOL BIOL, V430, P5246, DOI [10.1016/j.jath.2018.11.005, 10.1016/j.jmb.2018.11.005]; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Li F, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100557; Lomize AL, 2011, BIOPHYS J, V100, P492; Mitternacht Simon, 2016, F1000Res, V5, P189, DOI 10.12688/f1000research.7931.1; Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318; Muller MP, 2019, CHEM REV, V119, P6086, DOI 10.1021/acs.chemrev.8b00608; Singh A, 2020, PROTEINS, V88, P1180, DOI 10.1002/prot.25889; Sinha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031349; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tsirigos KD, 2018, CURR OPIN STRUC BIOL, V50, P9, DOI 10.1016/j.sbi.2017.10.003; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vakser IA, 1996, PROTEIN ENG, V9, P37, DOI 10.1093/protein/9.1.37; Vakser IA, 2020, CURR OPIN STRUC BIOL, V64, P160, DOI 10.1016/j.sbi.2020.07.001	22	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0267531	10.1371/journal.pone.0267531	http://dx.doi.org/10.1371/journal.pone.0267531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580077	Green Published, Green Submitted, gold			2022-12-26	WOS:000835654800001
J	Luminati, O; Brentani, A; Fluckiger, B; de Campos, BLD; Raess, M; Roosli, M; de Hoogh, K; Fink, G				Luminati, Ornella; Brentani, Alexandra; Fluckiger, Benjamin; de Campos, Bartolomeu Ledebur de Antas; Raess, Michelle; Roosli, Martin; de Hoogh, Kees; Fink, Guenther			Assessing the association between air pollution and child development in Sao Paulo, Brazil	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; EXPOSURE; MORTALITY; ASTHMA; SCHOOL	BackgroundOutdoor air pollution is increasingly recognised as a key threat to population health globally, with particularly high risks for urban residents. In this study, we assessed the association between residential nitrogen dioxide (NO2) exposure and children's cognitive and behavioural development using data from Sao Paulo Brazil, one of the largest urban agglomerations in the world. MethodsWe used data from the Sao Paulo Western Region Birth Cohort, a longitudinal cohort study aiming to examine determinants as well as long-term implications of early childhood development. Cross-sectional data from the 72-month follow-up was analysed. Data on NO2 concentration in the study area was collected at 80 locations in 2019, and land use regression modelling was used to estimate annual NO2 concentration at children's homes. Associations between predicted NO2 exposure and children's cognitive development as well as children's behavioural problems were estimated using linear regression models adjusted for an extensive set of confounders. All results were expressed per 10 mu g/m(3) increase in NO2. Results1143 children were included in the analysis. We found no association between NO2 and children's cognitive development (beta -0.05, 95% CI [-0.20; 0.10]) or behavioural problems (beta 0.02, 95% CI [-0.80; 0.12]). ConclusionNo association between child cognition or child behaviour and NO2 was found in this cross-sectional analysis. Further research will be necessary to understand the extent to which these null results reflect a true absence of association or other statistical, biological or adaptive factors not addressed in this paper.	[Luminati, Ornella; Fluckiger, Benjamin; de Campos, Bartolomeu Ledebur de Antas; Raess, Michelle; Roosli, Martin; de Hoogh, Kees; Fink, Guenther] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Luminati, Ornella; Fluckiger, Benjamin; de Campos, Bartolomeu Ledebur de Antas; Raess, Michelle; Roosli, Martin; de Hoogh, Kees; Fink, Guenther] Univ Basel, Basel, Switzerland; [Brentani, Alexandra] Univ Sao Paulo, Dept Pediat, Med Sch, Sao Paulo, Brazil	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Fink, G (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Fink, G (corresponding author), Univ Basel, Basel, Switzerland.	guenther.fink@swisstph.ch	Brentani, Alexandra/G-4535-2013; Röösli, Martin/A-2658-2008	Brentani, Alexandra/0000-0001-6650-9705; Röösli, Martin/0000-0002-7475-1531; Fluckiger, Benjamin/0000-0002-6838-3648				Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Andrade MDF, 2017, ATMOS ENVIRON, V159, P66, DOI 10.1016/j.atmosenv.2017.03.051; Babadjouni RM, 2017, J CLIN NEUROSCI, V43, P16, DOI 10.1016/j.jocn.2017.04.028; Bravo MA, 2016, J EXPO SCI ENV EPID, V26, P150, DOI 10.1038/jes.2014.90; Brentani A, 2020, INT J EPIDEMIOL; Calderon-Garciduenas L, 2015, PRIM HEALTH CARE RES, V16, P329, DOI 10.1017/S146342361400036X; Clifford A, 2016, ENVIRON RES, V147, P383, DOI 10.1016/j.envres.2016.01.018; Costa AF, 2017, ENVIRON HEALTH PERSP, V125, P349, DOI 10.1289/EHP98; Costa LG, 2020, PHARMACOL THERAPEUT, V210, DOI 10.1016/j.pharmthera.2020.107523; Saldiva SRDM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102236; European Environment Agency, AIR POLL SOURC 2019; Forns J, 2017, ENVIRON RES, V159, P416, DOI 10.1016/j.envres.2017.08.031; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Gehring U, 2015, LANCET RESP MED, V3, P933, DOI 10.1016/S2213-2600(15)00426-9; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Gouveia N, 2004, J EPIDEMIOL COMMUN H, V58, P11, DOI 10.1136/jech.58.1.11; Gouveia N, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051000223, 10.11606/s1518-8787.2017051000223]; Hahad O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124306; Khreis H, 2017, ENVIRON INT, V100, P1, DOI 10.1016/j.envint.2016.11.012; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Luminati O, 2021, ENVIRON POLLUT, V289, DOI 10.1016/j.envpol.2021.117832; Pisani L, 2018, INT J EDUC RES, V91, P1, DOI 10.1016/j.ijer.2018.06.007; Porta D, 2016, EPIDEMIOLOGY, V27, P228, DOI 10.1097/EDE.0000000000000405; Pujol J, 2016, NEUROIMAGE, V129, P175, DOI 10.1016/j.neuroimage.2016.01.036; Ribeiro AG, 2019, ENVIRON RES, V170, P243, DOI 10.1016/j.envres.2018.12.034; Sao Paulo P., 2020, MAPA DIGITAL CIDADE; Schneider RM, 2020, S PAULO ENCY BRIATNN; Schraufnagel DE, 2019, CHEST, V155, P417, DOI 10.1016/j.chest.2018.10.041; StataCorp, 2021, STATA STAT SOFTWARE; Suades-Gonzalez E, 2015, ENDOCRINOLOGY, V156, P3473, DOI 10.1210/en.2015-1403; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; United Nations Statistics Divisions, UNDATA WORLD INF 202; Veras MM, 2017, CELL TISSUE RES, V367, P445, DOI 10.1007/s00441-016-2509-4; WHO, 2021, WHO GLOB AIR QUAL PA; WHO, 2009, COUNTR PROF ENV BURD; World Health Organization Regional office for europe: health effects of PM, 2013, REV EV HLTH ASP AIR, P6	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268192	http://dx.doi.org/10.1371/journal.pone.0268192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560170	gold, Green Published			2022-12-26	WOS:000835326900030
J	Mugenyi, L; Nanfuka, M; Byawaka, J; Agaba, C; Mijumbi, A; Kagimu, D; Mugisha, K; Shabbar, J; Etukoit, M				Mugenyi, Levicatus; Nanfuka, Mastula; Byawaka, Jaffer; Agaba, Collins; Mijumbi, Andrew; Kagimu, David; Mugisha, Kenneth; Shabbar, Jaffer; Etukoit, Michael			Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis	PLOS ONE			English	Article							AFRICA	BackgroundFew studies have analysed the effect of HIV universal test and treat (UTT) on retention and mortality among people living with HIV (PLHIV) in routine care. We examined six-month retention and mortality at 11 health facilities (HFs) run by a large NGO, The AIDS Support Organisation (TASO), before and after UTT. MethodsWe used a quasi-experimental study using patient data extracted from 11 TASO HFs. Two periods, one before UTT (2015-2016) and the other during UTT (2017-2018) were compared. The primary outcome was six-month retention defined as the proportion of PLHIV who were alive and in care at six months from enrolment. The secondary outcome was six-month mortality defined as the proportion of PLHIV who died within six months from enrolment. We performed an interrupted time series analysis using graphical aids to study trends in six-month retention and mortality and a segmented regression to evaluate the effect of UTT. We used a generalized linear mixed model (GLMM) and generalized estimating equations (GEE) to account for facility-level clustering. ResultsOf the 20,171 PLHIV registered between 2015 and 2018 and included in the analysis, 12,757 (63.2%) were enrolled during the UTT period. 5256/7414 (70.9%) of the pre-UTT period compared to 12239/12757 (95.9%) of the UTT were initiated on ART treatment with 6 months from enrolment. The median time from enrolment to initiating ART was 14 (interquartile range (IQR): 0-31) days for the pre-UTT compared to 0 (IQR: 0-0) days for the UTT period. The median age at enrolment was 32.5 years for the pre-UTT and 35.0 years for the UTT period. Overall, the six-month retention just after scale-up of UTT, increased by 9.2 percentage points (p = 0.002) from the baseline value of 82.6% (95% CI: 77.6%-87.5%) but it eventually decreased at a rate 1.0 percentage point (p = 0.014) for cohorts recruited each month after UTT. The baseline six-month mortality was 3.3% (95% CI: 2.4%-4.2%) and this decreased by 1.6 percentage points (p = 0.003) immediately after UTT. The six-month mortality continued decreasing at a rate of 0.1 percentage points (p = 0.002) for cohorts enrolled each month after UTT. Retention differed between some health facilities with Rukungiri HF having the highest and Soroti the lowest retention. Retention was slightly higher among males and younger people. Mortality was highest among people aged 50 years and more. The effect of UTT on retention and mortality was similar across sex and age groups. ConclusionOverall, UTT significantly led to an immediate increase in retention and decrease in mortality among PLHIV enrolled in HIV care from 11 HFs run by TASO in Uganda. However, retention (and mortality) significantly decreased for cohorts enrolled each month after UTT. Retention was highest in Rukungiri and lowest in Soroti HFs and slightly higher in males and younger people. Mortality was highest in older patients and lowest in adolescents. We recommend for innovative interventions to improve the overall retention particularly in facilities reporting low retention in order to achieve the UNAIDS 2030 target of 95-95-95.	[Mugenyi, Levicatus; Nanfuka, Mastula; Byawaka, Jaffer; Agaba, Collins; Mijumbi, Andrew; Kagimu, David; Mugisha, Kenneth; Etukoit, Michael] AIDS Support Org, Kampala, Uganda; [Mugenyi, Levicatus] Uganda Virus Res Inst, Med Res Council, Entebbe, Uganda; [Mugenyi, Levicatus] London Sch Hyg & Trop Med, Entebbe Unit, Entebbe, Uganda; [Shabbar, Jaffer] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Lancs, England	Uganda Virus Research Institute; Liverpool School of Tropical Medicine	Mugenyi, L (corresponding author), AIDS Support Org, Kampala, Uganda.; Mugenyi, L (corresponding author), Uganda Virus Res Inst, Med Res Council, Entebbe, Uganda.; Mugenyi, L (corresponding author), London Sch Hyg & Trop Med, Entebbe Unit, Entebbe, Uganda.	lmugenyi005@gmail.com		Mugenyi, Levi/0000-0002-9423-2472				Alhaj M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25239; Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Brown LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210126; Brown LB, 2016, AIDS, V30, P2855, DOI 10.1097/QAD.0000000000001250; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Constance EK, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.32.17174; Girum T, 2020, AIDS RES THER, V17, DOI 10.1186/s12981-020-00274-3; Havlir D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25455; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Inguane CA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20846; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Khan S., 2018, UNIVERSAL TEST TREAT, P406; Makhema J., 2019, NEW ENGL J MED, V381; Moges NA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05168-3; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Naimi AI, 2020, AM J EPIDEMIOL, V189, P508, DOI 10.1093/aje/kwaa044; Nash D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20637; Opito R., 2019, INT J HIVAIDS PREVEN, V5; Opito R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239087; R Core Team, 2020, R LANG ENV STAT COMP; StataCorp, 2015, STATACORP STATA STAT; Therapy A., 2021, HIV INFECT TIME DIAG, P1; UNAIDS, 2018, UNAIDS DAT 2018, P1; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2016, PREV HIV TEST TREAT; WHO, 2015, GUID START ANT THER; World Health Organization, 2013, CONSOLIDATED GUIDELI	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268226	10.1371/journal.pone.0268226	http://dx.doi.org/10.1371/journal.pone.0268226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580126	Green Accepted, gold, Green Published			2022-12-26	WOS:000835654800015
J	Al-Shaer, AE; Pal, A; Shi, Q; Carson, MS; Regan, J; Behee, M; Buddenbaum, N; Drawdy, C; Davis, T; Virk, R; Shaikh, SR				Al-Shaer, Abrar E.; Pal, Anandita; Shi, Qing; Carson, Meredith S.; Regan, Jennifer; Behee, Madeline; Buddenbaum, Nicole; Drawdy, Catie; Davis, Traci; Virk, Rafia; Shaikh, Saame Raza			Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass-dependent therapeutic window for resolvin E1	FASEB JOURNAL			English	Article						diversity outbred mice; heterogeneity; obesity; resolvin E1; specialized pro-resolving mediators	INSULIN-RESISTANCE; LIPID MEDIATORS; RESOLUTION; MOUSE; INFLAMMATION; D1; PHAGOCYTOSIS; ADIPOCYTES	Resolvin E1 (RvE1), a specialized pro-resolving mediator (SPM), improves glucose homeostasis in inbred mouse models of obesity. However, an impediment toward translation is that obesity is a highly heterogenous disease in which individuals will respond very differently to interventions such as RvE1. Thus, there is a need to study SPMs in the context of modeling the heterogeneity of obesity that is observed in humans. We investigated how RvE1 controls the concentration of key circulating metabolic biomarkers using diversity outbred (DO) mice, which mimic human heterogeneity. We first demonstrate that weights of DO mice can be classified into distinct distributions of fat mass (i.e., modeling differing classes of obesity) in response to a high-fat diet and in the human population when examining body composition. Next, we show RvE1 administration based on body weight for four consecutive days after giving mice a high-fat diet led to approximately half of the mice responding positively for serum total gastric inhibitory polypeptide (GIP), glucagon, insulin, glucose, leptin, and resistin. Interestingly, RvE1 improved hyperleptinemia most effectively in the lowest class of fat mass despite adjusting the dose of RvE1 with increasing adiposity. Furthermore, leptin levels after RvE1 treatment were the lowest in those mice that were also RvE1 positive responders for insulin and resistin. Collectively, these results suggest a therapeutic fat mass-dependent window for RvE1, which should be considered in future clinical trials. Moreover, the data underscore the importance of studying SPMs with heterogenous mice as a step toward precision SPM administration in humans.	[Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA; [Shaikh, Saame Raza] Univ N Carolina, Sch Med, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Shaikh, SR (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu			NIH [AT008375, P30DK05635]; National Science Foundation Graduate Research Fellowship Program [1650116]; ODS Supplement	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); ODS Supplement	This work was supported by NIH AT008375 (SRS), NIH P30DK05635 (SRS), an ODS Supplement to NIH P30DK05635 (SRS). This material is also based on work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1650116 to AEA. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation	Al-Shaer AE, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158936; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Brennan EP, 2019, CLIN SCI, V133, P2121, DOI 10.1042/CS20190067; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Claria J, 2017, MOL ASPECTS MED, V58, P83, DOI 10.1016/j.mam.2017.03.004; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Crouch MJ, 2019, J LEUKOCYTE BIOL, V106, P241, DOI 10.1002/JLB.3HI1017-405RR; Deb A, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101178; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; English JT, 2017, PROSTAG LEUKOTR ESS, V117, P17, DOI 10.1016/j.plefa.2017.01.004; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Gemperle C, 2021, PROSTAG LEUKOTR ESS, V174, DOI 10.1016/j.plefa.2021.102363; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon-Larsen P, 2021, ADV NUTR, V12, P2023, DOI 10.1093/advances/nmab040; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Herrera BS, 2015, INFECT IMMUN, V83, P792, DOI 10.1128/IAI.02444-14; Jung TW, 2019, CLIN EXP PHARMACOL P, V46, P898, DOI 10.1111/1440-1681.13131; Jung TW, 2018, AM J PHYSIOL-ENDOC M, V315, pE543, DOI 10.1152/ajpendo.00408.2017; Jung TW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01603-9; Lopez-Vicario C, 2019, FASEB J, V33, P7072, DOI 10.1096/fj.201802587R; Lopez-Vicario C, 2016, EUR J PHARMACOL, V785, P133, DOI 10.1016/j.ejphar.2015.03.092; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shimizu T, 2022, FASEB J, V36, DOI 10.1096/fj.202100053R; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Sima C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13185-7; Smallwood TL, 2014, G3-GENES GENOM GENET, V4, P2353, DOI 10.1534/g3.114.014704; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Yaeger MJ, 2021, TOXICOL SCI, V183, P170, DOI 10.1093/toxsci/kfab081	35	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22354	10.1096/fj.202200350R	http://dx.doi.org/10.1096/fj.202200350R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AI	35616343				2022-12-26	WOS:000800257100001
J	Jamalluddin, N; Massawe, FJ; Mayes, S; Ho, WK; Symonds, RC				Jamalluddin, Norain; Massawe, Festo J.; Mayes, Sean; Ho, Wai Kuan; Symonds, Rachael C.			Genetic diversity analysis and marker-trait associations in Amaranthus species	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENOME; SPP.; HYPOCHONDRIACUS; DOMESTICATION; POLYMORPHISM; SECURITY; CROP; L.	Amaranth (Amaranthus spp.) is a highly nutritious, underutilized vegetable and pseudo-cereal crop. It possesses diverse abiotic stress tolerance traits, is genetically diverse and highly phenotypically plastic, making it an ideal crop to thrive in a rapidly changing climate. Despite considerable genetic diversity there is a lack of detailed characterization of germplasm or population structures. The present study utilized the DArTSeq platform to determine the genetic relationships and population structure between 188 amaranth accessions from 18 agronomically important vegetable, grain, and weedy species. A total of 74, 303 SNP alleles were generated of which 63, 821 were physically mapped to the genome of the grain species A. hypochondriacus. Population structure was inferred in two steps. First, all 188 amaranth accessions comprised of 18 species and second, only 120 A. tricolor accessions. After SNP filtering, a total of 8,688 SNPs were generated on 181 amaranth accessions of 16 species and 9,789 SNPs generated on 118 A. tricolor accessions. Both SNP datasets produced three major sub-populations (K = 3) and generate consistent taxonomic classification of the amaranth sub-genera (Amaranthus Amaranthus, Amaranthus Acnida and Amaranthus albersia), although the accessions were poorly demarcated by geographical origin and morphological traits. A. tricolor accessions were well discriminated from other amaranth species. A genome-wide association study (GWAS) of 10 qualitative traits revealed an association between specific phenotypes and genetic variants within the genome and identified 22 marker trait associations (MTAs) and 100 MTAs (P <= 0.01, P <= 0.001) on 16 amaranth species and 118 A.tricolor datasets, respectively. The release of SNP markers from this panel has produced invaluable preliminary genetic information for phenotyping and cultivar improvement in amaranth species.	[Jamalluddin, Norain; Massawe, Festo J.; Mayes, Sean; Ho, Wai Kuan] Univ Nottingham Malaysia, Sch Biosci, Future Food Beacon, Jalan Broga, Semenyih, Selangor, Malaysia; [Mayes, Sean] Univ Nottingham, Biosci, Plant & Crop Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Mayes, Sean; Ho, Wai Kuan] NIAB, Crops Future UK CIC, Cambridge, England; [Symonds, Rachael C.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England	University of Nottingham Malaysia; University of Nottingham; Liverpool John Moores University	Symonds, RC (corresponding author), Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England.	R.C.Symonds@ljmu.ac.uk	Jamalluddin, Norain/EWC-9526-2022; Massawe, Festo/K-4555-2013	Mayes, Sean/0000-0003-4770-3662; Symonds, Rachael/0000-0001-6838-2904; Massawe, Festo/0000-0002-0744-4777	Malaysian Government	Malaysian Government	NJ Received a MyBrain15 PhD Scholarship from the Malaysian Government https://biasiswa.mohe.gov.my/MyBrain15/v2/index_myphd2018.php.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achigan-Dako EG, 2014, EUPHYTICA, V197, P303, DOI 10.1007/s10681-014-1081-9; Alam M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203465; Alemayehu FR, 2015, J AGRON CROP SCI, V201, P321, DOI 10.1111/jac.12108; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; Costea M, 2004, CAN J PLANT SCI, V84, P631, DOI 10.4141/P02-183; Das S., 2016, AMARANTHUS PROMISING, P49; Das S, 2012, GENET RESOUR CROP EV, V59, P289, DOI 10.1007/s10722-011-9684-7; Deb S, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.579529; Nguyen DC, 2019, BREEDING SCI, V69, P640, DOI 10.1270/jsbbs.19050; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Franu║ois O., 2016, RUNNING STRUCTURE LI, P1; Gates DJ, 2016, J MOL EVOL, V83, P26, DOI 10.1007/s00239-016-9750-z; Grubben GJH., 1981, GENETIC RESOURCES AM, V57; Guillen-Portal FR., 1999, PERSPECTIVES NEW CRO, P190; Hassani SMR, 2020, MOL BIOL REP, V47, P2123, DOI 10.1007/s11033-020-05312-x; Ho WK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3393-8; Jamalluddin N, 2019, J HORTIC SCI BIOTECH, V94, P448, DOI 10.1080/14620316.2018.1537725; Jimenez FR, 2013, CROP SCI, V53, P532, DOI 10.2135/cropsci2012.07.0413; Jimenez-Aguilar DM, 2017, J FOOD COMPOS ANAL, V58, P33, DOI 10.1016/j.jfca.2017.01.005; KAUFFMAN CS, 1990, ADVANCES IN NEW CROPS, P127; Khaing AA, 2013, PLANT BREEDING, V132, P165, DOI 10.1111/pbr.12027; Kietlinski KD, 2014, CROP SCI, V54, P220, DOI 10.2135/cropsci2013.03.0173; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Krichen L, 2012, HEREDITAS, V149, P163, DOI 10.1111/j.1601-5223.2012.02245.x; Lee JR, 2008, CONSERV GENET, V9, P243, DOI 10.1007/s10592-007-9323-1; Li HH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1424-5; Lightfoot DJ, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0412-4; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mallory MA, 2008, CROP SCI, V48, P1098, DOI 10.2135/cropsci2007.08.0457; Marees AT, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1608; Massawe, 2021, FOOD SECURITY NUTR, P125; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; Mosyakin SL, 1996, ANN BOT FENN, V33, P275; Pailles Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00138; Rastogi A, 2013, CRIT REV FOOD SCI, V53, P109, DOI 10.1080/10408398.2010.517876; Sarker U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206388; Sogbohossou OED, 2014, SCI HORTIC-AMSTERDAM, V178, P31, DOI 10.1016/j.scienta.2014.08.003; Stetter MG, 2020, MOL BIOL EVOL, V37, P1407, DOI 10.1093/molbev/msz304; Stetter MG, 2017, MOL ECOL, V26, P871, DOI 10.1111/mec.13974; Stetter MG, 2017, MOL PHYLOGENET EVOL, V109, P80, DOI 10.1016/j.ympev.2016.12.029; Stetter MG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00816; Sunil M, 2014, DNA RES, V21, P585, DOI 10.1093/dnares/dsu021; Suresh S, 2014, PLANT BIOSYST, V148, P635, DOI 10.1080/11263504.2013.788095; Umakanta Sarker, 2014, Journal of Food, Agriculture & Environment, V12, P168; Voichek Y, 2020, NAT GENET, V52, P534, DOI 10.1038/s41588-020-0612-7; Win Htet Oo, 2013, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V58, P336, DOI 10.7740/kjcs.2013.58.4.336; Wu XB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01960	52	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267752	10.1371/journal.pone.0267752	http://dx.doi.org/10.1371/journal.pone.0267752			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551526	Green Published, gold			2022-12-26	WOS:000868164600031
J	Mermin-Bunnell, K; Ahn, WK				Mermin-Bunnell, Kellen; Ahn, Woo-Kyoung			It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19 public health compliance among liberals and conservatives	PLOS ONE			English	Article							PSYCHOLOGICAL PREDICTORS; ANXIETY	The COVID-19 pandemic is far from over, in part due to poor adoption of public health mitigation measures in the U.S. and the continued spread of the Delta and Omicron variants. Current public health messaging used in the U.S. could be improved to better combat mistrust about COVID-19 and its mitigation measures, especially vaccines. We propose that a disgust-inducing public health campaign will be more effective than current approaches, primarily among conservatives, who are both sensitive to moralized disgust and are less compliant with U.S. public health guidelines. Using a convenience sample across two studies (n = 1610), we found that presenting disgusting images related to the COVID-19 pandemic increased public health compliance more among conservatives than among liberals. Among unvaccinated conservative participants, disgusting images significantly increased willingness to be vaccinated compared to less disgusting images of COVID-19 or perks offered for COVID-19 vaccines. Using disgusting images for public health messaging has the potential to improve compliance among conservatives and accelerate the end of the COVID-19 pandemic in the U.S.	[Mermin-Bunnell, Kellen; Ahn, Woo-Kyoung] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Mermin-Bunnell, Kellen] Emory Univ, Sch Med, Atlanta, GA USA	Yale University; Emory University	Ahn, WK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	woo-kyoung.ahn@yale.edu		Ahn, Woo-kyoung/0000-0002-5203-2376; Mermin-Bunnell, Kellen/0000-0002-4612-8152	Yale University Internal Research Fund	Yale University Internal Research Fund	Yale University Internal Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakey SM, 2017, J CLIN PSYCHOL MED S, V24, P270, DOI 10.1007/s10880-017-9514-y; Blakey SM, 2015, COGNITIVE THER RES, V39, P816, DOI 10.1007/s10608-015-9701-9; Chwe H., 2021, COVID STATES PROJECT, DOI [10.31219/osf.io/rz34x, DOI 10.31219/OSF.IO/RZ34X]; Clay R, 2017, SOC PSYCHOL PERS SCI, V8, P162, DOI 10.1177/1948550616664957; Clifford S, 2018, AM J POLIT SCI, V62, P266, DOI 10.1111/ajps.12350; Clifford S, 2016, POLIT BEHAV, V38, P155, DOI 10.1007/s11109-015-9310-z; Cox RC, 2020, J ANXIETY DISORD, V76, DOI 10.1016/j.janxdis.2020.102315; Gollwitzer A, 2020, NAT HUM BEHAV, V4, P1186, DOI 10.1038/s41562-020-00977-7; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Grossman G, 2020, P NATL ACAD SCI USA, V117, P24144, DOI 10.1073/pnas.2007835117; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2012, RIGHTEOUS MIND WHY G; Honein MA, 2020, MMWR-MORBID MORTAL W, V69, P1860, DOI 10.15585/mmwr.mm6949e2; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Ives M., 2021, NEW YORK TIMES; Kahane G, 2018, PSYCHOL REV, V125, P131, DOI 10.1037/rev0000093; Laakasuo M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45526; Luz PM, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000517; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; Mckay D, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102233; Milkman KL., 2021, MEGA STUDY TEXT BASE; Moore Ryan C, 2020, medRxiv, DOI 10.1101/2020.04.08.20057067; Olson LR, 2006, PS-POLIT SCI POLIT, V39, P455; Porzig-Drummond R, 2009, SOC SCI MED, V68, P1006, DOI 10.1016/j.socscimed.2009.01.013; Rosenthal E., 2020, NEW YORK TIMES; Rozin P, 2013, TRENDS COGN SCI, V17, P367, DOI 10.1016/j.tics.2013.06.001; Shook NJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238015; Terrizzi JA, 2013, EVOL HUM BEHAV, V34, P99, DOI 10.1016/j.evolhumbehav.2012.10.003; Tracy JL, 2019, J PERS SOC PSYCHOL, V116, P15, DOI 10.1037/pspa0000141; Trujillo KL, 2021, POLIT RES QUART, V74, P464, DOI 10.1177/1065912920907695; Wagemans FMA, 2018, EMOTION, V18, P277, DOI 10.1037/emo0000359	31	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267735	10.1371/journal.pone.0267735	http://dx.doi.org/10.1371/journal.pone.0267735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551525	Green Published, gold			2022-12-26	WOS:000868164600030
J	Volynkina, A; Lisitskaya, Y; Kolosov, A; Shaposhnikova, L; Pisarenko, S; Dedkov, V; Dolgova, A; Platonov, A; Kulichenko, A				Volynkina, Anna; Lisitskaya, Yana; Kolosov, Albert; Shaposhnikova, Lyudmila; Pisarenko, Sergey; Dedkov, Vladimir; Dolgova, Anna; Platonov, Alexander; Kulichenko, Alexander			Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Russia	PLOS ONE			English	Article							GENETIC-ANALYSIS; REASSORTMENT; MIGRATION; SEGMENT	In this report, we present new data on the diversity and geographical distribution of genetic variants in Crimean-Congo hemorrhagic fever virus (CCHFV) in Russia. Partial S, M, and L segment sequences of the CCHFV genome were obtained from 500 serum samples from CCHF patients and 103 pools of ticks collected in the south of the European region of Russia in 2007-2017. The investigated viral strains belonged to the lineages Europe 1 (596 samples), Africa 3 (1 sample) and a new genetic lineage, Europe 3 (6 samples). The Russian CCHFV strains of the Europe 1 lineage formed four subgroups (Va-Vd) correlated with the geographical site of virus isolation. Segment reassortment events between strains of different subgroups within lineage Europe 1 were revealed. The complete S, M and L genome segments of 18 CCHFV strains belonging to different subgroups of the Europe 1 lineage and the complete S segments of 3 strains of the Europe 3 lineage and 1 strain of the Africa 3 lineage were sequenced. The analysis of the geographical distribution of CCHFV genetic variants in southern Russia revealed local viral populations with partially overlapping boundaries.	[Volynkina, Anna; Lisitskaya, Yana; Kolosov, Albert; Shaposhnikova, Lyudmila; Pisarenko, Sergey; Kulichenko, Alexander] Fed Serv Consumer Rights Protect & Human Well Bei, Stavropol Res Antiplague Inst, Stavropol, Russia; [Dedkov, Vladimir; Dolgova, Anna] Fed Serv Consumer Rights Protect & Human Well Bei, St Petersburg Pasteur Inst, St Petersburg, Russia; [Dedkov, Vladimir] Sechenov First Moscow State Med Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Platonov, Alexander] Fed Serv Consumer Rights Protect & Human Well Bei, Cent Res Inst Epidemiol, Moscow, Russia	Saint-Petersburg Pasteur Institute; Sechenov First Moscow State Medical University	Volynkina, A (corresponding author), Fed Serv Consumer Rights Protect & Human Well Bei, Stavropol Res Antiplague Inst, Stavropol, Russia.	volyn444@mail.ru	Dedkov, Vladimir G/M-7010-2018; Dolgova, Anna/G-7414-2017	Dedkov, Vladimir G/0000-0002-5500-0169; Dolgova, Anna/0000-0001-8730-4872	Russian Sciense Foundation [20-64-46014]	Russian Sciense Foundation	Anna Volynkina, Vladimir Dedkov, Anna Dolgova, Alexander Platonov: RSF grant N. 20-64-46014, Russian Sciense Foundation URL https://www.rscf.ru/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carroll SA, 2010, MOL PHYLOGENET EVOL, V55, P1103, DOI 10.1016/j.ympev.2010.01.006; Dedkov VG, 2017, ANTIVIR RES, V146, P146, DOI 10.1016/j.antiviral.2017.08.018; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Ebihara H., 2016, CREATE NEW ORDER BUN; Flick Ramon, 2007, P35, DOI 10.1007/978-1-4020-6106-6_4; Guo R, 2017, VIROL SIN, V32, P80, DOI 10.1007/s12250-016-3936-9; Hewson R, 2004, J GEN VIROL, V85, P3059, DOI 10.1099/vir.0.80121-0; Hewson Roger, 2007, P45, DOI 10.1007/978-1-4020-6106-6_5; Kuhn JH, 2004, ARCH VIROL, V149, P2199, DOI 10.1007/s00705-004-0354-3; Kulichenko AN, 2016, MOL GENET MICROBIOL+, V31, P94, DOI 10.3103/S0891416816020051; Kulichenko AN., 2012, AKTUALNYE VOPROSY, V3, P42; Lukashev AN, 2018, INFECT GENET EVOL, V59, P23, DOI 10.1016/j.meegid.2018.01.016; Lukashev AN, 2005, J GEN VIROL, V86, P2333, DOI 10.1099/vir.0.80974-0; Mild M, 2010, J GEN VIROL, V91, P199, DOI 10.1099/vir.0.014878-0; Ozkaya E, 2010, VIRUS RES, V149, P64, DOI 10.1016/j.virusres.2009.12.014; Papa A, 2016, J MED VIROL, V88, P769, DOI 10.1002/jmv.24400; Papa A, 2015, ANTIVIR RES, V120, P57, DOI 10.1016/j.antiviral.2015.05.005; Sherifi K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003168; Smirnova SE, 2007, CRIMEAN CONGO HEMORR; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Volynkina AS., 2012, PROBLEMS PARTICULARL, V4, P80; Yashina L, 2003, J GEN VIROL, V84, P1199, DOI 10.1099/vir.0.18805-0; Yashina L, 2003, J CLIN MICROBIOL, V41, P860, DOI 10.1128/JCM.41.2.860-862.2003; Zhou ZR, 2013, J GEN VIROL, V94, P2536, DOI 10.1099/vir.0.056374-0; Zivcec M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040106	27	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0266177	10.1371/journal.pone.0266177	http://dx.doi.org/10.1371/journal.pone.0266177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I1ZV	35551538	Green Published, gold			2022-12-26	WOS:000868164600012
J	Oh, MK; Joo, H; Kim, IS				Oh, Mi-Kyung; Joo, Hansol; Kim, In-Sook			Prohaptoglobin inhibits the transforming growth factor-beta-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells	PLOS ONE			English	Article							GENE-EXPRESSION; HAPTOGLOBIN; IDENTIFICATION; SPECIFICITY; MECHANISMS; MOUSE; LINE	Transforming growth factor-beta (TGF-beta) is an important inducer of the epithelial-to-mesenchymal transition (EMT) in various cancers. Our previous study demonstrated that prohaptoglobin (proHp) stimulates Smad1/5 activation via ALK1, a TGF-beta type I receptor, in endothelial cells, suggesting that proHp plays a role in TGF-beta signaling. However, the function of proHp in cellular events downstream of Smads remains unclear. The current study investigated the effects of proHp on TGF-beta-mediated Smad-dependent EMT induction and cell invasion in vitro using proHp-overexpressing SK-Hep1 liver cancer cells. The results of Western blotting, quantitative real-time RT-PCR, and immunocytochemistry indicated that proHp downregulated expression of mesenchymal marker and EMT regulator such as N-cadherin, vimentin, and twist, and upregulated expression of the epithelial marker E-cadherin. Compared with control cells, proHp-overexpressing cells exhibited high levels of ALK1/2/3 receptors and markedly increased Smad1/5 phosphorylation. Interestingly, proHp attenuated TGF-beta-induced expression of mesenchymal markers and Smad2/3 phosphorylation. It also significantly suppressed cell invasion and migration. Knockdown of Smad1/5 abolished the inhibitory effects of proHp on TGF-beta-stimulated Smad2/3 phosphorylation and mesenchymal marker expression. These findings indicate that proHp suppresses the TGF-beta-induced EMT and cell invasion in vitro by enhancing Smad1/5 activation via ALK1/2/3 receptors and thus suppressing the Smad2/3 signaling pathway in SK-Hep1 cells. This study suggests that proHp may prevent a de-differentiation of hepatic cells and induce a cell differentiation by regulating the Smad signaling pathway.	[Oh, Mi-Kyung; Joo, Hansol; Kim, In-Sook] Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea; [Oh, Mi-Kyung] Seoul Natl Univ, Biomax Inst, Seoul, South Korea	Catholic University of Korea; Seoul National University (SNU)	Kim, IS (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea.	ikim@catholic.ac.kr			National Research Foundation of Korea(NRF) - Korea government(MEST) [NRF-2016R1A2B1009425]	National Research Foundation of Korea(NRF) - Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST) (NRF-2016R1A2B1009425; Recipient:ISK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chao JS, 2020, AM J TRANSL RES, V12, P2099; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Eun JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110744; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007; Goto M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16555-3; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; HANLEY JM, 1985, ARCH BIOCHEM BIOPHYS, V239, P404, DOI 10.1016/0003-9861(85)90706-4; HANLEY JM, 1983, J BIOL CHEM, V258, P7858; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Huntoon KM, 2013, MOL IMMUNOL, V55, P345, DOI 10.1016/j.molimm.2013.03.008; Ito N, 2021, GLYCOCONJUGATE J, V38, P45, DOI 10.1007/s10719-020-09970-8; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim IS, 2001, BIOCHEM BIOPH RES CO, V284, P738, DOI 10.1006/bbrc.2001.5041; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee CC, 2013, CLIN CHEM LAB MED, V51, P429, DOI 10.1515/cclm-2012-0197; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Lirdprapamongkol K, 2012, BIOCHEM BIOPH RES CO, V422, P429, DOI 10.1016/j.bbrc.2012.05.009; Malfettone A, 2017, CANCER LETT, V392, P39, DOI 10.1016/j.canlet.2017.01.037; Miyoshi E, 2008, PROTEOMICS, V8, P3257, DOI 10.1002/pmic.200800046; Naryzhny S. N., 2021, Biomeditsinskaya Khimiya, V67, P105, DOI 10.18097/PBMC20216702105; Naryzhny S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126533; Nishino Kimihiro, 2018, Oncotarget, V9, P12732, DOI 10.18632/oncotarget.24332; Oh MK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216289; Oh MK, 2015, FEBS LETT, V589, P1009, DOI 10.1016/j.febslet.2015.03.006; OLIVIERO S, 1987, EMBO J, V6, P1905, DOI 10.1002/j.1460-2075.1987.tb02450.x; Park HJ, 2013, IMMUNOLOGY, V140, P133, DOI 10.1111/imm.12125; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tai CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171269; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wicher KB, 2004, P NATL ACAD SCI USA, V101, P14390, DOI 10.1073/pnas.0405692101; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang HL, 2017, AM J PHYSIOL-LUNG C, V313, pL615, DOI 10.1152/ajplung.00079.2017	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0266409	10.1371/journal.pone.0266409	http://dx.doi.org/10.1371/journal.pone.0266409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580109	gold, Green Published			2022-12-26	WOS:000835654800021
J	Zahra, S; Khan, D; Gupta, R; Popp, J; Olah, J				Zahra, Samia; Khan, Dilawar; Gupta, Rakesh; Popp, Jozsef; Olah, Judit			Assessing the asymmetric impact of physical infrastructure and trade openness on ecological footprint: An empirical evidence from Pakistan	PLOS ONE			English	Article							CO2 EMISSIONS; ECONOMIC-GROWTH; TRANSPORT SECTOR; ROAD TRANSPORT; ENVIRONMENTAL DEGRADATION; ENERGY-CONSUMPTION; RENEWABLE ENERGY; URBAN METABOLISM; PUBLIC TRANSPORT; CARBON FOOTPRINT	This study analyzed the asymmetric impact of the physical infrastructure and trade openness on Pakistan's ecological footprint over the period 1970-2019 using the non-linear autoregressive distributed lag model. The study results posit that positive and negative shocks to physical infrastructure increase and decrease the ecological footprint asymmetrically in the short-run and symmetrically in the long-run. Likewise, the positive and negative shocks to trade openness increase and decrease the ecological footprint asymmetrically, both in the short and in the long run. Furthermore, urbanization also positively and significantly increases Pakistan's ecological footprint in the short and long run. Moreover, a 1% increase in physical infrastructure increases the ecological footprint by 0.32%, while a 1% decrease in physical infrastructure decreases the ecological footprint by 0.33% in the long run. Similarly, a 1% increase in trade openness causes a 0.09% increase in the ecological footprint in the long term, while a 1% reduction in trade openness causes a 0.61% reduction in the ecological footprint. The results also conclude that urbanization is a major determinant of Pakistan's long-term ecological footprint. Thus, a 1% increase in urbanization causes a 1.31% increase in the ecological footprint in the long run. Finally, this study recommends that policies regarding physical infrastructure be formulated keeping in view its environmental impact. In addition, strict environmental policies should be implemented to reduce the environmental degradation effect of trade openness.	[Zahra, Samia] Higher Educ Arch & Lib Dept, Peshawar, Khyber Pakhtunk, Pakistan; [Khan, Dilawar] Kohat Univ Sci & Technol, Kohat, Pakistan; [Gupta, Rakesh] Griffith Univ Brisbane, Dept Accounting Finance & Econ, Brisbane, Australia; [Popp, Jozsef] WSB Univ, Fac Appl Sci, Dept Management, Dabrowa Gornicza, Poland; [Olah, Judit] Univ Debrecen, Fac Econ & Business, Debrecen, Hungary; [Olah, Judit] Univ Johannesburg, Coll Business & Econ, Johannesburg, South Africa	Kohat University of Science & Technology; Griffith University; WSB University; University of Debrecen; University of Johannesburg	Zahra, S (corresponding author), Higher Educ Arch & Lib Dept, Peshawar, Khyber Pakhtunk, Pakistan.	samiazahra022@gmail.com	Khan, Dilawar/K-3683-2019; Gupta, Rakesh/J-2793-2013	Khan, Dilawar/0000-0001-5872-267X; Gupta, Rakesh/0000-0001-6334-3420; Zahra, Samia/0000-0002-8832-053X	 [018/RID/2018/19]		The project was funded under the program of the Minister of Science and Higher Education titled "Regional Initiative of Excellence" in 2019-2022, project number 018/RID/2018/19, the amount of funding PLN 10 788 423,16.	Ahmed Z, 2020, RESOUR POLICY, V67, DOI 10.1016/j.resourpol.2020.101677; Ahmed Z, 2020, SUSTAIN CITIES SOC, V55, DOI 10.1016/j.scs.2020.102064; Ahmed Z, 2019, ENVIRON SCI POLLUT R, V26, P26782, DOI 10.1007/s11356-019-05911-7; Alola AA, 2019, SCI TOTAL ENVIRON, V658, P260, DOI 10.1016/j.scitotenv.2018.12.212; Alola AA, 2019, SCI TOTAL ENVIRON, V685, P702, DOI 10.1016/j.scitotenv.2019.05.139; Alola AA, 2018, ENERG ENVIRON-UK, V29, P1438, DOI 10.1177/0958305X18779577; Andres L, 2018, TRANSPORT POLICY, V61, P60, DOI 10.1016/j.tranpol.2017.10.008; Angel S., 2005, DYNAMICS GLOBAL URBA; Asher S, 2020, ECON J, V130, P1173, DOI 10.1093/ej/ueaa013; Baabou W, 2017, ENVIRON SCI POLICY, V69, P94, DOI 10.1016/j.envsci.2016.12.013; Baccini P, 2012, METABOLISM OF THE ANTHROPOSPHERE: ANALYSIS, EVALUATION, DESIGN, 2ND EDITION, P1; Baloch MA, 2019, ENVIRON SCI POLLUT R, V26, P6199, DOI 10.1007/s11356-018-3992-9; Barrett J., 2003, LOCAL ENVIRON, V8, P167, DOI DOI 10.1080/1354983032000048488; Bello MO, 2018, J ENVIRON MANAGE, V219, P218, DOI 10.1016/j.jenvman.2018.04.101; Ben Abdallah M, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10060217; Bhandari K, 2014, J CLEAN PROD, V85, P234, DOI 10.1016/j.jclepro.2014.05.013; Bougheas S, 2000, CAN J ECON, V33, P506, DOI 10.1111/0008-4085.00026; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; BROWN RL, 1975, J ROY STAT SOC B MET, V37, P149; Carrasco Sierra A., 2020, INT J ENTREPRENEURIA, V8, P42, DOI DOI 10.37335/IJEK.V8I2.116; Chandran VGR, 2013, RENEW SUST ENERG REV, V24, P445, DOI 10.1016/j.rser.2013.03.054; Charfeddine L, 2017, RENEW SUST ENERG REV, V76, P138, DOI 10.1016/j.rser.2017.03.031; Chen H, 2020, SAGE OPEN, V10, DOI 10.1177/2158244019894071; Chester M., 2008, ENV LIFE CYCLE ASSES; Chester MV, 2010, ATMOS ENVIRON, V44, P1071, DOI 10.1016/j.atmosenv.2009.12.012; Chi GQ, 2005, J URBAN PLAN D-ASCE, V131, P170, DOI 10.1061/(ASCE)0733-9488(2005)131:3(170); Danis, 2020, SUSTAIN CITIES SOC, V54, DOI 10.1016/j.scs.2019.101996; Danish,, 2018, NAT HAZARDS, V90, P27, DOI 10.1007/s11069-017-3031-z; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Dogan E, 2019, ENERG ENVIRON-UK, V30, P1065, DOI 10.1177/0958305X19834279; Du HB, 2019, EARTHS FUTURE, V7, P718, DOI 10.1029/2018EF001117; Du HB, 2019, ENERGY, V175, P195, DOI 10.1016/j.energy.2019.03.052; Eckstein D., 2021, WHO SUFFERS MOST EXT; Emir F, 2019, ENERG ENVIRON-UK, V30, P427, DOI 10.1177/0958305X18793108; Erdogan S, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102338; Gassner A, 2018, LAND USE POLICY, V72, P85, DOI 10.1016/j.landusepol.2017.12.012; Gavurova B, 2020, J TOUR SERV, V11, P38, DOI 10.29036/jots.v11i21.175; Ghita SI, 2019, AMFITEATRU ECON, V21, P554, DOI 10.24818/EA/2019/52/554; Global Footprint Network, 2020, ECOLOGICAL FOOTPRINT; Go Pakistan., 2020, EC SURV PAK EC ADV W; GODFREY LG, 1978, ECONOMETRICA, V46, P1303, DOI 10.2307/1913830; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Hubacek K, 2009, J CLEAN PROD, V17, P1241, DOI 10.1016/j.jclepro.2009.03.011; Ibrahim MH., 2015, AGR FOOD ECON, V3, P1, DOI DOI 10.1186/S40100-014-0020-3; Jafri MAH, 2021, ENVIRON SCI POLLUT R, V28, P16129, DOI 10.1007/s11356-020-11787-9; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Khan D, 2021, ENERGIES, V14, DOI 10.3390/en14133923; Kharbach M, 2017, SUSTAIN CITIES SOC, V35, P396, DOI 10.1016/j.scs.2017.08.016; Kitzes J, 2009, ECOL ECON, V68, P1991, DOI 10.1016/j.ecolecon.2008.06.022; Koengkan M., 2018, REV ESTUDOS SOCIAIS, V20, P4, DOI DOI 10.19093/RES5277; Kurniawan R, 2018, ENERG POLICY, V121, P576, DOI 10.1016/j.enpol.2018.07.023; Liddle B, 2013, ENVIRON MODELL SOFTW, V40, P255, DOI 10.1016/j.envsoft.2012.10.002; Lin D, 2018, RESOURCES-BASEL, V7, DOI 10.3390/resources7030058; Lin D, 2016, WILEY SER RENEW RESO, P179; Luo W, 2018, RESOUR CONSERV RECY, V137, P113, DOI 10.1016/j.resconrec.2018.05.015; Majeed MT., 2018, PAKISTAN J COMMERCE, V12, P758; Majeed MT, 2021, ENVIRON SCI POLLUT R, V28, P32945, DOI 10.1007/s11356-021-13130-2; Matthews HS., 2008, IMPORTANCE CARBON FO; Meyer D., 2016, ADM PUBLICA, V24, P52; Moore J, 2013, J ENVIRON MANAGE, V124, P51, DOI 10.1016/j.jenvman.2013.03.009; Muhammad S, 2020, ENERGY, V196, DOI 10.1016/j.energy.2020.117102; Munir K, 2018, MANAG ENVIRON QUAL, V29, P1123, DOI 10.1108/MEQ-05-2018-0087; Nathaniel S, 2020, ENVIRON SCI POLLUT R, V27, P19616, DOI 10.1007/s11356-020-08466-0; Nathaniel S, 2020, J CLEAN PROD, V272, DOI 10.1016/j.jclepro.2020.122709; Nathaniel SP, 2021, GEOJOURNAL, V86, P2057, DOI 10.1007/s10708-020-10175-7; Gil MTN, 2020, ECON SOCIOL, V13, P24, DOI 10.14254/2071-789X.2020/13-1/2; Olah J, 2021, ENERGIES, V14, DOI 10.3390/en14144366; Olah J, 2020, ENERGIES, V13, DOI 10.3390/en13092323; Pereira AM, 2005, REV DEV ECON, V9, P177, DOI 10.1111/j.1467-9361.2005.00271.x; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Poumanyvong P, 2010, ECOL ECON, V70, P434, DOI 10.1016/j.ecolecon.2010.09.029; Qin S., 2021, INT J ENTREPRENEURIA, V9, P112; Rajiani I, 2018, POL J MANAG STUD, V18, P296, DOI 10.17512/pjms.2018.18.1.22; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Randelovic D, 2016, ECOL ENG, V95, P800, DOI 10.1016/j.ecoleng.2016.07.015; Rashid A, 2018, J CLEAN PROD, V170, P362, DOI 10.1016/j.jclepro.2017.09.186; Saboori B, 2014, ENERGY, V66, P150, DOI 10.1016/j.energy.2013.12.048; Saidi S, 2017, TRANSPORT RES D-TR E, V53, P415, DOI 10.1016/j.trd.2017.04.031; Santos G, 2017, TRANSPORT POLICY, V59, P71, DOI 10.1016/j.tranpol.2017.06.007; Sarkodie SA, 2018, ENVIRON SCI POLLUT R, V25, P21993, DOI 10.1007/s11356-018-2347-x; Shahbaz M, 2015, RENEW SUST ENERG REV, V51, P89, DOI 10.1016/j.rser.2015.06.014; Shin Y., 2014, FESTSCHRIFT HONOR PE, P281, DOI DOI 10.1007/978-1-4899-8008-3_9; Smirnova E, 2021, ENERGY, V230, DOI 10.1016/j.energy.2021.120903; Strydom C., 2020, J CONT MANAGEMENT, V17, P22; Tantau A, 2019, AMFITEATRU ECON, V21, P697, DOI 10.24818/EA/2019/52/697; Temerbulatova Z, 2020, J INT STUDIES, V13, DOI DOI 10.14254/2071-8330.2020/13-1/21; Timilsina GR, 2009, ENERG POLICY, V37, P4523, DOI 10.1016/j.enpol.2009.06.009; Tuchschmid M., 2011, CARBON, V2; Ullah S, 2021, ENVIRON SCI POLLUT R, V28, P7450, DOI 10.1007/s11356-020-11093-4; Ulucak R, 2018, J CLEAN PROD, V188, P144, DOI 10.1016/j.jclepro.2018.03.191; Umar M, 2020, J ENVIRON MANAGE, V271, DOI 10.1016/j.jenvman.2020.111026; Uslu A, 2020, J TOUR SERV, V11, P1, DOI 10.29036/jots.v11i21.147; Uttara S., 2012, INT J RES ENG APPL S, V2, P1637, DOI DOI 10.1111/j.1911-3846.2011.01101.x; Vasa L, 2018, ECON ANN-XXI, V168, P44, DOI 10.21003/ea.V168-09; Vetter S, 2014, ACTA POLYTECH HUNG, V11, P119; Wackernagel M., 1998, OUR ECOLOGICAL FOOTP; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; Wang JY, 2019, SCI TOTAL ENVIRON, V656, P165, DOI 10.1016/j.scitotenv.2018.11.354; WDI, 2020, WORLD BANK DEV IND; Yang L, 2020, ENVIRON SCI POLLUT R, V27, P16472, DOI 10.1007/s11356-020-08123-6; Zahra S, 2022, ENVIRON SCI POLLUT R, V29, P54698, DOI 10.1007/s11356-022-19669-y; Zahra S, 2022, ENVIRON SCI POLLUT R, V29, P2523, DOI 10.1007/s11356-021-15665-w; Zameer H, 2020, ENVIRON SCI POLLUT R, V27, P29539, DOI 10.1007/s11356-020-09112-5; Zhang CG, 2013, ENERG POLICY, V63, P918, DOI 10.1016/j.enpol.2013.07.142; Zhi-Guo L, 2018, ENERG ENVIRON-UK, V29, P216, DOI 10.1177/0958305X17745273	109	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0262782	10.1371/journal.pone.0262782	http://dx.doi.org/10.1371/journal.pone.0262782			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580086	Green Published, gold			2022-12-26	WOS:000835654800013
J	Liu, X; Pappas, EJ; Husby, ML; Motsa, BB; Stahelin, RV; Pienaar, E				Liu, Xiao; Pappas, Ethan J.; Husby, Monica L.; Motsa, Balindile B.; Stahelin, Robert, V; Pienaar, Elsje			Mechanisms of phosphatidylserine influence on viral production: A computational model of Ebola virus matrix protein assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CONVALESCENT PLASMA; VP40; DISEASE; INFECTION; OLIGOMERIZATION; TRAFFICKING; FAVIPIRAVIR; KINETICS; DOMAIN	Ebola virus (EBOV) infections continue to pose a global public health threat, with high mortality rates and sporadic outbreaks in Central and Western Africa. A quantitative understanding of the key processes driving EBOV assembly and budding could provide valuable insights to inform drug development. Here, we use a computational model to evaluate EBOV matrix assembly. Our model focuses on the assembly kinetics of VP40, the matrix protein in EBOV, and its interaction with phosphatidylserine (PS) in the host cell membrane. It has been shown that mammalian cells transfected with VP40-expressing plasmids are capable of producing virus-like particles (VLPs) that closely resemble EBOV virions. Previous studies have also shown that PS levels in the host cell membrane affects VP40 association with the plasma membrane inner leaflet and that lower membrane PS levels result in lower VLP production. Our computational findings indicate that PS may also have a direct influence on VP40 VLP assembly and budding, where a higher PS level will result in a higher VLP budding rate and filament dissociation rate. Our results further suggest that the assembly of VP40 filaments follow the nucleation-elongation theory, where initialization and oligomerization of VP40 are two distinct steps in the assembly process. Our findings advance the current understanding of VP40 VLP formation by identifying new possible mechanisms of PS influence on VP40 assembly. We propose that these mechanisms could inform treatment strategies targeting PS alone or in combination with other VP40 assembly steps.	[Liu, Xiao; Pappas, Ethan J.; Pienaar, Elsje] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Husby, Monica L.; Motsa, Balindile B.; Stahelin, Robert, V] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Pappas, Ethan J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Pienaar, E (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	epienaar@purdue.edu		Pappas, Ethan/0000-0001-6139-8532; Stahelin, Robert/0000-0001-5443-7863	NIH/NIAID [AI081077]; NIH/NIGMS [T32GM075762]; Frederick N. Andrews Fellowship; Purdue Pharmacy Live Cell Imaging Facility [NIH OD027034]; Indiana CTSI [UL1TR001108]	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Frederick N. Andrews Fellowship; Purdue Pharmacy Live Cell Imaging Facility; Indiana CTSI	These studies were supported by the NIH/NIAID (AI081077) to R. V. S., the NIH/NIGMS to M. L. H. (T32GM075762), the Indiana CTSI (UL1TR001108) to R. V. S and E. P., and the Frederick N. Andrews Fellowship to X. L. We would like to thank the Purdue Pharmacy Live Cell Imaging Facility for confocal imaging (NIH OD027034 to R. V. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2014, VIRUSES-BASEL, V6, P3837, DOI 10.3390/v6103837; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Aruna A, 2019, MMWR-MORBID MORTAL W, V68, P1162, DOI 10.15585/mmwr.mm6850a3; Aschenbrenner DS, 2021, AM J NURS, V121, P22, DOI 10.1097/01.NAJ.0000742484.81331.b2; Bai CQ, 2016, CLIN INFECT DIS, V63, P1288, DOI 10.1093/cid/ciw571; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Chatani Eri, 2018, Biophys Rev, V10, P527, DOI 10.1007/s12551-017-0353-8; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Dayeh MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196402; Del Vecchio K, 2018, J BIOL CHEM, V293, P3335, DOI 10.1074/jbc.M117.816280; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Dunning J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162199; Dunning J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001997; Fan JN, 2020, BIOCHEM BIOPH RES CO, V527, P387, DOI 10.1016/j.bbrc.2020.04.041; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Gc JB, 2017, BIOCHEM BIOPH RES CO, V493, P176, DOI 10.1016/j.bbrc.2017.09.052; Gc JB, 2016, PHYS CHEM CHEM PHYS, V18, P28409, DOI 10.1039/c6cp03776c; Gc JB, 2016, PROTEIN SCI, V25, P1648, DOI 10.1002/pro.2969; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Husby M. L., 2021, BIORXIV, DOI [10.1101/2021.06.08.447555, DOI 10.1101/2021.06.08.447555]; Husby ML, 2018, FASEB J, V32; Jeevan BGC, 2017, BBA-BIOMEMBRANES, V1859, P2012, DOI 10.1016/j.bbamem.2017.07.007; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Johnson K. A, 2016, SCI REP-UK, V6, P1; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kalenga OI, 2019, NEW ENGL J MED, V381, P373, DOI 10.1056/NEJMsr1904253; Kende M, 2019, ANTIVIR RES, V163, P179, DOI 10.1016/j.antiviral.2018.12.020; Khan A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0043-3; Konde MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169255; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; Krebs E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217559; LANGE G, 1988, EUR J BIOCHEM, V178, P61, DOI 10.1111/j.1432-1033.1988.tb14429.x; Lawson B. A. J., 2017, ARXIV, DOI [10.48550/arXiv.1706.06763, DOI 10.48550/ARXIV.1706.06763]; Li HY, 2020, J AM CHEM SOC, V142, P1367, DOI 10.1021/jacs.9b10869; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Madelain V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06215-z; Maekawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35762; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Markham A, 2021, DRUGS, V81, P175, DOI 10.1007/s40265-020-01452-3; Martyushev A, 2016, ANTIVIR RES, V135, P62, DOI 10.1016/j.antiviral.2016.10.004; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Nanbo A, 2019, DNA CELL BIOL, V38, P115, DOI 10.1089/dna.2018.4485; Nickbakhsh S, 2019, P NATL ACAD SCI USA, V116, P27142, DOI 10.1073/pnas.1911083116; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pasin C, 2019, J VIROL, V93, DOI 10.1128/JVI.00579-19; Piorkowski G, 2017, ANTIVIR RES, V140, P95, DOI 10.1016/j.antiviral.2017.01.017; Sahr F, 2017, J INFECTION, V74, P302, DOI 10.1016/j.jinf.2016.11.009; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Spouge JL, 1996, MATH BIOSCI, V138, P1, DOI 10.1016/S0025-5564(96)00064-8; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stahelin RV, 2014, EXPERT OPIN THER TAR, V18, P115, DOI 10.1517/14728222.2014.863877; Sueblinvong V, 2015, CRIT CARE MED, V43, P2066, DOI 10.1097/CCM.0000000000001197; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Nguyen VK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08884-0; Nguyen VK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00257; Wan W, 2020, ELIFE, V9, DOI 10.7554/eLife.59225; Wang PY, 2021, EUR J MED CHEM, V217, DOI 10.1016/j.ejmech.2021.113381; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zhang JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050295; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zitzmann C, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00725	81	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102025	10.1016/j.jbc.2022.102025	http://dx.doi.org/10.1016/j.jbc.2022.102025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35568195	Green Published, Green Submitted, gold			2022-12-26	WOS:000818686700004
J	Savinid, KW; Moate, PJ; Williams, SRO; Bathid, C; Hemsworth, J; Wang, J; Ram, D; Zawadzki, J; Rochfort, S; Cocks, BG				Savinid, Keith W.; Moate, Peter J.; Williams, S. R. O.; Bathid, Carolyn; Hemsworth, Joanne; Wang, Jianghui; Ram, Doris; Zawadzki, Jody; Rochfort, Simone; Cocks, Benjamin G.			Dietary wheat and reduced methane yield are linked to rumen microbiome changes in dairy cows	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SP NOV.; METHANOGENESIS; FERMENTATION; EMISSIONS; SEQUENCES; BACTERIA; CATTLE	Fermentation of pasture grasses and grains in the rumen of dairy cows and other ruminants produces methane as a by-product, wasting energy and contributing to the atmospheric load of greenhouse gasses. Many feeding trials in farmed ruminants have tested the impact of dietary components on feed efficiency, productivity and methane yield (MeY). Such diets remodel the rumen microbiome, altering bacterial, archaeal, fungal and protozoan populations, with an altered fermentation outcome. In dairy cows, some dietary grains can reduce enteric methane production. This is especially true of wheat, in comparison to corn or barley. Using a feeding trial of cows fed rolled wheat, corn or barley grain, in combination with hay and canola, we identified wheat-associated changes in the ruminal microbiome. Ruminal methane production, pH and VFA concentration data together with 16S rRNA gene amplicon sequences were used to compare ruminal bacterial and archaeal populations across diets. Differential abundance analysis of clustered sequences (OTU) identified members of the bacterial families Lachnospiraceae, Acidaminococcaceae, Eubacteriaceae, Prevotellaceae, Selenomonadaceae, Anaerovoracaceae and Fibrobacteraceae having a strong preference for growth in wheat-fed cows. Within the methanogenic archaea, (at >99% 16S rRNA sequence identity) the growth of Methanobrevibacter millerae was favoured by the non-wheat diets, while Methanobrevibacter olleyae was unaffected. From the wheat-preferring bacteria, correlation analysis found OTU strongly linked to reduced MeY, reduced pH and raised propionic acid levels. OTU from the genera Shuttleworthia and Prevotella_7 and especially Selenomonadaceae had high anti-methane correlations. An OTU likely representing (100% sequence identity) the fumarate-reducing, hydrogen-utilising, rumen bacterium Mitsuokella jalaludinii, had an especially high negative correlation coefficient (-0.83) versus MeY and moderate correlation (-0.6) with rumen pH, strongly suggesting much of the MeY suppression is due to reduced hydrogen availablity. Other OTU, representing as yet unknown species from the Selenomonadaceae family and the genera Prevotella_7, Fibrobacter and Syntrophococcus also had high to moderate negative MeY correlations, but low correlation with pH. These latter likely represent bacterial species able to reduce MeY without causing greater ruminal acidity, making them excellent candidates, provided they can be isolated, for development as anti-methane probiotics.	[Savinid, Keith W.; Bathid, Carolyn; Hemsworth, Joanne; Wang, Jianghui; Ram, Doris; Zawadzki, Jody; Rochfort, Simone; Cocks, Benjamin G.] AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia; [Moate, Peter J.; Williams, S. R. O.] Agr Victoria Res, Ellinbank, Victoria, Australia		Savinid, KW (corresponding author), AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia.	keith.savin@agriculture.vic.gov.au		Bath, Carolyn/0000-0002-1157-6844; Savin, Keith/0000-0001-8347-0320	Agriculture Victoria Research, Victoria, Australia	Agriculture Victoria Research, Victoria, Australia	This work was funded by Agriculture Victoria Research, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hess PS, 2019, J SCI FOOD AGR, V99, P3451, DOI 10.1002/jsfa.9563; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1988, KG LACTATE DETERMINE; Baird DB, 1994, THESIS U OTAGO; Beauchemin KA, 2020, ANIMAL, V14, pS2, DOI 10.1017/S1751731119003100; Black JL, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11040951; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Deighton MH, 2014, ANIM FEED SCI TECH, V197, P47, DOI 10.1016/j.anifeedsci.2014.08.003; Downes J, 2002, INT J SYST EVOL MICR, V52, P1469, DOI 10.1099/00207713-52-5-1469; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Gruninger RJ, 2019, ANIMAL, V13, P1843, DOI 10.1017/S1751731119000752; Guyader J, 2016, J ANIM SCI, V94, P3147, DOI 10.2527/jas.2015-0141; Haisan J, 2014, J DAIRY SCI, V97, P3110, DOI 10.3168/jds.2013-7834; HERRERASALDANA R, 1990, J DAIRY SCI, V73, P142, DOI 10.3168/jds.S0022-0302(90)78657-2; Huang S, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.630605; Lan GQ, 2002, INT J SYST EVOL MICR, V52, P713, DOI [10.1099/ijs.0.01930-0, 10.1099/00207713-52-3-713]; Lana RP, 1998, J ANIM SCI, V76, P2190; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Mamuad L, 2014, J MICROBIOL, V52, P120, DOI 10.1007/s12275-014-3518-1; Mamuad LL, 2012, J MICROBIOL, V50, P925, DOI 10.1007/s12275-012-2497-3; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Moate RJ, 2017, J DAIRY SCI, V100, P7139, DOI 10.3168/jds.2016-12482; Moate PJ, 2014, J DAIRY SCI, V97, P5073, DOI 10.3168/jds.2013-7588; Newbold CJ, 2005, BRIT J NUTR, V94, P27, DOI 10.1079/BJN20051445; O'Mara FP, 2011, ANIM FEED SCI TECH, V166-67, P7, DOI 10.1016/j.anifeedsci.2011.04.074; Packer EL, 2011, AUST VET J, V89, P338, DOI 10.1111/j.1751-0813.2011.00802.x; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	31	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2022	17	5							e0268157	10.1371/journal.pone.0268157	http://dx.doi.org/10.1371/journal.pone.0268157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6M7VJ	35587477	gold, Green Published			2022-12-26	WOS:000889069700001
J	Bonachela, JA; Choua, M; Heath, MR				Bonachela, Juan A.; Choua, Melinda; Heath, Michael R.			Unconstrained coevolution of bacterial size and the latent period of plastic phage	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-SIZE; NUTRIENT-UPTAKE; GROWTH; BACTERIOPHAGE; VIRUSES; MODEL; EVOLUTION; DENSITY; ECOLOGY	Viruses play critical roles in the dynamics of microbial communities. Lytic viruses, for example, kill significant fractions of autotrophic and heterotrophic microbes daily. The dynamic interplay between viruses and microbes results from an overlap of physiological, ecological, and evolutionary responses: environmental changes trigger host physiological changes, affecting the ecological interactions of host and virus and, ultimately, the evolutionary pressures influencing the two populations. Recent theoretical work studied how the dependence of viral traits on host physiology (viral plasticity) affects the evolutionarily stable host cell size and viral infection time emerging from coevolution. Here, we broaden the scope of the framework to consider any coevolutionary outcome, including potential evolutionary collapses of the system. We used the case study of Escherichia coli and T-like viruses under chemostat conditions, but the framework can be adapted to any microbe-virus system. Oligotrophic conditions led to smaller, lower-quality but more abundant hosts, and infections that were longer but produced a reduced viral offspring. Conversely, eutrophic conditions resulted in fewer but larger higher-quality hosts, and shorter but more productive infections. The virus influenced host evolution decreasing host size more noticeably for low than for high dilution rates, and for high than for low nutrient input concentration. For low dilution rates, the emergent infection time minimized host need/use, but higher dilution led to an opportunistic strategy that shortened the duration of infections. System collapses driven by evolution resulted from host failure to adapt quickly enough to the evolving virus. Our results contribute to understanding the eco-evolutionary dynamics of microbes and virus, and to improving the predictability of current models for host-virus interactions. The large quantitative and qualitative differences observed with respect to a classic description (in which viral traits are assumed to be constant) highlights the importance of including viral plasticity in theories describing short- and long-term host-virus dynamics.	[Bonachela, Juan A.] Rutgers State Univ, Dept Ecol Evolut Nat Resources, New Brunswick, NJ 08901 USA; [Choua, Melinda] Blue Remediat Ltd, Glasgow, Scotland; [Heath, Michael R.] Univ Strathclyde, Dept Math & Stat, Marine Populat Modelling Grp, Glasgow, Scotland	Rutgers State University New Brunswick; University of Strathclyde	Bonachela, JA (corresponding author), Rutgers State Univ, Dept Ecol Evolut Nat Resources, New Brunswick, NJ 08901 USA.	juan.bonachela@rutgers.edu	; Bonachela, Juan/H-9848-2016	Heath, Michael/0000-0001-6602-3107; Bonachela, Juan/0000-0002-3316-8120	Simons Foundation [826106]; Marine Alliance for Science and Technology for Scotland (MASTS) pooling scheme, Scottish Funding Council [HR09011]	Simons Foundation; Marine Alliance for Science and Technology for Scotland (MASTS) pooling scheme, Scottish Funding Council	JAB was supported by a grant from the Simons Foundation (award #826106); MC and MRH were supported to varying extents by the Marine Alliance for Science and Technology for Scotland (MASTS) pooling scheme, Scottish Funding Council grant reference HR09011.	ABEDON ST, 1989, MICROB ECOL, V18, P79, DOI 10.1007/BF02030117; Armstrong RA, 2008, DEEP-SEA RES PT I, V55, P1311, DOI 10.1016/j.dsr.2008.05.004; Birch EW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002746; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bonachela JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17774-4; Bonachela JA, 2014, J THEOR BIOL, V345, P32, DOI 10.1016/j.jtbi.2013.12.006; Bonachela JA, 2011, J STAT PHYS, V144, P303, DOI 10.1007/s10955-011-0179-x; Bull JJ, 2006, J THEOR BIOL, V241, P928, DOI 10.1016/j.jtbi.2006.01.027; Bull JJ, 2006, AM NAT, V167, pE39, DOI 10.1086/499374; Caceres C, 2019, ISME J, V13, P2834, DOI 10.1038/s41396-019-0473-1; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; Choua M, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.637490; Choua M, 2020, J THEOR BIOL, V498, DOI 10.1016/j.jtbi.2020.110263; Choua M, 2019, AM NAT, V193, P346, DOI 10.1086/701668; Collins JR, 2015, GLOBAL BIOGEOCHEM CY, V29, P1471, DOI 10.1002/2014GB005037; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Delbruck M, 1940, J GEN PHYSIOL, V23, P631, DOI 10.1085/jgp.23.5.631; DeLong JP, 2022, NAT REV MICROBIOL, V20, P83, DOI 10.1038/s41579-021-00612-w; Dercole F, 2008, PRINC SER THEOR COMP, P1; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Edwards KF, 2018, AM NAT, V191, P566, DOI 10.1086/696849; Emerson JB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00120-19; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gallet R, 2017, ISME J, V11, P1559, DOI 10.1038/ismej.2017.35; Gnezda-Meijer K, 2006, FEMS MICROBIOL ECOL, V55, P136, DOI 10.1111/j.1574-6941.2005.00008.x; Golec P, 2014, FEMS MICROBIOL LETT, V351, P156, DOI 10.1111/1574-6968.12372; Grant NA, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00469-20; Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Knowles B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18078-4; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Levin S., 1999, FRAGILE DOMINION; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Martinez-Garcia R, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006094; Menge DNL, 2009, J THEOR BIOL, V257, P104, DOI 10.1016/j.jtbi.2008.10.032; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pourtois J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00221; SCHULZE KL, 1964, ARCH MIKROBIOL, V48, P1, DOI 10.1007/BF00406595; Shao YP, 2008, GENETICS, V180, P471, DOI 10.1534/genetics.108.090100; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tilman D., 1982, Monographs in Population Biology, pi; Tozzi S, 2004, MAR ECOL PROG SER, V274, P123, DOI 10.3354/meps274123; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Ward BA, 2017, AM NAT, V189, P170, DOI 10.1086/689992; WEBB V, 1982, CAN J MICROBIOL, V28, P1277, DOI 10.1139/m82-190; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weitz JS, 2008, THEOR ECOL, V1, P13, DOI 10.1007/s12080-007-0001-1; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Weld RJ, 2004, J THEOR BIOL, V227, P1, DOI 10.1016/S0022-5193(03)00262-5; Wirtz KW, 2002, J BIOTECHNOL, V97, P147, DOI 10.1016/S0168-1656(02)00064-0; Wortel M., 2021, BIORXIV; Yoshida M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0257-1; You LC, 2002, J BACTERIOL, V184, P1888, DOI 10.1128/JB.184.7.1888-1894.2002	61	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268596	http://dx.doi.org/10.1371/journal.pone.0268596			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617195	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000835048800022
J	Correia-Caeiro, C; Burrows, A; Wilson, DA; Abdelrahman, A; Miyabe-Nishiwaki, T				Correia-Caeiro, Catia; Burrows, Anne; Wilson, Duncan Andrew; Abdelrahman, Abdelhady; Miyabe-Nishiwaki, Takako			CalliFACS: The common marmoset Facial Action Coding System	PLOS ONE			English	Article							CALLITHRIX-JACCHUS; MODEL; EXPRESSION; MUSCLES; EVOLUTION; MOVEMENT; MUSCULATURE; CHIMPANZEES; IMITATION; PRIMATE	Facial expressions are subtle cues, central for communication and conveying emotions in mammals. Traditionally, facial expressions have been classified as a whole (e.g. happy, angry, bared-teeth), due to automatic face processing in the human brain, i.e., humans categorise emotions globally, but are not aware of subtle or isolated cues such as an eyebrow raise. Moreover, the same facial configuration (e.g. lip corners pulled backwards exposing teeth) can convey widely different information depending on the species (e.g. humans: happiness; chimpanzees: fear). The Facial Action Coding System (FACS) is considered the gold standard for investigating human facial behaviour and avoids subjective interpretations of meaning by objectively measuring independent movements linked to facial muscles, called Action Units (AUs). Following a similar methodology, we developed the CalliFACS for the common marmoset. First, we determined the facial muscular plan of the common marmoset by examining dissections from the literature. Second, we recorded common marmosets in a variety of contexts (e.g. grooming, feeding, play, human interaction, veterinary procedures), and selected clips from online databases (e.g. YouTube) to identify their facial movements. Individual facial movements were classified according to appearance changes produced by the corresponding underlying musculature. A diverse repertoire of 33 facial movements was identified in the common marmoset (15 Action Units, 15 Action Descriptors and 3 Ear Action Descriptors). Although we observed a reduced range of facial movement when compared to the HumanFACS, the common marmoset's range of facial movements was larger than predicted according to their socio-ecology and facial morphology, which indicates their importance for social interactions. CalliFACS is a scientific tool to measure facial movements, and thus, allows us to better understand the common marmoset's expressions and communication. As common marmosets have become increasingly popular laboratory animal models, from neuroscience to cognition, CalliFACS can be used as an important tool to evaluate their welfare, particularly in captivity.	[Correia-Caeiro, Catia; Wilson, Duncan Andrew; Miyabe-Nishiwaki, Takako] Kyoto Univ, Primate Res Inst, Inuyama, Japan; [Burrows, Anne] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA USA; [Burrows, Anne] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA USA; [Wilson, Duncan Andrew] Kyoto Univ, Grad Sch Letters, Kyoto, Japan; [Abdelrahman, Abdelhady] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Scotland	Kyoto University; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyoto University; Glasgow Caledonian University	Correia-Caeiro, C (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Japan.	catia_caeiro@hotmail.com		Wilson, Duncan/0000-0003-0096-454X	Research Units for Exploring Future Horizons (Human & Nature Interlaced Life Science) under the Kyoto University Research Coordination Alliance; CCC	Research Units for Exploring Future Horizons (Human & Nature Interlaced Life Science) under the Kyoto University Research Coordination Alliance; CCC	This work was supported by the Research Units for Exploring Future Horizons (Human & Nature Interlaced Life Science) under the Kyoto University Research Coordination Alliance to TMN (Host/Principal Investigator) and CCC (Invited Visiting Junior Associate Professor). The funders had no role in study design, data collection and analysis, decision to publsih, or preparation of this work.	Andersen PH, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11061643; Ash H, 2018, PHYSIOL BEHAV, V185, P14, DOI 10.1016/j.physbeh.2017.12.018; Bakker J, 2014, LAB ANIMAL, V43, P315, DOI 10.1038/laban.568; Beattie J, 1927, P ZOOL SOC LOND, V1927, P593; BERZIN F, 1993, ANN ANAT, V175, P195, DOI 10.1016/S0940-9602(11)80182-2; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Buchanan-Smith HM, 2012, APPL ANIM BEHAV SCI, V137, P166, DOI 10.1016/j.applanim.2011.07.002; Bugnyar T, 1997, ANIM BEHAV, V54, P817, DOI 10.1006/anbe.1996.0497; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Burkart JM, 2020, ANIM COGN, V23, P581, DOI 10.1007/s10071-020-01363-6; Burkart JM, 2015, NEUROSCI RES, V93, P8, DOI 10.1016/j.neures.2014.09.003; Burkart JM, 2009, ANIM BEHAV, V77, P1291, DOI 10.1016/j.anbehav.2009.02.006; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Burrows AM, 2011, ANAT REC, V294, P645, DOI 10.1002/ar.21355; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Caeiro CC, 2017, APPL ANIM BEHAV SCI, V189, P66, DOI 10.1016/j.applanim.2017.01.005; Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Camerlink I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35905-3; Catia C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15091-4; Clark PR, 2020, AM J PHYS ANTHROPOL, V173, P411, DOI 10.1002/ajpa.24129; Correia-Caeiro C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245117; Cyranoski D, 2009, NATURE, V459, P492, DOI 10.1038/459492a; de Boer RA, 2013, AM J PRIMATOL, V75, P1084, DOI 10.1002/ajp.22167; Descovich KA, 2017, ALTEX-ALTERN ANIM EX, V34, P409, DOI 10.14573/altex.1607161; DIGBY LJ, 1993, FOLIA PRIMATOL, V61, P123, DOI 10.1159/000156739; Diogo R, 2009, J ANAT, V215, P300, DOI 10.1111/j.1469-7580.2009.01111.x; Dobson SD, 2009, AM J PHYS ANTHROPOL, V138, P70, DOI 10.1002/ajpa.20902; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 2002, FACIAL ACTION CODING; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; Faulkes CG., 2009, GENETIC STRUCTURE PO, P103, DOI [10.1371/journal.pone.0008326, DOI 10.1371/JOURNAL.PONE.0008326]; Galvao-Coelho NL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00175; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; Ghazanfar AA, 2020, CURR BIOL, V30, DOI 10.1016/j.cub.2020.09.049; Hackley SA, 2015, PSYCHOPHYSIOLOGY, V52, P1263, DOI 10.1111/psyp.12501; HILL W. C. OSMAN, 1959, TRANS AMER PHIL SOC, V49, P1, DOI 10.2307/1005807; Hjortsjo C. H., 1969, MANS FACE MIMIC LANG; Huber E, 1930, Q REV BIOL, V5, P389, DOI 10.1086/394364; Humphrey T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73426-0; Immordino-Yang MH, 2007, MIND BRAIN EDUC, V1, P3, DOI 10.1111/j.1751-228X.2007.00004.x; Jongkees BJ, 2016, NEUROSCI BIOBEHAV R, V71, P58, DOI 10.1016/j.neubiorev.2016.08.020; Julle-Daniere E, 2015, PEERJ, V3, DOI 10.7717/peerj.1248; Kaplan G, 2006, DEV PSYCHOBIOL, V48, P551, DOI 10.1002/dev.20155; Kemp C, 2013, ANIM COGN, V16, P773, DOI 10.1007/s10071-013-0611-5; Kret ME, 2020, NEUROSCI BIOBEHAV R, V115, P378, DOI 10.1016/j.neubiorev.2020.01.027; Kuhbandner C, 2009, SOC COGN AFFECT NEUR, V4, P286, DOI 10.1093/scan/nsp010; LIGHTOLLER G. S., 1934, PROC ZOOL SOC LONDON, V1934, P259; LIPP HP, 1978, BRAIN BEHAV EVOLUT, V15, P241, DOI 10.1159/000123781; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Miller CT, 2016, NEURON, V90, P219, DOI 10.1016/j.neuron.2016.03.018; Mitchell JF, 2015, NEUROSCI RES, V93, P20, DOI 10.1016/j.neures.2015.01.008; Morozov A, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0117-21.2021; Nakajima S., 2011, J VET BEHAV, V1, P95, DOI [10.1016/j.jveb.2010.08.015, DOI 10.1016/J.JVEB.2010.08.015]; Okano H, 2021, ANNU REV NEUROSCI, V44, P27, DOI 10.1146/annurev-neuro-030520-101844; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Parr LA, 2007, EMOTION, V7, P172, DOI 10.1037/1528-3542.7.1.172; Prins NW, 2017, J NEUROSCI METH, V284, P35, DOI 10.1016/j.jneumeth.2017.04.004; Reighard J., 1900, SCIENCE, V11, P344, DOI [10.1126/science.11.270.344, DOI 10.1126/SCIENCE.11.270.344]; Sadoun A, 2019, NEUROBIOL AGING, V74, P1, DOI 10.1016/j.neurobiolaging.2018.10.003; Saito A, 2015, NEUROSCI RES, V93, P99, DOI 10.1016/j.neures.2014.12.011; Sanchis-Jurado V, 2020, GRAEF ARCH CLIN EXP, V258, P2701, DOI 10.1007/s00417-020-04782-w; Santana SE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0275; Schiel N, 2017, DEV NEUROBIOL, V77, P244, DOI 10.1002/dneu.22458; STEVENSON MF, 1976, ANIM BEHAV, V24, P428, DOI 10.1016/S0003-3472(76)80053-X; Sugiyama T, 2013, PERCEPT MOTOR SKILL, V116, P406, DOI 10.2466/22.27.PMS.116.2.406-414; SUTCLIFFE AG, 1984, INT J PRIMATOL, V5, P591, DOI 10.1007/BF02692286; Tada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066018; Taylor AB, 2004, J MORPHOL, V261, P276, DOI 10.1002/jmor.10249; Tennie C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13915; Thompson CL, 2014, J ZOOL, V294, P161, DOI 10.1111/jzo.12164; Tsunoda T, 2008, PHYSIOL BEHAV, V93, P172, DOI 10.1016/j.physbeh.2007.08.012; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Vinyard CJ., 2009, EVOLUTIONARY MORPHOL, P395, DOI [10.1007/978-1-4419-0293-1_20, DOI 10.1007/978-1-4419-0293-1_20]; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Waller BM, 2008, PHYSIOL BEHAV, V95, P93, DOI 10.1016/j.physbeh.2008.05.002; Waller BM, 2020, NEUROSCI BIOBEHAV R, V113, P1, DOI 10.1016/j.neubiorev.2020.02.031; Waller BM, 2006, EMOTION, V6, P367, DOI 10.1037/1528-3542.6.3.367; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Waller BM, 2012, INT J PRIMATOL, V33, P809, DOI 10.1007/s10764-012-9611-6; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Wexler DA., 1972, J SUPPLEMENTAL ABSTR, V2, P116; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Yamazaki Y, 2009, JPN PSYCHOL RES, V51, P182, DOI 10.1111/j.1468-5884.2009.00398.x; Yan WJ, 2013, J NONVERBAL BEHAV, V37, P217, DOI 10.1007/s10919-013-0159-8; ZAMETKIN AJ, 1979, ANN NEUROL, V5, P453, DOI 10.1002/ana.410050509	91	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0266442	10.1371/journal.pone.0266442	http://dx.doi.org/10.1371/journal.pone.0266442			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M7RM	35580128	gold, Green Published			2022-12-26	WOS:000835654800003
J	Hacker, K; Greenlee, AZ; Hill, A; Schneider, D; Levy, M; Iqbal, J				Hacker, Kathryn; Greenlee, Andrew Z.; Hill, Alison; Schneider, Daniel; Levy, Michael; Iqbal, Javaid			Spatiotemporal trends in bed bug metrics: New York City	PLOS ONE			English	Article							LECTULARIUS HEMIPTERA CIMICIDAE; CIMEX-LECTULARIUS; INFESTATION; MANAGEMENT; RESISTANCE	Bed bug outbreaks pose a major challenge in urban environments and cause significant strain on public resources. Few studies have systematically analyzed this insect epidemic or the potential effects of policies to combat bed bugs. Here we use three sources of administrative data to characterize the spatial-temporal trends of bed bug inquiries, complaints, and reports in New York City. Bed bug complaints have significantly decreased (p < 0.01) from 2014-2020, the absolute number of complaints per month dropping by half (875 average complaints per month to 440 average complaints per month); conversely, complaints for other insects including cockroaches and flies did not decrease over the same period. Despite the decrease of bed bug complaints, areas with reported high bed bug infestation tend to remain infested, highlighting the persistence of these pests. There are limitations to the datasets; still the evidence available suggests that interventions employed by New York City residents and lawmakers are stemming the bed bug epidemic and may serve as a model for other large cities.	[Hacker, Kathryn; Levy, Michael] Univ Penn, Dept Epidemiol, Biostat, Informat, Philadelphia, PA 19104 USA; [Hacker, Kathryn] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Greenlee, Andrew Z.; Schneider, Daniel] Univ Illinois, Dept Urban & Reg Planning, Urbana, IL USA; [Hill, Alison] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Hacker, K (corresponding author), Univ Penn, Dept Epidemiol, Biostat, Informat, Philadelphia, PA 19104 USA.; Hacker, K (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	kphacker@umich.edu		Hacker, Kathryn/0000-0001-5267-1699	National Socio-Environmental Synthesis Center; National Science Foundation [DBI-1639145]; University of Pennsylvania Diversity Postdoc Fellowship; National Institute of General Medical Sciences of the National Institutes of Health [K12GM081259]	National Socio-Environmental Synthesis Center; National Science Foundation(National Science Foundation (NSF)); University of Pennsylvania Diversity Postdoc Fellowship; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Socio-Environmental Synthesis Center under funding received from National Science Foundation Grant DBI-1639145. KPH was supported by the University of Pennsylvania Diversity Postdoc Fellowship and National Institute of General Medical Sciences of the National Institutes of Health under Award Number K12GM081259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoundi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124576; [Anonymous], 2020, NEIGHBORHOOD TABULAT; [Anonymous], DAT NEW YORK CIT COM; [Anonymous], LOCAL LAW 69 2017 CO; Ashcroft R, 2015, INT J PUBLIC HEALTH, V60, P827, DOI 10.1007/s00038-015-0713-8; Bashir B, 2013, AM J KIDNEY DIS, V62, P974, DOI 10.1053/j.ajkd.2013.04.020; BedBug Central, 2008, HIST RES; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Bonnefoy X., 2008, Public health significance of urban pests; Calgary O, HOUSING MAINTENANCE; Carter L, 2005, INFORM SYST J, V15, P5, DOI 10.1111/j.1365-2575.2005.00183.x; City of New York, NYC 311 NYC311; Cooper R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136462; CORNWELL P B, 1974, International Pest Control, V16, P17; Crawley SE, 2021, PEST MANAG SCI, V77, P5334, DOI 10.1002/ps.6574; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; Divjan A, 2019, J ALLERGY CLIN IMMUN, V143, pAB236, DOI 10.1016/j.jaci.2018.12.721; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Doggett S. L., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P407; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Doggett SL, 2009, AUST FAM PHYSICIAN, V38, P880; Gangloff-Kaufmann J., 2006, American Entomologist, V52, P105; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; HALLAS T, 1977, Entomologiske Meddelelser, V45, P77; Jacobson James B., 2011, Morbidity and Mortality Weekly Report, V60, P1269; Kantor J, 2016, J AM ACAD DERMATOL, V75, P627, DOI 10.1016/j.jaad.2016.04.025; Kilpinen O., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P395; Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789; Lowe EC, 2019, J PEST SCI, V92, P987, DOI 10.1007/s10340-019-01087-8; Mabud TS, 2014, J MED ENTOMOL, V51, P50, DOI 10.1603/ME13120; McLafferty S, 2020, HEALTH PLACE, V62, DOI 10.1016/j.healthplace.2019.102282; Miller DM, 2015, VIRGINIA COOPERATIVE; Monov M., 1980, Veterinarna Sbirka, V78, P21; Moraga P, 2018, R J, V10, P495; nyc gov, BEDBUGS INFORM TENAN; Pilkington E, 2010, GUARDIAN 1021; QGIS Development Team, QGIS GEOGR INF SYST; Raab RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0117805; Ralph N, 2013, J ENVIRON HEALTH, V76, P38; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483; Schneider D, 2019, J AM PLANN ASSOC, V85, P96, DOI 10.1080/01944363.2019.1591294; Susser SR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000838; Sutherland C, 2020, PEOPLE NAT, V2, P776, DOI 10.1002/pan3.10096; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang L, 2013, FLA ENTOMOL, V96, P131, DOI 10.1653/024.096.0117; Wong M., 2013, J HOUS COMMUNITY DEV, V70, P20; Xie S, 2019, P NATL ACAD SCI USA, V116, P6473, DOI 10.1073/pnas.1814647116	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268798	http://dx.doi.org/10.1371/journal.pone.0268798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617203	gold, Green Published			2022-12-26	WOS:000835048800033
J	King, SN; Greenwell, E; Kaissieh, N; Devara, L; Carter, Z; Fox, J; Blackburn, M				King, Suzanne N.; Greenwell, Evan; Kaissieh, Nada; Devara, Lekha; Carter, Zachary; Fox, James; Blackburn, Megan			Acute effects of radiation treatment to submental muscles on burrowing and swallowing behaviors in a rat model	PLOS ONE			English	Article							NECK-CANCER PATIENTS; LICKING BEHAVIOR; WEIGHT-LOSS; HEAD; CHEMORADIATION; RADIOTHERAPY; DYSPHAGIA; ASPIRATION; DISORDERS; TONGUE	Swallowing impairments are a major complication of radiation treatment for oropharyngeal cancers, influencing oral intake and quality of life. The timing and functional consequences of radiation treatment on the swallowing process is not clearly understood. A rodent radiation injury model was used to investigate the onset of oral and pharyngeal dysfunctions in deglutition related to radiation treatment. This study tested the hypothesis that (Wall et al., 2013) alterations in normal biting, licking, and swallowing performance would be measurable following 64Gy of fractionated radiation to the submental muscles; and (Kotz et al., 2004) radiation will affect the animal's general well-being as measured via burrowing activity. Seven rats received radiation using a clinical linear accelerator given in 8 fractions of 8Gy and another seven animals received sham anesthesia only treatment. Swallowing bolus transit/size was assessed via videofluoroscopy, tongue movement during drinking was measured via an electrical lick sensor, and biting was analyzed from acoustic recordings of a vermicelli pasta test. Burrowing activity was measured by the amount of gravel substrate displaced within a container. Measurements were taken at baseline, during treatment (1-4 weeks), and after completion of treatment (weeks 5 & 6). Decreases in licking frequency and increases in inter-lick interval were observed 5- and 6-weeks post-treatment. Significant decreases in burrowing performance, swallowing frequency, and inter-swallow interval were observed starting the last week of treatment and continuing up to 2-weeks after completion. Results suggest that tongue dysfunction is one of the first treatment related feeding problems to present immediately after the completion of radiation to the submental muscles.	[King, Suzanne N.; Greenwell, Evan; Kaissieh, Nada] Univ Louisville, Sch Med, Dept Otolaryngol Head & Neck Surg & Commun Disorde, Louisville, KY 40202 USA; [Devara, Lekha] Univ Louisville, Sch Med, Louisville, KY USA; [Carter, Zachary; Fox, James; Blackburn, Megan] Univ Louisville, Dept Radiat Oncol, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville	King, SN (corresponding author), Univ Louisville, Sch Med, Dept Otolaryngol Head & Neck Surg & Commun Disorde, Louisville, KY 40202 USA.	s.king@louisville.edu						Agarwal J, 2011, DYSPHAGIA, V26, P399, DOI 10.1007/s00455-011-9326-4; Akagunduz OO, 2019, ANN OTO RHINOL LARYN, V128, P73, DOI 10.1177/0003489418804260; Andrews N, 2012, EUR J PAIN, V16, P485, DOI 10.1016/j.ejpain.2011.07.012; Benedict PA, 2018, LARYNGOSCOPE, V128, P1783, DOI 10.1002/lary.27033; Dale T, 2016, RADIOTHER ONCOL, V118, P304, DOI 10.1016/j.radonc.2016.01.019; DAVIS JD, 1994, BEHAV NEUROSCI, V108, P767, DOI 10.1037/0735-7044.108.4.767; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Eisbruch A, 2002, INT J RADIAT ONCOL, V53, P23, DOI 10.1016/S0360-3016(02)02712-8; Farrugia M, 2021, CANCERS, V13, DOI 10.3390/cancers13071638; Francis DO, 2010, ANN OTO RHINOL LARYN, V119, P391, DOI 10.1177/000348941011900605; Gould FDH, 2016, J APPL PHYSIOL, V120, P495, DOI 10.1152/japplphysiol.00946.2015; HARA I, 1995, J ORAL REHABIL, V22, P315, DOI 10.1111/j.1365-2842.1995.tb00092.x; Hardee JP, 2014, RADIOL ONCOL, V48, P247, DOI 10.2478/raon-2014-0025; Kane JR, 2011, J COMMUN DISORD, V44, P529, DOI 10.1016/j.jcomdis.2011.04.005; King SN., 2021, J APPL PHYSL 1985; King SN, 2021, DYSPHAGIA, V36, P457, DOI 10.1007/s00455-020-10162-7; King SN, 2020, DYSPHAGIA, V35, P814, DOI 10.1007/s00455-019-10087-w; King SN, 2016, DYSPHAGIA, V31, P339, DOI 10.1007/s00455-016-9710-1; Kotz T, 2004, HEAD NECK-J SCI SPEC, V26, P365, DOI 10.1002/hed.10385; Krekeler BN, 2017, LARYNGOSCOPE, V127, pE29, DOI 10.1002/lary.26045; Kumar R, 2014, ORAL ONCOL, V50, P65, DOI 10.1016/j.oraloncology.2013.10.002; Lal P, 2009, ASIA-PAC J CLIN ONCO, V5, P264, DOI 10.1111/j.1743-7563.2009.01241.x; Langius JAE, 2013, BRIT J CANCER, V109, P1093, DOI 10.1038/bjc.2013.458; Langius JAE, 2013, NUTR CANCER, V65, P76, DOI 10.1080/01635581.2013.741749; Lazarus CL, 1996, LARYNGOSCOPE, V106, P1157, DOI 10.1097/00005537-199609000-00021; Lever TE, 2015, JOVE-J VIS EXP, DOI 10.3791/52319; Lin XB, 2013, CHEM SENSES, V38, P685, DOI 10.1093/chemse/bjt038; Logemann JA, 2008, HEAD NECK-J SCI SPEC, V30, P148, DOI 10.1002/hed.20672; Newman LA, 2002, HEAD NECK-J SCI SPEC, V24, P68, DOI 10.1002/hed.10000; Nolan MW, 2017, RADIAT RES, V187, P397, DOI 10.1667/RR14669.1; Nordin NA, 2017, DYSPHAGIA, V32, P427, DOI 10.1007/s00455-016-9776-9; Orsbon CP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64935-z; Pauloski BR, 2006, HEAD NECK-J SCI SPEC, V28, P1069, DOI 10.1002/hed.20459; Pearson WG, 2012, DYSPHAGIA, V27, P445, DOI 10.1007/s00455-011-9392-7; Plowman EK, 2013, BEHAV BRAIN RES, V237, P157, DOI 10.1016/j.bbr.2012.09.031; Russell JA, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0254-y; Russell JA, 2013, DYSPHAGIA, V28, P95, DOI 10.1007/s00455-012-9417-x; Rutten K, 2014, EUR J PAIN, V18, P204, DOI 10.1002/j.1532-2149.2013.00358.x; Soderstrom K, 2017, RADIOTHER ONCOL, V122, P192, DOI 10.1016/j.radonc.2016.09.001; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Starmer HM, 2015, DYSPHAGIA, V30, P430, DOI 10.1007/s00455-015-9618-1; Steele CM, 2010, DYSPHAGIA, V25, P323, DOI 10.1007/s00455-010-9301-5; Van den Steen L, 2019, HEAD NECK-J SCI SPEC, V41, P2197, DOI 10.1002/hed.25684; van der Laan HP, 2015, RADIOTHER ONCOL, V115, P56, DOI 10.1016/j.radonc.2015.01.019; Wall LR, 2013, DYSPHAGIA, V28, P481, DOI 10.1007/s00455-013-9491-8; Wang YJ, 2020, BMJ SUPPORT PALLIAT, V10, P452, DOI 10.1136/bmjspcare-2020-002216; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; Wodarski R, 2016, PAIN, V157, P2350, DOI 10.1097/j.pain.0000000000000657; Zhou T, 2017, EFFECTS IONIZING IRR, P8	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268457	10.1371/journal.pone.0268457	http://dx.doi.org/10.1371/journal.pone.0268457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560040	gold, Green Published			2022-12-26	WOS:000834668000011
J	Molnar, C; Gal, J; Szanto, D; Fulop, LV; Szegedi, A; Siro, P; Nagy, E; Lengyel, S; Kappelmayer, J; Fulesdi, B				Molnar, Csilla; Gal, Judit; Szanto, Dorottya; Fulop, Laszlo V.; Szegedi, Andrea; Siro, Peter; Nagy, Endre; Lengyel, Szabolcs; Kappelmayer, Janos; Fulesdi, Bela			Takotsubo cardiomyopathy in patients suffering from acute non-traumatic subarachnoid hemorrhage-A single center follow-up study	PLOS ONE			English	Article							NEUROGENIC STUNNED MYOCARDIUM; LEFT-VENTRICULAR DYSFUNCTION; CLINICAL CHARACTERISTICS; STRESS CARDIOMYOPATHY; WALL-MOTION; PREDICTORS; PREVALENCE; VASOSPASM; PATTERNS; ANEURYSM	Background Takotsubo cardiomyopathy (TTC) is an important complication of subarachnoid hemorrhage (SAH), that may delay surgical or endovascular treatment and may influence patient outcome. This prospective follow-up study intended to collect data on the prevalence, severity, influencing factors and long-term outcome of TTC in patients suffering from non-traumatic SAH. Methods Consecutive patients admitted with the diagnosis of non-traumatic SAH were included. Intitial assessment consisted of cranial CT, Hunt-Hess, Fisher and WFNS scoring, 12-lead ECG, transthoracic echocardiography (TTE), transcranial duplex sonography and collecting laboratory parameters (CK, CK-MB, cardiac troponin T, NT-proBNP and urine metanephrine and normetanephrine). Diagnosis of TTC was based on modified Mayo criteria. TTC patients were dichotomized to mild and severe forms. Follow-up of TTE, Glasgow Outcome Scale assessment, Barthel's and Karnofsky scoring occurred on days 30 and 180. Results One hundred thirty six patients were included. The incidence of TTC in the entire cohort was 28.7%; of them, 20.6% and 8.1% were mild and severe, respectively. TTC was more frequent in females (30/39; 77%) than in males (9/39; 23%) and was more severe. The occurrence of TTC was related to mFisher scores and WFNS scores. Although the severity of TTC was related to mFisher score, Hunt-Hess score, WFNS score and GCS, multivariate analysis showed the strongest relationship with mFisher scores. Ejection fraction differences between groups were present on day 30, but disappeared by day 180, whereas wall motion score index was still higher in the severe TTC group at day 180. By the end of the follow-up period (180 days), 70 (74.5%) patients survived in the non-TTC, 22 (81.5%) in the mild TTC and 3 (27%) in the severe TTC group (n = 11) (p = 0.002). At day 180, GOS, Barthel, and Karnofsky outcome scores were higher in patients in the control (non-TTC) and the mild TTC groups than in the severe TTC group. Conclusions Takotsubo cardiomyopathy is a frequent finding in patients with SAH, and severe TTC may be present in 8% of SAH cases. The severity of TTC may be an independent predictor of mortality and outcome at 6 months after disease onset. Therefore, a regular follow-up of ECG and TTE abnormalities is warranted in patients with subrachnoid hemorrhage for early detection of TTC.	[Molnar, Csilla; Gal, Judit; Szanto, Dorottya; Siro, Peter; Fulesdi, Bela] Univ Debrecen, Fac Med, Dept Anesthesiol & Intens Care, Debrecen, Hungary; [Fulop, Laszlo V.; Szegedi, Andrea] Univ Debrecen, Fac Med, Dept Cardiol, Debrecen, Hungary; [Nagy, Endre] Univ Debrecen, Fac Med, Dept Internal Med, Debrecen, Hungary; [Lengyel, Szabolcs] Hungarian Acad Sci, Ctr Ecol Res, Budapest, Hungary; [Kappelmayer, Janos] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Debrecen	Fulesdi, B (corresponding author), Univ Debrecen, Fac Med, Dept Anesthesiol & Intens Care, Debrecen, Hungary.	fulesdi@med.unideb.hu		Fulesdi, Bela/0000-0003-2541-9740	Hungarian Brain research program [KTIA_13_NAP-A-II/5]	Hungarian Brain research program	Hungarian Brain research program [grant number KTIA_13_NAP-A-II/5], the founder is the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd TT, 2014, INT J CARDIOL, V176, P1362, DOI 10.1016/j.ijcard.2014.07.279; Akashi YJ, 2004, J NUCL MED, V45, P1121; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cinotti R, 2016, INTENS CARE MED, V42, P173, DOI 10.1007/s00134-015-4106-5; Crago EA, 2004, ACTA NEUROL SCAND, V110, P248, DOI 10.1111/j.1600-0404.2004.00311.x; DAVIES KR, 1991, BRIT J ANAESTH, V67, P58, DOI 10.1093/bja/67.1.58; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Dias A, 2019, CARDIOVASC REVASCULA, V20, P70, DOI 10.1016/j.carrev.2018.11.015; Dias A, 2018, ECHOCARDIOGR-J CARD, V35, P179, DOI 10.1111/echo.13762; Dias V, 2009, CARDIOLOGY, V113, P287, DOI 10.1159/000205963; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dote K, 1991, J Cardiol, V21, P203; Duello KM, 2015, NEUROCRIT CARE, V23, P59, DOI 10.1007/s12028-014-0105-6; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Kerro A, 2017, J CRIT CARE, V38, P27, DOI 10.1016/j.jcrc.2016.10.010; Khush K, 2005, J AM SOC ECHOCARDIOG, V18, P168, DOI 10.1016/j.echo.2004.08.045; Kilbourn KJ, 2013, CLIN NEUROL NEUROSUR, V115, P909, DOI 10.1016/j.clineuro.2012.09.006; Kim H, 2018, INT J CARDIOL, V267, P22, DOI 10.1016/j.ijcard.2018.04.139; Kothavale A, 2006, NEUROCRIT CARE, V4, P199, DOI 10.1385/NCC:4:3:199; Kume T, 2005, CIRC J, V69, P934, DOI 10.1253/circj.69.934; Lebeau R, 2018, ECHO RES PRACT, V5, P63, DOI 10.1530/ERP-18-0006; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; Madias JE, 2016, CLIN NEUROL NEUROSUR, V145, P104, DOI 10.1016/j.clineuro.2016.04.006; Madias JE, 2014, EUR J INTERN MED, V25, pE47, DOI 10.1016/j.ejim.2014.01.002; Malik AN, 2015, WORLD NEUROSURG, V83, P880, DOI 10.1016/j.wneu.2015.01.013; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Mutoh T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0482-4; Nasr DM, 2017, NEUROCRIT CARE, V27, P356, DOI 10.1007/s12028-017-0412-9; Parekh N, 2000, J AM COLL CARDIOL, V36, P1328, DOI 10.1016/S0735-1097(00)00857-3; Pelliccia F, 2017, CIRCULATION, V135, P2426, DOI 10.1161/CIRCULATIONAHA.116.027121; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Shimizu M, 2008, INTERNAL MED, V47, P269, DOI 10.2169/internalmedicine.47.0499; Song BG, 2011, CLIN CARDIOL, V34, P693, DOI 10.1002/clc.20953; Talahma M, 2016, CLIN NEUROL NEUROSUR, V141, P65, DOI 10.1016/j.clineuro.2015.12.005; Temes RE, 2010, NEUROCRIT CARE, V13, P359, DOI 10.1007/s12028-010-9447-x; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Zaroff JG, 2000, J AM SOC ECHOCARDIOG, V13, P774, DOI 10.1067/mje.2000.105763	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268525	10.1371/journal.pone.0268525	http://dx.doi.org/10.1371/journal.pone.0268525			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617162	gold, Green Submitted, Green Published			2022-12-26	WOS:000835048800009
J	Perry, SM; Whitt, JG; Reyna, KS				Perry, Shelby M. M.; Whitt, Jeffrey G. G.; Reyna, Kelly S. S.			The normal stages of development for the California valley quail	PLOS ONE			English	Article							PRIMITIVE STREAK; EMBRYOS; CHICK	One challenge in avian embryology is establishing a standard developmental timetable, primarily because eggs incubated for identical durations can vary in developmental progress, even within the same species. For remedy, avian development is classified into distinct stages based on the formation of key morphological structures. Developmental stages exist for a few galliform species, but the literature is lacking a description of normal stages for California valley quail (Callipepla californica). Thus, the objective of this study was to stage and document the morphological and structural development of California valley quail. Over two laying seasons, 390 eggs were incubated at 37.8 degrees C in 60% RH for <= 23 days. Eggs were opened every <= 6 hours to document embryonic development, including, blastoderm diameter, anterior angle of nostril to beak tip, and lengths of wing, tarsus, third toe, total beak, total foot, and embryo. California valley quail embryos were staged and compared to domestic chicken (Gallus gallus domesticus), the staging standard for galliformes, as well as Japanese quail (Coturnix japonica), blue-breasted quail (Synoicus chinensis) and northern bobwhite quail (Colinus virginianus). This study produced the first description of the 43 normal stages of development for California valley quail. Compared with other galliformes, the California valley quail has a different number of stages and displays developmental heterochrony in stages 1-24, and morphological and developmental differences in stages 25-hatch. The observed differences emphasize the importance of staging individual avian species instead of relying on poultry animal models or close relatives for developmental reference. This is extremely important in species-specific embryological studies that evaluate critical windows of development or evaluate the impacts of environmental change on avian development. This study also suggests that staging frequencies of <= 6 hours and egg transport protocols should be standardized for future staging studies.	[Perry, Shelby M. M.; Whitt, Jeffrey G. G.; Reyna, Kelly S. S.] Texas A&M Univ, Quail Res Lab, Commerce, TX 75428 USA	Texas A&M University System	Reyna, KS (corresponding author), Texas A&M Univ, Quail Res Lab, Commerce, TX 75428 USA.	Kelly.Reyna@tamuc.edu		Reyna, Kelly/0000-0003-3202-2135	Texas AgriLife Extension; Texas A&M University System; Texas A&M University Commerce	Texas AgriLife Extension; Texas A&M University System; Texas A&M University Commerce	Funding was provided by grants to KR from Texas AgriLife Extension, the Texas A & M University System, and Texas A & M University Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth SJ, 2010, J ANAT, V216, P3, DOI 10.1111/j.1469-7580.2009.01173.x; Aleksandrowicz E, 2015, ALTEX-ALTERN ANIM EX, V32, P143, DOI 10.14573/altex.1410031; BrandSaberi B, 1996, INT J DEV BIOL, V40, P411; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; Clifford D. H., 1984, Laboratory animal medicine, P527; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; FANT R. J., 1957, JOUR WILDLIFE MANAGEMENT, V21, P324, DOI 10.2307/3796552; Flecknell P., 2015, LAB ANIMAL MED, V3rd, P1135, DOI DOI 10.1016/B978-0-12-409527-4.00024-9; Gobeli A, 2017, COMP BIOCHEM PHYS C, V195, P9, DOI 10.1016/j.cbpc.2017.02.001; GRAHAM DL, 1975, GROWTH, V39, P389; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; HALL BK, 1981, J EMBRYOL EXP MORPH, V66, P175; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENDRICKX AG, 1965, BIOL BULL-US, V129, P523, DOI 10.2307/1539730; Le Douarin NM, 2013, DEV GROWTH DIFFER, V55, P1, DOI 10.1111/dgd.12015; Lwigale PY, 2008, METHOD CELL BIOL, V87, P59, DOI 10.1016/S0091-679X(08)00203-3; MILLER ER, 1975, POULTRY SCI, V54, P901, DOI 10.3382/ps.0540901; Mlitz V, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020248; Mueller CA., 2015, PHYSL AVIAN EMBRYO, V6th, P739, DOI 10.1016/B978-0-12-407160-5.00032-4; Nakamura Y, 2019, ANIM SCI J, V90, P35, DOI 10.1111/asj.13119; Needham J., 1934, HIST EMBRYOLOGY, P274, DOI [10.1042/bj0281372, DOI 10.1042/BJ0281372]; PADGETT CS, 1960, ANAT REC, V137, P1, DOI 10.1002/ar.1091370102; REMPEL ARTHUR G., 1957, NORTHWEST SCI, V31, P1; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reyna KS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219368; Reyna KS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184670; Reyna KS., 2012, P NATL QUAIL S, V7, P138; RICHARDSON MK, 1990, DEVELOPMENT, V109, P81; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Spratt NT, 1942, J EXP ZOOL, V89, P69, DOI 10.1002/jez.1400890104; Stern CD, 2018, INT J DEV BIOL, V62, P43, DOI 10.1387/ijdb.170299cs; Tomecek JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3709; Wilsey C., 2019, SURVIVAL DEGREES 389	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268524	10.1371/journal.pone.0268524	http://dx.doi.org/10.1371/journal.pone.0268524			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6J0EP	35580090	Green Published, gold			2022-12-26	WOS:000886501700010
J	Straub, F; Kuppler, J; Fellendorf, M; Teuscher, M; Vogt, J; Ayasse, M				Straub, Florian; Kuppler, Jonas; Fellendorf, Martin; Teuscher, Miriam; Vogt, Juliane; Ayasse, Manfred			Land-use stress alters cuticular chemical surface profile and morphology in the bumble bee Bombus lapidarius	PLOS ONE			English	Article							SPECIES RICHNESS; SOCIAL INSECT; USE INTENSITY; BODY-SIZE; TERRESTRIS; HYMENOPTERA; BIODIVERSITY; DIVERSITY; HOMOGENIZATION; COMMUNICATION	Pollinators and other insects are currently undergoing a massive decline. Several stressors are thought to be of importance in this decline, with those having close relationships to agricultural management and practice seemingly playing key roles. In the present study, we sampled Bombus lapidarius L. workers in grasslands differing in their management intensity and management regime across three different regions along a north-south gradient in Germany. We analyzed the bees with regard to (1) their cuticular hydrocarbon profile (because of its important role in communication in social insects) and amount of scent by using gas chromatography and (2) the size of each individual by using wing distances as a proxy for body size. Our analysis revealed changes related to land-use intensity and temperature in the cuticular scent profile of bumble bees. Decreasing body size and increasing total scent amount were explained by an interaction of land-use intensity and study region, but not by land-use intensity alone. Thus, land-use intensity and temperature influence intracolonial communication and size, both of which can have strong effects on foraging. Land management and climate are therefore probably detrimental for colony maintenance and the reproductive success of bumble bees.	[Straub, Florian; Kuppler, Jonas; Fellendorf, Martin; Ayasse, Manfred] Ulm Univ, Inst Evolutionary Ecol & Conservat Genom, Ulm, Germany; [Teuscher, Miriam; Vogt, Juliane] Tech Univ Munich, Chair Terr Ecol, Freising Weihenstephan, Germany; [Vogt, Juliane] Stn Unstrut Hainich Eichsfeld, Nat 2000, Horselberg Hainich, Germany	Ulm University; Technical University of Munich	Straub, F (corresponding author), Ulm Univ, Inst Evolutionary Ecol & Conservat Genom, Ulm, Germany.	florian.straub@uni-ulm.de		Straub, Florian/0000-0002-7483-1822; Teuscher, Miriam/0000-0002-8701-4477	German Research Foundation DFG [AY 12/6-4]	German Research Foundation DFG(German Research Foundation (DFG))	The work has been funded by the German Research Foundation DFG (https://www. dfg.de/) within the DFG Priority Program 1374 "Biodiversity-Exploratories" (MA: AY 12/6-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biodiversity include intensification shown with	Allan E, 2015, ECOL LETT, V18, P834, DOI 10.1111/ele.12469; Amiet F, 2014, BIENEN MITTELEUROPAS; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Ayasse M, 2014, ANNU REV ENTOMOL, V59, P299, DOI 10.1146/annurev-ento-011613-161949; Ayasse M, 1999, CHEMOECOLOGY, V9, P119, DOI 10.1007/s000490050042; Batary P, 2015, CONSERV BIOL, V29, P1006, DOI 10.1111/cobi.12536; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Binkenstein J, 2013, OECOLOGIA, V173, P461, DOI 10.1007/s00442-013-2627-6; BLOMQUIS.GJ, 1973, J INSECT PHYSIOL, V19, P1639, DOI 10.1016/0022-1910(73)90094-2; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bunk E, 2010, CHEMOECOLOGY, V20, P189, DOI 10.1007/s00049-010-0044-4; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Dance C, 2017, ECOTOX ENVIRON SAFE, V139, P194, DOI 10.1016/j.ecoenv.2017.01.041; De la Rua P, 2001, MOL ECOL, V10, P1733, DOI 10.1046/j.1365-294X.2001.01303.x; De Palma A, 2015, J APPL ECOL, V52, P1567, DOI 10.1111/1365-2664.12524; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Diaz S., 2019, GLOBAL ASSESSMENT RE, DOI [10.5281/zenodo.3553579, 10.5281/zenodo.3831674]; Ekroos J, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108255; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; FREE J. B., 1955, INSECTES SOCIAUX, V2, P303, DOI 10.1007/BF02331508; Gefen E, 2015, COMP BIOCHEM PHYS A, V182, P58, DOI 10.1016/j.cbpa.2014.12.004; Gerard M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33429-4; Gossner MM, 2016, NATURE, V540, P266, DOI 10.1038/nature20575; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Goulson D, 2009, J INSECT CONSERV, V13, P177, DOI 10.1007/s10841-008-9140-y; Habbachi W, 2009, J CHEM ECOL, V35, P1423, DOI 10.1007/s10886-009-9722-5; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; HANSSON BS, 1990, J CHEM ECOL, V16, P1611, DOI 10.1007/BF01014094; Hartig F., 2022, DHARMA RESIDUAL DIAG; HEINRICH B, 1983, PHYSIOL ZOOL, V56, P552, DOI 10.1086/physzool.56.4.30155878; Hellwig N, 2022, AGR ECOSYST ENVIRON, V326, DOI 10.1016/j.agee.2021.107764; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Layer H., 2018, THESIS ULM U; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; LOFSTEDT C, 1986, OIKOS, V46, P250, DOI 10.2307/3565474; Menzel F, 2018, FUNCT ECOL, V32, P657, DOI 10.1111/1365-2435.13008; Michener C. D., 2000, The bees of the world; Millard J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23228-3; Morse D. H., 1979, Proceedings of the Fourth International Symposium on Pollination, Maryland, 1978., P447; Neumuller U, 2021, BIODIVERS CONSERV, V30, P3003, DOI 10.1007/s10531-021-02233-4; Neumuller U, 2020, LANDSCAPE ECOL, V35, P2209, DOI 10.1007/s10980-020-01096-4; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otte T, 2018, J CHEM ECOL, V44, P235, DOI 10.1007/s10886-018-0934-4; R Core Team, 2020, R LANG ENV STAT COMP; Rottler AM, 2013, J CHEM ECOL, V39, P67, DOI 10.1007/s10886-012-0229-0; Rottler-Hoermann AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150599; Roulston TH, 2002, EVOL ECOL, V16, P49, DOI 10.1023/A:1016048526475; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Seidelmann K, 2014, ECOL ENTOMOL, V39, P656, DOI 10.1111/een.12145; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Sramkova A, 2008, NATURWISSENSCHAFTEN, V95, P515, DOI 10.1007/s00114-008-0353-4; Sramkova A, 2009, CHEMOECOLOGY, V19, P55, DOI 10.1007/s00049-009-0009-7; STONE GN, 1989, J EXP BIOL, V147, P303; Stout JC, 2000, APIDOLOGIE, V31, P129, DOI 10.1051/apido:2000111; Straub F, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.697355; Szentgyorgyi H, 2016, APIDOLOGIE, V47, P653, DOI 10.1007/s13592-015-0415-5; Tainsh F, 2021, APIDOLOGIE, V52, P101, DOI 10.1007/s13592-020-00801-1; Tappert L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42756; Theodorou P, 2021, EVOL APPL, V14, P53, DOI 10.1111/eva.13087; Tscharntke T, 2021, TRENDS ECOL EVOL, V36, P919, DOI 10.1016/j.tree.2021.06.010; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P., 2019, Entomologische Nachrichten und Berichte, V63, P1; WESTRICH P., 2008, EUCERA, V1, P33; Widmer A, 1998, HEREDITY, V81, P563, DOI 10.1046/j.1365-2540.1998.00407.x; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	76	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5							e0268474	10.1371/journal.pone.0268474	http://dx.doi.org/10.1371/journal.pone.0268474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L3MJ	35560000	Green Published, gold			2022-12-26	WOS:000834668000007
J	Zemni, I; Kacem, M; Dhouib, W; Bennasrallah, C; Hadhri, R; Abroug, H; Ben Fredj, M; Mokni, M; Bouanene, I; Belguith, AS				Zemni, Imen; Kacem, Meriem; Dhouib, Wafa; Bennasrallah, Cyrine; Hadhri, Rim; Abroug, Hela; Ben Fredj, Manel; Mokni, Moncef; Bouanene, Ines; Belguith, Asma Sriha			Breast cancer incidence and predictions (Monastir, Tunisia: 2002-2030): A registry-based study	PLOS ONE			English	Article							GLOBAL CANCER; MORTALITY; WOMEN; STATISTICS; DIAGNOSIS; COUNTRIES; ESTROGEN; YOUNG; AGE	IntroductionBreast cancer is a major public health problem worldwide. It is the leading cause of cancer deaths in females. In developing countries like Tunisia, the frequency of this cancer is still growing. The aim of this study was to determine the crude and standardized incidence rates, trends and predictions until 2030 of breast cancer incidence rates in a Tunisian governorate. MethodsThis is a descriptive study including all female patients diagnosed with breast cancer in Monastir between 2002 and 2013. The data were collected from the cancer register of the center. Tumors were coded according to the 10(th) version of international classification of disease (ICD-10). Trends and predictions until 2030 were calculated using Poisson linear regression. ResultsA total of 1028 cases of female breast cancer were recorded. The median age of patients was 49 years (IQR: 41-59 years) with a minimum of 16 years and a maximum of 93 years. The age-standardized incidence rate (ASR) was of 39.12 per 100000 inhabitants. It increased significantly between 2002 and 2013 with APC of 8.4% (95% CI: 4.9; 11.9). Prediction until 2030 showed that ASR would reach 108.77 (95% CI: 57.13-209.10) per 100000 inhabitants. ConclusionThe incidence and the chronological trends of breast cancer highlighted that this disease is of a serious concern in Tunisia. Strengthening preventive measures is a primary step to restrain its burden.	[Zemni, Imen; Kacem, Meriem; Dhouib, Wafa; Bennasrallah, Cyrine; Abroug, Hela; Ben Fredj, Manel; Bouanene, Ines; Belguith, Asma Sriha] Univ Monastir, Fattouma Bourguiba Univ Hosp, Dept Epidemiol & Prevent Med, Monastir, Tunisia; [Zemni, Imen; Kacem, Meriem; Dhouib, Wafa; Bennasrallah, Cyrine; Abroug, Hela; Ben Fredj, Manel; Bouanene, Ines; Belguith, Asma Sriha] Univ Monastir, Fac Med Monastir, Dept Epidemiol, Monastir, Tunisia; [Zemni, Imen; Kacem, Meriem; Dhouib, Wafa; Bennasrallah, Cyrine; Abroug, Hela; Ben Fredj, Manel; Belguith, Asma Sriha] Univ Monastir, Technol & Med Imaging Res Lab, LTIM, LR12ES06, Monastir, Tunisia; [Hadhri, Rim] Univ Monastir, Fattouma Bourguiba Univ Hosp, Dept Pathol, Monastir, Tunisia; [Mokni, Moncef] Univ Sousse, Farhat Hached Univ Hosp, Fac Med Sousse, Dept Pathol, Sousse, Tunisia; [Mokni, Moncef] Canc Register Ctr, Sousse, Tunisia	Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Monastir; Universite de Monastir; Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Sousse; Hopital Farhat Hached	Zemni, I (corresponding author), Univ Monastir, Fattouma Bourguiba Univ Hosp, Dept Epidemiol & Prevent Med, Monastir, Tunisia.; Zemni, I (corresponding author), Univ Monastir, Fac Med Monastir, Dept Epidemiol, Monastir, Tunisia.; Zemni, I (corresponding author), Univ Monastir, Technol & Med Imaging Res Lab, LTIM, LR12ES06, Monastir, Tunisia.	imen11zemni@gmail.com		Zemni, Imen/0000-0002-3273-7811; BOUANENE, INES/0000-0002-8403-5053				Akarolo-Anthony SN, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2737; [Anonymous], CANC TOMORROW; [Anonymous], TUNISIA FACT SHEET C; [Anonymous], WHAT ARE RISK FACTOR; [Anonymous], BREAST CANC FACT SHE; [Anonymous], INT ASS CANC REGISTR; [Anonymous], 2015, STAT PREVENTABLE CAN; [Anonymous], CANC TODAY; [Anonymous], BREAST CERVICAL CANC; [Anonymous], CSR 1975 2017; [Anonymous], ICD 10 VERSION 2008; [Anonymous], REGISTRE CANCERS NOR; [Anonymous], WORLD WHO 2000 2025; Azamjah Nasrindokht, 2019, Asian Pac J Cancer Prev, V20, P2015, DOI 10.31557/APJCP.2019.20.7.2015; Barchuk A, 2018, CANCER EPIDEMIOL, V55, P73, DOI 10.1016/j.canep.2018.05.008; Bellanger M, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00207; Ben Abdallah M, 2009, Tunis Med, V87, P417; Breast Cancer, CSR 1975 2010; Breen N, 2011, CANCER-AM CANCER SOC, V117, P2209, DOI 10.1002/cncr.25679; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Dafni U, 2019, BREAST CARE, V14, P344, DOI 10.1159/000503219; Daubisse-Marliac L, 2011, ANN ONCOL, V22, P329, DOI 10.1093/annonc/mdq396; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Dimitrova N, 2017, EUR J CANCER, V83, P43, DOI 10.1016/j.ejca.2017.06.011; Dubey Ashutosh Kumar, 2015, Asian Pac J Cancer Prev, V16, P4237; Hadi MA, 2019, BREAST J, V25, P795, DOI 10.1111/tbj.13335; Heer E, 2020, LANCET GLOB HEALTH, V8, P1027, DOI 10.1016/S2214-109X(20)30215-1; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Lazaar-Ben Gobrane H, 2011, SANTE PUBLIQUE, V23, P31; Lima SM, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.100985; Missaoui N, 2012, BREAST J, V18, P289, DOI 10.1111/j.1524-4741.2012.01242.x; Najjar H, 2010, INT J SURG, V8, P448, DOI 10.1016/j.ijsu.2010.05.012; Rahib L, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4708; Recencement, INS; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reyna C, 2014, J MULTIDISCIP HEALTH, V7, P419, DOI 10.2147/JMDH.S49994; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sekeroglu B, 2021, HEALTH INFORM J, V27, DOI 10.1177/1460458220983878; Sharma R, 2019, BREAST CANCER-TOKYO, V26, P428, DOI 10.1007/s12282-018-00941-4; Shin HR, 2010, CANCER CAUSE CONTROL, V21, P1777, DOI 10.1007/s10552-010-9604-8; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Zaheer S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7330-z	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268035	http://dx.doi.org/10.1371/journal.pone.0268035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L8YU	35617209	Green Published, gold			2022-12-26	WOS:000835048800021
J	El Deeb, O; Jalloul, M				El Deeb, Omar; Jalloul, Maya			Efficacy versus abundancy: Comparing vaccination schemes	PLOS ONE			English	Article							COVID-19; EPIDEMIC; SARS-COV-2; VACCINES; MODEL	We introduce a novel compartmental model accounting for the effects of vaccine efficacy, deployment rates and timing of initiation of deployment. We simulate different scenarios and initial conditions, and we find that higher abundancy and rate of deployment of low efficacy vaccines lowers the cumulative number of deaths in comparison to slower deployment of high efficacy vaccines. We also forecast that, at the same daily deployment rate, the earlier introduction of vaccination schemes with lower efficacy would also lower the number of deaths with respect to a delayed introduction of high efficacy vaccines, which can however, still achieve lower numbers of infections and better herd immunity.	[El Deeb, Omar] Lebanese Amer Univ, Dept Nat Sci, Beirut, Lebanon; [El Deeb, Omar] Lebanese Univ, Fac Technol, Aabey, Lebanon; [Jalloul, Maya] Lebanese Amer Univ, Dept Econ, Beirut, Lebanon	Lebanese American University; Lebanese American University	El Deeb, O (corresponding author), Lebanese Amer Univ, Dept Nat Sci, Beirut, Lebanon.; El Deeb, O (corresponding author), Lebanese Univ, Fac Technol, Aabey, Lebanon.	omar.eldeeb@lau.edu.lb		El Deeb, Omar/0000-0001-9786-8292				ALTMANN M, 1995, J MATH BIOL, V33, P661, DOI 10.1007/BF00298647; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2020, LANCET, V396, P583, DOI [10.1016/S0140-6736(20)31818-3, 10.1038/d41586-020-02265-w]; [Anonymous], 2020, WHO DIR GEN OP REM M; [Anonymous], ECONOMIST; [Anonymous], 2021, TRACK SARS COV 2 VAR; [Anonymous], 2021, BBC; [Anonymous], 2021, ECONOMIST; [Anonymous], 2019, REP WHO CHIN JOINT M; Baba IA, 2021, RESULTS PHYS, V20, DOI 10.1016/j.rinp.2020.103716; Baraniuk C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n912; Barlow P, 2021, LANCET PLANET HEALTH, V5, pE102, DOI 10.1016/S2542-5196(20)30291-6; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Brauer F, 2019, TEXTS APPL MATH, V69, P1, DOI 10.1007/978-1-4939-9828-9; Brauer F, 2005, MATH BIOSCI, V198, P119, DOI 10.1016/j.mbs.2005.07.006; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; British Society for immunology, 2021, TYP VACC COVID 19; Brooks-Pollock E, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0276; Center for Disease Control and Prevention (CDC), 2021, INT GUID END IS PREC; Chaabane S, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8050415; Chagla Z, 2021, ANN INTERN MED, V174, pJC28, DOI 10.7326/ACPJ202103160-028; Chagla Z, 2021, ANN INTERN MED, V174, pJC15, DOI 10.7326/ACPJ202102160-015; Chaturvedi D, 2021, INFECT GENET EVOL, V92, DOI 10.1016/j.meegid.2021.104834; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008; El Deeb O, 2021, FRONT APPL MATH STAT, V6, DOI 10.3389/fams.2020.620064; El Deeb O, 2020, MATH BIOSCI ENG, V17, P5618, DOI 10.3934/mbe.2020302; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Gross B, 2020, EPL-EUROPHYS LETT, V131, DOI 10.1209/0295-5075/131/58003; Hays J.N., 2005, EPIDEMICS PANDEMICS; Heida R, 2022, EXPERT REV VACCINES, V21, P957, DOI 10.1080/14760584.2021.1903878; Huremovic D., 2019, PSYCHIAT PANDEMICS, DOI [10.1007/978-3-030-15346-5_2, DOI 10.1007/978-3-030-15346-5_2]; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n612; Jackson J.K., 2021, C RES SERV; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Khan T, 2021, PHYS SCRIPTA, V96, DOI 10.1088/1402-4896/ac0e00; Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y; Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Mazzaferro S, 2021, J NEPHROL, V34, P633, DOI 10.1007/s40620-021-00974-7; Moghadas SM, 2021, CLIN INFECT DIS, V73, P2257, DOI 10.1093/cid/ciab079; Mullard Asher, 2020, Nature, DOI 10.1038/d41586-020-03370-6; Paltiel AD, 2021, ANN INTERN MED, V174, P568, DOI 10.7326/M20-7866; Piret J, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.631736; Plotkin SA, 2011, NAT REV MICROBIOL, V9, P889, DOI 10.1038/nrmicro2668; Porter R., 2001, CAMBRIDGE ILLUSTRATE; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Spassiani I, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030463; Stern AM, 2005, HEALTH AFFAIR, V24, P611, DOI 10.1377/hlthaff.24.3.611; Tang ZM, 2021, NANO TODAY, V36, DOI 10.1016/j.nantod.2020.101019; Tarricone R, 2020, EUR HEART J SUPPL, V22, pP4, DOI 10.1093/eurheartj/suaa185; Trigger SA, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/abb2e2; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; van Tulleken C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1108; Viguerie A, 2021, APPL MATH LETT, V111, DOI 10.1016/j.aml.2020.106617; Vinceti M, 2021, ENVIRON RES, V197, DOI 10.1016/j.envres.2021.111097; Weiss H., 2013, MAT MATEMATICS, DOI DOI 10.1016/J.CHAOS.2020.110057; Worldometer, COVID 19 COR PAND; Yang CY, 2020, MATH BIOSCI ENG, V17, P2708, DOI 10.3934/mbe.2020148	62	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2022	17	5							e0267840	10.1371/journal.pone.0267840	http://dx.doi.org/10.1371/journal.pone.0267840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5I2FN	35552553	gold, Green Submitted, Green Published			2022-12-26	WOS:000868179400002
J	Chen, D; Zhuangid, QF; Zhang, WJ; Zhu, LA				Chen, Dong; Zhuangid, Qifeng; Zhang, Wenjie; Zhu, Liang			Estimation of Landsat-like daily evapotranspiration for crop water consumption monitoring using TSEB model and data fusion	PLOS ONE			English	Article							ENERGY-BALANCE MODEL; SURFACE-TEMPERATURE; RIVER-BASIN; ENVIRONMENTAL-FACTORS; 2-SOURCE MODEL; MODIS; SOIL; VALIDATION; ACCURACY; SYSTEMS	Evapotranspiration (ET) plays an essential role in agricultural water resource management. Understanding regional agricultural water consumption characteristics can be improved by predicting ET using remote sensing. However, due to the lack of high-resolution images on clear-sky days or the limitation of ET reconstruction on cloudy-sky days, it remains challenging to continuously derive ET at the field scale. In this study, the Landsat and MODIS data were initially fused to obtain the Landsat-like vegetation index and land surface temperature on clear-sky days. Then the two-source energy balance (TSEB) model was applied to calculate the daily ET during the clear-sky. A canopy resistance-based gap-filling method was involved in reconstructing regional ET on cloudy days while considering different environmental factors. The estimations were validated by automatic weather system data (AWS) and eddy covariance (EC) measurements in Guantao County. The results demonstrated that the proposed scheme performed well in estimating cropland ET, with an RMSE of 0.86 mm.d(-1) and an R-2 of 0.65, and the NSE and PBias were 0.61 and -0.29%, respectively. The crop water consumption analysis revealed that the daily ET of winter wheat peaked during the maturation stage. Nevertheless, summer maize water consumption peaked in the middle of the growing season in this area. The temperature during the early development stage and the soil moisture in the mid and late growth stages had the greatest impact on the ET of winter wheat. During the entire growing period, soil moisture had the largest effect on the ET of summer maize. The findings showed that the TSEB model can be effectively applied to field-scale water consumption monitoring in North China through MODIS and Landsat data fusion and ET temporal reconstruction considering environmental factors.	[Chen, Dong; Zhuangid, Qifeng; Zhang, Wenjie] Nanjing Tech Univ, Coll Geomat Sci & Technol, Nanjing, Peoples R China; [Zhu, Liang] Chinese Acad Sci, Aerosp Informat Res Inst, Beijing, Peoples R China	Nanjing Tech University; Chinese Academy of Sciences	Zhuangid, QF (corresponding author), Nanjing Tech Univ, Coll Geomat Sci & Technol, Nanjing, Peoples R China.	zhuangqf@njtech.edu.cn		Zhuang, Qifeng/0000-0002-4498-7922	project of the National Key Research and Development Program of China [2018YFE0107000]	project of the National Key Research and Development Program of China	This research was funded by the project of the National Key Research and Development Program of China (2018YFE0107000)"	Alfieri JG, 2017, HYDROL EARTH SYST SC, V21, P83, DOI 10.5194/hess-21-83-2017; Allen RG, 2007, J IRRIG DRAIN ENG, V133, P395, DOI 10.1061/(ASCE)0733-9437(2007)133:4(395); Boulet G, 2012, AGR FOREST METEOROL, V161, P148, DOI 10.1016/j.agrformet.2012.03.008; BRUTSAERT W, 1992, J GEOPHYS RES-ATMOS, V97, P18377, DOI 10.1029/92JD00255; Chen F, 2001, MON WEATHER REV, V129, P587, DOI 10.1175/1520-0493(2001)129<0587:CAALSH>2.0.CO;2; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Djaman K, 2018, J IRRIG DRAIN ENG; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Gao F, 2006, IEEE T GEOSCI REMOTE, V44, P2207, DOI 10.1109/TGRS.2006.872081; Ghaderi A, 2020, HYDROLOGY-BASEL, V7, DOI 10.3390/hydrology7020036; Gokmen M, 2012, REMOTE SENS ENVIRON, V121, P261, DOI 10.1016/j.rse.2012.02.003; JACKSON RD, 1983, AGR WATER MANAGE, V7, P351, DOI 10.1016/0378-3774(83)90095-1; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jia ZZ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017037; Kustas WP, 1999, AGR FOREST METEOROL, V94, P13, DOI 10.1016/S0168-1923(99)00005-2; Li Y, 2017, AGR FOREST METEOROL, V244, P82, DOI 10.1016/j.agrformet.2017.05.023; Liang SL, 2001, REMOTE SENS ENVIRON, V76, P213, DOI 10.1016/S0034-4257(00)00205-4; Liu SM, 2013, J HYDROL, V487, P24, DOI 10.1016/j.jhydrol.2013.02.025; Mallick K, 2014, REMOTE SENS ENVIRON, V141, P243, DOI 10.1016/j.rse.2013.10.022; Merlin O, 2014, AGR FOREST METEOROL, V184, P188, DOI 10.1016/j.agrformet.2013.10.002; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Morillas L, 2014, AGR FOREST METEOROL, V189, P140, DOI 10.1016/j.agrformet.2014.01.018; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; NORMAN JM, 1995, AGR FOREST METEOROL, V77, P263, DOI 10.1016/0168-1923(95)02265-Y; Norman JM, 2000, WATER RESOUR RES, V36, P2263, DOI 10.1029/2000WR900033; Paul G, 2014, J HYDROL, V509, P231, DOI 10.1016/j.jhydrol.2013.11.040; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; Shuttleworth WJ, 1989, FIFE VARIATION ENERG; Sobrino JA, 2004, INT J REMOTE SENS, V25, P215, DOI 10.1080/0143116031000115210; Su Z, 2002, HYDROL EARTH SYST SC, V6, P85, DOI 10.5194/hess-6-85-2002; SUGITA M, 1991, WATER RESOUR RES, V27, P747, DOI 10.1029/90WR02706; Sun HY, 2019, AGR WATER MANAGE, V211, P202, DOI 10.1016/j.agwat.2018.09.046; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Wu BF, 2012, J HYDROL, V436, P67, DOI 10.1016/j.jhydrol.2012.02.043; Xu EQ, 2019, ECOL INDIC, V102, P154, DOI 10.1016/j.ecolind.2019.02.045; Xu JM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040554; Xu TR, 2015, REMOTE SENS-BASEL, V7, P3400, DOI 10.3390/rs70303400; Yang Y, 2019, AGR WATER MANAGE, V222, P386, DOI 10.1016/j.agwat.2019.06.014; Yang YM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071149; Yang YT, 2015, WATER RESOUR RES, V51, P3145, DOI 10.1002/2014WR015619; Yu MZ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010006; Zhuang QF, 2016, INT J APPL EARTH OBS, V47, P50, DOI 10.1016/j.jag.2015.11.015; Zhuang QF, 2015, WATER-SUI, V7, P6673, DOI 10.3390/w7126653	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2022	17	5							e0267811	10.1371/journal.pone.0267811	http://dx.doi.org/10.1371/journal.pone.0267811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6S3XZ	35588437	gold, Green Published			2022-12-26	WOS:000892925300001
J	Batsaikhan, B; Huang, CI; Yeh, ML; Huang, CF; Lin, YH; Liang, PC; Hsieh, MY; Lin, YC; Huang, JF; Chuang, WL; Lee, JC; Yu, ML; Kuo, HT; Dai, CY				Batsaikhan, Batbold; Huang, Ching-I.; Yeh, Ming-Lun; Huang, Chung-Feng; Lin, Yi-Hung; Liang, Po-Cheng; Hsieh, Ming-Yen; Lin, Yi-Ching; Huang, Jee-Fu; Chuang, Wan-Long; Lee, Jin-Ching; Yu, Ming-Lung; Kuo, Hsing-Tao; Dai, Chia-Yen			Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; MIXED CRYOGLOBULINEMIA; EXTRAHEPATIC MANIFESTATIONS; VIROLOGICAL RESPONSE; INTERFERON THERAPY; VIRUS-INFECTION; RIBAVIRIN; VASCULITIS; PEGINTERFERON; ANTIBODIES	BackgroundHigh dosage and longer duration of antiviral treatment has been suggested to treat cryoglobulinemia patients. We aimed to investigate the efficacy of antiviral treatment in cryoglobulinemia patients and analyze the associated factors of persistent cryoglobulinemia. MethodsTotally 148 patients after completion of anti-HCV treatment were enrolled in our study. Serum cryoglobulinemia precipitation was assessed and analyzed for the associated factors after antiviral therapy. ResultsFifty-one (34.5%) out of 148 patients were positive for serum cryoglobulinemia after completion of antiviral therapy. In multivariate analysis, advanced fibrosis (Odds Ratio [OR]- 4.13, 95% Confidence Interval [95% CI]- 1.53-11.17, p = 0.005) and platelet counts (OR-0.98, 95% CI- 0.97-0.99, p = 0.010) were independently and significantly associated with persistent cryoglobulinemia. The factors associated with the persistent cryoglobulinemia in SVR patients were advanced fibrosis (OR-1.93, 95% CI- 1.02-3.65, p = 0.041) and platelet count (OR-0.98, 95% CI- 0.96-0.99, p = 0.041) by multivariate analysis. Multivariate logistic regression analysis showed persistent (OR-4.83, 95% CI- 1.75-13.36, p = 0.002) was significantly associated with advanced fibrosis in patients with cryoglobulinemia follow up after antiviral therapy. ConclusionsThe prevalence of the persistent cryoglobulinemia is 34.5% after completing antiviral therapy and it is associated with advanced fibrosis, also HCV clearance.	[Batsaikhan, Batbold] Mongolian Natl Med Sci, Inst Med Sci, Dept Internal Med, Ulaanbaatar, Mongolia; [Huang, Ching-I.] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Huang, Ching-I.; Yeh, Ming-Lun; Huang, Chung-Feng; Lin, Yi-Hung; Liang, Po-Cheng; Hsieh, Ming-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Sect, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Lin, Yi-Ching; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Lin, Yi-Hung] Kaohsiung Med Univ, Kaohsiung Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Liang, Po-Cheng; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yi-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Yi-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life, Dept Biotechnol, Kaohsiung, Taiwan; [Kuo, Hsing-Tao] Chi Med Ctr, Dept Internal Med, Div Hepatogastroenterol, Tainan, Taiwan; [Dai, Chia-Yen] Natl Pingtung Univ Sci & Technol, Coll Profess Studies, Pingtung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Pingtung University Science & Technology	Dai, CY (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Profess Studies, Pingtung, Taiwan.	daichiayen@gmail.com	Batsaikhan, Batbold/AAW-7860-2020; Chuang, Wan-Long/ABF-7427-2021	Batsaikhan, Batbold/0000-0003-3109-2166; Chuang, Wan-Long/0000-0002-2376-421X	Chi-Mei Hospital-Kaohsiung Medical University Hospital [109CM-KMU-004, KMU-DK 105006, KMUH 1100R08, KMUH 105-5R07]	Chi-Mei Hospital-Kaohsiung Medical University Hospital	This study was partly supported by a grant from the Chi-Mei Hospital-Kaohsiung Medical University Hospital (109CM-KMU-004) by Kuo TH and Dai CY, KMU-DK 105006, KMUH 1100R08 and KMUH 105-5R07 by Dai CY and Yu ML. The sponsors have no role in the design of the study and in the collection, analysis, and interpretation of date in the present study.	AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Batsaikhan B, 2018, J GASTROEN HEPATOL, V33, P1897, DOI 10.1111/jgh.14275; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2005, ARTHRITIS RHEUM-US, V52, P911, DOI 10.1002/art.20958; Cacoub P, 2019, CLIN GASTROENTEROL H, V17, P518, DOI 10.1016/j.cgh.2018.05.021; Cacoub P, 2016, THER ADV INFECT DIS, V3, P3, DOI 10.1177/2049936115585942; Casato M, 1997, BLOOD, V90, P3865, DOI 10.1182/blood.V90.10.3865; Cresta P, 1999, GUT, V45, P122, DOI 10.1136/gut.45.1.122; Dai CY, 2011, HEPATOLOGY, V53, P1399, DOI 10.1002/hep.24197; Dammacco F, 2013, NEW ENGL J MED, V369, P1035, DOI 10.1056/NEJMra1208642; Dammacco F, 2010, BLOOD, V116, P343, DOI 10.1182/blood-2009-10-245878; Fabrizi F, 2007, INT J ARTIF ORGANS, V30, P212, DOI 10.1177/039139880703000306; FERRI C, 1991, INFECTION, V19, P417, DOI 10.1007/BF01726453; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; Ferri C., 2012, EULAR TXB RHEUMATIC; Gantumur G, 2021, J CHIN MED ASSOC, V84, P757, DOI 10.1097/JCMA.0000000000000561; Gragnani L, 2016, HEPATOLOGY, V64, P1473, DOI 10.1002/hep.28753; Gragnani L, 2015, HEPATOLOGY, V61, P1145, DOI 10.1002/hep.27623; Holz LE, 2012, HEPATOLOGY, V56, P1602, DOI 10.1002/hep.25821; Kong FY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0324-2; Landau DA, 2008, ARTHRITIS RHEUM-US, V58, P604, DOI 10.1002/art.23305; Lauletta G, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1280-6; Levine JW, 2005, J RHEUMATOL, V32, P1164; LUNEL F, 1994, GASTROENTEROLOGY, V106, P1291, DOI 10.1016/0016-5085(94)90022-1; Mahale P, 2018, GUT, V67, P553, DOI 10.1136/gutjnl-2017-313983; Mazzaro C, 2011, CLIN EXP RHEUMATOL, V29, P933; Motyckova G, 2011, AM J HEMATOL, V86, P500, DOI 10.1002/ajh.22023; Obrisca B, 2019, CLIN RHEUMATOL, V38, P3677, DOI 10.1007/s10067-019-04625-y; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Saadoun D, 2006, HEPATOLOGY, V43, P1337, DOI 10.1002/hep.21190; Saadoun D, 2017, GASTROENTEROLOGY, V153, P49, DOI [10.1053/j.gastro.2017.03.006, 10.1053/j.gastro]; Saadoun D, 2016, ANN RHEUM DIS, V75, P1777, DOI 10.1136/annrheumdis-2015-208339; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Stasi C, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-21; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Terrier B, 2013, AM J CARDIOL, V111, P265, DOI 10.1016/j.amjcard.2012.09.028; Vermeersch P, 2008, CLIN CHEM, V54, P39, DOI 10.1373/clinchem.2007.090134; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Vigani AG, 2011, J VIRAL HEPATITIS, V18, pe91, DOI 10.1111/j.1365-2893.2010.01385.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu Ming-Lung, 2015, Clin Liver Dis (Hoboken), V5, P17, DOI 10.1002/cld.442	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	5								10.1371/journal.pone.0268180	http://dx.doi.org/10.1371/journal.pone.0268180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M2YM	35560166	Green Published, gold			2022-12-26	WOS:000835326900012
